Citrus Sinensis ID: 001103
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1157 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.261 | 0.324 | 0.363 | 3e-48 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.231 | 0.326 | 0.386 | 3e-47 | |
| Q55A09 | 1331 | Probable serine/threonine | yes | no | 0.219 | 0.190 | 0.362 | 7e-45 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.228 | 0.109 | 0.379 | 6e-44 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.221 | 0.279 | 0.375 | 6e-44 | |
| Q6XHB2 | 1726 | Probable serine/threonine | no | no | 0.225 | 0.151 | 0.382 | 1e-43 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.227 | 0.161 | 0.374 | 2e-42 | |
| A7J1T2 | 961 | Mitogen-activated protein | N/A | no | 0.211 | 0.254 | 0.375 | 5e-42 | |
| A7J1T0 | 961 | Mitogen-activated protein | N/A | no | 0.211 | 0.254 | 0.368 | 9e-42 | |
| Q1HKZ5 | 959 | Mitogen-activated protein | yes | no | 0.212 | 0.256 | 0.366 | 3e-41 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 194 bits (493), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 121/333 (36%), Positives = 174/333 (52%), Gaps = 30/333 (9%)
Query: 814 FVQDDVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIK 873
+ DD+S C P + + ES D R D + +D DA + E E I
Sbjct: 619 YTSDDISTGC-DPRLKDHESTSSSLDSTSYRNDPQVLD----DADVGECE--------IP 665
Query: 874 DSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
+DL + +G G++G VY W GT++A+K+ F G + + EF E I+
Sbjct: 666 WNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA------LAEFRSEVRIMR 719
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
L HPNVV F G V P ++ VTE++ GSL +L R +D R+++ + +D A G
Sbjct: 720 RLRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMG 777
Query: 994 MEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG-GVRGTLPW 1050
M LH IVH DLK NLLV+ KVGDFGLSR+K NT +S GT W
Sbjct: 778 MNCLHTSTPTIVHRDLKTPNLLVD----NNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEW 833
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110
MAPE+L N +EK DVYSFG+ +WE+ T P+ M+ ++G + R +IP+
Sbjct: 834 MAPEVLR--NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKE 891
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
DP +++ ECW +P RPSF ++T L+ +
Sbjct: 892 LDPVVGRIILECWQTDPNLRPSFAQLTEVLKPL 924
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (485), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 113/292 (38%), Positives = 167/292 (57%), Gaps = 24/292 (8%)
Query: 860 AEMEAGIYGLQI-IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQ 918
A E G+ G + I DL +++G+G+FGTV+R +W G+D+A+K + + F
Sbjct: 533 ANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER--- 589
Query: 919 EWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL----ARK 974
+ EF RE I+ L HPN+V F G V P ++ VTEY+ GSL +L AR+
Sbjct: 590 ---VNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGARE 644
Query: 975 DRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
LD R++L + D A GM YLH +N IVH DLK NLLV+ ++ KV DFGLS
Sbjct: 645 Q--LDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVD----KKYTVKVCDFGLS 698
Query: 1033 RIKCNTLVSG-GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
R+K +T +S GT WMAPE+L + +EK DVYSFG+ +WE+ T ++P+ N++
Sbjct: 699 RLKASTFLSSKSAAGTPEWMAPEVLR--DEPSNEKSDVYSFGVILWELATLQQPWGNLNP 756
Query: 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
++ + R +IP +P+ ++E CW+ P RPSF I + LR +
Sbjct: 757 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (465), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 102/281 (36%), Positives = 160/281 (56%), Gaps = 27/281 (9%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
+ +I SD++ +E+G G F V +G W+G D+A+K++ + + +E +I+EF E
Sbjct: 1065 VTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSN----KDKAREEMIQEFKAE 1120
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR------ILDRRK 982
++ +L HPN+V YG N M V E++ +G+L ++ K LD
Sbjct: 1121 VELLGSLQHPNLVTCYGYSLN----PMCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTL 1176
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG 1042
L + D A GM++LH +NI+H DLK NLL++ + K+ D G++R T
Sbjct: 1177 ILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMD----KHFNIKIADLGIARETSFTQTMT 1232
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN---MHCGAIIGGIL 1099
+ GT+ W APE+L + ++K DVYS+ I ++E++TGEEPY M+ G ++
Sbjct: 1233 TI-GTVAWTAPEILR--HESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVA--- 1286
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
S LRP++P+ CDP W+KL+ CWS +P RPSF EITN L
Sbjct: 1287 SKGLRPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 180 bits (457), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 109/287 (37%), Positives = 158/287 (55%), Gaps = 23/287 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
I ++LE Q +G G FG V RG WR TD+AIK I + F +SS + F E I
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK--KLMLMMD 989
+S L HPNVV F G G VTE+M GSLR L +L++ +L L +D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 990 AAFGMEYLH--MKNIVHFDLKCDNLLVNLR-DPQRPI--------CKVGDFGLSRIKCN- 1037
A GM YLH I+H DL N+L++ DP+ P+ CK+ DFGLSR+K
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 1038 -TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096
+ ++ V G +P+MAPE+ G +N SEK DVYS+G+ ++E++T +EP +M +
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN--SEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+ RP IP +W++++ +CW NP +RP+F +I L+ M
Sbjct: 2342 LAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVHLKEM 2388
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 101/269 (37%), Positives = 150/269 (55%), Gaps = 13/269 (4%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
I S+L+ +LG GTFG VY+G WRG+ +AIK+IK + +++EF +E I
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+S L HPN+V P + +TEY+ GSL L K ++ + L + A
Sbjct: 712 LSRLRHPNIVLLMAACTAPP--NLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWM 1051
GM YLH+ ++H D+K NLL++ + K+ DFGLS++K + G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLD----EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
+PELL G + +EKVDVY+FGI +WE+ TGE PY+ + + + + +LRP IP
Sbjct: 826 SPELLMGED--YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAW 883
Query: 1112 DPEWRKLMEECWSFNPAARPSFTEITNRL 1140
+ L++ CW +P RPSFTEI N L
Sbjct: 884 PYQLSHLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum GN=roco4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 106/277 (38%), Positives = 153/277 (55%), Gaps = 16/277 (5%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLI---KEFWRE 928
+ D+++E +++G G FG V++G+ D ++ IK S LG S + +I +EF RE
Sbjct: 1021 LADNEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIK-SLILGDSEGETEMIEKFQEFQRE 1078
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
I+SNL+HPN+V YG++ N P M E++ G L H L K + KL LM+
Sbjct: 1079 VFIMSNLNHPNIVKLYGLMHNPPRMVM----EFVPCGDLYHRLLDKAHPIKWSVKLRLML 1134
Query: 989 DAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPIC-KVGDFGLSRIKCNTLVSGGVR 1045
D A G+EY+ +N IVH DL+ N+ + D P+C KV DFGLS+ +++ G+
Sbjct: 1135 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLL 1192
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI--IGGILSNTL 1103
G WMAPE + +EK D YSF + ++ I+TGE P+ G I I I L
Sbjct: 1193 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 1252
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
RP IPE C P R ++E CWS +P RP F+ I L
Sbjct: 1253 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 1289
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 175 bits (443), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 106/283 (37%), Positives = 157/283 (55%), Gaps = 20/283 (7%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
II ++ +++G G++G V+ GKW+G D+A+K+ K + SE + L EF E
Sbjct: 1358 IINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQ----KLSETQLL--EFRAEMA 1411
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
+S L H N+V F G P + VTEYM G+LR VL D + KL L+ A
Sbjct: 1412 FLSELKHSNIVTFIGACIKKPN--ICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGA 1469
Query: 991 AFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-CNTLVSGGVRGT 1047
A G++YLH N IVH D+K N+LV+ + K+ DFG +RIK NT ++ GT
Sbjct: 1470 AMGIDYLHSSNPMIVHRDIKPANILVD----EHFNVKIADFGFARIKEDNTTMTRC--GT 1523
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
W APE++ G + EK DV+SFG+ MWE++TG+EP+A + + IL RP I
Sbjct: 1524 PCWTAPEVIRGE--KYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDILEGG-RPII 1580
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150
P C E+ KL+++CW RP+ TE+ +L +++ K
Sbjct: 1581 PSDCPHEFAKLIKKCWHAKAHKRPTMTEVVQQLMLITEQFDHK 1623
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A7J1T2|M313A_XENLA Mitogen-activated protein kinase kinase kinase 13-A OS=Xenopus laevis GN=map3k13-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 5e-42, Method: Compositional matrix adjust.
Identities = 101/269 (37%), Positives = 146/269 (54%), Gaps = 24/269 (8%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++ ELQ LGSG G V+ GK+RG ++AIK++++ ++E IK + L
Sbjct: 168 EISELQWLGSGAQGAVFLGKFRGEEVAIKKVRE--------QKETDIKH-------LRKL 212
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPN++AF GV P + EY +G L VL R R + R + A GM
Sbjct: 213 KHPNIIAFKGVCTQAP--CYCLIMEYCAHGQLYEVL-RAGRKVSPRLLVDWSNGIASGMN 269
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
YLH+ I+H DLK N+LV D K+ DFG S+ + GT+ WMAPE+
Sbjct: 270 YLHLHKIIHRDLKSPNVLVTHTD----TVKISDFGTSKELSDKSTKMSFAGTVAWMAPEV 325
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
+ N VSEKVD++SFG+ +WE++TGE PY ++ AII G+ SN+L +P C +
Sbjct: 326 IR--NEPVSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF 383
Query: 1116 RKLMEECWSFNPAARPSFTEITNRLRVMS 1144
+ LM++ W P RPSF +I L + S
Sbjct: 384 KILMKQTWHSKPRNRPSFRQILMHLDIAS 412
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis GN=map3k13-b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (438), Expect = 9e-42, Method: Compositional matrix adjust.
Identities = 99/269 (36%), Positives = 145/269 (53%), Gaps = 24/269 (8%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++ ELQ LGSG G V+ GK+RG ++AIK++++ ++E IK + L
Sbjct: 170 EISELQWLGSGAQGAVFLGKFRGEEVAIKKVRE--------QKETDIKH-------LRKL 214
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPN++AF GV P + EY G L VL R R + + + A GM
Sbjct: 215 KHPNIIAFKGVCTQAP--CYCILMEYCAQGQLYEVL-RAGRKVTPKLLVEWSTGIASGMN 271
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
YLH+ I+H DLK N+LV D K+ DFG S+ + GT+ WMAPE+
Sbjct: 272 YLHLHKIIHRDLKSPNVLVTHAD----TVKISDFGTSKELSDKSTKMSFAGTVAWMAPEV 327
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
+ N VSEKVD++SFG+ +WE++TGE PY ++ AII G+ SN+L +P C +
Sbjct: 328 IR--NEPVSEKVDIWSFGVLLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF 385
Query: 1116 RKLMEECWSFNPAARPSFTEITNRLRVMS 1144
+ LM++ W P RPSF +I L + +
Sbjct: 386 KILMKQTWQSKPRNRPSFRQILMHLDIAA 414
|
May have a role in the JNK signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q1HKZ5|M3K13_MOUSE Mitogen-activated protein kinase kinase kinase 13 OS=Mus musculus GN=Map3k13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 99/270 (36%), Positives = 143/270 (52%), Gaps = 24/270 (8%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++ ELQ LGSG G V+ GK+R ++AIK++++ + E IK + L
Sbjct: 166 EISELQWLGSGAQGAVFLGKFRAEEVAIKKVRE--------QNETDIKH-------LRKL 210
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPN++AF GV P + EY +G L VL R R + R + A GM
Sbjct: 211 KHPNIIAFKGVCTQAP--CYCIIMEYCAHGQLYEVL-RAGRKITPRLLVDWSTGIASGMN 267
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
YLH+ I+H DLK N+LV D K+ DFG S+ + GT+ WMAPE+
Sbjct: 268 YLHLHKIIHRDLKSPNVLVTHTD----AVKISDFGTSKELSDKSTKMSFAGTVAWMAPEV 323
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
+ N VSEKVD++SFG+ +WE++TGE PY ++ AII G+ SN+L +P C +
Sbjct: 324 IR--NEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF 381
Query: 1116 RKLMEECWSFNPAARPSFTEITNRLRVMST 1145
+ LM++ W P RPSF + L + S
Sbjct: 382 KILMKQTWQSKPRNRPSFRQTLMHLDIASA 411
|
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1157 | ||||||
| 359477846 | 1188 | PREDICTED: uncharacterized protein LOC10 | 0.987 | 0.961 | 0.540 | 0.0 | |
| 147841871 | 1230 | hypothetical protein VITISV_040388 [Viti | 0.991 | 0.932 | 0.522 | 0.0 | |
| 255554200 | 1132 | serine/threonine protein kinase, putativ | 0.945 | 0.966 | 0.507 | 0.0 | |
| 356533838 | 1178 | PREDICTED: uncharacterized protein LOC10 | 0.949 | 0.932 | 0.464 | 0.0 | |
| 356574716 | 1169 | PREDICTED: uncharacterized protein LOC10 | 0.949 | 0.940 | 0.455 | 0.0 | |
| 357442709 | 1180 | Mitogen-activated protein kinase kinase | 0.945 | 0.927 | 0.446 | 0.0 | |
| 297843280 | 1043 | kinase family protein [Arabidopsis lyrat | 0.861 | 0.955 | 0.452 | 0.0 | |
| 15219796 | 1042 | PB1 domain-containing protein tyrosine k | 0.860 | 0.955 | 0.444 | 0.0 | |
| 2494111 | 1029 | Contains similarity to Glycine protein k | 0.748 | 0.841 | 0.463 | 0.0 | |
| 297741916 | 952 | unnamed protein product [Vitis vinifera] | 0.323 | 0.392 | 0.786 | 1e-177 |
| >gi|359477846|ref|XP_003632032.1| PREDICTED: uncharacterized protein LOC100264925 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1134 bits (2932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 650/1203 (54%), Positives = 802/1203 (66%), Gaps = 61/1203 (5%)
Query: 1 MTREDPSTSGQPLCRDRGNVVSSNRVDAERSVNNVCLQTGEEFSSEFLRDRVAVRRITVM 60
MT E SGQ C + N VSS ++ A+R+ +++C QTGEEFS+EFLRDRVA RR + M
Sbjct: 1 MTGETSGFSGQHFCNNPDNAVSSGQLAADRNAHDICAQTGEEFSAEFLRDRVAPRRASAM 60
Query: 61 NDGKYLQTIQAGVNINQNHQVVCGDLNGIVGLRRMDNEGNANASDFAETFGYAVEAKKNN 120
D Q N+NHQ+V LNGI+GLRR D+E +++ DF GYA E +
Sbjct: 61 IDTDQRQPKGWCKGFNENHQMVYEPLNGILGLRRGDSECSSDILDFVPGKGYAAEVENRV 120
Query: 121 YPDNLSRCQLQYGAVGQNSGIFFYENHCDQVATELSGSPVYVVESPQSYHPCGPGYAESP 180
Y D SR +Y A SG F + +CDQ + + ESPQ +H G G +++
Sbjct: 121 YLDKASRIHREYSAPRLGSGQLFEDFNCDQAVPGHATPSFNIPESPQPHHCQGSGVSDAS 180
Query: 181 FTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQPHTIK 240
F+ KMKFLCSFGGRI PRP+DGKLRYVGGET+IISIRK+L+W EL++KTSAICNQ HTIK
Sbjct: 181 FSDKMKFLCSFGGRILPRPNDGKLRYVGGETKIISIRKNLSWVELVKKTSAICNQLHTIK 240
Query: 241 YQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLGEPDSPNSLEGKTT 300
YQLPGEDLDALISV SDEDLHHMIEEY E ERI GSQRLRIFLV +GEP+SP+S E + T
Sbjct: 241 YQLPGEDLDALISVSSDEDLHHMIEEYHELERIEGSQRLRIFLVPVGEPESPSSFETRAT 300
Query: 301 QQTDADNQYVSAVNGMLDASPRKSSSGQTLTSHT--TQMGRDSPTFAYISEIKDHSLNSS 358
QQ +AD QYV AVNGMLD SPRK+SSGQ+++S T T RD P F + E+KD + +SS
Sbjct: 301 QQNEADYQYVVAVNGMLDPSPRKNSSGQSVSSQTGNTCDYRDPPFFHPL-EMKDGA-SSS 358
Query: 359 NVGGMFSNNANR-LPPICVAGKSLNPSVPVTTFSSQSIDPFNSNAHFYVDWPC-DGNGND 416
N+ GMF+N A + L + + KS S PV+ Q+ DP NS HF+ D DG+ +
Sbjct: 359 NLVGMFTNPAAQFLTSLQIPTKSFQQSPPVSPLPVQNRDPQNSAMHFFEDHAYHDGHESA 418
Query: 417 NPCVMDKFLCDHSYDVNSLSHY-DNLHDHHPLMNYHKHNQNLVETDQTNNC-HLHLHNCG 474
+ V D++ CD++Y V+S S+Y +N + PLMNYH HN++ +ETDQ N LH+ N
Sbjct: 419 SQFVTDQWPCDNAYCVDSPSYYHNNPYGPVPLMNYHHHNKHFLETDQINKLPSLHVQNRP 478
Query: 475 LSRDIVH--------------CTPERVLSDSRLRVHDNSSTHRLEEGIISQSPRNIGRAK 520
SRD V ER LSDS+LR H+ + LEEGII SP K
Sbjct: 479 -SRDFVFSPVLGQSEVDFERPVLKERALSDSQLRGHEGRPDYHLEEGIIPLSPWTFEVQK 537
Query: 521 SPSV-VSSSSRGFSMHWQDVIDEKHQGTTCKNQPSFKMLES------CNDNFKTVQEIKA 573
SPS+ +S+S + +S Q++ +EK+Q +NQP+ + + D + EI
Sbjct: 538 SPSLALSNSPQEWSFQPQEISNEKYQ-EAYQNQPTLIVDDHKGNNGLGQDTWNWEDEIDT 596
Query: 574 MNGNLASSDPHWKHHIGNKEVTPNNKAIENKINYQPSSNLPIRDSP------NSGSSNFS 627
G D T N ++N + Y P+S I SP + N +
Sbjct: 597 QVGQERKHDKVITDLTSQDNSTLPNTKLQN-VCYNPNSVPSIHISPLEFQDHGDTTMNSA 655
Query: 628 LQIATAESSAGFIIEHLYGYQLDTTTMPEFQVKNSNATKDEKCALTEI--SQPVSPGSSV 685
+ E+SA + E + Y L +T P+F VK+ NATKD + A+TE+ S+ V SS
Sbjct: 656 STLMIPENSADIVREQPHDYSLGAST-PKFLVKSQNATKDMQHAMTEVISSESVPNESSR 714
Query: 686 KLSSKDEKSTMTEISQP----VTPGSSGKLSVSSQAVANQEWISPSS---KLTSAASSRE 738
LS + + E + P +TP + K S N + SS A S
Sbjct: 715 PLSVAIQGTGDQEAAVPSSASLTPSAGNKSDPSLNLQKNYPLSTESSFENPDKKAVMSGV 774
Query: 739 ATINDEDPRIYYNY---GAEKIVISRSNEGQNPRIAVHAQVVLSENDDEHNVLKSAVIVE 795
+T+ DEDP + + G E R N G A+ Q S+N N +AVIVE
Sbjct: 775 STLKDEDPLNFPCHEVDGPEGHFYERLNPGD----AIFVQSQPSDNHHNGNTPGAAVIVE 830
Query: 796 DVTDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTETESAHPDSDHEDVRGD-GREVDESI 854
DVTD +PPGI SSS ++P V+D+ SD ++T + A +SD ++ G+ GR++ ESI
Sbjct: 831 DVTDILPPGIPSSSPLIPQVEDEASD-----VITSSGEAEAESDIQESEGEEGRDLGESI 885
Query: 855 SDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGR 914
SDAAMAEMEA IYGLQIIK++DLEEL+ELGSGTFGTVY GKWRGTD+AIKRIKKSCF GR
Sbjct: 886 SDAAMAEMEASIYGLQIIKNADLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFAGR 945
Query: 915 SSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK 974
SSEQE L K+FWREA I+SNLHHPNVVAFYGVVP+GPGGT+ATVTEYMVNGSLRHVL RK
Sbjct: 946 SSEQERLTKDFWREARILSNLHHPNVVAFYGVVPDGPGGTLATVTEYMVNGSLRHVLLRK 1005
Query: 975 DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034
DR LDRRK+L++ MDAAFGMEYLH+KNIVHFDLKCDNLLVN+RD QRPICKVGDFGLSRI
Sbjct: 1006 DRSLDRRKRLIIAMDAAFGMEYLHLKNIVHFDLKCDNLLVNMRDTQRPICKVGDFGLSRI 1065
Query: 1035 KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI 1094
K NTLVSGGVRGTLPWMAPELLNGS+NRVSEKVDV+SFG+AMWEI+TGEEPYANMHCGAI
Sbjct: 1066 KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGVAMWEILTGEEPYANMHCGAI 1125
Query: 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNH 1154
IGGI+SNTLRP IPERCDP+WRKLMEECWS +PAARPSFTEITNRLRVMS A+QTKR N
Sbjct: 1126 IGGIVSNTLRPPIPERCDPDWRKLMEECWSPDPAARPSFTEITNRLRVMSMAIQTKRHNQ 1185
Query: 1155 AIR 1157
A R
Sbjct: 1186 ANR 1188
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147841871|emb|CAN78098.1| hypothetical protein VITISV_040388 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1118 bits (2891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 648/1240 (52%), Positives = 806/1240 (65%), Gaps = 93/1240 (7%)
Query: 1 MTREDPSTSGQPLCRDRGNVVSSNRVDAERSVNNVCLQTGEEFSSEFLRDRVAVRRITVM 60
MT E SGQ C + N VSS+R+ A+R+ +++C QTGEEFS+EFLRDRVA RR + M
Sbjct: 1 MTGEASGFSGQHFCNNPDNAVSSSRLAADRNAHDICAQTGEEFSAEFLRDRVAPRRASAM 60
Query: 61 NDGKYLQTIQAGVNINQNHQVVCGDLNGIVGLRRMDNEGNANASDFAETFGYAVEAKKNN 120
D Q N+NHQ+V LNGI+GLRR D+E +++ DF GYA E +
Sbjct: 61 IDTDQRQPKGWCKGFNENHQMVYEPLNGILGLRRGDSECSSDILDFVPGKGYAAEVENRV 120
Query: 121 YPDNLSRCQLQYGAVGQNSGIFFYENHCDQVATELSGSPVYVVESPQSYHPCGPGYAESP 180
Y D SR +Y A SG F + +CDQ + ++ ESPQ +H G G +++
Sbjct: 121 YLDKASRIHREYSAPRLGSGQLFEDFNCDQAVPGHATPSFHIPESPQPHHCQGSGVSDAS 180
Query: 181 FTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQPHTIK 240
F+ KMKFLCSFGGRI PRP+DGKLRYVGGET+IISIRK+L+W EL++KTSAICNQ HTIK
Sbjct: 181 FSDKMKFLCSFGGRILPRPNDGKLRYVGGETKIISIRKNLSWVELVKKTSAICNQLHTIK 240
Query: 241 YQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLGEPDSPNSLEGKTT 300
YQLPGEDLDALISV SDEDLHHMIEEY E ERI GSQRLRIFLV +GEP+SP+S E + T
Sbjct: 241 YQLPGEDLDALISVSSDEDLHHMIEEYHELERIEGSQRLRIFLVPVGEPESPSSFETRAT 300
Query: 301 QQTDADNQYVSAVNGMLDASPRKSSSGQTLTSHT--TQMGRDSPTFAYISEIKDHSLNSS 358
QQ +AD QYV AVNGMLD SPRK+SSGQ+++S T T RD PTF + E+KD + +SS
Sbjct: 301 QQNEADYQYVVAVNGMLDPSPRKNSSGQSVSSQTGNTCDYRDPPTFFHPLEMKDGA-SSS 359
Query: 359 NVGGMFSNNANR-LPPICVAGKSLNPSVPVTTFSSQSIDPFNSNAHFYVDWPC-DGNGND 416
N+ GMF+N A + L + KS S PV+ Q+ DP NS HF+ D DG+ +
Sbjct: 360 NLVGMFTNPAAQFLTSLQTPTKSFQQSPPVSPLPVQNRDPQNSAMHFFEDHAYHDGHESA 419
Query: 417 NPCVMDKFLCDHSYDVNSLSHY-DNLHDHHPLMNYHKHNQNLVETDQTNNC-HLHLHNCG 474
+ V D++ CD++Y V+S S+Y +N + PLMNYH HN++ +ETDQ N LH+ N
Sbjct: 420 SQFVTDQWPCDNAYCVDSPSYYHNNPYGPVPLMNYHHHNKHFLETDQINKLPSLHVQNRP 479
Query: 475 LSRDIV----------------------HCTPE---------------------RVLSDS 491
SRD V H P+ VLSDS
Sbjct: 480 -SRDFVFSPVHGQSEVDFERPVLKERAFHSHPKDPLGLLSGSTNDLVGSHHRMLHVLSDS 538
Query: 492 RLRVHDNSSTHRLEEGIISQSPRNIGRAKSPSV-VSSSSRGFSMHWQDVIDEKHQGTTCK 550
+LR H+ + LEEGI SP KSPS+ +S+S + +S Q++ +EK+Q +
Sbjct: 539 QLRGHEGRPDYHLEEGITPLSPWTFEVQKSPSLALSNSPQEWSFQPQEISNEKYQ-EAYQ 597
Query: 551 NQPSFKMLES------CNDNFKTVQEIKAMNGNLASSDPHWKHHIGNKEVTPNNKAIEN- 603
NQP+ + + D + EI G D T N ++N
Sbjct: 598 NQPTLIVDDHRGNNGLGQDTWNWEDEIDTQVGQERKHDKVITDLTSQDNSTLPNTKLQNV 657
Query: 604 --KINYQPSSNLPIRDSPNSG--SSNFSLQIATAESSAGFIIEHLYGYQLDTTTMPEFQV 659
N PS ++ + + + G + N + + E+SA + E + Y L +T P+F V
Sbjct: 658 CYNPNSVPSIHISLLEFQDHGDXTMNSASTLMIPENSADIVREQPHDYSLGAST-PKFLV 716
Query: 660 KNSNATKDEKCALTEI--SQPVSPGSSVKLSSKDEKSTMTEISQP----VTPGSSGKLSV 713
K+ NATKD + A+TE+ S+ V SS LS + + E + P +TP + K
Sbjct: 717 KSQNATKDMQHAMTEVISSESVPNESSRPLSVAIQGTGDQEAAAPSSASLTPSAGNKSGP 776
Query: 714 SSQAVANQEWISPSS---KLTSAASSREATINDEDPRIYYNYGAEKIVISRSNEGQNPRI 770
S N + SS +A S +T+ DEDP + + Y + E NP
Sbjct: 777 SLNLQTNYPLSTESSFENPDKNAVMSGVSTLKDEDP-LNFPYHEVEGPEGHFYERLNPGD 835
Query: 771 AVHAQVVLSENDDEHNVLKSAVIVEDVTDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTE 830
A+ Q S+N N AVIVEDVTD +PPGI SSS ++P V+D+ SD ++T
Sbjct: 836 AIFVQSQPSDNHHNGNTPGGAVIVEDVTDILPPGIPSSSPLIPQVEDEASD-----VITS 890
Query: 831 TESAHPDSDHEDVRGD-GREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFG 889
+ A +SD ++ G+ GR++ ESISDAAMAEMEA IYGLQ+IK++DLEEL+ELGSGTFG
Sbjct: 891 SGEAEAESDIQESEGEEGRDLGESISDAAMAEMEASIYGLQMIKNADLEELKELGSGTFG 950
Query: 890 TVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949
TVY GKWRGTD+AIKRIKKSCF GRSSEQE L K+FWREA I+SNLHHPNVVAFYGVVP+
Sbjct: 951 TVYHGKWRGTDVAIKRIKKSCFAGRSSEQERLTKDFWREARILSNLHHPNVVAFYGVVPD 1010
Query: 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKC 1009
GPGGT+ATVTEYMVNGSLRHVL RKDR LDRRK+L++ MDAAFGMEYLH+KNIVHFDLKC
Sbjct: 1011 GPGGTLATVTEYMVNGSLRHVLLRKDRSLDRRKRLIIAMDAAFGMEYLHLKNIVHFDLKC 1070
Query: 1010 DNLLVNLRDPQRPICK------------VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLN 1057
DNLLVN+RD QRPICK VGDFGLSRIK NTLVSGGVRGTLPWMAPELLN
Sbjct: 1071 DNLLVNMRDTQRPICKLEMHFIKRLPFQVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLN 1130
Query: 1058 GSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRK 1117
GS+NRVSEKVDV+SFG+AMWEI+TGEEPYANMHCGAIIGGI+SNTLRP IPERCDP+WRK
Sbjct: 1131 GSSNRVSEKVDVFSFGVAMWEILTGEEPYANMHCGAIIGGIVSNTLRPPIPERCDPDWRK 1190
Query: 1118 LMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNHAIR 1157
LMEECWS +PAARPSFTEITNRLRVMS A+QTKR N A R
Sbjct: 1191 LMEECWSPDPAARPSFTEITNRLRVMSMAIQTKRHNQANR 1230
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554200|ref|XP_002518140.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223542736|gb|EEF44273.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1056 bits (2730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/1195 (50%), Positives = 753/1195 (63%), Gaps = 101/1195 (8%)
Query: 1 MTREDPSTSGQPLCRDRGNVVSSNRVDAERSVNNVCLQTGEEFSSEFLRDRVAVRRITVM 60
MTRE P +SGQ D+ V+ R +R+VNN+C+QTGEEF++EFLR R+AVRR+
Sbjct: 1 MTRETPGSSGQLFYGDKFQVLYCGRAAEDRNVNNICVQTGEEFATEFLRHRIAVRRVLDE 60
Query: 61 NDGKYLQTIQAGVNINQNHQVVCGDLNGIVGLRRMDNEGNANASDFAETFGYAVEAKKNN 120
N Q Q G N NQN Q+V + G+RR D+E ++ SDF GYA + +
Sbjct: 61 N-----QLAQIGSNYNQNQQMVYDSPSSFHGIRRKDSE--SDDSDFTPKTGYAADMETRT 113
Query: 121 YPDNLSRCQLQYGAVGQNSGIFFYENHCDQVATELSGSPVYVVESPQSYHPCGPGYAESP 180
YPD L+R Q +Y GQN G + + + D+V + YVVESP SYHP G ES
Sbjct: 114 YPDKLNRYQWEYYPCGQNPGKYTGDVNSDRVNIDSITPQKYVVESPLSYHPYGSEVPESA 173
Query: 181 FTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQPHTIK 240
F KMKFLCSFGGRI PRP+DGKLRYVGGETRIISIRK++ WEEL +KT AI NQPHTIK
Sbjct: 174 FFGKMKFLCSFGGRILPRPNDGKLRYVGGETRIISIRKNVAWEELAKKTLAIYNQPHTIK 233
Query: 241 YQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLGEPDSPNSLEGKTT 300
YQLPGEDLDALISVCS+EDLHHM+EEYQE E GGSQRLRIFL+S EPDSPNS +G+T
Sbjct: 234 YQLPGEDLDALISVCSNEDLHHMMEEYQEIEANGGSQRLRIFLISSVEPDSPNSFDGRTP 293
Query: 301 QQTDADNQYVSAVNGMLDASPRKSSSGQTLTSHTTQMG----------RDSPTFAYISEI 350
Q +DAD QYV AVN M D SP+KSSSGQ+L S Q G RDSPT Y +
Sbjct: 294 QHSDADYQYVFAVNAMPDVSPQKSSSGQSLASQPNQFGIASDHGPTFHRDSPTSVYALDN 353
Query: 351 KDHSLNSSNVGGMFSNNANRLP-PICVAGKSLNPSVPVTTFSSQSIDPFNSNAHFYVDWP 409
KD S S V G F N + P+ + G S N P+T + Q + N N F +
Sbjct: 354 KDCSPTSPIVVGAFLNPTVQCSSPLQLQGTSFNQPPPLTPLTIQHGNLKNINIQFNGEQS 413
Query: 410 C-DGNGNDNPCVMDKFLCDHSYDVNSLSHYDNLHDHHPLMNYHKHNQNLVETDQ-TNNCH 467
C + N + N DK ++ S + LMN+H+H+ L+E D + +
Sbjct: 414 CPEANESINIFPKDKI----PFEDTSAYYTRVAQGPQILMNHHRHHPYLLEVDHNSKSSD 469
Query: 468 LHLHNCGLSRDIVHCT--------------PERVLSDSRLRVHDNSSTHRLEEGIISQSP 513
++ HN S D + ER LSDS+L+ H+ S L+E +
Sbjct: 470 MYFHNRSPSGDFLQYQLNVPSDLDLERPKLKERALSDSQLQEHNEGSKGYLQEAVNPLRL 529
Query: 514 RNIGRAKSPSVVSSSSRGFSMHWQDVIDEKHQGTTCKNQPSFKMLESCNDNFKTVQE-IK 572
+ GR KSPS+ S+ M WQ +++E+HQ +N+ SF + +N QE +K
Sbjct: 530 WHDGREKSPSLALSNLSQEPMMWQGLMNEEHQEAKYENECSFTL-----ENVDLKQESLK 584
Query: 573 AMNGNLASSDPHWKHHIGNKEVTPNNKAIENKINYQPSSNL---PIRDSPNSGSSNFSLQ 629
++ +A H G+KE N + N + Y+ N+ P+ P + SL
Sbjct: 585 RVHCGIA------LHDEGSKECE-RNMSNGNPMEYKNLENVEVNPLLCFPRKNAMKNSLD 637
Query: 630 IATAESSAGFIIEHLYGYQLD-----TTTMPEFQVKNSNATKDEKCALTEISQPVSPGSS 684
Y+LD TT+P+ KN N +KD++ A TE
Sbjct: 638 DPRE-------------YRLDCQSGTVTTLPDLFFKNQNVSKDQQSAATE---------- 674
Query: 685 VKLSSKDEKSTMTEISQPVTPGSSGKLSVSSQAVANQEWISPSSKLTSAASSREATINDE 744
+ S + +T P+ ++ + + S + +AAS R + E
Sbjct: 675 -RKSGQQISDVLTRCHHPL----------PHESCDQKPNVQNSKSVATAASGRVVSPYYE 723
Query: 745 DPRIYYNYGAEKIVISRSNEGQNPRIAVHAQVVLSENDDEHN--VLKSAVIVEDVTDSIP 802
DP Y E + I GQ ++ + + DD H VL S V+VEDVT + P
Sbjct: 724 DPVNYPGNNVEDVSI----RGQ-LQMELKIRDAPKWLDDLHQNRVLGSVVLVEDVTGTTP 778
Query: 803 PGILSSSSVVPFVQDDVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEM 862
P I +S ++P V++D SD+ S I TE ES P+S+ ED DG D+SI+D A+ E+
Sbjct: 779 PDIPLASRIIPHVEEDASDEFESHI-TEVESTAPESESEDAEADGGGTDDSINDVAITEI 837
Query: 863 EAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLI 922
EAGIYGLQIIK++D+EEL+ELGSGTFGTVY GKWRGTD+AIKRIKKSCF GR SEQE L
Sbjct: 838 EAGIYGLQIIKNTDIEELRELGSGTFGTVYYGKWRGTDVAIKRIKKSCFSGRISEQERLT 897
Query: 923 KEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
K+FWREA I+SNLHHPNVVAFYGVVP+GPGGTMATVTEYMVNGSLRH L +KD++LD RK
Sbjct: 898 KDFWREAKILSNLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRHALQKKDKVLDHRK 957
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG 1042
+L++ +DAAFGMEYLH+K+IVHFDLKCDNLLVNLRD QRPICKVGDFGLSRIK NTLVSG
Sbjct: 958 RLIIALDAAFGMEYLHLKDIVHFDLKCDNLLVNLRDSQRPICKVGDFGLSRIKRNTLVSG 1017
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102
GVRGTLPWMAPELL+G++NRVSEKVDVYSFGI MWE++TGEEPYANMHCGAIIGGI+SNT
Sbjct: 1018 GVRGTLPWMAPELLDGNSNRVSEKVDVYSFGIVMWEVLTGEEPYANMHCGAIIGGIVSNT 1077
Query: 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNHAIR 1157
LRP IPERCDPEWRKLMEECWSF P+ARPSFTEITNRLRVMS ALQ KRRN A R
Sbjct: 1078 LRPPIPERCDPEWRKLMEECWSFYPSARPSFTEITNRLRVMSMALQPKRRNLANR 1132
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356533838|ref|XP_003535465.1| PREDICTED: uncharacterized protein LOC100810711 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2423), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 575/1237 (46%), Positives = 740/1237 (59%), Gaps = 139/1237 (11%)
Query: 1 MTREDPSTSGQPLCRDRGNVVSSNRVDAERSVNNVCLQTGEEFSSEFLRDRVAVRRITVM 60
M+ EDP SG+ D +V S+R+ ++ +N+CLQTGEEFS+EFLRDRVA+RR V+
Sbjct: 1 MSNEDPGISGKQYI-DTVSVGLSDRISSDDDSDNICLQTGEEFSAEFLRDRVALRRFPVV 59
Query: 61 NDGKYLQTIQAGVNINQN-HQVVCGDLNGIVGLRRMDNEGNANASDFAETFGYAVEAKKN 119
+ + NI +N +Q+V DL ++GLRR +++ N++ S+ A GYAVE
Sbjct: 60 TNADQHMPNRLDFNIKENNYQLVYEDLKHVLGLRRTESDSNSDLSEIASVRGYAVEVDGR 119
Query: 120 NYPDNLSRCQLQYGAVGQNSGIF-------FYE-NHCDQVATELSGSPVYVVESPQSYHP 171
YP+NLSR Q ++G Q SG F F E N CDQV + + VYVVESP HP
Sbjct: 120 AYPNNLSRYQCEHGGFRQASGKFSRQLSGKFSEGNGCDQVNSGPNAPSVYVVESPHC-HP 178
Query: 172 CGPGYAESPFTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSA 231
G ++E F +K+KFLCSFGGRI PRP+DGKLRYVGGETRIISIRK++TWEELMRKTSA
Sbjct: 179 YGSVFSEGSFYKKIKFLCSFGGRILPRPNDGKLRYVGGETRIISIRKNITWEELMRKTSA 238
Query: 232 ICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLGEPDS 291
IC+Q H IKYQLPGEDLDALISVCS+EDLHHMIEE +E ER GGSQRLR FL+ E +S
Sbjct: 239 ICSQTHIIKYQLPGEDLDALISVCSNEDLHHMIEECEELERAGGSQRLRNFLIPSNECES 298
Query: 292 PNSLEGKTTQQTDADNQYVSAVNGMLDASPRKSSSGQTLTSHTTQMG-----------RD 340
P+S E + Q +DAD YV AVNG+LD SPRK+S+G +L SH Q G RD
Sbjct: 299 PSSNEARVNQPSDADYHYVVAVNGLLDPSPRKNSNGLSLASHANQFGNTSDYNSPHFYRD 358
Query: 341 SPTFAYISEIKDHSLNSSNVGGMFSNNANRLPPICVAGKSLNPSVPVTTFSSQSIDPFNS 400
S T A+ SE+KD + NS N+ G+ S + P+ +AGKS + P++ Q DP S
Sbjct: 359 SSTSAFASEMKDCTPNSPNLVGILSKPGTQFFPV-LAGKSFSQMSPLSPTCVQPKDPKIS 417
Query: 401 NAHFYVDWPCDG-NGNDNPCVMDKFLCDHSY------DVNSLSHYDNLHDHHPLMNYHKH 453
N + D P N + P VM+K C++S V+ ++H++NL +NYH +
Sbjct: 418 NVQLFKDKPYHAINESITPFVMEKVPCNNSLFVENANYVDPVAHHNNLAQGPTCVNYHPN 477
Query: 454 NQNLVETDQT----NNCHLHLHN-----------CGLSRDIVHCTP-------------- 484
NQ +VE D N HLH N C L+ D++ P
Sbjct: 478 NQYIVEPDLIRKPGENLHLHRRNNSSNEFVSSAACSLT-DMIFERPLVNNEGSYHFNKVV 536
Query: 485 ------ERVLSDSRLR---------VHDNSSTHRLEEG--IISQSPRNIGRAKSPSVVSS 527
+ SDS +R H +S+ +E + Q P ++ R PS+ +S
Sbjct: 537 SRPHESSSLFSDSDVREGSWYRMLHAHSDSTLKENDENYKVHLQFPLSVERDNLPSLKNS 596
Query: 528 SS-RGFSMHWQDVIDEKHQGTTCKNQPSFKMLESCNDNFKTVQEIKAMNGNLA-SSDPHW 585
SS S+ ++ID K +N P F +S N V EI LA S+ +
Sbjct: 597 SSLEECSIQPGEMIDRKEHLAKYQNLPIFGKTDSFN-----VSEIGKDILQLADKSNDFF 651
Query: 586 KHHIGNKEVTPNNKAIENK-INYQPSSNLPIRDSPNSGSSNFSLQIATAESSAGFI---- 640
+ G + AI+ K + Y SS+ SP+ SS +L S+A FI
Sbjct: 652 DENAG---AMSQDNAIDLKHLQYIYSSHGVCSSSPDFQSSECNL------STASFISLES 702
Query: 641 IEHLYGYQLDTTTMPEFQVKNSNATKDEKCALTEISQPVSPGSSVKLSSKDEKSTMTEIS 700
+L G LD T EF ++ ++ + A+ E T+
Sbjct: 703 TRNLRGKPLDRTAS-EFSRRSQYSSMVHQYAMPE----------------------TKDG 739
Query: 701 QPVTPGSSGKLSVSSQAVANQEWISPSSKLTSAASSREATINDEDPRIYYNYGAEKIVIS 760
QP+ P S ++ ++ I P S + +S RE I EDP Y + VI
Sbjct: 740 QPLLP-------CSFESQTDRGSILPISYMDMCSSLREVVIPVEDPAYYLHQKEHNTVIK 792
Query: 761 RSNEGQNPRIAVHAQVVLSENDDEHNVLKSAVIVEDVTDSIPPGILSSSSVVPFVQDDVS 820
VH V + +V+ D GI S VV V ++
Sbjct: 793 NQCSEYINEFCVHKPVA-----------EPVAVVKGPRDYNSSGIQSCLKVVSNVDEEAD 841
Query: 821 DDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEEL 880
+ SP E +P+S+ + D ++ D A AE EA IYGLQ I++ DLEEL
Sbjct: 842 VEPTSPEKEGIECDNPESESKHAESDSGNFNKPNGDRATAETEAEIYGLQNIENDDLEEL 901
Query: 881 QELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
QELGSGTFGTVY GKWRGTD+AIKRIK SCF GR SEQE L K+FWREA I+S LHHPNV
Sbjct: 902 QELGSGTFGTVYHGKWRGTDVAIKRIKSSCFSGRLSEQERLTKDFWREAQILSTLHHPNV 961
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK 1000
VAFYGVVP+ PGGT+ATVTEYM++GSLR+VL +KD++LDRRK+L++ +DAAFGMEYLH+K
Sbjct: 962 VAFYGVVPDDPGGTLATVTEYMLHGSLRNVLMKKDKVLDRRKRLLIAIDAAFGMEYLHLK 1021
Query: 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSN 1060
NIVHFDLKCDNLLVNL DP+RP+CKVGDFGLSRIK NTLVSGGVRGTLPWMAPELL+G++
Sbjct: 1022 NIVHFDLKCDNLLVNLGDPERPVCKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLDGNS 1081
Query: 1061 NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLME 1120
RVSEKVD++SFGIAMWE++TGEEPYANMHCGAIIGGI++NTLRP IP+RCD EW+KLME
Sbjct: 1082 CRVSEKVDIFSFGIAMWEMLTGEEPYANMHCGAIIGGIVNNTLRPPIPKRCDSEWKKLME 1141
Query: 1121 ECWSFNPAARPSFTEITNRLRVMSTALQTKRRNHAIR 1157
ECWS +PAARP+FT+I NRLR MS ++ KR N A R
Sbjct: 1142 ECWSPDPAARPTFTDIKNRLRNMSDSVPKKRHNIARR 1178
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574716|ref|XP_003555491.1| PREDICTED: uncharacterized protein LOC100807361 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2410), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/1227 (45%), Positives = 737/1227 (60%), Gaps = 128/1227 (10%)
Query: 1 MTREDPSTSGQPLCRDRGNVVSSNRVDAERSVNNVCLQTGEEFSSEFLRDRVAVRRITVM 60
M+ ED SG+ D +V S+R+ ++ + +CLQTGEEFS+EFLRDRVA R+ V+
Sbjct: 1 MSNEDHGVSGKQYI-DAVSVGLSDRIPSDDDADYICLQTGEEFSAEFLRDRVASRKFPVI 59
Query: 61 NDGKYLQTIQAGVNINQNH-QVVCGDLNGIVGLRRMDNEGNANASDFAETFGYAVEAKKN 119
D + NI +N Q+V DL ++GLRR +++ N++ + A GY E
Sbjct: 60 TDADQHLPNRLDANIRENSPQLVYEDLKHVLGLRRTESDSNSDLLEIASVRGYVDEVDSR 119
Query: 120 NYPDNLSRCQLQYGAVGQNSGIF-------FYE-NHCDQVATELSGSPVYVVESPQSYHP 171
YP+NL+R Q ++ Q SG F F E N CDQV + + VYVVESP S HP
Sbjct: 120 AYPNNLNRYQCEHSGFRQASGTFSRQLSGKFSEGNGCDQVNSGPNAPSVYVVESPHSCHP 179
Query: 172 CGPGYAESPFTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSA 231
G ++E F +K+KFLCSFGGRI PRP+DGKLRYVGGETRIISIRK++ WEELMRKTSA
Sbjct: 180 YGSVFSEGSFYKKIKFLCSFGGRILPRPNDGKLRYVGGETRIISIRKNIKWEELMRKTSA 239
Query: 232 ICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLGEPDS 291
IC+Q H IKYQLPGEDLDALISVCS+EDLHHMIEEY+E ER GGSQ LRIFL+ E +S
Sbjct: 240 ICSQTHIIKYQLPGEDLDALISVCSNEDLHHMIEEYEELERAGGSQWLRIFLIPSNECES 299
Query: 292 PNSLEGKTTQQTDADNQYVSAVNGMLDASPRKSSSGQTLTSHTTQMG-----------RD 340
P+S E + Q +DAD YV AVNGML+ SP+K+S+G +L +HT+Q G RD
Sbjct: 300 PSSNEARVNQPSDADYHYVVAVNGMLNPSPQKNSNGLSLANHTSQFGNTTDYNSPHFYRD 359
Query: 341 SPTFAYISEIKDHSLNSSNVGGMFSNNANRLPPICVAGKSLNPSVPVTTFSSQSIDPFNS 400
S T A+ SE+KD + S N+ G+ S ++ +AGKS+N P++ Q DP S
Sbjct: 360 SSTSAFASEMKDCTPTSPNLVGILSKPGSQYF-TALAGKSVNQMSPLSPACVQPTDPKIS 418
Query: 401 NAHFYVDWPCDG-NGNDNPCVMDKFLCDHSYDVNSLSHYDNLHDHHPLMNYHKHNQNLVE 459
N + D P + N + P V +K C++S V++ ++ D + H+ NQ +V+
Sbjct: 419 NVQIFKDKPYNAINESITPFVTEKVPCNNSLYVDNTNYIDPVAYHN--------NQYIVK 470
Query: 460 TDQT----NNCHLHLHN-----------CGLSRDIVHCTP-------------------- 484
+D N HLH N C L+ D++ P
Sbjct: 471 SDLIRKPGKNLHLHRRNNSSNEFVSSTACSLT-DLIFERPLVTNEGSYHFNKVVSRPHES 529
Query: 485 ERVLSDSRLR---------VHDNSSTHRLEEG--IISQSPRNIGRAKSPSVVSSSS-RGF 532
+ S+S +R H +S+ +E + Q P ++ R PS+ +S S
Sbjct: 530 SSLFSESDVREGSRYRMLHAHSDSTLKENDENYKVHLQFPLSVERDNFPSLKNSCSLEEC 589
Query: 533 SMHWQDVIDEKHQGTTCKNQPSFKMLESCNDNFKTVQEIKAMNGNLASSDPHWKHHIGNK 592
S+ ID K +N P F M D+F ++ K + + +S+ + ++G
Sbjct: 590 SIQPGKTIDRKEHSAKYQNLPIFGM----TDSFNVSEKGKEILQHADNSNDFFNENVG-- 643
Query: 593 EVTPNNKAIENKINYQPSSNLPIRDSPNSGSSNFSLQIATAES--SAGFIIEHLYGYQLD 650
++ +N + Y + + SP+ SS +L A++ S S + +G LD
Sbjct: 644 AMSQDNSIDLKHLQYIYTPHGVCSSSPDFQSSECNLSTASSISLESTRNLRGQPHGLSLD 703
Query: 651 TTTMPEFQVKNSNATKDEKCALTEISQPVSPGSSVKLSSKDEKSTMTEISQPVTPGSSGK 710
T EF ++ N++ + A+ E T+ QP+ PGS
Sbjct: 704 RTA-SEFSTRSQNSSMHHQYAMPE----------------------TKDGQPLFPGSF-- 738
Query: 711 LSVSSQAVANQEWISPSSKLTSAASSREATINDEDPRIYYNYGAEKIVISRSNEGQNPRI 770
++ + I P S + +S RE I EDP YN ++ QN I
Sbjct: 739 -----ESQTERGSILPISYMDMGSSLREVVIPVEDPA--YNLHQKE---------QNTVI 782
Query: 771 AVHAQVVLSENDDEHNVLKSAVIVEDVTDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTE 830
++E V +S +V+ D I GI S V V ++ + SP
Sbjct: 783 KNQCSEYINEFCVNKPVPESVAVVKGAMDYISSGIQSCLKDVSNVDEEAEVEPTSPEKEG 842
Query: 831 TESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGT 890
E +P+S+ + D V++ + D A AE EA +YGLQ I+++DLEELQELGSGTFGT
Sbjct: 843 IECDNPESESKHAESDSGNVNKPMGDRATAETEAEVYGLQNIENADLEELQELGSGTFGT 902
Query: 891 VYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950
VY GKWRGTD+AIKRIK SCF GR SEQE L K+FWREA I+S LHHPNVVAFYGVVP+G
Sbjct: 903 VYHGKWRGTDVAIKRIKSSCFSGRLSEQERLTKDFWREAQILSTLHHPNVVAFYGVVPDG 962
Query: 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCD 1010
PGGT+ATVTEYMV+GSLR+VL +KDR+LDRRK+L++ MDAAFGMEYLH+KNIVHFDLKCD
Sbjct: 963 PGGTLATVTEYMVHGSLRNVLTKKDRVLDRRKRLLIAMDAAFGMEYLHLKNIVHFDLKCD 1022
Query: 1011 NLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVY 1070
NLLVNL D +RP+CKVGDFGLSRIK NTLVSGGVRGTLPWMAPELL+G++ RVSEKVD++
Sbjct: 1023 NLLVNLGDLERPVCKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLDGNSCRVSEKVDIF 1082
Query: 1071 SFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
SFGIAMWEI+TGEEPY+NMHCGAIIGGI++NTLRP IP+RCD EW+KLMEECWS +PAAR
Sbjct: 1083 SFGIAMWEILTGEEPYSNMHCGAIIGGIVNNTLRPPIPKRCDSEWKKLMEECWSPDPAAR 1142
Query: 1131 PSFTEITNRLRVMSTALQTKRRNHAIR 1157
P+FTEITNRLR MS +L KR N R
Sbjct: 1143 PTFTEITNRLRSMSDSLPKKRHNIVKR 1169
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442709|ref|XP_003591632.1| Mitogen-activated protein kinase kinase kinase 13-A [Medicago truncatula] gi|92882345|gb|ABE86676.1| Octicosapeptide/Phox/Bem1p; Protein kinase [Medicago truncatula] gi|355480680|gb|AES61883.1| Mitogen-activated protein kinase kinase kinase 13-A [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2271), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 552/1235 (44%), Positives = 729/1235 (59%), Gaps = 141/1235 (11%)
Query: 1 MTREDPSTSGQPLCRDRGNVVSSNRVDAERS-VNNVCLQTGEEFSSEFLRDRVAVRRITV 59
M+ EDP SG + +VV S+ +++ +N+CLQTGEEFS+EFLRDRVA+RR+ V
Sbjct: 1 MSNEDPGISGYQY-KGTTSVVFSDITSSDKDDEDNICLQTGEEFSAEFLRDRVALRRLPV 59
Query: 60 MNDGKYLQTIQAGVNIN-----QNHQVVCGDLNGIVGLRRMDNEGNANASDFAETFGYAV 114
+ D + Q + ++ N N+Q+V + N ++GL RM ++ N + S+ A GY
Sbjct: 60 ITDSE--QHLPNRLDFNTINNSNNYQLVHENQNHVLGLGRMGSDSNLDLSEIALARGYVA 117
Query: 115 EAKKNNYPDNLSRCQLQYGAVGQNSGIFF------YENHCDQVATELSGSPVYVVESPQS 168
E Y +NLSR Q ++G + Q S F + + DQ ++ + +Y VESP+S
Sbjct: 118 EVDNRGYHNNLSRYQCEHGPIRQASSAFSRQLSGRFSDGSDQGSSIPNTPTIYAVESPRS 177
Query: 169 YHPCGPGYAESPFTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRK 228
HP G ++E F +K+KFLCSFGGRI PRP+DGKLRYVGGETRIISI K++T EEL K
Sbjct: 178 CHPYGTVFSEGSFYKKIKFLCSFGGRILPRPNDGKLRYVGGETRIISIGKNMTHEELTGK 237
Query: 229 TSAICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLGE 288
T ICNQ H IKYQLPGEDLDALISVCSDEDLHHMIEEY+E ER GGSQRLRIFLV+ E
Sbjct: 238 TYGICNQTHIIKYQLPGEDLDALISVCSDEDLHHMIEEYEELERAGGSQRLRIFLVTSNE 297
Query: 289 PDSPNSLEGKTTQQTDADNQYVSAVNGMLDASPRKSSSGQTLTSHTTQMG---------- 338
+SP+S E + QQ+D D YV AVNGMLD SPRK+SSG +L SHT Q
Sbjct: 298 SESPSSNELRVNQQSDVDYHYVVAVNGMLDPSPRKNSSGMSLASHTNQFANTSDYNSPHF 357
Query: 339 -RDSPTFAYISEIKDHSLNSSNVGGMFSNNANRLPPICVAGKSLN--PSVPVTTFSSQSI 395
R+S T ++ SE KD + SS + + S L + V G+S N P P+
Sbjct: 358 HRESSTSSFDSEAKDCNPTSSKLTSIMSKRGPYLTALNVPGRSFNQKPPSPIRVLPK--- 414
Query: 396 DPFNSNAHFYVDWPCD-GNGNDNPCVMDK------FLCDHSYDVNSLSHYDNLHDHHPLM 448
D S + D P + N N P V +K D++ VN +++Y+ L P +
Sbjct: 415 DLKISKVQLFKDQPYNVANENIIPFVAEKVPGDNSLYVDNTNFVNPIAYYNKLPQGSPCV 474
Query: 449 NYHKHNQNLVETD--QTNNCHLHLHNCGLSRDIVHCTP--------ERVLSDSRL----- 493
N H NQ +E+D + +N H H S + V ER L ++ L
Sbjct: 475 NCHPSNQYTLESDHVKKSNDEFHFHKRSNSNEFVSSAICNQRDMIFERPLVNNELGSYHF 534
Query: 494 ------RVHDNSST---------------HRLEEGII----------SQSPRNIGRAKSP 522
H++SS H L + + Q P N+ R K
Sbjct: 535 NKIVSYHPHESSSVFSVSNDRDVSQYRMLHALSDSTLLENSENYKGQLQFPLNVERDKLS 594
Query: 523 SVVSSSSRG-FSMHWQDVIDEKHQGTTCKNQPSFKMLESCNDNFKTVQEIKAMNGNLASS 581
S+ +SSS G S+H ++ D K + +N P+F + +FK + EI N +
Sbjct: 595 SLETSSSLGECSVHLGEINDGKERMILHQNLPTF----GTSTSFKRLSEIGTENLHCKDK 650
Query: 582 DPHWKHHIGNKEVTPNNKAIENKINYQPSSNLPIRDSPNSGSSNFSLQIATAESSAGFII 641
+ W N++V K +++ I YQ ++ D +SG N S + S G +
Sbjct: 651 NIGWL----NEKVGVMPKHLQH-IYYQHGASSSSPDLQSSG-YNASAAPFISSQSIGSMT 704
Query: 642 EHLYGYQLDTTTMPEFQVKNSN-ATKDEKCALTEISQPVSPGSSVKLSSKDEKSTMTEIS 700
E +G LDT EF V + N +T + T+ QP PGS + +ST ++I
Sbjct: 705 EQPHGIPLDTIAY-EFSVTSQNSSTHQYDVSETKDGQPPPPGSF------ELRSTESQID 757
Query: 701 QPVTPGSSGKLSVSSQAVANQEWISPSSKLTSAASSREATINDEDPRIYYNYGAEKIVIS 760
+ S+ A++ + +S +S RE ++D++P Y N E IV
Sbjct: 758 -----------TESTLAISYPDMVS--------SSLREVVVHDDNPAYYQNQKDENIVTD 798
Query: 761 RSNEGQNPRIAVHAQVVLSENDDEH--NVLKSAVIVEDVTDSIPPGILSSSSVVPFVQDD 818
+ E DE N KSA +V++ + I GI S V ++
Sbjct: 799 KR---------------YYEYIDEFCINKPKSAAVVKETVEYISLGIQSCLQAVSNTAEE 843
Query: 819 VSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLE 878
D S P+ + + + D + + D+ +E+E+ ++GLQII++ D+E
Sbjct: 844 --DKHTSLEKAGVLCVIPEFESKPPKADSGNFTKPMGDSKTSEIESELHGLQIIENGDIE 901
Query: 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
EL ELGSGTFGTVY GKWRGTD+AIKRIK SCF GR SEQE L K+FWREA I+S LHHP
Sbjct: 902 ELHELGSGTFGTVYHGKWRGTDVAIKRIKNSCFAGRFSEQERLTKDFWREAKILSTLHHP 961
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH 998
NVVAFYGVVP+GPGGT+ATV EYMV+GSLR+VL +K+R+LDRRK++M+ MDAAFGMEYLH
Sbjct: 962 NVVAFYGVVPDGPGGTLATVAEYMVHGSLRNVLLKKERVLDRRKRIMIAMDAAFGMEYLH 1021
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNG 1058
+KNIVHFDLKCDNLLVNL DP+RP+CKVGDFGLSRIK NTLVSGGVRGTLPWMAPELL+G
Sbjct: 1022 LKNIVHFDLKCDNLLVNLGDPERPVCKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLDG 1081
Query: 1059 SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKL 1118
+++RVSEKVD++SFGI MWEI+TGEEPYANMHCGAIIGGI+SNTLRP IP+RCD EW++L
Sbjct: 1082 NSSRVSEKVDIFSFGITMWEILTGEEPYANMHCGAIIGGIVSNTLRPSIPKRCDSEWKRL 1141
Query: 1119 MEECWSFNPAARPSFTEITNRLRVMSTALQTKRRN 1153
MEECWS +P RP FTE+ NRLR MS ALQ KR N
Sbjct: 1142 MEECWSPDPEIRPCFTEVKNRLRNMSAALQKKRPN 1176
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843280|ref|XP_002889521.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297335363|gb|EFH65780.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/1193 (45%), Positives = 677/1193 (56%), Gaps = 196/1193 (16%)
Query: 4 EDPSTSGQPLCRDR--GNVVSSNRVDAERSVNNVCLQTGEEFSSEFLRDRVAVRRITVMN 61
E P +S Q L RDR G V ++ R D N+C QTGEEFS+EFLRD A RR+
Sbjct: 2 EFPGSSNQHLGRDRFNGEVGNNTRDD------NICSQTGEEFSNEFLRDFGAQRRV---- 51
Query: 62 DGKYLQTIQAGVNINQNHQVVCGDLNGIVGLRRMDN---EGNANASDFAETFGYAVEAKK 118
G + I+ N N +V D N I+GL+R+D+ EG ++S GY E+
Sbjct: 52 QGGVSRNIEGNYN---NRHLVYEDFNRILGLQRVDSNMSEGINSSS------GYFAESNV 102
Query: 119 NNYPDNLSRCQLQYGAVGQNSGIFFYENHCDQVATELSGSPVYVVESPQSYHPCGPGYAE 178
+ P + Q AT S VY+ E
Sbjct: 103 ADSPRKMF-----------------------QTAT----SDVYLPEV------------- 122
Query: 179 SPFTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQPHT 238
+K LCSFGGRI RP DGKLRY+GGETRIISIRK + ELM KT A+CN PHT
Sbjct: 123 ------LKLLCSFGGRILQRPGDGKLRYIGGETRIISIRKHVGLNELMHKTYALCNHPHT 176
Query: 239 IKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLGEP-DSPN---- 293
IKYQLPGEDLDALISVCSDEDL HMIEEYQE E GSQR+R+FLVS E +SP
Sbjct: 177 IKYQLPGEDLDALISVCSDEDLLHMIEEYQEAETKAGSQRIRVFLVSSTESSESPKIFNE 236
Query: 294 ---SLEGKTTQQTDADN-QYVSAVNGMLDASPRKSSSGQTLTSHTTQMG----------- 338
++ T QQTD D+ QYVSA+N ++D SP+KSSSGQ+ TS TTQ G
Sbjct: 237 RNMNINRNTNQQTDIDHYQYVSALNNVVDVSPQKSSSGQSGTSQTTQFGNASEFSPTFHL 296
Query: 339 RDSPTFAYISEIKDHSLNSSNVGGMFSN-NANRLPPICVAGKSLNPSVPVTTFSSQS--I 395
RDSPT + E KD NS ++N NA P +P +F QS
Sbjct: 297 RDSPTSVHTWEHKD--CNSPTFMKPYANTNAVHFMPKM--------QIPRNSFGQQSPPA 346
Query: 396 DPFNSNAHFYVDWP--CDGNGNDNPCVMD-KFLCDHSYDVNSLSHYD-----NLHDHHPL 447
PF+++ D P D NG +P + F H + ++ + NLHD P
Sbjct: 347 SPFSAHKRANTDVPYFADQNGFFDPYLAAPNFPQQHRFFFDTTTQKQKHPEVNLHDRRPS 406
Query: 448 MNYHKHNQNLVETDQTNNCHLHLHNCGLSRDIVHCTPERVLSDSRLRVHDNSSTHRLEEG 507
+ + H Q + ++ + LSD +L HD S + E
Sbjct: 407 DDIYPHGQAYMGAEKL------------------TLKKNALSDPQL--HDESQINNGLEA 446
Query: 508 IISQSPRNIGRAKSPSVVSSSSRGFSMHWQDVIDEKHQGTTCKNQPSFKMLESCNDNFKT 567
Q P I R K+ VV++S W+D D K + + +N+
Sbjct: 447 FTKQ-PWKILR-KNLHVVATSK------WEDSDDIYFNNPEGKRSKELVLTKEVPNNW-- 496
Query: 568 VQEIKAMNG--NLASSDPHWKHHIGNKEVTPNNKAIENKINYQPSSNLPIRDSPNSGSSN 625
++G N S D K G+ + + + N+QP++ + DS +SGSS
Sbjct: 497 ------IDGDHNPGSFDQATKKQGGSNSNSSFSPNYFSP-NHQPAAQVTSSDSQDSGSSV 549
Query: 626 FSLQIATAESSAGFIIEHLYGYQLDTTTMPEFQVKNSNATKDEKCALTEISQPVSPGSSV 685
FSL + T E+ + G+Q D + + +++ + D+ C T+ S
Sbjct: 550 FSLSVNTNENYLDCSKDKFNGFQHDMSL--DILIRSHTSATDQLCCTTKSS--------- 598
Query: 686 KLSSKDEKSTMTEISQPVTPGSSGKLSVSSQAVANQEWISPSSKLTSAASSREATINDED 745
D S T PV QE + P L + +S ++ +
Sbjct: 599 --DKADYSSPNTNF--PV-------------EFLRQEPMIPRHDLET--NSDDSDTQNSL 639
Query: 746 PR---IYYNYGAEKIVISRSNEGQNPRIAVHAQVVLSENDD--EHNVLKSAVIVEDVTDS 800
PR I+Y+ + V SR +H Q E+DD + +L +IVEDVT+
Sbjct: 640 PREESIHYSGLPLRKVGSRET------TFMHTQ----ESDDFFKSKLLGPQLIVEDVTNE 689
Query: 801 IPPGILSSSSVVPFVQDDVSDDCPSPIV-TETESAHPDSDHEDVRGDGREVDESISDAAM 859
+ L S+++VP V + DD S E +A +S+ E+ R D+S S+AAM
Sbjct: 690 VISDNLLSATIVPHVHSESDDDHKSYTREKEITNADHESEMEEKYKKSRNTDDSFSEAAM 749
Query: 860 AEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQE 919
E+EAGIYGLQIIK++DLE+L ELGSGTFGTVY GKWRGTD+AIKRIK SCF G SSEQ
Sbjct: 750 VEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNSCFSGGSSEQA 809
Query: 920 WLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD 979
K+FWREA I++NLHHPNVVAFYGVVP+GPGGTMATVTEYMVNGSLRHVL RKDR+LD
Sbjct: 810 RQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRHVLQRKDRLLD 869
Query: 980 RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039
RRKKLM+ +D+AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK NTL
Sbjct: 870 RRKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKRNTL 929
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099
VSGGVRGTLPWMAPELLNGS+NRVSEKVDV+SFGI MWEI+TGEEPYAN+HCGAIIGGI+
Sbjct: 930 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYANLHCGAIIGGIV 989
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152
+NTLRP +PERC+ EWRKLME+CWSF+P RPSFTEI RLR M+ ALQ KRR
Sbjct: 990 NNTLRPAVPERCEAEWRKLMEQCWSFDPGVRPSFTEIVERLRSMTVALQPKRR 1042
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219796|ref|NP_171964.1| PB1 domain-containing protein tyrosine kinase [Arabidopsis thaliana] gi|332189614|gb|AEE27735.1| PB1 domain-containing protein tyrosine kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/1197 (44%), Positives = 669/1197 (55%), Gaps = 201/1197 (16%)
Query: 1 MTREDPSTSGQPLCRDRGNVVSSNRVDAERSVNNVCLQTGEEFSSEFLRDRVAVRRITVM 60
M E P +S Q L RDR N E N C QTGEEFS+EFLRD A RR +
Sbjct: 1 MRMEFPGSSNQHLGRDRFN--------GEVGCGNNCSQTGEEFSNEFLRDFGAQRR---L 49
Query: 61 NDGKYLQTIQAGVNINQNHQVVCGDLNGIVGLRRMDN---EGNANASDFAETFGYAVEAK 117
G + ++ N N +V D N I+GL+R+D+ EG N+S+ GY E+
Sbjct: 50 QHGGVNRNVEGNYN---NRHLVYEDFNRILGLQRVDSNMSEG-INSSN-----GYFAESN 100
Query: 118 KNNYPDNLSRCQLQYGAVGQNSGIFFYENHCDQVATELSGSPVYVVESPQSYHPCGPGYA 177
+ P + + + S VY+ E
Sbjct: 101 VADSPRKMFQTAI---------------------------SDVYLPEV------------ 121
Query: 178 ESPFTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQPH 237
+K LCSFGGRI RP DGKLRY+GGETRIISIRK + ELM KT A+CN PH
Sbjct: 122 -------LKLLCSFGGRILQRPGDGKLRYIGGETRIISIRKHVGLNELMHKTYALCNHPH 174
Query: 238 TIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV-SLGEPDSPN--- 293
TIKYQLPGEDLDALISVCSDEDL HMIEEYQE E GSQR+R+FLV S +SP
Sbjct: 175 TIKYQLPGEDLDALISVCSDEDLLHMIEEYQEAETKAGSQRIRVFLVPSTESSESPKIFH 234
Query: 294 ----SLEGKTTQQTDADN-QYVSAVNGMLDASPRKSSSGQTLTSHTTQMG---------- 338
++ T QQTD D+ QYVSA+NG++D SP+KSSSGQ+ TS TTQ G
Sbjct: 235 ERNMNINRNTNQQTDIDHYQYVSALNGIVDVSPQKSSSGQSGTSQTTQFGNASEFSPTFH 294
Query: 339 -RDSPTFAYISEIKDHSLNSSNVGGMFSN-NANRLPPICVAGKSLNPSVPVTTFSSQS-- 394
RDSPT + E KD NS + N NA P +P +F QS
Sbjct: 295 LRDSPTSVHTWEHKDS--NSPTFMKPYGNTNAVHFMPKM--------QIPRNSFGQQSPP 344
Query: 395 IDPFNSNAHFYVDWP--CDGNGNDNPCV-------MDKFLCDHSYDVNSLSHYD-NLHDH 444
PF+ + D P D NG +P + ++F + + H + NLHD
Sbjct: 345 TSPFSVHKRANTDVPYFADQNGFFDPYLAAPNFPQQNRFFFETT--TQKQKHPEVNLHDR 402
Query: 445 HPLMNYHKHNQNLVETDQTNNCHLHLHNCGLSRDIVHCTPERVLSDSRLRVHDNSSTHRL 504
P + + H Q + ++ + LSD +L HD S +
Sbjct: 403 RPSDDIYPHGQAYIGAEKM------------------TLKKNALSDPQL--HDESQINNG 442
Query: 505 EEGIISQSPRNIGRAKSPSVVSSSSRGFSMHWQDVID---EKHQGTTCKNQPSFKMLESC 561
E Q P I R K+ VV++S W+D D +G CK K + +
Sbjct: 443 LEAFTKQ-PWKILR-KNLRVVATSK------WEDSDDIYFNNPEGKRCKELELTKEVPNS 494
Query: 562 NDNFKTVQEIKAMNGNLASSDPHWKHHIGNKEVTPNNKAIENKINYQPSSNLPIRDSPNS 621
N + N S D K G+ + + + N+QP++ + DS +S
Sbjct: 495 WIN---------RDNNPDSFDQATKKQDGSNSNSSFSPNYFSP-NHQPAAQITSSDSQDS 544
Query: 622 GSSNFSLQIATAESSAGFIIEHLYGYQLDTTTMPEFQVKNSNATKDEKCALTEISQPVSP 681
GSS FSL + T E+ E G+Q D + + +++ + D+ C+ T+ S
Sbjct: 545 GSSVFSLSVNTNENYLDCSREKFNGFQHDMSL--DILIRSHTSATDQLCSTTKSS----- 597
Query: 682 GSSVKLSSKDEKSTMTEISQ-PVTP----GSSGKLSVSSQAVANQEWISPSSKLTSAASS 736
SS + + + Q P+ P ++ S + +++ +E I S S
Sbjct: 598 -DKADYSSPNTNFPVVFLRQEPMIPRHDLETNSDDSDTQKSLPREESIHYSGLPLRKVGS 656
Query: 737 REATINDEDPRIYYNYGAEKIVISRSNEGQNPRIAVHAQVVLSENDDEHNVLKSAVIVED 796
RE T + G++ S+ +L +IVED
Sbjct: 657 RETTF-------MHTQGSDDFFKSK-------------------------LLGPQLIVED 684
Query: 797 VTDSIPPGILSSSSVVPFVQDDVSDDCPSPIV-TETESAHPDSDHEDVRGDGREVDESIS 855
VT+ + L S+++VP V + DD S E +A +S+ E+ R D+S S
Sbjct: 685 VTNEVISDNLLSATIVPQVNRESDDDHKSYTREKEITNADHESEMEEKYKKSRNTDDSFS 744
Query: 856 DAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRS 915
+AAM E+EAGIYGLQIIK++DLE+L ELGSGTFGTVY GKWRGTD+AIKRIK SCF G S
Sbjct: 745 EAAMVEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNSCFSGGS 804
Query: 916 SEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD 975
SEQ K+FWREA I++NLHHPNVVAFYGVVP+GPGGTMATVTEYMVNGSLRHVL RKD
Sbjct: 805 SEQARQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRHVLQRKD 864
Query: 976 RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035
R+LDRRKKLM+ +D+AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK
Sbjct: 865 RLLDRRKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 924
Query: 1036 CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII 1095
NTLVSGGVRGTLPWMAPELLNGS+NRVSEKVDV+SFGI MWEI+TGEEPYAN+HCGAII
Sbjct: 925 RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYANLHCGAII 984
Query: 1096 GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152
GGI++NTLRP +PERC+ EWRKLME+CWSF+P RPSFTEI RLR M+ ALQ KRR
Sbjct: 985 GGIVNNTLRPPVPERCEAEWRKLMEQCWSFDPGVRPSFTEIVERLRSMTVALQPKRR 1041
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|2494111|gb|AAB80620.1| Contains similarity to Glycine protein kinase 6 (gb|M67449) [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1857), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/1026 (46%), Positives = 586/1026 (57%), Gaps = 160/1026 (15%)
Query: 185 MKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLP 244
+K LCSFGGRI RP DGKLRY+GGETRIISIRK + ELM KT A+CN PHTIKYQLP
Sbjct: 105 LKLLCSFGGRILQRPGDGKLRYIGGETRIISIRKHVGLNELMHKTYALCNHPHTIKYQLP 164
Query: 245 GEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV-SLGEPDSPNSLEGK----- 298
GEDLDALISVCSDEDL HMIEEYQE E GSQR+R+FLV S +SP +
Sbjct: 165 GEDLDALISVCSDEDLLHMIEEYQEAETKAGSQRIRVFLVPSTESSESPKIFHERNMNIN 224
Query: 299 --TTQQTDADN-QYVSAVNGMLDASPRKSSSGQTLTSHTTQMG-----------RDSPTF 344
T QQTD D+ QYVSA+NG++D SP+KSSSGQ+ TS TTQ G RDSPT
Sbjct: 225 RNTNQQTDIDHYQYVSALNGIVDVSPQKSSSGQSGTSQTTQFGNASEFSPTFHLRDSPTS 284
Query: 345 AYISEIKDHSLNSSNVGGMFSN-NANRLPPICVAGKSLNPSVPVTTFSSQS--IDPFNSN 401
+ E KD NS + N NA P +P +F QS PF+ +
Sbjct: 285 VHTWEHKDS--NSPTFMKPYGNTNAVHFMPKM--------QIPRNSFGQQSPPTSPFSVH 334
Query: 402 AHFYVDWP--CDGNGNDNPCV-------MDKFLCDHSYDVNSLSHYD-NLHDHHPLMNYH 451
D P D NG +P + ++F + + H + NLHD P + +
Sbjct: 335 KRANTDVPYFADQNGFFDPYLAAPNFPQQNRFFFETT--TQKQKHPEVNLHDRRPSDDIY 392
Query: 452 KHNQNLVETDQTNNCHLHLHNCGLSRDIVHCTPERVLSDSRLRVHDNSSTHRLEEGIISQ 511
H Q + ++ + LSD +L HD S + E Q
Sbjct: 393 PHGQAYIGAEKM------------------TLKKNALSDPQL--HDESQINNGLEAFTKQ 432
Query: 512 SPRNIGRAKSPSVVSSSSRGFSMHWQDVID---EKHQGTTCKNQPSFKMLESCNDNFKTV 568
P I R K+ VV++S W+D D +G CK K + + N
Sbjct: 433 -PWKILR-KNLRVVATSK------WEDSDDIYFNNPEGKRCKELELTKEVPNSWIN---- 480
Query: 569 QEIKAMNGNLASSDPHWKHHIGNKEVTPNNKAIENKINYQPSSNLPIRDSPNSGSSNFSL 628
+ N S D K G+ + + + N+QP++ + DS +SGSS FSL
Sbjct: 481 -----RDNNPDSFDQATKKQDGSNSNSSFSPNYFSP-NHQPAAQITSSDSQDSGSSVFSL 534
Query: 629 QIATAESSAGFIIEHLYGYQLDTTTMPEFQVKNSNATKDEKCALTEISQPVSPGSSVKLS 688
+ T E+ E G+Q D + + +++ + D+ C+ T+ S
Sbjct: 535 SVNTNENYLDCSREKFNGFQHDMSL--DILIRSHTSATDQLCSTTKSS-----------D 581
Query: 689 SKDEKSTMTEISQPVTPGSSGKLSVSSQAVANQEWISPSSKLTSAASSREATINDEDPRI 748
D S T PV ++ S + +++ +E I S SRE T
Sbjct: 582 KADYSSPNTNF--PVDLETNSDDSDTQKSLPREESIHYSGLPLRKVGSRETTF------- 632
Query: 749 YYNYGAEKIVISRSNEGQNPRIAVHAQVVLSENDDEHNVLKSAVIVEDVTDSIPPGILSS 808
+ G++ S+ +L +IVEDVT+ + L S
Sbjct: 633 MHTQGSDDFFKSK-------------------------LLGPQLIVEDVTNEVISDNLLS 667
Query: 809 SSVVPFVQDDVSDDCPSPIVTETESAHPDSDHEDVRG---------------DGREVDES 853
+++VP V + DD S E E + D + E G R D+S
Sbjct: 668 ATIVPQVNRESDDDHKS-YTREKEITNADHESEMEVGVYLSGIFFILQEKYKKSRNTDDS 726
Query: 854 ISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLG 913
S+AAM E+EAGIYGLQIIK++DLE+L ELGSGTFGTVY GKWRGTD+AIKRIK SCF G
Sbjct: 727 FSEAAMVEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNSCFSG 786
Query: 914 RSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR 973
SSEQ K+FWREA I++NLHHPNVVAFYGVVP+GPGGTMATVTEYMVNGSLRHVL R
Sbjct: 787 GSSEQARQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRHVLQR 846
Query: 974 KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
KDR RKKLM+ +D+AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR
Sbjct: 847 KDR----RKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 902
Query: 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-- 1091
IK NTLVSGGVRGTLPWMAPELLNGS+NRVSEKVDV+SFGI MWEI+TGEEPYAN+HC
Sbjct: 903 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYANLHCVF 962
Query: 1092 -----GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
G GGI++NTLRP +PERC+ EWRKLME+CWSF+P RPSFTEI RLR M+ A
Sbjct: 963 EQDELGLSFGGIVNNTLRPPVPERCEAEWRKLMEQCWSFDPGVRPSFTEIVERLRSMTVA 1022
Query: 1147 LQTKRR 1152
LQ KRR
Sbjct: 1023 LQPKRR 1028
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741916|emb|CBI33351.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1618), Expect = e-177, Method: Compositional matrix adjust.
Identities = 299/380 (78%), Positives = 336/380 (88%), Gaps = 6/380 (1%)
Query: 779 SENDDEHNVLKSAVIVEDVTDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTETESAHPDS 838
S+N N +AVIVEDVTD +PPGI SSS ++P V+D+ SD ++T + A +S
Sbjct: 578 SDNHHNGNTPGAAVIVEDVTDILPPGIPSSSPLIPQVEDEASD-----VITSSGEAEAES 632
Query: 839 DHEDVRGD-GREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWR 897
D ++ G+ GR++ ESISDAAMAEMEA IYGLQIIK++DLEEL+ELGSGTFGTVY GKWR
Sbjct: 633 DIQESEGEEGRDLGESISDAAMAEMEASIYGLQIIKNADLEELKELGSGTFGTVYHGKWR 692
Query: 898 GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMAT 957
GTD+AIKRIKKSCF GRSSEQE L K+FWREA I+SNLHHPNVVAFYGVVP+GPGGT+AT
Sbjct: 693 GTDVAIKRIKKSCFAGRSSEQERLTKDFWREARILSNLHHPNVVAFYGVVPDGPGGTLAT 752
Query: 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLR 1017
VTEYMVNGSLRHVL RKDR LDRRK+L++ MDAAFGMEYLH+KNIVHFDLKCDNLLVN+R
Sbjct: 753 VTEYMVNGSLRHVLLRKDRSLDRRKRLIIAMDAAFGMEYLHLKNIVHFDLKCDNLLVNMR 812
Query: 1018 DPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMW 1077
D QRPICKVGDFGLSRIK NTLVSGGVRGTLPWMAPELLNGS+NRVSEKVDV+SFG+AMW
Sbjct: 813 DTQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGVAMW 872
Query: 1078 EIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEIT 1137
EI+TGEEPYANMHCGAIIGGI+SNTLRP IPERCDP+WRKLMEECWS +PAARPSFTEIT
Sbjct: 873 EILTGEEPYANMHCGAIIGGIVSNTLRPPIPERCDPDWRKLMEECWSPDPAARPSFTEIT 932
Query: 1138 NRLRVMSTALQTKRRNHAIR 1157
NRLRVMS A+QTKR N A R
Sbjct: 933 NRLRVMSMAIQTKRHNQANR 952
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1157 | ||||||
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.321 | 0.357 | 0.696 | 2.2e-198 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.338 | 0.350 | 0.590 | 4.3e-180 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.269 | 0.25 | 0.703 | 1.2e-173 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.266 | 0.268 | 0.712 | 3.8e-169 | |
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.302 | 0.278 | 0.612 | 2e-164 | |
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.305 | 0.335 | 0.556 | 4.9e-144 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.318 | 0.315 | 0.561 | 9.1e-143 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.236 | 0.358 | 0.378 | 2.1e-41 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.234 | 0.659 | 0.348 | 5.6e-40 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.221 | 0.274 | 0.377 | 6.5e-40 |
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 2.2e-198, Sum P(2) = 2.2e-198
Identities = 261/375 (69%), Positives = 298/375 (79%)
Query: 781 NDD--EHNVLKSAVIVEDVTDSIPPGILSSSSVVPFVQDDVSDDCPSPI-VTETESAHPD 837
+DD + +L +IVEDVT+ + L S+++VP V + DD S E +A +
Sbjct: 667 SDDFFKSKLLGPQLIVEDVTNEVISDNLLSATIVPQVNRESDDDHKSYTREKEITNADHE 726
Query: 838 SDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWR 897
S+ E+ R D+S S+AAM E+EAGIYGLQIIK++DLE+L ELGSGTFGTVY GKWR
Sbjct: 727 SEMEEKYKKSRNTDDSFSEAAMVEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKWR 786
Query: 898 GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMAT 957
GTD+AIKRIK SCF G SSEQ K+FWREA I++NLHHPNVVAFYGVVP+GPGGTMAT
Sbjct: 787 GTDVAIKRIKNSCFSGGSSEQARQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMAT 846
Query: 958 VTEYMVNGSLRHVLARXXXXXXXXXXXXXXXXAAFGMEYLHMKNIVHFDLKCDNLLVNLR 1017
VTEYMVNGSLRHVL R +AFGMEYLHMKNIVHFDLKCDNLLVNLR
Sbjct: 847 VTEYMVNGSLRHVLQRKDRLLDRRKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNLR 906
Query: 1018 DPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMW 1077
DPQRPICKVGDFGLSRIK NTLVSGGVRGTLPWMAPELLNGS+NRVSEKVDV+SFGI MW
Sbjct: 907 DPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGIVMW 966
Query: 1078 EIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEIT 1137
EI+TGEEPYAN+HCGAIIGGI++NTLRP +PERC+ EWRKLME+CWSF+P RPSFTEI
Sbjct: 967 EILTGEEPYANLHCGAIIGGIVNNTLRPPVPERCEAEWRKLMEQCWSFDPGVRPSFTEIV 1026
Query: 1138 NRLRVMSTALQTKRR 1152
RLR M+ ALQ KRR
Sbjct: 1027 ERLRSMTVALQPKRR 1041
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1208 (430.3 bits), Expect = 4.3e-180, Sum P(3) = 4.3e-180
Identities = 235/398 (59%), Positives = 286/398 (71%)
Query: 755 EKIVISRSNEGQNPRIAVHAQVVLSENDDEHNVLKSAVIVEDVTDSIPPGILSSSSVVPF 814
E + S ++E N +I VH + + + E + + + D+ P S + +
Sbjct: 720 ENFLFSIASESPNSKI-VH-ETQKNRTEREGGLGHVRIPIMDLNQPAP-ATASETYSLKT 776
Query: 815 VQDDVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKD 874
++D P +T ++ + E G + + S D EMEA +YGLQIIK+
Sbjct: 777 PREDSPQSIPHAKITSGDTIFLSEEAEANTG---QKENSFKDTLFVEMEASVYGLQIIKN 833
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
+DLE+L ELGSGT+GTVY G WRGTD+AIKRI+ SCF GRSSEQE L K+FWREA I+SN
Sbjct: 834 ADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWREAQILSN 893
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARXXXXXXXXXXXXXXXXAAFGM 994
LHHPNVVAFYG+VP+G GGT+ATVTE+MVNGSLRH L + AAFGM
Sbjct: 894 LHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIAMDAAFGM 953
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPE 1054
EYLH KNIVHFDLKC+NLLVNLRDPQRPICKVGD GLSRIK NTLVSGGVRGTLPWMAPE
Sbjct: 954 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGTLPWMAPE 1013
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
LLNGS+ RVSEKVDV+S+GI++WEI+TGEEPYA+MHCGAIIGGI+ NTLRP IP+ C PE
Sbjct: 1014 LLNGSSTRVSEKVDVFSYGISLWEILTGEEPYADMHCGAIIGGIVKNTLRPPIPKSCSPE 1073
Query: 1115 WRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152
W+KLME+CWS +P +RP FTEIT RLR MS + TK +
Sbjct: 1074 WKKLMEQCWSVDPDSRPPFTEITCRLRSMSMEVVTKSK 1111
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 1.2e-173, Sum P(5) = 1.2e-173
Identities = 228/324 (70%), Positives = 255/324 (78%)
Query: 836 PDSDHEDVRGDGREVDESISDAAMAEM--EAGIYGLQIIKDSDLEELQELGSGTFGTVYR 893
PDS+ +D + + R AA+ + E GLQIIK+ DLEEL+ELGSGTFGTVY
Sbjct: 928 PDSEPKDEKTETRH-------AALPPLGSEFDYSGLQIIKNEDLEELRELGSGTFGTVYH 980
Query: 894 GKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953
GKWRG+D+AIKRIKKSCF GRSSEQE L EFW EA I+S LHHPNVVAFYGVV +GPGG
Sbjct: 981 GKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEILSKLHHPNVVAFYGVVKDGPGG 1040
Query: 954 TMATVTEYMVNGSLRHVLARXXXXXXXXXXXXXXXXAAFGMEYLHMKNIVHFDLKCDNLL 1013
T+ATVTEYMV+GSLRHVL R AAFGMEYLH KN VHFDLKCDNLL
Sbjct: 1041 TLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAAFGMEYLHSKNTVHFDLKCDNLL 1100
Query: 1014 VNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFG 1073
VNL+DP RPICKVGDFGLS+IK NTLVSGGVRGTLPWMAPELLNGS+++VSEKVDV+SFG
Sbjct: 1101 VNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFG 1160
Query: 1074 IAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSF 1133
I +WEI+TGEEPYANMH GAIIGGI++NTLRP IP CD EWR LMEECW+ NP ARPSF
Sbjct: 1161 IVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPGFCDDEWRTLMEECWAPNPMARPSF 1220
Query: 1134 TEITNRLRVMS---TALQTKRRNH 1154
TEI RLRVMS T+ Q+K H
Sbjct: 1221 TEIAGRLRVMSSAATSTQSKPSAH 1244
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1157 (412.3 bits), Expect = 3.8e-169, Sum P(4) = 3.8e-169
Identities = 221/310 (71%), Positives = 248/310 (80%)
Query: 837 DSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKW 896
D + ED + + R ++A+ + GLQII + DLEEL+ELGSGTFGTVY GKW
Sbjct: 825 DCEQEDEKSETRNAGLPPVGPSLADYDTS--GLQIIMNDDLEELKELGSGTFGTVYHGKW 882
Query: 897 RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956
RG+D+AIKRIKKSCF GRSSEQE L EFW EA I+S LHHPNVVAFYGVV +GPG T+A
Sbjct: 883 RGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEILSKLHHPNVVAFYGVVKDGPGATLA 942
Query: 957 TVTEYMVNGSLRHVLARXXXXXXXXXXXXXXXXAAFGMEYLHMKNIVHFDLKCDNLLVNL 1016
TVTEYMV+GSLRHVL R AAFGMEYLH KNIVHFDLKCDNLLVNL
Sbjct: 943 TVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAAFGMEYLHAKNIVHFDLKCDNLLVNL 1002
Query: 1017 RDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAM 1076
+DP RPICKVGDFGLS+IK NTLVSGGVRGTLPWMAPELLNGS+++VSEKVDV+SFGI +
Sbjct: 1003 KDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVL 1062
Query: 1077 WEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
WEI+TGEEPYANMH GAIIGGI++NTLRP IP CD +WR LMEECW+ NP ARPSFTEI
Sbjct: 1063 WEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYCDSDWRILMEECWAPNPTARPSFTEI 1122
Query: 1137 TNRLRVMSTA 1146
RLRVMSTA
Sbjct: 1123 AGRLRVMSTA 1132
|
|
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1138 (405.7 bits), Expect = 2.0e-164, Sum P(5) = 2.0e-164
Identities = 221/361 (61%), Positives = 270/361 (74%)
Query: 806 LSSSSVVPFVQDD--VSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEME 863
++SS + P + D + D + + + + D+ + G E ++ +A + ++
Sbjct: 896 VASSQIHPQIHFDGNIKPDVSTITIPDLNTVDTQEDYSQSQIKGAESTDATLNAGVPLID 955
Query: 864 -----AGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQ 918
+G+ LQ+IK+ DLEEL+ELGSGTFGTVY GKWRGTD+AIKRIK+SCF+GRSSEQ
Sbjct: 956 FMAADSGMRSLQVIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFIGRSSEQ 1015
Query: 919 EWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARXXXXX 978
E L EFW EA I+S LHHPNV+AFYGVV +GPGGT+ATVTEYMVNGSLRHVL
Sbjct: 1016 ERLTSEFWHEAEILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLL-SNRHL 1074
Query: 979 XXXXXXXXXXXAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT 1038
AAFGMEYLH K+IVHFDLKCDNLLVNL+DP RPICKVGDFGLS+IK NT
Sbjct: 1075 DRRKRLIIAMDAAFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLSKIKRNT 1134
Query: 1039 LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGI 1098
LV+GGVRGTLPWMAPELL+GS+++VSEKVDV+SFGI +WEI+TGEEPYANMH GAIIGGI
Sbjct: 1135 LVTGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1194
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST-ALQTKRR--NHA 1155
++NTLRP +P CDPEWR LME+CW+ +P RP+F EI RLR MS+ A+ TK NH
Sbjct: 1195 VNNTLRPTVPNYCDPEWRMLMEQCWAPDPFVRPAFPEIARRLRTMSSSAVHTKPHAVNHQ 1254
Query: 1156 I 1156
I
Sbjct: 1255 I 1255
|
|
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 4.9e-144, Sum P(3) = 4.9e-144
Identities = 198/356 (55%), Positives = 260/356 (73%)
Query: 796 DVTDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTETESAHPDS-DHEDVRGDGREVDESI 854
++ +S+ L ++ V ++ D P + E ES H ++ D ++ D +
Sbjct: 700 ELMESVKRAALEGAAEVKAHPEEAKDQV-RPELVENESEHMNAQDEPEIDSDSDNPNNFK 758
Query: 855 SDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGR 914
+ AE EA GLQ I++ DLEE++ELG GT+G+VY GKW+G+D+AIKRIK SCF G+
Sbjct: 759 IEQTKAEAEAKSRGLQSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAIKRIKASCFAGK 818
Query: 915 SSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARX 974
SE+E LI++FW+EA ++S+LHHPNVV+FYG+V +GP G++ATV E+MVNGSL+ L +
Sbjct: 819 PSERERLIEDFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMVNGSLKQFLQKK 878
Query: 975 XXXXXXXXXXXXXXXAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034
AFGMEYLH KNIVHFDLKC+NLLVN+RDPQRPICK+GD GLS++
Sbjct: 879 DRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKV 938
Query: 1035 KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI 1094
K TLVSGGVRGTLPWMAPELL+G +N VSEK+DVYSFGI MWE++TGEEPYA+MHC +I
Sbjct: 939 KQKTLVSGGVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGEEPYADMHCASI 998
Query: 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150
IGGI++N LRP+IP+ CDPEW+ LME CW+ P RPSFTEI+ +LR M+ A+ K
Sbjct: 999 IGGIVNNALRPKIPQWCDPEWKGLMESCWTSEPTERPSFTEISQKLRTMAAAMNLK 1054
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1071 (382.1 bits), Expect = 9.1e-143, Sum P(3) = 9.1e-143
Identities = 211/376 (56%), Positives = 259/376 (68%)
Query: 778 LSENDDEHNVLKSAVIVEDVTDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTETESAHPD 837
L +++EH + + E V S+ S P D+ + + + E
Sbjct: 794 LKGSEEEHIKQELQNVAEGVAASVLQSSTPSYHEPPIKVDEYAFNSKGEVSRNDEMKQQS 853
Query: 838 SDHEDVRGDGRE-VDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKW 896
+ +D+R E ++ S + + LQIIKDSDLEEL+ELGSGTFGTVY GKW
Sbjct: 854 THFKDIRNQLLERLNFGYSGSDSLDQ------LQIIKDSDLEELRELGSGTFGTVYHGKW 907
Query: 897 RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956
RGTD+AIKRI CF G+ SEQE +I +FW EA ++ LHHPNVVAFYGVV + PGG++A
Sbjct: 908 RGTDVAIKRINDRCFAGKPSEQERMIDDFWNEAQNLAGLHHPNVVAFYGVVLDSPGGSVA 967
Query: 957 TVTEYMVNGSLRHVLARXXXXXXXXXXXXXXXXAAFGMEYLHMKNIVHFDLKCDNLLVNL 1016
TVTEYMVNGSLR+ L + AFGMEYLH K IVHFDLK DNLLVNL
Sbjct: 968 TVTEYMVNGSLRNALQKNVRNFDRCKRQLIAMDIAFGMEYLHGKKIVHFDLKSDNLLVNL 1027
Query: 1017 RDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAM 1076
RDP RPICKVGD GLS++KC TL+SGGVRGTLPWMAPELLNG+++ VSEKVDV+SFGI +
Sbjct: 1028 RDPHRPICKVGDLGLSKVKCQTLISGGVRGTLPWMAPELLNGTSSLVSEKVDVFSFGIVL 1087
Query: 1077 WEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
WE+ TGEEPYA++H GAIIGGI+SNTLRPQIP+ CD +W+ LME CWS P+ RPSFTEI
Sbjct: 1088 WELFTGEEPYADLHYGAIIGGIVSNTLRPQIPDFCDMDWKLLMERCWSAEPSERPSFTEI 1147
Query: 1137 TNRLRVMSTALQTKRR 1152
N LR M+T L +K +
Sbjct: 1148 VNELRTMATKLPSKEQ 1163
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 2.1e-41, P = 2.1e-41
Identities = 111/293 (37%), Positives = 161/293 (54%)
Query: 853 SISDAAM--AEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSC 910
S S + M +M++ +I+ + DL +++G G+ GTVY G W G+D+A+K K
Sbjct: 462 STSSSVMNKVDMDSDCLDYEILWE-DLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQE 520
Query: 911 FLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHV 970
+ SE+ +I F +E ++ L HPNV+ F G V + P + VTE++ GSL +
Sbjct: 521 Y----SEE--IITSFKQEVSLMKRLRHPNVLLFMGAVAS-PQ-RLCIVTEFLPRGSLFRL 572
Query: 971 LARXXXXXXXXXXXXXXXXAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGD 1028
L R A GM YLH + I+H DLK NLLV+ + KV D
Sbjct: 573 LQRNKSKLDLRRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVD----RNWTVKVAD 628
Query: 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088
FGLSRIK T ++ RGT WMAPE+L N EK DVYSFG+ +WE++T + P+ N
Sbjct: 629 FGLSRIKHETYLTTNGRGTPQWMAPEVLR--NEAADEKSDVYSFGVVLWELVTEKIPWEN 686
Query: 1089 MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
++ +IG + R ++P+ DP+W LME CW P RPSF E+ ++LR
Sbjct: 687 LNAMQVIGAVGFMNQRLEVPKDVDPQWIALMESCWHSEPQCRPSFQELMDKLR 739
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 428 (155.7 bits), Expect = 5.6e-40, Sum P(2) = 5.6e-40
Identities = 100/287 (34%), Positives = 146/287 (50%)
Query: 876 DLEELQ---ELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQ-EWLIKEFWREAHI 931
DL +L G FG +Y+G + G D+AIK +++ S E+ +++ ++F +E +
Sbjct: 126 DLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERP---ENSPEKAQFMEQQFQQEVSM 182
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARXXXXXX-XXXXXXXXXXA 990
++NL HPN+V F G P VTEY GS+R L R
Sbjct: 183 LANLKHPNIVRFIGACRK-PM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 240
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPW 1050
A GM Y+H +N +H DLK DNLL++ + I K+ DFG++RI+ T GT W
Sbjct: 241 ARGMAYVHGRNFIHRDLKSDNLLISA---DKSI-KIADFGVARIEVQTEGMTPETGTYRW 296
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110
MAPE++ + ++KVDVYSFGI +WE+ITG P+ NM +++ +RP +P
Sbjct: 297 MAPEMIQ--HRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPND 354
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNHAIR 1157
C P +M CW NP RP F E+ L T + T R R
Sbjct: 355 CLPVLSDIMTRCWDANPEVRPCFVEVVKLLEAAETEIMTTARKARFR 401
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 6.5e-40, Sum P(2) = 6.5e-40
Identities = 103/273 (37%), Positives = 144/273 (52%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
+DL + +G G++G VY W GT++A+K+ F G + + EF E I+
Sbjct: 667 NDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA------LAEFRSEVRIMRR 720
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARXXXXXXXXXXXXXXXXAAFGM 994
L HPNVV F G V P ++ VTE++ GSL +L R A GM
Sbjct: 721 LRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGM 778
Query: 995 EYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG-GVRGTLPWM 1051
LH IVH DLK NLLV D + KVGDFGLSR+K NT +S GT WM
Sbjct: 779 NCLHTSTPTIVHRDLKTPNLLV---DNNWNV-KVGDFGLSRLKHNTFLSSKSTAGTPEWM 834
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
APE+L N +EK DVYSFG+ +WE+ T P+ M+ ++G + R +IP+
Sbjct: 835 APEVLR--NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKEL 892
Query: 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
DP +++ ECW +P RPSF ++T L+ ++
Sbjct: 893 DPVVGRIILECWQTDPNLRPSFAQLTEVLKPLN 925
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1157 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-75 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-74 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-73 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-59 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-55 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-49 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-48 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-48 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-46 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-45 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 3e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-44 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-43 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-43 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-42 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-42 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-40 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-40 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-39 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-39 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-38 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-38 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-38 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-37 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-37 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-36 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-35 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-34 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-34 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-34 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-34 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-34 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-34 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-33 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-33 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-32 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-32 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-31 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-31 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-31 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-30 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-30 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-30 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-30 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-30 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-29 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-29 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-29 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-28 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-28 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-28 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-28 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-28 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-27 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-26 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-24 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-22 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-21 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 2e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-21 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 3e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-20 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 1e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-19 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-19 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-18 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-17 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-15 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.002 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 1e-75
Identities = 102/278 (36%), Positives = 141/278 (50%), Gaps = 34/278 (12%)
Query: 877 LEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
LE ++LG G FG VY+G +G T +A+K +K+ +SE+E +EF EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-----ASEEE--REEFLEEAS 53
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
I+ L HPN+V GV G + VTEYM G L L + L + L + +
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGT 1047
A GMEYL KN VH DL N LV + + K+ DFGLSR GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT----ENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMH----CGAIIGGILSNT 1102
+ WMAPE L + + + K DV+SFG+ +WEI T GE+PY M + G
Sbjct: 168 IKWMAPESLK--DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG----- 220
Query: 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
R PE C E +LM +CW+++P RP+F+E+ L
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 3e-74
Identities = 99/274 (36%), Positives = 138/274 (50%), Gaps = 26/274 (9%)
Query: 877 LEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
L ++LG G FG VY+G +G ++A+K +K+ +SEQ+ I+EF REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQ--IEEFLREAR 53
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARKDRILDRRKKLMLMMD 989
I+ L HPN+V GV + V EYM G L L + + L L +
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMI--VMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGT 1047
A GMEYL KN +H DL N LV + + K+ DFGLSR + G +
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
+ WMAPE L + + K DV+SFG+ +WEI T GEEPY M ++ + R
Sbjct: 168 IRWMAPESLK--EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG-YRLP 224
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P C PE KLM +CW+ +P RP+F+E+ L
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 4e-73
Identities = 99/273 (36%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 877 LEELQELGSGTFGTVYRGKWRGT------DIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
L ++LG G FG VY+GK +G ++A+K +K+ SEQ+ I+EF REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-----SEQQ--IEEFLREAR 53
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
I+ L HPNVV GV + V EYM G L L + L L +
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYI--VMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQI 111
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGTL 1048
A GMEYL KN +H DL N LV + + K+ DFGLSR + G + +
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
WMAPE L + + K DV+SFG+ +WEI T GE+PY M ++ + + R
Sbjct: 168 RWMAPESLK--EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQ 224
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P C PE LM +CW+ +P RP+F+E+ L
Sbjct: 225 PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 8e-68
Identities = 101/282 (35%), Positives = 135/282 (47%), Gaps = 43/282 (15%)
Query: 882 ELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+LG G FG VY+GK +G T++A+K +K+ +SE+E K+F +EA ++ L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEE--RKDFLKEARVMKKLG 54
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR---------ILDRRKKLMLM 987
HPNVV GV + V EYM G L L RK R L + L
Sbjct: 55 HPNVVRLLGVCTEE--EPLYLVLEYMEGGDLLDYL-RKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV--- 1044
+ A GMEYL K VH DL N LV + + K+ DFGLSR +
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISDFGLSR----DVYDDDYYRK 163
Query: 1045 --RGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099
G LP WMAPE L + + K DV+SFG+ +WEI T G PY + ++ L
Sbjct: 164 KTGGKLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-YL 220
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
R PE C E +LM CW +P RP+F+E+ RL
Sbjct: 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 1e-59
Identities = 89/269 (33%), Positives = 139/269 (51%), Gaps = 24/269 (8%)
Query: 877 LEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
E L++LGSG+FGTVY+ K +GT A+K +KK SE+ + RE I+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR------SEKSKKDQTARREIRILRR 54
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLMMDAAFG 993
L HPN+V + V EY G L L+R + D KK+ L + G
Sbjct: 55 LSHPNIVRLIDAF--EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI--LRG 110
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-CNTLVSGGVRGTLPWMA 1052
+EYLH I+H DLK +N+L++ + + K+ DFGL++ ++ GT +MA
Sbjct: 111 LEYLHSNGIIHRDLKPENILLD----ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--ANMHCG-AIIGGILSNTLRPQIPE 1109
PE+L G N KVDV+S G+ ++E++TG+ P+ N+ +I IL L P+
Sbjct: 167 PEVLLGGNG-YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK 225
Query: 1110 RCD--PEWRKLMEECWSFNPAARPSFTEI 1136
E + L+++C + +P+ RP+ EI
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 22/264 (8%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E L++LG G+FG VY + + T +AIK IKK + + + RE I+ L
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-------KIKKDRERILREIKILKKL 54
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLMMDAAFGM 994
HPN+V Y V + + V EY G L +L ++ R+ D + + + +
Sbjct: 55 KHPNIVRLYDVFEDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI--LSAL 110
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPE 1054
EYLH K IVH DLK +N+L++ + K+ DFGL+R GT +MAPE
Sbjct: 111 EYLHSKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM-HCGAIIGGILSNTLRPQIPE-RCD 1112
+L G + VD++S G+ ++E++TG+ P+ + I PE
Sbjct: 167 VLLG--KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS 224
Query: 1113 PEWRKLMEECWSFNPAARPSFTEI 1136
PE + L+ + +P R + E
Sbjct: 225 PEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 80/261 (30%), Positives = 124/261 (47%), Gaps = 49/261 (18%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FGTVY + + T +AIK IKK + L++E RE I+ L+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-------DSSSLLEELLREIEILKKLNHPNI 53
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK 1000
V YGV + + V EY GSL+ +L + L + L +++ G+EYLH
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN-TLVSGGVRGTLPWMAPELLNGS 1059
I+H DLK +N+L++ + + K+ DFGLS++ + + + GT +MAPE+L G
Sbjct: 112 GIIHRDLKPENILLDSDNGK---VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG- 167
Query: 1060 NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLM 1119
SEK D++S G+ ++E+ PE + L+
Sbjct: 168 KGYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 1120 EECWSFNPAARPSFTEITNRL 1140
+ +P RPS EI L
Sbjct: 195 RKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-49
Identities = 96/273 (35%), Positives = 138/273 (50%), Gaps = 26/273 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
I +L+ +G G FG V G +RG +A+K +K + + F EA +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK---------DDSTAAQAFLAEASV 53
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDA 990
++ L HPN+V GVV G + VTEYM GSL L + R ++ ++L +D
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYI--VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP- 1049
GMEYL KN VH DL N+LV+ + KV DFGL++ SG LP
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDSG----KLPV 163
Query: 1050 -WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W APE L + S K DV+SFGI +WEI + G PY + ++ + R +
Sbjct: 164 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEA 220
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
PE C PE K+M++CW +PA RP+F ++ +L
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 1e-48
Identities = 95/274 (34%), Positives = 136/274 (49%), Gaps = 24/274 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGT-DIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I S+L L+ELGSG FG V+ GKWRG D+AIK I++ G SE + F EA
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSEDD-----FIEEAK 51
Query: 931 IISNLHHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ L HPN+V YGV P + VTEYM NG L + L + L L + D
Sbjct: 52 VMMKLSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT--LVSGGVRGT 1047
MEYL +H DL N LV + + KV DFGL+R + S G +
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQGTKFP 164
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
+ W PE+ + +R S K DV+SFG+ MWE+ + G+ PY ++ + + +
Sbjct: 165 VKWAPPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR 222
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P+ E +M CW P RP+F ++ ++L
Sbjct: 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-48
Identities = 80/260 (30%), Positives = 131/260 (50%), Gaps = 21/260 (8%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G+FG+VY + T +A+K ++ L SE+E ++ RE I+S+L HPN+
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEE--LEALEREIRILSSLQHPNI 61
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR-KKLMLMMDAAFGMEYLHM 999
V +YG + T+ EY+ GSL +L + ++ + +K + G+ YLH
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEGLAYLHS 119
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK---CNTLVSGGVRGTLPWMAPELL 1056
IVH D+K N+LV+ + K+ DFG ++ +G VRGT WMAPE++
Sbjct: 120 NGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAIIGGILSNTLRPQIPERCDPEW 1115
G D++S G + E+ TG+ P++ + A + I S+ P+IPE E
Sbjct: 176 RGEE--YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 1116 RKLMEECWSFNPAARPSFTE 1135
+ + +C +P RP+ E
Sbjct: 234 KDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 91/272 (33%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 881 QELGSGTFGTVYRGKWRGT-----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ +G G FG V RG+ + D+AIK +K S+++ L +F EA I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLTEASIMGQF 62
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPN++ GVV + +TEYM NGSL L D + + ++ A GM+
Sbjct: 63 DHPNIIRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN---TLVSGGVRGTLPWMA 1052
YL N VH DL N+LVN +CKV DFGLSR + T + G + + W A
Sbjct: 121 YLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
PE + + + + DV+SFGI MWE+++ GE PY +M +I + R P C
Sbjct: 177 PEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPMDC 233
Query: 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+LM +CW + RP+F++I + L M
Sbjct: 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 86/288 (29%), Positives = 145/288 (50%), Gaps = 33/288 (11%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR------GTDIAIKRIKKSCFLGRSSEQEWLI 922
L+I+K+++LE+++ LGSG FGTVY+G W +AIK +++ +
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKA-----N 53
Query: 923 KEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL-RHVLARKDRILDRR 981
KE EA++++++ HP+VV G+ + +T+ M G L +V KD I
Sbjct: 54 KEILDEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNI---G 107
Query: 982 KKLML--MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KC 1036
+ +L + A GM YL K +VH DL N+LV + PQ K+ DFGL+++
Sbjct: 108 SQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLDVDE 163
Query: 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAII 1095
+ G + + WMA E + + + K DV+S+G+ +WE++T G +PY + I
Sbjct: 164 KEYHAEGGKVPIKWMALESIL--HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEI 220
Query: 1096 GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+L R P C + ++ +CW + +RP+F E+ N M
Sbjct: 221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 92/278 (33%), Positives = 139/278 (50%), Gaps = 24/278 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
++ +D+ +LG G +G VY G W+ +A+K +K E ++EF +EA
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEA 53
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMM 988
++ + HPN+V GV P +TE+M G+L L +R ++ L +
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS-GGVRG 1046
+ MEYL KN +H DL N LV + + KV DFGLSR + +T + G +
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKF 167
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105
+ W APE L + N+ S K DV++FG+ +WEI T G PY + + +L R
Sbjct: 168 PIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRM 224
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+ PE C P+ +LM CW +NP+ RPSF EI M
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-45
Identities = 59/98 (60%), Positives = 75/98 (76%), Gaps = 4/98 (4%)
Query: 188 LCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQPH--TIKYQLPG 245
LCS+GGRI PRP DG+LRYVGGETRI+S+ +S++++EL+ K S + T+KYQLP
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 246 EDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFL 283
EDLDALISV +DEDL +M+EEY GGS RLR+FL
Sbjct: 61 EDLDALISVSNDEDLKNMMEEYDRLS--GGSARLRVFL 96
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 94/277 (33%), Positives = 132/277 (47%), Gaps = 29/277 (10%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I + ++ L++LG+G FG V+ G W T +A+K +K G K+F EA
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP----GTMDP-----KDFLAEAQ 53
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD- 989
I+ L HP ++ Y V + VTE M GSL L R KL ++D
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEE--PIYIVTELMKYGSLLEYLQGGA---GRALKLPQLIDM 108
Query: 990 ---AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS-GGV 1044
A GM YL +N +H DL N+LV + ICKV DFGL+R IK + + G
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADFGLARVIKEDIYEAREGA 164
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
+ + W APE NR S K DV+SFGI + EI+T G PY M ++ +
Sbjct: 165 KFPIKWTAPEAAL--YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR 222
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P P C E +M +CW +P RP+F + +L
Sbjct: 223 MPC-PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 99/267 (37%), Positives = 142/267 (53%), Gaps = 25/267 (9%)
Query: 881 QELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN 939
+++G G FG VY+G + T++A+K +C RS+ L ++F +EA I+ HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TC---RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 940 VVAFYGV-VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH 998
+V GV V P + V E + GSL L +K L +K L + +DAA GMEYL
Sbjct: 54 IVKLIGVCVQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL--VSGGVRGTLP--WMAPE 1054
KN +H DL N LV + + K+ DFG+SR + + VS G +P W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113
LN R + + DV+S+GI +WE + G+ PY M I S P P+ C
Sbjct: 166 ALN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPE 222
Query: 1114 EWRKLMEECWSFNPAARPSFTEITNRL 1140
E +LM +CW+++P RPSF+EI N L
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 92/269 (34%), Positives = 132/269 (49%), Gaps = 27/269 (10%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I L+ ++LG+G FG V+ G W G T +A+K +K G S + +L +EA
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP----GTMSPEAFL-----QEAQ 53
Query: 931 IISNLHHPNVVAFYGVVPNG-PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
I+ L H +V Y V P + VTEYM GSL L + R ++ M
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEP---IYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMA 109
Query: 990 A--AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS-GGVR 1045
A A GM YL +N +H DL N+LV + +CK+ DFGL+R I+ + + G +
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADFGLARLIEDDEYTAREGAK 165
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104
+ W APE N R + K DV+SFGI + EI+T G PY M ++ +
Sbjct: 166 FPIKWTAPEAAN--YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM 223
Query: 1105 PQIPERCDPEWRKLMEECWSFNPAARPSF 1133
P+ P C E LM +CW +P RP+F
Sbjct: 224 PR-PPNCPEELYDLMLQCWDKDPEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-43
Identities = 93/292 (31%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIK 923
+ + ++ELG G+FG VY G +G T +AIK + +S +E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-----ENASMRE--RI 54
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNG-PGGTMATVTEYMVNGSLRHVLARKDR------ 976
EF EA ++ + +VV GVV G P T+ V E M G L+ L R R
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQP--TL-VVMELMAKGDLKSYL-RSRRPEAENN 110
Query: 977 ----ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
+K + + + A GM YL K VH DL N +V K+GDFG++
Sbjct: 111 PGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMT 166
Query: 1033 RIKCNT-LVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYAN 1088
R T G +G LP WMAPE L + + K DV+SFG+ +WE+ T E+PY
Sbjct: 167 RDIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224
Query: 1089 MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
+ ++ ++ PE C + +LM CW +NP RP+F EI + L
Sbjct: 225 LSNEEVLKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 85/265 (32%), Positives = 131/265 (49%), Gaps = 21/265 (7%)
Query: 880 LQELGSGTFGTVYRGKWRGT-DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
++LGSG FG V+ G W+ +AIK +K S+ ++F +E + L H
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALKRLRHK 62
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYL 997
++++ + V G + +TE M GSL L + ++L + + A GM YL
Sbjct: 63 HLISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGTLPWMAPELL 1056
+N +H DL N+LV + +CKV DFGL+R IK + +S + W APE
Sbjct: 121 EEQNSIHRDLAARNILVG----EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
+ + S K DV+SFGI ++E+ T G+ PY M+ + I + P P +C E
Sbjct: 177 S--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC-PAKCPQEI 233
Query: 1116 RKLMEECWSFNPAARPSFTEITNRL 1140
K+M ECW+ P RPSF + L
Sbjct: 234 YKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 91/272 (33%), Positives = 130/272 (47%), Gaps = 32/272 (11%)
Query: 882 ELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
ELG G FG+V +G + ++A+K +K+ + + KEF REA +++ L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ----EHIAAGK---KEFLREASVMAQLD 54
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
HP +V GV G + V E G L L +K R + L A GM Y
Sbjct: 55 HPCIVRLIGVC-KGEP--LMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAY 110
Query: 997 LHMKNIVHFDLKCDN-LLVNLRDPQRPICKVGDFGLSR-IKCN----TLVSGGVRGTLPW 1050
L K+ VH DL N LLVN R K+ DFG+SR + + G R L W
Sbjct: 111 LESKHFVHRDLAARNVLLVN-----RHQAKISDFGMSRALGAGSDYYRATTAG-RWPLKW 164
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109
APE +N + S K DV+S+G+ +WE + G +PY M GA + +L + R PE
Sbjct: 165 YAPECIN--YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGERLPRPE 221
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
C E +M CW + P RP+F+E+ + R
Sbjct: 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 87/277 (31%), Positives = 131/277 (47%), Gaps = 39/277 (14%)
Query: 881 QELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++LG G+FG V RG+W + +A+K C L + ++ +F +EA I+ +L
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-----C-LKSDKLSD-IMDDFLKEAAIMHSL 53
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLM-------M 988
H N++ YGVV P + VTE GSL DR+ L+ +
Sbjct: 54 DHENLIRLYGVVLTHP---LMMVTELAPLGSLL------DRLRKDALGHFLISTLCDYAV 104
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR----IKCNTLVSGGV 1044
A GM YL K +H DL N+L+ D K+GDFGL R + + ++ +
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
+ W APE L S DV+ FG+ +WE+ T GEEP+A + I+ I
Sbjct: 161 KVPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE 218
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
R + PE C + +M +CW+ NPA RP+F + L
Sbjct: 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 94/269 (34%), Positives = 127/269 (47%), Gaps = 22/269 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGT-DIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I DL L+ELG+G FG V GKWRG D+AIK IK+ G SE E F EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
++ L H +V YGV + VTEYM NG L + L + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQR--PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV 109
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP- 1049
GM YL K +H DL N LV+ + KV DFGLSR + + V P
Sbjct: 110 CEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 1050 -WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W PE+L S + S K DV++FG+ MWE+ + G+ PY + + + S LR
Sbjct: 166 RWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-SQGLRLYR 222
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P + +M CW RP+F ++
Sbjct: 223 PHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 89/299 (29%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIK 923
++ + +ELG G FG V+ G+ +A+K +K++ K
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARK 53
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKK 983
+F REA +++N H N+V FYGV G M V EYM +G L L K
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTEGDPPIM--VFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 984 -------------LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLV--NLRDPQRPICKVGD 1028
L + + A GM YL ++ VH DL N LV +L + K+GD
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL------VVKIGD 165
Query: 1029 FGLSR--IKCNTLVSGGVRGTLP--WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIIT-G 1082
FG+SR + GG LP WM PE ++ + + + DV+SFG+ +WEI T G
Sbjct: 166 FGMSRDVYTTDYYRVGGHT-MLPIRWMPPESIMYR---KFTTESDVWSFGVVLWEIFTYG 221
Query: 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
++P+ + +I I L Q P C E +M CW +P R + +I RL+
Sbjct: 222 KQPWYGLSNEEVIECITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-39
Identities = 92/274 (33%), Positives = 135/274 (49%), Gaps = 24/274 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGT-DIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I S+L ++ELGSG FG V+ GKWR +AIK I + G SE++ F EA
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEED-----FIEEAK 51
Query: 931 IISNLHHPNVVAFYGV-VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ L HP +V YGV P + VTE+M NG L + L ++ L + L + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLVSGGVRGT 1047
GMEYL + +H DL N LV+ + KV DFG++R + S G +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
+ W PE+ N ++ S K DV+SFG+ MWE+ T G+ P+ ++ I S R
Sbjct: 165 VKWSPPEVFN--FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-SRGFRLY 221
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P+ ++M CW P RP+F E+ +
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 92/270 (34%), Positives = 134/270 (49%), Gaps = 26/270 (9%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+L+ LQ +G G FG V G +RG +A+K IK + + F EA +++ L
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----------NDATAQAFLAEASVMTQL 56
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDAAFGM 994
H N+V GV+ GG + VTEYM GSL L + R +L L +D M
Sbjct: 57 RHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP--WMA 1052
EYL N VH DL N+LV+ + + KV DFGL++ +T +G LP W A
Sbjct: 116 EYLEANNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTG----KLPVKWTA 167
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
PE L + S K DV+SFGI +WEI + G PY + ++ + + P+ C
Sbjct: 168 PEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGC 224
Query: 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
P +M++CW + A RPSF ++ +L
Sbjct: 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 100/295 (33%), Positives = 138/295 (46%), Gaps = 44/295 (14%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
S + L+ELG G FG VY+G+ G T +AIK +K++ + + +EF +
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-----AEPKVQ--QEFRQ 57
Query: 928 EAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD------------ 975
EA ++S+L HPN+V GV M + EY+ +G L L R
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCM--LFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 976 ---RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
LD L + + A GMEYL + VH DL N LV + K+ DFGLS
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTV-KISDFGLS 171
Query: 1033 R-IKCNTLVSGGVRGTLP--WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYA 1087
R I + LP WM PE +L G + + + D++SFG+ +WEI + G +PY
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYG---KFTTESDIWSFGVVLWEIFSYGLQPYY 228
Query: 1088 NMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142
+I I S L P PE C LM ECW+ PA RP F +I RLR
Sbjct: 229 GFSNQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 89/274 (32%), Positives = 135/274 (49%), Gaps = 24/274 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I S+L +QE+GSG FG V+ G W +AIK I++ G SE++ F EA
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEED-----FIEEAQ 51
Query: 931 IISNLHHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ L HP +V YGV P + V E+M +G L L + + L + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSP---ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT--LVSGGVRGT 1047
GM YL N++H DL N LV + + KV DFG++R + S G +
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFP 164
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
+ W +PE+ S ++ S K DV+SFG+ MWE+ + G+ PY N ++ I + R
Sbjct: 165 VKWSSPEVF--SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLY 221
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P +LM+ CW P RPSF+ + ++L
Sbjct: 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 99/279 (35%), Positives = 145/279 (51%), Gaps = 35/279 (12%)
Query: 883 LGSGTFGTVYRGKWRGTD--------IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
LGSG FG VY G +A+K ++K +++QE KEF +EAH++SN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-----ATDQEK--KEFLKEAHLMSN 55
Query: 935 LHHPNVVAFYGV-VPNGPGGTMATVTEYMVNGSLRHVL--ARKDR----ILDRRKKLMLM 987
+HPN+V GV + N P + E M G L L AR +R +L ++ L +
Sbjct: 56 FNHPNIVKLLGVCLLNEP---QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP-ICKVGDFGLSR-IKCNTLVSGGVR 1045
+D A G YL + +H DL N LV+ + + K+GDFGL+R I +
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
Query: 1046 GTLP--WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101
G LP WMAPE LL+G S DV+SFG+ MWEI+T G++PY ++ ++ + +
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQS---DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
R Q PE C + +LM CW+ +P+ RP+F I L
Sbjct: 230 G-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 87/271 (32%), Positives = 137/271 (50%), Gaps = 29/271 (10%)
Query: 876 DLEEL---QELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
+L++L + +G G FG V +G++ G +A+K IK C + + F E ++
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--C--------DVTAQAFLEETAVM 53
Query: 933 SNLHHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM-LMMDA 990
+ LHH N+V GV+ NG + V E M G+L + L + R L +L+ +D
Sbjct: 54 TKLHHKNLVRLLGVILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV 109
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPW 1050
A GMEYL K +VH DL N+LV+ + + KV DFGL+R+ ++ + + W
Sbjct: 110 AEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGLARV--GSMGVDNSKLPVKW 163
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109
APE L + + S K DV+S+G+ +WE+ + G PY M + + R + PE
Sbjct: 164 TAPEALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-KECVEKGYRMEPPE 220
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
C + LM CW P RPSF ++ +L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 88/278 (31%), Positives = 132/278 (47%), Gaps = 27/278 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
I+ D+ + +G G FG VY+G + +A+K K ++F
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-------EKFL 55
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
+EA+I+ HP++V GV+ P + V E G LR L LD ++
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILY 112
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC-KVGDFGLSRIKCNTLVSGGVR 1045
+ + YL K VH D+ N+LV+ P C K+GDFGLSR + +
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESYYKASK 167
Query: 1046 GTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT 1102
G LP WMAPE +N R + DV+ FG+ MWEI+ G +P+ + +IG I N
Sbjct: 168 GKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENG 224
Query: 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
R +P C P LM +CW+++P+ RP FTE+ +L
Sbjct: 225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 881 QELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+G G FG VY+G G +AIK+I E +K +E ++ NL HP
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLE---KIKEEA---LKSIMQEIDLLKNLKHP 59
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF------ 992
N+V + G + ++ + EY NGSLR +I+ + + A +
Sbjct: 60 NIVKYIGSIETS--DSLYIILEYAENGSLR-------QIIKKFGPFPESLVAVYVYQVLQ 110
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWM 1051
G+ YLH + ++H D+K N+L + K+ DFG++ ++ + V GT WM
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDG----VVKLADFGVATKLNDVSKDDASVVGTPYWM 166
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
APE++ S S D++S G + E++TG PY +++ A + I+ + P +PE
Sbjct: 167 APEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGI 223
Query: 1112 DPEWRKLMEECWSFNPAARPS 1132
PE + + +C+ +P RP+
Sbjct: 224 SPELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 91/262 (34%), Positives = 134/262 (51%), Gaps = 24/262 (9%)
Query: 877 LEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
L+ +++LG+G FG V+ G + G T +AIK +K+ G S + F EA+++ L
Sbjct: 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQ----GSMS-----PEAFLAEANLMKQL 58
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLM-MDAAFGM 994
HP +V Y VV P + +TEYM NGSL L + I KL+ M A GM
Sbjct: 59 QHPRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT--LVSGGVRGTLPWMA 1052
++ KN +H DL+ N+LV+ + CK+ DFGL+R+ + G + + W A
Sbjct: 116 AFIERKNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA 171
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
PE +N + K DV+SFGI + EI+T G PY M +I + P+ P+ C
Sbjct: 172 PEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-PDNC 228
Query: 1112 DPEWRKLMEECWSFNPAARPSF 1133
E +LM CW P RP+F
Sbjct: 229 PEELYELMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 84/277 (30%), Positives = 132/277 (47%), Gaps = 47/277 (16%)
Query: 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
E L+++G G FG VY+ + + G ++AIK IK L ++E +I E I+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK----LESKEKKEKII----NEIQILK 52
Query: 934 NLHHPNVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK-----KLML 986
HPN+V +YG + + M E+ GSL+ +L ++ L + K +L
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVM----EFCSGGSLKDLLKSTNQTLTESQIAYVCKELL 108
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-----RIKCNTLVS 1041
G+EYLH I+H D+K N+L+ K+ DFGLS NT+V
Sbjct: 109 K-----GLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSAQLSDTKARNTMV- 158
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101
GT WMAPE++NG K D++S GI E+ G+ PY+ + + I +N
Sbjct: 159 ----GTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN 212
Query: 1102 ---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTE 1135
LR PE+ E++ +++C NP RP+ +
Sbjct: 213 GPPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 4e-36
Identities = 92/279 (32%), Positives = 139/279 (49%), Gaps = 30/279 (10%)
Query: 877 LEELQELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+EE+ +G+G FG V RG+ R +AIK +K G + +Q ++F EA I
Sbjct: 8 IEEV--IGAGEFGEVCRGRLKLPGKREIFVAIKTLKS----GYTEKQR---RDFLSEASI 58
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ HPN++ GVV + +TE+M NG+L L + D + + ++ A
Sbjct: 59 MGQFDHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIA 116
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI----KCNTLVSGGVRGT 1047
GM+YL N VH DL N+LVN +CKV DFGLSR + + + G
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 1048 LP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104
+P W APE + + + + DV+S+GI MWE+++ GE PY +M +I I +
Sbjct: 173 IPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL 230
Query: 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
P P C +LM +CW + ARP F +I + L M
Sbjct: 231 PP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 877 LEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
L+ +++LG G FG V ++ G +A+K + S +E +F RE
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-------EEQHRSDFEREIE 58
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
I+ L H N+V + GV G ++ + EY+ +GSLR L R ++ ++ L+
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP- 1049
GM+YL + +H DL N+LV + + + K+ DFGL+++ P
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILV---ESEDLV-KISDFGLAKVL--PEDKDYYYVKEPG 172
Query: 1050 -----WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI----- 1098
W APE L ++ S DV+SFG+ ++E+ T G+ + + GI
Sbjct: 173 ESPIFWYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230
Query: 1099 ----LSNTLRPQI----PERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
L L+ P C E LM+ CW P RPSF ++ +
Sbjct: 231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 82/293 (27%), Positives = 140/293 (47%), Gaps = 61/293 (20%)
Query: 870 QIIKDSD----LEELQELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIK 923
I+ + D + L+++G G G VY+ R T ++AIK+++ L + +++ LI
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKE--LII 63
Query: 924 EFWREAHIISNLHHPNVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR 981
E I+ + HPN+V +Y +V G + V EYM GSL ++ + ++
Sbjct: 64 ---NEILIMKDCKHPNIVDYYDSYLV----GDELWVVMEYMDGGSLTDIITQNFVRMNEP 116
Query: 982 KKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIK 1035
+ + + G+EYLH +N++H D+K DN+L++ + K+ DFG + + K
Sbjct: 117 QIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----KDGSVKLADFGFAAQLTKEKSK 172
Query: 1036 CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII 1095
N++V GT WMAPE++ + KVD++S GI E+ GE PY
Sbjct: 173 RNSVV-----GTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLRE------ 219
Query: 1096 GGILSNTLR----------PQI--PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
LR P + PE+ PE++ + +C +P RPS E+
Sbjct: 220 -----PPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-34
Identities = 89/271 (32%), Positives = 128/271 (47%), Gaps = 30/271 (11%)
Query: 882 ELGSGTFGTV----YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
ELGSG FG V Y+ + + D+AIK +K + ++ + E REA I+ L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK-------NENEKSVRDEMMREAEIMHQLDN 54
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
P +V GV + V E G L L+ K + + LM + GM+YL
Sbjct: 55 PYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 998 HMKNIVHFDLKCDN-LLVNLRDPQRPICKVGDFGLSRI-----KCNTLVSGGVRGTLPWM 1051
KN VH DL N LLVN + K+ DFGLS+ S G + L W
Sbjct: 112 EGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWY 165
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPER 1110
APE +N + S + DV+S+GI MWE + G++PY M ++ I R P
Sbjct: 166 APECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAE 222
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
C PE LM++CW + RP+F ++ R+R
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-34
Identities = 93/282 (32%), Positives = 132/282 (46%), Gaps = 43/282 (15%)
Query: 883 LGSGTFGTVYRGKWRGTD-----IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
LG G FG+V G+ D +A+K +K L + E I+EF EA + + H
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMK----LDIHTYSE--IEEFLSEAACMKDFDH 60
Query: 938 PNVVAFYGVV-----PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML------ 986
PNV+ GV M + +M +G L L R+ +KL L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPM-VILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKF 118
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG---- 1042
M+D A GMEYL +N +H DL N + LR+ +C V DFGLS+ + SG
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM--LREDMT-VC-VADFGLSK----KIYSGDYYR 170
Query: 1043 -GVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
G +P W+A E L ++ + K DV++FG+ MWEI T G+ PY + I
Sbjct: 171 QGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-NHEIYDY 227
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
L + R + PE C E LM CW +P RP+FT++ L
Sbjct: 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 91/268 (33%), Positives = 133/268 (49%), Gaps = 26/268 (9%)
Query: 883 LGSGTFGTVYRG--KWRG---TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+G+G FG V+RG K G +AIK +K G + +Q ++F EA I+ H
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKP----GYTEKQR---QDFLSEASIMGQFSH 65
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
N++ GVV +TEYM NG+L L D + + ++ A GM+YL
Sbjct: 66 HNIIRLEGVVTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN----TLVSGGVRGTLPWMAP 1053
N VH DL N+LVN CKV DFGLSR+ + T + G + + W AP
Sbjct: 124 SDMNYVHRDLAARNILVN----SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
E + + + + DV+SFGI MWE+++ GE PY +M ++ I ++ R P C
Sbjct: 180 EAI--AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCP 236
Query: 1113 PEWRKLMEECWSFNPAARPSFTEITNRL 1140
+LM +CW + A RP F +I N L
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 92/270 (34%), Positives = 137/270 (50%), Gaps = 27/270 (10%)
Query: 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
+I ++S L+ +++LG+G FG V+ G W G T +A+K +K G S + +L E
Sbjct: 2 EIPRES-LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKP----GTMSPESFL-----EE 51
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLM 987
A I+ L H +V Y VV P + VTEYM GSL L + R L + +
Sbjct: 52 AQIMKKLRHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA 108
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS-GGVR 1045
A GM Y+ N +H DL+ N+LV +CK+ DFGL+R I+ N + G +
Sbjct: 109 AQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 1046 GTLPWMAPEL-LNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
+ W APE L G R + K DV+SFGI + E++T G PY M+ ++ +
Sbjct: 165 FPIKWTAPEAALYG---RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGY 220
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSF 1133
R P+ C +LM +CW +P RP+F
Sbjct: 221 RMPCPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-34
Identities = 88/266 (33%), Positives = 133/266 (50%), Gaps = 22/266 (8%)
Query: 881 QELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+ +G G FG V+ G+ R T +A+K SC R + L +F +EA I+ HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK----SC---RETLPPDLKAKFLQEARILKQYSHP 53
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH 998
N+V GV + V E + G L + L ++ + ++ +AA GMEYL
Sbjct: 54 NIVRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE 111
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL--VSGGVRGT-LPWMAPEL 1055
K+ +H DL N LV ++ + K+ DFG+SR + + + +GG++ + W APE
Sbjct: 112 SKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
LN R S + DV+SFGI +WE + G PYAN+ I +R PE C
Sbjct: 168 LN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDA 224
Query: 1115 WRKLMEECWSFNPAARPSFTEITNRL 1140
+LME CW ++P RPSF+ + L
Sbjct: 225 VYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 89/269 (33%), Positives = 129/269 (47%), Gaps = 28/269 (10%)
Query: 883 LGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+G+G FG V G+ R +AIK +K G + +Q ++F EA I+ H
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQR---RDFLSEASIMGQFDH 64
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
PN++ GVV + VTEYM NGSL L + D + + ++ A GM+YL
Sbjct: 65 PNIIHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-----KCNTLVSGGVRGTLPWMA 1052
VH DL N+LVN +CKV DFGLSR+ + GG + + W A
Sbjct: 123 SDMGYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEAAYTTRGG-KIPIRWTA 177
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
PE + + + + DV+S+GI MWE+++ GE PY M +I I P P C
Sbjct: 178 PEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-PMDC 234
Query: 1112 DPEWRKLMEECWSFNPAARPSFTEITNRL 1140
+LM +CW + RP F +I + L
Sbjct: 235 PAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 87/270 (32%), Positives = 127/270 (47%), Gaps = 36/270 (13%)
Query: 883 LGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941
LG G FG V++G + T +A+K K+ QE IK F EA I+ HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDL------PQELKIK-FLSEARILKQYDHPNIV 55
Query: 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN 1001
GV + V E + G L +K L ++ + +DAA GM YL KN
Sbjct: 56 KLIGVCTQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 1002 IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP--WMAPELLNGS 1059
+H DL N LV + + K+ DFG+SR + + + S +P W APE LN
Sbjct: 114 CIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN-- 167
Query: 1060 NNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI--------PER 1110
R S + DV+S+GI +WE + G PY G+ + R Q+ P++
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYP---------GMTNQQAREQVEKGYRMSCPQK 218
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
C + K+M+ CW + P RP F+E+ L
Sbjct: 219 CPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 92/296 (31%), Positives = 143/296 (48%), Gaps = 47/296 (15%)
Query: 877 LEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
L+ +Q+LG G FG+V ++ G +A+K+++ S ++E +++F RE
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEH---LRDFEREIE 57
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
I+ +L H N+V + GV + + V EY+ GSLR L + LD RK L+
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR--GTL 1048
GMEYL K VH DL N+LV K+GDFGL+++ VR G
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVE----SENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 1049 P--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC--------------- 1091
P W APE L ++ S DV+SFG+ ++E+ T Y++ C
Sbjct: 174 PIFWYAPESLT--ESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQ 227
Query: 1092 GAIIG----GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
G +I +L N R P C E +M+ECW+ +P+ RPSF+E+ ++ +
Sbjct: 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 41/277 (14%)
Query: 875 SDLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
SDLE ++ LG G+ G VY+ K G A+K+I G ++ L+ RE +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLL----RELKTL 53
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA- 991
+ P VV YG G ++ V EYM GSL +L + +I + +L A
Sbjct: 54 RSCESPYVVKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVGKI----PEPVLAYIARQ 107
Query: 992 --FGMEYLH-MKNIVHFDLKCDNLLVNLR-DPQRPICKVGDFGLSRI------KCNTLVS 1041
G++YLH ++I+H D+K NLL+N + + K+ DFG+S++ +CNT V
Sbjct: 108 ILKGLDYLHTKRHIIHRDIKPSNLLINSKGEV-----KIADFGISKVLENTLDQCNTFV- 161
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGI 1098
GT+ +M+PE + G + S D++S G+ + E G+ P+ ++ I
Sbjct: 162 ----GTVTYMSPERIQGESY--SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI 215
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTE 1135
E PE+R + C +P RPS E
Sbjct: 216 CDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 90/284 (31%), Positives = 133/284 (46%), Gaps = 33/284 (11%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKEFWR 927
S+L+E+ LG G FG V+ K +G + + +K ++K+ + E L EF R
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRR 57
Query: 928 EAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARKDRI-------LD 979
E + L H NVV G+ M + EY G L+ L A K + L
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 980 RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039
++K+ L A GM++L VH DL N LV+ QR KV LS+ N+
Sbjct: 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQR-EVKVSLLSLSKDVYNSE 171
Query: 1040 VSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIG 1096
+P W+APE + + S K DV+SFG+ MWE+ T GE P+ + ++
Sbjct: 172 YYKLRNALIPLRWLAPEAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN 229
Query: 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
+ + L +PE C KLM CW+ NP RPSF+E+ + L
Sbjct: 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 47/278 (16%)
Query: 878 EELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E ++++G G+FG VY R K G +K I L SE+E ++ E I+ L
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID----LSNMSEKE--REDALNEVKILKKL 56
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL-RHVLARK--------DRILDRRKKLML 986
+HPN++ +Y G + V EY G L + + +K ++ILD
Sbjct: 57 NHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD------W 108
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLV 1040
+ ++YLH + I+H D+K N+ + + K+GDFG+S++ T+V
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDLAKTVV 164
Query: 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--ANMHCGAIIGGI 1098
GT +++PEL N + K D++S G ++E+ T + P+ N+ + I
Sbjct: 165 -----GTPYYLSPELCQ--NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELALKI 215
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
L P IP + E R L+ +P RPS +I
Sbjct: 216 LKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 69/261 (26%), Positives = 122/261 (46%), Gaps = 19/261 (7%)
Query: 881 QELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+ LGSG+FG+VY G D +K+ + +K+ +E ++S L HPN+
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-----ILDRRKKLMLMMDAAFGME 995
V + G + E + GSL +L + I ++++L G+E
Sbjct: 65 VQYLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------GLE 116
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
YLH +N VH D+K N+LV D + K+ DFG+++ + +G+ WMAPE+
Sbjct: 117 YLHDRNTVHRDIKGANILV---DTNGVV-KLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
+ D++S G + E+ TG+ P++ + A + I + P IP+ E
Sbjct: 173 IA-QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231
Query: 1116 RKLMEECWSFNPAARPSFTEI 1136
+ + +C +P+ RP+ E+
Sbjct: 232 KDFILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-32
Identities = 94/299 (31%), Positives = 140/299 (46%), Gaps = 53/299 (17%)
Query: 870 QIIKDSDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLI 922
++ +DS + L+ LG G FG VY G +RG D +A+K + +SC SEQ+
Sbjct: 2 EVPRDS-ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----SEQDES- 54
Query: 923 KEFWREAHIISNLHHPNVVAFYGV----VPNGPGGTMATVTEYMVNGSLRHVLARKDR-- 976
+F EA I+S +H N+V GV +P + E M G L+ L R++R
Sbjct: 55 -DFLMEALIMSKFNHQNIVRLIGVSFERLPR------FILLELMAGGDLKSFL-RENRPR 106
Query: 977 -----ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031
L + L D A G +YL + +H D+ N L+ + P R + K+ DFG+
Sbjct: 107 PERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGM 165
Query: 1032 SR-IKCNTLVSGGVRGTLP--WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPY 1086
+R I + G R LP WM PE L+G + K DV+SFG+ +WEI + G PY
Sbjct: 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI---FTSKTDVWSFGVLLWEIFSLGYMPY 222
Query: 1087 ANMHCGAII-----GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
++ GG R P+ C ++M +CW P RP+F I R+
Sbjct: 223 PGRTNQEVMEFVTGGG------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 88/271 (32%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 883 LGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
LG+G FG V G +A+K +K + SSE+E L+ E I+S+L
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT---AHSSEREALMSEL----KIMSHL 95
Query: 936 -HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFG 993
+H N+V G G G + +TEY G L + L RK + L L A G
Sbjct: 96 GNHENIVNLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IK--CNTLVSGGVRGTLPW 1050
M +L KN +H DL N+L+ I K+ DFGL+R I N +V G R + W
Sbjct: 154 MAFLASKNCIHRDLAARNVLLT----HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109
MAPE + N + + DV+S+GI +WEI + G PY M + ++ R PE
Sbjct: 210 MAPESI--FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
E +M+ CW +P RP+F +I +
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-31
Identities = 92/280 (32%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 883 LGSGTFGTVYRGKWRGTD-----IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
LG G FG+V + + D +A+K +K F SS+ I+EF REA + H
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSD----IEEFLREAACMKEFDH 60
Query: 938 PNVVAFYGVV----PNGPGGTMATVTEYMVNGSLRHVLARKDRI------LDRRKKLMLM 987
PNV+ GV G + +M +G L H RI L + + M
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRG 1046
+D A GMEYL KN +H DL N ++N +C V DFGLS+ I G
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVC-VADFGLSKKIYSGDYYRQGCAS 175
Query: 1047 TLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
LP W+A E L ++N + DV++FG+ MWEI+T G+ PYA + I ++
Sbjct: 176 KLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
Q P+ C + +LM +CWS P RPSF + ++L ++
Sbjct: 234 LKQPPD-CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 83/268 (30%), Positives = 127/268 (47%), Gaps = 24/268 (8%)
Query: 882 ELGSGTFGTVYRGKWRGTDIAIKRIKKSC---FLGRSSEQEWLIKEFWREAHIISNLHHP 938
ELGSG FGTV +G ++ +K+ +K+ L + L E REA+++ L +P
Sbjct: 2 ELGSGNFGTVKKGMYK-----MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNP 56
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH 998
+V G+ + V E G L L K++ + + L+ + GM+YL
Sbjct: 57 YIVRMIGICE---AESWMLVMELAELGPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLE 112
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGTLP--WMAPE 1054
N VH DL N+L+ + K+ DFGLS+ G P W APE
Sbjct: 113 ETNFVHRDLAARNVLL----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113
+N + S K DV+SFG+ MWE + G++PY M + ++ + R + P+RC P
Sbjct: 169 CMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCPP 225
Query: 1114 EWRKLMEECWSFNPAARPSFTEITNRLR 1141
E LM+ CW++ RP F + RLR
Sbjct: 226 EMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 32/270 (11%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
L+ +G G+FG VY+ + T+ +AIK I L + ++ I++ +E +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDE---IEDIQQEIQFL 53
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
S P + +YG G + + EY GS +L K LD ++ +
Sbjct: 54 SQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKCNTLVSGGVRG 1046
G+EYLH + +H D+K N+L++ + K+ DFG+S K NT V G
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVSGQLTSTMSKRNTFV-----G 160
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106
T WMAPE++ + EK D++S GI E+ GE P +++H ++ I N P
Sbjct: 161 TPFWMAPEVI--KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-PS 217
Query: 1107 IPERC-DPEWRKLMEECWSFNPAARPSFTE 1135
+ ++ + C + +P RPS E
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 88/282 (31%), Positives = 144/282 (51%), Gaps = 36/282 (12%)
Query: 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
+I ++S ++ +++LG+G FG V+ G + T +A+K +K G S ++ F E
Sbjct: 2 EIPRES-IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP----GTMS-----VQAFLEE 51
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML-- 986
A+++ L H +V Y VV + +TEYM GSL L D K++L
Sbjct: 52 ANLMKTLQHDKLVRLYAVVTKEE--PIYIITEYMAKGSLLDFLKS-----DEGGKVLLPK 104
Query: 987 MMD----AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG 1042
++D A GM Y+ KN +H DL+ N+LV+ + +CK+ DFGL+R+ + +
Sbjct: 105 LIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTA 160
Query: 1043 --GVRGTLPWMAPELLN-GSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
G + + W APE +N GS + K DV+SFGI ++EI+T G+ PY M ++ +
Sbjct: 161 REGAKFPIKWTAPEAINFGS---FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P+ E C E +M+ CW RP+F + + L
Sbjct: 218 QRGYRMPR-MENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 90/294 (30%), Positives = 131/294 (44%), Gaps = 54/294 (18%)
Query: 880 LQELGSGTFGTVYRGKWR--GTD----IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
++ELG FG +Y+G G D +AIK +K ++ Q+W EF +EA +++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-----NNPQQW--GEFQQEASLMA 62
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD----------------RI 977
LHHPN+V GVV M + EY+ G L L +
Sbjct: 63 ELHHPNIVCLLGVVTQEQPVCM--LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 978 LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---- 1033
LD L + + A GMEYL VH DL N+L+ ++ K+ D GLSR
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG----EQLHVKISDLGLSREIYS 176
Query: 1034 -----IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYA 1087
++ +L+ + WM PE + + S D++SFG+ +WEI + G +PY
Sbjct: 177 ADYYRVQPKSLLP------IRWMPPEAI--MYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
Query: 1088 NMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
+I + L P E C P LM ECW P+ RP F +I RLR
Sbjct: 229 GFSNQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 83/269 (30%), Positives = 123/269 (45%), Gaps = 24/269 (8%)
Query: 883 LGSGTFGTVYRG-----KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
LG+G FG + RG R +AI ++ C S +Q + F EA + H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQR---RGFLAEALTLGQFDH 65
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
N+V GV+ G TM VTEYM NG+L L + + L + + ++ A GM+YL
Sbjct: 66 SNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG-LSRIKCNTLVSG-GVRGTLPWMAPEL 1055
VH L +LVN +CK+ F L K + + + + W APE
Sbjct: 124 SEMGYVHKGLAAHKVLVN----SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
+ + S DV+SFGI MWE+++ GE PY +M +I + + R P C
Sbjct: 180 IQ--YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNL 236
Query: 1115 WRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+LM +CW RP F++I + L M
Sbjct: 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 92/258 (35%), Positives = 125/258 (48%), Gaps = 26/258 (10%)
Query: 882 ELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+LG G FG V+ G W G T +AIK +K G S + +L +EA ++ L H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEAFL-----QEAQVMKKLRHEKL 63
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM-DAAFGMEYLHM 999
V Y VV P + VTEYM GSL L + R +L+ M A GM Y+
Sbjct: 64 VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS-GGVRGTLPWMAPE-LL 1056
N VH DL+ N+LV + +CKV DFGL+R I+ N + G + + W APE L
Sbjct: 121 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
G R + K DV+SFGI + E+ T G PY M ++ + R P C
Sbjct: 177 YG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESL 232
Query: 1116 RKLMEECWSFNPAARPSF 1133
LM +CW P RP+F
Sbjct: 233 HDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 84/265 (31%), Positives = 127/265 (47%), Gaps = 18/265 (6%)
Query: 883 LGSGTFGTVYRGKWRGTD-IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941
+G G FG VY G +D I KS L R ++ E +++F +E I+ + HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS--LNRITDLE-EVEQFLKEGIIMKDFSHPNVL 59
Query: 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN 1001
+ G+ G + V YM +G LR+ + + + + + A GMEYL K
Sbjct: 60 SLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 1002 IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLVSGGVRGTLP--WMAPELL 1056
VH DL N +++ + KV DFGL+R K V LP WMA E L
Sbjct: 119 FVHRDLAARNCMLD----ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
+ + K DV+SFG+ +WE++T G PY ++ I +L Q PE C
Sbjct: 175 Q--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ-PEYCPDPL 231
Query: 1116 RKLMEECWSFNPAARPSFTEITNRL 1140
++M CW P RP+F+E+ +R+
Sbjct: 232 YEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 92/282 (32%), Positives = 134/282 (47%), Gaps = 36/282 (12%)
Query: 880 LQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
L+ELG G+FG VY G R T +A+K + +S +S +E + EF EA ++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----ASLRERI--EFLNEASVM 63
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLA--RKD------RILDRRKKL 984
+VV GVV G V E M +G L+ L R + R +++
Sbjct: 64 KGFTCHHVVRLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 985 MLMM-DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSG 1042
+ M + A GM YL+ K VH DL N +V K+GDFG++R I
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 1043 GVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099
G +G LP WMAPE L + + D++SFG+ +WEI + E+PY + ++ ++
Sbjct: 178 GGKGLLPVRWMAPESLK--DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
Q P+ C LM CW FNP RP+F EI N L+
Sbjct: 236 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 91/268 (33%), Positives = 130/268 (48%), Gaps = 32/268 (11%)
Query: 882 ELGSGTFGTVYRGKWRGT-DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+LG G FG V+ G W GT +AIK +K + + F +EA I+ L H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQIMKKLRHDKL 63
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF----GMEY 996
V Y VV P + VTE+M GSL L D + KL ++D A GM Y
Sbjct: 64 VPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAY 117
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS-GGVRGTLPWMAPE 1054
+ N +H DL+ N+LV +CK+ DFGL+R I+ N + G + + W APE
Sbjct: 118 IERMNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 1055 L-LNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
L G R + K DV+SFGI + E++T G PY M ++ + R P+ C
Sbjct: 174 AALYG---RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCP 229
Query: 1113 PEWRKLMEECWSFNPAARPSFTEITNRL 1140
+LM+ CW +P RP+F I + L
Sbjct: 230 ESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 98/298 (32%), Positives = 138/298 (46%), Gaps = 45/298 (15%)
Query: 873 KDSDLEELQELGSGTFGTVYRG--KWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWRE 928
+D E++ +G G FG V R K G + AIK +K+ +SE + ++F E
Sbjct: 2 EDIKFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-----ASENDH--RDFAGE 52
Query: 929 AHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD-------- 979
++ L HHPN++ G N G + EY G+L L RK R+L+
Sbjct: 53 LEVLCKLGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKE 109
Query: 980 --------RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031
++ L D A GM+YL K +H DL N+LV + K+ DFGL
Sbjct: 110 HGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG----ENLASKIADFGL 165
Query: 1032 SRIKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYAN 1088
SR + G LP WMA E LN S + K DV+SFG+ +WEI++ G PY
Sbjct: 166 SR--GEEVYVKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCG 221
Query: 1089 MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
M C + L R + P CD E +LM +CW P RP F +I+ +L M A
Sbjct: 222 MTCAELYEK-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 18/269 (6%)
Query: 881 QELGSGTFGTVYRG--KWRGTDIAIKR--IKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+ +G GT+G VY G +A+K+ + + S Q+ ++K E + +L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
H N+V + G ++ EY+ GS+ L R ++ + G+ Y
Sbjct: 67 HLNIVQYLGF-ETTEE-YLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAY 123
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG---VRGTLPWMAP 1053
LH K I+H DLK DNLLV+ ICK+ DFG+S+ + + ++G++ WMAP
Sbjct: 124 LHSKGILHRDLKADNLLVD----ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE---- 1109
E+++ + S KVD++S G + E+ G P+++ A + + + P IP
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEITN 1138
P + C++ NP RP+ E+
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 92/283 (32%), Positives = 135/283 (47%), Gaps = 40/283 (14%)
Query: 881 QELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
+ELG G+FG VY G +G T +AIK + ++ +S +E + EF EA ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-----ASMRERI--EFLNEASVMK 64
Query: 934 --NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL--------ARKDRILDRRKK 983
N HH VV GVV G + E M G L+ L + KK
Sbjct: 65 EFNCHH--VVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 984 LMLMM-DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS 1041
++ M + A GM YL+ VH DL N +V + K+GDFG++R I
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYR 176
Query: 1042 GGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
G +G LP WM+PE L + + DV+SFG+ +WEI T E+PY M ++ +
Sbjct: 177 KGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
+ L + P+ C +LM CW +NP RPSF EI + ++
Sbjct: 235 MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 91/285 (31%), Positives = 132/285 (46%), Gaps = 43/285 (15%)
Query: 883 LGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HH 937
+G G FG V + + + D AIKR+K+ +S+ + ++F E ++ L HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH--RDFAGELEVLCKLGHH 55
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD----------------RR 981
PN++ G + G + EY +G+L L RK R+L+ +
Sbjct: 56 PNIINLLGACEHR--GYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQ 112
Query: 982 KKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS 1041
+ L D A GM+YL K +H DL N+LV + + K+ DFGLSR +
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSR--GQEVYV 166
Query: 1042 GGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
G LP WMA E LN S + DV+S+G+ +WEI++ G PY M C +
Sbjct: 167 KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK- 223
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
L R + P CD E LM +CW P RPSF +I L M
Sbjct: 224 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 92/293 (31%), Positives = 137/293 (46%), Gaps = 43/293 (14%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+D++ +G G FG V + + + D AIKR+K+ +S+ + ++F E
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH--RDFAGELE 59
Query: 931 IISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD---------- 979
++ L HHPN++ G + G + EY +G+L L RK R+L+
Sbjct: 60 VLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANS 116
Query: 980 ------RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
++ L D A GM+YL K +H DL N+LV + + K+ DFGLSR
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSR 172
Query: 1034 IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMH 1090
+ + G LP WMA E LN S + DV+S+G+ +WEI++ G PY M
Sbjct: 173 GQ--EVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
Query: 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
C + L R + P CD E LM +CW P RPSF +I L M
Sbjct: 229 CAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 30/270 (11%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I L+ ++LG+G FG V+ + + T +A+K +K G S ++ F EA+
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP----GSMS-----VEAFLAEAN 53
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD- 989
++ L H +V + VV P + +TE+M GSL L + ++ L ++D
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDF 107
Query: 990 ---AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-KCNTLVS-GGV 1044
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+R+ + N + G
Sbjct: 108 SAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREGA 163
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
+ + W APE +N + + K DV+SFGI + EI+T G PY M +I L
Sbjct: 164 KFPIKWTAPEAINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGY 220
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSF 1133
R PE C E +M CW P RP+F
Sbjct: 221 RMPRPENCPEELYNIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 88/287 (30%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 870 QIIKDSDLEELQELGSGTFGTVYRGKW--RGTDI----AIKRIKKSCFLGRSSEQEWLIK 923
+I+K+++L +L+ LGSG FGTV++G W G I AIK I+ RS Q + +
Sbjct: 2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-----RSGRQTF--Q 54
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGS-LRHVLARKDRILDRRK 982
E + +L H +V G+ PG ++ VT+ GS L HV +D LD ++
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQR 110
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTL 1039
L + A GM YL +VH +L N+L L+ I ++ DFG++ +
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKY 166
Query: 1040 VSGGVRGTLPWMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGG 1097
+ + WMA E +L G R + + DV+S+G+ +WE+++ G EPYA M +
Sbjct: 167 FYSEHKTPIKWMALESILFG---RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPD 222
Query: 1098 ILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
+L R P+ C + +M +CW + RP+F E+ N M+
Sbjct: 223 LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 45/288 (15%)
Query: 877 LEELQELGSGTFGTVY------RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
L+ +++LG G FG V G G +A+K +K I + +E
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP----ESGGNH---IADLKKEIE 58
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
I+ NL+H N+V + G+ G + + E++ +GSL+ L R ++ +++L +
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT---LVSGGVRG 1046
GM+YL + VH DL N+LV K+GDFGL++ I+ + V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG------AIIG---- 1096
+ W APE L S ++ DV+SFG+ ++E++T Y + +IG
Sbjct: 175 PVFWYAPECLIQSKFYIAS--DVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHG 228
Query: 1097 --------GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+L R P C E +LM +CW F P+ R +F +
Sbjct: 229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 73/264 (27%), Positives = 125/264 (47%), Gaps = 27/264 (10%)
Query: 879 ELQE-LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++ E LG G++G+VY+ + G +AIK + E ++E +E I+
Sbjct: 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVV----------PVEEDLQEIIKEISILKQC 55
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
P +V +YG + V EY GS+ ++ ++ L + ++ G+E
Sbjct: 56 DSPYIVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV-SGGVRGTLPWMAPE 1054
YLH +H D+K N+L+N + K+ DFG+S +T+ V GT WMAPE
Sbjct: 114 YLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---TLRPQIPERC 1111
++ + K D++S GI E+ G+ PY+++H I I + TL PE+
Sbjct: 170 VI--QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS--DPEKW 225
Query: 1112 DPEWRKLMEECWSFNPAARPSFTE 1135
PE+ +++C +P RPS +
Sbjct: 226 SPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHP 938
L++LG G+FG VY + +A+K + K + ++ F RE I+++L H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAKK-----LESKSKEVERFLREIQILASLNHPP 58
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI--LDRRKKLMLMMDAAFGMEY 996
N+V Y + + V EY+ GSL +L + R L + L ++ +EY
Sbjct: 59 NIVKLYDFFQDEGSLYL--VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-------GTLP 1049
LH K I+H D+K +N+L+ D + K+ DFGL+++ + + + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 1050 WMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS-------- 1100
+MAPE+L G S S D++S GI ++E++TG P+ + L
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 1101 ---NTLRPQIPERCDPEWRKLMEECWSFNPAARPS 1132
+ L P PE L+++ + +P R S
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
|
Length = 384 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 45/302 (14%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKE 924
+ L + LG G FG V + + G D +A+K +K +E++ + +
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKD--LSD 61
Query: 925 FWREAHIISNL-HHPNVVAFYGV-VPNGPGGTMATVTEYMVNGSLRHVL---------AR 973
E ++ + H N++ GV GP + V EY +G+LR L A
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 974 KDRILDRRKKLML--MMDAAF----GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027
D + L ++ A+ GME+L K +H DL N+LV + + K+
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT----EDHVMKIA 174
Query: 1028 DFGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GE 1083
DFGL+R I G LP WMAPE L + + + DV+SFG+ +WEI T G
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 1084 EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
PY + + +L R + P+ C E LM +CW P+ RP+F ++ L M
Sbjct: 233 SPYPGIPVEELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
Query: 1144 ST 1145
T
Sbjct: 292 LT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 21/283 (7%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
++I+K+++L++++ LGSG FGTVY+G W G ++ +I + + R + KE
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENV---KIPVAIKVLRENTSPKANKEIL 57
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGS-LRHVLARKDRILDRRKKLM 985
EA++++ + P V G+ T+ VT+ M G L +V KDRI + L
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRI-GSQDLLN 113
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSG 1042
+ A GM YL +VH DL N+LV + P K+ DFGL+R I +
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEYHAD 169
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101
G + + WMA E + + R + + DV+S+G+ +WE++T G +PY + I +
Sbjct: 170 GGKVPIKWMALESI--LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 227
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
PQ P C + +M +CW + RP F E+ + M+
Sbjct: 228 ERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 9e-28
Identities = 83/283 (29%), Positives = 140/283 (49%), Gaps = 21/283 (7%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
L+I+K+++ ++++ LGSG FGTVY+G W G + I K R + KE
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEIL 57
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGS-LRHVLARKDRILDRRKKLM 985
EA++++++ +P+V G+ T+ +T+ M G L +V KD I + L
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNI-GSQYLLN 113
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLVSG 1042
+ A GM YL + +VH DL N+LV + PQ K+ DFGL+++ +
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAE 169
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101
G + + WMA E + + + + DV+S+G+ +WE++T G +PY + I IL
Sbjct: 170 GGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEK 226
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
R P C + +M +CW + +RP F E+ M+
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 37/274 (13%)
Query: 880 LQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
++G GTFG VY G +A+K I+ + + IKE E ++ L H
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIR----IQDN--DPKTIKEIADEMKVLELLKH 58
Query: 938 PNVVAFYGV-VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF---G 993
PN+V +YGV V + EY G+L +L RILD ++ + G
Sbjct: 59 PNLVKYYGVEVHR---EKVYIFMEYCSGGTLEELLEHG-RILDEH---VIRVYTLQLLEG 111
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSG----GVRGTL 1048
+ YLH IVH D+K N+ ++ + K+GDFG + ++K NT G + GT
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 1049 PWMAPELLNGSNNRVSEK---VDVYSFGIAMWEIITGEEPYANM-HCGAIIGGILSNTLR 1104
+MAPE++ + + D++S G + E+ TG+ P++ + + I+ + + +
Sbjct: 168 AYMAPEVI--TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-K 224
Query: 1105 PQIPER--CDPEWRKLMEECWSFNPAARPSFTEI 1136
P IP+ PE + ++ C +P RP+ +E+
Sbjct: 225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 91/279 (32%), Positives = 131/279 (46%), Gaps = 38/279 (13%)
Query: 875 SDLEELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
DLE L ELG+G G V + G +A+K I R E + K+ RE I+
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI-------RLEINEAIQKQILRELDIL 53
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR-----KDRILDRRKKLMLM 987
+ P +V FYG N G ++ EYM GSL +L +RIL + +L
Sbjct: 54 HKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111
Query: 988 MDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG 1046
G+ YLH K I+H D+K N+LVN R Q +C DFG+S N+L V G
Sbjct: 112 -----GLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLC---DFGVSGQLVNSLAKTFV-G 161
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS------ 1100
T +MAPE + G N S K D++S G+++ E+ TG PY GI
Sbjct: 162 TSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPP--ENDPPDGIFELLQYIV 217
Query: 1101 NTLRPQIP-ERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
N P++P + P+++ + C +P RPS+ E+
Sbjct: 218 NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 87/298 (29%), Positives = 130/298 (43%), Gaps = 58/298 (19%)
Query: 876 DLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
++E ++++G G FG V++ + G T +A+K +K+ S++ + +F RE
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQ---ADFQRE 58
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR--------------K 974
A +++ HPN+V GV G M + EYM G L L
Sbjct: 59 AALMAEFDHPNIVKLLGVC--AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 975 DRILDRRK-------KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027
R +L + A GM YL + VH DL N LV + + K+
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVKIA 172
Query: 1028 DFGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GE 1083
DFGLSR I +P WM PE + NR + + DV+++G+ +WEI + G
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 1084 EPYANMHCGAII-----GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+PY M +I G +LS P+ C E LM CWS P+ RPSF I
Sbjct: 231 QPYYGMAHEEVIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 877 LEELQELGSGTFGTV--YR----GKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
L++++ LG G FG V Y G +A+K +K+ C G+ + W +E +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWK-----KEIN 58
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
I+ L+H N+V + G G + + EY+ GSLR L + L+ + L+
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQI 116
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR--GTL 1048
GM YLH ++ +H DL N+L+ D R + K+GDFGL++ VR G
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLL---DNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 1049 P--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN---------------MHC 1091
P W A E L N+ S DV+SFG+ ++E++T + + M
Sbjct: 173 PVFWYAVECLK--ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+I +L +R P+ C E LM+ CW RP+F + L+ M
Sbjct: 231 VRLI-ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 30/271 (11%)
Query: 881 QELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
Q+LG+G F + Y R GT +A+K++ SSEQE +++ +E +++ L+HP
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR----KDRILDRRKKLMLMMDAAFGM 994
+++ G E+M GS+ H+L++ K+ ++ + +L G+
Sbjct: 64 HIIRMLGATCED--SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR-----GL 116
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT------LVSGGVRGTL 1048
YLH I+H D+K NLL+ D ++ DFG + + G + GT+
Sbjct: 117 SYLHENQIIHRDVKGANLLI---DSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTI 172
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY-ANMHCG--AIIGGILSNTLRP 1105
+MAPE+L G S DV+S G + E+ T + P+ A H A+I I S T P
Sbjct: 173 AFMAPEVLRGEQYGRS--CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
IPE P R + C P RP E+
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 87/297 (29%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 877 LEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLI-------------- 922
L +++LG G FG V+ + D +K+ +++ L+
Sbjct: 7 LNFVEKLGEGQFGEVHLCE---ADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 923 KEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL-----RHVLARKDRI 977
++F +E I+S L PN+ GV P + + EYM NG L +HV
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 978 LDRR----KKLMLM-MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
+ + L+ M A GM YL N VH DL N LV I K+ DFG+S
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG---KNYTI-KIADFGMS 177
Query: 1033 R--IKCNTLVSGGVRGTLP--WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIIT--GEEP 1085
R + G R LP WMA E +L G + + K DV++FG+ +WEI+T E+P
Sbjct: 178 RNLYSSDYYRVQG-RAPLPIRWMAWESVLLG---KFTTKSDVWAFGVTLWEILTLCREQP 233
Query: 1086 YANMHCGAII---GGILSNTLRPQI---PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
Y ++ +I G + R P C + +LM ECW + RP+F EI
Sbjct: 234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 89/296 (30%), Positives = 136/296 (45%), Gaps = 52/296 (17%)
Query: 883 LGSGTFGTVYRG---KWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
LG G FG V + + +G T +A+K +K++ SSE L+ EF +++ +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEF----NLLKQV 60
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL--ARK------------------- 974
+HP+V+ YG G + + EY GSLR L +RK
Sbjct: 61 NHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 975 --DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
+R L + + GM+YL +VH DL N+LV + K+ DFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV----AEGRKMKISDFGLS 174
Query: 1033 R--IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYA 1087
R + ++ V +G +P WMA E L ++ + + DV+SFG+ +WEI+T G PY
Sbjct: 175 RDVYEEDSYVKRS-KGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
Query: 1088 NMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+ + +L R + PE C E LM CW P RP+F +I+ L M
Sbjct: 232 GIAPERLF-NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E++ ++G GT+G VY+ + + T +A+K+I+ +E+E RE ++ L
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKL 55
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYM---VNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
HPN+V +V + G++ V EYM + G L + + K M +
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFT--ESQIKCYMKQL--LE 111
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI----KCNTLVSGGVRGTL 1048
G++YLH I+H D+K N+L+N + K+ DFGL+R + + TL
Sbjct: 112 GLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARPYTKRNSADYTNRVI--TL 165
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ PELL G+ R +VD++S G + E+ G+
Sbjct: 166 WYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 89/295 (30%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
IK D+ ELG G FG V+ + +A+K +K++ R ++
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--------QD 53
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL---ARKDRILDRR 981
F REA +++ L H ++V FYGV G + V EYM +G L L +IL
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 982 KK-----------LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030
+ L + A GM YL + VH DL N LV Q + K+GDFG
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----QGLVVKIGDFG 167
Query: 1031 LSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPY 1086
+SR I G R LP WM PE + + + + D++SFG+ +WEI T G++P+
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
Query: 1087 ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
+ I I + + P C PE +M+ CW P R +I +RL+
Sbjct: 226 YQLSNTEAIECI-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 80/264 (30%), Positives = 125/264 (47%), Gaps = 22/264 (8%)
Query: 883 LGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG VY G ++A+K++ F S E + + E ++ NL H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP---FDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAFGMEYLH 998
V +YG + + T++ EYM GS++ L + + RK +++ G+EYLH
Sbjct: 67 VQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE---GVEYLH 121
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR----IKCNTLVSGGVRGTLPWMAPE 1054
IVH D+K N+L RD + K+GDFG S+ I + V GT WM+PE
Sbjct: 122 SNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
+++G K DV+S G + E++T + P+A A I I + PQ+P P+
Sbjct: 178 VISGEGY--GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235
Query: 1115 WRKLMEECWSFNPAARPSFTEITN 1138
R + + N RPS E+
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 874 DSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
D E +Q +GSGT+G VY+ + T +AIK IK + + +E +
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGD-DFEIIQQEISM 53
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ HPN+VA++G + V EY GSL+ + L + + +
Sbjct: 54 LKECRHPNIVAYFGSYLR--RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL 111
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RI-----KCNTLVSGGVR 1045
G+ YLH +H D+K N+L+ + K+ DFG+S ++ K + +
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVSAQLTATIAKRKSFI----- 162
Query: 1046 GTLPWMAPELL-NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104
GT WMAPE+ K D+++ GI E+ + P ++H + I +
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP 222
Query: 1105 P---QIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
P + E+ P + +++C + +P RP+ T++
Sbjct: 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 90/303 (29%), Positives = 132/303 (43%), Gaps = 47/303 (15%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKE 924
IK D+ +ELG G FG V+ + +A+K +K R K+
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--------KD 53
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLA------------ 972
F REA +++NL H ++V FYGV G G + V EYM +G L L
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVC--GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 973 ---RKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029
+ L + L + A GM YL ++ VH DL N LV + K+GDF
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGDF 167
Query: 1030 GLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEP 1085
G+SR + G LP WM PE + + + + DV+SFG+ +WEI T G++P
Sbjct: 168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQP 225
Query: 1086 YANMHCGAIIGGILSNTL--RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+ + +I I + RP++ C E +M CW P R + EI L +
Sbjct: 226 WFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
Query: 1144 STA 1146
A
Sbjct: 283 GKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 8e-26
Identities = 86/283 (30%), Positives = 145/283 (51%), Gaps = 21/283 (7%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
L+I+K+++L+ ++ LGSG FGTVY+G W +K L ++ + + EF E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDE 59
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGS-LRHVLARKDRILDRRKKLML- 986
A I++++ HP++V GV + T+ VT+ M +G L +V KD I +L+L
Sbjct: 60 ALIMASMDHPHLVRLLGVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNI---GSQLLLN 113
Query: 987 -MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLVSG 1042
+ A GM YL + +VH DL N+LV + P K+ DFGL+R+ +
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLEGDEKEYNAD 169
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101
G + + WMA E ++ + + + DV+S+G+ +WE++T G +PY + I +
Sbjct: 170 GGKMPIKWMALECIH--YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG 227
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
PQ P C + +M +CW + +RP F E+ M+
Sbjct: 228 ERLPQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 76/278 (27%), Positives = 121/278 (43%), Gaps = 33/278 (11%)
Query: 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E ++ +G G VY +AIKRI L + + E +E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID----LEKCQTS---VDELRKEVQAM 53
Query: 933 SNLHHPNVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDR--ILDRRKKLMLMM 988
S +HPNVV +Y VV G + V Y+ GSL ++ LD ++
Sbjct: 54 SQCNHPNVVKYYTSFVV----GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK 109
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVR-- 1045
+ G+EYLH +H D+K N+L+ + K+ DFG+S + + VR
Sbjct: 110 EVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 1046 --GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103
GT WMAPE++ + K D++SFGI E+ TG PY+ ++ L N
Sbjct: 166 FVGTPCWMAPEVME-QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND- 223
Query: 1104 RPQIPE-----RCDPEWRKLMEECWSFNPAARPSFTEI 1136
P + + +RK++ C +P+ RP+ E+
Sbjct: 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E+L++LG GT+G VY+ + + T +A+K+I+ +E+E + RE ++ L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKEL 55
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLMMDAAFG 993
HPN+V V+ + V EY + L+ L ++ L K +M + G
Sbjct: 56 KHPNIVKLLDVIHTERKLYL--VFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLR--G 110
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGTLPW 1050
+ Y H I+H DLK N+L+N + K+ DFGL+R I T V TL +
Sbjct: 111 LAYCHSHRILHRDLKPQNILINR----DGVLKLADFGLARAFGIPLRTYTHEVV--TLWY 164
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
APE+L GS + S VD++S G E+ITG+
Sbjct: 165 RAPEILLGSKH-YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 46/277 (16%)
Query: 883 LGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEW-LIKEFWREAHIISNLHHPN 939
+GSG+FG+VY G G +A+K+++ S +++ ++ RE ++ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 940 VVAFYGVVPNG----------PGGTMAT-VTEYMVNGSLRHVLARK--DRILDRRKKLML 986
+V + G + PGG++A + Y G+ L R +IL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILK------- 117
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG 1046
G+ YLH + I+H D+K N+LV D + I K+ DFG+S+ +S G
Sbjct: 118 ------GLNYLHNRGIIHRDIKGANILV---DNKGGI-KISDFGISKKLEANSLSTKTNG 167
Query: 1047 TLP-------WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099
P WMAPE++ ++ + K D++S G + E++TG+ P+ + I I
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSY--TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
N P+IP E +E+ + + RP+ E+
Sbjct: 226 EN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 75/279 (26%), Positives = 123/279 (44%), Gaps = 61/279 (21%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G+FG V + + T A+K +KK + + E E E +I+S ++HP +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK-KIIKRKEVEHT----LTERNILSRINHPFI 55
Query: 941 V----AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL----ML 986
V AF Y + V EY G L L+++ R + R + ++
Sbjct: 56 VKLHYAFQTEEKLY----------L--VLEYAPGGELFSHLSKEGRFSEERARFYAAEIV 103
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLV 1040
+ +EYLH I++ DLK +N+L++ K+ DFGL++ + NT
Sbjct: 104 L-----ALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKELSSEGSRTNTFC 154
Query: 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--ANMHCGAIIGGI 1098
GT ++APE+L G + VD +S G+ ++E++TG+ P+ + I I
Sbjct: 155 -----GTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EIYEKI 205
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEIT 1137
L + LR PE PE R L+ +P R
Sbjct: 206 LKDPLR--FPEFLSPEARDLISGLLQKDPTKRLGSGGAE 242
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 68/271 (25%), Positives = 132/271 (48%), Gaps = 35/271 (12%)
Query: 878 EELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E+++ +G G FG V+ R K + IK+I + ++ + E ++ L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE---QMTKDERLAAQN---ECQVLKLL 56
Query: 936 HHPNVVAFYG----------VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
HPN++ +Y V+ PGGT+A ++ R + +LD L
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLA-----------EYIQKRCNSLLDEDTILH 105
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR 1045
+ + ++H K I+H DLK N+L++ + + K+GDFG+S+I + + V
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVV 162
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105
GT +++PEL G ++K D+++ G ++E+ + + + + A++ I+S T P
Sbjct: 163 GTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP 220
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
I +R P+ R+L+ + +P+ RP ++I
Sbjct: 221 -ISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L +G G G V++ K R T +A+K++ R E + + RE +
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALRRLE-GGIPNQALREIKALQAC 56
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLMMDAAFG 993
HP VV V P+G G V EYM L VL ++R L K M M+ G
Sbjct: 57 QHPYVVKLLDVFPHGSG--FVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK--G 111
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR------GT 1047
+ Y+H I+H DLK NLL++ + K+ DFGL+R+ R T
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADG----VLKIADFGLARL----FSEEEPRLYSHQVAT 163
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
+ APELL G+ + VD+++ G E++ G
Sbjct: 164 RWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 88/274 (32%), Positives = 124/274 (45%), Gaps = 24/274 (8%)
Query: 881 QELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+ LG G FG+V G+ D +K K+ + + E +++F EA + HPNV
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNV 62
Query: 941 VAFYGV----VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL---ML---MMDA 990
+ GV V + + + +M +G L H R+ D + L ML M D
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDL-HSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLP 1049
A GMEYL K+ +H DL N ++N +C V DFGLS +I G +P
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLN---ENMNVC-VADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 1050 --WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
W+A E L ++ + K DV+SFG+ MWEI T G+ PY + I L R +
Sbjct: 178 VKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY-DYLRQGNRLK 234
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P C LM CW NP RPSF + L
Sbjct: 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 70/260 (26%), Positives = 127/260 (48%), Gaps = 19/260 (7%)
Query: 876 DLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D E L ++G G+FG V++ K A+K+I S R E E EA +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE------EAIDEARVLA 54
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARKDRILDRRKKLMLMMDAAF 992
L ++ +Y + G + V EY NG L +L ++ R L + +
Sbjct: 55 KLDSSYIIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL 112
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-KCNTLVSGGVRGTLPWM 1051
G+ +LH K I+H D+K NL ++ D K+GD G++++ NT + + GT ++
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVAKLLSDNTNFANTIVGTPYYL 168
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
+PEL + +EK DV++ G+ ++E TG+ P+ + GA+I I+ P + +
Sbjct: 169 SPELC--EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMY 225
Query: 1112 DPEWRKLMEECWSFNPAARP 1131
+ +L+++C + + RP
Sbjct: 226 SQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 83/297 (27%), Positives = 133/297 (44%), Gaps = 39/297 (13%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+++ DLE + +LG+G G+V + K T + KK +G S + K+ RE I
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA--KKVVHIGAKSS---VRKQILRELQI 56
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL------M 985
+ P +V+FYG N M E+M GSL DRI + +
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMC--MEFMDCGSL-------DRIYKKGGPIPVEILGK 107
Query: 986 LMMDAAFGMEYLHMKN-IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+ + G+ YL+ + I+H D+K N+LVN R Q +C DFG+S N++ V
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLC---DFGVSGELINSIADTFV 163
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA--NMHCGAIIG--GILS 1100
GT +M+PE + G V K DV+S GI++ E+ G+ P+A N+ GIL
Sbjct: 164 -GTSTYMSPERIQGGKYTV--KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 1101 ------NTLRPQIPERCDPE-WRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150
P++P PE R ++ C +P RP+ ++ + +
Sbjct: 221 LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 31/267 (11%)
Query: 882 ELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941
ELG G FG VY+ + + T + K + E E +F E I+S HPN+V
Sbjct: 12 ELGDGAFGKVYKAQHKETGL--FAAAKIIQIESEEELE----DFMVEIDILSECKHPNIV 65
Query: 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN 1001
Y + + E+ G+L ++ +R L + + + +LH
Sbjct: 66 GLYEAYFYENKLWI--LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 1002 IVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKCNTLVSGGVRGTLPWMAPEL 1055
++H DLK N+L+ L K+ DFG+S K +T + GT WMAPE+
Sbjct: 124 VIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEV 174
Query: 1056 L---NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---TLRPQIPE 1109
+ +N K D++S GI + E+ E P+ ++ ++ IL + TL P
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL--DQPS 232
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ + ++ C +P RP+ E+
Sbjct: 233 KWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 89/298 (29%), Positives = 136/298 (45%), Gaps = 40/298 (13%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
IK ++ +ELG G FG V+ + +A+K +K + R K+
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--------KD 53
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK--DRI----- 977
F REA +++NL H ++V FYGV G + V EYM +G L L D +
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 978 -----LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
L + + L + A GM YL ++ VH DL N LV + + K+GDFG+S
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKIGDFGMS 167
Query: 1033 RIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYAN 1088
R +T V G + WM PE + + + + DV+S G+ +WEI T G++P+
Sbjct: 168 RDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
Query: 1089 MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
+ +I I + Q P C E LM CW P R + EI + L+ ++ A
Sbjct: 226 LSNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 95/302 (31%), Positives = 131/302 (43%), Gaps = 60/302 (19%)
Query: 881 QELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLI--------------KEFW 926
++LG G FG V+ + G + K + K L S Q L+ +F
Sbjct: 11 EKLGEGQFGEVHLCEAEGME---KFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 927 REAHIISNLHHPNVVAFYGV-VPNGPGGTMATVTEYMVNGSLRHVLAR---------KDR 976
+E I+S L PN++ V + + P + +TEYM NG L L+R D
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 977 ILDRRKKLMLM-MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035
+ L+ M A GM+YL N VH DL N LV + K+ DFG+SR
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG----KNYTIKIADFGMSR-- 178
Query: 1036 CNTLVSGGV-----RGTLP--WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIIT--GEEP 1085
L SG R LP WM+ E +L G S DV++FG+ +WEI+T E+P
Sbjct: 179 --NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS---DVWAFGVTLWEILTLCKEQP 233
Query: 1086 YANMHCGAII---GGILSNTLR----PQIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
Y+ + +I G + R P+ P C KLM CW N RPSF EI
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPK-PALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292
Query: 1139 RL 1140
L
Sbjct: 293 TL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 87/303 (28%), Positives = 135/303 (44%), Gaps = 56/303 (18%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKE 924
I S + ++ELG FG VY+G GT +AIK +K L +E
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP-------LREE 54
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK---------- 974
F EA + S L HPN+V GVV ++ + Y + L L +
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 975 -DRI----LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029
D+ L+ + ++ A GME+L ++VH DL N+LV + K+ D
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNVKISDL 168
Query: 1030 GLSR---------IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII 1080
GL R + N+L+ + WM+PE + + S D++S+G+ +WE+
Sbjct: 169 GLFREVYAADYYKLMGNSLLP------IRWMSPEAI--MYGKFSIDSDIWSYGVVLWEVF 220
Query: 1081 T-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW-RKLMEECWSFNPAARPSFTEITN 1138
+ G +PY +I I + + P P+ C P W LM ECW+ P+ RP F +I +
Sbjct: 221 SYGLQPYCGYSNQDVIEMIRNRQVLP-CPDDC-PAWVYTLMLECWNEFPSRRPRFKDIHS 278
Query: 1139 RLR 1141
RLR
Sbjct: 279 RLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 67/269 (24%), Positives = 123/269 (45%), Gaps = 21/269 (7%)
Query: 878 EELQELGSGTFG--TVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++ LG G FG T+YR + + K + L R SE+E ++ E I+S L
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN----LTRLSEKE--RRDALNEIVILSLL 56
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGM 994
HPN++A+Y + T+ EY G+L + R K ++ + L + +
Sbjct: 57 QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG--VRGTLPWMA 1052
Y+H I+H D+K N+ + + K+GDFG+S+I + S V GT +M+
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGISKI-LGSEYSMAETVVGTPYYMS 169
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
PEL G + + K D+++ G ++E++T + + + ++ I+ P +
Sbjct: 170 PELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYS 226
Query: 1113 PEWRKLMEECWSFNPAARPSFTEITNRLR 1141
E L+ +P RP+ E+ ++
Sbjct: 227 SELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 880 LQELGSGTFGTVYRGKWRGTD--IAIKRI-KKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
L+ +G G FG V + R T A+K + K+ C S ++ E I+ L+
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS------VRNVLNERRILQELN 58
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
HP +V + + M V + ++ G LR+ L++K + + + K + + +EY
Sbjct: 59 HPFLVNLWYSFQDEE--NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEY 115
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELL 1056
LH K I+H D+K DN+L++ ++ + DF ++ ++ GT +MAPE+L
Sbjct: 116 LHSKGIIHRDIKPDNILLD----EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL 171
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
V+ VD +S G+ +E + G+ PY
Sbjct: 172 CRQGYSVA--VDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 70/273 (25%), Positives = 126/273 (46%), Gaps = 40/273 (14%)
Query: 880 LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
L+ +G G +G VYRGK T +A+K I + + + + + RE ++S L
Sbjct: 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLD-----TPDDD--VSDIQREVALLSQLRQ 58
Query: 938 ---PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
PN+ +YG GP + + EY GS+R ++ K + + +++ + +
Sbjct: 59 SQPPNITKYYGSYLKGP--RLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVAL 114
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKCNTLVSGGVRGTL 1048
+Y+H ++H D+K N+LV +C DFG++ K +T V GT
Sbjct: 115 KYIHKVGVIHRDIKAANILVT-NTGNVKLC---DFGVAALLNQNSSKRSTFV-----GTP 165
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
WMAPE++ K D++S GI ++E+ TG PY+++ + ++ + P++
Sbjct: 166 YWMAPEVITEGKY-YDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-MLIPKSKPPRLE 223
Query: 1109 ERCDPEWRKLMEE----CWSFNPAARPSFTEIT 1137
+ + KL+ E C P R S E+
Sbjct: 224 DN---GYSKLLREFVAACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 75/262 (28%), Positives = 116/262 (44%), Gaps = 23/262 (8%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG GT+G VY + T IAIK I + R S + E E + S L H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHE---EIALHSYLKHRNI 67
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF--GMEYLH 998
V + G G E + GSL +L K L ++ ++ G++YLH
Sbjct: 68 VQYLGSDSEN--GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMAPELLN 1057
IVH D+K DN+LVN + K+ DFG S R+ + GTL +MAPE+++
Sbjct: 126 DNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 1058 GSNNRVSEKVDVYSFGIAMWEIITGEEPYANM---HCGAIIGGILSNTLRPQIPERCDPE 1114
D++S G + E+ TG+ P+ + G+ + P+IPE E
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--IHPEIPESLSAE 240
Query: 1115 WRKLMEECWSFNPAARPSFTEI 1136
+ + C+ +P R S ++
Sbjct: 241 AKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 18/261 (6%)
Query: 880 LQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
++ +G G++G V R + G IK++ L +S +E E +EA ++S L H
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLN----LRNASRRERKAAE--QEAQLLSQLKH 58
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLA-RKDRILDRRKKLMLMMDAAFGMEY 996
PN+VA Y G G + V + G L H L +K ++L + + + A ++Y
Sbjct: 59 PNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL-VSGGVRGTLPWMAPEL 1055
LH K+I+H DLK N+ + + I KVGD G++R+ N ++ + GT +M+PEL
Sbjct: 118 LHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
SN + K DV++ G ++E+ T + + +++ I+ L P +P+ PE
Sbjct: 174 F--SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPEL 230
Query: 1116 RKLMEECWSFNPAARPSFTEI 1136
+L+ S P RPS I
Sbjct: 231 GELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++L ++G GT+G VY+ + + T +AIK+IK E E + K RE ++ L
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKEL 55
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD--RRKKLMLMMDAAFG 993
+HPN++ V G + V E+M + L ++ + R L K + + G
Sbjct: 56 NHPNIIKLLDVFR--HKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL--LQG 110
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR------GT 1047
+ + H I+H DLK +NLL+N + K+ DFGL+R VR T
Sbjct: 111 LAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLAR-----SFGSPVRPYTHYVVT 161
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
+ APELL G S VD++S G E+++
Sbjct: 162 RWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 4e-22
Identities = 90/295 (30%), Positives = 126/295 (42%), Gaps = 47/295 (15%)
Query: 883 LGSGTFGTVYRGKWRGTD---------IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
LG G FG V R + G D +A+K +K + + LI E +I
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEM-ELMKLIG 75
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARK--------------DRIL 978
H N++ GV G + + EY G+LR L AR+ + L
Sbjct: 76 K--HKNIINLLGVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 979 DRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR----I 1034
+ + A GMEYL + +H DL N+LV + + K+ DFGL+R I
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARGVHDI 187
Query: 1035 KCNTLVSGGVRGTLPWMAPELLNGSNNRV-SEKVDVYSFGIAMWEIIT-GEEPYANMHCG 1092
S G R + WMAPE L +RV + + DV+SFGI MWEI T G PY +
Sbjct: 188 DYYKKTSNG-RLPVKWMAPEALF---DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147
+ +L R P C E LM ECW P RP+F ++ L + A+
Sbjct: 244 ELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 77/282 (27%), Positives = 121/282 (42%), Gaps = 46/282 (16%)
Query: 881 QELGSGTFGTVYRGKWR----------GTDIAI--KRIKKSCFLGRSSEQEWLIKEFWRE 928
+ LG GTF +Y+G R G ++++ K + R S F+
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD---HRDSL------AFFET 51
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
A ++S L H ++V YGV M V EY+ G L L R+ + KL +
Sbjct: 52 ASLMSQLSHKHLVKLYGVCVR-DENIM--VEEYVKFGPLDVFLHREKNNVSLHWKLDVAK 108
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLV---NLRDPQRPICKVGDFGLSRIKCNTLVSGGVR 1045
A + YL K +VH ++ N+LV L + P K+ D G+ T++S R
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREER 164
Query: 1046 -GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
+PW+APE + ++ D +SFG + EI + GEEP + + S
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--------SSEKE 216
Query: 1104 R-----PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
R ++P E L+ +CW+++P RPSF I L
Sbjct: 217 RFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 73/277 (26%), Positives = 128/277 (46%), Gaps = 34/277 (12%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQE--WLIKEFWREAHIIS 933
D E L+ +G G+FGTV + + R +D I K+ + G +E+E L+ E +I+
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDY-GNMTEKEKQQLVSEV----NILR 54
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL--ARKDR-ILDRRKKLMLMMDA 990
L HPN+V +Y + + T+ V EY G L ++ +K+R ++ ++
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 991 AFGMEYLHMKN-----IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTL 1039
+ H ++ ++H DLK N+ ++ K+GDFGL++I T
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099
V GT +M+PE LN + EK D++S G ++E+ P+ + + I
Sbjct: 171 V-----GTPYYMSPEQLN--HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK 223
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
R IP R E ++++ + +P RPS E+
Sbjct: 224 EGKFRR-IPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 75/264 (28%), Positives = 122/264 (46%), Gaps = 25/264 (9%)
Query: 883 LGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG VY G ++A+K+++ F S E + E ++ NL H +
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVL----ARKDRILDRRKKLMLMMDAAFGMEY 996
V +YG + + T++ E+M GS++ L A + + + + +L G+ Y
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GVSY 121
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG----GVRGTLPWMA 1052
LH IVH D+K N+ LRD + K+GDFG S+ +SG V GT WM+
Sbjct: 122 LHSNMIVHRDIKGANI---LRDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
PE+++G K D++S G + E++T + P+A A I I + P +P
Sbjct: 178 PEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235
Query: 1113 PEWRKLMEECWSFNPAARPSFTEI 1136
R ++ + RPS E+
Sbjct: 236 DHCRDFLKRIF-VEAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-21
Identities = 31/87 (35%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 199 PSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQP-HTIKYQLPGEDLDALISVCSD 257
KLRY GG R +S+ +++EEL K K + P ED D L+S+ SD
Sbjct: 1 TVRVKLRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYPDEDGD-LVSITSD 59
Query: 258 EDLHHMIEEYQEQERIGGSQRLRIFLV 284
EDL IEE + GS+ LR+ +
Sbjct: 60 EDLEEAIEEARSL----GSKTLRLHVF 82
|
Length = 84 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-21
Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 21/262 (8%)
Query: 883 LGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG VY G ++A K+++ F S E + E ++ NL H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAFGMEYLH 998
V +YG + + T+ EYM GS++ L + + RK +++ GM YLH
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE---GMSYLH 123
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG-GVR---GTLPWMAPE 1054
IVH D+K N+ LRD + K+GDFG S+ +SG G+R GT WM+PE
Sbjct: 124 SNMIVHRDIKGANI---LRDSAGNV-KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
+++G K DV+S G + E++T + P+A A I I + PQ+P
Sbjct: 180 VISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237
Query: 1115 WRKLMEECWSFNPAARPSFTEI 1136
R + C RPS E+
Sbjct: 238 ARDFL-GCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 3e-21
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 39/209 (18%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLG-RSSEQEWLIKEFWREAHIISNLHHPN 939
LG GT+ VY+ + + T +AIK+IK LG R ++ + RE ++ L HPN
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK----LGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR----KKLMLMMDAAFGME 995
++ V + + V E+M L V+ KD+ + K MLM G+E
Sbjct: 64 IIGLLDVFGHK--SNINLVFEFM-ETDLEKVI--KDKSIVLTPADIKSYMLMT--LRGLE 116
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGT----LPWM 1051
YLH I+H DLK +NLL+ + K+ DFGL+R S + T W
Sbjct: 117 YLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARS----FGSPNRKMTHQVVTRWY 168
Query: 1052 -APELLNGSNNRVSEKVDVYSFGIAMWEI 1079
APELL G+ + Y G+ MW +
Sbjct: 169 RAPELLFGARH--------YGVGVDMWSV 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 78/271 (28%), Positives = 126/271 (46%), Gaps = 36/271 (13%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
S+LE + +GSG GTVY+ R T A+K I + ++ + ++ RE I+
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-------YGNHEDTVRRQICREIEIL 126
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
+++HPNVV + + + G + + E+M GSL I D + +
Sbjct: 127 RDVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILS 179
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLVSGGVRG 1046
G+ YLH ++IVH D+K NLL+N K+ DFG+SRI CN+ V G
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVSRILAQTMDPCNSSV-----G 230
Query: 1047 TLPWMAPELLNGSNNRVSEK---VDVYSFGIAMWEIITGEEPYANMHCG--AIIGGILSN 1101
T+ +M+PE +N N + D++S G+++ E G P+ G A + +
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM 290
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPS 1132
+ P+ P E+R + C PA R S
Sbjct: 291 SQPPEAPATASREFRHFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-21
Identities = 83/297 (27%), Positives = 132/297 (44%), Gaps = 48/297 (16%)
Query: 881 QELGSGTFGTVYRGKWRGTD---------IAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ LG G FG V + G D +A+K +K ++E++ + + E +
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-----ATEKD--LSDLVSEMEM 73
Query: 932 ISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARK----------DRILD 979
+ + H N++ G G + + EY G+LR L AR+ R+ D
Sbjct: 74 MKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 980 RRKKLMLMMDAAF----GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035
+ ++ + GMEYL + +H DL N+LV + + K+ DFGL+R
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADFGLARDV 187
Query: 1036 CNT-LVSGGVRGTLP--WMAPELLNGSNNRV-SEKVDVYSFGIAMWEIIT-GEEPYANMH 1090
N G LP WMAPE L +RV + + DV+SFG+ MWEI T G PY +
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244
Query: 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL-RVMSTA 1146
+ +L R P C E +M +CW P+ RP+F ++ L R+++
Sbjct: 245 VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 29/282 (10%)
Query: 880 LQELGSGTFGTVYRGKWRGTDIAIKR--IKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
LQE GTFG ++ G + K+ S Q + +E+ ++ L H
Sbjct: 14 LQE---GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ---VTLLLQESCLLYGLSH 67
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSL-------RHVLARKDRILDRRKKLMLMMDA 990
N++ V + YM G+L R A + L ++ + + +
Sbjct: 68 QNILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR----IKCNTLVSGGVRG 1046
A GM YLH + ++H D+ N +++ + + K+ D LSR + + L R
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVID--EELQ--VKITDNALSRDLFPMDYHCLGDNENR- 181
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105
+ WMA E L N S DV+SFG+ +WE++T G+ PY + + +
Sbjct: 182 PVKWMALESL--VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147
Q P C E +M CW+ +P RPSF+++ L L
Sbjct: 240 Q-PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 68/274 (24%), Positives = 110/274 (40%), Gaps = 62/274 (22%)
Query: 883 LGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V K + + A+K +KK + + + + E I+ +HP +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-----EHIFSEKEILEECNHPFI 55
Query: 941 VAFYGVVPNGPGGTMAT---------VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
V Y T + EY + G L +L R + L A
Sbjct: 56 VKLY-----------RTFKDKKYIYMLMEYCLGGELWTIL--------RDRGLFDEYTAR 96
Query: 992 F-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
F EYLH + I++ DLK +NLL++ K+ DFG ++ + G
Sbjct: 97 FYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKK-----LKSGQ 147
Query: 1045 R-----GTLPWMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG--AIIG 1096
+ GT ++APE +LN + VD +S GI ++E++TG P+ I
Sbjct: 148 KTWTFCGTPEYVAPEIILNKGYDFS---VDYWSLGILLYELLTGRPPFGEDDEDPMEIYN 204
Query: 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
IL + + P D + L+++ NP R
Sbjct: 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-21
Identities = 81/247 (32%), Positives = 114/247 (46%), Gaps = 44/247 (17%)
Query: 924 EFWREAHIISNLHHPNVVAFYGV-VPNGPGGTMATVTEYMVNGSLRHVLARKD------- 975
+F +E I+S L +PN++ GV V + P + +TEYM NG L L++++
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 976 ----RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031
+ L + + A GM+YL N VH DL N LV K+ DFG+
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG----NHYTIKIADFGM 175
Query: 1032 SRIKCNTLVSGGV-----RGTLP--WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIIT-- 1081
SR L SG R LP WMA E +L G S DV++FG+ +WE+ T
Sbjct: 176 SR----NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS---DVWAFGVTLWEMFTLC 228
Query: 1082 GEEPYANMHCGAII---GGILSNTLRPQI----PERCDPEWRKLMEECWSFNPAARPSFT 1134
E+PY+ + +I G N R QI C KLM CWS + RP+F
Sbjct: 229 KEQPYSLLSDEQVIENTGEFFRNQGR-QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN 287
Query: 1135 EITNRLR 1141
+I + LR
Sbjct: 288 KIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-20
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 201 DGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQP-HTIKYQLPGEDLDALISVCSDED 259
K++Y G R + + +S+++E+L K + + K + P ED D L+++ SDED
Sbjct: 2 RVKVKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYPDEDGD-LVTISSDED 60
Query: 260 LHHMIEEYQEQERIGGSQRLRIFL 283
L IEE R GS++LR+F+
Sbjct: 61 LEEAIEEA----RRSGSKKLRLFV 80
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 73/223 (32%), Positives = 109/223 (48%), Gaps = 43/223 (19%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E+L + GT+G VYR + + T +A+K++K E+E RE +I+ L
Sbjct: 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLK------MEKEKEGFPITSLREINILLKL 61
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR---------RKKLML 986
HPN+V VV G + + YMV + H L K +++ K LML
Sbjct: 62 QHPNIVTVKEVVV---GSNLDKI--YMVMEYVEHDL--KS-LMETMKQPFLQSEVKCLML 113
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-----IKCNT-LV 1040
+ + G+ +LH I+H DLK NLL+N R I K+ DFGL+R +K T LV
Sbjct: 114 QLLS--GVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
TL + APELL G+ S +D++S G E++T +
Sbjct: 168 V-----TLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 45/282 (15%)
Query: 879 ELQEL-GSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
EL E+ G GT+G VY+ + + T +AIK + ++E IKE E +I+
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIK------IMDIIEDEEEEIKE---EYNILRKY 59
Query: 936 -HHPNVVAFYGV----VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKK----LML 986
+HPN+ FYG P G + V E GS+ L + R +R K +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYI 118
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR------IKCNTLV 1040
+ + G+ YLH ++H D+K N+L+ ++ + + DFG+S + NT +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLV---DFGVSAQLDSTLGRRNTFI 174
Query: 1041 SGGVRGTLPWMAPELLNGSNNR---VSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGG 1097
GT WMAPE++ + DV+S GI E+ G+ P +MH +
Sbjct: 175 -----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229
Query: 1098 ILSN---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
I N TL+ PE ++ + EC N RP E+
Sbjct: 230 IPRNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 4e-20
Identities = 74/263 (28%), Positives = 125/263 (47%), Gaps = 28/263 (10%)
Query: 881 QELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+++G G GTV+ G ++AIK+I L + ++E +I E ++ L +P
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEIL----VMKELKNP 76
Query: 939 NVVAF---YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
N+V F + V G + V EY+ GSL V+ + +D + + + +E
Sbjct: 77 NIVNFLDSFLV-----GDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALE 129
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-SRIKCNTLVSGGVRGTLPWMAPE 1054
+LH ++H D+K DN+L+ + K+ DFG ++I + GT WMAPE
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPERCDP 1113
++ + KVD++S GI E++ GE PY N + + I +N T Q PE+ P
Sbjct: 186 VV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243
Query: 1114 EWRKLMEECWSFNPAARPSFTEI 1136
+R + C + R S E+
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 74/258 (28%), Positives = 111/258 (43%), Gaps = 26/258 (10%)
Query: 880 LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-H 936
L+ + G FG+VY K R T AIK +KKS + ++ + E I+
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-----VTNVKAERAIMMIQGE 55
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
P V Y + + V EY+ NG L + L + + G+E
Sbjct: 56 SPYVAKLYYSFQSK--DYLYLVMEYL-NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELL 1056
LH + I+H D+K +NLL++ Q K+ DFGLSR N L + GT ++APE +
Sbjct: 113 LHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETI 165
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER----CD 1112
G + + D +S G ++E + G P+ A+ ILS R PE C
Sbjct: 166 LGVGD--DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR--RINWPEEVKEFCS 221
Query: 1113 PEWRKLMEECWSFNPAAR 1130
PE L+ +PA R
Sbjct: 222 PEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 48/283 (16%)
Query: 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
DLE ++ELG G +G V + + GT +A+KRI+ + S EQ+ L+ + IS
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL-----DIS 53
Query: 934 --NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL----RHVLARKDRILDR---RKKL 984
++ P V FYG + G + E M + SL + V + I + + +
Sbjct: 54 MRSVDCPYTVTFYGALFRE--GDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV 110
Query: 985 MLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG 1043
++ +EYLH K +++H D+K N+L+N R+ Q +C DFG+S +++
Sbjct: 111 SIVK----ALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLC---DFGISGYLVDSVAKTI 162
Query: 1044 VRGTLPWMAPELLNGSNNR--VSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101
G P+MAPE +N N+ K DV+S GI M E+ TG PY +
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK-------TPFQ 215
Query: 1102 TLR-------PQIP-ERCDPEWRKLMEECWSFNPAARPSFTEI 1136
L+ PQ+P E+ PE++ + +C N RP++ E+
Sbjct: 216 QLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 24/249 (9%)
Query: 883 LGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG VY G ++A+K++ F S E + E ++ NL H +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVL----ARKDRILDRRKKLMLMMDAAFGMEY 996
V +YG + + ++ EYM GS++ L A + + R + +L G+ Y
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GVSY 121
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVR---GTLPWMA 1052
LH IVH D+K N+L RD + K+GDFG S RI+ + G++ GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
PE+++G K DV+S + E++T + P+A A I I + +P +P+
Sbjct: 178 PEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235
Query: 1113 PEWRKLMEE 1121
R +++
Sbjct: 236 DACRDFLKQ 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-20
Identities = 75/260 (28%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 878 EELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+L+E+G G+FG VY R +AIK K + G+ S ++W ++ +E + L
Sbjct: 18 TDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKW--QDIIKEVRFLQQL 72
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPN + + G T V EY + GS +L + L + + A G+
Sbjct: 73 RHPNTIEYKGCYLRE--HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC--NTLVSGGVRGTLPWMAP 1053
YLH +H D+K N+L L +P K+ DFG + + N+ V GT WMAP
Sbjct: 130 YLHSHERIHRDIKAGNIL--LTEPG--TVKLADFGSASLVSPANSFV-----GTPYWMAP 180
Query: 1054 E-LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
E +L + KVDV+S GI E+ + P NM+ + + I N
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWS 240
Query: 1113 PEWRKLMEECWSFNPAARPS 1132
+R ++ C P RPS
Sbjct: 241 DYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 9e-20
Identities = 72/267 (26%), Positives = 131/267 (49%), Gaps = 28/267 (10%)
Query: 883 LGSGTFGTVYRG-KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941
LG G +GTVY G +G IA+K+++ ++E+E+ ++ E ++ +L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY--EKLQEEVDLLKSLKHVNIV 65
Query: 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR----KDRILDRRKKLMLMMDAAFGMEYL 997
+ G + T++ E++ GS+ +L R + + + K +L G+ YL
Sbjct: 66 QYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG-------GVRGTLPW 1050
H +VH D+K +N+++ I K+ DFG +R + G + GT W
Sbjct: 119 HNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPE 1109
MAPE++N S K D++S G ++E+ TG+ P A+M A + I ++ L P++P+
Sbjct: 175 MAPEVINESGY--GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPD 232
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ C + + RPS ++
Sbjct: 233 SFSAAAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-19
Identities = 38/89 (42%), Positives = 53/89 (59%), Gaps = 11/89 (12%)
Query: 199 PSDGKLRYVGGETRIISIRKSLTWEELMRKTSAIC---NQPHTIKYQLPGEDLDALISVC 255
D KLRY GGETR +S+ + +++E+L K + NQ T+KYQ ED D L+S+
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLT 56
Query: 256 SDEDLHHMIEEYQEQERIGGSQRLRIFLV 284
SDEDL IEEY GS++LR+ +
Sbjct: 57 SDEDLEEAIEEYDSL----GSKKLRLHVF 81
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-19
Identities = 83/293 (28%), Positives = 126/293 (43%), Gaps = 48/293 (16%)
Query: 883 LGSGTFGTVYRGKWRGTD---------IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
LG G FG V + G D +A+K +K S E + + E ++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-------SDATEKDLSDLISEMEMMK 78
Query: 934 NL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARK--------------DRI 977
+ H N++ G G + + EY G+LR L AR+ +
Sbjct: 79 MIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 978 LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKC 1036
L + + A GMEYL K +H DL N+LV + + K+ DFGL+R I
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKIADFGLARDIHH 192
Query: 1037 NTLVSGGVRGTLP--WMAPELLNGSNNRV-SEKVDVYSFGIAMWEIIT-GEEPYANMHCG 1092
G LP WMAPE L +R+ + + DV+SFG+ +WEI T G PY +
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL-RVMS 1144
+ +L R P C E +M +CW P+ RP+F ++ L R+++
Sbjct: 250 ELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 89/330 (26%), Positives = 130/330 (39%), Gaps = 86/330 (26%)
Query: 883 LGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
LG G FG V + G + +A+K +K+ +SE + L+ E HI
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKALMTELKILIHI---G 68
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNG-------SLRHV------------------ 970
HH NVV G PGG + + EY G S R
Sbjct: 69 HHLNVVNLLGACTK-PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127
Query: 971 -----LARKDR---------ILDRR--------------KKLMLMMD-------AAFGME 995
L I D+ K+ + + D A GME
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLV-SGGVRGTLPWMA 1052
+L + +H DL N+L++ + + K+ DFGL+R K V G R L WMA
Sbjct: 188 FLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243
Query: 1053 PELLNGSNNRV-SEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPER 1110
PE + ++V + + DV+SFG+ +WEI + G PY + L R + PE
Sbjct: 244 PESIF---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEY 300
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
PE +M +CW NP RP+F+E+ L
Sbjct: 301 ATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 56/167 (33%), Positives = 81/167 (48%), Gaps = 10/167 (5%)
Query: 978 LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IK- 1035
LD L A GM +L KN +H DL N+L+ I K+ DFGL+R I+
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFGLARDIRN 266
Query: 1036 -CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGA 1093
N +V G R + WMAPE + N + + DV+S+GI +WEI + G PY M +
Sbjct: 267 DSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
Query: 1094 IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
++ R PE E +M+ CW +P RP+F +I +
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 883 LGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKE------FWREAHIISN 934
LG GT+G V + G +AIK++K ++ L+ RE I++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
+ H N++ V G + V + M L+ V+ RK R+ + + K +++ G+
Sbjct: 77 IKHENIMGLVDVYVEG--DFINLVMDIM-ASDLKKVVDRKIRLTESQVKC-ILLQILNGL 132
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG-------- 1046
LH +H DL N+ +N + ICK+ DFGL+R S +
Sbjct: 133 NVLHKWYFMHRDLSPANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 1047 -------TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
TL + APELL G+ + VD++S G E++TG
Sbjct: 189 EMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 31/266 (11%)
Query: 879 ELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+L+ +G G+FG VY+G T +AIK I E E I++ +E ++S
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
P + +YG G + + EY+ GS +L K L+ ++ + G++Y
Sbjct: 61 SPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL------SRIKCNTLVSGGVRGTLPW 1050
LH + +H D+K N+L++ ++ K+ DFG+ ++IK NT V GT W
Sbjct: 117 LHSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110
MAPE++ S K D++S GI E+ GE P +++H ++ I N+ P + +
Sbjct: 168 MAPEVIKQSAYDF--KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQ 224
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEI 1136
+++ +E C + +P RP+ E+
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 3e-19
Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 32/292 (10%)
Query: 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+L+E+G G+FG VY + T+ + IKK + G+ S ++W ++ +E + + HP
Sbjct: 29 DLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSNEKW--QDIIKEVKFLQRIKHP 85
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH 998
N + + G T V EY + GS +L + L + + A G+ YLH
Sbjct: 86 NSIEYKGCYLRE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGTLPWMAPE-L 1055
N++H D+K N+L L +P + K+ DFG + I N+ V GT WMAPE +
Sbjct: 143 SHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115
L + KVDV+S GI E+ + P NM+ + + I N + P EW
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQSNEW 249
Query: 1116 ----RKLMEECWSFNPAARPSFTEITNRLRVMSTALQT------KRRNHAIR 1157
R ++ C P RP+ E+ + V+ +T +R A+R
Sbjct: 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVR 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 63/258 (24%), Positives = 114/258 (44%), Gaps = 33/258 (12%)
Query: 891 VYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG----V 946
+Y+G + ++ I+ KK + LI E + + N++ YG +
Sbjct: 36 IYKGIFNNKEVIIRTFKKF-----HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90
Query: 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHF 1005
V + P ++ + EY G LR VL K++ L + KL + +D G+ L+ N +
Sbjct: 91 VDDLPRLSL--ILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK 147
Query: 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRI-------KCNTLVSGGVRGTLPWMAPELLNG 1058
+L + LV + K+ GL +I N +V + + ++LN
Sbjct: 148 NLTSVSFLVT----ENYKLKIICHGLEKILSSPPFKNVNFMV---------YFSYKMLND 194
Query: 1059 SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKL 1118
+ + K D+YS G+ +WEI TG+ P+ N+ I I++ ++P C E + +
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCI 254
Query: 1119 MEECWSFNPAARPSFTEI 1136
+E C S + RP+ EI
Sbjct: 255 VEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 75/275 (27%), Positives = 117/275 (42%), Gaps = 38/275 (13%)
Query: 883 LGSGTFGTVYRGKWRGT-DI-AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+ G +G V+ K + T DI AIK IKK+ + ++ + L E I+S P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-----ERDILSQAQSPYV 55
Query: 941 VAFY----GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
V Y G + V EY+ G L +L LD + + + +EY
Sbjct: 56 VKLYYSFQGK------KNLYLVMEYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALEY 108
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN---------TLVSGGVRGT 1047
LH I+H DLK DN+L++ K+ DFGLS++ + GT
Sbjct: 109 LHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-RPQ 1106
++APE++ G + S+ VD +S G ++E + G P+ I IL+ + P+
Sbjct: 165 PDYIAPEVILGQGH--SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE 222
Query: 1107 IPERCDPEWRKLMEECWSFNPAARP---SFTEITN 1138
E E L+ + +P R S EI N
Sbjct: 223 DVE-VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 37/223 (16%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
++ E+L +G GT+G VYR + + +A+K+++ +E++ + RE ++
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD------NERDGIPISSLREITLL 60
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR---------KK 983
NL HPN+V VV ++ V EY LA +LD K
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEY-----CEQDLAS---LLDNMPTPFSESQVKC 112
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLV 1040
LML + G++YLH I+H DLK NLL+ + K+ DFGL+R + +
Sbjct: 113 LMLQLLR--GLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGLARTYGLPAKPMT 166
Query: 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
V TL + APELL G + +D+++ G + E++ +
Sbjct: 167 PKVV--TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 879 ELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+L++LG GT+ TVY+G+ R T +A+K I G S RE ++ L
Sbjct: 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-------IREISLMKELK 56
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDAAFGME 995
H N+V + V+ + V EYM +++ R LD G+
Sbjct: 57 HENIVRLHDVIHT--ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGTLPWMA 1052
+ H ++H DLK NLL+N +R K+ DFGL+R I NT + V TL + A
Sbjct: 115 FCHENRVLHRDLKPQNLLIN----KRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRA 168
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
P++L GS S +D++S G M E+ITG
Sbjct: 169 PDVLLGSRT-YSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 31/266 (11%)
Query: 879 ELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+L+ +G G+FG V++G T +AIK I E E I++ +E ++S
Sbjct: 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIID-------LEEAEDEIEDIQQEITVLSQCD 60
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
P V +YG G + + EY+ GS +L + D + ++ + G++Y
Sbjct: 61 SPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDY 116
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL------SRIKCNTLVSGGVRGTLPW 1050
LH + +H D+K N+L++ ++ K+ DFG+ ++IK NT V GT W
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110
MAPE++ S K D++S GI E+ GE P ++MH ++ I N P +
Sbjct: 168 MAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGE 224
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEI 1136
+++ ++ C + +P+ RP+ E+
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-19
Identities = 76/258 (29%), Positives = 120/258 (46%), Gaps = 20/258 (7%)
Query: 879 ELQELGSGTFGTVYRGK-WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+L+E+G G+FG VY + R +++ IKK + G+ S ++W ++ +E + L H
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVA--IKKMSYSGKQSNEKW--QDIIKEVRFLQKLRH 74
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
PN + + G T V EY + GS +L + L + + A G+ YL
Sbjct: 75 PNTIQYRGCYLRE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGTLPWMAPE- 1054
H N++H D+K N+L L +P + K+GDFG + I N V GT WMAPE
Sbjct: 132 HSHNMIHRDVKAGNIL--LSEPG--LVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
+L + KVDV+S GI E+ + P NM+ + + I N
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 1115 WRKLMEECWSFNPAARPS 1132
+R ++ C P RP+
Sbjct: 243 FRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-18
Identities = 85/292 (29%), Positives = 123/292 (42%), Gaps = 46/292 (15%)
Query: 883 LGSGTFGTVYRGKWRGTD---------IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
LG G FG V + G D +A+K +K + L+ E I
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGK 76
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARK--------------DRIL 978
H N++ G G + + EY G+LR L AR+ + L
Sbjct: 77 ---HKNIINLLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 979 DRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT 1038
+ + A GMEYL + +H DL N+LV + + K+ DFGL+R N
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT----EDNVMKIADFGLARDVHNI 187
Query: 1039 -LVSGGVRGTLP--WMAPELLNGSNNRV-SEKVDVYSFGIAMWEIIT-GEEPYANMHCGA 1093
G LP WMAPE L +RV + + DV+SFG+ +WEI T G PY +
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 1094 IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL-RVMS 1144
+ +L R P C E +M ECW P+ RP+F ++ L RV++
Sbjct: 245 LFK-LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-18
Identities = 51/155 (32%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGT 1047
A GME+L + +H DL N+L++ + + K+ DFGL+R + + G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 1048 LPWMAPELLNGSNNRV-SEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105
L WMAPE + +RV + + DV+SFG+ +WEI + G PY + L R
Sbjct: 245 LKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
+ P+ PE + M +CW P+ RP+F+E+ L
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 41/291 (14%)
Query: 868 GLQIIKD-SDLEELQE-LGSGTFGTVYR--GKWRGTDIAIKRIKKSCFLGRSSEQEWLIK 923
GL+ + D +D E+ E +G GT+G VY+ K G+ A+K + + E E+ I
Sbjct: 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNIL 72
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGP---GGTMATVTEYMVNGSLRHV---LARKDRI 977
+ + N HPNVV FYG+ GG + V E GS+ + L +
Sbjct: 73 QS------LPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 978 LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS----- 1032
LD ++ A G+++LH I+H D+K +N+L+ K+ DFG+S
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTS 180
Query: 1033 -RIKCNTLVSGGVRGTLPWMAPELL---NGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088
R++ NT V GT WMAPE++ + + DV+S GI E+ G+ P +
Sbjct: 181 TRLRRNTSV-----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
Query: 1089 MHCGAIIGGILSN---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
MH + I N TL PE+ + + +C + ARPS T +
Sbjct: 236 MHPVKTLFKIPRNPPPTLLH--PEKWCRSFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 75/279 (26%), Positives = 132/279 (47%), Gaps = 31/279 (11%)
Query: 879 ELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+L+++G G+FG V++G T +AIK I E E I++ +E ++S
Sbjct: 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-------LEEAEDEIEDIQQEITVLSQCD 60
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
P V +YG + + EY+ GS +L + LD + ++ + G++Y
Sbjct: 61 SPYVTKYYGSYLKDT--KLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDY 116
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL------SRIKCNTLVSGGVRGTLPW 1050
LH + +H D+K N+L++ + K+ DFG+ ++IK NT V GT W
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110
MAPE++ S K D++S GI E+ GE P++ +H ++ I N P +
Sbjct: 168 MAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGN 224
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149
++ +E C + P+ RP+ E+ ++ A +T
Sbjct: 225 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKT 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-18
Identities = 76/264 (28%), Positives = 119/264 (45%), Gaps = 26/264 (9%)
Query: 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN 939
L E+G G+FG VY T+ + +KK + G+ + ++W ++ +E + L HPN
Sbjct: 26 LHEIGHGSFGAVYFATNSHTN-EVVAVKKMSYSGKQTNEKW--QDIIKEVKFLQQLKHPN 82
Query: 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
+ + G T V EY + GS +L + L + + A G+ YLH
Sbjct: 83 TIEYKGCYLKE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK--CNTLVSGGVRGTLPWMAPE-LL 1056
N++H D+K N+L L +P + K+ DFG + N+ V GT WMAPE +L
Sbjct: 140 HNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSPANSFV-----GTPYWMAPEVIL 190
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW- 1115
+ KVDV+S GI E+ + P NM+ + + I N P EW
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLQSNEWT 246
Query: 1116 ---RKLMEECWSFNPAARPSFTEI 1136
R ++ C P RP+ E+
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-18
Identities = 80/251 (31%), Positives = 113/251 (45%), Gaps = 55/251 (21%)
Query: 924 EFWREAHIISNLHHPNVVAFYGV-VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
+F +E I+S L PN++ GV V P + +TEYM NG L L+ LD ++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDP---LCMITEYMENGDLNQFLSS--HHLDDKE 119
Query: 983 K--------------------LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022
+ L + + A GM+YL N VH DL N LV
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLT 176
Query: 1023 ICKVGDFGLSRIKCNTLVSGGV-----RGTLP--WMAPE-LLNGSNNRVSEKVDVYSFGI 1074
I K+ DFG+SR L +G R LP WMA E +L G S DV++FG+
Sbjct: 177 I-KIADFGMSR----NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS---DVWAFGV 228
Query: 1075 AMWEIIT--GEEPYANMHCGAII---GGILSNTLRPQI----PERCDPEWRKLMEECWSF 1125
+WEI+ E+PY + +I G + R Q+ P C +LM +CWS
Sbjct: 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGR-QVYLFRPPPCPQGLYELMLQCWSR 287
Query: 1126 NPAARPSFTEI 1136
+ RPSF++I
Sbjct: 288 DCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-17
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGT 1047
A GME+L + +H DL N+L++ + + K+ DFGL+R + + G R
Sbjct: 184 ARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
L WMAPE + + + + DV+SFG+ +WEI + G PY + L + R +
Sbjct: 240 LKWMAPESI--FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
PE PE ++M CW +P RP+F+ + L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 38/270 (14%)
Query: 879 ELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+++G G GTVY G ++AIK++ L + ++E +I E ++
Sbjct: 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMN----LQQQPKKELIINEIL----VMRENK 74
Query: 937 HPNVVAF---YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
HPN+V + Y V G + V EY+ GSL V+ + +D + + +
Sbjct: 75 HPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQA 127
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL------SRIKCNTLVSGGVRGT 1047
+E+LH ++H D+K DN+L+ + K+ DFG + K +T+V GT
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GT 178
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQ 1106
WMAPE++ + KVD++S GI E++ GE PY N + + I +N T Q
Sbjct: 179 PYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ 236
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
PE+ +R + C + R S E+
Sbjct: 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 877 LEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
+ EL LG G G+V + + + T A+K I + L K+ RE I +
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-------TDPNPDLQKQILRELEINKS 55
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL----RHVLARKDRILDRRKKLMLMMDA 990
P +V +YG + ++ EY GSL + V R RI ++ ++
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-----VLGKI 110
Query: 991 AF----GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG 1046
A G+ YLH + I+H D+K N+L+ R Q +C DFG+S N+L +G G
Sbjct: 111 AESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLC---DFGVSGELVNSL-AGTFTG 165
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY---ANMHCGAIIGGILSNTL 1103
T +MAPE + G ++ DV+S G+ + E+ P+ G I +LS +
Sbjct: 166 TSFYMAPERIQGKPYSITS--DVWSLGLTLLEVAQNRFPFPPEGEPPLGPI--ELLSYIV 221
Query: 1104 RPQIPERCDPE-----W----RKLMEECWSFNPAARPS 1132
PE D W + +++C +P RP+
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 59/254 (23%), Positives = 102/254 (40%), Gaps = 74/254 (29%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D + + +G G+F TV K + T+ AIK + K + +E +K E ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVL 55
Query: 933 SNL-HHPNVVAFYGVVPNGPGGTMAT---------VTEYMVNGSLRHVLARKDRILDRRK 982
+ L HP ++ Y T V EY NG L + RK LD +
Sbjct: 56 TRLNGHPGIIKLYY-----------TFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEK- 102
Query: 983 KLMLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLV--NLRDPQRPICKVGDFGLSR 1033
F +EYLH K I+H DLK +N+L+ ++ K+ DFG ++
Sbjct: 103 ------CTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH------IKITDFGTAK 150
Query: 1034 IKCNTLVSGGVR---------------------GTLPWMAPELLNGSNNRVSEKVDVYSF 1072
+ + GT +++PELLN + D+++
Sbjct: 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN--EKPAGKSSDLWAL 208
Query: 1073 GIAMWEIITGEEPY 1086
G +++++TG+ P+
Sbjct: 209 GCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 23/264 (8%)
Query: 881 QELGSGTFGTVYRGKWRGTDIAIKRIK--KSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
Q LG G+FGTVY K + A +R+K K +G + E + + +EA ++S L HP
Sbjct: 6 QRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNETV--QANQEAQLLSKLDHP 62
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLR---HVLARKDRILDRRKKLMLMMDAAFGME 995
+V F+ +TEY L L + L + + G+
Sbjct: 63 AIVKFHASFLERD--AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLVSGGVRGTLPWMA 1052
Y+H + I+H DLK N+ + + + K+GDFG+SR+ C+ ++ GT +M+
Sbjct: 121 YMHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMS 173
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
PE L + K D++S G ++E+ + + +++ I+ P +PE
Sbjct: 174 PEAL--KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYS 230
Query: 1113 PEWRKLMEECWSFNPAARPSFTEI 1136
+ +M+ + +P+ RPS EI
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 45/282 (15%)
Query: 881 QELGSGTFGTVYRGK-WRGTDIA---IKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
E+G+G FG V G+ RG A +K ++ S ++ E L+ F +E L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-----ATPDEQLL--FLQEVQPYRELN 53
Query: 937 HPNVVAFYG----VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR---RKKLMLMM- 988
HPNV+ G +P V E+ G L++ L R +R + +K ++ M
Sbjct: 54 HPNVLQCLGQCIESIP------YLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMA 106
Query: 989 -DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL--SRIKCNTLVSGGVR 1045
+ A G+ +LH + +H DL N + K+GD+GL + + ++
Sbjct: 107 CEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLALEQYPEDYYITKDCH 162
Query: 1046 GT-LPWMAPELLNGSNNRV-----SEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
L W+APEL+ + ++K +++S G+ MWE+ T ++PY ++ ++ +
Sbjct: 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
Query: 1099 LSNTL----RPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ +PQ+ + W ++M+ CW +P RP+ E+
Sbjct: 223 VREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-17
Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 12/168 (7%)
Query: 975 DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLV-NLRDPQRPICKVGDFGLSR 1033
LD L A GM++L KN +H D+ N+L+ + R + K+ DFGL+R
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-----VAKICDFGLAR 260
Query: 1034 I---KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANM 1089
N +V G R + WMAPE + V DV+S+GI +WEI + G+ PY +
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQS--DVWSYGILLWEIFSLGKSPYPGI 318
Query: 1090 HCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEIT 1137
+ ++ + P+ PE +M+ CW+ P RP+F++I+
Sbjct: 319 LVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 63/266 (23%), Positives = 125/266 (46%), Gaps = 18/266 (6%)
Query: 878 EELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E ++++G G+FG +Y + K IK I + + E +E +++ +
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRIL-DRRKKLMLMMDAAFGM 994
HPN+V F+ G + V EY G L + R+ +L + L + + G+
Sbjct: 57 KHPNIVTFFASFQEN--GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL-VSGGVRGTLPWMAP 1053
+++H + I+H D+K N+ ++ + K+GDFG++R +++ ++ GT +++P
Sbjct: 115 KHIHDRKILHRDIKSQNIFLS---KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113
E+ N + K D++S G ++E+ T + P+ + ++ I P P
Sbjct: 172 EICQ--NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF-SR 228
Query: 1114 EWRKLMEECWSFNPAARPSFTEITNR 1139
+ R L+ + + +P RPS T I R
Sbjct: 229 DLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 39/274 (14%)
Query: 881 QELGSGTFGTVYRG---------KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ LG GTF +++G + T++ +K + KS R+ + F+ A +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSES-----FFEAASM 52
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+S L H ++V YGV G M V EY+ GSL L + +++ KL + A
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLA 110
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQR-----PICKVGDFGLSRIKCNTLVSGGVRG 1046
+ + +L K + H ++ N+L+ +R+ R P K+ D G+S L +
Sbjct: 111 WALHFLEDKGLTHGNVCAKNVLL-IREEDRKTGNPPFIKLSDPGIS---ITVLPKEILLE 166
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG-EEPYANMHCGAIIGGILSNTLRP 1105
+PW+ PE + N +S D +SFG +WEI +G ++P + + + R
Sbjct: 167 RIPWVPPECIENPQN-LSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRH 222
Query: 1106 QIPERCDPEWRKL---MEECWSFNPAARPSFTEI 1136
Q+P P+W +L + +C + P RPSF I
Sbjct: 223 QLPA---PKWTELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 1e-16
Identities = 75/312 (24%), Positives = 126/312 (40%), Gaps = 85/312 (27%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ +++LG GTFG+VY + + G +AIK++KK + E + RE + L
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKK-----KFYSWEECMNL--REVKSLRKL 54
Query: 936 -HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM-------LM 987
HPN+V V + V EYM G+L + + DR+ K ++
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYM-EGNLYQL------MKDRKGKPFSESVIRSII 105
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCN----TLVSG 1042
G+ ++H H DLK +NLLV+ + + K+ DFGL+R I+ VS
Sbjct: 106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAREIRSRPPYTDYVS- 160
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---------- 1092
T + APE+L S + S VD+++ G M E+ T P + G
Sbjct: 161 ----TRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTL-RP---LFPGSSEIDQLYKI 211
Query: 1093 -AIIG-------------------------GILSNTLRPQIPERCDPEWRKLMEECWSFN 1126
+++G + L P PE L+++ ++
Sbjct: 212 CSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNAS----PEAIDLIKDMLRWD 267
Query: 1127 PAARPSFTEITN 1138
P RP+ ++
Sbjct: 268 PKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 878 EELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E + ELG G FG VY+ K + T A K I+ SE+E ++++ E I++
Sbjct: 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK------SEEE--LEDYMVEIEILATC 66
Query: 936 HHPNVV----AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+HP +V AFY G + + E+ G++ ++ DR L + ++
Sbjct: 67 NHPYIVKLLGAFYW------DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS-GGVRGTLPW 1050
++YLH I+H DLK N+L+ L K+ DFG+S TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 1051 MAPELLNGSNNRVSE---KVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
MAPE++ + + K D++S GI + E+ E P+ ++ ++ I + + P +
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTL 235
Query: 1108 --PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P + E+R ++ +P RPS ++
Sbjct: 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 28/264 (10%)
Query: 880 LQELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+++G G GTVY G ++AIK++ L + ++E +I E ++ +
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMN----LQQQPKKELIINEIL----VMRENKN 75
Query: 938 PNVVAF---YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
PN+V + Y V G + V EY+ GSL V+ + +D + + + +
Sbjct: 76 PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQAL 128
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-SRIKCNTLVSGGVRGTLPWMAP 1053
++LH ++H D+K DN+L+ + K+ DFG ++I + GT WMAP
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPERCD 1112
E++ + KVD++S GI E++ GE PY N + + I +N T Q PER
Sbjct: 185 EVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLS 242
Query: 1113 PEWRKLMEECWSFNPAARPSFTEI 1136
+R + C + R S E+
Sbjct: 243 AVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E+++++G GT+G VY+ + R T+ IA+K+I+ E E + RE ++ +
Sbjct: 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIR------LEQEDEGVPSTAIREISLLKEM 58
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
H N+V VV + + V EY+ +H+ + D + R + G+
Sbjct: 59 QHGNIVRLQDVVHSEK--RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGTLPWMA 1052
Y H ++H DLK NLL+ D + K+ DFGL+R I T V TL + A
Sbjct: 117 YCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRA 171
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
PE+L GS + S VD++S G E++
Sbjct: 172 PEILLGSRH-YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 28/264 (10%)
Query: 880 LQELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+++G G GTVY G ++AI+++ L + ++E +I E ++ +
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIINEIL----VMRENKN 76
Query: 938 PNVVAF---YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
PN+V + Y V G + V EY+ GSL V+ + +D + + + +
Sbjct: 77 PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQAL 129
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-SRIKCNTLVSGGVRGTLPWMAP 1053
E+LH ++H D+K DN+L+ + K+ DFG ++I + GT WMAP
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPERCD 1112
E++ + KVD++S GI E+I GE PY N + + I +N T Q PE+
Sbjct: 186 EVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 1113 PEWRKLMEECWSFNPAARPSFTEI 1136
+R + C + R S E+
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 61/270 (22%), Positives = 118/270 (43%), Gaps = 23/270 (8%)
Query: 883 LGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+G G F VY+ G +A+K+++ + + Q+ L +E ++ L HPNV
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL-----KEIDLLKQLDHPNV 64
Query: 941 VAFY-GVVPNGPGGTMATVTEYMVNGSLRHVL---ARKDRILDRRKKLMLMMDAAFGMEY 996
+ + + N + V E G L ++ ++ R++ R + +E+
Sbjct: 65 IKYLASFIENN---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-KCNTLVSGGVRGTLPWMAPEL 1055
+H K I+H D+K N+ + + K+GD GL R T + + GT +M+PE
Sbjct: 122 MHSKRIMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--ANMHCGAIIGGILSNTLRPQIPERCDP 1113
++ N + K D++S G ++E+ + P+ M+ ++ I P +
Sbjct: 178 IHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235
Query: 1114 EWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
E R L+ C + +P RP + + + M
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 66/269 (24%), Positives = 130/269 (48%), Gaps = 31/269 (11%)
Query: 878 EELQELGSGTFGT--VYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+++++G G+FG + + K G IK I S + S +E +E +E ++SN+
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINIS----KMSPKER--EESRKEVAVLSNM 56
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL-------RHVLARKDRILDRRKKLMLMM 988
HPN+V + G + V +Y G L R VL +D+ILD ++ L
Sbjct: 57 KHPNIVQYQESFEEN--GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL-- 112
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL-VSGGVRGT 1047
++++H + I+H D+K N+ + + K+GDFG++R+ +T+ ++ GT
Sbjct: 113 ----ALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIARVLNSTVELARTCIGT 164
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
+++PE+ N + K D+++ G ++E+ T + + + ++ I+ + P +
Sbjct: 165 PYYLSPEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPV 221
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ R L+ + + NP RPS I
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 72/269 (26%), Positives = 128/269 (47%), Gaps = 27/269 (10%)
Query: 878 EELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
E + ELG G FG VY+ + + T + + + + SE+E ++++ E I+++ H
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGV----LAAAKVIDTKSEEE--LEDYMVEIDILASCDH 61
Query: 938 PNVV----AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
PN+V AFY + + E+ G++ V+ +R L + ++
Sbjct: 62 PNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV-SGGVRGTLPWMA 1052
+ YLH I+H DLK N+L L K+ DFG+S T+ GT WMA
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171
Query: 1053 PELL--NGSNNRVSE-KVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI-- 1107
PE++ S +R + K DV+S GI + E+ E P+ ++ ++ I + + P +
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTLAQ 230
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P R E++ +++C N AR + T++
Sbjct: 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-16
Identities = 56/160 (35%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLVS 1041
L A GME+L KN VH DL N+L+ Q I K+ DFGL+R + + VS
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVS 295
Query: 1042 GGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
G LP WMAPE + +N + DV+S+GI +WEI + G PY M +
Sbjct: 296 KG-STFLPVKWMAPESI--FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
+ + R P+ E +M +CW+ P RPSF +++
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 40/220 (18%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
EEL E+G G +GTVY+ + G +A+K+++ L ++E I+ L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP--LSEEGIPLSTLRE-------IALL 52
Query: 936 ------HHPNVVAFYGV--VPNGPGGTMAT-VTEYMVNGSLRHVLAR-------KDRILD 979
HPN+V V P T V E+ V+ L L++ + I D
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKD 111
Query: 980 RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039
++L+ G+++LH IVH DLK N+LV D Q K+ DFGL+RI +
Sbjct: 112 LMRQLLR------GVDFLHSHRIVHRDLKPQNILVT-SDGQ---VKIADFGLARIYSFEM 161
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEI 1079
V TL + APE+L S+ VD++S G E+
Sbjct: 162 ALTSVVVTLWYRAPEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 66/267 (24%), Positives = 128/267 (47%), Gaps = 23/267 (8%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD---IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D + L++LG G++G+VY+ K R +D A+K + LG S++E + E I+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVD----LGSMSQKERE--DAVNEIRIL 53
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMD 989
++++HPN++++ +G + V EY G L +++ K +++ ++ + +
Sbjct: 54 ASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
G++ LH + I+H DLK N+L+ D + K+GD G+S++ + + GT
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNMAKTQI-GTPH 166
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109
+MAPE+ S K D++S G ++E+ T P+ + + P IP
Sbjct: 167 YMAPEVW--KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-PPIPP 223
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ + + P RP+ +I
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 879 ELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+L +LG GT+ TVY+G+ + TD +A+K I R +E RE ++ +L
Sbjct: 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDLK 62
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
H N+V + ++ ++ V EY+ + L+ L ++ + + G+ Y
Sbjct: 63 HANIVTLHDIIHTEK--SLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC-NTLVSGGVRGTLPWMAPEL 1055
H + ++H DLK NLL+N +R K+ DFGL+R K T TL + P++
Sbjct: 120 CHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITG 1082
L GS + S ++D++ G +E+ TG
Sbjct: 176 LLGSTD-YSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D +++++G GT+G VY+G+ + T +A+K+I+ SE+E + RE ++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR------LESEEEGVPSTAIREISLLK 54
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLA-RKDRILDRRKKLMLMMDAAF 992
L HPN+V V+ + + E++ +++ + K + +D L+ +
Sbjct: 55 ELQHPNIVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDA----ELVKSYLY 108
Query: 993 ----GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVR 1045
G+ + H + ++H DLK NLL++ + + K+ DFGL+R I V
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGLARAFGIPVRVYTHEVV- 163
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
TL + APE+L GS R S VD++S G E+ T
Sbjct: 164 -TLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++++++G GT+G VY+ + + G +A+K+I+ +E E + RE ++ L
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKEL 55
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRR--KKLMLMMDAAF 992
+HPN+V VV + + V E+ ++ L+ + LD K + +
Sbjct: 56 NHPNIVRLLDVVHSE--NKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-- 110
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG------ 1046
G+ Y H ++H DLK NLL++ + K+ DFGL+R VR
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLARA-----FGVPVRTYTHEVV 161
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
TL + APE+L GS + S VD++S G E++
Sbjct: 162 TLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 884 GSGTFGTVYRGKW----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN 939
G GT+G VY+ K G + AIK+ K G + + + RE ++ L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHEN 63
Query: 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-----ARKDRILDRRKKLMLMMDAAFGM 994
VV+ V ++ + +Y L ++ A++ I K L+ G+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVK-SLLWQILNGV 121
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS----GGVRGTLPW 1050
YLH ++H DLK N+LV P+R + K+GD GL+R+ L V T+ +
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
APELL G+ + +D+++ G E++T E +
Sbjct: 182 RAPELLLGARHYTK-AIDIWAIGCIFAELLTLEPIF---KG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 32/244 (13%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
D E+L ELG+G G V + R + + + R K L + + RE ++
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMAR--KLIHLEIKPA---IRNQIIRELKVLHE 55
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI----LDRRKKLMLMMDA 990
+ P +V FYG + G ++ E+M GSL VL + RI L + +L
Sbjct: 56 CNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLR--- 110
Query: 991 AFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
G+ YL K I+H D+K N+LVN R K+ DFG+S +++ + V GT
Sbjct: 111 --GLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRS 163
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP--------YANMHCGAIIGGILSN 1101
+M+PE L G++ V D++S G+++ E+ G P M + G
Sbjct: 164 YMSPERLQGTHYTVQS--DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221
Query: 1102 TLRP 1105
+ RP
Sbjct: 222 SHRP 225
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 879 ELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+L +LG GT+ TV++G+ + T+ +A+K I R +E RE ++ NL
Sbjct: 9 KLDKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVSLLKNLK 61
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
H N+V + ++ T+ V EY+ + L+ L ++ + M G+ Y
Sbjct: 62 HANIVTLHDIIHTERCLTL--VFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-------CNTLVSGGVRGTLP 1049
H + I+H DLK NLL+N ++ K+ DFGL+R K N +V TL
Sbjct: 119 CHKRKILHRDLKPQNLLIN----EKGELKLADFGLARAKSVPTKTYSNEVV------TLW 168
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
+ P++L GS S +D++ G ++E+ TG
Sbjct: 169 YRPPDVLLGS-TEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 68/230 (29%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E L +LG GTFG VY+ + G +A+K+I +E++ RE I+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH------NEKDGFPITALREIKIL 61
Query: 933 SNLHHPNVVAFYGVVPNGPG------GTMATVTEYMVNGSLRHVLARKDRILDRR--KKL 984
L HPNVV + P G++ VT YM + L +L L K
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNT 1038
ML + G+ YLH +I+H D+K N+L++ + I K+ DFGL+R
Sbjct: 121 MLQLLE--GINYLHENHILHRDIKAANILID----NQGILKIADFGLARPYDGPPPNPKG 174
Query: 1039 LVSGGVRG------TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
GG R T + PELL G + VD++ G E+ T
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 67/268 (25%), Positives = 127/268 (47%), Gaps = 20/268 (7%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
L+ +G G+FG + +D A+K I+ L +SS +++ +EA +++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR----LPKSSSA---VEDSRKEAVLLA 53
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL-RHVLARKDRILDRRKKLMLMMDAAF 992
+ HPN+VAF G + V EY G L + + ++ ++ L +
Sbjct: 54 KMKHPNIVAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-GTLPWM 1051
G++++H K ++H D+K N+ + Q K+GDFG +R+ + GT ++
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV 167
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
PE+ N + K D++S G ++E+ T + P+ +I + + +P +P
Sbjct: 168 PPEIW--ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHY 224
Query: 1112 DPEWRKLMEECWSFNPAARPSFTEITNR 1139
E R L+++ + NP +RPS T I +R
Sbjct: 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-15
Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGT 1047
A GME+L KN VH DL N+L+ + + K+ DFGL+R N + G
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
L WMAPE + NN + DV+SFGI +WEI T G PY + + R
Sbjct: 305 LKWMAPESI--FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P E ++M++CW RP F+++
Sbjct: 363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-15
Identities = 66/205 (32%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 917 EQEWLIKEFWREAHIISNLHHPNVVAFY--GVVPNGPGGTMATVTEYMVNGSLRHVLARK 974
E+E F RE + + L+HPN+VA G P G + V EY+ +LR VLA
Sbjct: 17 EEEHQRARFRRETALCARLYHPNIVALLDSGEAPP---GLLFAVFEYVPGRTLREVLA-A 72
Query: 975 DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034
D L + LM+ + H + IVH DLK N++V+ RP KV DFG+
Sbjct: 73 DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG-VRPHAKVLDFGIG-- 129
Query: 1035 KCNTLVSGG-------------VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
TL+ G V GT + APE L G V+ D+Y++G+ E +T
Sbjct: 130 ---TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--VTPNSDLYAWGLIFLECLT 184
Query: 1082 GEEPYANMHCGAIIGGILSNTLRPQ 1106
G+ GA + IL L P
Sbjct: 185 GQRVVQ----GASVAEILYQQLSPV 205
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E L +G G +G V + + + T +AIK+ K+S + E + K RE ++ L
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES------EDDEDVKKTALREVKVLRQL 57
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
H N+V G + V EY V +L +L L + +
Sbjct: 58 RHENIVNLKEAFRRK--GRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR------GTLP 1049
Y H NI+H D+K +N+LV+ + K+ DFG +R L + T
Sbjct: 115 YCHSHNIIHRDIKPENILVSESG----VLKLCDFGFAR----ALRARPASPLTDYVATRW 166
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ APELL G N + VDV++ G M E++ GE
Sbjct: 167 YRAPELLVGDTN-YGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 69/256 (26%), Positives = 114/256 (44%), Gaps = 29/256 (11%)
Query: 883 LGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG GTFG V R K G A+K ++K + + + E+ ++ N HP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-----VAHTVTESRVLQNTRHPFL 57
Query: 941 VAF-YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
A Y + + V EY G L L+R +R+ + + +EYLH
Sbjct: 58 TALKYAFQTHD---RLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 113
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWMAPE 1054
+++V+ D+K +NL+++ +D K+ DFGL C +S G GT ++APE
Sbjct: 114 RDVVYRDIKLENLMLD-KDGH---IKITDFGL----CKEGISDGATMKTFCGTPEYLAPE 165
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
+L +N VD + G+ M+E++ G P+ N + IL +R P PE
Sbjct: 166 VL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPE 221
Query: 1115 WRKLMEECWSFNPAAR 1130
+ L+ +P R
Sbjct: 222 AKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-14
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 20/217 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+KD D E + ELG+G G V + + + + + + R L + + + RE +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARK-----LIHLEIKPAIRNQIIRELQV 56
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ + P +V FYG + G ++ E+M GSL VL RI ++++ + A
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKEAKRI---PEEILGKVSIA 111
Query: 992 F--GMEYLHMKN-IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTL 1048
G+ YL K+ I+H D+K N+LVN R K+ DFG+S +++ + V GT
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTR 166
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP 1085
+M+PE L G++ V D++S G+++ E+ G P
Sbjct: 167 SYMSPERLQGTHYSVQS--DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 58/271 (21%), Positives = 121/271 (44%), Gaps = 21/271 (7%)
Query: 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+++G G F VYR G +A+K+++ + + + + +E ++ L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-----KEIDLLKQLNHP 62
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL---ARKDRILDRRKKLMLMMDAAFGME 995
NV+ +Y + V E G L ++ ++ R++ + + +E
Sbjct: 63 NVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGTLPWMAPE 1054
++H + ++H D+K N+ + + K+GD GL R T + + GT +M+PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--ANMHCGAIIGGILSNTLRPQIPERCD 1112
++ N + K D++S G ++E+ + P+ M+ ++ I P +
Sbjct: 177 RIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
E R+L+ C + +P RP T + + + M
Sbjct: 235 EELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++L +LG G++ TVY+G+ + T +A+K I R +E REA ++ +L
Sbjct: 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAIREASLLKDL 60
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
H N+V + ++ T+ V EY+ L+ + L + + G+
Sbjct: 61 KHANIVTLHDIIHTKK--TLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC---NTLVSGGVRGTLPWMA 1052
Y H + ++H DLK NLL++ R K+ DFGL+R K T + V TL +
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGE----LKLADFGLARAKSVPSKTYSNEVV--TLWYRP 171
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
P++L GS S +D++ G +E+ TG
Sbjct: 172 PDVLLGSTE-YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 20/217 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+KD D E++ ELG+G G V++ + + + + R L + + + RE +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARK-----LIHLEIKPAIRNQIIRELQV 56
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ + P +V FYG + G ++ E+M GSL VL + RI ++++ + A
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIA 111
Query: 992 F--GMEYLHMKN-IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTL 1048
G+ YL K+ I+H D+K N+LVN R K+ DFG+S +++ + V GT
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTR 166
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP 1085
+M+PE L G++ V D++S G+++ E+ G P
Sbjct: 167 SYMSPERLQGTHYSVQS--DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 46/286 (16%)
Query: 875 SDLEELQE-LGSGTFGTVYR--GKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
SD E+ E +G GT+G V++ K G+ A+K + + E E+ I + +
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD--- 73
Query: 932 ISNLHHPNVVAFYGV-----VPNGPGGTMATVTEYMVNGSL----RHVLARKDRILDRRK 982
HPNVV FYG+ V NG + V E GS+ + L R +R ++
Sbjct: 74 -----HPNVVKFYGMYYKKDVKNG--DQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPI 125
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKC 1036
++ +A G+++LH+ +H D+K +N+L+ K+ DFG+S R++
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRR 181
Query: 1037 NTLVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA 1093
NT V GT WMAPE++ ++ + DV+S GI E+ G+ P A++H
Sbjct: 182 NTSV-----GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236
Query: 1094 IIGGILSN---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ I N TL PE E+ + +C + + RP+ +++
Sbjct: 237 ALFKIPRNPPPTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 32/222 (14%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E ++ LG+G+FG V + +G+ A+K + K+ + + + E ++ E I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVL----NEKRIL 55
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA- 991
++ HP +V YG + + V EY+ G L L + R + + AA
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYL--VMEYVPGGELFSHLRKSGRF----PEPVARFYAAQ 109
Query: 992 --FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLVSGGVRG 1046
+EYLH +IV+ DLK +NLL+ D I K+ DFG ++ + TL G
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLL---DSDGYI-KITDFGFAKRVKGRTYTLC-----G 160
Query: 1047 TLPWMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA 1087
T ++APE +L+ + VD ++ GI ++E++ G P+
Sbjct: 161 TPEYLAPEIILSKGYGK---AVDWWALGILIYEMLAGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-14
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 46/238 (19%)
Query: 883 LGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+G G G VY +A+K+I++ SE L K F REA I ++L HP +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIHPGI 64
Query: 941 VAFYGVVPNGPG--GTMATVTEYMVNGSLRHV---------LARKDRILDRRKKLMLMMD 989
V Y + +G TM + Y + L+ V LA K + L +
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIFHK 121
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-------------- 1035
+EY+H K ++H DLK DN+L+ L + D+G + K
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 1036 -----CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088
+ + G + GT +MAPE L G SE D+Y+ G+ +++++T PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 3e-14
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 54/228 (23%)
Query: 880 LQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLI--KEFWREAHIISNL 935
L+ +GSG +G V K G +AIK+I F + LI K RE ++ +L
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-VF-------DDLIDAKRILREIKLLRHL 56
Query: 936 HHPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKD--RILDRRKKLM----- 985
H N++ ++ VTE M D +++ + L
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELM----------ETDLHKVIKSPQPLTDDHIQ 106
Query: 986 -LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSG 1042
+ G++YLH N++H DLK N+LVN + C K+ DFGL+R
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDPDEDEK 160
Query: 1043 GV-------RGTLPWM-APELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
G R W APELL S++R ++ +D++S G E++T
Sbjct: 161 GFLTEYVVTR----WYRAPELL-LSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-14
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 879 ELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+L++LG GT+ TV++G+ + T+ +A+K I R +E RE ++ +L
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVSLLKDLK 62
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
H N+V + +V T+ V EY+ + L+ + I+ + + G+ Y
Sbjct: 63 HANIVTLHDIVHTDKSLTL--VFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-CNTLVSGGVRGTLPWMAPEL 1055
H + ++H DLK NLL+N +R K+ DFGL+R K T TL + P++
Sbjct: 120 CHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITG 1082
L GS + S ++D++ G +E+ +G
Sbjct: 176 LLGS-SEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 67/290 (23%)
Query: 880 LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+ ++G GT+G VY+ + + T +A+K+++ +E+E RE I+ L+H
Sbjct: 12 IGQIGEGTYGQVYKARDKDTGELVALKKVR------LDNEKEGFPITAIREIKILRQLNH 65
Query: 938 PNVVAFYGVVPNGPG--------GTMATVTEYM---VNGSLRHVLA--RKDRILDRRKKL 984
N+V +V + G V EYM + G L L +D I K+L
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+ G+ Y H KN +H D+KC N+L+N + K+ DFGL+R+ S
Sbjct: 126 LE------GLNYCHKKNFLHRDIKCSNILLN----NKGQIKLADFGLARL----YNSEES 171
Query: 1045 RG------TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT------GEEPYANMH-- 1090
R TL + PELL G R +DV+S G + E+ T + A +
Sbjct: 172 RPYTNKVITLWYRPPELLLG-EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 1091 ---CGA--------IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAA 1129
CG+ +I NT++P+ R R+L EE +SF P
Sbjct: 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYR-----RRLREE-FSFIPTP 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 69/257 (26%), Positives = 124/257 (48%), Gaps = 23/257 (8%)
Query: 880 LQELGSGTFGTVY-----RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
L+ LG G+FG V+ G G A+K +KK+ R + + E I++
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM------ERDILAE 54
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
++HP +V + G + + +++ G L L+++ + K L + A +
Sbjct: 55 VNHPFIVKLHYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALAL 111
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG-GVRGTLPWMAP 1053
++LH I++ DLK +N+L+ D + I K+ DFGLS+ + GT+ +MAP
Sbjct: 112 DHLHSLGIIYRDLKPENILL---DEEGHI-KLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113
E++N + ++ D +SFG+ M+E++TG P+ + IL L +P+ P
Sbjct: 168 EVVNRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSP 223
Query: 1114 EWRKLMEECWSFNPAAR 1130
E + L+ + NPA R
Sbjct: 224 EAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 29/224 (12%)
Query: 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
DL++L E+G G FGTV + + GT +A+KRI+ S + EQ+ L+ + + ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEK--EQKRLLMDL--DV-VM 57
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL----RHVLARKDRILDRR---KKLM 985
+ P +V FYG + G E M + SL ++V ++ K +
Sbjct: 58 RSSDCPYIVKFYGALFRE--GDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAV 114
Query: 986 LMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+ A + YL + I+H D+K N+L++ K+ DFG+S +++
Sbjct: 115 ATVKA---LNYLKEELKIIHRDVKPSNILLDRNGN----IKLCDFGISGQLVDSIAKTRD 167
Query: 1045 RGTLPWMAPELLNGSNNRVSEKV--DVYSFGIAMWEIITGEEPY 1086
G P+MAPE ++ + R V DV+S GI ++E+ TG+ PY
Sbjct: 168 AGCRPYMAPERID-PSARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 875 SDLEELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
S L+ ++G G+ G V K G +A+K++ L + +E L + E I+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD----LRKQQRRELL----FNEVVIM 70
Query: 933 SNLHHPNVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
+ HPN+V Y +V G + V E++ G+L ++ ++ + + +
Sbjct: 71 RDYQHPNIVEMYSSYLV----GDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAV 124
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-SRIKCNTLVSGGVRGTLP 1049
+ +LH + ++H D+K D++L+ D + K+ DFG +++ + GT
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLT-SDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPY 180
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088
WMAPE++ S +VD++S GI + E++ GE PY N
Sbjct: 181 WMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 879 ELQELGSGTFGTVYRGKWRGTD--IAIKRI----KKSCFLGRSSEQEWLIKEFWREAHII 932
+L+ LG G+ G V+ D +A+K+I +S K RE II
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV------------KHALREIKII 56
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMAT--------------VTEYMVNGSLRHVLARKDRIL 978
L H N+V Y V+ GP G+ T V EYM L +VL + +
Sbjct: 57 RRLDHDNIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLS 112
Query: 979 DRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---- 1034
+ +L M G++Y+H N++H DLK N+ +N D + K+GDFGL+RI
Sbjct: 113 EEHARL-FMYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARIVDPH 168
Query: 1035 -KCNTLVSGGVRGTLPWM-APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090
+S G+ W +P LL NN ++ +D+++ G E++TG+ +A H
Sbjct: 169 YSHKGYLSEGL--VTKWYRSPRLLLSPNN-YTKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 30/257 (11%)
Query: 883 LGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG GTFG V + K G A+K +KK + + L E ++ N HP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVLQNSRHPFL 57
Query: 941 VAF-YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
A Y + + V EY G L L+R +R+ + + ++YLH
Sbjct: 58 TALKYSFQTHD---RLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS 113
Query: 1000 -KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWMAP 1053
KN+V+ DLK +NL+++ +D K+ DFGL C + G GT ++AP
Sbjct: 114 EKNVVYRDLKLENLMLD-KDGH---IKITDFGL----CKEGIKDGATMKTFCGTPEYLAP 165
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113
E+L +N VD + G+ M+E++ G P+ N + IL +R P P
Sbjct: 166 EVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSP 221
Query: 1114 EWRKLMEECWSFNPAAR 1130
E + L+ +P R
Sbjct: 222 EAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 874 DSDLEELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
S + ++ +GSG +G V G +AIK+I + + L K RE I
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDVPTLAKRTLRELKI 57
Query: 932 ISNLHHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
+ + H N++A ++ P G V ++ L H I+ + L
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHH-------IIHSDQPLTEEHIR 110
Query: 991 AF------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
F G++Y+H N++H DLK NLLVN + ++GDFG++R ++
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFGMARGLSSSPTEHKY 166
Query: 1045 R-----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII 1080
T + APELL S + +D++S G E++
Sbjct: 167 FMTEYVATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 68/309 (22%), Positives = 127/309 (41%), Gaps = 55/309 (17%)
Query: 796 DVTDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESIS 855
D T +PP S + + D+SD + E + DS E D+
Sbjct: 5 DTTPPLPPRSYSGGAADEDLYSDISDG-------DLEYSDDDSASES--------DDDDD 49
Query: 856 DAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLG 913
D + + +++ ++ L G+ G V+ G + +K +K L
Sbjct: 50 DGLIPTKQKA---REVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL- 105
Query: 914 RSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR 973
EA ++ N++HP+V+ + +G T + Y + L L +
Sbjct: 106 -------------IEAMLLQNVNHPSVIRMKDTLVSGAI-TCMVLPHY--SSDLYTYLTK 149
Query: 974 KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
+ R L + L++ G+ YLH + I+H D+K +N+ +N D +C +GD G ++
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQ 205
Query: 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII------------T 1081
G+ GT+ APE+L + ++ + K D++S GI ++E++ T
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVL--ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
Query: 1082 GEEPYANMH 1090
EE + H
Sbjct: 264 PEEYVKSCH 272
|
Length = 357 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 76/265 (28%), Positives = 127/265 (47%), Gaps = 37/265 (13%)
Query: 880 LQELGSGTFGTVYR-----GKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
L+ LG G +G V++ G G A+K +KK+ + R+ + K E +I+
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKA---ERNILEA 56
Query: 935 LHHPNVV----AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
+ HP +V AF GG + + EY+ G L L R+ ++ L +
Sbjct: 57 VKHPFIVDLIYAFQ------TGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EI 109
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR----- 1045
+ +E+LH + I++ DLK +N+L+ D Q + K+ DFGL C + G
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILL---DAQGHV-KLTDFGL----CKESIHEGTVTHTFC 161
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105
GT+ +MAPE+L S + + VD +S G M++++TG P+ + I IL L
Sbjct: 162 GTIEYMAPEILMRSGH--GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-- 217
Query: 1106 QIPERCDPEWRKLMEECWSFNPAAR 1130
+P PE R L+++ NP++R
Sbjct: 218 NLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 69/283 (24%), Positives = 130/283 (45%), Gaps = 48/283 (16%)
Query: 881 QELGSGTFGTVYRGK-WRGTDIA---IKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
QE+G+G FG V + + T +A +K +K + S EQ EF ++ L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQN----EFLQQGDPYRILQ 53
Query: 937 HPNVVAFYG----VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM---- 988
HPN++ G +P V EY G L+ L+++ R +L+L+
Sbjct: 54 HPNILQCLGQCVEAIP------YLLVFEYCELGDLKSYLSQEQW-HRRNSQLLLLQRMAC 106
Query: 989 DAAFGMEYLHMKNIVHFDLKCDN--LLVNLRDPQRPICKVGDFGL--SRIKCNTLVS-GG 1043
+ A G+ ++H N +H DL N L +L KVGD+G+ SR K + + +
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLT------VKVGDYGIGPSRYKEDYIETEDD 160
Query: 1044 VRGTLPWMAPELLNGSNNRV-----SEKVDVYSFGIAMWEII-TGEEPYANMHCGAIIGG 1097
L W+APEL+ + + ++ +V++ G+ +WE+ +PY+++ ++
Sbjct: 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH 220
Query: 1098 ILSNT----LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
++ + +PQ+ W ++++ CW +P R + E+
Sbjct: 221 VIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 69/256 (26%), Positives = 110/256 (42%), Gaps = 29/256 (11%)
Query: 883 LGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG GTFG V R K G A+K +KK + + L E+ ++ N HP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLQNTRHPFL 57
Query: 941 VAF-YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
A Y + + V EY NG ++R+ + + + YLH
Sbjct: 58 TALKYSFQTHD---RLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS 113
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWMAPE 1054
++V+ DLK +NL+++ +D K+ DFGL C +S G GT ++APE
Sbjct: 114 CDVVYRDLKLENLMLD-KDGH---IKITDFGL----CKEGISDGATMKTFCGTPEYLAPE 165
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
+L +N VD + G+ M+E++ G P+ N + IL +R P PE
Sbjct: 166 VLE--DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPE 221
Query: 1115 WRKLMEECWSFNPAAR 1130
+ L+ +P R
Sbjct: 222 AKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 64/254 (25%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
++++ LG G G V+ + +GT A+K + K + R+ +K E I+
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-----VKRVLTEQEIL 55
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLML 986
+ L HP + Y + T V +Y G L R+L R+ L
Sbjct: 56 ATLDHPFLPTLYA--------SFQTETYLCLVMDYCPGGELF-------RLLQRQPGKCL 100
Query: 987 MMDAA-F-------GMEYLHMKNIVHFDLKCDNLLVN------LRD---------PQRPI 1023
+ A F +EYLH+ IV+ DLK +N+L++ L D P+
Sbjct: 101 SEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160
Query: 1024 CKVGDFGLSRIKCNTLV------SGGVR-----GTLPWMAPELLNGSNNRVSEKVDVYSF 1072
K G R N++ R GT ++APE+++G + VD ++
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTL 218
Query: 1073 GIAMWEIITGEEPY 1086
GI ++E++ G P+
Sbjct: 219 GILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 41/234 (17%)
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKK 983
F+ A ++S + H ++ +GV G M V E++ +G L V RK++ + K
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPL-DVCLRKEKGRVPVAWK 119
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLV---NLRDPQRPICKVGDFGLSRIKCNTLV 1040
+ + A + YL KN+VH ++ N+L+ L + P K+ D G+S T +
Sbjct: 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----TAL 175
Query: 1041 SGGVR-GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEI-ITGEEP------------Y 1086
S R +PW+APE + G N+ +S D +SFG + EI GE P Y
Sbjct: 176 SREERVERIPWIAPECVPGGNS-LSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234
Query: 1087 ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
H ++PE E L+ +C ++ P RPSF I L
Sbjct: 235 EKKH---------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 24/262 (9%)
Query: 873 KDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
K SD E + LG+G+FG V K +GT AIK +KK L + + + + +E
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQE----KS 70
Query: 931 IISNLHHPNVVAFY-GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
I+ L HP +V + + E++V G L L + R + K +
Sbjct: 71 ILMELSHPFIVNMMCSFQDEN---RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY-HAE 126
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTL 1048
EYLH K+I++ DLK +NLL+ D + + KV DFG + ++ T + GT
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLL---DNKGHV-KVTDFGFAKKVPDRTFT---LCGTP 179
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
++APE++ + + VD ++ G+ ++E I G P+ + I IL+ L + P
Sbjct: 180 EYLAPEVIQSKGH--GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL--KFP 235
Query: 1109 ERCDPEWRKLMEECWSFNPAAR 1130
D R L++ + R
Sbjct: 236 NWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 40/262 (15%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS-NLHHPN 939
LG G+FG V + +GT+ AIK +KK L + ++ E +++ HP
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMV-----ERRVLALAWEHPF 57
Query: 940 VVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
+ + T T V EY+ G L + R + R + + G
Sbjct: 58 LTHLFC--------TFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICG 108
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTL 1048
+++LH K I++ DLK DN+L++ +D K+ DFG+ C ++G + GT
Sbjct: 109 LQFLHKKGIIYRDLKLDNVLLD-KDGH---IKIADFGM----CKENMNGEGKASTFCGTP 160
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
++APE+L G + +E VD +SFG+ ++E++ G+ P+ + IL++ RP P
Sbjct: 161 DYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFP 216
Query: 1109 ERCDPEWRKLMEECWSFNPAAR 1130
E + + + + +P R
Sbjct: 217 RWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 52/281 (18%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
L++LG G++ TVY+G R G +A+K I +E + REA ++ L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKT-------EEGVPFTAIREASLLKGLKH 62
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
N+V + ++ T+ V EYM + L + + L + M G+ Y+
Sbjct: 63 ANIVLLHDIIHTKE--TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGTLPWMAPE 1054
H ++I+H DLK NLL++ K+ DFGL+R I T S V TL + P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE----LKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
+L G+ + S +D++ G E++ G+ + + + E+ +
Sbjct: 174 VLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFPGV---------------SDVFEQLEKI 217
Query: 1115 WRKL---MEECWS------------FNPAARPSFTEITNRL 1140
W L E+ W F P + RL
Sbjct: 218 WTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRL 258
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPN 939
LG G+FG V + +GTD A+K +KK L + E + E +++ HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD-DVECTMTE----KRVLALAGKHPF 57
Query: 940 VVAFYGVVPNGPGGTMAT---VTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGME 995
+ + T V EY+ G L H+ + D + + G++
Sbjct: 58 LTQLHSCFQ-----TKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQ 110
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPW 1050
+LH + I++ DLK DN+L++ K+ DFG+ C + GGV GT +
Sbjct: 111 FLHERGIIYRDLKLDNVLLD----SEGHIKIADFGM----CKEGILGGVTTSTFCGTPDY 162
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
+APE+L+ + VD ++ G+ ++E++ G+ P+
Sbjct: 163 IAPEILSYQPYGPA--VDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 32/207 (15%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E+L+++G GT+GTV++ K R T +A+KR++ + E + RE ++ L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKEL 56
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
H N+V Y V+ + T+ V EY + L+ + +D M G+
Sbjct: 57 KHKNIVRLYDVLHSDKKLTL--VFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-----IKCNTLVSGGVRGTLPW 1050
+ H N++H DLK NLL+N + K+ DFGL+R ++C S V TL +
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLARAFGIPVRC---YSAEVV-TLWY 165
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMW 1077
P++L G+ +YS I MW
Sbjct: 166 RPPDVLFGAK--------LYSTSIDMW 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 76/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
++E L ELG G +G+VY+ R T + A+K I R E + E I+
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDIL 53
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
P +V FYG G + EYM GSL + A + ++ + A
Sbjct: 54 HKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111
Query: 993 GMEYLHMK---NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
+K NI+H D+K N+LVN Q +C DFG+S +L + G
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLC---DFGVSGNLVASLAKTNI-GCQS 166
Query: 1050 WMAPELLN--GSNNRVSEKV--DVYSFGIAMWEIITGEEPY-----ANM--HCGAIIGGI 1098
+MAPE + G N + V DV+S G+++ E+ G PY AN+ AI+ G
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
P +P + + + +C + P RP++ ++
Sbjct: 227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 69/222 (31%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 876 DLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D++ + LG G GTVY+ +A+K I L + E L K+ E I+
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP----LDITVE---LQKQIMSELEILY 54
Query: 934 NLHHPNVVAFYGV--VPNGPGGTMATVTEYMVNGSL-------RHVLARKDRILDRRKKL 984
P ++ FYG V N ++ TE+M GSL HVL R
Sbjct: 55 KCDSPYIIGFYGAFFVEN----RISICTEFMDGGSLDVYRKIPEHVLGR----------- 99
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+ + G+ YL I+H D+K N+LVN R Q +C DFG+S N++ V
Sbjct: 100 -IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLC---DFGVSTQLVNSIAKTYV 154
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
GT +MAPE ++G + DV+S GI+ E+ G PY
Sbjct: 155 -GTNAYMAPERISGEQYGIHS--DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V +++ T AIK +KK + R E E L+ E R ++ HP +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD-EVESLMCE-KRIFETANSERHPFL 64
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSL-RHVLARKDRILDRRKKLMLMMDAA---FGMEY 996
V + + V EY G L H+ D + R AA G++Y
Sbjct: 65 VNLFACFQTE--DHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFY----AACVVLGLQY 116
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWM 1051
LH IV+ DLK DNLL+ D + + K+ DFGL C + G R GT ++
Sbjct: 117 LHENKIVYRDLKLDNLLL---DTEGFV-KIADFGL----CKEGMGFGDRTSTFCGTPEFL 168
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
APE+L + + VD + G+ ++E++ GE P+
Sbjct: 169 APEVLTET--SYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L +GSG +G V T +AIK+ L R + K +RE ++ ++
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKK------LSRPFQSAIHAKRTYRELRLLKHM 71
Query: 936 HHPNVVAFYGV-VPNGPGGTMATVTEYMVN----GSLRHVLARKDRILDRRKKLML--MM 988
H NV+ V P V Y+V L +++ + ++ D + ++ ++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDV--YLVTHLMGADLNNIVKCQ-KLSDDHIQFLVYQIL 128
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVRG 1046
G++Y+H I+H DLK N+ VN D C K+ DFGL+R + ++G V
Sbjct: 129 R---GLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLAR-HTDDEMTGYV-A 177
Query: 1047 TLPWMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
T + APE +LN + ++ VD++S G M E++TG+
Sbjct: 178 TRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 30/226 (13%)
Query: 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
K E+L++LG G++ TVY+GK + G +A+K I R E+E REA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-------RLQEEEGTPFTAIREAS 55
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
++ L H N+V + ++ T+ V EY V+ L + + L + +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-------CNTLVSGG 1043
G+ Y+H + I+H DLK NLL++ K+ DFGL+R K N +V
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGLARAKSVPSHTYSNEVV--- 165
Query: 1044 VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM 1089
TL + P++L GS S +D++ G E+I G + M
Sbjct: 166 ---TLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
DLE L E+GSGT G VY+ +++ G +A+K+++++ G E K + ++
Sbjct: 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEEN----KRILMDLDVVL 68
Query: 934 NLHH-PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM------- 985
H P +V YG +T+ V + + D++L R + +
Sbjct: 69 KSHDCPYIVKCYG----------YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK 118
Query: 986 LMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+ + + YL K ++H D+K N+L++ K+ DFG+S ++
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG----NVKLCDFGISGRLVDSKAKTRS 174
Query: 1045 RGTLPWMAPELLNGSNNRVSEKV--DVYSFGIAMWEIITGEEPYANMHCGA---IIGGIL 1099
G +MAPE ++ + + DV+S GI++ E+ TG+ PY N C ++ IL
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN--CKTEFEVLTKIL 232
Query: 1100 SNTLRPQIP--ERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P +P E P++ ++ C + + RP + E+
Sbjct: 233 QEEP-PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 874 DSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
S E+L ++G GTFG V++ + + T +A+K++ +E+E RE I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKI 64
Query: 932 ISNLHHPNVVAFYGVV---PNGPGGTMATVTEYMVNGSLRHVLAR------KDRILDRRK 982
+ L H NVV + + Y+V H LA L K
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSF--YLVFEFCEHDLAGLLSNKNVKFTLSEIK 122
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR------IKC 1036
K+M M+ G+ Y+H I+H D+K N+L+ +D I K+ DFGL+R
Sbjct: 123 KVMKMLLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSK 176
Query: 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
+ V TL + PELL G + +D++ G M E+ T
Sbjct: 177 PNRYTNRVV-TLWYRPPELLLGERD-YGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 880 LQELGSGTFGTVYRGKWR---GTDIAIKRI--KKSCFLGRSSEQEWLIKEFWREAHII-S 933
L+ LGSG FG VY+ + + +A+K I F E++ I + E II
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDR----ILDRRKKLMLMM 988
L HPN+V +Y + V + + L H + K++ +R + + M
Sbjct: 65 QLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 989 DAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGT 1047
A + YLH K IVH DL +N+++ D + DFGL++ K V GT
Sbjct: 123 VLA--LRYLHKEKRIVHRDLTPNNIMLGEDDK----VTITDFGLAKQKQPESKLTSVVGT 176
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--ANMHCGAIIGGILSNTLRP 1105
+ + PE++ N EK DV++FG ++++ T + P+ NM A I+ P
Sbjct: 177 ILYSCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT--KIVEAVYEP 232
Query: 1106 QIPERCDPE-WRKLMEECWSFNPAARPSFTEITNRL 1140
+PE E ++ C + + ARP +++ +
Sbjct: 233 -LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS-NLHHPN 939
LG G+FG V+ + +GT+ AIK +KK L + ++ E ++S HP
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLAWEHPF 57
Query: 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
+ Y + V EY+ G L + + D + + G+++LH
Sbjct: 58 LTHLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHS 114
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWMAPE 1054
K IV+ DLK DN+L++ K+ DFG+ C + G + GT ++APE
Sbjct: 115 KGIVYRDLKLDNILLDTDGH----IKIADFGM----CKENMLGDAKTCTFCGTPDYIAPE 166
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
+L G + + VD +SFG+ ++E++ G+ P+
Sbjct: 167 ILLG--QKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 37/215 (17%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-H 936
L ++G GTF V + + R G AIK +KK +S EQ + RE + L
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQ---VNNL-REIQALRRLSP 56
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
HPN++ V+ + G +A V E M + +L ++ + R L ++ M +++
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP------- 1049
+H I H D+K +N+L+ I K+ DFG R G+ P
Sbjct: 116 MHRNGIFHRDIKPENILIK-----DDILKLADFGSCR---------GIYSKPPYTEYIST 161
Query: 1050 -WM-APE-LLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
W APE LL ++ K+D+++ G +EI++
Sbjct: 162 RWYRAPECLL--TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 55/287 (19%)
Query: 881 QELGSGTFGTVYRGK----WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+E+G+G FG V G+ + + +K ++ S +S QE + +F EA +L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-----ASVQEQM--KFLEEAQPYRSLQ 53
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYM----------VNGSLRHVLARKDRILDRRKKLML 986
H N++ G VT Y+ + G LR + D +
Sbjct: 54 HSNLLQCLGQC--------TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM 105
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGG 1043
+ A G+ +LH N +H DL N L+ K+GD+GLS K +
Sbjct: 106 ACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSHNKYKEDYYVTPDQ 161
Query: 1044 VRGTLPWMAPELLNGSNNRV-----SEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGG 1097
+ L W+APEL++ + + +++ +V+S G+ +WE+ G +PY ++
Sbjct: 162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---- 217
Query: 1098 ILSNTLRPQIPERCDPE--------WRKLMEECWSFNPAARPSFTEI 1136
+L+ T+R Q + P W ++M+ CW P RPS E+
Sbjct: 218 VLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 66/263 (25%), Positives = 113/263 (42%), Gaps = 42/263 (15%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKE-----FWRE---AHII 932
LG G+FG V + +G A+K +KK L + ++++ W H+
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
+ F V E++ G L + K R D + +
Sbjct: 63 CTFQTKEHLFF--------------VMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVC 107
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GT 1047
G+++LH K I++ DLK DN++++ RD K+ DFG+ C V G R GT
Sbjct: 108 GLQFLHSKGIIYRDLKLDNVMLD-RDGH---IKIADFGM----CKENVFGDNRASTFCGT 159
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
++APE+L G S VD +SFG+ ++E++ G+ P+ + I +T P
Sbjct: 160 PDYIAPEILQGLKYTFS--VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHY 215
Query: 1108 PERCDPEWRKLMEECWSFNPAAR 1130
P E + ++E+ + +P R
Sbjct: 216 PRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 879 ELQEL-GSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
EL EL G+GT+G VY+G+ G AIK + + ++E IK+ E +++
Sbjct: 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIK------VMDVTGDEEEEIKQ---EINMLKKY 59
Query: 936 -HHPNVVAFYGVV----PNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMD 989
HH N+ +YG P G + V E+ GS+ ++ K L + +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLVSGG 1043
G+ +LH ++H D+K N+L+ + K+ DFG+S + NT +
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTVGRRNTFI--- 172
Query: 1044 VRGTLPWMAPELLNGSNNRVSE---KVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS 1100
GT WMAPE++ N + K D++S GI E+ G P +MH + I
Sbjct: 173 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230
Query: 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
N ++ +++ +E C N + RP+ ++
Sbjct: 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 65/230 (28%), Positives = 112/230 (48%), Gaps = 38/230 (16%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD---IAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
+K D ++ LG+G+FG V ++ D +AIKR +KS + + + + E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ-----VDHVFSE 81
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKK 983
I++ ++HP V YG + + V E+++ G L R R + +
Sbjct: 82 RKILNYINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLV 1040
++L+ EYL NIV+ DLK +NLL++ + K+ DFG +++ + TL
Sbjct: 140 IVLIF------EYLQSLNIVYRDLKPENLLLD----KDGFIKMTDFGFAKVVDTRTYTLC 189
Query: 1041 SGGVRGTLPWMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIITGEEP-YAN 1088
GT ++APE LLN + + + D ++ GI ++EI+ G P YAN
Sbjct: 190 -----GTPEYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPPFYAN 231
|
Length = 340 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 877 LEELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
L+ ++G G+ G V K G +A+K++ L + +E L + E I+ +
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMD----LRKQQRRELL----FNEVVIMRD 75
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
HH NVV Y G + V E++ G+L ++ ++ + + + +
Sbjct: 76 YHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRAL 131
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-SRIKCNTLVSGGVRGTLPWMAP 1053
YLH + ++H D+K D++L L R K+ DFG +++ + GT WMAP
Sbjct: 132 SYLHNQGVIHRDIKSDSIL--LTSDGR--IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088
E++ S +VD++S GI + E+I GE PY N
Sbjct: 188 EVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-12
Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 24/212 (11%)
Query: 879 ELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+L+++GSG +GTV R G +AIK+ L R + E K +RE ++ ++
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKK------LYRPFQSELFAKRAYRELRLLKHMK 72
Query: 937 HPNVVAFYGVVPNGPGGTMATVTE-YMVN---GSLRHVLARKDRILDRRKKLMLMMDAAF 992
H NV+ V P ++ + Y+V G+ L + +++ + R + L+
Sbjct: 73 HENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-LVYQMLK 129
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMA 1052
G++Y+H I+H DLK NL VN + K+ DFGL+R + ++ ++G V T + A
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLAR-QTDSEMTGYVV-TRWYRA 183
Query: 1053 PE-LLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
PE +LN ++ VD++S G M E++TG+
Sbjct: 184 PEVILNWM--HYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-12
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 48/288 (16%)
Query: 879 ELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
+LQ +G G FG V R + G ++AIK+I K L K +RE ++ +L
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP------FSTPVLAKRTYRELKLLKHLR 67
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
H N+++ + + P + VTE + G+ H L R L+++ + G++Y
Sbjct: 68 HENIISLSDIFIS-PLEDIYFVTELL--GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKY 123
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELL 1056
+H +VH DLK N+L+N + IC DFGL+RI+ + G T + APE++
Sbjct: 124 VHSAGVVHRDLKPSNILIN-ENCDLKIC---DFGLARIQDPQMT--GYVSTRYYRAPEIM 177
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGE-----EPYANMHC----------GAIIGGILS- 1100
+ + +VD++S G E++ G+ + + N +I I S
Sbjct: 178 L-TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236
Query: 1101 NTLR--PQIPER-----------CDPEWRKLMEECWSFNPAARPSFTE 1135
NTLR +P+R DP L+E+ F+P R S E
Sbjct: 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 877 LEELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
LE ++G G+ G V R K G +A+K + L + +E L + E I+ +
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD----LRKQQRRELL----FNEVVIMRD 74
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
H NVV Y G + + E++ G+L ++++ L+ + + +
Sbjct: 75 YQHQNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQAL 130
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-SRIKCNTLVSGGVRGTLPWMAP 1053
YLH + ++H D+K D++L+ L K+ DFG ++I + + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
E++ S +VD++S GI + E++ GE PY
Sbjct: 187 EVI--SRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-12
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 883 LGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG GTFG V R K G A+K +KK + + L E+ ++ N HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLKNTRHPFL 57
Query: 941 VAF-YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
+ Y + V EY+ G L L+R +R+ + + ++YLH
Sbjct: 58 TSLKYSFQTKD---RLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHS 113
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWMAPE 1054
IV+ DLK +NL+++ +D K+ DFGL C ++ GT ++APE
Sbjct: 114 GKIVYRDLKLENLMLD-KDGH---IKITDFGL----CKEGITDAATMKTFCGTPEYLAPE 165
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088
+L +N VD + G+ M+E++ G P+ N
Sbjct: 166 VL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++++++G GT+G VY+ + + G +A+K+I+ +E E + RE ++ L
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKEL 56
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF--- 992
+HPN+V V+ + V E++ + L+ + D L L+ F
Sbjct: 57 NHPNIVKLLDVIHTE--NKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLL 110
Query: 993 -GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGTL 1048
G+ + H ++H DLK NLL+N K+ DFGL+R + T V TL
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVV--TL 164
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
+ APE+L G S VD++S G E++T
Sbjct: 165 WYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 66/253 (26%), Positives = 120/253 (47%), Gaps = 23/253 (9%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+G G+FG V + + R T A+K I+K+ + RS L E +++ ++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-----ERTVLAQVNCPFI 55
Query: 941 V--AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH 998
V F P + V ++ G L H L R+ R R + + +E LH
Sbjct: 56 VPLKFSFQSP----EKLYLVLAFINGGELFHHLQREGRFDLSRARFY-TAELLCALENLH 110
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-CNTLVSGGVRGTLPWMAPELLN 1057
N+++ DLK +N+L++ + +C DFGL ++ + + GT ++APELL
Sbjct: 111 KFNVIYRDLKPENILLDYQG-HIALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 1058 GSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRK 1117
G ++ VD ++ G+ ++E++TG P+ + + + IL LR P+ D + +
Sbjct: 167 GHG--YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKD 222
Query: 1118 LMEECWSFNPAAR 1130
L+ S +P R
Sbjct: 223 LLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 75/275 (27%), Positives = 109/275 (39%), Gaps = 37/275 (13%)
Query: 881 QELGSGTFGTVYRGKWR----------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+ LG GT +Y G + IK I K L S L F+ A
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK--VLDPSHRDISL--AFFETAS 56
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
++ + H ++V YGV M V E++ G L + RK +L K +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIM--VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQL 114
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLV---NLRDPQRPICKVGDFG-----LSRIKCNTLVSG 1042
A + YL K++VH ++ N+L+ + P K+ D G LSR +C +
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI-- 172
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEI-ITGEEPYANMHCGAIIGGILSN 1101
PW+APE + S N +S D +SFG +WEI GE P + A
Sbjct: 173 ------PWIAPECVEDSKN-LSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKERFYEG 224
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P C E LM C +++P RP F I
Sbjct: 225 QCMLVTPS-CK-ELADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E+L+++G GT+G VY+ + + T +A+K+ + ++E + RE ++ L
Sbjct: 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLLQML 57
Query: 936 HH-PNVVAFYGVV---PNGPGGTMATVTEYMVNGSLRHVLAR----KDRILDRRKKLMLM 987
+V V ++ V EY+ + L+ + R L + M
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-----IKCNT--LV 1040
G+ + H ++H DLK NLLV D Q+ + K+ D GL R +K T +V
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
TL + APE+L GS + S VD++S G E+ +
Sbjct: 174 ------TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 71/273 (26%), Positives = 124/273 (45%), Gaps = 33/273 (12%)
Query: 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LGSG GTV K G A+K + + SE + E + N ++
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVD----MEGMSEAD--KNRAQAEVCCLLNCDFFSI 93
Query: 941 VA----FYGVVPNGPGGT--MATVTEYMVNGSLRHVL---ARKDRILDRRKKLMLMMDAA 991
V F P P +A V +Y G LR + A+ +R + +L +
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR----GT 1047
+ ++H K+++H D+K N+L+ + K+GDFG S++ T VS V GT
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLC----SNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGT 208
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--ANMHCGAIIGGILSNTLRP 1105
++APE+ S+K D++S G+ ++E++T + P+ NM ++ L+ P
Sbjct: 209 PYYVAPEIWR--RKPYSKKADMFSLGVLLYELLTLKRPFDGENME--EVMHKTLAGRYDP 264
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
+P PE ++++ S +P RPS +++ N
Sbjct: 265 -LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296
|
Length = 496 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 878 EELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEF-WREAHIISN 934
E+L ++G G++G V+ R + G +AIK+ F+ SE + +IK+ RE ++
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKK-----FV--ESEDDPVIKKIALREIRMLKQ 56
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
L HPN+V V + V EY + ++ + L + R + ++ +
Sbjct: 57 LKHPNLVNLIEVFRRKR--KLHLVFEY-CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLP 1049
+ H N +H D+K +N+L+ + K+ DFG +RI L G T
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFARI----LTGPGDDYTDYVATRW 165
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ APELL G + + VDV++ G E++TG+
Sbjct: 166 YRAPELLVG-DTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 29/279 (10%)
Query: 868 GLQIIKD-----SDLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEW 920
LQ++ D + L+ ++G G+ G V K G +A+K++ L + +E
Sbjct: 8 ALQMVVDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMD----LRKQQRREL 63
Query: 921 LIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR 980
L + E I+ + H NVV Y G + V E++ G+L ++ ++
Sbjct: 64 L----FNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDIVTHTR--MNE 115
Query: 981 RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-SRIKCNTL 1039
+ + + + LH + ++H D+K D++L+ D + K+ DFG +++
Sbjct: 116 EQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT-HDGR---VKLSDFGFCAQVSKEVP 171
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099
+ GT WMAPEL+ S +VD++S GI + E++ GE PY N + I
Sbjct: 172 RRKSLVGTPYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 229
Query: 1100 SNTLRPQIP--ERCDPEWRKLMEECWSFNPAARPSFTEI 1136
N L P++ + P + ++ +PA R + E+
Sbjct: 230 DN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 54/223 (24%), Positives = 110/223 (49%), Gaps = 27/223 (12%)
Query: 876 DLEELQELGSGTFGTVY-----RGKWRGTDIAIKRIKKSCFLGRS-----SEQEWLIKEF 925
+ E L+ LG+G +G V+ G G A+K +KK+ + ++ + E + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
R++ + LH+ AF + + +Y+ G L L++++R ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQ------TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLVSGG 1043
+ +E+LH I++ D+K +N+L+ D + + DFGLS+ + +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILL---DSNGHVV-LTDFGLSKEFHEDEVERAYS 165
Query: 1044 VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
GT+ +MAP+++ G + + VD +S G+ M+E++TG P+
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 56/242 (23%)
Query: 875 SDLEELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E ++ + +G +G VY R K A+K+I K + R+ I++ + E I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ-----IQQVFVERDIL 55
Query: 933 SNLHHPNVVAFYG----------VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
+ +P VV+ + V+ GG AT+ + + G+L +AR
Sbjct: 56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMAR--------- 104
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTL 1039
M + +EYLH IVH DLK DNLL+ K+ DFGLS+I T
Sbjct: 105 --MYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLSKIGLMSLTTN 158
Query: 1040 VSGG-------------VRGTLPWMAPE--LLNGSNNRVSEKVDVYSFGIAMWEIITGEE 1084
+ G V GT ++APE L G + VD ++ GI ++E + G
Sbjct: 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG----YGKPVDWWAMGIILYEFLVGCV 214
Query: 1085 PY 1086
P+
Sbjct: 215 PF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E + E+G G +GTVY+ + G +A+K ++ + ++ L RE ++ L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQ------TNEDGLPLSTVREVALLKRL 56
Query: 936 H---HPNVVAFYGVVPNGPGG--TMATVTEYMVNGSLRHVLARK-------DRILDRRKK 983
HPN+V V T T+ V+ LR L + + I D
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD---- 112
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG 1043
LM G+++LH IVH DLK +N+LV K+ DFGL+RI +
Sbjct: 113 --LMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKLADFGLARIYSCQMALTP 166
Query: 1044 VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEI 1079
V TL + APE+L S + VD++S G E+
Sbjct: 167 VVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 883 LGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V + K G A K++ K R EQ L E I+ + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 941 V----AFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGME 995
V AF + V M G L+ H+ + + + G+E
Sbjct: 56 VSLAYAFE------TKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMAPE 1054
+LH + IV+ DLK +N+L++ ++ D GL+ +K + G GT +MAPE
Sbjct: 110 HLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPE 164
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
+L G VD ++ G ++E+I G P+
Sbjct: 165 VLQGE--VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 63/274 (22%), Positives = 121/274 (44%), Gaps = 39/274 (14%)
Query: 876 DLEELQELGSGTFGTVY-----RGKWRGTDIAIKRIKKSCFLGRSSEQEWL-----IKEF 925
+ E L+ LG+G +G V+ G G A+K +KK+ + ++ E + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
R + LH+ AF + + +Y+ G L L +++ + ++
Sbjct: 61 VRRCPFLVTLHY----AFQ------TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR 1045
+ + +++LH I++ D+K +N+L+ D + + + DFGLS+ L R
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILL---DSEGHV-VLTDFGLSKE---FLAEEEER 162
Query: 1046 -----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY----ANMHCGAIIG 1096
GT+ +MAPE++ G + + VD +S G+ +E++TG P+ I
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222
Query: 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
IL + +P P+ E R +++ +P R
Sbjct: 223 RILKS--KPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS-NLHHPN 939
LG G+FG V + +GTD AIK +KK L Q+ + E I++ HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPF 57
Query: 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
+ A + + V EY VNG ++ R D + + + +LH
Sbjct: 58 LTALHCCFQTKD--RLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWMAPE 1054
+++ DLK DN+L++ CK+ DFG+ C + GV GT ++APE
Sbjct: 115 HGVIYRDLKLDNILLD----AEGHCKLADFGM----CKEGILNGVTTTTFCGTPDYIAPE 166
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
+L S VD ++ G+ M+E++ G+ P+
Sbjct: 167 ILQELEYGPS--VDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 877 LEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
E ++ +G+GT+G VY+G+ G AIK + + ++E IK E +++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIK------VMDVTEDEEEEIKL---EINMLKK 68
Query: 935 L-HHPNVVAFYGVV----PNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMM 988
HH N+ +YG P G + V E+ GS+ ++ K L +
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLVSG 1042
+ G+ +LH ++H D+K N+L+ + K+ DFG+S + NT +
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTVGRRNTFI-- 182
Query: 1043 GVRGTLPWMAPELLNGSNNRVSE---KVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099
GT WMAPE++ N + + D++S GI E+ G P +MH + I
Sbjct: 183 ---GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239
Query: 1100 SNTLRPQIPERCDPEWRK----LMEECWSFNPAARPS 1132
N P++ + +W K +E C N +RPS
Sbjct: 240 RNP-PPKLKSK---KWSKKFIDFIEGCLVKNYLSRPS 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E L +G G++G V + K + T +AIK+ FL S + + + K RE ++ L
Sbjct: 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKK-----FL-ESEDDKMVKKIAMREIRMLKQL 57
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
H N+V V + V E++ + L L + LD + + G+E
Sbjct: 58 RHENLVNLIEVFRRKK--RLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIE 114
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG-----VRGTLPW 1050
+ H NI+H D+K +N+LV+ Q + K+ DFG +R TL + G T +
Sbjct: 115 FCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFAR----TLAAPGEVYTDYVATRWY 166
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
APELL G + + VD+++ G + E++TGE
Sbjct: 167 RAPELLVG-DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 69/265 (26%), Positives = 121/265 (45%), Gaps = 22/265 (8%)
Query: 883 LGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII-SNLHHPN 939
+G G+FG V + + + A+K ++K L + E K E +++ N+ HP
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE-----KHIMSERNVLLKNVKHPF 57
Query: 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
+V + + V +Y+ G L + L R+ L+ R + + A + YLH
Sbjct: 58 LVGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLHS 114
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLVSGGVRGTLPWMAPELLN 1057
NIV+ DLK +N+L+ D Q I + DFGL + I+ N S GT ++APE+L+
Sbjct: 115 LNIVYRDLKPENILL---DSQGHIV-LTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLH 169
Query: 1058 GSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--TLRPQIPERCDPEW 1115
VD + G ++E++ G P+ + + + IL+ L+P I
Sbjct: 170 --KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 227
Query: 1116 RKLMEECWSFNPAARPSFTEITNRL 1140
L+++ + A+ F EI N +
Sbjct: 228 EGLLQKDRTKRLGAKDDFMEIKNHI 252
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 883 LGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942
+ + K T +A+K+I L S+++ +K +E L HPN++
Sbjct: 10 FEDLMIVHLAKHKPTNTLVAVKKI----NLDSCSKED--LKLLQQEIITSRQLQHPNILP 63
Query: 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML---MMDAAFGMEYLHM 999
+ + V+ M GS +L K + +L + + D ++Y+H
Sbjct: 64 YVTSFIVD--SELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGT------------ 1047
K +H +K ++L+ KV GL +++ G R
Sbjct: 120 KGFIHRSVKASHILL------SGDGKVVLSGLR--YSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090
LPW++PE+L + +EK D+YS GI E+ G P+ +M
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 880 LQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
L+++GSG +G+V K G +AIK+ L R + E K +RE ++ ++ H
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKK------LSRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 938 PNVVAFYGVVPNGPGG----TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
NV+ V + G V YM L+ ++ L K L+ G
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP---LSEDKVQYLVYQMLCG 129
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
++Y+H I+H DLK NL VN D + K+ DFGL+R + ++G V T + AP
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVN-EDCE---LKILDFGLAR-HADAEMTGYVV-TRWYRAP 183
Query: 1054 E-LLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
E +LN + ++ VD++S G M E++TG+
Sbjct: 184 EVILNWMH--YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 63/252 (25%), Positives = 115/252 (45%), Gaps = 38/252 (15%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIA-----------IKRIKKSCFLGRSSEQEWLIKE 924
D E L+ +G G FG V K + D +KR + +CF E++ L+
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF---REERDVLVNG 58
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKK 983
+ I+ LH+ AF + V +Y V G L +L++ +DR+ + +
Sbjct: 59 ---DNQWITTLHY----AFQD------ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG--LSRIKCNTLVS 1041
L + ++ +H + VH D+K DN+L+++ R + DFG L ++ T+ S
Sbjct: 106 FYLA-EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQS 160
Query: 1042 GGVRGTLPWMAPELLNGSNN---RVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGI 1098
GT +++PE+L + + + D +S G+ M+E++ GE P+ G I
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
Query: 1099 LSNTLRPQIPER 1110
+++ R Q P +
Sbjct: 221 MNHKERFQFPAQ 232
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 26/236 (11%)
Query: 875 SDLEELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
DLE ++ +G+GTFG V+ R + A+K + + EQ E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-----VHNEKRVL 55
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
+ HP ++ + + M + EY+ G L L R L +
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYM--LMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVC 112
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS---RIKCNTLVSGGVRGTLP 1049
+EYLH K IV+ DLK +N+L++ ++ K+ DFG + R + TL GT
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLD-KEGH---IKLTDFGFAKKLRDRTWTLC-----GTPE 163
Query: 1050 WMAPELL-NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104
++APE++ + +N+ VD ++ GI ++E++ G P+ + + I IL+ L
Sbjct: 164 YLAPEVIQSKGHNKA---VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE 216
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V + R T A K+++K R E L E I+ ++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKQILEKVNSRFV 62
Query: 941 VAF-YGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGMEYLH 998
V+ Y + V M G L+ H+ + D + + + G+E LH
Sbjct: 63 VSLAYAYETKD---ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMAPELLN 1057
+ IV+ DLK +N+L++ R + D GL+ I + G V GT+ +MAPE++
Sbjct: 120 RERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVK 174
Query: 1058 GSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
N R + D + G ++E+I G+ P+
Sbjct: 175 --NERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 882 ELGSGTFGTVYRGKWR-GTD---IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
++G GT+G VY+ K + G D A+K+I E + RE ++ L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----------EGTGISMSACREIALLRELKH 57
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLA--------RKDRILDRRKKLMLMMD 989
PNV+A V + + + +Y L H++ +K L R L+
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS----GGVR 1045
G+ YLH ++H DLK N+LV P+R K+ D G +R+ + L V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
T + APELL G+ + ++ +D+++ G E++T E + HC
Sbjct: 177 VTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIF---HC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 882 ELGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
++G GT+G VY+ K + D A+K+I E + RE ++ L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----------EGTGISMSACREIALLRELKH 57
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLA--------RKDRILDRRKKLMLMMD 989
PNV++ V + + + +Y L H++ +K L R L+
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS----GGVR 1045
G+ YLH ++H DLK N+LV P+R K+ D G +R+ + L V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
T + APELL G+ + ++ +D+++ G E++T E + HC
Sbjct: 177 VTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIF---HC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 65/262 (24%), Positives = 105/262 (40%), Gaps = 37/262 (14%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWL--IKEFWREAH 930
D + L ++G G +G V+ K + T +A+KR+KKS L ++ E
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-------FKLNEVRHVLTERD 53
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
I++ +V + +A EY+ G R +L +L M +
Sbjct: 54 ILTTTKSEWLVKLLYAFQDDEYLYLAM--EYVPGGDFRTLLNNL-GVLSEDHARFYMAEM 110
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGT 1047
++ LH +H DLK +N L++ K+ DFGLS+ N++V G+
Sbjct: 111 FEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLSKGIVTYANSVV-----GS 161
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104
+MAPE+L G VD +S G ++E + G P+ G+ N
Sbjct: 162 PDYMAPEVLRGKG--YDFTVDYWSLGCMLYEFLCGFPPF----SGSTPNETWENLKYWKE 215
Query: 1105 -PQIPERCDPEWRKLMEECWSF 1125
Q P DP L +E W
Sbjct: 216 TLQRPVYDDPR-FNLSDEAWDL 236
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 6e-10
Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 48/223 (21%)
Query: 880 LQELGSGTFGTVYRGKWRGTD------IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
LQ+LG G +G V W+ D +A+K+I + F + Q + F RE +
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKIFDA-FRNATDAQ----RTF-REIMFLQ 61
Query: 934 NL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
L HPN+V V+ + V EYM + H + R + IL+ K +M
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYM--ETDLHAVIRAN-ILEDVHKRYIMYQLLK 118
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWM- 1051
++Y+H N++H DLK N+L+N D + K+ DFGL+R +L P +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLN-SDCR---VKLADFGLAR----SLSELEENPENPVLT 170
Query: 1052 ---------APELLNGSNNRVSEKVDVYSFGIAMWEI--ITGE 1083
APE+L GS Y+ G+ MW + I GE
Sbjct: 171 DYVATRWYRAPEILLGSTR--------YTKGVDMWSVGCILGE 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 876 DLEELQELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D E +Q +GSGT+G VY+ + G AIK IK E ++++ E ++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQ---EIIMMK 61
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLR---HVLARKDRILDRRKKLMLMMDA 990
+ H N+VA++G + E+ GSL+ HV L + + +
Sbjct: 62 DCKHSNIVAYFGSYLR--RDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRET 115
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLP 1049
G+ YLH K +H D+K N+L+ K+ DFG+S +I GT
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVSAQITATIAKRKSFIGTPY 171
Query: 1050 WMAPELL----NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAIIGGILSNTLR 1104
WMAPE+ G N++ D+++ GI E+ + P ++H A+ SN
Sbjct: 172 WMAPEVAAVERKGGYNQL---CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228
Query: 1105 PQIPERC--DPEWRKLMEECWSFNPAARPS 1132
P++ ++ + ++ + NP RP+
Sbjct: 229 PKLKDKMKWSNSFHHFVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 34/270 (12%)
Query: 876 DLEELQELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D E +Q +GSGT+G VY+ + G A+K IK + LI++ E ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-----EPGDDFSLIQQ---EIFMVK 61
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLR---HVLARKDRILDRRKKLMLMMDA 990
H N+VA++G + + EY GSL+ HV L + + +
Sbjct: 62 ECKHCNIVAYFGSYLSRE--KLWICMEYCGGGSLQDIYHVTGP----LSELQIAYVCRET 115
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-SRIKCNTLVSGGVRGTLP 1049
G+ YLH K +H D+K N+L+ K+ DFG+ ++I GT
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFGVAAKITATIAKRKSFIGTPY 171
Query: 1050 WMAPELL----NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAIIGGILSNTLR 1104
WMAPE+ NG N++ D+++ GI E+ + P ++H A+ SN
Sbjct: 172 WMAPEVAAVEKNGGYNQL---CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP 228
Query: 1105 PQIPERC--DPEWRKLMEECWSFNPAARPS 1132
P++ ++ + ++ + NP RP+
Sbjct: 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-09
Identities = 60/236 (25%), Positives = 110/236 (46%), Gaps = 31/236 (13%)
Query: 860 AEMEAGIYGLQIIKDSDL------EELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCF 911
+E ++ Y +Q+ DS ++L+ +GSG G V G ++A+K+
Sbjct: 1 SEEDSQFYSVQV-ADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKK------ 53
Query: 912 LGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE-YMV----NGS 966
L R + + K +RE ++ ++H N+++ V P ++ + Y+V + +
Sbjct: 54 LSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDAN 111
Query: 967 LRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026
L V+ + LD + L+ G+++LH I+H DLK N++V K+
Sbjct: 112 LCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKI 164
Query: 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
DFGL+R C + T + APE++ G + E VD++S G M E++ G
Sbjct: 165 LDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 56/266 (21%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 875 SDLEELQELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
++ + +++G G F VYR +A+K+++ + + Q+ + +E ++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-----KEIDLL 56
Query: 933 SNLHHPNVVAFY-GVVPNGPGGTMATVTEYMVNGSLRHVL---ARKDRILDRRKKLMLMM 988
L+HPNV+ + + + + V E G L ++ ++ R++ R +
Sbjct: 57 KQLNHPNVIKYLDSFIEDN---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGT 1047
+E++H + ++H D+K N+ + + K+GD GL R T + + GT
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN--MHCGAIIGGILSNTLRP 1105
+M+PE ++ N + K D++S G ++E+ + P+ M+ ++ I P
Sbjct: 170 PYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARP 1131
E + R+L+ C +P RP
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 881 QELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-H 937
+ LG G+FG V + + + A+K +KK L Q+ ++ E I+S H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNH 55
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGMEY 996
P + Y + V E++ G L H+ +K R D + + + +
Sbjct: 56 PFLTQLYCCFQTPD--RLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMF 111
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-CNTLVSGGVRGTLPWMAPEL 1055
LH K I++ DLK DN+L++ + CK+ DFG+ + N + GT ++APE+
Sbjct: 112 LHDKGIIYRDLKLDNVLLD-HEGH---CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
L S VD ++ G+ ++E++ G P+
Sbjct: 168 LQEMLYGPS--VDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 64/272 (23%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 876 DLEELQELGSGTFGTVY-----RGKWRGTDIAIKRIKKSCFLGRSSEQEWL-----IKEF 925
+ E L+ LG+G +G V+ G G A+K ++K+ + ++ E + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
R++ + LH+ AF + + +Y+ G + L ++D + +
Sbjct: 61 VRQSPFLVTLHY----AFQ------TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY 110
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR 1045
+ +E+LH IV+ D+K +N+L+ D + + + DFGLS+ L R
Sbjct: 111 -SGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVV-LTDFGLSK---EFLSEEKER 162
Query: 1046 -----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS 1100
GT+ +MAPE++ G + VD +S GI ++E++TG P+ +
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 1101 NTLR--PQIPERCDPEWRKLMEECWSFNPAAR 1130
L+ P P PE + L+ + +P R
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 58/232 (25%), Positives = 106/232 (45%), Gaps = 30/232 (12%)
Query: 866 IYGLQIIKDSDLEELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIK 923
I LQ+ K D + ++ +G G FG V R K A+K + K + RS
Sbjct: 35 IRKLQM-KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS-----A 88
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKK 983
FW E I++ + P VV + + M V EYM G L ++++ D + +
Sbjct: 89 FFWEERDIMAFANSPWVVQLFCAFQDDKYLYM--VMEYMPGGDLVNLMSNYD--VPEKWA 144
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG-------LSRIKC 1036
+ ++ +H ++H D+K DN+L++ + K+ DFG ++C
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADFGTCMKMDETGMVRC 200
Query: 1037 NTLVSGGVRGTLPWMAPELL--NGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
+T V GT +++PE+L G + + D +S G+ ++E++ G+ P+
Sbjct: 201 DTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 878 EELQELGSGTFGTVYRG---KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
E + E+G G +G V++ K G +A+KR++ + +E + RE ++ +
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVAVLRH 57
Query: 935 LH---HPNVVAFYGV--VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
L HPNVV + V V T T+ V+ L L + + + MM
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 990 AAF-GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTL 1048
G+++LH +VH DLK N+LV K+ DFGL+RI + V TL
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEI 1079
+ APE+L S+ + VD++S G E+
Sbjct: 174 WYRAPEVLLQSS--YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 872 IKDSDLEELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+K D E ++ +G G FG V R K A+K + K + RS FW E
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS-----AFFWEER 94
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
I++ + P VV + + + V EYM G L ++++ D + + +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAE 150
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-------SRIKCNTLVSG 1042
++ +H +H D+K DN+L++ + K+ DFG ++C+T V
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204
Query: 1043 GVRGTLPWMAPELL--NGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
GT +++PE+L G + + D +S G+ ++E++ G+ P+
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V + R T A KR++K R E L E I+ ++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL-----NEKQILEKVNSQFV 62
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
V + V M G L+ H+ + + + L + G+E LH
Sbjct: 63 VNLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMAPELLNG 1058
+N V+ DLK +N+L+ D I ++ D GL+ +I + G V GT+ +MAPE+LN
Sbjct: 121 ENTVYRDLKPENILL---DDYGHI-RISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLN- 174
Query: 1059 SNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
N R + D + G ++E+I G+ P+
Sbjct: 175 -NQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD------IAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
D+E + +G G FG V W TD +A+K++ F S K +RE
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKMPN-VFQNLVS-----CKRVFREL 50
Query: 930 HIISNLHHPNVVAFYGVVPN---GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
++ H NV++ ++ P + VTE M L ++ + K+ L
Sbjct: 51 KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFL 109
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK--------CNT 1038
G++YLH I+H D+K NLLVN + IC DFGL+R++
Sbjct: 110 Y-QILRGLKYLHSAGILHRDIKPGNLLVN-SNCVLKIC---DFGLARVEEPDESKHMTQE 164
Query: 1039 LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
+V+ R APE+L GS + VD++S G E++
Sbjct: 165 VVTQYYR------APEILMGS-RHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 18/229 (7%)
Query: 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+G G+FG V K + G+ A+K ++K L + EQ ++ E ++ NL HP +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHPFL 58
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK 1000
V + + V +Y+ G L L R+ L+ R + + A + YLH
Sbjct: 59 VGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRARFY-AAEVASAIGYLHSL 115
Query: 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL-VSGGVRGTLPWMAPELLNGS 1059
NI++ DLK +N+L+ D Q + + DFGL + + GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR-- 169
Query: 1060 NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
VD + G ++E++ G P+ + + IL L Q+P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL--QLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 61/250 (24%), Positives = 112/250 (44%), Gaps = 38/250 (15%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIA-----------IKRIKKSCFLGRSSEQEWLIKE 924
D E ++ +G G FG V K + T+ +KR + +CF E+ L+
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACF---REERNVLVNG 58
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKK 983
+ I+ LH+ AF + V +Y V G L +L++ +DR+ + +
Sbjct: 59 ---DCQWITTLHY----AFQD------ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG--LSRIKCNTLVS 1041
+ + + +H + VH D+K DN+L+++ R + DFG L + T+ S
Sbjct: 106 FYIA-EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQS 160
Query: 1042 GGVRGTLPWMAPELLNGSNN---RVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGI 1098
GT +++PE+L + + + D +S G+ M+E++ GE P+ G I
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
Query: 1099 LSNTLRPQIP 1108
+++ R Q P
Sbjct: 221 MNHEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 61/261 (23%), Positives = 116/261 (44%), Gaps = 33/261 (12%)
Query: 837 DSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVY--RG 894
D D +R + + +D +S A + I L++ K D + ++ +G G FG V R
Sbjct: 9 DCDIPALRKN-KNIDNFLSRYEKAAEK--ITKLRM-KAEDFDVIKVIGRGAFGEVQLVRH 64
Query: 895 KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954
K A+K + K + RS FW E I+++ + +V + +
Sbjct: 65 KSSKQVYAMKLLSKFEMIKRSDS-----AFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119
Query: 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLV 1014
M V EYM G L ++++ D + + + ++ +H +H D+K DN+L+
Sbjct: 120 M--VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175
Query: 1015 NLRDPQRPICKVGDFGL-------SRIKCNTLVSGGVRGTLPWMAPELL--NGSNNRVSE 1065
+ K+ DFG ++C+T V GT +++PE+L G +
Sbjct: 176 DKSGH----LKLADFGTCMKMDANGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGR 226
Query: 1066 KVDVYSFGIAMWEIITGEEPY 1086
+ D +S G+ ++E++ G+ P+
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-09
Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 880 LQELGSGTFGTV----YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++ELG G +G V +AIK+I ++ L K RE ++ +
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKIT------NVFSKKILAKRALRELKLLRHF 58
Query: 936 H-HPNVVAFYGVVPNGPGGTMATVTEYMVNGS-LRHVLARKD--RILDRRKKLMLMMDAA 991
H N+ Y M V N L L D +I+ + L DA
Sbjct: 59 RGHKNITCLY---------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT---DAH 106
Query: 992 F---------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS 1041
F G++Y+H N++H DLK NLLVN D + IC DFGL+R N +
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA-DCELKIC---DFGLARGFSENPGEN 162
Query: 1042 GGVR----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
G T + APE++ S ++ +DV+S G + E++
Sbjct: 163 AGFMTEYVATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-09
Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 918 QEWLIKEFW-----REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLA 972
Q ++K W EA ++ L HP V+A V G G T + +Y L L
Sbjct: 195 QRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKY--RSDLYTYLG 251
Query: 973 RKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG-- 1030
+ R L + + ++Y+H + I+H D+K +N+LVN P+ IC +GDFG
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN--GPED-IC-LGDFGAA 307
Query: 1031 -LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWE 1078
+R +T G+ GT+ APE+L G + + VD++S G+ ++E
Sbjct: 308 CFARGSWSTPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 7e-09
Identities = 32/116 (27%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 971 LARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030
L +K+ L + ++ + LH NI+H D+K +N+L + + +C D+G
Sbjct: 99 LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC---DYG 155
Query: 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
L +I GTL + +PE + G N VS D ++ G+ +E++TG+ P+
Sbjct: 156 LCKIIGTPSCY---DGTLDYFSPEKIKGHNYDVS--FDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIA-----------IKRIKKSCFLGRSSEQEWLIKE 924
D E L+ +G G FG V K + T +KR + +CF E++ L+
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACF---REERDVLVNG 58
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKK 983
+ I+NLH+ AF + V +Y V G L +L++ +DR+ + +
Sbjct: 59 ---DRRWITNLHY----AFQD------ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG--LSRIKCNTLVS 1041
L + ++ +H VH D+K DN+L++ R + DFG L + T+ S
Sbjct: 106 FYLA-EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR----LADFGSCLRLLADGTVQS 160
Query: 1042 GGVRGTLPWMAPELLN---GSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
GT +++PE+L R + D +S G+ M+E++ GE P+
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 883 LGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSS------EQEWLIKEFWREAHIISN 934
+G GTFG VY R K A+K + K + + E+ L++ E+ I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
L F + + VT+YM G L L ++ R + R K + + +
Sbjct: 61 LK------FSFQTDS----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLAL 109
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK------CNTLVSGGVRGTL 1048
E+LH +IV+ DLK +N+L++ +C DFGLS+ NT GT
Sbjct: 110 EHLHKYDIVYRDLKPENILLD-ATGHIALC---DFGLSKANLTDNKTTNTFC-----GTT 160
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
++APE+L ++ VD +S G+ ++E+ G P+
Sbjct: 161 EYLAPEVLLDEKG-YTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D L LG G+FG V + +GTD AIK +KK + ++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI--------------QDDDVEC 46
Query: 934 NLHHPNVVAFYGVVP-----NGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKLM 985
+ V+A G P + TM V EY+ G L + + + R +
Sbjct: 47 TMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVF 105
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR 1045
+ A G+ +LH K I++ DLK DN+++ D + I K+ DFG+ C + GV
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHI-KIADFGM----CKENMWDGVT 157
Query: 1046 -----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
GT ++APE++ + + VD ++FG+ ++E++ G+ P+
Sbjct: 158 TKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-08
Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 12/174 (6%)
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VS 1041
+L ++ +H + ++H DLK N+ + I K+GDFG S+ +++ V+
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101
GT ++APEL R S+K D++S G+ ++E++T P+ I+ +L
Sbjct: 229 SSFCGTPYYLAPELW--ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI--TNRLRVMSTALQTKRRN 1153
P P + L++ S NPA RP+ ++ T L+ ++ Q R+
Sbjct: 287 KYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRH 339
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPN 939
+G G++ V + + T+ A+K +KK + + +W+ E H+ +HP
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKE-LVNDDEDIDWV----QTEKHVFEQASNHPF 57
Query: 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
+V + + V EY+ G L + R+ ++ + + + + + YLH
Sbjct: 58 LVGLHSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY-SAEISLALNYLHE 114
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR----GTLPWMAPEL 1055
+ I++ DLK DN+L+ D + I K+ D+G+ + L G GT ++APE+
Sbjct: 115 RGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEI 167
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
L G + S VD ++ G+ M+E++ G P+
Sbjct: 168 LRGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V + R T A K++ K R + ++ E I++ +H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-----EKRILAKVHSRFI 55
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLR-HV--LARKDRILDRRKKLMLMMDAAFGMEYL 997
V+ + V M G LR H+ + ++ + G+E+L
Sbjct: 56 VSLAYAFQTKT--DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMAPELL 1056
H + I++ DLK +N+L++ R + D GL+ +K + G GT +MAPELL
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
G S VD ++ G+ ++E+I P+
Sbjct: 170 QGEEYDFS--VDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-08
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 878 EELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L +GSG +G+V G +A+K+ L R + K +RE ++ ++
Sbjct: 20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKK------LSRPFQSIIHAKRTYRELRLLKHM 73
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTE-YMVN---GSLRHVLARKDRILDRRKKLMLMMDAA 991
H NV+ V P ++ + Y+V G+ + + + ++ D + L+
Sbjct: 74 KHENVIGLLDVFT--PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQIL 130
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWM 1051
G++Y+H +I+H DLK NL VN D + K+ DFGL+R + + G T +
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVN-EDCE---LKILDFGLARHTDDEMT--GYVATRWYR 184
Query: 1052 APE-LLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
APE +LN + + VD++S G M E++TG
Sbjct: 185 APEIMLNWMHYNQT--VDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 39/217 (17%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+G G +G V K T+ +AIK+I + F R + L RE ++ +L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTL-----REIKLLRHLDHENV 66
Query: 941 VAFYGVVPNGPGGTMA-----TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
+A ++P P A V E M + L H + R + L + G++
Sbjct: 67 IAIKDIMP--PPHREAFNDVYIVYELM-DTDL-HQIIRSSQTLSDDHCQYFLYQLLRGLK 122
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNT-------LVSGGVRG 1046
Y+H N++H DLK NLL+N C K+ DFGL+R +V
Sbjct: 123 YIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLARTTSEKGDFMTEYVV------ 170
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
T + APELL + + +DV+S G E++ +
Sbjct: 171 TRWYRAPELLLNCSEYTT-AIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 51/296 (17%)
Query: 879 ELQEL-GSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
++QE+ G G++G V G +AIK+I F S L RE ++ L
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRIL-----REIKLLRLL 56
Query: 936 HHPNVVAFYGV-VPNGPG--GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
HP++V + +P + V E M L V+ D + + L
Sbjct: 57 RHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLY-QLLR 114
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN----TLVSGGVRGTL 1048
++Y+H N+ H DLK N+L N D + IC DFGL+R+ N + T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-ADCKLKIC---DFGLARVAFNDTPTAIFWTDYVATR 170
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEE--PYAN-MHCGAIIGGILS----- 1100
+ APEL ++ + +D++S G E++TG+ P N +H +I +L
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230
Query: 1101 --------------NTLRPQIP-------ERCDPEWRKLMEECWSFNPAARPSFTE 1135
+++R + P DP +L+E +F+P RP+ E
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V + R T A K+++K R E L E I+ ++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL-----NEKQILEKVNSRFV 62
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
V+ + V M G L+ H+ + + + + + G+E LH
Sbjct: 63 VSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMAPELLNG 1058
+ IV+ DLK +N+L+ D I ++ D GL+ + + G V GT+ +MAPE++
Sbjct: 121 ERIVYRDLKPENILL---DDHGHI-RISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVK- 174
Query: 1059 SNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
N R + D ++ G ++E+I G+ P+
Sbjct: 175 -NERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 874 DSDLEELQELGSGTFGTVYRG--KWRGTDIAIKRI---KKSCFLGRSSEQEWLIKEFWRE 928
+ L +G G +G V K G +AIK+I + F R+ RE
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----------LRE 53
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATV---TEYMVNGSLRHVLARKDRILDRRKKLM 985
I+ H N++ ++ + V E M L ++ + D + +
Sbjct: 54 IKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFL 112
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGG 1043
+ G++Y+H N++H DLK NLL+N C K+ DFGL+RI G
Sbjct: 113 YQI--LRGLKYIHSANVLHRDLKPSNLLLNTN------CDLKICDFGLARIADPEHDHTG 164
Query: 1044 VR----GTLPWMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
T + APE +LN ++ +D++S G + E+++
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKG--YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 878 EELQELGSGTFGTV---YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
+ L+ +GSG G V Y G ++AIK+ L R + K +RE ++
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTV-TGQNVAIKK------LSRPFQNVTHAKRAYRELVLMKL 71
Query: 935 LHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
++H N++ V P ++ V E M + +L V+ LD + L+
Sbjct: 72 VNHKNIIGLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIQMD---LDHERMSYLLY 125
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVRG 1046
G+++LH I+H DLK N++V C K+ DFGL+R + +
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVV 179
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
T + APE++ G E VD++S G M E+I G
Sbjct: 180 TRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V + R T A K+++K R E L E I+ ++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKRILEKVNSRFV 62
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
V+ + V M G L+ H+ + D ++ + + G+E L
Sbjct: 63 VSLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMAPELLNG 1058
+ IV+ DLK +N+L++ R R + D GL+ +I V G V GT+ +MAPE++N
Sbjct: 121 ERIVYRDLKPENILLDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVIN- 174
Query: 1059 SNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
N + + D + G ++E+I G+ P+
Sbjct: 175 -NEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 883 LGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+G G+FG V K + A+K ++K L + EQ+ ++ E R ++ N+ HP +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK-EQKHIMAE--RNV-LLKNVKHPFL 58
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK 1000
V + + V +Y+ G L L R+ + R + + A + YLH
Sbjct: 59 VGLHYSFQTAD--KLYFVLDYVNGGELFFHLQRERSFPEPRARFY-AAEIASALGYLHSL 115
Query: 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLVSGGVRGTLPWMAPELLNG 1058
NI++ DLK +N+L+ D Q + + DFGL + I+ + S GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHV-VLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLR- 169
Query: 1059 SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104
VD + G ++E++ G P+ + + IL+ LR
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR 214
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKE----FWREA 929
D L LG G+FG V + +GTD AIK +KK + + ++++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ LH F + + V EY+ G L + + + + + K+ +
Sbjct: 61 PFLTQLHS----CFQTM------DRLYFVMEYVNGGDLMYHI----QQVGKFKEPHAVFY 106
Query: 990 AA---FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR- 1045
AA G+ +LH K I++ DLK DN+++ D + I K+ DFG+ C + GG
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHI-KIADFGM----CKENIFGGKTT 158
Query: 1046 ----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
GT ++APE++ + + VD ++FG+ ++E++ G+ P+
Sbjct: 159 RTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 24/264 (9%)
Query: 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+G G+FG V K + G A+K ++K L R EQ+ ++ E ++ N+ HP +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAE---RNVLLKNVKHPFL 58
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLM-MDAAFGMEYLHM 999
V + + V +++ G L L R+ + R + + +A G YLH
Sbjct: 59 VGLHYSFQTTE--KLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS 114
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGTLPWMAPELL 1056
NIV+ DLK +N+L+ D Q + + DFGL + + +T + GT ++APE++
Sbjct: 115 INIVYRDLKPENILL---DSQGHVV-LTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEVI 168
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--TLRPQIPERCDPE 1114
VD + G ++E++ G P+ + IL LRP
Sbjct: 169 R--KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226
Query: 1115 WRKLMEECWSFNPAARPSFTEITN 1138
+L+E+ A+ F EI
Sbjct: 227 LEELLEKDRQRRLGAKEDFLEIQE 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 877 LEELQELGSGTFGTV---YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
+ L +GSG +G+V Y + R +A+K+ L R + + +RE ++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKK------LSRPFQSLIHARRTYRELRLLK 69
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTE-YMVN---GSLRHVLARKDRILDRRKKLMLMMD 989
++ H NV+ V P ++ E Y+V G+ + + + ++ D + L+
Sbjct: 70 HMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQ 126
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
G++Y+H I+H DLK N+ VN D + ++ DFGL+R + + G T
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVN-EDCE---LRILDFGLARQADDEMT--GYVATRW 180
Query: 1050 WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ APE +LN + ++ VD++S G M E++ G+
Sbjct: 181 YRAPEIMLNWMH--YNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 3e-07
Identities = 60/261 (22%), Positives = 104/261 (39%), Gaps = 76/261 (29%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E ++ +G G FG V+ + + T A+K ++KS + R+ E I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-----VRAERDIL 55
Query: 933 SNLHHPNVV----AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
++ P +V +F Y V EYM G L ++L RKD +
Sbjct: 56 ADADSPWIVKLYYSFQDEEHLY------------LVMEYMPGGDLMNLLIRKDVFPEETA 103
Query: 983 K-----LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS----- 1032
+ L+L +D+ + + +H D+K DN+L+ D I K+ DFGL
Sbjct: 104 RFYIAELVLALDSVHKLGF------IHRDIKPDNILI---DADGHI-KLADFGLCKKMNK 153
Query: 1033 ----------RIKCNTLVSGGVR---------------GTLPWMAPELLNGSNNRVSEKV 1067
+ VR GT ++APE+L G+ +
Sbjct: 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLEC 211
Query: 1068 DVYSFGIAMWEIITGEEPYAN 1088
D +S G+ ++E++ G P+ +
Sbjct: 212 DWWSLGVILYEMLYGFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 27/169 (15%)
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML---MMDAAFG 993
HPN++ + V G + ++ +M GS +L K + + ++ + A G
Sbjct: 58 HPNIMTSWTVFTTG--SWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILFGALRG 113
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-------- 1045
+ YLH +H ++K ++L++ V GLS + LV G +
Sbjct: 114 LNYLHQNGYIHRNIKASHILISGDG------LVSLSGLSHLYS--LVRNGQKAKVVYDFP 165
Query: 1046 ----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090
LPW++PELL + K D+YS GI E+ TG P+ +M
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L+ +GSG G V D +AIK+ L R + + K +RE ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKK------LSRPFQNQTHAKRAYRELVLMKCV 73
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTE-YMV----NGSLRHVLARKDRILDRRKKLMLMMDA 990
+H N+++ V P ++ + Y+V + +L V+ + LD + L+
Sbjct: 74 NHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQM 128
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPW 1050
G+++LH I+H DLK N++V K+ DFGL+R + + T +
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEII 1080
APE++ G + E VD++S G M E++
Sbjct: 185 RAPEVILGMGYK--ENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 873 KDSDLEELQELGSGTFGTVYRGKWRGT-DI-AIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
KD D++ L +G G FG V + + T DI A+K +KKS L + E +E E
Sbjct: 1 KDFDVKSL--VGRGHFGEVQVVREKATGDIYAMKVMKKSVLL--AQETVSFFEE---ERD 53
Query: 931 IISNLHHPNVVAF-YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
I+S + P + Y + V EY G L +L R + D + +
Sbjct: 54 ILSISNSPWIPQLQYAFQDKD---NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCN-TLVSGGVRGT 1047
+ +H VH D+K +N+L+ D I K+ DFG + R+ N + S GT
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLI---DRTGHI-KLADFGSAARLTANKMVNSKLPVGT 166
Query: 1048 LPWMAPELL---NGSNNRVSE-KVDVYSFGIAMWEIITGEEPYA 1087
++APE+L NG + D +S G+ +E+I G P+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 52/223 (23%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D L LG G+FG V + +GTD AIK +KK + + ++ E +++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV-----EKRVLA 55
Query: 934 NLHHPNVVA-----FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
P + F V + V EY+ G L + + + + + +
Sbjct: 56 LQDKPPFLTQLHSCFQTV------DRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAA 108
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR--- 1045
+ + G+ +LH + I++ DLK DN++++ K+ DFG+ C + GV
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGH----IKIADFGM----CKEHMVDGVTTRT 160
Query: 1046 --GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
GT ++APE++ + + VD +++G+ ++E++ G+ P+
Sbjct: 161 FCGTPDYIAPEII--AYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-07
Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 77/285 (27%)
Query: 928 EAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML- 986
E H+ +HPN+V + + VT +M GS + ++ +D +L +
Sbjct: 49 ELHVSKLFNHPNIVPYRATFI--ADNELWVVTSFMAYGSAKDLIC--THFMDGMSELAIA 104
Query: 987 --MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN-TLVSGG 1043
+ ++Y+H VH +K ++L+++ G LS ++ N ++++ G
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVD---------GKVYLSGLRSNLSMINHG 155
Query: 1044 VRG------------TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
R LPW++PE+L + K D+YS GI E+ G P+ +M
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215
Query: 1092 GAIIGGILSNTL------------------------------------RPQIPERC---- 1111
++ L+ T+ RP E
Sbjct: 216 TQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPY 275
Query: 1112 ----DPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152
P + +E+C NP ARPS + + N S Q KRR
Sbjct: 276 NRTFSPHFHHFVEQCLQRNPDARPSASTLLNH----SFFKQIKRR 316
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 28/241 (11%)
Query: 850 VDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKR---I 906
+ S D +E G ++K + L+ +GSG G V D ++R I
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKR--YQNLKPIGSGAQGIV----CAAYDAILERNVAI 54
Query: 907 KKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE-YMV-- 963
KK L R + + K +RE ++ ++H N++ V P ++ + Y+V
Sbjct: 55 KK---LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT--PQKSLEEFQDVYIVME 109
Query: 964 --NGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021
+ +L V+ + LD + L+ G+++LH I+H DLK N++V
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SD 162
Query: 1022 PICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
K+ DFGL+R + + T + APE++ G + E VD++S G M E+I
Sbjct: 163 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMIK 220
Query: 1082 G 1082
G
Sbjct: 221 G 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 883 LGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G FG V + K G A K++ K +S E+ L+ E I+ ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999
V + + V M G L+ H+ +R L+ + + G+ +LH
Sbjct: 56 VNLAYAFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMAPELLNG 1058
+IV+ D+K +N+L++ + C++ D GL+ +K ++ GT +MAPE+L
Sbjct: 114 MDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKE 168
Query: 1059 SNNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088
VD ++ G +++E++ G P+ +
Sbjct: 169 EPYSYP--VDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 20/163 (12%)
Query: 928 EAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR--ILDRRKKLM 985
EAHI+ ++HP+++ G T + Y + L LA K I D L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYN-KFTCLILPRYKTD--LYCYLAAKRNIAICD---ILA 186
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP--ICKVGDFGLS--RIKCNTLVS 1041
+ ++YLH I+H D+K +N+ +N P +C +GDFG + + N
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN-----HPGDVC-LGDFGAACFPVDINANKY 240
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEE 1084
G GT+ APELL + + VD++S GI ++E+ T +
Sbjct: 241 YGWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 16/134 (11%)
Query: 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLR 1017
V EY+ G L + R+ ++ + + + + +LH + I++ DLK DN+L++
Sbjct: 74 VIEYVNGGDLMFHMQRQRKLPEEHARFY-AAEICIALNFLHERGIIYRDLKLDNVLLD-- 130
Query: 1018 DPQRPICKVGDFGLSRIKCNTLVSGG-----VRGTLPWMAPELLNGSNNRVSEKVDVYSF 1072
K+ D+G+ C + G GT ++APE+L G S VD ++
Sbjct: 131 --ADGHIKLTDYGM----CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS--VDWWAL 182
Query: 1073 GIAMWEIITGEEPY 1086
G+ M+E++ G P+
Sbjct: 183 GVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII---SNLHH 937
+G G++ V + + T A+K IKK + +W+ E H+ SN H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWV----QTEKHVFETASN--H 55
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
P +V + + V E++ G L + R+ ++ + + + + + +L
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFY-SAEISLALNFL 112
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLVSGGVRGTLPWMAPEL 1055
H + I++ DLK DN+L+ D + I K+ D+G+ + I+ S GT ++APE+
Sbjct: 113 HERGIIYRDLKLDNVLL---DAEGHI-KLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEI 167
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
L G + S VD ++ G+ M+E++ G P+
Sbjct: 168 LRGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-06
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+G+G+FG VY T +AIK++ Q+ K RE I+ NL+H N+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVL----------QDPQYKN--RELLIMKNLNHINI 121
Query: 941 V---AFY---GVVPNGPGGTMATVTEYM---VNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ +Y N + V E++ V+ ++H AR + L +
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH-YARNNHALPLFLVKLYSYQLC 180
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG----- 1046
+ Y+H K I H DLK NLL+ DP K+ DFG ++ N L G R
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFGSAK---NLL--AGQRSVSYIC 232
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
+ + APEL+ G+ N + +D++S G + E+I G
Sbjct: 233 SRFYRAPELMLGATNYTTH-IDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-05
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 886 GTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAF 943
G FG VY R K A+K +KK+ + ++ + + E R+A +S P +V
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ-VQAE--RDALALSK--SPFIVHL 69
Query: 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIV 1003
Y + + + V EY++ G ++ +L D + + + A ++YLH I+
Sbjct: 70 YYSLQSA--NNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGII 126
Query: 1004 HFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
H DLK DN+L++ K+ DFGLS++ N
Sbjct: 127 HRDLKPDNMLIS----NEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 877 LEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
E L +G G +G V + + + T +AIK+ K S E E + + RE ++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS------EENEEVKETTLRELKMLRT 56
Query: 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRIL-DRRKKLMLMMDAAFG 993
L N+V G + V EY+ L + + + ++ + + + A
Sbjct: 57 LKQENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-- 112
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMA- 1052
+ + H +IVH D+K +NLL++ D + K+ DFG +R L G ++A
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHND----VLKLCDFGFAR----NLSEGSNANYTEYVAT 164
Query: 1053 -----PELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
PELL G+ + VD++S G + E+ G+
Sbjct: 165 RWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 44/171 (25%), Positives = 66/171 (38%), Gaps = 25/171 (14%)
Query: 880 LQELGSGTFGTVYRGKWRGTDIAIK-RIKKSCFLGRSSEQEWLIKEFW--REAHIISNLH 936
++ + G +Y G + G IK RI K R E + I+ REA I+S
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRY---RHPELDERIRRERTRREARIMSRAR 57
Query: 937 HP--NVVAFYGVVPNGPGGTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDAAFG 993
NV A Y V P V EY + G L+ ++ + +L + G
Sbjct: 58 KAGVNVPAVYFVDPEN----FIIVMEY-IEGEPLKDLI---NSNGMEELELSREIGRLVG 109
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
LH I+H DL N++++ I + DFGL+ L V
Sbjct: 110 K--LHSAGIIHGDLTTSNMILSGGK----IYLI-DFGLAEFS-KDLEDRAV 152
|
Length = 211 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-04
Identities = 69/325 (21%), Positives = 131/325 (40%), Gaps = 68/325 (20%)
Query: 861 EMEAGIYGLQI----------IKD--SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRI 906
E E G + LQ I D S L+E + G G Y+GK + +K I
Sbjct: 664 ENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 907 KKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGS 966
+S I + + L HPN+V G+ + G + + EY+ +
Sbjct: 724 NDV-----NSIPSSEIADMGK-------LQHPNIVKLIGLCRSEKGAYL--IHEYIEGKN 769
Query: 967 LRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK---NIVHFDLKCDNLLVNLRDPQRPI 1023
L VL ++ +RR+K+ + + A + +LH + +V +L + ++++ +D P
Sbjct: 770 LSEVL--RNLSWERRRKIAIGIAKA--LRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPH 823
Query: 1024 CKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
++ GL +S ++APE ++EK D+Y FG+ + E++TG+
Sbjct: 824 LRLSLPGLLCTDTKCFISSA------YVAPE--TRETKDITEKSDIYGFGLILIELLTGK 875
Query: 1084 EP------------------YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSF 1125
P Y++ H I + + + + E L C +
Sbjct: 876 SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV--SVNQNEIVEVMNLALHCTAT 933
Query: 1126 NPAARPSFTEITNRLRVMSTALQTK 1150
+P ARP ++ L+ + +A ++
Sbjct: 934 DPTARPCANDV---LKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 1e-04
Identities = 67/294 (22%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
++ E ++++G+G FG V+ K + T K I R Q + E +++
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI------EVNVM 66
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR---------KDRILDRRKK 983
L H N+V + N + + E+ G L + + + I+D ++
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 984 LMLMMDAAFGMEYLHM-------KNIVHFDLKCDNLLV---------------NLRDPQR 1021
L+ + Y H + ++H DLK N+ + NL R
Sbjct: 127 LL------HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG--R 178
Query: 1022 PICKVGDFGLSR-IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII 1080
PI K+GDFGLS+ I ++ V GT + +PELL +K D+++ G ++E+
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 1081 TGEEPYANMHCGAIIGGILSNTLR-PQIPERC-DPEWRKLMEECWSFNPAARPS 1132
+G+ P+ H ++S R P +P + E L++ + + RPS
Sbjct: 238 SGKTPF---HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 53/267 (19%), Positives = 108/267 (40%), Gaps = 33/267 (12%)
Query: 829 TETESAHPDSDHEDVRGDGR--EVDESISD-AAMAEMEAGIYGLQIIKDSDLEELQELGS 885
+ + A PD+ + DE ++ + ++ AG +G I +
Sbjct: 120 LDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEAR 179
Query: 886 GTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945
+ +GK + + KR+K E E L + L+H N++
Sbjct: 180 RGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILA---------LGRLNHENILKIEE 230
Query: 946 VVPNGPGGTMAT------VTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDAAFGMEYLH 998
++ + M T + +M + + KDR +L + + +M + A +EY+H
Sbjct: 231 ILRSEANTYMITQKYDFDLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCA--VEYIH 284
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG--GVRGTLPWMAPELL 1056
K ++H D+K +N+ +N +GDFG + + G GT+ +PE+L
Sbjct: 285 DKKLIHRDIKLENIFLNCDGK----IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL 340
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGE 1083
G E D++S G+ + ++++ +
Sbjct: 341 AGDG--YCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 40/189 (21%), Positives = 67/189 (35%), Gaps = 26/189 (13%)
Query: 965 GSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024
SL +L + R L+ + + + + LH + L + L+ L
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-------- 52
Query: 1025 KVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEE 1084
G K R +MAPE++ G + +EK D+YS GI ++E + E
Sbjct: 53 ----DGSVAFKTPEQS----RPDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYEL 102
Query: 1085 PYANMH-CGAIIGGILSNTLRPQIPERCDPE-------WRKLMEECWSFNPAARPSFTEI 1136
PY AI+ +L+ +R + E + M C S P R +
Sbjct: 103 PYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHY 162
Query: 1137 TNRLRVMST 1145
R +
Sbjct: 163 LAHCRALFA 171
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 875 SDLEELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E ++ +G G FG V + K G A+K+++KS L + EQ ++ E I+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK--EQVAHVRA---ERDIL 55
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
+ +P VV Y + + + EY+ G + +L +KD + + +
Sbjct: 56 AEADNPWVVKLYYSFQDE--NYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETIL 112
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
++ +H +H D+K DNLL++ + K+ DFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 38/165 (23%), Positives = 76/165 (46%), Gaps = 17/165 (10%)
Query: 962 MVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021
++NG H + + ++ + G+E++H + +V+ DLK N+L++ +
Sbjct: 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EH 133
Query: 1022 PICKVGDFGL----SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMW 1077
++ D GL S+ K + V GT +MAPE+L D +S G ++
Sbjct: 134 GHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQ-KGTAYDSSADWFSLGCMLF 187
Query: 1078 EIITGEEPYANMHCGAIIGGI--LSNTLRPQIPERCDPEWRKLME 1120
+++ G P+ H I ++ T+ ++P+ PE + L+E
Sbjct: 188 KLLRGHSPF-RQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 84/267 (31%)
Query: 876 DLEELQELGSGTFGTV--YRGKWRGTDIAIKRIKKSCFLGRS--------------SEQE 919
D E L+ +G G FG V + K G A+K ++K+ L + ++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 920 WLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD 979
W++K F+ + + Y ++ PGG M T+ L +KD + +
Sbjct: 62 WVVKMFYS---------FQDKLNLYLIMEFLPGGDMMTL------------LMKKDTLTE 100
Query: 980 RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL-------- 1031
+ + + ++ +H +H D+K DNLL++ + K+ DFGL
Sbjct: 101 EETQFYIA-ETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLCTGLKKAH 155
Query: 1032 ----------------------SRIKCNTL------VSGGVRGTLPWMAPELL--NGSNN 1061
S+ K T ++ GT ++APE+ G N
Sbjct: 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN- 214
Query: 1062 RVSEKVDVYSFGIAMWEIITGEEPYAN 1088
+ D +S G+ M+E++ G P+ +
Sbjct: 215 ---KLCDWWSLGVIMYEMLIGYPPFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 19/136 (13%)
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL----SRIKCNTLVSGGVRGT 1047
G+E++H + +V+ DLK N+L++ R + D GL S+ K + V GT
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVR----ISDLGLACDFSKKKPHASV-----GT 158
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGILSNTLR 1104
+MAPE+L S D +S G +++++ G P+ I L T+
Sbjct: 159 HGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMA 215
Query: 1105 PQIPERCDPEWRKLME 1120
++P+ PE R L+E
Sbjct: 216 VELPDSFSPELRSLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1157 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.85 | |
| smart00666 | 81 | PB1 PB1 domain. Phox and Bem1p domain, present in | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| PF00564 | 84 | PB1: PB1 domain; InterPro: IPR000270 The Phox and | 98.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.24 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.22 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.17 | |
| cd05992 | 81 | PB1 The PB1 domain is a modular domain mediating s | 98.16 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.97 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.9 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.9 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.79 | |
| cd06407 | 82 | PB1_NLP A PB1 domain is present in NIN like protei | 97.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.69 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.68 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.62 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.54 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.53 | |
| cd06408 | 86 | PB1_NoxR The PB1 domain is present in the Epichloe | 97.44 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.17 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.11 | |
| cd06405 | 79 | PB1_Mekk2_3 The PB1 domain is present in the two m | 97.1 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.72 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.58 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.46 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.44 | |
| cd06404 | 83 | PB1_aPKC PB1 domain is an essential modular domain | 96.41 | |
| cd06401 | 81 | PB1_TFG The PB1 domain found in TFG protein, an on | 96.31 | |
| cd06398 | 91 | PB1_Joka2 The PB1 domain is present in the Nicotia | 96.11 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.92 | |
| cd06396 | 81 | PB1_NBR1 The PB1 domain is an essential part of NB | 95.6 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.47 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.3 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.12 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.01 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.84 | |
| PLN02236 | 344 | choline kinase | 94.8 | |
| cd06397 | 82 | PB1_UP1 Uncharacterized protein 1. The PB1 domain | 94.67 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.15 | |
| cd06402 | 87 | PB1_p62 The PB1 domain is an essential part of p62 | 93.49 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.2 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=432.93 Aligned_cols=269 Identities=25% Similarity=0.346 Sum_probs=231.6
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
..+.|.+.+.||+|+||.|.+|.. +|+.||||++.+........ ..+....+.+|+++|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeeeec-
Confidence 346788999999999999999977 58889999999876655433 12223446799999999999999999999988
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....||||||++||+|.+.+..++ .+.+.....+++||+.||.|||++||+||||||+|||+..+. +.-.+||+|||
T Consensus 248 -~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-e~~llKItDFG 324 (475)
T KOG0615|consen 248 -PDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-EDCLLKITDFG 324 (475)
T ss_pred -CCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-cceEEEecccc
Confidence 557899999999999999987654 477778888999999999999999999999999999998544 66899999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCCC--CC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSE-KVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLR--PQ 1106 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~-KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~lr--pe 1106 (1157)
+|+...+...+.++||||.|.|||++.+.+..+.. ++|+|||||+||-+|+|.+||....... ..++|..+.+. +.
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 99998888888899999999999999876555554 8999999999999999999999876666 77778777554 34
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.+.+++++.++||.+||..||++|||+.++|++.|..-..
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 5677999999999999999999999999999999987443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=416.95 Aligned_cols=258 Identities=32% Similarity=0.509 Sum_probs=226.5
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+++.++.||+|+.|+||+++++ +..+|+|++... ......+++.+|+++++.++||+||++|++|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 44568888999999999999999996 667999999543 124567899999999999999999999999998
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+.. .++|+||||++|+|..+++..+ .+++....+++.++++||.|||. ++||||||||+|||++ ..+.|||||
T Consensus 149 ~~~-~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN----skGeVKicD 222 (364)
T KOG0581|consen 149 NGE-EISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN----SKGEVKICD 222 (364)
T ss_pred CCc-eEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec----cCCCEEecc
Confidence 432 6999999999999999998764 48999999999999999999995 8999999999999999 889999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChhHHHHHhhhcCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM-----HCGAIIGGILSNTL 1103 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~-----~~eeil~~Il~~~l 1103 (1157)
||.++...+. ...+++||..|||||+++|. .|+.++||||||++|+||++|+.||... ...+++..|..+ .
T Consensus 223 FGVS~~lvnS-~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-p 298 (364)
T KOG0581|consen 223 FGVSGILVNS-IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-P 298 (364)
T ss_pred ccccHHhhhh-hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-C
Confidence 9999988777 55678999999999999976 6788999999999999999999999874 455677777654 4
Q ss_pred CCCCCCC-CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1104 RPQIPER-CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1104 rpeip~~-iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
++.+|.. ++++++.||..||++||.+|||++||++|.+.....
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 5667776 999999999999999999999999999998877543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=414.28 Aligned_cols=271 Identities=45% Similarity=0.798 Sum_probs=239.0
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEECCce-EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGTD-IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~-VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
.+.+...++.+.+.||+|+||+||+|.|+|+. ||||++........ . .+.|.+|+.+|.+|+|||||+++|++
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~-----~-~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE-----S-RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH-----H-HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34455566677778999999999999999999 99999987533221 1 67899999999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhcc-ccccccHHHHHHHHHHHHHHHHHHHHCC-ceeccCCccceeeccCCCCCC-eE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGMEYLHMKN-IVHFDLKCDNLLVNLRDPQRP-IC 1024 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr-~gr~L~e~qVlkIa~QLa~ALeYLHSkG-IIHRDLKPENILLd~dd~e~g-~V 1024 (1157)
..++. .++||||||++|+|.+++.+ ..+.+++..++.++.||++||+|||+++ ||||||||+|||++ ... ++
T Consensus 109 ~~~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~----~~~~~~ 183 (362)
T KOG0192|consen 109 TSPPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD----LKGKTL 183 (362)
T ss_pred cCCCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc----CCCCEE
Confidence 88532 68999999999999999987 3678999999999999999999999999 99999999999999 665 99
Q ss_pred EEEecCCcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC
Q 001103 1025 KVGDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l 1103 (1157)
||+|||+++..... ...+...||+.|||||++.+....|+.|+||||||++||||+||+.||...........+.....
T Consensus 184 KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 184 KIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL 263 (362)
T ss_pred EECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999999876654 34444789999999999985334689999999999999999999999999999888888888999
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
++.++..+++.+..||..||..||.+||++.+++..|+.+.......
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 99999999999999999999999999999999999999998766543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=424.67 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=229.7
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|+..+.||+|+|+.||++++ .|..||+|++.+..+.... ..+++.+|++|-+.|+|||||++|++|++ .
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~-----~reKv~~EIeIHr~L~HpnIV~f~~~FED--s 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK-----QREKVLNEIEIHRSLKHPNIVQFYHFFED--S 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc-----hHHHHHHHHHHHHhcCCCcEEeeeeEeec--C
Confidence 5799999999999999999988 5888999999987655433 35788999999999999999999999999 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
.++|||+|+|..++|.++++ ..+.++|..+++++.||+.||.|||+++|||||||..|+|++ ++.+|||+|||||
T Consensus 91 ~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~----~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN----ENMNVKIGDFGLA 165 (592)
T ss_pred CceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec----CcCcEEeccccee
Confidence 79999999999999999998 456799999999999999999999999999999999999999 8889999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
.....+ ....+.||||.|.|||++... ..+..+||||+||+||.||.|++||+.....+.+..|....+. +|..+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~l 241 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHL 241 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--ccccc
Confidence 976644 667779999999999999854 5689999999999999999999999999999999999877664 67789
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+.++++||.+||+.||.+|||+++++.+-.+
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 9999999999999999999999999998776
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=408.81 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=225.2
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+..++|++++.||+|+||+||+++.+ ++-||+|++++.....++ ..+...+|..+|..++||+||+++..|++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~-----e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK-----EVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh-----hHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 44579999999999999999999874 667999999987655442 25678899999999999999999999998
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+.+|+|+||+.||.|...|.+.+. +++..+..++.+|+.||.|||++|||||||||+|||++ .+|+++|+||
T Consensus 97 --~~kLylVld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----~~GHi~LtDF 169 (357)
T KOG0598|consen 97 --EEKLYLVLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----EQGHIKLTDF 169 (357)
T ss_pred --CCeEEEEEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----CCCcEEEecc
Confidence 6789999999999999999976654 88999999999999999999999999999999999999 8899999999
Q ss_pred CCcccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1030 GLSRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1030 GLAkl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
|+|+.... ...+.++|||+.|||||++.+. .|+..+||||||+++|||++|.+||.+.+....+..|..... ...+
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-~~~p 246 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-PLPP 246 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-CCCC
Confidence 99996443 4556678999999999999965 689999999999999999999999999998888888876653 3456
Q ss_pred CCCcHHHHHHHHHHhccCCCCCC----CHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARP----SFTEITNRLRVM 1143 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRP----SaeELLe~Lr~L 1143 (1157)
..++.+.++||+++|++||++|- ++++|.+|..+.
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~ 285 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFK 285 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence 66999999999999999999994 677777765443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=401.33 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=224.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.++||.|+||+||+|++ ++..||||.+.+..+ .....+-+..|+++|+.|+|||||++++++..
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-- 80 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL------NKKLVELLLSEIKILKELKHPNIVRLLDCIED-- 80 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--
Confidence 36899999999999999999998 477899999987633 23445678899999999999999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCC--CeEEEEec
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR--PICKVGDF 1029 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~--g~VKLiDF 1029 (1157)
.+.+|||||||.||+|.+++.+.+ .+++..++.++.||+.||++||+++||||||||+||||+...... ..+||+||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 669999999999999999998766 499999999999999999999999999999999999998543233 78999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIP 1108 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpeip 1108 (1157)
|+|+...+.....+.||++.|||||+++ ..+|+.|+|+||+|+|||+|++|+.||......+++..+..+ ...+.++
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~--~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIM--SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHH--hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 9999988888878899999999999997 357899999999999999999999999998888888776544 4455677
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
..++..+.+|+...|+.++..|-++.+...+.
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 77888889999999999999998887766543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=407.33 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=227.2
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
....||.+.+.||.|+|++||+|+. .++.||||++.+.-+.. +...+.+.+|...|.+| .||.|++||..|+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-----e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-----EKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-----hcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 3457999999999999999999988 47789999998864432 23357788999999999 8999999999999
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+|+|+||+++|+|.++|++.+ .|++...++++.||+.||+|||++|||||||||||||++ .++++||+|
T Consensus 145 D--~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd----~dmhikITD 217 (604)
T KOG0592|consen 145 D--EESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD----KDGHIKITD 217 (604)
T ss_pred c--ccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc----CCCcEEEee
Confidence 9 668999999999999999998765 599999999999999999999999999999999999999 889999999
Q ss_pred cCCcccccCC------------ccc--CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHH
Q 001103 1029 FGLSRIKCNT------------LVS--GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI 1094 (1157)
Q Consensus 1029 FGLAkl~~~~------------~~s--ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eei 1094 (1157)
||-|+..... ... .+++||..|.+||++... ..+..+|||+||||||+|+.|++||.+.+...+
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 9999854321 112 458999999999999854 568889999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1095 l~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
++.|+...+ .++..+++.+++||+++|..||.+|.+..+|-+|+.+-.-
T Consensus 296 FqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 296 FQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred HHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 999987655 5788999999999999999999999999999998655433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=390.28 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=225.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeec
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPN 949 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~d 949 (1157)
....|++.+.||+|+||+|++|++ .+..||||++.+....... ....+.+.+|+.+++.+. ||||+++++++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 346899999999999999999988 5788999987765222111 123456678999999999 9999999999988
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCC-CeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR-PICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~-g~VKLiD 1028 (1157)
. ..+|+||||+.||+|.+++.+ .+++.+..+..++.||+.||+|||++||+||||||+|||++ .+ +.+||+|
T Consensus 92 ~--~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld----~~~~~~Kl~D 164 (370)
T KOG0583|consen 92 P--TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD----GNEGNLKLSD 164 (370)
T ss_pred C--CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec----CCCCCEEEec
Confidence 4 459999999999999999988 55688899999999999999999999999999999999999 55 8999999
Q ss_pred cCCcccc-cCCcccCCCCCCCcccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1029 FGLSRIK-CNTLVSGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1029 FGLAkl~-~~~~~sts~~GTp~YmAPEVL~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
||++... ........+|||+.|+|||++.+.. |. +.++||||+||+||.|++|+.||.......+...+....+ .
T Consensus 165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~-g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--~ 241 (370)
T KOG0583|consen 165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYS-GKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--K 241 (370)
T ss_pred cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcC-CchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--c
Confidence 9999877 4556677799999999999999764 32 5899999999999999999999999887777777765544 5
Q ss_pred CCCCC-cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERC-DPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~i-SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+|..+ +++++.||.+||..||.+|+++.+|+.+.|...
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 77777 999999999999999999999999999998876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=377.36 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=226.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
....+|++++.||.|+||.|.+++.+ |..||+|++++..... -..++...+|..+|+.+.||+++++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-----lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-----LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-----HHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 45578999999999999999999884 6779999998864432 2235678899999999999999999999988
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+||||||++||.|..++++.++ +++..++.++.||+.||+|||+++|++|||||||||+| .+|++||+||
T Consensus 116 --~~~lymvmeyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----~~G~iKitDF 188 (355)
T KOG0616|consen 116 --NSNLYMVMEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----QNGHIKITDF 188 (355)
T ss_pred --CCeEEEEEeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----cCCcEEEEec
Confidence 6799999999999999999976654 89999999999999999999999999999999999999 8999999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
|+|+..... +.+.||||.|+|||+++.+ .|..++|||||||++|||+.|.+||...+...++..|+...+. +|.
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~ 262 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPS 262 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCc
Confidence 999876554 4458999999999999965 5788999999999999999999999999999999999988774 788
Q ss_pred CCcHHHHHHHHHHhccCCCCC-----CCHHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAAR-----PSFTEITNRLRVMST 1145 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskR-----PSaeELLe~Lr~Lk~ 1145 (1157)
.+++++++||+.+|+.|-.+| ....+|.+|.|+-..
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 899999999999999999999 355677777666543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=401.46 Aligned_cols=254 Identities=25% Similarity=0.434 Sum_probs=223.2
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC--ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVV 947 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG--t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf 947 (1157)
.+...+|.+++.||+|+||+|++++.++ ..||||+++|.....+.. ++....|.+|+.... ||.++++|..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeeccccc
Confidence 3456799999999999999999999864 459999999987766543 567788999988875 99999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
++ ..++|+||||+.||++..+.+ .+.+++..+..|+++++.||.|||++||||||||.+|||+| .+|++||+
T Consensus 439 QT--~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----~eGh~kiA 510 (694)
T KOG0694|consen 439 QT--KEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----TEGHVKIA 510 (694)
T ss_pred cc--CCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----ccCcEEec
Confidence 99 679999999999999655543 34599999999999999999999999999999999999999 88999999
Q ss_pred ecCCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1028 DFGLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1028 DFGLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|||+++..- ....+.++||||.|||||++.+. .|+..+|||||||+|||||.|+.||.+.+.++++..|+.... .
T Consensus 511 DFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~--~ 586 (694)
T KOG0694|consen 511 DFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV--R 586 (694)
T ss_pred ccccccccCCCCCccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--C
Confidence 999999644 55567789999999999999965 689999999999999999999999999999999999986644 5
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPS-----FTEITNRLR 1141 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr 1141 (1157)
+|..++.+..++|+++|+++|++|-. +++|..+..
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF 626 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence 78889999999999999999999953 577776643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.90 Aligned_cols=262 Identities=28% Similarity=0.486 Sum_probs=212.4
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
+.+...+|++.+.||+|+||.||+|.+. +..||||+++.... ......+.+|+.+++++ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-------ASEHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-------hHHHHHHHHHHHHHHHhccCccee
Confidence 3456678999999999999999999752 34699999875311 11245688999999999 899999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------------------------------------------
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------------------------------------- 975 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------------------------------------- 975 (1157)
++++++... ...++++|||+++|+|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 75 NLLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eEEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 999988653 457899999999999998886421
Q ss_pred ---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc-
Q 001103 976 ---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL- 1039 (1157)
Q Consensus 976 ---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~- 1039 (1157)
..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++......
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~----~~~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPD 229 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc----CCCcEEEeecccccccccCcc
Confidence 2367788899999999999999999999999999999998 67789999999997543221
Q ss_pred --ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1040 --VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1040 --~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
......+++.|+|||++.+. .++.++|||||||+||||++ |..||........+...+........+..+++++.
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred hhcccCCCCCccccCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 12223467889999998754 57899999999999999997 99999876654444444444444556778899999
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+||.+||+.||.+|||+.++++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=382.80 Aligned_cols=256 Identities=22% Similarity=0.419 Sum_probs=219.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|+++++||.|+||+||++.+ +|..+|.|.++... . .+...+.+..|+.+|++|+|||||++|++-..+.
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-m-----d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-M-----DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-c-----cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 35789999999999999999877 68889999988442 2 2334678899999999999999999999655554
Q ss_pred CCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCccceeeccCCCCCCeE
Q 001103 952 GGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHM--KN--IVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHS--kG--IIHRDLKPENILLd~dd~e~g~V 1024 (1157)
...++||||||.+|+|..+++. ..+.++++.+|+++.|++.||..+|+ .. |+||||||.||+++ .++.|
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~----~~gvv 167 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT----ANGVV 167 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc----CCCce
Confidence 6679999999999999988864 45779999999999999999999999 44 99999999999999 88899
Q ss_pred EEEecCCcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC
Q 001103 1025 KVGDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l 1103 (1157)
||+|||+++..... ....+++|||.||+||++.+. +|+.++|||||||++|||+.-++||.+.....+...|..+.+
T Consensus 168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 99999999976554 345678999999999999865 689999999999999999999999999988888888887766
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
++......|..+..||..|+..||+.||+.-.++..+.
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 54333678999999999999999999998544444443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=359.12 Aligned_cols=263 Identities=23% Similarity=0.378 Sum_probs=222.3
Q ss_pred cccCCCeeEE--EEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEEL--QELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeIL--rkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+...+++.. ..||+|++|.||+|+++|+.||||++++.. .......+.+.+|+.+|++++||||+++++++.
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFH-----KGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccc-----cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 3334444444 679999999999999999999999987642 122334577889999999999999999999987
Q ss_pred c--CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEE
Q 001103 949 N--GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 949 d--e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
+ +....+++||||+.+|+|.+++.+. +.+++...+.++.|++.||.|||+. +++||||||+|||++ .++.+|
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~----~~~~~k 163 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLK 163 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC----CCCcEE
Confidence 6 4445789999999999999999764 4588899999999999999999984 999999999999998 678999
Q ss_pred EEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1026 VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
|+|||+++....... ...|+..|+|||++.+....++.++|||||||++|||++|+.||...........+.....++
T Consensus 164 l~dfg~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 241 (283)
T PHA02988 164 IICHGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241 (283)
T ss_pred EcccchHhhhccccc--cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999999875443322 346899999999997633468999999999999999999999999888777777776666667
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.++..+++++++||.+||+.||.+|||+.++++.|..+..
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 7777789999999999999999999999999999998763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=380.67 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=217.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|...+.||+|+||+||++... |...|||.+.... ... .+.+.+|+++|++|+|||||+++|.......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPT----SESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chh----HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 46778899999999999999885 6889999887641 111 5678899999999999999999997544322
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCC-CCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQ-RPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e-~g~VKLiDFGL 1031 (1157)
..++|+|||+++|+|.+++++.+..+++..++.+..|+++||+|||++|||||||||+|||++ . ++.+||+|||+
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~----~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD----PSNGDVKLADFGL 164 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe----CCCCeEEeccCcc
Confidence 478999999999999999988765799999999999999999999999999999999999998 5 68999999999
Q ss_pred cccccC----CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhHHHHHhhhcCCCCC
Q 001103 1032 SRIKCN----TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN-MHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1032 Akl~~~----~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g-~~~eeil~~Il~~~lrpe 1106 (1157)
++.... ......+.||+.|||||++... .....++|||||||++.||+||+.||.. ......+..+......|.
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPE 243 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCC
Confidence 986553 2223457899999999999842 2233589999999999999999999998 455555555655556678
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+|..+++++++||.+|+++||.+|||+.++|+++....
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 99999999999999999999999999999999987654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=392.14 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=223.7
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+..++|++++.||+|+||.||+|+. +|..+|+|++++..+..+.. +..+..|..+|...++|.||+||-.|+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q-----v~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ-----VEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh-----HHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 35678999999999999999999987 47779999999986654432 577889999999999999999999999
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ..++||||||++||++..+|.+.+ .|++..++.++.+++.|++.||+.|+|||||||+|+||| ..|++||+|
T Consensus 212 D--~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD----~~GHiKLSD 284 (550)
T KOG0605|consen 212 D--KEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID----AKGHIKLSD 284 (550)
T ss_pred C--CCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec----CCCCEeecc
Confidence 9 679999999999999999998765 499999999999999999999999999999999999999 889999999
Q ss_pred cCCcccccC----------------------C--c-----c-------------------cCCCCCCCcccCcccccCCC
Q 001103 1029 FGLSRIKCN----------------------T--L-----V-------------------SGGVRGTLPWMAPELLNGSN 1060 (1157)
Q Consensus 1029 FGLAkl~~~----------------------~--~-----~-------------------sts~~GTp~YmAPEVL~G~~ 1060 (1157)
|||+..... . . . ..+.+|||.|+|||++.+.
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k- 363 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK- 363 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-
Confidence 999862110 0 0 0 1124799999999999976
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC--CCCCCCCCCcHHHHHHHHHHhccCCCCCC---CHHH
Q 001103 1061 NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT--LRPQIPERCDPEWRKLMEECWSFNPAARP---SFTE 1135 (1157)
Q Consensus 1061 ~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~--lrpeip~~iSpeLrdLIkrCLqkDPskRP---SaeE 1135 (1157)
.|+..+|||||||||||||.|.+||.+....+....|+.-. +..+-...+++++++||.+||. ||.+|- +++|
T Consensus 364 -gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 364 -GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred -CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 47899999999999999999999999999999999987654 3333445578999999999999 999994 7999
Q ss_pred HHHHHHHHHHH
Q 001103 1136 ITNRLRVMSTA 1146 (1157)
Q Consensus 1136 LLe~Lr~Lk~a 1146 (1157)
|-+|.++-...
T Consensus 442 IK~HPfF~~v~ 452 (550)
T KOG0605|consen 442 IKKHPFFKGVD 452 (550)
T ss_pred HhcCCccccCC
Confidence 99887765433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.24 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=214.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||.||+++++ ++.||||++...... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-----RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--Q 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--C
Confidence 37899999999999999999985 778999998754211 11224567899999999999999999998877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+.+++|.+++.+.+ .+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~----~~~~~kl~Dfg~~ 148 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD----KEGHIKLTDFGFA 148 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEEecCcc
Confidence 68999999999999999987544 588999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
....... ...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... ..++..++
T Consensus 149 ~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~ 222 (291)
T cd05612 149 KKLRDRT--WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLD 222 (291)
T ss_pred hhccCCc--ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCC
Confidence 7654322 235799999999999864 56899999999999999999999999888777777776554 34667789
Q ss_pred HHHHHHHHHHhccCCCCCCC-----HHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPS-----FTEITNRLRVM 1143 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPS-----aeELLe~Lr~L 1143 (1157)
+.+++||++||+.||.+||+ +.+++++.|..
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 99999999999999999995 99999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=372.96 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=214.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
+.|+.+.++|+|+||+||+|+++ |+.||||++... ++.....+-.+||+++|++|+|||+|.++.+|.. .
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--k 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--K 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--c
Confidence 35888999999999999999984 777999988753 2334455667899999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++|+|||+. ++.+.|.+....++...+..+++|++.|+.|||++++||||||||||||+ .++.+||||||+|
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit----~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT----QNGVVKLCDFGFA 148 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe----cCCcEEeccchhh
Confidence 789999999987 66666767666799999999999999999999999999999999999999 8899999999999
Q ss_pred cccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc--C-------
Q 001103 1033 RIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--T------- 1102 (1157)
Q Consensus 1033 kl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~--~------- 1102 (1157)
+... +....+-++.|.+|+|||.+.|. ..|+..+||||+||++.||++|.+.|++..+-+.+..|... .
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 9776 55566668899999999999974 57899999999999999999999999998877665555320 0
Q ss_pred ----------CCCCCC----------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 ----------LRPQIP----------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 ----------lrpeip----------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+.+-+ ..++..+.+|++.||+.||++|++-++++.+-.+
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 110101 1245678899999999999999999999998655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=388.63 Aligned_cols=260 Identities=37% Similarity=0.640 Sum_probs=227.2
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEECCc-eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGT-DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~kGt-~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
.+++....+..+++||+|-||.||+|+|+++ .||+|.++...+. .+.|.+|+++|++|+|++||++|+++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---------~~~f~~Ea~iMk~L~H~~lV~l~gV~ 270 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---------PEAFLREAQIMKKLRHEKLVKLYGVC 270 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---------hhHHHHHHHHHHhCcccCeEEEEEEE
Confidence 3455556677789999999999999999987 7999999875322 25678999999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhcc-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr-~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.. ++.+|||||||..|+|.++|+. .+..+...+.+.++.||++|++||+++++|||||-..||||+ ++..+||
T Consensus 271 ~~--~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----~~~~vKI 344 (468)
T KOG0197|consen 271 TK--QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----EDLVVKI 344 (468)
T ss_pred ec--CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec----cCceEEE
Confidence 88 4479999999999999999986 567799999999999999999999999999999999999999 7889999
Q ss_pred EecCCcccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1027 GDFGLSRIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
+|||+|+...+... ..+-.-...|.|||.+.- ..++.|+|||||||+||||+| |+.||.++...+++..+. .++
T Consensus 345 sDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~Gy 421 (468)
T KOG0197|consen 345 SDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGY 421 (468)
T ss_pred cccccccccCCCceeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccC
Confidence 99999996444332 233335667999999984 478999999999999999999 999999999998887774 667
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
+.+-|..||+++.+||..||..+|++|||++.+...|..+...
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 7788999999999999999999999999999999888877653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.77 Aligned_cols=255 Identities=20% Similarity=0.285 Sum_probs=208.7
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|++++.||+|+||.||++.+ .++.||||++.+..... ......+.+|++++++++|++|+++++.+.+ .+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKRILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-----hhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CC
Confidence 378899999999999999987 47889999987653211 1123457789999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
.+++||||+.+|+|..++... ...+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~----~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 899999999999998877543 34589999999999999999999999999999999999998 6778999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh--cCCCCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS--NTLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~--~~lrpeip~~ 1110 (1157)
.............||..|+|||++.+. .++.++|||||||++|+|++|+.||...........+.. ......++..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc
Confidence 865444444456799999999999854 578999999999999999999999987554322222211 1223346667
Q ss_pred CcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPS-----FTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~L 1143 (1157)
+++++.+||.+||+.||.+||+ +++++++.+..
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 8999999999999999999987 89999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=364.63 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=215.6
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++.+.||+|+||.||+|+++ ++.||||++++..... ......+.+|+.++++++||||+++++.+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 89 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-----MKQVQHVAQEKSILMELSHPFIVNMMCSFQD- 89 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-
Confidence 3468999999999999999999984 6779999998642211 1234678899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.+.+|+||||+.+++|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 90 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~Dfg 163 (329)
T PTZ00263 90 -ENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD----NKGHVKVTDFG 163 (329)
T ss_pred -CCEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC----CCCCEEEeecc
Confidence 568999999999999999987544 578889999999999999999999999999999999998 77899999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
++....... ...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.... ..++..
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~ 237 (329)
T PTZ00263 164 FAKKVPDRT--FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNW 237 (329)
T ss_pred CceEcCCCc--ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCC
Confidence 997654332 235799999999999864 46889999999999999999999999887777777766543 346777
Q ss_pred CcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPS-----FTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~ 1142 (1157)
+++.+++||.+||+.||.+||+ +++++++.+.
T Consensus 238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 8999999999999999999986 7999998765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=360.41 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=212.2
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||+|++. +..||||++++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--D 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--C
Confidence 37999999999999999999984 678999999865221 11234678889999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kL~Dfg~a 148 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLS 148 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEEEeCcCC
Confidence 68999999999999999996543 588999999999999999999999999999999999998 6789999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC----
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP---- 1108 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip---- 1108 (1157)
..... .....+||+.|+|||++.+. .++.++|||||||+||||++|+.||......+....+.........+
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc
Confidence 75443 23446799999999999865 67899999999999999999999999887766665554322111111
Q ss_pred --CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1109 --ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1109 --~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+++++.+||.+||+.+|.+||++++++++.+..
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 24689999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=392.07 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=228.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.-|+..+.||.|+.|.|-+|++ +|+..|||++.+..... +.....+.+|+-||+.|.|||++++|++|.+ +
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-----~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~ 84 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-----SSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--K 84 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc-----cccccchhhhhHHHHHhcCCCeeeeeeeecc--C
Confidence 3578889999999999999998 68899999998763221 2234678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+|+||++||.|.++|.++++ +++..+.++++||+.|+.|||..+|+||||||+|+|++ ..+.+||+|||+|
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd----~~~nIKIADFGMA 159 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD----VKNNIKIADFGMA 159 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh----cccCEeeecccee
Confidence 799999999999999999987765 78888999999999999999999999999999999999 6667999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
.+..+.....+-||+|.|+|||+++|.+|. +.++||||-|||||.||+|++||.+.+...++..+..+.+ ++|..++
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYd-G~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYD-GRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNIS 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCC-CCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCC
Confidence 988888887888999999999999998765 7899999999999999999999998888888877776655 5779999
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+++++||.+||..||++|.|+++|++|++...
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 99999999999999999999999999988654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=381.18 Aligned_cols=266 Identities=25% Similarity=0.400 Sum_probs=226.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCCh------hHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSS------EQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~------e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
..+|++++.||+|.||.|.+|+. .++.||||++.+..+..... ....-++++.+|+.+|++|.|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 46899999999999999999998 47779999998765433211 11112468899999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhcccccc-ccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~-L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+..+.....+|||+|||..|.+.+.= ..+. +.+.++++|+++++.||+|||.+|||||||||+|+|++ +.++|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~----~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS----SDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc----CCCcE
Confidence 99998889999999999999886553 2333 89999999999999999999999999999999999999 77999
Q ss_pred EEEecCCcccc------cCCcccCCCCCCCcccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 001103 1025 KVGDFGLSRIK------CNTLVSGGVRGTLPWMAPELLNGSN--NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096 (1157)
Q Consensus 1025 KLiDFGLAkl~------~~~~~sts~~GTp~YmAPEVL~G~~--~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~ 1096 (1157)
||+|||.+... .........+|||.|+|||.+.+.. ...+.+.|||||||+||.|+.|+.||-+....+++.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999998743 1112222367999999999987632 234678999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1097 ~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.|+...+..+....+.+.+++||++||.+||.+|.++.+|..|+|....
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9998888776666789999999999999999999999999999987654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=362.39 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=208.4
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLV 958 (1157)
+.||+|+||.||++++ .|+.||||++++..... ......+.+|+.++++++||||+++++.+.. ...+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA-----KDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEE
Confidence 3699999999999987 47789999998642211 2224567789999999999999999999887 5689999
Q ss_pred EEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-C
Q 001103 959 TEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC-N 1037 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~-~ 1037 (1157)
|||+.+++|..++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEeeCCCCcccccC
Confidence 9999999999888654 4588999999999999999999999999999999999998 67789999999987532 2
Q ss_pred CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHH
Q 001103 1038 TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRK 1117 (1157)
Q Consensus 1038 ~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrd 1117 (1157)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.... ..++..+++++++
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKS 224 (323)
T ss_pred CCcccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 2233456799999999999754 57899999999999999999999999887777666665443 3567789999999
Q ss_pred HHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1118 LMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1118 LIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
||.+||++||++|| ++.+++++.+.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h~~f 254 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence 99999999999999 89999998664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.97 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=205.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|+++++||+|+||+||+|+.+ +..||+|+++...... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKNLKHANIVTLHDIIHT-- 74 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-------cchhHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 468999999999999999999884 6779999987542111 12456789999999999999999999877
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....++||||+.+ +|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~DfG~ 149 (288)
T cd07871 75 ERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFGL 149 (288)
T ss_pred CCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 5689999999975 89888876666688999999999999999999999999999999999998 677899999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-------
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL------- 1103 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l------- 1103 (1157)
+...... .......|++.|+|||++.+. ..++.++|||||||++|+|++|++||.+....+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 8754322 223345689999999998753 3578999999999999999999999988766554443321100
Q ss_pred -------------CC--------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1104 -------------RP--------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1104 -------------rp--------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+ .....+++++++||.+||++||.+|||+++++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 00 011246788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=361.40 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=214.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|++. +..||||++++..... ......+.+|++++..++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-----RNQIAHVRAERDILADADSPWIVKLYYSFQD--E 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-----ccHHHHHHHHHHHHHhcCCCCccchhhheec--C
Confidence 37999999999999999999985 7889999998653221 1224668889999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~----~~~~~kL~Dfg~~ 148 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLADFGLC 148 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEeecCCCC
Confidence 6899999999999999999765 4689999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCCc------------------------------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC
Q 001103 1033 RIKCNTL------------------------------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082 (1157)
Q Consensus 1033 kl~~~~~------------------------------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG 1082 (1157)
....... ......||+.|+|||++.+. .++.++|||||||+||+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccC
Confidence 7543322 22345699999999999865 678999999999999999999
Q ss_pred CCCCCCCChhHHHHHhhh--cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCC-HHHHHHHHHHH
Q 001103 1083 EEPYANMHCGAIIGGILS--NTLRPQIPERCDPEWRKLMEECWSFNPAARPS-FTEITNRLRVM 1143 (1157)
Q Consensus 1083 k~PF~g~~~eeil~~Il~--~~lrpeip~~iSpeLrdLIkrCLqkDPskRPS-aeELLe~Lr~L 1143 (1157)
+.||...........+.. .....+....+++++.+||.+||. ||.+||+ +++++++.+.-
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~ 289 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence 999998887777666665 223222233469999999999997 9999999 99999987653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=385.91 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=219.9
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de 950 (1157)
-.+|.++++||.|+||.||+|+. .|..||||.|+++... ..+ -.-+||++.|++|+ |||||++.+++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s----~ee---~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS----WEE---CMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc----HHH---HHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 35789999999999999999987 4777999999876221 111 22368999999998 99999999999885
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.. .+|+|||||+. +|+++++..++.|++..++.|+.||++||+|+|++|+.||||||||||+. ....+||+|||
T Consensus 82 ~~-~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~----~~~~iKiaDFG 155 (538)
T KOG0661|consen 82 DR-ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS----GNDVIKIADFG 155 (538)
T ss_pred Cc-eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec----ccceeEecccc
Confidence 33 89999999976 99999999899999999999999999999999999999999999999998 57799999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC--------
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-------- 1102 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~-------- 1102 (1157)
+|+........+.++.|.+|+|||++... ..|+.++|+|++|||++|+.+-++.|++....+.+..|..-.
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 99988777777788999999999998765 568999999999999999999999999988877766664310
Q ss_pred ---------CCCCCC-----------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1103 ---------LRPQIP-----------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1103 ---------lrpeip-----------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+...+| ..+++++.+||.+||++||.+|||+.+.+++..+...
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 001111 2268899999999999999999999999998765543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=375.64 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=227.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
-+|++.+.||+|.||.|.++.. .|+.||||.+++.... .+...-.+.+|++||..|+||||+++|.+|.+ .
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-----deqDlvhIRREIeIMSsLNHPhII~IyEVFEN--k 125 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-----DEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--K 125 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-----cHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--C
Confidence 4788999999999999999976 5889999999886432 23335678999999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+.|||||..+|.|++++.+.+. +++..++.+++||+.|+.|||.++++|||||.+|||++ .++++||+|||++
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD----~N~NiKIADFGLS 200 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD----QNNNIKIADFGLS 200 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec----CCCCeeeeccchh
Confidence 689999999999999999987654 99999999999999999999999999999999999999 8889999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
-+........+|||+|.|.+||+++|.+|. +..+|.|||||+||.|+.|..||.+.+-..++.+|..+.++.+ .-+
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~-GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~P 276 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYK-GPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETP 276 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCC-CCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCC
Confidence 988888888889999999999999998765 7899999999999999999999999998888888887766532 235
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
....-||++||..+|++|.|+++|..++|.-
T Consensus 277 SdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 277 SDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred chHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 5788999999999999999999999999854
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=361.96 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=207.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+++.+ ++.||||++++.... .......+.+|+.+++.++||+|+++++.+.+ .
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDILVEADSLWVVKMFYSFQD--K 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 47899999999999999999884 678999999864221 12234677889999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++||+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~----~~~~vkL~DFGla 148 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLC 148 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCCEEEeeccCc
Confidence 68999999999999999987644 589999999999999999999999999999999999998 6779999999998
Q ss_pred ccccCCc------------------------------------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHH
Q 001103 1033 RIKCNTL------------------------------------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAM 1076 (1157)
Q Consensus 1033 kl~~~~~------------------------------------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVIL 1076 (1157)
+...... .....+||+.|+|||++.+. .++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil 226 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIM 226 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHH
Confidence 7432110 11245799999999999754 578999999999999
Q ss_pred HHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC--CCcHHHHHHHHHHhccCCC---CCCCHHHHHHHHHH
Q 001103 1077 WEIITGEEPYANMHCGAIIGGILSNTLRPQIPE--RCDPEWRKLMEECWSFNPA---ARPSFTEITNRLRV 1142 (1157)
Q Consensus 1077 YELLTGk~PF~g~~~eeil~~Il~~~lrpeip~--~iSpeLrdLIkrCLqkDPs---kRPSaeELLe~Lr~ 1142 (1157)
|||++|+.||.+....+....+........++. .+++++++||.+|+. +|. .||++++|+++.+.
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f 296 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF 296 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCC
Confidence 999999999998887777777765332223332 368999999999775 444 46899999998554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=373.81 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=223.8
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC--ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG--t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
..+....|++++.||+|.-|+||+++.++ ..+|+|++.+..+..+ ....+...|.+||+.++||.++.||..|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~r-----kKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASR-----KKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhh-----hHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 34555788999999999999999999977 4699999998865543 2356677899999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhcc-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr-~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+. ..+.|++||||+||+|..++++ .++.+++..++.++.+++.||+|||..|||+||||||||||. ++|+|.|
T Consensus 147 et--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr----edGHIML 220 (459)
T KOG0610|consen 147 ET--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR----EDGHIML 220 (459)
T ss_pred ec--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe----cCCcEEe
Confidence 88 6799999999999999988865 457899999999999999999999999999999999999998 8899999
Q ss_pred EecCCccccc------------------------------------C---------------------CcccCCCCCCCc
Q 001103 1027 GDFGLSRIKC------------------------------------N---------------------TLVSGGVRGTLP 1049 (1157)
Q Consensus 1027 iDFGLAkl~~------------------------------------~---------------------~~~sts~~GTp~ 1049 (1157)
+||.|+.... . ...+.+++||..
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 9999875200 0 012335789999
Q ss_pred ccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCC
Q 001103 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAA 1129 (1157)
Q Consensus 1050 YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPsk 1129 (1157)
|+|||++.|. ..+.++|||+|||+|||||.|..||.+....+.+..|+...+...-...++-.+++||+++|.+||.+
T Consensus 301 YlAPEvI~G~--GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 301 YLAPEVIRGE--GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred cccceeeecC--CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999976 45889999999999999999999999999999999999887766555578899999999999999999
Q ss_pred CCC----HHHHHHHHH
Q 001103 1130 RPS----FTEITNRLR 1141 (1157)
Q Consensus 1130 RPS----aeELLe~Lr 1141 (1157)
|.. +.+|-+|..
T Consensus 379 Rlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhccccchHHhhcCcc
Confidence 987 888877643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=361.73 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=210.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||++++. ++.||||++++.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQD--E 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--C
Confidence 47999999999999999999984 678999999864221 12234667889999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+.+|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~ 148 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLC 148 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEeecccc
Confidence 68999999999999999987644 589999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCCc---------------------------------------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHH
Q 001103 1033 RIKCNTL---------------------------------------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFG 1073 (1157)
Q Consensus 1033 kl~~~~~---------------------------------------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLG 1073 (1157)
....... .....+||+.|+|||++.+. .++.++||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG 226 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLG 226 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecch
Confidence 6432110 11124699999999998754 578999999999
Q ss_pred HHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC--CCcHHHHHHHHHHhccCCCCCCC---HHHHHHHHHH
Q 001103 1074 IAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE--RCDPEWRKLMEECWSFNPAARPS---FTEITNRLRV 1142 (1157)
Q Consensus 1074 VILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~--~iSpeLrdLIkrCLqkDPskRPS---aeELLe~Lr~ 1142 (1157)
|++|+|++|..||...........+........++. .+++++++||.+||. +|.+|++ +++++++.+.
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 999999999999998887776666654333333333 468999999999997 9999987 9999998765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.00 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=202.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|+. +++.||||+++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-------TPFTAIREASLLKGLKHANIVLLHDIIHT-- 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-------cchhHHHHHHHHhhCCCCCcCeEEEEEec--
Confidence 46899999999999999999998 47789999987542111 12356789999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....++||||+. ++|.+++.+....+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 149 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGL 149 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECCCCc
Confidence 568999999996 577777766656688999999999999999999999999999999999998 677899999999
Q ss_pred cccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhc---C----
Q 001103 1032 SRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSN---T---- 1102 (1157)
Q Consensus 1032 Akl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~---~---- 1102 (1157)
+..... ........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.... ..+..+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 875332 2223345689999999998754 35788999999999999999999999875432 222222110 0
Q ss_pred ---------CCC-----CCC---------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1103 ---------LRP-----QIP---------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1103 ---------lrp-----eip---------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+.+ ..+ ...++.+++||.+||++||++|||+.+++++.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 000 000 123567899999999999999999999999887643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=345.02 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=202.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+++++ +..||||+++..... ......+.+|+++++.++||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 72 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN------EEVKETTLRELKMLRTLKQENIVELKEAFRR--R 72 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc------ccchhhHHHHHHHHHhCCCccccchhhhEec--C
Confidence 36899999999999999999985 567999998764211 1224567889999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+++||||+.++.+..+. +....+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~----~~~~~kl~Dfg~~ 147 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFA 147 (287)
T ss_pred CEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccCc
Confidence 6899999999987775544 3344588999999999999999999999999999999999998 6779999999999
Q ss_pred ccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc--C------
Q 001103 1033 RIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--T------ 1102 (1157)
Q Consensus 1033 kl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~--~------ 1102 (1157)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||...........+... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 7643321 22345799999999999754 4788999999999999999999999876654433222110 0
Q ss_pred -----------CC-C----------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 -----------LR-P----------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 -----------lr-p----------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.. + .....++.++++||++||++||++|||+++++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 00 0 011236788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=379.24 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=220.3
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
......|+.+++||+|.||.||+|++ +|..||+|+++..... +.......||+.||++|+||||++|.++..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~------~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK------EGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC------CcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 34456789999999999999999998 5777999999875322 222456789999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
....+.+|||+|||+. +|.-++...+-.|++.++..++.||+.||+|||++||+|||||..||||+ .++.+||+|
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----n~G~LKiaD 261 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----NNGVLKIAD 261 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----CCCCEEecc
Confidence 8656789999999987 99999988777799999999999999999999999999999999999999 889999999
Q ss_pred cCCcccccCC--cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC----
Q 001103 1029 FGLSRIKCNT--LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT---- 1102 (1157)
Q Consensus 1029 FGLAkl~~~~--~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~---- 1102 (1157)
||||++.... ...+..+-|.+|.|||++.|. ..|+..+|+||+||||.||+.|++.|++....+.+..|...-
T Consensus 262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred ccceeeccCCCCcccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 9999964433 345667899999999999987 479999999999999999999999999999888777775310
Q ss_pred ---CC-CCCC-------------------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 ---LR-PQIP-------------------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 ---lr-peip-------------------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
++ ..+| ..+++...+|+..||..||.+|.|+.+.|+.-++
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 00 0111 2257778899999999999999999999986544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=351.37 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=210.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||.||++++. +..+|+|++.... .......+.+|++++++++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 34579999999999999999999985 6679999887531 12235678999999999999999999999887
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
.+.+++||||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----~~~~~kl~D 147 (331)
T cd06649 75 --DGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCD 147 (331)
T ss_pred --CCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc----CCCcEEEcc
Confidence 568999999999999999987543 488999999999999999999986 699999999999998 677899999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhh---------
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL--------- 1099 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il--------- 1099 (1157)
||++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 9998754332 23345799999999999864 57899999999999999999999997655433221110
Q ss_pred ------------------------------------hcCCCCCC-CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1100 ------------------------------------SNTLRPQI-PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1100 ------------------------------------~~~lrpei-p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
....++.. ...+++++++||.+||++||++|||+++|+++.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00011111 22467899999999999999999999999999887
Q ss_pred HHHH
Q 001103 1143 MSTA 1146 (1157)
Q Consensus 1143 Lk~a 1146 (1157)
....
T Consensus 305 ~~~~ 308 (331)
T cd06649 305 KRSE 308 (331)
T ss_pred hhcc
Confidence 6543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.21 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=202.0
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC--
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP-- 951 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~-- 951 (1157)
+|++.+.||+|+||.||+|++ .+..||||++...... ......+.+|+++++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 588999999999999999987 4678999998753111 111346789999999999999999999875432
Q ss_pred -CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 952 -GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 952 -~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
...+|+|||||. ++|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN----ADCKLKICDFG 148 (338)
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEccCc
Confidence 235899999995 58888886544 488999999999999999999999999999999999998 77899999999
Q ss_pred CcccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh------
Q 001103 1031 LSRIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS------ 1100 (1157)
Q Consensus 1031 LAkl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~------ 1100 (1157)
+++..... .......||+.|+|||++.+....++.++|||||||++|+|++|++||.+......+..+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 98753221 12234579999999999875435678999999999999999999999987654332211110
Q ss_pred --------------------cCCCCC---CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1101 --------------------NTLRPQ---IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1101 --------------------~~lrpe---ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
...... ....+++.+.+||.+||+.||++|||+++++++.+...
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 000000 01236788999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=361.28 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=215.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC---ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG---TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG---t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||.||+|++++ ..||+|++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 455789999999999999999998742 46999998764221 1223456789999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ .+.+|+||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 102 ~--~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~ikL~D 174 (340)
T PTZ00426 102 D--ESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMTD 174 (340)
T ss_pred e--CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEec
Confidence 7 568999999999999999987544 588999999999999999999999999999999999998 678999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..... .++
T Consensus 175 FG~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p 248 (340)
T PTZ00426 175 FGFAKVVDTR--TYTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--YFP 248 (340)
T ss_pred CCCCeecCCC--cceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCC
Confidence 9999765332 2346799999999999754 568899999999999999999999998877766677665433 456
Q ss_pred CCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
..+++.++++|++||+.||.+|+ ++++++++.+.
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 77899999999999999999995 89999998764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=338.13 Aligned_cols=256 Identities=30% Similarity=0.557 Sum_probs=213.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+...+|++.+.||+|+||.||+|.++ +..||+|.++.... ......+.+|+.++++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------DKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 34568999999999999999999763 45699998875421 1223568899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.. ....++||||+++|+|.+++.+....+++..++.++.|++.||+|||++|++||||||+|||++ .++.+||
T Consensus 75 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----~~~~~~l 148 (266)
T cd05064 75 ITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKI 148 (266)
T ss_pred Eec--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----CCCcEEE
Confidence 877 5689999999999999999977656789999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccCCccc--CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1027 GDFGLSRIKCNTLVS--GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~s--ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
+|||.+......... ....++..|+|||.+.+. .++.++|||||||++|||++ |+.||........+..+... .
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~ 225 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-F 225 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-C
Confidence 999987653222211 123356789999998754 57899999999999999775 99999988777766665443 4
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
....+..++..+.+++.+||+.+|.+||++++|++.|..+
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 4456778899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=353.23 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=206.8
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 883 LGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
||+|+||.||++++. +..||+|++++.... .......+.+|+.++++++||||+++++++.. ...+|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEc
Confidence 799999999999984 667999998764221 12234667889999999999999999999877 568999999
Q ss_pred eecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC-Cc
Q 001103 961 YMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN-TL 1039 (1157)
Q Consensus 961 YmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~-~~ 1039 (1157)
|+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.... ..
T Consensus 74 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC----CCCcEEEEECcccccCccCCC
Confidence 999999999987644 588999999999999999999999999999999999998 677999999999875322 22
Q ss_pred ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 001103 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLM 1119 (1157)
Q Consensus 1040 ~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLI 1119 (1157)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... ..++..+++++++||
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 224 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--LRFPDGFDRDAKDLL 224 (312)
T ss_pred ccccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHH
Confidence 33456799999999999854 57899999999999999999999999887777777666443 356778999999999
Q ss_pred HHHhccCCCCCC---CHHHHHHHHHHH
Q 001103 1120 EECWSFNPAARP---SFTEITNRLRVM 1143 (1157)
Q Consensus 1120 krCLqkDPskRP---SaeELLe~Lr~L 1143 (1157)
.+||+.||.+|| ++.+++++.+.-
T Consensus 225 ~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred HHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 999999999997 578888886643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.34 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=206.1
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|++++.||+|+||+||+|++ .+..||||++.+..... ......+.+|+++++.++||||+++++++.+ ..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-----RNQVAHVKAERDILAEADNEWVVKLYYSFQD--KD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CC
Confidence 689999999999999999988 46679999998643221 2234678899999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++ ..+++||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~----~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID----LDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC----CCCCEEEeeCcCCc
Confidence 8999999999999999987644 488899999999999999999999999999999999998 67799999999975
Q ss_pred cccC------------------------------------------------CcccCCCCCCCcccCcccccCCCCCCCc
Q 001103 1034 IKCN------------------------------------------------TLVSGGVRGTLPWMAPELLNGSNNRVSE 1065 (1157)
Q Consensus 1034 l~~~------------------------------------------------~~~sts~~GTp~YmAPEVL~G~~~~yS~ 1065 (1157)
.... .......+||+.|+|||++.+. .++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~ 227 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQ 227 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCC
Confidence 3210 0011235799999999999754 5789
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--CCCcHHHHHHHHHHhc--cCCCCCCCHHHHHHHHH
Q 001103 1066 KVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--ERCDPEWRKLMEECWS--FNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1066 KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~~iSpeLrdLIkrCLq--kDPskRPSaeELLe~Lr 1141 (1157)
++|||||||+||||++|+.||...........+........++ ..+++++++||.+|+. .++..||++++++++.+
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 9999999999999999999998877666555554322222233 3578999999999664 45556999999999876
Q ss_pred H
Q 001103 1142 V 1142 (1157)
Q Consensus 1142 ~ 1142 (1157)
.
T Consensus 308 f 308 (381)
T cd05626 308 F 308 (381)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=380.50 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=218.7
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|....+||+|+.|.||.++. ++..||||++....... .+-+.+|+.+|+.++|+|||++++.|.. .
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--------keLilnEi~Vm~~~~H~NiVnfl~Sylv--~ 342 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--------KELLLNEILVMRDLHHPNIVNFLDSYLV--G 342 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--------hhhhHHHHHHHHhccchHHHHHHHHhcc--c
Confidence 4578889999999999999987 46679999998763221 3567899999999999999999999877 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|.|||||+||+|.+++.... +++.++..|+++++.||+|||.+||||||||.+|||++ .++.+||+|||+|
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~----~~g~vKltDFGFc 416 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT----MDGSVKLTDFGFC 416 (550)
T ss_pred ceeEEEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec----cCCcEEEeeeeee
Confidence 67999999999999999997544 89999999999999999999999999999999999999 7778999999999
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpeip~~ 1110 (1157)
....... ...+.+|||.|||||++.. ..|+.++||||||++++||+.|++||-..+....+..|..+ ......+..
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEK 494 (550)
T ss_pred eccccccCccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccc
Confidence 8755443 4556789999999999984 46899999999999999999999999988877777777655 445567888
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+|++|++|+.+||..|+.+|+++.+||+|...
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 99999999999999999999999999998654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=361.54 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=207.3
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||++++ .++.||||++.+.... .......+.+|+++++.++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-----KKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--A 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 3789999999999999999988 4678999998764211 12234678889999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+++|+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~----~~~~~kl~DfGla 148 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID----RGGHIKLSDFGLS 148 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEEeecccc
Confidence 6899999999999999998754 4588999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCCc------------------------------------------------ccCCCCCCCcccCcccccCCCCCCC
Q 001103 1033 RIKCNTL------------------------------------------------VSGGVRGTLPWMAPELLNGSNNRVS 1064 (1157)
Q Consensus 1033 kl~~~~~------------------------------------------------~sts~~GTp~YmAPEVL~G~~~~yS 1064 (1157)
+...... .....+||+.|+|||++.+. .++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~ 226 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCC
Confidence 5211100 00124699999999999754 578
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC--CCcHHHHHHHHHHhccCCCCC---CCHHHHHHH
Q 001103 1065 EKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE--RCDPEWRKLMEECWSFNPAAR---PSFTEITNR 1139 (1157)
Q Consensus 1065 ~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~--~iSpeLrdLIkrCLqkDPskR---PSaeELLe~ 1139 (1157)
.++|||||||+||||++|++||........+..+........++. .+++++++||.+||. +|.+| +++.+++++
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999999999999988777666666654332333333 478999999999998 66665 699999998
Q ss_pred HHH
Q 001103 1140 LRV 1142 (1157)
Q Consensus 1140 Lr~ 1142 (1157)
.+.
T Consensus 306 p~~ 308 (377)
T cd05629 306 PFF 308 (377)
T ss_pred CCc
Confidence 765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=354.51 Aligned_cols=247 Identities=25% Similarity=0.410 Sum_probs=207.8
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLV 958 (1157)
+.||+|+||.||+++. .|..||+|++++..... ......+.+|+++++.++||||+++++.+.. ...+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-----KDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEE
Confidence 3699999999999987 46789999998653211 2224567789999999999999999999987 5689999
Q ss_pred EEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC-
Q 001103 959 TEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN- 1037 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~- 1037 (1157)
|||+++++|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 74 ~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc----CCCCEEecccHHhccccCC
Confidence 9999999998888654 3588999999999999999999999999999999999998 677999999999875322
Q ss_pred CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHH
Q 001103 1038 TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRK 1117 (1157)
Q Consensus 1038 ~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrd 1117 (1157)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..... .++..+++++++
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~ 224 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKS 224 (323)
T ss_pred CCccccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 2223346799999999999754 578999999999999999999999988777776666654433 466788999999
Q ss_pred HHHHHhccCCCCCC-----CHHHHHHHHHHH
Q 001103 1118 LMEECWSFNPAARP-----SFTEITNRLRVM 1143 (1157)
Q Consensus 1118 LIkrCLqkDPskRP-----SaeELLe~Lr~L 1143 (1157)
||.+||+.||.+|+ ++.+++++.+..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~ 255 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence 99999999999998 899999986553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=356.08 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=207.2
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLV 958 (1157)
+.||+|+||.||+++. .+..||||++.+..... ......+.+|+++++.++||||+++++.+.. ...+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-----KDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEE
Confidence 3699999999999987 46789999998653221 1224567889999999999999999999887 5689999
Q ss_pred EEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC-
Q 001103 959 TEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN- 1037 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~- 1037 (1157)
|||+++|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~----~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD----KDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC----CCCcEEEecCcCCccCCCc
Confidence 9999999998888654 4588999999999999999999999999999999999998 677999999999875322
Q ss_pred CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHH
Q 001103 1038 TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRK 1117 (1157)
Q Consensus 1038 ~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrd 1117 (1157)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... ..++..+++++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKS 224 (328)
T ss_pred ccccccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHH
Confidence 2233446799999999999754 57899999999999999999999998877666666554332 3567789999999
Q ss_pred HHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1118 LMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1118 LIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
||.+||++||.+|+ ++.+++++.+.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 99999999999997 89999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.50 Aligned_cols=254 Identities=27% Similarity=0.363 Sum_probs=201.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC---CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC---CCCceeEEeeeee
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL---HHPNVVAFYGVVP 948 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k---Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L---~HPNIVkLygvf~ 948 (1157)
.+|++++.||+|+||+||+|++. +..||||+++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC------chHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 37899999999999999999873 56799999876422111 113345666666655 6999999999875
Q ss_pred c---CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 949 N---GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 949 d---e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
. .....+++||||+. ++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++ .++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~----~~~~~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc----CCCCE
Confidence 3 22457899999997 5888887653 34588999999999999999999999999999999999998 67799
Q ss_pred EEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1025 KVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
||+|||++.............||+.|+|||++.+. .++.++|||||||++|||++|++||.+......+..+......
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999999765544444556799999999998754 5788999999999999999999999988776666555432100
Q ss_pred C-------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1105 P-------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1105 p-------------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+ .+...+++.+++||.+||+.||++|||+.+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 0 011346788899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=361.36 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=207.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||.||+++.. ++.||||++.+.... .......+.+|+.+|+.++||||+++++.+.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-----MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--K 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 37999999999999999999884 677999998764221 11224667889999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|+||||+++|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+|
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~ikL~DFG~a 148 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLC 148 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC----CCCCEEEEeCCCC
Confidence 6899999999999999999754 3588899999999999999999999999999999999998 6779999999997
Q ss_pred ccccC--------------------------------------------CcccCCCCCCCcccCcccccCCCCCCCchhH
Q 001103 1033 RIKCN--------------------------------------------TLVSGGVRGTLPWMAPELLNGSNNRVSEKVD 1068 (1157)
Q Consensus 1033 kl~~~--------------------------------------------~~~sts~~GTp~YmAPEVL~G~~~~yS~KSD 1068 (1157)
..... .......+||+.|+|||++.+. .++.++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~D 226 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCD 226 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCccee
Confidence 42100 0011235799999999999754 5788999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCCCCCcHHHHHHHHHHhccCCCCCC---CHHHHHHHHHH
Q 001103 1069 VYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPERCDPEWRKLMEECWSFNPAARP---SFTEITNRLRV 1142 (1157)
Q Consensus 1069 IWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip~~iSpeLrdLIkrCLqkDPskRP---SaeELLe~Lr~ 1142 (1157)
||||||+||+|++|+.||......+....+....... .....+++++.+||.+|+ .+|.+|+ ++.+++++.+.
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~ 304 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence 9999999999999999999887666555554322222 223468899999999987 5999999 99999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.13 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=206.4
Q ss_pred CeeEEEEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 001103 876 DLEELQELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPN 949 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~d 949 (1157)
+|++++.||+|+||+||+++. .+..||+|++.+..... .....+.+.+|+.+++.+ +||+|+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh----hhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 588999999999999999876 36779999998643211 122345678899999999 59999999999877
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+.+++||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Df 149 (332)
T cd05614 77 --EAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD----SEGHVVLTDF 149 (332)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC----CCCCEEEeeC
Confidence 56899999999999999988654 3588999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccC--CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHhhhcCC
Q 001103 1030 GLSRIKCN--TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGGILSNTL 1103 (1157)
Q Consensus 1030 GLAkl~~~--~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~Il~~~l 1103 (1157)
|+++.... .......+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||..... ......+. ..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~ 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KC 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cC
Confidence 99875322 2223346799999999999754 3467899999999999999999999974322 22222232 23
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
.+.++..+++.+++||.+||+.||.+|| ++.+++++.|.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 270 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence 4456778899999999999999999999 88899998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=351.11 Aligned_cols=249 Identities=24% Similarity=0.429 Sum_probs=206.7
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHH---HhCCCCceeEEeeeeecCC
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII---SNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkIL---K~L~HPNIVkLygvf~de~ 951 (1157)
|++++.||+|+||.||+++++ ++.||||++++..... ....+.+.+|++++ +.++||||+++++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-- 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-----RDEVESLMCEKRIFETANSERHPFLVNLFACFQT-- 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--
Confidence 678999999999999999884 6779999998653211 11234556666554 56789999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+|+||||+.+++|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~----~~~~~kL~Dfg~ 147 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD----TEGFVKIADFGL 147 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCcEEeCcccC
Confidence 5689999999999999888754 3589999999999999999999999999999999999998 678999999999
Q ss_pred cccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1032 SRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1032 Akl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+..... .++..
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--~~p~~ 223 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRF 223 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCC
Confidence 874322 2223446799999999999754 578899999999999999999999998887777776655433 46677
Q ss_pred CcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
+++.+.+||.+||+.||.+|| ++.+++++.+.
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 899999999999999999999 68899887654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=341.28 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=203.6
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC------------------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHh
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR------------------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k------------------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~ 934 (1157)
...+|++.++||+|+||.||++.+. +..||+|++.... .......+.+|++++++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhh
Confidence 3468999999999999999999752 2359999887531 12235678899999999
Q ss_pred CCCCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc------------------ccccHHHHHHHHHHHHHHHHH
Q 001103 935 LHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD------------------RILDRRKKLMLMMDAAFGMEY 996 (1157)
Q Consensus 935 L~HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g------------------r~L~e~qVlkIa~QLa~ALeY 996 (1157)
++||||+++++++.+ ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|
T Consensus 76 l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 153 (304)
T cd05096 76 LKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153 (304)
T ss_pred cCCCCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999987 457899999999999998885421 236778899999999999999
Q ss_pred HHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHH
Q 001103 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFG 1073 (1157)
Q Consensus 997 LHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLG 1073 (1157)
||++||+||||||+|||++ ..+.+||+|||++....... ......++..|+|||++.+. .++.++||||||
T Consensus 154 lH~~~ivH~dlkp~Nill~----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG 227 (304)
T cd05096 154 LSSLNFVHRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFG 227 (304)
T ss_pred HHHCCccccCcchhheEEc----CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHH
Confidence 9999999999999999998 67899999999987543221 12234467889999998754 578999999999
Q ss_pred HHHHHHHc--CCCCCCCCChhHHHHHhhh------cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1074 IAMWEIIT--GEEPYANMHCGAIIGGILS------NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1074 VILYELLT--Gk~PF~g~~~eeil~~Il~------~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
|++|+|++ +..||........+..+.. .......+..+++.+.+||.+||+.||.+|||+.+|.+.|+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99999986 6788987766555443321 11112234567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=354.38 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=214.1
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||+||++++ .+..||||++++.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPWIPQLQYAFQD--K 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--C
Confidence 3789999999999999999988 4778999999865221 12234667889999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+++++|.+++.+....+++..++.++.|++.||+|||+++|+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~----~~~~~kL~Dfg~a 149 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSA 149 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC----CCCCEEeccCCCC
Confidence 689999999999999999987766799999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCCc--ccCCCCCCCcccCcccccCC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1033 RIKCNTL--VSGGVRGTLPWMAPELLNGS----NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1033 kl~~~~~--~sts~~GTp~YmAPEVL~G~----~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
....... ......||+.|+|||++... ...++.++|||||||++|+|++|+.||........+..+........
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 7643322 22335699999999998632 23578899999999999999999999998877777666654432222
Q ss_pred CC--CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1107 IP--ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1107 ip--~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
++ ..+++++++||..||+ +|.+||++.+++++.+..
T Consensus 230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~ 267 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS 267 (330)
T ss_pred CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence 33 3578999999999998 999999999999987643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=382.67 Aligned_cols=258 Identities=34% Similarity=0.625 Sum_probs=228.0
Q ss_pred ccccccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 868 GLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 868 ~i~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
..|+|..+.+..++-||+|+.|.||+|+.++..||||+++.- -.-+++-|++|+|||||.|.|+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEeeee
Confidence 455566666667788999999999999999999999976531 12467889999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.. ..++|||||||..|.|+++|+.. +.+.......+..+|+.|+.|||.++|||||||.-||||. .+..|||+
T Consensus 182 tq--sPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs----~~d~VKIs 254 (904)
T KOG4721|consen 182 TQ--SPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS----YDDVVKIS 254 (904)
T ss_pred cC--CceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee----ccceEEec
Confidence 88 45899999999999999999764 4577778888999999999999999999999999999999 55699999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
|||-++...+-.+...|+||..|||||+++. ...+.|+|||||||+|||||||..||...+...++..+-.+.+....
T Consensus 255 DFGTS~e~~~~STkMSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv 332 (904)
T KOG4721|consen 255 DFGTSKELSDKSTKMSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV 332 (904)
T ss_pred cccchHhhhhhhhhhhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC
Confidence 9999987666666677999999999999984 46799999999999999999999999999888888877777888889
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
|..++.-|+-||++||+-.|..|||+.+|+.||......+-.
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 999999999999999999999999999999999988776544
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=360.01 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=207.1
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|++++.||+|+||+||+|+. .+..||||++.+... ........+.+|+++++.++|||||++++.+.+ ..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CC
Confidence 689999999999999999988 466799999876421 112335678899999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+|+|||||++|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~----~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEeECCCCc
Confidence 899999999999999998764 3588999999999999999999999999999999999998 67899999999974
Q ss_pred cccC------------------------------------------------CcccCCCCCCCcccCcccccCCCCCCCc
Q 001103 1034 IKCN------------------------------------------------TLVSGGVRGTLPWMAPELLNGSNNRVSE 1065 (1157)
Q Consensus 1034 l~~~------------------------------------------------~~~sts~~GTp~YmAPEVL~G~~~~yS~ 1065 (1157)
.... .......+||+.|+|||++.+. .++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~ 227 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQ 227 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCC
Confidence 2110 0011235799999999999754 5789
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC--CCCCcHHHHHHHHHHhccCCCCCCC---HHHHHHHH
Q 001103 1066 KVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI--PERCDPEWRKLMEECWSFNPAARPS---FTEITNRL 1140 (1157)
Q Consensus 1066 KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei--p~~iSpeLrdLIkrCLqkDPskRPS---aeELLe~L 1140 (1157)
++|||||||+||||++|++||...........+........+ ...+++++.++|.+|+ .+|.+|++ +.+++++.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 306 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP 306 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence 999999999999999999999988776666555543322233 3457899999999987 49999987 99999986
Q ss_pred HH
Q 001103 1141 RV 1142 (1157)
Q Consensus 1141 r~ 1142 (1157)
+.
T Consensus 307 ~f 308 (382)
T cd05625 307 FF 308 (382)
T ss_pred Cc
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=378.49 Aligned_cols=271 Identities=32% Similarity=0.586 Sum_probs=228.2
Q ss_pred ccccccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 868 GLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 868 ~i~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
..|.|..+++.+...||+|.||+||+|+|.| .||||+++.... . .+..+.|.+|+..|++-+|.||+-+.|++
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p---t---~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP---T---PEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCC---C---HHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 3567777888999999999999999999987 589999987532 1 22468899999999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
..++ +.||..+|+|.+|+.+++.....|++.+.+.|+.|+++|+.|||.++|||||||..|||+. +++.|||+
T Consensus 458 ~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~----~~~kVkIg 530 (678)
T KOG0193|consen 458 MNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH----EDLKVKIG 530 (678)
T ss_pred cCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc----cCCcEEEe
Confidence 8853 4899999999999999988888899999999999999999999999999999999999998 66899999
Q ss_pred ecCCcccccCC---cccCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC
Q 001103 1028 DFGLSRIKCNT---LVSGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l 1103 (1157)
|||++.....- .-.....|...|||||+++. ...+|++.+||||||+++|||++|.+||.....+.++..+-.+.+
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l 610 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL 610 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc
Confidence 99998753211 11122458889999999864 356799999999999999999999999996666666655555544
Q ss_pred CCC---CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 001103 1104 RPQ---IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152 (1157)
Q Consensus 1104 rpe---ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesksR 1152 (1157)
.+. ....+++++++|+..||++++++||.+.+|+..|+.+...+.+..|
T Consensus 611 ~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R 662 (678)
T KOG0193|consen 611 MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR 662 (678)
T ss_pred CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence 443 3456788999999999999999999999999999988876655555
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.07 Aligned_cols=259 Identities=19% Similarity=0.307 Sum_probs=216.0
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+...+|++++.||+|+||.||+++++ +..||+|++.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK-----RSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 355678999999999999999999884 6779999997642211 112345778999999999999999999988
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~~kL~D 185 (370)
T cd05596 114 D--DKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (370)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----CCCCEEEEe
Confidence 7 56899999999999999988643 478888999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCCc--ccCCCCCCCcccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1029 FGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSN--NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1029 FGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~--~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
||++....... .....+||+.|+|||++.+.. ..++.++|||||||+||||++|+.||........+..+......
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc
Confidence 99987644322 233467999999999986532 34788999999999999999999999988877777777654433
Q ss_pred CCCCC--CCcHHHHHHHHHHhccCCCC--CCCHHHHHHHHHH
Q 001103 1105 PQIPE--RCDPEWRKLMEECWSFNPAA--RPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 peip~--~iSpeLrdLIkrCLqkDPsk--RPSaeELLe~Lr~ 1142 (1157)
..++. .++.++++||.+||+.+|.+ |+++++++++.+.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 34444 57999999999999999998 9999999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.46 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=208.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC-ceeEEeeeeecCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP-NVVAFYGVVPNGPG 952 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP-NIVkLygvf~de~~ 952 (1157)
+|++++.||+|+||.||+|+++ ++.||||++++..... ......+..|.+++..+.|+ +|+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-----DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--M 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--C
Confidence 5889999999999999999985 4579999998653211 12245677899999999765 58889888877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|+||||+++|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~~ 148 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMC 148 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc----CCCCEEEeecCcc
Confidence 68999999999999998886544 478899999999999999999999999999999999998 6778999999998
Q ss_pred cccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
.... ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+.... ..++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 224 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Confidence 7432 22233346799999999999864 57889999999999999999999999888777777776443 3567788
Q ss_pred cHHHHHHHHHHhccCCCCCCCH-----HHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSF-----TEITNRLRV 1142 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSa-----eELLe~Lr~ 1142 (1157)
++++.+||.+||.+||.+|++. .+++++.+.
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~ 260 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence 9999999999999999999976 788877543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=351.50 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=207.3
Q ss_pred EEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 881 QELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
+.||+|+||.||+++. .++.||||++++..... .......+.+|+.+++.++||||+++++++.. .+.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh----hhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeE
Confidence 6799999999999976 36679999998642211 11223567789999999999999999999987 5689
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
|+||||+.+++|.+++.+.+ .+.+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD----AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEeeCcCCeec
Confidence 99999999999999886544 477888889999999999999999999999999999998 6789999999998743
Q ss_pred c-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHH
Q 001103 1036 C-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114 (1157)
Q Consensus 1036 ~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpe 1114 (1157)
. .........||+.|+|||++.+. .++.++|||||||+||||++|+.||........+..+.... ..++..++++
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPE 226 (323)
T ss_pred ccCCCcccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 2 22233446799999999999754 46889999999999999999999999888777777666543 3567788999
Q ss_pred HHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1115 WRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1115 LrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
+++||.+||++||.+|| ++.+++++.+.
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~ 259 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence 99999999999999999 89999998764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.52 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=210.4
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|++.+.||+|+||+||++.+ +++.||||++...... .......+.+|+.+++.++||||+++++.+.+ ..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CC
Confidence 488999999999999999987 4778999998764221 11223557789999999999999999999877 45
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
.+++||||+.+++|..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++ +.+.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 899999999999999887553 34589999999999999999999999999999999999998 6789999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh--cCCCCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS--NTLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~--~~lrpeip~~ 1110 (1157)
.............|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.. ......++..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc
Confidence 765444333456799999999999754 578899999999999999999999987654332222211 1223345667
Q ss_pred CcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARP-----SFTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~Lk 1144 (1157)
+++.+++||.+||..||.+|| ++++++++.+...
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 899999999999999999999 9999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=336.60 Aligned_cols=253 Identities=37% Similarity=0.625 Sum_probs=211.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
..+|++++.||+|+||.||+|.+.+ ..||+|.++... .......+.+|+++++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 4578999999999999999998743 348999876431 12234678899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccc
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDN 1011 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPEN 1011 (1157)
+.. ....+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|
T Consensus 77 ~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N 154 (283)
T cd05048 77 CTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN 154 (283)
T ss_pred EcC--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence 876 567899999999999999886531 457888999999999999999999999999999999
Q ss_pred eeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 001103 1012 LLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYA 1087 (1157)
Q Consensus 1012 ILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~ 1087 (1157)
||++ .++.+||+|||++....... ......+++.|+|||.+.+. .++.++|||||||++|||++ |..||.
T Consensus 155 il~~----~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 155 CLVG----EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred EEEc----CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 9998 67789999999987543221 22334578899999998743 57899999999999999998 999999
Q ss_pred CCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1088 NMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1088 g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+....+....+... ..+..+..+++++.+|+.+||+.||.+||++.+|+++|+.
T Consensus 229 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 229 GFSNQEVIEMIRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCHHHHHHHHHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 88777766665543 3445677899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=358.92 Aligned_cols=260 Identities=30% Similarity=0.521 Sum_probs=213.4
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
+.+...+|++.+.||+|+||.||++++. +..||||+++.... ......+.+|+++++.+ +|||||
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------TDEREALMSELKILSHLGQHKNIV 105 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------HHHHHHHHHHHHHHHhhccCCcee
Confidence 3455678999999999999999998863 23599999875421 11246688999999999 899999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------------------------------------------
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------------------------------------- 975 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------------------------------------- 975 (1157)
++++.+.. ....++|||||.+|+|.+++.+..
T Consensus 106 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (374)
T cd05106 106 NLLGACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE 183 (374)
T ss_pred eEeeEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence 99999887 568999999999999998875321
Q ss_pred -----------------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 976 -----------------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 976 -----------------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++..+++++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~----~~~~~kL~DfGla 259 (374)
T cd05106 184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGLA 259 (374)
T ss_pred cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe----CCCeEEEeeceee
Confidence 2367888999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1033 RIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1033 kl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
+...... ......++..|+|||++.+. .++.++|||||||++|+|++ |+.||........+.........+..+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 337 (374)
T cd05106 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP 337 (374)
T ss_pred eeccCCcceeeccCCCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC
Confidence 7543322 11223356789999998743 57899999999999999997 999998876655555555555566667
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
...+++++++|.+||+.||.+|||+.++++.|+.+.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=367.18 Aligned_cols=254 Identities=20% Similarity=0.271 Sum_probs=203.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||+||+|.+ .+..||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 456899999999999999999988 46789999886431 2234799999999999999998876432
Q ss_pred ------CCCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCC
Q 001103 951 ------PGGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021 (1157)
Q Consensus 951 ------~~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~ 1021 (1157)
....+++||||+++ +|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++. ..
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~---~~ 207 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP---NT 207 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC---CC
Confidence 12357899999986 66665542 3456899999999999999999999999999999999999972 33
Q ss_pred CeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc
Q 001103 1022 PICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1022 g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~ 1101 (1157)
+.+||+|||+|+............||+.|+|||++.+. ..++.++|||||||+||||++|.+||.+....+.+..+...
T Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 47999999999865544444456789999999998754 35789999999999999999999999887655544443321
Q ss_pred C---------------------------CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1102 T---------------------------LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1102 ~---------------------------lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
. +...++...++++++||.+||++||.+|||+.+++++.+.-
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 0 01123445788999999999999999999999999998864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=348.43 Aligned_cols=250 Identities=21% Similarity=0.367 Sum_probs=208.8
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~ 952 (1157)
+|++++.||+|+||.||+++++ +..||||++++..... ......+..|..++..+ +|++|+++++++.. .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-----DDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--M 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--C
Confidence 5889999999999999999885 5579999998653211 12234566788888877 58999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kL~DfG~~ 148 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC----CCCcEEEccCCCc
Confidence 68999999999999998886544 488999999999999999999999999999999999998 7789999999998
Q ss_pred cccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
+... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..... .++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSM 224 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCcC
Confidence 7533 22233456799999999999854 578999999999999999999999998888877777765443 466778
Q ss_pred cHHHHHHHHHHhccCCCCCCCH-----HHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSF-----TEITNRLR 1141 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSa-----eELLe~Lr 1141 (1157)
++++.+||.+||++||.+|++. .+++++.+
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 259 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCC
Confidence 9999999999999999999974 77777643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.31 Aligned_cols=255 Identities=29% Similarity=0.454 Sum_probs=214.5
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|++.+.||+|++|.||++.. .+..||+|++...... .........+.+|++++++++||||+++++++.+ .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--C
Confidence 4688899999999999999987 4788999998754221 1122234678899999999999999999999987 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++++|||+++++|.+++... +.+++..++.++.|++.||.|||+.||+||||||+|||++ .++.++|+|||++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~----~~~~~~l~dfg~~ 151 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 151 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 5899999999999999988654 3478899999999999999999999999999999999998 6678999999998
Q ss_pred ccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1033 RIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1033 kl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
+....... .....|+..|+|||++.+. .++.++||||||+++|+|++|+.||...........+........++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 75432211 1235688999999999864 47899999999999999999999998877666666665555666788
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..++..+.+||.+||.++|.+|||+.+++++.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 889999999999999999999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.14 Aligned_cols=249 Identities=35% Similarity=0.612 Sum_probs=208.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..+|++++.||+|+||.||+++++. ..+|+|.+..... ....+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--Q 71 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---------cHHHHHHHHHHHHHCCCCCceeEEEEEcc--C
Confidence 3578999999999999999999854 4799998764311 12467889999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+++|+|.+++......+++..++.++.|++.||+|||+++|+||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~d~g~~ 147 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMT 147 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc----CCCeEEECCCCCc
Confidence 679999999999999999876545688999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1033 RIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1033 kl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
........ .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||........+..+.... +...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~ 224 (256)
T cd05114 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPK 224 (256)
T ss_pred cccCCCceeccCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCC
Confidence 75432221 2223456789999998754 57889999999999999999 999999887777766665443 334566
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
..+.++.+||.+||+.+|.+||+++++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 6788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.28 Aligned_cols=254 Identities=31% Similarity=0.581 Sum_probs=211.8
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
.+...+|+++++||+|+||.||+|... +..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---------hHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 355678999999999999999999874 56699998764311 13578899999999999999999999876
Q ss_pred CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
....+++|||+.+++|.+++.+. ...+++..++.++.|++.||+|||+++++||||||+|||++ ..+.+||+|
T Consensus 73 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~d 146 (261)
T cd05072 73 --EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIAD 146 (261)
T ss_pred --CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec----CCCcEEECC
Confidence 56789999999999999998653 45588889999999999999999999999999999999998 677899999
Q ss_pred cCCcccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...........+... .+.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~ 223 (261)
T cd05072 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRM 223 (261)
T ss_pred CccceecCCCceeccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 999976543221 2223467789999998754 57889999999999999998 99999887766666555433 344
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.....++.++.+||.+||..+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4556688999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=357.33 Aligned_cols=258 Identities=31% Similarity=0.510 Sum_probs=210.3
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeE
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVA 942 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVk 942 (1157)
.+...+|++.+.||+|+||.||+|++. +..||||+++.... ....+.+.+|+++++.+ +||||++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~il~~l~~HpnIv~ 103 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHINIVN 103 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------cHHHHHHHHHHHHHHHhcCCcceee
Confidence 344568999999999999999999752 34699999875321 11235678999999999 8999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhcccc-----------------------------------------------
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD----------------------------------------------- 975 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g----------------------------------------------- 975 (1157)
+++++.. ....++|||||++|+|.+++.+..
T Consensus 104 l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 104 LLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 9999977 567899999999999998885421
Q ss_pred ---------------------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 976 ---------------------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 976 ---------------------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
..+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~----~~~~~kl~D 257 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICD 257 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE----CCCcEEEec
Confidence 2467888999999999999999999999999999999998 667899999
Q ss_pred cCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1029 FGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1029 FGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
||++........ .....++..|+|||++.+. .++.++|||||||++|||++ |..||........+...+....+
T Consensus 258 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 335 (375)
T cd05104 258 FGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335 (375)
T ss_pred CccceeccCcccccccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc
Confidence 999875433221 1123356679999999754 57899999999999999998 99999887655555555555555
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
...+...+.++++||.+||+.||++|||+.+|++.|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 556667789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.27 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=206.2
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLV 958 (1157)
+.||+|+||.||++++ .+..||+|++++..... ......+.+|+++++.++||||+++++++.. ...+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEE
Confidence 3699999999999987 46789999998653211 1224567789999999999999999999887 5689999
Q ss_pred EEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 959 TEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
|||+++|+|..++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~----~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC----CCCCEEEecCCCCeecCC
Confidence 9999999998888654 458999999999999999999997 7999999999999998 677999999999875322
Q ss_pred -CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1038 -TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1038 -~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
........||+.|+|||++.+. .++.++|||||||+||+|++|+.||...........+.... ..++..+++++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 224 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAK 224 (325)
T ss_pred CCcccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 2223346799999999999754 57899999999999999999999998877766666654433 346777899999
Q ss_pred HHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
+||.+||+.||++|+ ++.+++++.+.
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence 999999999999996 99999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=352.93 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=203.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|+++++||+|+||+||++++. ++.||||++.... .......+.+|+++++.++|+||+++++++.. .
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--N 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--C
Confidence 46778899999999999999884 7789999986531 12335678899999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+++||||+.+++|.... ...+..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DfG~~ 215 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVS 215 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEcccccc
Confidence 6899999999999986543 245677888999999999999999999999999999998 6789999999999
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH---HHHHhhhcCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA---IIGGILSNTLRP 1105 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee---il~~Il~~~lrp 1105 (1157)
....... ......||..|+|||++... ....+.++|||||||+||||++|+.||....... ....+ ......
T Consensus 216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 294 (353)
T PLN00034 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPP 294 (353)
T ss_pred eecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCC
Confidence 7643322 22345799999999987431 1234568999999999999999999997433222 22222 223344
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
..+..+++++++||.+||+.||++|||+.+++++.+....
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 5566789999999999999999999999999999887664
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=363.14 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=228.3
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de 950 (1157)
...|++.+.||+|.||.||+++.+ |+.+|+|++.+....... ....+.+|+++|++|. |||||++++.|.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~- 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFED- 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEc-
Confidence 357888999999999999999884 777999999987544322 2467889999999998 9999999999998
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
...+++|||+|.||.|.+.+.+. .+++..+..++.|++.+++|||+.||+||||||+|+|+.......+.+|++|||
T Consensus 108 -~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 108 -PDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred -CCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 55899999999999999998766 399999999999999999999999999999999999998665445789999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIP 1108 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip 1108 (1157)
++............+||+.|+|||++.+. .|+..+|+||+|+++|.|++|.+||.+.........+....+.. ...
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence 99987776677788999999999999853 68999999999999999999999999999888888887775533 345
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..++..+++||+.||..||.+|+|+.++|+|+|.-
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 56899999999999999999999999999998743
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=376.37 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=218.9
Q ss_pred CCeeEEEEecccCcEEEEEEEECC--ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kG--t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|.+.+.||+|+||.||+|+.++ +.||+|.+.+.. ..+..++.+.+|++|++.|+|||||.++++|+. .
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g------r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~ 73 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG------RNEKELKNLRQEVRILRSLKHPNIVEMLESFET--S 73 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC------CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--c
Confidence 467888999999999999999864 459999998752 123346788999999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+|.||+.| +|..+|... +.++++.+..++.+++.||.|||+++|+|||+||.|||++ ..+++||||||+|
T Consensus 74 ~~~~vVte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~----~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 74 AHLWVVTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE----KGGTLKLCDFGLA 147 (808)
T ss_pred ceEEEEehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec----CCCceeechhhhh
Confidence 689999999988 999999754 4599999999999999999999999999999999999998 8899999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
+..... ...+...|||.|||||++.+. .|+..+|+||||||+|||+.|++||-...-..++..|...... .|...
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~ 223 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTA 223 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--Ccccc
Confidence 976543 345668899999999999865 6788999999999999999999999988877888888766554 45578
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+..+..|++.+|.+||.+|.+-.+++.|..
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 999999999999999999999999998754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=349.87 Aligned_cols=246 Identities=24% Similarity=0.408 Sum_probs=206.2
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||+++++ ++.||||++++..... ......+..|..+++.+ +||||+++++++.. ...+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-----DDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-----ccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEE
Confidence 36999999999999984 6779999998642211 12245667788888876 69999999999987 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+++|+|..++.+. +.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 74 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~----~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeeCCCCeecCc
Confidence 99999999999888654 3588999999999999999999999999999999999998 67799999999987532
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........+..+..... .++..++++++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLSQDAV 224 (320)
T ss_pred CCCcccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHH
Confidence 22233446799999999999754 578899999999999999999999998888777777765433 45667899999
Q ss_pred HHHHHHhccCCCCCCCH------HHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSF------TEITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSa------eELLe~Lr~ 1142 (1157)
+||.+||++||.+||++ ++++++.+.
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 225 DILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred HHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 99999999999999998 888887665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.47 Aligned_cols=246 Identities=24% Similarity=0.405 Sum_probs=206.7
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||.||+|+++ ++.||||++++..... ......+..|.++++.+ +||||+++++++.. .+.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-----DDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-----hhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEE
Confidence 36999999999999985 5679999998643211 12245567788888866 79999999999987 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+++++|...+.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 74 v~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~----~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 74 VMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeecccceeccc
Confidence 99999999999888654 3588999999999999999999999999999999999998 67899999999987532
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||........+..+..... .++..+++++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~ 224 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPVWLSKEAV 224 (321)
T ss_pred CCccccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 22233456799999999999754 578899999999999999999999999888887777765443 35667899999
Q ss_pred HHHHHHhccCCCCCC-------CHHHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARP-------SFTEITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRP-------SaeELLe~Lr~ 1142 (1157)
+||.+||++||.+|| ++.+++++.+.
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 999999999999999 89999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.65 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=208.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+++.+ +..||||++++.... .......+.+|+.++..++||+|+++++.+.+ .
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQD--K 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 37899999999999999999884 677999999764221 12234678889999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~----~~~~vkL~DfG~~ 148 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSDFGLC 148 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEeeccCC
Confidence 68999999999999999987544 588999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCC------------------------------------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHH
Q 001103 1033 RIKCNT------------------------------------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAM 1076 (1157)
Q Consensus 1033 kl~~~~------------------------------------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVIL 1076 (1157)
...... ......+||+.|+|||++.+. .++.++|||||||+|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil 226 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIM 226 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceecccccee
Confidence 643211 011235799999999999754 578899999999999
Q ss_pred HHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC--CCcHHHHHHHHHHhccCCCCCC---CHHHHHHHHHH
Q 001103 1077 WEIITGEEPYANMHCGAIIGGILSNTLRPQIPE--RCDPEWRKLMEECWSFNPAARP---SFTEITNRLRV 1142 (1157)
Q Consensus 1077 YELLTGk~PF~g~~~eeil~~Il~~~lrpeip~--~iSpeLrdLIkrCLqkDPskRP---SaeELLe~Lr~ 1142 (1157)
|||++|+.||...........+........++. .+++++++||.+|+. ||.+|+ ++.+++++.+.
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f 296 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF 296 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCC
Confidence 999999999998887777766654332223333 368999999999875 999997 58999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=357.78 Aligned_cols=259 Identities=20% Similarity=0.328 Sum_probs=214.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||.||++++. +..||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK-----RSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 45578999999999999999999984 6679999997642211 1123557789999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+||
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----~~~~~kL~DF 186 (370)
T cd05621 115 --DKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADF 186 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEEec
Confidence 56899999999999999998643 478899999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCc--ccCCCCCCCcccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1030 GLSRIKCNTL--VSGGVRGTLPWMAPELLNGSN--NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1030 GLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~--~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
|++....... .....+||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||........+..+.......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 9998653322 223567999999999987532 237889999999999999999999999888777777776654444
Q ss_pred CCCC--CCcHHHHHHHHHHhccCCCC--CCCHHHHHHHHHHH
Q 001103 1106 QIPE--RCDPEWRKLMEECWSFNPAA--RPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 eip~--~iSpeLrdLIkrCLqkDPsk--RPSaeELLe~Lr~L 1143 (1157)
.++. .+++.++++|..||+.++.+ |+++.+++++.|.-
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~ 308 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence 4444 46899999999999865544 89999999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.57 Aligned_cols=259 Identities=29% Similarity=0.565 Sum_probs=213.0
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCce----EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGTD----IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~----VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
.+...+|++++.||+|+||+||+|++ .+.. ||||+++... .....+.+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45667899999999999999999987 3333 8899876431 122346788899999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+++... ..++++||+.+|+|.+++.+....+++..++.++.|++.||+|||+++|+||||||+|||++ ..+.+
T Consensus 76 g~~~~~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~----~~~~~ 148 (316)
T cd05108 76 GICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK----TPQHV 148 (316)
T ss_pred EEEcCC---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec----CCCcE
Confidence 998763 46789999999999999987666788999999999999999999999999999999999998 66789
Q ss_pred EEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1025 KVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |+.||.+....... .+..
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~ 225 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE 225 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHh
Confidence 9999999986443221 1223356789999998754 57899999999999999998 99999877655543 3444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.......+..++.++.++|.+||..+|.+||++.+++..+..+...
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 4444555677889999999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.94 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=207.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|.++++||+|+||+||+++++ +..||+|+++...... ....+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 75 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIVHT-- 75 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-------cchhHHHHHHHHHhCCCCCcceEEEEEee--
Confidence 468999999999999999999884 6679999987542111 12346689999999999999999999887
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+..++||||+.+ +|..++...+..+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 150 (309)
T cd07872 76 DKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (309)
T ss_pred CCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcccc
Confidence 5689999999976 78887766666688999999999999999999999999999999999998 677899999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC--------
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-------- 1102 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~-------- 1102 (1157)
+...... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 8754322 222335689999999998753 357899999999999999999999998776554433332110
Q ss_pred -------------CCC-------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1103 -------------LRP-------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1103 -------------lrp-------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.+. .....+++++++||.+||+.||.+|||+.+++++.+.-...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 01124688999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.16 Aligned_cols=251 Identities=35% Similarity=0.643 Sum_probs=211.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
+...+|++.+.||+|+||.||++..++..+|+|.++... ..+.+.+|+.++++++|++++++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 71 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE- 71 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-
Confidence 455689999999999999999999999999999886431 135678999999999999999999976542
Q ss_pred CCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....+++|||+++++|.+++.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg 147 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFG 147 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----CCCcEEecCCc
Confidence 457899999999999999987643 3488999999999999999999999999999999999998 67799999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
++....... ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...........+. ....+..+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 222 (256)
T cd05082 148 LTKEASSTQ--DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPD 222 (256)
T ss_pred cceeccccC--CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCC
Confidence 987543322 223456789999998754 57889999999999999997 999998777666555553 334456677
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+++.+++||.+||+.+|++|||+.++++.|..
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.72 Aligned_cols=254 Identities=34% Similarity=0.651 Sum_probs=212.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++.+.||+|+||.||+|.++ ++.||+|++.... .....+.+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 44568999999999999999999884 6779999876431 113567889999999999999999999877
Q ss_pred CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
...++++|||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++ .++.+||+|
T Consensus 74 --~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~d 147 (263)
T cd05052 74 --EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVAD 147 (263)
T ss_pred --CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCcEEeCC
Confidence 56789999999999999988653 34588999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccCCccc--CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTLVS--GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~~s--ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
||++......... ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+....+. .....
T Consensus 148 f~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 224 (263)
T cd05052 148 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRM 224 (263)
T ss_pred CccccccccceeeccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCC
Confidence 9998765433221 122346689999998754 57889999999999999998 999998877666555543 34556
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+..+++++.++|.+||+.+|++||++.++++.|..+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 67788999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.77 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=201.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||++++ .|..||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc------chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 36899999999999999999987 467899999875421 1122456778999999999999999999986532
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
...+|+||||+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~----~~~~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 165 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEe
Confidence 1357999999976 55555532 378888999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC----
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL---- 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l---- 1103 (1157)
|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred cCCCccccccCccCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 99999765444444456799999999999864 578899999999999999999999987654332221111000
Q ss_pred ----------------CC--------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1104 ----------------RP--------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 ----------------rp--------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+ ......++++++||.+||..||++|||+.+++++.|..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00 01112467899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.66 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=209.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+++.. ++.||||++.+.... .....+.+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-----KRAETACFREERDVLVNGDRRWITNLHYAFQD--E 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--C
Confidence 47999999999999999999884 677999999753211 12234567889999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|+||||+.+|+|.+++.+....+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~ 149 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLADFGSC 149 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC----CCCCEEEEECCce
Confidence 689999999999999999977666789999999999999999999999999999999999998 6779999999998
Q ss_pred ccccCCc--ccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1033 RIKCNTL--VSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1033 kl~~~~~--~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
....... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||......+....+........+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 6543322 22234699999999998631 234688999999999999999999999887766666666543322222
Q ss_pred ---CCCCcHHHHHHHHHHhccCCCC--CCCHHHHHHHHHH
Q 001103 1108 ---PERCDPEWRKLMEECWSFNPAA--RPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 ---p~~iSpeLrdLIkrCLqkDPsk--RPSaeELLe~Lr~ 1142 (1157)
...+++++++||.+||..++.+ |+++++++++.+.
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 2347899999999999765444 7899999999765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.05 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=205.4
Q ss_pred EEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 881 QELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
+.||+|+||.||+++. .|+.||+|++++.... ......+.+|++++++++||||+++++++.. .+.+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------VRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEE
Confidence 6799999999999875 4678999999864221 1123456789999999999999999999987 5689
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
|+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++...
T Consensus 74 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----CCCcEEEeeccCCccc
Confidence 9999999999999988654 3589999999999999999999999999999999999998 6778999999998764
Q ss_pred cCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHH
Q 001103 1036 CNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114 (1157)
Q Consensus 1036 ~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpe 1114 (1157)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... ..++..+++.
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~ 224 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPE 224 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 433 233456799999999999754 56889999999999999999999999887777766665443 3467778999
Q ss_pred HHHHHHHHhccCCCCCCC-----HHHHHHHHHH
Q 001103 1115 WRKLMEECWSFNPAARPS-----FTEITNRLRV 1142 (1157)
Q Consensus 1115 LrdLIkrCLqkDPskRPS-----aeELLe~Lr~ 1142 (1157)
+++||.+||+.||.+||+ +.+++++.+.
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~ 257 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence 999999999999999999 6677776543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.76 Aligned_cols=259 Identities=20% Similarity=0.321 Sum_probs=213.0
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+...+|++++.||+|+||.||+++++ +..||+|++.+.... .......+.+|+.+++.++||||+++++.+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 345679999999999999999999984 667999998764221 1122355788999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----~~~~ikL~D 185 (371)
T cd05622 114 D--DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (371)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----CCCCEEEEe
Confidence 7 56899999999999999998653 478889999999999999999999999999999999998 678999999
Q ss_pred cCCcccccCCc--ccCCCCCCCcccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1029 FGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSN--NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1029 FGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~--~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
||++....... .....+||+.|+|||++.+.. ..++.++|||||||+||||++|+.||...........+......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 99997643322 233567999999999987532 23788999999999999999999999988877777777654333
Q ss_pred CCC--CCCCcHHHHHHHHHHhccCCCC--CCCHHHHHHHHHH
Q 001103 1105 PQI--PERCDPEWRKLMEECWSFNPAA--RPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 pei--p~~iSpeLrdLIkrCLqkDPsk--RPSaeELLe~Lr~ 1142 (1157)
..+ ...+++++++||..||..++.+ |+++++++++++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 333 3468999999999999854443 7899999998865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.41 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=217.0
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|..+++||+|.||.||+|++ +|+.||||+++.....+.- -....||+++|+.++|+||+.+.++|.. .
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi------~~talREIK~Lqel~h~nIi~LiD~F~~--~ 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI------NRTALREIKLLQELKHPNIIELIDVFPH--K 73 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc------cHHHHHHHHHHHHccCcchhhhhhhccC--C
Confidence 4688889999999999999998 5788999999976433221 2456799999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+.||+|||+. +|+.+++.....+...++..++.++++||+|||++.|+||||||.|+|++ .++.+||+|||+|
T Consensus 74 ~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis----~~g~lKiADFGLA 148 (318)
T KOG0659|consen 74 SNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS----SDGQLKIADFGLA 148 (318)
T ss_pred CceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc----CCCcEEeecccch
Confidence 689999999976 99999999999999999999999999999999999999999999999999 8889999999999
Q ss_pred ccccCCcc-cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC---CC-
Q 001103 1033 RIKCNTLV-SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP---QI- 1107 (1157)
Q Consensus 1033 kl~~~~~~-sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp---ei- 1107 (1157)
+....+.. .+..+-|.+|.|||.+.|. ..|+..+|+||+|||+.||+-|.+-|.+..+-+.+..|....-.| ++
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 97655433 3334789999999999987 478999999999999999999999999988777766664321111 11
Q ss_pred ----------------------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1108 ----------------------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1108 ----------------------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
-..++.++.+|+..||..||.+|.++.|.+++-.+-
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 112467788999999999999999999999987765
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.20 Aligned_cols=254 Identities=35% Similarity=0.615 Sum_probs=212.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
..+|++.+.||+|+||+||+|+++ ...||||+++... .......+.+|+.+++.++||||+++++.+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence 457899999999999999999884 2358999876531 1222456888999999999999999999987
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. .+..+++|||+++++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----~~~~~~l~d 149 (266)
T cd05033 76 K--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSD 149 (266)
T ss_pred c--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCCEEECc
Confidence 7 5678999999999999999977666789999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccC--Cc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1029 FGLSRIKCN--TL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1029 FGLAkl~~~--~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
||++..... .. ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+... ..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~ 226 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YR 226 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CC
Confidence 999986531 11 12223456789999998753 57889999999999999998 99999887766666655433 33
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
...+..+++.+.+|+.+||+.+|++||++.+++++|..+
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 445667899999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.22 Aligned_cols=251 Identities=33% Similarity=0.491 Sum_probs=203.4
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|++++.||+|+||+||+++.. +..||+|++.... ..........+|+.++++++||||+++++++.. ...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNY 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccc--ccc
Confidence 789999999999999999995 4469999998752 112223344569999999999999999999988 668
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
++++|||+.+++|.+++. ..+.+++..++.++.||+.||.|||+++|+|+||||+|||++ .++.++|+|||.+..
T Consensus 73 ~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~----~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD----ENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES----TTSEEEESSGTTTEE
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 999999999999999997 445589999999999999999999999999999999999999 788999999999875
Q ss_pred c-cCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHhhhcCCCCCC--C
Q 001103 1035 K-CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC---GAIIGGILSNTLRPQI--P 1108 (1157)
Q Consensus 1035 ~-~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~---eeil~~Il~~~lrpei--p 1108 (1157)
. ..........++..|+|||++.. ...++.++||||||+++|+|++|..||..... ...+............ .
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 2 33334445679999999999872 13578999999999999999999999998732 2233322222111111 1
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
...++.+.++|.+||+.||++||++.+++++.|
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 123489999999999999999999999998765
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=346.15 Aligned_cols=246 Identities=25% Similarity=0.455 Sum_probs=202.0
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHh-CCCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN-LHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~-L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||+|+++ +..||||++++..... ......+..|..++.. ++||||+++++++.. ...+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-----DDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEE
Confidence 36999999999999985 5569999998653211 1123445566667665 489999999999887 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
||||+++|+|..++.... .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD----KDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC----CCCCEEEccCcCCeECCC
Confidence 999999999998886544 589999999999999999999999999999999999998 677999999999975322
Q ss_pred -CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1038 -TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1038 -~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+... .+.++..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAK 224 (316)
T ss_pred CCCccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 2333456799999999999864 5789999999999999999999999988877776666533 3456778899999
Q ss_pred HHHHHHhccCCCCCCCHH-HHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSFT-EITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSae-ELLe~Lr~ 1142 (1157)
+||.+||+.||.+||++. +++++.+.
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIRQHPFF 251 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcCccc
Confidence 999999999999999865 77776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=357.30 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=222.4
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+...+|++..+||.|..++||+|+. ++..||||++..+. .....+.+.+|++.|+.++||||+++|..|.
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk-------c~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK-------CNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh-------hhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 35568999999999999999999988 57789999998642 1222678899999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. +..+|+||.||.+|++.++++.. ...+++..+..|++++++||.|||++|.||||||+.||||+ .+|.|||+
T Consensus 95 v--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~----~dG~VkLa 168 (516)
T KOG0582|consen 95 V--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID----SDGTVKLA 168 (516)
T ss_pred e--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc----CCCcEEEc
Confidence 8 56899999999999999999863 34599999999999999999999999999999999999999 88899999
Q ss_pred ecCCcccccCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1028 DFGLSRIKCNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1028 DFGLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
|||.+....... ....++||++|||||+++..-..|+.|+||||||++..||.+|..||......+++..-+.+.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 999876432211 125678999999999976666789999999999999999999999999999888776666554
Q ss_pred CCCCCC--------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1103 LRPQIP--------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1103 lrpeip--------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.+.... ...+..++++|..||.+||.+|||+.+++++-++-..
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 432211 2356789999999999999999999999998766543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=345.40 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=207.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++.++||+|+||.||+++++ +..+|+|++.... .......+.+|+++++.++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 44578999999999999999999985 6679999887531 12234678899999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
.+.+++||||+.+++|.+++.+.+ .+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----~~~~~kL~D 147 (333)
T cd06650 75 --DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 147 (333)
T ss_pred --CCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc----CCCCEEEee
Confidence 568999999999999999987543 488899999999999999999985 799999999999998 677899999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHh----------
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGI---------- 1098 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~I---------- 1098 (1157)
||++...... ......||..|+|||++.+. .++.++|+|||||++|+|++|+.||...........+
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9998754332 22345799999999999754 5788999999999999999999999764432221100
Q ss_pred ---------------------------------hhcCCCCCCC-CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1099 ---------------------------------LSNTLRPQIP-ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1099 ---------------------------------l~~~lrpeip-~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
......+.++ ...+.++++||.+||++||.+|||+.+++++.+.-.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 0011111111 235788999999999999999999999999887654
Q ss_pred H
Q 001103 1145 T 1145 (1157)
Q Consensus 1145 ~ 1145 (1157)
.
T Consensus 305 ~ 305 (333)
T cd06650 305 S 305 (333)
T ss_pred C
Confidence 3
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=325.33 Aligned_cols=257 Identities=21% Similarity=0.390 Sum_probs=210.5
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||+|++ .++.||||.++...... ......+.+|+++++.++||||+++++.+.+ .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-----AKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--D 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC-----HHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--C
Confidence 5799999999999999999987 57889999887532211 2234667889999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 GTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
+..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+|+||||+|||++ ..+.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----~~~~~~l~d~ 150 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc----CCCCEEECcc
Confidence 688999999999999988753 334578899999999999999999999999999999999998 6678999999
Q ss_pred CCcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--hHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC--GAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~--eeil~~Il~~~lrpe 1106 (1157)
|++....... ......|++.|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ......+.....++.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC
Confidence 9987643322 22335689999999998754 568899999999999999999999965432 334444433344444
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.....+..+++||.+||+.+|.+||++.++++.++.++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 44567889999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.20 Aligned_cols=253 Identities=27% Similarity=0.355 Sum_probs=198.7
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC---CCCceeEEeeeeecC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL---HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L---~HPNIVkLygvf~de 950 (1157)
+|++++.||+|+||+||+++++ ++.||+|.++........ ...+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 5889999999999999999884 677999998764221111 12344566666554 799999999987642
Q ss_pred ---CCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 951 ---PGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 951 ---~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
....++++|||+.+ +|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||
T Consensus 75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKL 149 (288)
T ss_pred cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEE
Confidence 23468999999985 888877653 34589999999999999999999999999999999999998 6778999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC----
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT---- 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~---- 1102 (1157)
+|||++.............||..|+|||++.+. .++.++|||||||++|+|++|++||........+..+....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 999999865544444456789999999999754 57899999999999999999999998776655444443210
Q ss_pred --------------CCC-------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 --------------LRP-------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 --------------lrp-------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+.. .+...++..+++||.+||++||.+|||+.+++.+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 000 111346788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=347.85 Aligned_cols=247 Identities=22% Similarity=0.371 Sum_probs=201.6
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||.||+++++ +..||||++++.... .......+.+|..+++.+ +||||+++++++.+ ...+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-----DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEE
Confidence 36999999999999984 677999999864221 122345678899999998 79999999999987 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+++|+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEECcCcccccccc
Confidence 99999999998888654 4589999999999999999999999999999999999998 67799999999987422
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------h-hHHHHHhhhcCCCCCC
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH--------C-GAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~--------~-eeil~~Il~~~lrpei 1107 (1157)
........+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.... . ......+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 224 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCC
Confidence 22233456799999999999864 57889999999999999999999996321 1 1122333322 3346
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCC------HHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPS------FTEITNRLRVM 1143 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPS------aeELLe~Lr~L 1143 (1157)
|..+++++.+||.+||+.||.+|++ +.+++++.|..
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~ 266 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 7788999999999999999999987 78999886653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.41 Aligned_cols=249 Identities=36% Similarity=0.614 Sum_probs=208.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEECCc-eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRGT-DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kGt-~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..+|++++.||+|+||+||++++++. .+|||.++.... ....+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--Q 71 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---------cHHHHHHHHHHHhcCCCCCeeeEEEEEcc--C
Confidence 46799999999999999999988654 599998875421 12457889999999999999999999876 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...+++|||+.+++|.+++......+++..++.++.|++.||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~d~g~~ 147 (256)
T cd05113 72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLS 147 (256)
T ss_pred CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCCEEECCCccc
Confidence 578999999999999999976555689999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1033 RIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1033 kl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
+....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...........+... .+...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (256)
T cd05113 148 RYVLDDEYTSSVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLYRPH 224 (256)
T ss_pred eecCCCceeecCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-CCCCCCC
Confidence 75433221 1223356789999999754 57889999999999999998 99999887766666665443 3344566
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
..+..+++++.+||..+|.+||++.+|++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 6789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.22 Aligned_cols=254 Identities=33% Similarity=0.578 Sum_probs=208.4
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
...+|++.+.||+|+||+||+|.+ .+..+|+|.++... .......+.+|+.++++++||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 346889999999999999999985 24569999887431 11224567889999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccc----------------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCcc
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARK----------------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCD 1010 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~----------------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPE 1010 (1157)
+.. ....|++|||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+
T Consensus 76 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 76 VTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred Eec--CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 877 55789999999999999988422 124788899999999999999999999999999999
Q ss_pred ceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 001103 1011 NLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPY 1086 (1157)
Q Consensus 1011 NILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF 1086 (1157)
|||++ ..+.+||+|||+++..... .......++..|+|||.+.+. .++.++|+|||||++|||++ |..||
T Consensus 154 nili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 154 NILIG----EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred eEEEc----CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 99998 6678999999999754322 122334567789999998754 57899999999999999998 99999
Q ss_pred CCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1087 ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1087 ~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+.....+...+... .....+..+++.++++|.+||+.||.+||++.+|+++|..
T Consensus 228 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 228 YGFSNQEVIEMVRKR-QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 887665555555433 3345677789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=345.67 Aligned_cols=246 Identities=24% Similarity=0.420 Sum_probs=202.7
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||.||+++++ |..||||++++..... ......+..|..++..+ +||+|+++++++.+ .+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-----DDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEE
Confidence 46999999999999984 6679999998653211 11234556777787754 89999999999987 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+.+++|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD----RDGHIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEeCccCCCeeccc
Confidence 99999999999888654 3588999999999999999999999999999999999998 67789999999987422
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... .+.++..++++++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESK 224 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 12223446799999999999854 5789999999999999999999999988777666666433 3456777899999
Q ss_pred HHHHHHhccCCCCCCCH-HHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSF-TEITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSa-eELLe~Lr~ 1142 (1157)
+||.+||+.||.+||++ ++++++.+.
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 99999999999999998 577766554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.66 Aligned_cols=246 Identities=22% Similarity=0.409 Sum_probs=206.1
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||+++++ +..||||++++..... ......+.+|..+++.+ +||||+++++++.. .+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-----DDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEE
Confidence 36999999999999984 5679999998653211 12245667888999888 79999999999887 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+.+++|..++.+.+ .+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD----SEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC----CCCcEEecccCCCeecCc
Confidence 999999999998886553 589999999999999999999999999999999999998 67799999999986532
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
........+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+..... .++..++++++
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--RYPRWLSKEAK 224 (318)
T ss_pred CCCcccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCHHHH
Confidence 22223345799999999999864 578899999999999999999999998877777666654433 45677899999
Q ss_pred HHHHHHhccCCCCCCCH-----HHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSF-----TEITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSa-----eELLe~Lr~ 1142 (1157)
+||.+||..||.+||++ .+++++.+.
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence 99999999999999999 999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=327.91 Aligned_cols=258 Identities=30% Similarity=0.556 Sum_probs=211.7
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCc----eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGT----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt----~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
++...+|++++.||+|+||+||+|++ ++. .||+|+++... .......+.+|+.+++.++||||++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 46678999999999999999999987 344 37999886531 122245688899999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+++... ..+++|||+++|+|.+++......+++..++.++.|++.||+|||+++|+||||||+|||++ ..+.+
T Consensus 76 ~~~~~~---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~----~~~~~ 148 (279)
T cd05109 76 GICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK----SPNHV 148 (279)
T ss_pred EEEcCC---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc----CCCcE
Confidence 998652 46789999999999999977666789999999999999999999999999999999999998 66789
Q ss_pred EEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1025 KVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
||+|||+++....... .....++..|+|||.+.+. .++.++|||||||+||||++ |..||...........+ .
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~ 225 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-E 225 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-H
Confidence 9999999976433221 1222356789999998754 57899999999999999998 99999877665554433 3
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.......+..++.++.++|.+||..||++||++.++++.|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 344445566789999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=345.64 Aligned_cols=246 Identities=25% Similarity=0.389 Sum_probs=201.6
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHH-HHHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH-IISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIk-ILK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||++++ .|+.||||++.+..... ......+.+|.. +++.++||||+++++.+.. ....|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-----KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEE
Confidence 3699999999999998 47789999997642211 111234445544 5688999999999999877 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
||||+.+++|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 74 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeccCCCccccc
Confidence 99999999999888654 4588999999999999999999999999999999999998 677999999999875322
Q ss_pred -CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1038 -TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1038 -~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..... .++..+++.+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSAR 224 (323)
T ss_pred CCCccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 2233446799999999999754 578899999999999999999999998877777776665433 35566899999
Q ss_pred HHHHHHhccCCCCCCCH----HHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSF----TEITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSa----eELLe~Lr~ 1142 (1157)
+||.+||+.||.+||++ .+++++.+.
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred HHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence 99999999999999987 577776553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.78 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=200.1
Q ss_pred ecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 883 LGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 883 LGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
||+|+||+||++++ +++.||+|++.+.... .......+..|+++++.++||||+++++++.. ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEe
Confidence 79999999999987 4678999998764221 11223567789999999999999999999877 567999999
Q ss_pred eecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 961 YMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 961 YmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
|+++|+|...+.. ....+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD----NDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeCccceecCC
Confidence 9999999877643 334589999999999999999999999999999999999998 677899999999875433
Q ss_pred C-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh----HHHHHhhhcCCCCCCCCCCc
Q 001103 1038 T-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG----AIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1038 ~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e----eil~~Il~~~lrpeip~~iS 1112 (1157)
. .......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...... .....+.. ....++..++
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 225 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN--DSVTYPDKFS 225 (280)
T ss_pred CCccccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc--cCCCCcccCC
Confidence 2 223345799999999999864 5788999999999999999999999865432 22222221 1234566789
Q ss_pred HHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARP-----SFTEITNRLRVM 1143 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRP-----SaeELLe~Lr~L 1143 (1157)
+.+++|+.+||+.||.+|| ++++++++.|.-
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~ 261 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence 9999999999999999999 889999987763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=328.58 Aligned_cols=254 Identities=33% Similarity=0.571 Sum_probs=207.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
+..++|++.+.||+|+||.||+|.+++ ..||||++.... . ......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~---~~~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----S---MRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----C---HHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 455789999999999999999998743 459999875431 1 11235688999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhcccc---------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVN 1015 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd 1015 (1157)
+++.. ....++||||+.+++|.+++.+.. ..+++..++.++.|++.||.|||+++++||||||+|||++
T Consensus 76 ~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~ 153 (277)
T cd05062 76 GVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEcC--CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc
Confidence 99876 567899999999999999886432 2356778899999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001103 1016 LRDPQRPICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHC 1091 (1157)
Q Consensus 1016 ~dd~e~g~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~ 1091 (1157)
.++.+||+|||++........ .....++..|+|||++.+. .++.++|||||||++|||++ |..||.....
T Consensus 154 ----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 154 ----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred ----CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 677899999999875332211 1123457789999998754 57899999999999999999 7999998877
Q ss_pred hHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1092 eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
......+..... ...+..++..+++||.+||+.+|.+|||+.++++.|+
T Consensus 228 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 228 EQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 766665554433 3456778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=325.06 Aligned_cols=253 Identities=35% Similarity=0.611 Sum_probs=211.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
+...+|++.+.||+|+||.||++.++ ++.||||.++.... ..+.+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------DPKDFLAEAQIMKKLRHPKLIQLYAVCTL- 72 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------cHHHHHHHHHHHHHCCCCCccceeEEEec-
Confidence 45568999999999999999999874 45699998875421 12557889999999999999999999877
Q ss_pred CCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+..+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 73 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~df 147 (261)
T cd05068 73 -EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADF 147 (261)
T ss_pred -CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc----CCCCEEECCc
Confidence 567899999999999999986543 5689999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCCccc--CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTLVS--GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~~s--ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|++......... .+...+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+......+..+... ....
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~ 224 (261)
T cd05068 148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMP 224 (261)
T ss_pred ceEEEccCCcccccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 998765432211 112234579999998754 57899999999999999999 99999988777666665433 3444
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=345.05 Aligned_cols=257 Identities=21% Similarity=0.331 Sum_probs=211.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+++++ +..+|+|++.+.... .......+.+|+.++..++|++|+++++.+.+ .
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-----KRAETACFREERDVLVNGDNQWITTLHYAFQD--E 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-----HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--C
Confidence 47899999999999999999985 556999998753211 12223557889999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+.+|+|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~----~~~~~kL~DfG~a 149 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADFGSC 149 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEeecchh
Confidence 689999999999999999987666789999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCC--cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1033 RIKCNT--LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1033 kl~~~~--~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
...... ......+||+.|+|||++.+. ...++.++|||||||+||||++|+.||........+..+.....+..+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC
Confidence 753322 122335799999999998631 235788999999999999999999999988877777777655433333
Q ss_pred C---CCCcHHHHHHHHHHhccCCCC--CCCHHHHHHHHHH
Q 001103 1108 P---ERCDPEWRKLMEECWSFNPAA--RPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p---~~iSpeLrdLIkrCLqkDPsk--RPSaeELLe~Lr~ 1142 (1157)
+ ..+++++++||.+||..++.+ |+++.+++++.+.
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f 269 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence 3 357999999999999765554 6899999999654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.95 Aligned_cols=253 Identities=34% Similarity=0.585 Sum_probs=210.3
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
...+|.+++.||+|+||.||+|++. +..||||+++... .....+.+.+|+++++.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-------CHHHHHHHHHHHHHHHhcCCCCchheee
Confidence 3457888999999999999999863 3569999886531 1123467889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhcccc-------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKD-------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNL 1012 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~g-------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENI 1012 (1157)
++.. ....+++|||+++++|.+++...+ ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 76 ~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 76 VCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred EEec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 9987 568999999999999999986432 3478889999999999999999999999999999999
Q ss_pred eeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 001103 1013 LVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYAN 1088 (1157)
Q Consensus 1013 LLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g 1088 (1157)
|++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++|||||||++|+|++ |+.||..
T Consensus 154 li~----~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 154 LVG----YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EEc----CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 998 67899999999987532221 12233467889999999754 57899999999999999998 9999988
Q ss_pred CChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1089 MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1089 ~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.........+..... ...+..++..+++||.+||+.||.+||++.++++.|.
T Consensus 228 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 228 LSNEEVIECITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 877777666654433 3456678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=366.99 Aligned_cols=256 Identities=25% Similarity=0.460 Sum_probs=226.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
+.|+.++++|+|+||.+++++++ ++.|++|.+.......+. .....+|+.+++++.|||||.+++.|.. +
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~------r~~A~~E~~lis~~~hP~iv~y~ds~~~--~ 75 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE------RRSAIQEMDLLSKLLHPNIVEYKDSFEE--D 75 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh------hHHHHHHHHHHHhccCCCeeeeccchhc--C
Confidence 57899999999999999988775 566999998876433321 2366789999999999999999999988 4
Q ss_pred Cc-EEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 953 GT-MATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 953 ~~-LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
++ ++|||+||+||+|.+.+++.. ..+++++++.++.||+.||.|||++.|+|||||+.|||++ .+..|||+|||
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt----k~~~VkLgDfG 151 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT----KDKKVKLGDFG 151 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc----ccCceeecchh
Confidence 45 999999999999999997754 7799999999999999999999999999999999999999 77788999999
Q ss_pred CcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
+|+...+.. ...+..||+.|++||++.+. +|..|+|||||||++|||++-+++|...+...++..|....+ .+++.
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-~Plp~ 228 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-SPLPS 228 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-CCCCc
Confidence 999887776 66678899999999999965 679999999999999999999999999999999888887664 56788
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
..+.+++.||+.||.++|..||++.+||.++..+..
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 899999999999999999999999999998555443
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=332.52 Aligned_cols=259 Identities=34% Similarity=0.564 Sum_probs=210.4
Q ss_pred CCeeEEEEecccCcEEEEEEEECC--c--eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRG--T--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPN 949 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kG--t--~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~d 949 (1157)
++|++.+.||+|+||.||+|.++. . .+++|.++... .....+.+.+|++++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 589999999999999999998743 2 36888776321 112245688999999999 79999999999877
Q ss_pred CCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLV 1014 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILL 1014 (1157)
.+..+++|||+++++|.+++.+.. ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 --RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred --CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 567899999999999999986432 347889999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhH
Q 001103 1015 NLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGA 1093 (1157)
Q Consensus 1015 d~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~ee 1093 (1157)
+ .++.+||+|||++..............+..|+|||++.+. .++.++|||||||++|||++ |..||.......
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 153 G----ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred C----CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 8 6778999999998643222122222335679999998754 57899999999999999997 999999887776
Q ss_pred HHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1094 IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1094 il~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
....+.. ......+..++..+++||.+||+.+|.+||+++++++.|..+....+.
T Consensus 227 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 227 LYEKLPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 6665543 334456677899999999999999999999999999999887765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=320.73 Aligned_cols=250 Identities=26% Similarity=0.469 Sum_probs=211.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||++.+ .+..|++|.+...... ......+.+|+++++.++||||+++++.+.+ .+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN------RREREEAIDEARVLAKLDSSYIIRYYESFLD--KG 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC------HHHHHHHHHHHHHHHhcCCCCeehheeeecc--CC
Confidence 578899999999999999988 4678999998754221 2234678899999999999999999999887 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~----~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe----CCCCEEEcccccc
Confidence 899999999999999998764 45689999999999999999999999999999999999998 6779999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
....... ......|++.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+.... .+.++..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMY 225 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccc
Confidence 7544322 23345689999999998754 46889999999999999999999998887666666655443 34456678
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
+++++++|.+||+.+|++||++.+++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.16 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=210.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+++++ ++.||+|++.+... ........+.+|..+++.++|++|+++++++.+ .
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQD--E 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 47999999999999999999884 56799999876321 112224567889999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+..|+||||+.+|+|.+++.+....+++..+..++.|++.||+|||++||+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~----~~~~~kl~DfG~a 149 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLADFGSC 149 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc----CCCCEEEEeccce
Confidence 689999999999999999987556789999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcc--cCCCCCCCcccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1033 RIKCNTLV--SGGVRGTLPWMAPELLNGSN---NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1033 kl~~~~~~--sts~~GTp~YmAPEVL~G~~---~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
........ ....+||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||........+..+.....+..+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC
Confidence 75433221 22356999999999986421 34688999999999999999999999988777777776654433333
Q ss_pred C---CCCcHHHHHHHHHHhccCCCC--CCCHHHHHHHHHH
Q 001103 1108 P---ERCDPEWRKLMEECWSFNPAA--RPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p---~~iSpeLrdLIkrCLqkDPsk--RPSaeELLe~Lr~ 1142 (1157)
+ ..+++++++||.+||..++.+ |+++++++++.+.
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f 269 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 269 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence 3 346899999999999876655 4789999988653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=359.60 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=208.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC---CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k---Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..|.+.+.||+|+||.||++... +..||+|.+... . ......+.+|+.+|+.++|||||++++++..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~------~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-- 136 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN------D--ERQAAYARSELHCLAACDHFGIVKHFDDFKS-- 136 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC------C--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--
Confidence 34899999999999999999873 456888866432 1 1223567789999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 952 GGTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
.+.+||||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++ ..+.+||+|
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~~kL~D 212 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGD 212 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC----CCCcEEEEe
Confidence 56899999999999999887542 34588999999999999999999999999999999999998 678999999
Q ss_pred cCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||........+..+......
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~- 289 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD- 289 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-
Confidence 99998643322 23456799999999999754 5789999999999999999999999988777777776655443
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
.++..+++++++||.+||..||++||++++++.+
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 4566789999999999999999999999999875
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.25 Aligned_cols=251 Identities=36% Similarity=0.676 Sum_probs=213.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
+...+|++.+.||+|+||.||++...++.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-- 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcC--
Confidence 4457899999999999999999999999999999875421 24678899999999999999999999887
Q ss_pred CCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~----~~~~~~l~d~g 147 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS----EDLVAKVSDFG 147 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe----CCCCEEEcccc
Confidence 567899999999999999987544 3689999999999999999999999999999999999998 67789999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
++........ ...++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+. .......+.
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 222 (256)
T cd05039 148 LAKEASQGQD--SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPE 222 (256)
T ss_pred cccccccccc--cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCcc
Confidence 9976533222 23356789999998743 57889999999999999997 999998877666555443 334455667
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+++++.+||.+||..+|.+|||++++++.|..
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.67 Aligned_cols=258 Identities=34% Similarity=0.581 Sum_probs=214.7
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
++..+|.+.+.||+|+||+||++... +..+|+|.+.... ......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------DNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 45678999999999999999999752 2348888876431 22356788999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhcccc------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKD------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNL 1012 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~g------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENI 1012 (1157)
+++.. ....+++|||+++++|.+++...+ ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 74 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEec--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 99877 568999999999999999886432 2489999999999999999999999999999999999
Q ss_pred eeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 001103 1013 LVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYAN 1088 (1157)
Q Consensus 1013 LLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g 1088 (1157)
|++ .++.+||+|||++....... ......++..|+|||.+.+. .++.++|+|||||++|+|++ |..||..
T Consensus 152 li~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 152 LVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred EEc----cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998 67899999999987543221 12223457789999998754 57899999999999999998 9999988
Q ss_pred CChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1089 MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1089 ~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
......+..+..... ...+..+++++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 226 ~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 226 LSNNEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 877777776665443 345567889999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.00 Aligned_cols=254 Identities=23% Similarity=0.291 Sum_probs=202.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||++.+ .+..||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 36899999999999999999987 467799999875421 1223466778999999999999999999886432
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
....|+||||+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~----~~~~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 161 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC----CCCCEEEe
Confidence 2357999999976 56565542 378888999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC----
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL---- 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l---- 1103 (1157)
|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred eCcccccCCCccccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999876555444556799999999999764 578999999999999999999999987664433322211000
Q ss_pred -------------------------C-----------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1104 -------------------------R-----------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 -------------------------r-----------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+ ...+...+.++++||.+||+.||++|||+.+++++.+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 0 001122356789999999999999999999999997663
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.03 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=227.7
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
..++|++.+.||+|.|+.|+++.+ .|+++|+|++....+..+. .+++.+|++|-+.|+|||||++++.+..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~------~e~l~rEarIC~~LqHP~IvrL~~ti~~- 81 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD------FQKLEREARICRKLQHPNIVRLHDSIQE- 81 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc------HHHHHHHHHHHHhcCCCcEeehhhhhcc-
Confidence 346788889999999999999876 5888999998877655442 4678899999999999999999999877
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.++.|||+|+|.|++|-.-+-+. ..+++..+-.++.||+.+|.|+|.+||||||+||+|+|+..++ ...-+||+|||
T Consensus 82 -~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-~~A~vKL~~FG 158 (355)
T KOG0033|consen 82 -ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-KGAAVKLADFG 158 (355)
T ss_pred -cceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-CCCceeecccc
Confidence 67999999999999996544332 4578888999999999999999999999999999999997554 56679999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC--CCCC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--PQIP 1108 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--peip 1108 (1157)
+|..........+++|||.|||||++.. .+|+..+|||+-|||||-||.|.+||.+.....++++|+.+.+. ++..
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence 9998888888889999999999999984 47899999999999999999999999999999999999887654 3345
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..++++.++||++||..||++|.|+.+.|+|.|...
T Consensus 237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 237 DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 678999999999999999999999999999988653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.29 Aligned_cols=249 Identities=37% Similarity=0.647 Sum_probs=207.9
Q ss_pred CCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..+|++.+.||+|+||.||++++++ ..+|+|++.+.... ...+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTK--Q 71 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcC--C
Confidence 3578899999999999999998854 46999988653211 2457789999999999999999999876 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~dfg~~ 147 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLA 147 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC----CCCcEEECCcccc
Confidence 688999999999999999976555789999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCccc--CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1033 RIKCNTLVS--GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1033 kl~~~~~~s--ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
+...+.... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||......+....+. ...+...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 224 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPK 224 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCC
Confidence 754432221 112244579999998754 57889999999999999999 899998777666665554 344455667
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
.+++++.+|+.+||..+|.+|||+.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 7899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=341.47 Aligned_cols=250 Identities=20% Similarity=0.351 Sum_probs=207.2
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~ 952 (1157)
+|++.+.||+|+||+||+++++ +..||||++++..... ....+.+..|..+++.+. |++|+++++++.+ .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-----DDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--V 73 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccCCCchhheeeEEec--C
Confidence 4788999999999999999884 6779999998642211 122356678888888885 5778889988877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+++|+|.+++.+.+ .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~----~~~~ikL~Dfg~~ 148 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeccccc
Confidence 68999999999999999886544 488999999999999999999999999999999999998 6778999999998
Q ss_pred ccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..... .++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--SYPKSL 224 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccC
Confidence 75322 2223446799999999999754 578899999999999999999999998888777777765443 466778
Q ss_pred cHHHHHHHHHHhccCCCCCCC-----HHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPS-----FTEITNRLR 1141 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr 1141 (1157)
++++.+|+.+||+++|.+|++ ..+++++.+
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAF 259 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcc
Confidence 999999999999999999997 466776643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.96 Aligned_cols=262 Identities=30% Similarity=0.510 Sum_probs=213.0
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
|.+...+|++++.||+|+||.||+|.+. ++.||+|+++.... ....+.+.+|+.+++++ +||||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------ASEYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------HHHHHHHHHHHHHHHhhccCcchh
Confidence 3455678999999999999999999753 35699998864311 11235677899999999 899999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------------------------------------------
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------------------------------------- 975 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------------------------------------- 975 (1157)
++++++... ...++++|||+.+++|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 75 NLLGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred heeeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 999988653 567899999999999998875321
Q ss_pred --------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc--
Q 001103 976 --------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL-- 1039 (1157)
Q Consensus 976 --------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~-- 1039 (1157)
..+++..+..++.|++.||+|||+++|+||||||+|||++ .++.+||+|||++.......
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~----~~~~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe----CCCcEEEeccccchhcccCcch
Confidence 2578899999999999999999999999999999999998 66789999999997543221
Q ss_pred -ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHH
Q 001103 1040 -VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRK 1117 (1157)
Q Consensus 1040 -~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrd 1117 (1157)
......++..|+|||++.+. .++.++|||||||+||||++ |..||.+....+.+...+........+...++++.+
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred hhccCCCCCccccCcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHH
Confidence 12223467789999998754 67899999999999999998 999998765545454455555555667778899999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1118 LMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1118 LIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
++.+||+.+|++||++.+++++|..+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=344.64 Aligned_cols=254 Identities=23% Similarity=0.291 Sum_probs=203.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc------CchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 36899999999999999999987 467799999875421 1122356778999999999999999999876432
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
...+|+||||+.+ +|...+.. .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC----CCCcEEEE
Confidence 2357999999976 66666642 377888999999999999999999999999999999998 67799999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC---
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--- 1104 (1157)
|||+++............||..|+|||++.+. .++.++|||||||+||+|++|+.||.+......+..++.....
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999876555444556799999999999864 5789999999999999999999999877655544433221000
Q ss_pred -------------------------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1105 -------------------------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1105 -------------------------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.......+.++++||.+||+.||.+|||+.+++++.|.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 001112346789999999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.85 Aligned_cols=245 Identities=38% Similarity=0.665 Sum_probs=209.8
Q ss_pred EEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 881 QELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
+.||+|+||.||++.+. +..||+|+++.... ......+.+|+++++.++|+||+++++++.. ....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-------EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc-------hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCce
Confidence 36999999999999885 66799999876421 1135678899999999999999999999887 6789
Q ss_pred EEEEEeecCCcchhhhccc--------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 956 ATVTEYMVNGSLRHVLARK--------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~--------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
+++|||+++++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----~~~~~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----CCCcEEEc
Confidence 9999999999999999775 46799999999999999999999999999999999999998 66899999
Q ss_pred ecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1028 DFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
|||.+...... .......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.. ..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~ 224 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GY 224 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC
Confidence 99999865432 223345688999999998754 57899999999999999999 6999998877766666654 44
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
....+..+++++.+++.+||+.+|.+|||+.+++++|.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 55667788999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.97 Aligned_cols=254 Identities=33% Similarity=0.591 Sum_probs=210.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
+...+|++.+.||+|+||.||++.+++ ..||+|.+.... .......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEEE
Confidence 455789999999999999999998743 459999876431 112235678899999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhcccc---------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVN 1015 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd 1015 (1157)
+++.. ....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++
T Consensus 76 ~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~ 153 (277)
T cd05032 76 GVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEcC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc
Confidence 99887 568899999999999999886422 2367888999999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001103 1016 LRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHC 1091 (1157)
Q Consensus 1016 ~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~ 1091 (1157)
.++.+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++ |+.||.....
T Consensus 154 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 154 ----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred ----CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 67899999999987543322 12234567899999998743 57889999999999999998 9999988777
Q ss_pred hHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1092 eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
......+. .......+..++.++.+||.+||+.+|.+|||+.++++.|.
T Consensus 228 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 228 EEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 76666665 33345567778999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=342.30 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=201.3
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHh-CCCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN-LHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~-L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||+|+++ +..||||++++..... +.....+..|..+++. ++||||+++++++.+ ...+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEE
Confidence 36999999999999985 5679999998653211 1113445667777776 489999999999987 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+++|+|..++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 74 v~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD----TDGHIKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEccCCcceECCC
Confidence 99999999999988654 3588899999999999999999999999999999999998 67789999999987432
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... +.++..++.+++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAK 224 (316)
T ss_pred CCCceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHH
Confidence 22223346799999999999754 57899999999999999999999999887776666654332 345667899999
Q ss_pred HHHHHHhccCCCCCCCHH-HHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSFT-EITNRLR 1141 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSae-ELLe~Lr 1141 (1157)
+||.+||+.||.+||++. +++++.+
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIRQHPF 250 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHHcCcc
Confidence 999999999999999996 7777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=327.19 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=204.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||.||+|++ .+..||+|++..... .....+.+|+.++++++||||+++++.+..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~- 77 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------DDFSLIQQEIFMVKECKHCNIVAYFGSYLS- 77 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------chHHHHHHHHHHHHhcCCCCeeeeeEEEEe-
Confidence 346899999999999999999997 467799999875311 112457789999999999999999999877
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++|+||||||+|||++ ..+.+||+|||
T Consensus 78 -~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg 151 (267)
T cd06646 78 -REKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFG 151 (267)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEECcCc
Confidence 56889999999999999988654 3588999999999999999999999999999999999998 67789999999
Q ss_pred CcccccCCc-ccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--
Q 001103 1031 LSRIKCNTL-VSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ-- 1106 (1157)
Q Consensus 1031 LAkl~~~~~-~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe-- 1106 (1157)
++....... ......|+..|+|||.+.+. ...++.++|+|||||++|+|++|+.||...........+....+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 987543222 22345689999999988532 23467899999999999999999999976554433333222222221
Q ss_pred -CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1107 -IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1107 -ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
....++..+++||.+||+.+|++||++++++++|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1234688999999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.88 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=212.5
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++++.||.|+||.||++.+ .+..+|+|++...... ....+.+.+|+++++.++||||+++++.+......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 588999999999999999987 4677999988754221 22246788899999999999999999988765567
Q ss_pred cEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHH-----HCCceeccCCccceeeccCCCCCCeEE
Q 001103 954 TMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLH-----MKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLH-----SkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
.++++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+|||++ ..+.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----~~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe----cCCCEE
Confidence 889999999999999998653 456899999999999999999999 88999999999999998 678999
Q ss_pred EEecCCcccccCCcc-cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1026 VGDFGLSRIKCNTLV-SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~-sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|+|||++........ .....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...........+... ..
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-KF 227 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-CC
Confidence 999999886544332 3345789999999998754 4788999999999999999999999987765555555443 33
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
+.++..++..+.+++.+||+.+|.+||++++|+++.
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 456778899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=325.03 Aligned_cols=251 Identities=33% Similarity=0.596 Sum_probs=212.2
Q ss_pred CCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.+|+++++||.|+||.||+|++. +..+|+|++..... .....+.+|+.+++.++||||+++++++.+ ..
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 75 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--------LKQQDFQKEVQALKRLRHKHLISLFAVCSV--GE 75 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--------hhHHHHHHHHHHHhcCCCcchhheeeeEec--CC
Confidence 57889999999999999999985 56799999875421 123567889999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++||||+++++|.+++.+. +..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~----~~~~~kl~d~g~~ 151 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLVCKVADFGLA 151 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc----CCceEEEccccch
Confidence 789999999999999999763 45689999999999999999999999999999999999998 6779999999998
Q ss_pred ccccCCcc-cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1033 RIKCNTLV-SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~-sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
........ .....++..|+|||.+.+. .++.++||||||+++|+|++ |+.||......+.+..+.. ..+...+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAK 228 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCC
Confidence 76433221 2233467789999998753 57889999999999999998 8999988877776666653 345566778
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++.+.++|.+||+.||.+|||+.+|++.|..
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 89999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.80 Aligned_cols=245 Identities=34% Similarity=0.619 Sum_probs=201.9
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLV 958 (1157)
+.||+|+||.||++++ .++.||+|.+.... .......+.+|+++++.++||||+++++++.. ....++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEE
Confidence 3699999999999988 57789999876431 12234678899999999999999999999877 5688999
Q ss_pred EEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCC
Q 001103 959 TEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT 1038 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~ 1038 (1157)
|||+.+++|.+++.+.+..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDG 147 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc----CCCcEEECccccCcccccc
Confidence 999999999999976666689999999999999999999999999999999999998 6678999999998754332
Q ss_pred ccc---CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHH
Q 001103 1039 LVS---GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114 (1157)
Q Consensus 1039 ~~s---ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpe 1114 (1157)
... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+. ...+...+..++..
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 224 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDA 224 (252)
T ss_pred cccccCCCCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHH
Confidence 111 111234569999998754 47889999999999999997 999998776655444443 33444567778999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1115 WRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1115 LrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+.+|+.+||+.+|.+|||+.++++.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.24 Aligned_cols=247 Identities=35% Similarity=0.646 Sum_probs=203.2
Q ss_pred eEEEEecccCcEEEEEEEEC------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 878 EELQELGSGTFGTVYRGKWR------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~k------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.+.+.||.|+||.||+|.++ +..|+||.++... .....+.+.+|++++++++||||+++++++..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-- 72 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-- 72 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeecccccccccccccccccccccc--
Confidence 46789999999999999997 5669999985421 12225788999999999999999999999985
Q ss_pred CCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.+.+++||||+++|+|.++|... ...+++..++.++.|++.||.|||+++|+|++|++.|||++ .++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~----~~~~~Kl~~f~ 148 (259)
T PF07714_consen 73 NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD----SNGQVKLSDFG 148 (259)
T ss_dssp SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE----TTTEEEEESTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 45699999999999999999876 56799999999999999999999999999999999999999 78899999999
Q ss_pred CcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1031 LSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1031 LAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
++...... .......+...|+|||.+.+. .++.++||||||+++|||++ |+.||...........+. ...+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-~~~~~~ 225 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-QGQRLP 225 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-TTEETT
T ss_pred cccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-ccccce
Confidence 99765221 122334577789999999754 47999999999999999999 789999988777777774 444456
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
.+..++..+.++|.+||..||.+|||+.+|++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 7778999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=342.36 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=199.4
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHH-HHHHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA-HIISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEI-kILK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||.||++++ .+..||+|++.+..... ......+.+|. .+++.++||||+++++.+.+ .+..|+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-----KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-----hhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEE
Confidence 3699999999999998 46779999998643211 11123444554 46788999999999999877 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
||||+++++|...+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEccCCCCccCCC
Confidence 99999999998887653 4578889999999999999999999999999999999998 677999999999875322
Q ss_pred -CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1038 -TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1038 -~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.... ..++...+.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAAC 224 (321)
T ss_pred CCCccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 2233446799999999999754 57889999999999999999999999887766666665443 356677889999
Q ss_pred HHHHHHhccCCCCCCCH----HHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSF----TEITNRLR 1141 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSa----eELLe~Lr 1141 (1157)
++|.+||++||.+||++ .+++++.+
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred HHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 99999999999999865 46666554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.74 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=198.7
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHH-HHHHHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWRE-AHIISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrE-IkILK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||++++. +..||+|++.+...... . ....+.+| ..+++.++||||+++++++.. .+.+|+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~----~-~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK----K-EEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh----h-HHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEE
Confidence 36999999999999984 56699999986422111 1 12233344 445788999999999999887 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+.+++|.+++.+.. .+.+..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~----~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEEccCCCCccccc
Confidence 999999999999887543 477888899999999999999999999999999999998 67799999999987532
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
........+||+.|+|||++.+. .++.++|||||||++|+|++|++||......+.+..+..... .++..+++.+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSAR 224 (325)
T ss_pred CCCCcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHH
Confidence 22233456799999999999864 578899999999999999999999998887777776655433 35567899999
Q ss_pred HHHHHHhccCCCCCCCHH----HHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSFT----EITNRLR 1141 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSae----ELLe~Lr 1141 (1157)
++|.+||+.||.+||++. +++++++
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred HHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 999999999999999876 5665543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.05 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=208.7
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|+..+.||+|+||+||++.+. ++.||+|++...... .......+.+|+++++.++|++|+++++.+.. ..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~ 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CC
Confidence 3678899999999999999884 678999998764221 11223557789999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++|||+.+++|..++... ...+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~----~~~~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC----CCCCEEEecCCcc
Confidence 899999999999998887653 34589999999999999999999999999999999999998 6678999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc--CCCCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--TLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~--~lrpeip~~ 1110 (1157)
.............|+..|+|||++.+. .++.++|+|||||++|+|++|..||...........+... .....++..
T Consensus 150 ~~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 150 VKIPEGESIRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227 (285)
T ss_pred eecCCCCcccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc
Confidence 754433333445799999999999754 5788999999999999999999999876654333333221 122345667
Q ss_pred CcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPS-----FTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~Lk 1144 (1157)
+++++.+|+..||+.||.+||+ +++++++.+.-.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 8899999999999999999999 889999866543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=360.77 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=213.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||+||++++ .++.||||++...... +.....+.+|+.++..++|+||++++..+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 46899999999999999999987 5788999998765221 222456788999999999999999988775422
Q ss_pred C------CcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 952 G------GTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 952 ~------~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
. ..+++||||+.+|+|.++++.. ...+++..++.++.|++.||.|||+++|+||||||+|||++ .++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~----~~~ 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----SNG 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe----CCC
Confidence 1 1478999999999999988642 35689999999999999999999999999999999999998 678
Q ss_pred eEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhh
Q 001103 1023 ICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il 1099 (1157)
.+||+|||+++..... ......+||+.|+|||++.+. .++.++|||||||+||||++|+.||........+..+.
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 9999999998754322 223346799999999999854 57899999999999999999999999888777777666
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1100 ~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..... .++..+++++++||.+||+.||.+||++.+++++.+
T Consensus 259 ~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 259 AGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 54443 467788999999999999999999999999998743
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.33 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=208.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||++++. +..+|+|.++.... ....+.+.+|+.+++.++||||+++++.+.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CC
Confidence 5889999999999999999884 67799999875321 1124567789999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhcc-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr-~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
.+|++|||+++++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+|||++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~----~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC----CCCcEEEcccCcc
Confidence 89999999999999988764 345588999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
....... ......|++.|+|||++.+. .++.++|+||||+++|+|++|+.||...........+..... ..++..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 224 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-KPLPSHY 224 (255)
T ss_pred eeecccccccccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-CCCCccc
Confidence 7543322 23345689999999998754 578899999999999999999999998776666665554433 3456778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
+..+++||.+||+.||.+||++.+++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.17 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=210.3
Q ss_pred CeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 876 DLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
+|++.+.||+|+||+||++.. .+..+|||.++..... ..........+.+|+++++.++|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCe
Confidence 577889999999999999987 5777999988754221 11223335678999999999999999999999987 578
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.+++|||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+|+|+||||+|||++ ..+.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC----CCCeEEeccchhhHh
Confidence 999999999999999997644 478999999999999999999999999999999999998 678999999999875
Q ss_pred ccC-------CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCC
Q 001103 1035 KCN-------TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQ 1106 (1157)
Q Consensus 1035 ~~~-------~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpe 1106 (1157)
... ........|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 321 1122345689999999999754 5688999999999999999999999876655444443332 34455
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
++..++.++.++|.+||+.+|.+||++.+++++.+
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 77788999999999999999999999999998653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.22 Aligned_cols=245 Identities=33% Similarity=0.586 Sum_probs=202.9
Q ss_pred EecccCcEEEEEEEE----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 882 ELGSGTFGTVYRGKW----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+||+|+||.||+|.+ .+..+|+|+++... ......+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEE
Confidence 589999999999976 35669999887541 112345778899999999999999999998754 35789
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
||||+.+++|.+++.+. +.+++..++.++.|++.||+|||++||+||||||.|||++ .++.+||+|||++.....
T Consensus 73 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~----~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc----CCCeEEECCCccccccCC
Confidence 99999999999998654 3588999999999999999999999999999999999998 677899999999875433
Q ss_pred Ccc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1038 TLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1038 ~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
... .....++..|+|||.+... .++.++|+|||||++|||++ |+.||...........+.. ...+..+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~ 224 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCP 224 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCC
Confidence 221 1122346789999998743 57889999999999999998 9999988776666655543 34456778899
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++.+||.+||+.||.+||++.+|...|..+
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=345.54 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=204.0
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC-
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG- 952 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~- 952 (1157)
+|++++.||+|+||+||++++ .++.||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 578899999999999999987 578899998864310 11124567899999999999999999999876321
Q ss_pred --CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 953 --GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 953 --~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
..+|+||||+. ++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC----CCCCEEecccc
Confidence 26899999997 4777777543 4589999999999999999999999999999999999998 67899999999
Q ss_pred CcccccCC--cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh--------
Q 001103 1031 LSRIKCNT--LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS-------- 1100 (1157)
Q Consensus 1031 LAkl~~~~--~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~-------- 1100 (1157)
++...... .......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+......+..+..
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99754322 222334689999999998864 3478899999999999999999999987765544433321
Q ss_pred ---------------cCCCC-------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1101 ---------------NTLRP-------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1101 ---------------~~lrp-------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
....+ .+....++++.+||.+||+.||.+|||+.+++++.+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 11111 123446889999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=330.58 Aligned_cols=246 Identities=21% Similarity=0.298 Sum_probs=196.1
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 883 LGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
||+|+||.||+++.+ |+.||+|++.+...... .....+..|++++++++||||+++++++.. ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-----SGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-----hhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEe
Confidence 799999999999874 77899999875422111 112345679999999999999999999877 568999999
Q ss_pred eecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc
Q 001103 961 YMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039 (1157)
Q Consensus 961 YmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~ 1039 (1157)
|+.+++|..++... ...+++..++.++.|++.||+|||++||+||||||+|||++ .++.++|+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc----CCCCEEEeeceeeeecCCCc
Confidence 99999998887543 34588899999999999999999999999999999999998 67789999999987654443
Q ss_pred ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh----HHHHHhhhcCCCCCCCCCCcHHH
Q 001103 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG----AIIGGILSNTLRPQIPERCDPEW 1115 (1157)
Q Consensus 1040 ~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e----eil~~Il~~~lrpeip~~iSpeL 1115 (1157)
......|+..|+|||++.+. .++.++|+|||||++|+|++|+.||...... ............. ....+++++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEES 226 (277)
T ss_pred eeeccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHH
Confidence 33445799999999999754 4789999999999999999999999765332 2222222222211 224578999
Q ss_pred HHHHHHHhccCCCCCCCHH----HHHHHHHH
Q 001103 1116 RKLMEECWSFNPAARPSFT----EITNRLRV 1142 (1157)
Q Consensus 1116 rdLIkrCLqkDPskRPSae----ELLe~Lr~ 1142 (1157)
++||.+||++||.+||++. +++.+.+.
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 9999999999999999994 45555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.20 Aligned_cols=255 Identities=21% Similarity=0.330 Sum_probs=208.1
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|++.+.||+|+||.||++.+. ++.||||.+.+..... ......+.+|+.+++.++|++|+++++.+.+ ..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-----hHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CC
Confidence 4778899999999999999884 6689999987643221 1223456789999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++ ..+.++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeccce
Confidence 899999999999999888543 34589999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---HHHHHhhhcCCCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---eil~~Il~~~lrpeip~ 1109 (1157)
.............|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+.. .....++.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSE 226 (285)
T ss_pred eecCCCccccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCc
Confidence 765443333445799999999999754 5789999999999999999999999865422 22222221 12234566
Q ss_pred CCcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPS-----FTEITNRLRVMS 1144 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~Lk 1144 (1157)
.+++++++||.+||+.||.+||| +++++++.+...
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 78899999999999999999999 999999888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.56 Aligned_cols=250 Identities=29% Similarity=0.480 Sum_probs=217.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
...|..++.||+|+||.||+|.+. ++.||+|++..... +..++.+.+|+.+|.+++++||.++|+.+..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-------~deIediqqei~~Ls~~~~~~it~yygsyl~-- 82 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-------EDEIEDIQQEISVLSQCDSPNITEYYGSYLK-- 82 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc-------chhhHHHHHHHHHHHhcCcchHHhhhhheee--
Confidence 456777899999999999999984 66799999987532 2336778899999999999999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
+..++++||||.||++.++|+.. ..+++..+..++++++.||.|||.++.+|||||+.|||+. ..+.+||+|||+
T Consensus 83 g~~LwiiMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s----~~g~vkl~DfgV 157 (467)
T KOG0201|consen 83 GTKLWIIMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS----ESGDVKLADFGV 157 (467)
T ss_pred cccHHHHHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe----ccCcEEEEecce
Confidence 67899999999999999999754 3458888888999999999999999999999999999998 668999999999
Q ss_pred cccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1032 SRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1032 Akl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
+....... ...+++|||.|||||++++. .|+.|+||||||++.+||++|.+||...+....+..|- ...+|.+...
T Consensus 158 a~ql~~~~~rr~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~ 234 (467)
T KOG0201|consen 158 AGQLTNTVKRRKTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGD 234 (467)
T ss_pred eeeeechhhccccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccc
Confidence 98765543 33678999999999999954 68999999999999999999999999998866555443 4455667778
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
+++.|++||..||.+||+.|||+.+|+++-
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 999999999999999999999999999973
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.60 Aligned_cols=254 Identities=31% Similarity=0.517 Sum_probs=207.3
Q ss_pred eeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 877 LEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
|++.+.||+|+||.||+|.+. +..||||+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 567889999999999999873 25599999875321 1222467889999999999999999999876532
Q ss_pred C----CcEEEEEEeecCCcchhhhccc-----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 952 G----GTMATVTEYMVNGSLRHVLARK-----DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 952 ~----~~LyLVMEYmeGGSL~dlLkr~-----gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
. ...+++|||+++++|..++... ...+++..++.++.|++.||.|||+++|+||||||+|||++ +++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~----~~~ 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR----EDM 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC----CCC
Confidence 2 2478999999999998887432 24588999999999999999999999999999999999998 677
Q ss_pred eEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHh
Q 001103 1023 ICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~I 1098 (1157)
.+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||......+.+..+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999875433221 1122356789999998643 57889999999999999999 99999888777776666
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1099 l~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
... .....+..+++++.++|.+||+.||.+||++.++++.|..+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 544 34456778899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.25 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=202.4
Q ss_pred eeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 877 LEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
|++++.||+|+||+||++.. .+..||+|+++.... ......+.+|++++++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 48899999999999988653 356799999875421 11245678899999999999999999988765
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....++++|||+.+++|.+++... .+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD----NDRLVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc----CCCcEEEeecc
Confidence 556789999999999999998653 489999999999999999999999999999999999998 66789999999
Q ss_pred CcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--------------
Q 001103 1031 LSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-------------- 1092 (1157)
Q Consensus 1031 LAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-------------- 1092 (1157)
++........ .....++..|+|||.+.+. .++.++||||||+++|+|++|..||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 9876443221 1123456779999998743 5788999999999999999999998643211
Q ss_pred HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1093 eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+............+..++.++++|+.+||+.+|++|||++++++.|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111112222333456678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=329.15 Aligned_cols=253 Identities=31% Similarity=0.547 Sum_probs=208.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
..+|+++++||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 346778899999999999999874 3569999987531 12235678899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccc---------------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccc
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARK---------------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDN 1011 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~---------------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPEN 1011 (1157)
+.. ....++++||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 77 ~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 77 VTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EcC--CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 877 45789999999999999887421 2347888899999999999999999999999999999
Q ss_pred eeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 001103 1012 LLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYA 1087 (1157)
Q Consensus 1012 ILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~ 1087 (1157)
||++ ..+.+||+|||+++...... ......+++.|+|||.+.+. .++.++|||||||++|||++ |..||.
T Consensus 155 il~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 155 VLVF----DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred eEec----CCCceEecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9998 66789999999987543221 12233467899999998743 57889999999999999998 899998
Q ss_pred CCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1088 NMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1088 g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+.........+..... ...+..++..+.+|+.+||+.+|.+||++++|+..|+.
T Consensus 229 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 229 GYSNQDVIEMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 8877777666655443 34677899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.13 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=209.6
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++++.||+|++|.||+++++ +..||+|++..... .....+.+.+|++++++++|||++++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 4889999999999999999874 56799999875421 122245678899999999999999999887542 45
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
.++++|||+++++|.+++... ...+++.+++.++.|++.||.|||++||+||||||+|||++ ..+.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~----~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe----cCCcEEEecccce
Confidence 689999999999999988753 45589999999999999999999999999999999999998 6779999999998
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
...... .......+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...........+..... +..+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDY 226 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCcccc
Confidence 754332 223345689999999998754 578899999999999999999999987776665555554433 3456778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
++++.+||.+||+.+|.+||++.+++++.+
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.31 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=205.9
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.++|+++++||+|+||.||+++++ +..||+|.++...... ....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-- 75 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIIHT-- 75 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-------chhHHHHHHHHHHhcCCCCcceEEEEEec--
Confidence 468999999999999999999884 6779999987542111 12346689999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+++||||+. ++|..++.+....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~dfg~ 150 (301)
T cd07873 76 EKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (301)
T ss_pred CCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----CCCcEEECcCcc
Confidence 568999999997 488888876666688999999999999999999999999999999999998 677899999999
Q ss_pred cccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-------
Q 001103 1032 SRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL------- 1103 (1157)
Q Consensus 1032 Akl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l------- 1103 (1157)
+....... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||......+.+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 151 ARAKSIPTKTYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229 (301)
T ss_pred hhccCCCCCcccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence 87543222 22334678999999998754 3578899999999999999999999987765544433221100
Q ss_pred ----------CCC-----------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1104 ----------RPQ-----------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 ----------rpe-----------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
... ....+++.+++||.+||+.||.+|||+++++++.|..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 000 1234688899999999999999999999999987764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.67 Aligned_cols=254 Identities=35% Similarity=0.613 Sum_probs=210.3
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--C---ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--G---TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--G---t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
..+|++.+.||+|+||.||+|++. + ..+|+|.++... . ......+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----T---EKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----C---HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999999873 2 258999876431 1 122467888999999999999999999987
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. .+..++||||+++++|.+++.+....+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~~~~~l~d 149 (267)
T cd05066 76 K--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVSD 149 (267)
T ss_pred c--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----CCCeEEeCC
Confidence 6 5688999999999999999987666689999999999999999999999999999999999998 677999999
Q ss_pred cCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1029 FGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1029 FGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
||++........ .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+....+... .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~ 226 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-Y 226 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-C
Confidence 999875433211 1122345689999999753 57899999999999999886 99999887766666655543 3
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+...+..+++.+.+++.+||+.+|.+||++.++++.|..+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 4455667899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.46 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=192.0
Q ss_pred EEEecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 880 LQELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
.++||+|+||+||+|+++ +..||+|++..... ...+.+|++++++++||||+++++++.......+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 468999999999999863 45699998875421 1346689999999999999999999876656789
Q ss_pred EEEEEeecCCcchhhhccc--------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 956 ATVTEYMVNGSLRHVLARK--------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~--------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
+++|||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+...+...+.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 999999865 777766421 23488999999999999999999999999999999999996444466789999
Q ss_pred ecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---------HH
Q 001103 1028 DFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---------AI 1094 (1157)
Q Consensus 1028 DFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---------ei 1094 (1157)
|||++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||...... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 999997643221 22346789999999998764 34788999999999999999999999754321 11
Q ss_pred HHHhhhcC-----------------------CC-------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHH
Q 001103 1095 IGGILSNT-----------------------LR-------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138 (1157)
Q Consensus 1095 l~~Il~~~-----------------------lr-------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe 1138 (1157)
+..+.... +. .......+.++.+||.+||++||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111000 00 0001123567889999999999999999999998
Q ss_pred HHH
Q 001103 1139 RLR 1141 (1157)
Q Consensus 1139 ~Lr 1141 (1157)
+.+
T Consensus 314 hp~ 316 (317)
T cd07868 314 DPY 316 (317)
T ss_pred CCC
Confidence 764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=343.47 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=199.2
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||.||+++++ ++.||+|++++..... ......+.+|+.++.++ +||||+++++++.. ...+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-----hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEE
Confidence 36999999999999884 5679999998753211 12245677888888877 89999999999987 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+++++|..++.+. +.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~----~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCCEEEeeCCccccccC
Confidence 99999999998887654 4589999999999999999999999999999999999998 67799999999987532
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------hhHHHHHhhhcCCCCCC
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH---------CGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~---------~eeil~~Il~~~lrpei 1107 (1157)
........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... .......+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 224 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCC
Confidence 22233446799999999999864 57889999999999999999999995311 11122223322 3356
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCC------HHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPS------FTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPS------aeELLe~Lr~ 1142 (1157)
|..++..+++||.+||+.||.+||+ +.+++++.+.
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 7788999999999999999999998 5788888654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.10 Aligned_cols=259 Identities=33% Similarity=0.573 Sum_probs=209.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--Cce--EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~--VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygv 946 (1157)
+...+|++.+.||+|+||.||+|+++ +.. +|+|.++... .......+.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 45678999999999999999999874 433 5666655321 122346788899999999 89999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccc
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDN 1011 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPEN 1011 (1157)
+.. .+..|+||||+++++|.+++.+.+ ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 77 CEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred ECC--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 877 568999999999999999986432 247889999999999999999999999999999999
Q ss_pred eeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001103 1012 LLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMH 1090 (1157)
Q Consensus 1012 ILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~ 1090 (1157)
||++ .++.+||+|||++.............++..|+|||.+.+. .++.++|||||||++|+|++ |.+||....
T Consensus 155 ili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 155 ILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEec----CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9998 6778999999998643221112222346779999998754 47889999999999999998 999998777
Q ss_pred hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1091 ~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
..+....+. .......+..+++++.+||.+||+.+|.+||++.+++..|..+...
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 229 CAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 666555443 3334445666889999999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.00 Aligned_cols=256 Identities=33% Similarity=0.557 Sum_probs=204.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
..+|++++.||+|+||+||+++. .+..||||++.... ....+.+.+|+++++.++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------AEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 35889999999999999999875 36679999876531 22246788999999999999999999987
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.......+++||||+++++|.+++.+....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----~~~~~~l~ 150 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----SENRVKIG 150 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC----CCCeEEEC
Confidence 65545678999999999999999976655689999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH----------
Q 001103 1028 DFGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA---------- 1093 (1157)
Q Consensus 1028 DFGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee---------- 1093 (1157)
|||++........ .....++..|+|||++.+. .++.++|||||||++|||++|..|+.......
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc
Confidence 9999885432211 1112244569999998754 57899999999999999999887764332110
Q ss_pred -----HHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1094 -----IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1094 -----il~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+..++........+..++.++.+||.+||+.+|++|||+.+|++.|..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01112223333445567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.78 Aligned_cols=258 Identities=26% Similarity=0.344 Sum_probs=218.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|+.+.+|++|+||.||+|+++ +..||+|+++...-... ..-.-+||+.+|.+++|||||.+-.+......
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G------FPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG------FPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC------CcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 57999999999999999999995 55699999987532111 12235789999999999999999999888777
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+. +|..++....++|...++..++.|++.||+|||.++|+||||||+|+|++ ..|.+||+|||+|
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~----~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS----HKGILKIADFGLA 224 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec----cCCcEEecccchh
Confidence 789999999987 99999988778899999999999999999999999999999999999999 8889999999999
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC---------
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT--------- 1102 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~--------- 1102 (1157)
+....+. ..+..+-|.+|.|||++.|. ..|+..+|+||+|||+.||+++++.|.+....+.+..|....
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 9876663 35567899999999999987 478999999999999999999999999988777766664311
Q ss_pred --------------------CCCCCCCC-CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1103 --------------------LRPQIPER-CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1103 --------------------lrpeip~~-iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
++..++.. +++.-.+|+..+|.+||.+|.|+++.|++-++.-
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 00111111 4577889999999999999999999999876644
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.46 Aligned_cols=252 Identities=33% Similarity=0.607 Sum_probs=209.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
+..++|+++++||+|+||.||++.+. +..+|+|.+...... ...+.+|+.++++++||+|+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 45568999999999999999999874 456999988754211 2457899999999999999999998754
Q ss_pred CCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++ .++.++|+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~----~~~~~~l~df 146 (260)
T cd05070 73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADF 146 (260)
T ss_pred --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe----CCceEEeCCc
Confidence 3578999999999999998653 34588999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|++........ .....++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||......+....+.. .....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 223 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMP 223 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 99975433221 1223456789999998743 57889999999999999999 9999988777666665543 34455
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+...+..+++||.+||..+|.+|||+.++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 677789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=324.56 Aligned_cols=256 Identities=30% Similarity=0.555 Sum_probs=207.4
Q ss_pred cCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
...+|++.+.||+|+||.||+|.+.+ ..||+|.+.... . ......+.+|+.+++.++|+||+++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~---~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----S---EQDESDFLMEALIMSKFNHQNIVRLIG 76 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----C---HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34679999999999999999998854 458888765431 1 122356888999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhcccc------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCC
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKD------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~g------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~ 1019 (1157)
++.+ ....++||||+.+++|.+++.+.. ..+++..++.++.||+.||+|||+++++||||||+|||++..+
T Consensus 77 ~~~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~- 153 (277)
T cd05036 77 VSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG- 153 (277)
T ss_pred EEcc--CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-
Confidence 8877 457789999999999999986543 2488999999999999999999999999999999999998332
Q ss_pred CCCeEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 001103 1020 QRPICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAII 1095 (1157)
Q Consensus 1020 e~g~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil 1095 (1157)
....+||+|||+++....... ......+..|+|||++.+. .++.++|||||||++|+|++ |..||.........
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~ 231 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 345799999999976432211 1122345679999998754 57999999999999999997 99999987766655
Q ss_pred HHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1096 GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1096 ~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+. ...+...+..++.++.+||.+||+.+|++|||+.+++++|.
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVT-GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 5443 33445567788999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.93 Aligned_cols=259 Identities=34% Similarity=0.555 Sum_probs=213.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
++..+|.+.+.||+|+||.||++++. +..+++|.++... ....+.+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------LAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------HHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 34568999999999999999999863 2348888876431 12235688999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCc
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKC 1009 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKP 1009 (1157)
+++.. ....++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 74 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 151 (291)
T cd05094 74 GVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT 151 (291)
T ss_pred EEEcc--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc
Confidence 99877 567899999999999999986432 3478899999999999999999999999999999
Q ss_pred cceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 001103 1010 DNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEP 1085 (1157)
Q Consensus 1010 ENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~P 1085 (1157)
+|||++ .++.+||+|||++....... ......++..|+|||.+.+. .++.++|||||||++|+|++ |+.|
T Consensus 152 ~Nil~~----~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 152 RNCLVG----ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred ceEEEc----cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999998 67799999999987543321 12234568889999998754 57889999999999999998 9999
Q ss_pred CCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1086 YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1086 F~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
|........+..+.... .+..+..++..+.+|+.+||+.+|.+||++.++++.|..+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 226 WFQLSNTEVIECITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred CCCCCHHHHHHHHhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 98877776666554433 33455667899999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.86 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=212.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIV 941 (1157)
+.+...+|++++.||+|+||.||+|++.+ ..||||+++.... ....+.+.+|+++++++. |||||
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-------SSEKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhcCCCCCee
Confidence 34556789999999999999999998732 3599999865311 122467889999999996 99999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------------------------------------------
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------------------------------------- 975 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------------------------------------- 975 (1157)
++++++.. ...+|||||||++|+|.+++.+..
T Consensus 105 ~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (400)
T cd05105 105 NLLGACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ 182 (400)
T ss_pred eEEEEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence 99999977 568999999999999988875421
Q ss_pred -------------------------------------------------ccccHHHHHHHHHHHHHHHHHHHHCCceecc
Q 001103 976 -------------------------------------------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFD 1006 (1157)
Q Consensus 976 -------------------------------------------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRD 1006 (1157)
+.+++..++.++.|++.||.|||+++|+|||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d 262 (400)
T cd05105 183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRD 262 (400)
T ss_pred ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 2367788899999999999999999999999
Q ss_pred CCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-C
Q 001103 1007 LKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-G 1082 (1157)
Q Consensus 1007 LKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-G 1082 (1157)
|||+|||++ ..+.+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|+|++ |
T Consensus 263 ikp~Nill~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g 336 (400)
T cd05105 263 LAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLG 336 (400)
T ss_pred CChHhEEEe----CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCC
Confidence 999999998 67789999999987543221 12234577889999998754 57899999999999999997 9
Q ss_pred CCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1083 k~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..||........+...+....++..+..+++++.+||.+||+.||++||++.+|.+.|..+.
T Consensus 337 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 337 GTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 99998766554444444455555667788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.02 Aligned_cols=258 Identities=30% Similarity=0.553 Sum_probs=212.6
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeE
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVA 942 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVk 942 (1157)
.+...+|++.+.||+|+||.||++.+.+ ..+|+|.+.... . ......+.+|+.+++++ +||||++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-----~--~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----T--EKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-----C--HHHHHHHHHHHHHHHhhcCCCCeee
Confidence 4556789999999999999999998742 458999887531 1 11245688999999999 8999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhcc---------------ccccccHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLAR---------------KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDL 1007 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr---------------~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDL 1007 (1157)
+++++.. .+.++++|||+.+++|..++.. ..+.+++..++.++.|++.||.|||+++|+||||
T Consensus 81 ~~~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 81 LLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred EEEEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 9999876 5679999999999999998853 2356889999999999999999999999999999
Q ss_pred CccceeeccCCCCCCeEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CC
Q 001103 1008 KCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GE 1083 (1157)
Q Consensus 1008 KPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk 1083 (1157)
||+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |.
T Consensus 159 kp~Nil~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 159 AARNVLVT----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred ceeeEEEc----CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCC
Confidence 99999998 677999999999976443221 1222356789999998754 57899999999999999997 99
Q ss_pred CCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1084 EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1084 ~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.||......+....+.. ......+..++..+.+|+.+||..||.+|||+.++++.|..+.
T Consensus 233 ~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 233 SPYPGIPVEELFKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99998777666655543 3444567778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.79 Aligned_cols=254 Identities=34% Similarity=0.582 Sum_probs=209.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
+...+|++.++||+|+||.||+|++.+ ..||+|+++.... ....+.+|+++++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---------CHHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 455689999999999999999998854 4699998875321 12467889999999999999999998744
Q ss_pred CCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...++||||+.+++|.+++.+. +..+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~----~~~~~~L~df 146 (262)
T cd05071 73 --EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADF 146 (262)
T ss_pred --CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc----CCCcEEeccC
Confidence 3578999999999999999753 34578899999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|++........ .....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...........+... ....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~ 223 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 223 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCC
Confidence 99875433221 1223467789999998744 57899999999999999999 89999887766666555433 3334
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+..+++.+.+||.+||+.+|++||++.++++.|+.+.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 56678999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.42 Aligned_cols=253 Identities=35% Similarity=0.623 Sum_probs=209.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--C---ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--G---TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--G---t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
.+|++.+.||+|+||.||+|+++ + ..||||+++... .......+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 57899999999999999999874 2 249999886531 12234678899999999999999999999876
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++||||+.+++|.+++....+.+++..++.++.|++.||.|||++|++||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----~~~~~kl~df 150 (269)
T cd05065 77 --SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDF 150 (269)
T ss_pred --CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----CCCcEEECCC
Confidence 5678999999999999999977666689999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCCcc----cCCC--CCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC
Q 001103 1030 GLSRIKCNTLV----SGGV--RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1030 GLAkl~~~~~~----sts~--~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~ 1102 (1157)
|++........ .... ..+..|+|||.+.+. .++.++|||||||++|||++ |..||...........+. ..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~ 227 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QD 227 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cC
Confidence 99875432211 1111 124579999998754 57899999999999999886 999998877766666554 33
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+...+..++..+.+++.+||+.+|.+||++++++..|..+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 44455667899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.51 Aligned_cols=261 Identities=29% Similarity=0.512 Sum_probs=212.5
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC---------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCce
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNV 940 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG---------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNI 940 (1157)
.+...+|.+.+.||+|+||.||++++.+ ..+|+|.++... . ......+.+|+.+++.+ +||||
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~---~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----T---EKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----C---hHHHHHHHHHHHHHHHhcCCCCE
Confidence 3445689999999999999999998632 359999887531 1 11245688899999999 79999
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
+++++++.. ....|+||||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++||
T Consensus 87 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 87 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred eeEEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999877 568899999999999999986532 347888999999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ .++.+||+|||++........ .....++..|+|||++.+. .++.++|+|||||++|+|++
T Consensus 165 dlkp~Nill~----~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 165 DLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred cccHHheEEc----CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcC
Confidence 9999999998 667899999999875432211 1112345689999998754 57899999999999999998
Q ss_pred CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1082 GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1082 Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
|..||...........+. .......+..++.++.+||.+||..+|.+|||+.++++.|..+....
T Consensus 239 g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 239 GGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CCCCCCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 899998776655555443 34445667778999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=360.53 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=228.4
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
-|...+.||+|.|.+|.++++ .|..||||++.+..+.. .....+.+|++.|+.++|||||++|.++.. ..
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~------~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QT 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT------LSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QT 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch------hhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cc
Confidence 466678899999999999987 79999999999875432 234678899999999999999999999877 66
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+|||+|+-++|+|.++|.++...+.+....+++.||+.|+.|+|+..+|||||||+||.+. ++.|.|||+|||++-
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF---EKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF---EKLGLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe---eecCceEeeeccccc
Confidence 89999999999999999999988899999999999999999999999999999999999987 477899999999998
Q ss_pred cccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcH
Q 001103 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113 (1157)
Q Consensus 1034 l~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSp 1113 (1157)
...+.....+.||+..|.|||++.|..|. .+++||||||||||.|++|++||+..+.-+.+-.|++-.+. +|..++.
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYD-APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--vPshvS~ 244 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYD-APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--VPSHVSK 244 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccC-CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--CchhhhH
Confidence 77777777789999999999999986443 46799999999999999999999999999999999877664 7888999
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1114 EWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1114 eLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+.++||..||..||.+|.|.++|...-|..
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq 274 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQ 274 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence 999999999999999999999999887653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=339.10 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=226.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
...++|++.+.||+|.||.||+|+.+ +-.||+|++.+..+ .......++.+|++|-..|+||||+++|++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-----~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-----LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-----HHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 34578999999999999999999985 44599999988642 223345789999999999999999999999998
Q ss_pred CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
....|+++||...|+|+..|... ...+++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||+|
T Consensus 94 --~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----~~~~lkiAd 167 (281)
T KOG0580|consen 94 --SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----SAGELKIAD 167 (281)
T ss_pred --cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----CCCCeeccC
Confidence 66899999999999999999743 34589999999999999999999999999999999999999 778999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
||.+.... .....+.|||..|.+||...+. .++..+|+|++|++.||++.|.+||......+.+++|..-.+ .+|
T Consensus 168 fGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--~~p 242 (281)
T KOG0580|consen 168 FGWSVHAP-SNKRKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--KFP 242 (281)
T ss_pred CCceeecC-CCCceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--cCC
Confidence 99997654 3444568999999999999865 568999999999999999999999999998899998876544 467
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..++...+++|.+||.++|.+|.+..++++++|...
T Consensus 243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 889999999999999999999999999999999765
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.01 Aligned_cols=253 Identities=31% Similarity=0.499 Sum_probs=203.0
Q ss_pred eEEEEecccCcEEEEEEEECCc----eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC--
Q 001103 878 EELQELGSGTFGTVYRGKWRGT----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP-- 951 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~kGt----~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~-- 951 (1157)
.+.+.||+|+||.||+|++... .+|+|.++.... .......+.+|+++++.++||||+++++.+....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 4568899999999999988532 489998765311 1222467889999999999999999998764321
Q ss_pred --CCcEEEEEEeecCCcchhhhcc-----ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 952 --GGTMATVTEYMVNGSLRHVLAR-----KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 952 --~~~LyLVMEYmeGGSL~dlLkr-----~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
....+++|||+.+|+|..++.. ....+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----ENMNV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----CCCCE
Confidence 2357899999999999887632 234588999999999999999999999999999999999998 67789
Q ss_pred EEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1025 KVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
||+|||+++....... .....+++.|+|||.+.+. .++.++|||||||++|+|++ |+.||...........+..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999886433221 1223467789999998753 57899999999999999999 8999988776666555544
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.. ....+..++..++++|.+||+.||.+|||+.+|++.|..+
T Consensus 230 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 33 3345667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.98 Aligned_cols=254 Identities=31% Similarity=0.545 Sum_probs=208.4
Q ss_pred CeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 876 DLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+|++.+.||+|+||.||+|+... ..+|+|.+..... ......+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-------SSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-------HHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47788999999999999998732 3488888765321 122467889999999999999999999987
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccc-----------------------cccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARK-----------------------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~-----------------------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
. .+..+++|||+.+++|.+++... ...+++..++.++.|++.||+|||+++|+||
T Consensus 74 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 Q--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred c--CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 7 56789999999999999887532 1347888999999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ +++.+||+|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++
T Consensus 152 dikp~nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 152 DLAARNVLVA----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred hhhhheEEEc----CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhc
Confidence 9999999998 67789999999987532221 12223467789999988654 57899999999999999998
Q ss_pred CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1082 GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1082 Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
|..||.+.........+ ........+..++.++.+||.+||+.+|.+||++.++++.|+.+..
T Consensus 226 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 226 GGNPYPGIAPERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 99999887766655544 3444555677889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=342.15 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=200.2
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHH-HHHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH-IISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIk-ILK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||++++ .|+.||||++.+..... ......+.+|.. +++.++||||+++++.+.. .+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-----RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEE
Confidence 3699999999999988 47789999997642211 112234455554 5778999999999999887 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+.+++|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 74 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~----~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD----SQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEeecCCcccCCC
Confidence 99999999998888654 4589999999999999999999999999999999999998 67799999999987532
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+..... .++...+..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 224 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAW 224 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHH
Confidence 22233456799999999999754 578899999999999999999999998877777776665433 34556889999
Q ss_pred HHHHHHhccCCCCCCCH----HHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSF----TEITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSa----eELLe~Lr~ 1142 (1157)
++|.+||+.+|.+||++ .+++++.+.
T Consensus 225 ~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 225 SILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred HHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 99999999999999977 467666443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.94 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=201.1
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC---CCCceeEEeeeeecCCCCcEEE
Q 001103 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL---HHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 883 LGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L---~HPNIVkLygvf~de~~~~LyL 957 (1157)
||+|+||+||+++++ +..||||++.+..... ......+..|..++..+ .||+|+++++.+.. ...+|+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-----KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-----hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEE
Confidence 799999999999884 7789999997642211 11234455677777665 69999999999987 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+.+|+|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 74 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD----ATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEecCCcCcCCCC
Confidence 99999999999888654 4589999999999999999999999999999999999998 67789999999987532
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
........+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+........ ...++++++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 226 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-KNVLSDEGR 226 (330)
T ss_pred CCCCccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-CccCCHHHH
Confidence 22233456799999999998753 3468899999999999999999999998877777666655443322 234789999
Q ss_pred HHHHHHhccCCCCCC----CHHHHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARP----SFTEITNRLRVM 1143 (1157)
Q Consensus 1117 dLIkrCLqkDPskRP----SaeELLe~Lr~L 1143 (1157)
+||.+||..||.+|| ++.+++++.+..
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 999999999999998 789999987653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.44 Aligned_cols=253 Identities=34% Similarity=0.595 Sum_probs=210.7
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
.+...+|+++++||+|+||.||+|.. .++.||+|.+..... ....+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---------SPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---------cHHHHHHHHHHHHhcCCcCeeeEEEEEcc
Confidence 35567899999999999999999987 467799998875421 12467889999999999999999998743
Q ss_pred CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
...+++|||+.+++|.+++... +..+++..++.++.|++.||+|||++|++||||||+||+++ .++.++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~d 145 (260)
T cd05067 73 ---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIAD 145 (260)
T ss_pred ---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc----CCCCEEEcc
Confidence 4689999999999999988653 45688999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |++||.+.........+. .....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05067 146 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRM 222 (260)
T ss_pred CcceeecCCCCcccccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCC
Confidence 99987544222 12234467789999998754 46889999999999999998 999998877666555543 34445
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+...+.++.++|.+||..+|++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 5677788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=349.16 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=196.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||.||++++ .++.||||+... ..+.+|++++++|+|||||++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 4556899999999999999999988 467799996432 345689999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++|||++. ++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+||
T Consensus 155 --~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----~~~~vkL~DF 226 (391)
T PHA03212 155 --NKFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCLGDF 226 (391)
T ss_pred --CCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----CCCCEEEEeC
Confidence 567899999995 5888887654 3588999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCC--cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-------hhHHHHHhhh
Q 001103 1030 GLSRIKCNT--LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-------CGAIIGGILS 1100 (1157)
Q Consensus 1030 GLAkl~~~~--~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-------~eeil~~Il~ 1100 (1157)
|++...... ......+||+.|+|||++.+. .++.++|||||||+||||++|+.||.... ....+..+..
T Consensus 227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 227 GAACFPVDINANKYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred CcccccccccccccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 999753221 223346799999999999754 57899999999999999999998875321 1111111111
Q ss_pred c--------------------------CCC-C-CCC-----CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1101 N--------------------------TLR-P-QIP-----ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1101 ~--------------------------~lr-p-eip-----~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
. ... + ..+ ..++.++.+||.+||++||.+|||+++++++.+..
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 0 000 0 000 12466899999999999999999999999998863
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=340.02 Aligned_cols=246 Identities=22% Similarity=0.370 Sum_probs=200.1
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||+++.. ++.||+|++++.... .......+.+|+.+++++ +||+|+++++++.. ...+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEE
Confidence 36999999999999884 567999999865221 122346678899999888 69999999999887 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC- 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~- 1036 (1157)
||||+++++|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD----ADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe----CCCCEEEeccccceeccC
Confidence 99999999998888654 3589999999999999999999999999999999999998 67789999999987532
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------hh-HHHHHhhhcCCCCCCCC
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH------CG-AIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~------~e-eil~~Il~~~lrpeip~ 1109 (1157)
........+||+.|+|||++.+. .++.++|||||||+||+|++|+.||.... .. .....+... +..++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~ 224 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPR 224 (327)
T ss_pred CCCceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCC
Confidence 22233456799999999999754 57899999999999999999999996421 11 222333322 345677
Q ss_pred CCcHHHHHHHHHHhccCCCCCCC------HHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPS------FTEITNRLRV 1142 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPS------aeELLe~Lr~ 1142 (1157)
.+++.+.++|.+||.+||.+|++ +.+++++.+.
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f 263 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence 88999999999999999999987 5688887543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.39 Aligned_cols=252 Identities=34% Similarity=0.599 Sum_probs=208.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
+...+|++.+.||+|+||.||++.+.+ ..+|+|++..... ....+.+|+++++.++|||++++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 445679999999999999999998854 4699998764311 12457789999999999999999998754
Q ss_pred CCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+++|||+.+++|.+++.+. ...+++..+..++.|++.||.|||++||+|+||||+|||++ +++.+||+||
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~----~~~~~~l~df 146 (260)
T cd05069 73 --EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIADF 146 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCeEEECCC
Confidence 3578999999999999998653 34578899999999999999999999999999999999998 6788999999
Q ss_pred CCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|++....... ......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.........+.. .....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~ 223 (260)
T cd05069 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMP 223 (260)
T ss_pred ccceEccCCcccccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 9997543322 11223467789999998753 57899999999999999999 9999998777666655543 34445
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+...+..+++||.+||.+||.+||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 667789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.89 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=210.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCC-ChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGR-SSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r-~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.|.+...||+|+||.||+|.+ .++.+|+|++........ ........+.+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 366778999999999999987 467899998876533222 22233455778899999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...+++|||+++++|.+++.+. +.+++..+..++.|++.||.|||++|++||||||+|||++ ..+.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~----~~~~~~l~dfg~~ 153 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGIS 153 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc----CCCCEEecccCCC
Confidence 6889999999999999999754 4588899999999999999999999999999999999998 7778999999998
Q ss_pred ccccCCc-------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1033 RIKCNTL-------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1033 kl~~~~~-------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
+...... ......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+.. ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~ 230 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASP 230 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCC
Confidence 7543211 11234588999999998754 568899999999999999999999987765555444433 4455
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
.++..++..++++|.+||+.||.+||++.+++++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 265 (267)
T cd06628 231 EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265 (267)
T ss_pred cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCC
Confidence 67778899999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=319.90 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=210.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++++ .+..||||++...... .........+.+|+++++++.||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 4789999999999999999987 4678999988643211 1112235678899999999999999999999877555
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++++|||+++++|.+++.+.. .+++..++.++.|++.||+|||+++|+|+||||+|||++ ..+.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD----SVGNVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----CCCCEEECcCccc
Confidence 67899999999999999987553 478888999999999999999999999999999999998 6778999999998
Q ss_pred ccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1033 RIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1033 kl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
...... .......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+......+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc
Confidence 753321 112235689999999998754 57889999999999999999999998776555555555444455667
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
...+..+.++|.+||. +|.+||++++++++.+
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 7788899999999995 9999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.54 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=206.2
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~ 951 (1157)
..|++.+.||+|+||.||+|++ .++.||+|++.... . ....+.+|+.+++++ +||||+++++.+....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----D-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----c-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 4677888999999999999988 46679999987541 1 124567899999998 7999999999986532
Q ss_pred ----CCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
...+|++|||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~----~~~~~~l 152 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKL 152 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC----CCCCEEE
Confidence 24689999999999999998763 35688999999999999999999999999999999999998 6778999
Q ss_pred EecCCcccccCC-cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1027 GDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
+|||++...... .......|+..|+|||++.+. ...++.++|+|||||++|+|++|+.||...........+....
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~ 232 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC
Confidence 999998754322 223346799999999998632 2357889999999999999999999998766554444443333
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+......++.++++||.+||..+|.+|||+.+++++.|
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 333344567899999999999999999999999998754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.56 Aligned_cols=262 Identities=29% Similarity=0.509 Sum_probs=210.7
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEE-------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKW-------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~-------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
|.+..++|++.+.||+|+||+||+|.+ .++.||||+++.... ......+.+|+.++.++ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv 74 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVV 74 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------hHHHHHHHHHHHHHHhccCCccHh
Confidence 345667899999999999999999975 256799999875311 11245688899999999 689999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------------------------------------------
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------------------------------------- 975 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------------------------------------- 975 (1157)
++++++... ...++++|||+++|+|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (343)
T cd05103 75 NLLGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV 153 (343)
T ss_pred hhcceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence 999987653 457899999999999998875421
Q ss_pred --------------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 976 --------------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 976 --------------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
..+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~----~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDI 229 (343)
T ss_pred CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc----CCCcEEEEeccccccc
Confidence 2367788899999999999999999999999999999998 6779999999998753
Q ss_pred cCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1036 CNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1036 ~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
.... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||........+............+...
T Consensus 230 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (343)
T cd05103 230 YKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 307 (343)
T ss_pred ccCcchhhcCCCCCCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCC
Confidence 2221 11223356789999998754 57899999999999999997 999998765444444444444455566678
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
++++.+++..||+.||.+|||+.+|+++|..+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.07 Aligned_cols=257 Identities=21% Similarity=0.423 Sum_probs=209.6
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++++ .+..+|||.+...... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-----DAKARADCIKEIDLLKQLNHPNVIKYYASFIE--D 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-----hHHHHHHHHHHHHHHHHccCCchhhhhheeEe--C
Confidence 4688889999999999999987 5778999988754211 12234678899999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 GTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
+..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+|||++ .++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df 150 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEECcc
Confidence 688999999999999988863 234588999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--hHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC--GAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~--eeil~~Il~~~lrpe 1106 (1157)
|++....... ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ......+.....++.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC
Confidence 9987543322 22345789999999998754 568899999999999999999999975443 233333333333333
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+...++++++||.+||..||.+|||+.+|++.+..+.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 34567889999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.80 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=195.7
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||.||+|++. +..||+|+..+. ....|+.++++++||||+++++++..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34468999999999999999999985 456999975432 22468999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++||||+. ++|..++......+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+||
T Consensus 129 --~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kl~Df 201 (357)
T PHA03209 129 --GAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDL 201 (357)
T ss_pred --CCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEecC
Confidence 567899999995 588888877667799999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChh---------HHHHHhh
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP-YANMHCG---------AIIGGIL 1099 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~P-F~g~~~e---------eil~~Il 1099 (1157)
|++.............||+.|+|||++.+. .++.++|||||||++|||+++..| |...... ..+..+.
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred ccccccccCcccccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 999764444444456799999999999754 578999999999999999985544 4332111 1111111
Q ss_pred hc--CCCCCCC------------------------------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1100 SN--TLRPQIP------------------------------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1100 ~~--~lrpeip------------------------------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.. ..+..++ ..++.++.+||.+||+.||.+|||+.+++++.+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 10 0000111 1346677889999999999999999999999875
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=323.98 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=208.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCce----EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTD----IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~----VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
+...+|++++.||+|+||+||+|.+ .+.. +++|.+... ........+..|+.+++++.||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4557899999999999999999998 3544 555554321 11223456778888999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.. ...+++|||+.+|+|.+++....+.+++..++.++.|++.||.|||+++++||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~----~~~~~k 149 (279)
T cd05111 77 ICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK----SDSIVQ 149 (279)
T ss_pred EECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEE
Confidence 8754 357889999999999999987667789999999999999999999999999999999999998 678999
Q ss_pred EEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhc
Q 001103 1026 VGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~ 1101 (1157)
|+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++ |+.||.+......... ...
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~ 226 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-LEK 226 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHC
Confidence 99999997543221 22334577889999998754 57899999999999999998 9999988765554333 334
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
......+..++..+.+++.+||..||.+|||+.++++.|..+..
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 44445566678899999999999999999999999998887664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.30 Aligned_cols=257 Identities=32% Similarity=0.535 Sum_probs=212.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEE
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAF 943 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkL 943 (1157)
+...+|++.+.||+|+||.||++.+. +..+|||+++.... ....+.+.+|+++++++ +||||+++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-------SSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-------hHHHHHHHHHHHHHHhccCCCCcceE
Confidence 44467999999999999999999752 23589998765311 12246788999999999 79999999
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
++.+.. .+..+++|||+.+++|.+++.+.. ..+++.+++.++.|++.||.|||+++|+|+||||+|||++ ..+
T Consensus 105 ~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~ 178 (302)
T cd05055 105 LGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGK 178 (302)
T ss_pred EEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc----CCC
Confidence 999877 567999999999999999986533 3489999999999999999999999999999999999998 677
Q ss_pred eEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHh
Q 001103 1023 ICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~I 1098 (1157)
.+||+|||++....... ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||........+...
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~ 256 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence 89999999987543221 12223467889999998754 57889999999999999998 99999887766555555
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1099 l~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.........+...++++.+||.+||..+|.+|||+.++++.|..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 555555556667889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=326.57 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=211.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
...+.|+++++||+|+||.||++++. +..+|+|++.... ......+.+|+.+++.++||||+++++.+..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--------EEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 34467999999999999999999984 6779999986531 2235678889999999999999999999877
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+.+++||||+++++|..++.+....+++..++.++.|++.+|.|||+++|+||||||+|||++ .++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~df 154 (292)
T cd06644 81 --DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT----LDGDIKLADF 154 (292)
T ss_pred --CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc----CCCCEEEccC
Confidence 5689999999999999888866666789999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCC-cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-C
Q 001103 1030 GLSRIKCNT-LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-R 1104 (1157)
Q Consensus 1030 GLAkl~~~~-~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-r 1104 (1157)
|++...... .......+++.|+|||++.+. ...++.++|+|||||++|+|++|..||...........+..... .
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (292)
T cd06644 155 GVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234 (292)
T ss_pred ccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc
Confidence 998653222 222345688999999998532 23468899999999999999999999987765555444433222 2
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...+..++.++.+||.+||+.+|.+||++++++++.+.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 272 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 23455678899999999999999999999999998664
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=317.35 Aligned_cols=253 Identities=34% Similarity=0.601 Sum_probs=211.5
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
+..++|++.+.||+|+||.||++.++ +..+|||.+..... ....+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---------SPEAFLQEAQIMKKLRHDKLVQLYAVCSE- 72 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---------CHHHHHHHHHHHhhCCCCCEeeeeeeeec-
Confidence 45678999999999999999999875 45699998875321 12567889999999999999999999876
Q ss_pred CCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+|+||||+|||++ .++.+||+||
T Consensus 73 -~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~----~~~~~~l~d~ 147 (261)
T cd05034 73 -EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADF 147 (261)
T ss_pred -CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc----CCCCEEECcc
Confidence 567899999999999999987643 5689999999999999999999999999999999999998 6789999999
Q ss_pred CCcccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|++........ .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+......+..+.. .+...
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~ 224 (261)
T cd05034 148 GLARLIEDDEYTAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMP 224 (261)
T ss_pred ccceeccchhhhhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 99875432211 1122356789999998754 57889999999999999998 9999988877776666653 33445
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+...+.++++++.+||+.+|.+||+++++++.|..
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 566678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.57 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=210.5
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||.||+++++ +..||+|.++... .......+.+|+.++++++||||+++++.+.. .
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--E 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--C
Confidence 36889999999999999999985 7789999886531 12224678899999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhccc--cccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 GTMATVTEYMVNGSLRHVLARK--DRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~--gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
+..++||||+++++|..++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~df 147 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDF 147 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC----CCCCEEEeec
Confidence 6899999999999999888653 2368999999999999999999997 5999999999999998 6778999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhh--hcCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSN----NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL--SNTL 1103 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~----~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il--~~~l 1103 (1157)
|++....... .....+++.|+|||.+.+.. ..++.++|+|||||++|+|++|+.||...........+. ....
T Consensus 148 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 148 GVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred CCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence 9987543332 22346888999999986431 245789999999999999999999997655433332221 1233
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.+.++..+++++++||.+||+.+|.+||++++++++.|.....
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 4456677899999999999999999999999999988765543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.72 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=213.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||.||++.++ +..+|+|++.... ....+.+.+|++++++++||||+++++.+.. .
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--------EEELEDFMVEIDILSECKHPNIVGLYEAYFY--E 74 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--------HHHHHHHHHHHHHHHhCCCCceeEEEEEEec--C
Confidence 46889999999999999999884 6779999986431 1224678899999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+++++|..++.+.++.+++..++.++.|++.||.|||+++|+|+||||+|||++ .++.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~----~~~~~~l~d~g~~ 150 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT----LDGDVKLADFGVS 150 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC----CCCCEEEccCccc
Confidence 689999999999999999877667799999999999999999999999999999999999998 6789999999988
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-CCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-RPQI 1107 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-rpei 1107 (1157)
...... .......+++.|+|||.+... ...++.++|+||||+++|+|++|+.||........+..+..... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ 230 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence 654322 223345689999999997532 23467899999999999999999999988776665555543322 2234
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+..++.++.+||.+||+.+|.+||++.+++++.+...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 5568899999999999999999999999999977543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=320.67 Aligned_cols=256 Identities=29% Similarity=0.423 Sum_probs=211.2
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++.+ .+..||+|++...... .........+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC---chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 4788999999999999999987 4678999988754321 1122345678899999999999999999999876556
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++++|||+++++|.+++.... .+++..++.++.|++.||+|||+++|+||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~----~~~~~~l~dfg~~ 153 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEccCCCc
Confidence 78899999999999999986544 478899999999999999999999999999999999998 6678999999998
Q ss_pred ccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1033 RIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1033 kl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
...... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+......+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 754321 111234588999999998754 57899999999999999999999998776555555555445556677
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+++.++++| .||..+|.+||++++++++.+
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 77889999999 677789999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=315.26 Aligned_cols=257 Identities=21% Similarity=0.407 Sum_probs=209.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||+|... |+.||+|.++...... ......+.+|++++++++|++|+++++.+.. .
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-----AKARQDCLKEIDLLKQLDHPNVIKYLASFIE--N 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--C
Confidence 47999999999999999999984 7889999987542222 1224678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 GTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
+..+++|||+++++|..++.. ....+++..++.++.|++.||.|||++||+||||||+||+++ .++.++|+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----~~~~~~l~d~ 150 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC----CCCcEEEecc
Confidence 688999999999999988854 245588999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--hHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC--GAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~--eeil~~Il~~~lrpe 1106 (1157)
|++....... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..... ......+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL 228 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC
Confidence 9987543322 22335689999999998754 578899999999999999999999965432 233333333333322
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
....++..++++|.+||..+|.+|||+.+|++.|+.+.
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 22367889999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=315.71 Aligned_cols=251 Identities=23% Similarity=0.413 Sum_probs=211.8
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|+.++.||+|+||.||.++. .+..+++|.+...... ......+.+|++++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS------EKERRDALNEIVILSLLQHPNIIAYYNHFMD--DN 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CC
Confidence 488999999999999998877 4677999988654211 1224567899999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
.++++|||+++++|.+++.+. +..+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~----~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe----CCCCEEECcCcce
Confidence 899999999999999998764 45689999999999999999999999999999999999998 6678999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
....... ......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+....+.+ .+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 225 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVY 225 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-Ccccc
Confidence 7543332 23345689999999998754 46788999999999999999999998877777776666554443 44668
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+.++.++|.+||..+|.+||++++++++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=315.39 Aligned_cols=249 Identities=34% Similarity=0.633 Sum_probs=208.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..+|++.+.||+|+||.||++.+. +..+|+|+++..... ...+.+|++++++++||+|+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTE--R 71 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEcc--C
Confidence 358899999999999999999885 778999988654211 2457789999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...+++|||+.+++|.+++......+++..++.++.|++.||+|||+++++||||||+||+++ ..+.+||+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 147 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMT 147 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc----CCCeEEECCCcce
Confidence 578999999999999999876666688999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1033 RIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1033 kl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
........ .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...........+... .....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPR 224 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCC
Confidence 75433221 2223356789999998754 57889999999999999998 99999887766666655433 2333455
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
..++.+.+|+.+||+.+|.+||++.++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 6789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.48 Aligned_cols=253 Identities=34% Similarity=0.573 Sum_probs=208.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE-------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW-------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~-------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
++..+|...++||+|+||.||+++. .+..+|+|.++... ......+.+|+++++.++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--------HHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 4567889999999999999999975 24468888876431 22346788999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhcccc--------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCcc
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKD--------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCD 1010 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~g--------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPE 1010 (1157)
+++.. ....+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+
T Consensus 74 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 74 GVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEEec--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 99877 557899999999999999986542 24788999999999999999999999999999999
Q ss_pred ceeeccCCCCCCeEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 001103 1011 NLLVNLRDPQRPICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPY 1086 (1157)
Q Consensus 1011 NILLd~dd~e~g~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF 1086 (1157)
|||++ +++.+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||
T Consensus 152 nil~~----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 152 NCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred hEEEc----CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99998 677999999999875432211 1223357889999998754 57899999999999999998 99999
Q ss_pred CCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1087 ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1087 ~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
...........+... .....+..+++.+.+||.+||+.||.+||++.+|++.|.
T Consensus 226 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 226 YQLSNTEAIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccCCHHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 877766666555433 334456678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=320.10 Aligned_cols=245 Identities=34% Similarity=0.611 Sum_probs=202.7
Q ss_pred EecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 882 ELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEE
Confidence 4899999999999773 3459999886531 12234678899999999999999999998754 36899
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
||||+++++|.+++......+++..++.++.|++.||.|||++|++||||||+|||++ ..+.+||+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc----CCCcEEeccCCccccccC
Confidence 9999999999999876566789999999999999999999999999999999999998 677899999999875332
Q ss_pred Ccc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1038 TLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1038 ~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+. ...+...+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECP 224 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCC
Confidence 211 1112245789999998754 57889999999999999996 999999887766554443 444556778889
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++.++|.+||..+|++||++.+|++.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=350.03 Aligned_cols=256 Identities=19% Similarity=0.245 Sum_probs=194.7
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC------CCceeEEe
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH------HPNVVAFY 944 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~------HPNIVkLy 944 (1157)
...+|+++++||+|+||+||+|.+ .+..||||+++... .....+..|+++++.+. |+++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 346899999999999999999988 46679999987531 11233445666666664 45688999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCC----
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDP---- 1019 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~---- 1019 (1157)
+++... ...+|+|||++ +++|.+++.+. +.+++..++.++.||+.||.|||+ .|||||||||+|||++.++.
T Consensus 198 ~~~~~~-~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNE-TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcC-CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988764 45789999988 66888887654 358899999999999999999998 59999999999999984321
Q ss_pred --------CCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 001103 1020 --------QRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091 (1157)
Q Consensus 1020 --------e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ 1091 (1157)
+...+||+|||++..... .....+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 123699999998764322 23346799999999999865 578999999999999999999999987665
Q ss_pred hHHHHHhhhcC--C-----------------------CCCC---------------CCCCcHHHHHHHHHHhccCCCCCC
Q 001103 1092 GAIIGGILSNT--L-----------------------RPQI---------------PERCDPEWRKLMEECWSFNPAARP 1131 (1157)
Q Consensus 1092 eeil~~Il~~~--l-----------------------rpei---------------p~~iSpeLrdLIkrCLqkDPskRP 1131 (1157)
.+.+..+.... + .+.. ....++.+.+||.+||++||.+||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 44333221110 0 0000 001135678999999999999999
Q ss_pred CHHHHHHHHHHHH
Q 001103 1132 SFTEITNRLRVMS 1144 (1157)
Q Consensus 1132 SaeELLe~Lr~Lk 1144 (1157)
|++++++|.|...
T Consensus 431 ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 431 NARQMTTHPYVLK 443 (467)
T ss_pred CHHHHhcCccccc
Confidence 9999999988753
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=324.12 Aligned_cols=253 Identities=31% Similarity=0.513 Sum_probs=206.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEECC------------------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRG------------------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kG------------------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L 935 (1157)
..+|+++++||+|+||.||++++.. ..||+|++..... ......+.+|+++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~e~~~l~~l 76 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-------DNAREDFLKEVKILSRL 76 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-------HHHHHHHHHHHHHHHhc
Confidence 4689999999999999999988742 3489998775421 12356788999999999
Q ss_pred CCCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------ccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD----------RILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 936 ~HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g----------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
+||||+++++++.. ....+++|||+.+++|..++.+.. ..+++..++.++.|++.||.|||+++|+||
T Consensus 77 ~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~ 154 (296)
T cd05051 77 SDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHR 154 (296)
T ss_pred CCCCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 99999999999887 468899999999999999986543 258999999999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ ..+.++|+|||++....... ......++..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 155 dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 155 DLATRNCLVG----KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred ccchhceeec----CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhc
Confidence 9999999998 66899999999987543221 22234567889999998754 57899999999999999998
Q ss_pred -CCCCCCCCChhHHHHHhhhc------CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1082 -GEEPYANMHCGAIIGGILSN------TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~~------~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+..||........+...... ......+..++.++.+||.+||+.||.+|||+.+|++.|.
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 78899877666555544322 1112234557789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=316.18 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=207.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++.+. +..+|+|++..... ...+.+.+|+.++++++||||+++++.+.. .
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 72 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--------DDFEIIQQEISMLKECRHPNIVAYFGSYLR--R 72 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--------hhHHHHHHHHHHHHhCCCCChhceEEEEEe--C
Confidence 58999999999999999999884 56799999875411 124678899999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|++|||+.+++|.+++......+++..++.++.|++.||.|||+++|+|+||||+||+++ ..+.+||+|||++
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 148 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVS 148 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC----CCCCEEECccccc
Confidence 689999999999999999877656689999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC---CC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP---QI 1107 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp---ei 1107 (1157)
....... ......++..|+|||.+.+. ...++.++|+||||+++|+|++|+.||...........+....+.+ ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (262)
T cd06613 149 AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228 (262)
T ss_pred hhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccc
Confidence 7544322 23345789999999998643 1257889999999999999999999998776555444443332222 22
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
+...+.++++||.+||..+|.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 34467889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=323.68 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=201.0
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||.||++++ .+..||+|++.... . ......+.+|++++++++||||+++++.+.. .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----T---VELQKQIMSELEILYKCDSPYIIGFYGAFFV--E 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----C---hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--C
Confidence 3688899999999999999987 46779999887541 1 1223568899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+++++|..+. .+++..+..++.|++.||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~----~~~~~~l~dfg~~ 142 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVS 142 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC----CCCCEEEeeCCcc
Confidence 6789999999999986542 367888899999999999999999999999999999998 6789999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-------HHHHHhhhcCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-------AIIGGILSNTLRP 1105 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-------eil~~Il~~~lrp 1105 (1157)
....... .....||..|+|||++.+. .++.++|+|||||++|+|++|+.||...... .....+.......
T Consensus 143 ~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (279)
T cd06619 143 TQLVNSI-AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219 (279)
T ss_pred eeccccc-ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC
Confidence 7544332 2346799999999999854 5789999999999999999999999653321 2222222222222
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
......++++++||.+||+.+|.+||++++++++.+..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 22345788999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=317.45 Aligned_cols=255 Identities=35% Similarity=0.606 Sum_probs=209.9
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--Cc---eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GT---DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt---~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
...+|+..+.||+|+||.||++++. +. .+|+|.++... .....+.+.+|+++++.++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 4457889999999999999999874 32 58999876431 112246688999999999999999999998
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.. .+..++||||+++++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 76 ~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~----~~~~~kl~ 149 (268)
T cd05063 76 TK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN----SNLECKVS 149 (268)
T ss_pred cc--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc----CCCcEEEC
Confidence 77 5678999999999999999977666789999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC
Q 001103 1028 DFGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1028 DFGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~ 1102 (1157)
|||++........ ......+..|+|||++.+. .++.++|||||||++|+|++ |+.||...........+...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~- 226 (268)
T cd05063 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG- 226 (268)
T ss_pred CCccceecccccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-
Confidence 9999875432211 1112234579999998754 57899999999999999997 99999877766666666443
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.....+..++.++.+|+.+||+.+|.+||++.++++.|..+
T Consensus 227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 34445566889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.49 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=200.1
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++++.||+|+||.||+|++ .+..||||+++..... +.....+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE------EGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ES 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc------CCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CC
Confidence 588999999999999999988 4778999998754211 1123567789999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccc--cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 954 TMATVTEYMVNGSLRHVLARK--DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~--gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+++||||+. ++|.+++... +..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc----CCCcEEECcccc
Confidence 8999999997 5787777542 25689999999999999999999999999999999999998 677899999999
Q ss_pred cccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC--------
Q 001103 1032 SRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-------- 1102 (1157)
Q Consensus 1032 Akl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~-------- 1102 (1157)
+....... ......+++.|+|||++.+. ..++.++|+|||||++|+|++|+.||...........+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 87543222 22334578999999998754 346889999999999999999999998765433322221100
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 -------------------LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 -------------------lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
........+++++++||.+||..||.+|||+.+++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 000112347889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=313.95 Aligned_cols=251 Identities=25% Similarity=0.469 Sum_probs=211.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++++.||+|+||.||++.. .+..+|||++...... ......+.+|+++++.++||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLE--DK 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEec--CC
Confidence 588999999999999999887 4667999998764221 1124678899999999999999999999876 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++||||+++++|.+++... +..+++..++.++.|++.+|+|||++||+|+||||+||+++. ....+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK---HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccCCCc
Confidence 899999999999999999764 345899999999999999999999999999999999999972 3457899999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
.............|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+..... ..++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYS 226 (256)
T ss_pred eecCCCccccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcC
Confidence 866554444446789999999999754 568899999999999999999999988776666655554433 34666789
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
++++++|.+||+.+|.+|||+.+++++.
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=326.68 Aligned_cols=260 Identities=28% Similarity=0.506 Sum_probs=213.2
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCce
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR---------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNV 940 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k---------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNI 940 (1157)
.+...+|++.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++.+ +||||
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCCc
Confidence 355678999999999999999999752 2358999876431 112246788999999999 89999
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
+++++++.. ....+++|||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 84 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred hheeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999887 568899999999999999886531 347788899999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ ..+.+||+|||+++...... ......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 162 dlkp~Nili~----~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 162 DLAARNVLVT----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred ccccceEEEc----CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcC
Confidence 9999999998 67799999999997543321 12223466789999998754 57899999999999999998
Q ss_pred CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1082 GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1082 Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
|..||......+....+. ...+...+..++.++++||.+||..+|.+|||+.++++.|+.+...
T Consensus 236 g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 236 GGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 889998887776666554 3334455677899999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.77 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=203.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||++.+ .+..||||++..... .......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ------SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh------hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 36899999999999999999987 466799999875411 1122356778999999999999999999876422
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
....|++|+++ +++|.++++. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~----~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC----CCCCEEEc
Confidence 23578999988 7788887753 3489999999999999999999999999999999999998 67889999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC---
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--- 1104 (1157)
|||++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865433 2346799999999998753 35788999999999999999999999876654444333211000
Q ss_pred ------------------CC--------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1105 ------------------PQ--------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1105 ------------------pe--------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+. .....++.+.+||.+||..||.+|||+.+++++.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 00 11235677899999999999999999999999988754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=316.12 Aligned_cols=245 Identities=34% Similarity=0.605 Sum_probs=205.7
Q ss_pred EEecccCcEEEEEEEEC---Cc--eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 881 QELGSGTFGTVYRGKWR---GT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k---Gt--~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
+.||+|++|.||++.+. ++ .||||++...... ...+.+.+|+.++++++||||+++++.+.. ...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPL 70 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeE
Confidence 36899999999999873 22 5899998765221 345788899999999999999999999876 578
Q ss_pred EEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 956 ATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
+++|||+++++|.+++.+.. ..+++..++.++.|++.||.|||+++++||||||+|||++ .++.+||+|||++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~----~~~~~kl~dfg~~~~ 146 (257)
T cd05040 71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRA 146 (257)
T ss_pred EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe----cCCEEEecccccccc
Confidence 99999999999999987654 5689999999999999999999999999999999999998 668999999999876
Q ss_pred ccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1035 KCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1035 ~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
..... ......++..|+|||.+.+. .++.++|||||||++|+|++ |+.||......+....+.........+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE 224 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCc
Confidence 43311 11224577889999998754 57889999999999999998 9999988777776666654444445566
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+..+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 78899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=314.20 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=211.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|+..+.||+|+||.||+|.. ++..|++|.+....... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc---cchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CC
Confidence 466778999999999999988 47789999987642211 122335678899999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.++++|||+++++|.+++.+.. .+++..++.++.|++.||.|||+.||+|+||||+||+++ ..+.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----~~~~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----TNGVVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccce
Confidence 8999999999999999987654 478999999999999999999999999999999999998 67799999999987
Q ss_pred cccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcH
Q 001103 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113 (1157)
Q Consensus 1034 l~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSp 1113 (1157)
............|+..|++||.+.... .++.++|+||||+++|+|++|+.||...........+......+.++..+++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 654443344567899999999986432 3789999999999999999999999877655554444443444566778899
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1114 EWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1114 eLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
.+++||.+||+.+|.+||++.+++.+.
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence 999999999999999999999999764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=317.98 Aligned_cols=256 Identities=31% Similarity=0.582 Sum_probs=211.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEECC-----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~kG-----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
...+|.+.+.||+|+||.||+|.+.. ..||||...... .....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 34678899999999999999998742 258999876431 022346788999999999999999999988
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.+ ...++||||+++++|.+++.+....+++..++.++.|++.||+|||+++++||||||+|||++ ..+.+||+
T Consensus 77 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~ 149 (270)
T cd05056 77 TE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS----SPDCVKLG 149 (270)
T ss_pred cC---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe----cCCCeEEc
Confidence 65 346899999999999999977666689999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1028 DFGLSRIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|||++........ .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.. ...
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~ 226 (270)
T cd05056 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-GER 226 (270)
T ss_pred cCceeeecccccceecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCc
Confidence 9999875433321 1122345689999998754 57899999999999999986 9999988776666555443 334
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
...+..+++++.+||.+||..+|.+|||+.++++.|..+..
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 45677889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=322.90 Aligned_cols=258 Identities=33% Similarity=0.555 Sum_probs=208.1
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEE
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAF 943 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkL 943 (1157)
.+...+|++.+.||+|+||.||+|.++ +..||+|.+.... . ......+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----S---LRERIEFLNEASVMKGFTCHHVVRL 74 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----C---HHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 455678999999999999999998753 3369999876431 1 1112457789999999999999999
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhhhcccc---------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLV 1014 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILL 1014 (1157)
++++.. ....++||||+.+|+|.+++.+.. ..++...++.++.|++.||.|||+++|+||||||+|||+
T Consensus 75 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili 152 (288)
T cd05061 75 LGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 152 (288)
T ss_pred EEEEcC--CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE
Confidence 999876 457899999999999999986422 224567788999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001103 1015 NLRDPQRPICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMH 1090 (1157)
Q Consensus 1015 d~dd~e~g~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~ 1090 (1157)
+ .++.+||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|||++ |..||....
T Consensus 153 ~----~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 153 A----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred c----CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8 677899999999875432211 1122356789999998754 57899999999999999998 899998877
Q ss_pred hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1091 ~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+....+..... ...+..+++.+++||.+||+.||.+|||+.++++.|+...
T Consensus 227 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 227 NEQVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 7776665554433 3456677899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=329.29 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=207.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++++. +..+|+|.+.... ......++.+|++++++++||||+++++.+.. .
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--D 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 37899999999999999999884 5668998876431 12234678899999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
+.+++||||+++++|.+++.+. +.+++..+..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 146 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGV 146 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe----cCCcEEEccCCC
Confidence 6899999999999999999765 458899999999999999999998 5999999999999998 667899999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh-----------
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS----------- 1100 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~----------- 1100 (1157)
+....... .....|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+..
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 147 SGQLIDSM-ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cccccccc-cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 87543322 2346799999999998754 478899999999999999999999975443222111100
Q ss_pred ------------------------cCCCCCCC-CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 001103 1101 ------------------------NTLRPQIP-ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKR 1151 (1157)
Q Consensus 1101 ------------------------~~lrpeip-~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesks 1151 (1157)
...++..+ ..++.++++||.+||..+|++||++++++++.+..........
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 299 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEVD 299 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccccch
Confidence 00111122 1367889999999999999999999999999998765444333
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=320.42 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=207.0
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||+|++ .++.||||++...... ......+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE------GGIPNQALREIKALQACQHPYVVKLLDVFPH--GS 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc------chhhHHHHHHHHHHHhCCCCCCcceeeEEec--CC
Confidence 588999999999999999998 4678999998764221 1224678899999999999999999999987 66
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+++||||+ +++|.+++......+++..++.++.|++.||.|||+++|+|+||||+||+++ ..+.++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~----~~~~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS----ADGVLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc----CCCcEEEeeeeecc
Confidence 899999999 9999999876667799999999999999999999999999999999999998 67889999999987
Q ss_pred cccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC------
Q 001103 1034 IKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP------ 1105 (1157)
Q Consensus 1034 l~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp------ 1105 (1157)
...... ......|+..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+......+..+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCCCccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 654332 23345689999999998653 346889999999999999999999998766554444333211000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1106 ----------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1106 ----------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
......+..+.+||.+||..+|.+||++++++++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0112456889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.09 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=208.2
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|++++.||+|+||.||++++. +..+|+|.+.... ......+.+|+++++.++||||+++++.+.. ...
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~ 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--------EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENN 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCE
Confidence 578899999999999999985 5568888875431 1224667889999999999999999999877 568
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.++||||+.+++|..++.+....+++..++.++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~----~~~~~kl~dfg~~~~ 152 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT----LDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----cCCCEEEcccccccc
Confidence 9999999999999988866556789999999999999999999999999999999999998 677899999999875
Q ss_pred ccCC-cccCCCCCCCcccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-CCCCCCC
Q 001103 1035 KCNT-LVSGGVRGTLPWMAPELLNG---SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-LRPQIPE 1109 (1157)
Q Consensus 1035 ~~~~-~~sts~~GTp~YmAPEVL~G---~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~-lrpeip~ 1109 (1157)
.... .......++..|+|||++.. ....++.++|+|||||++|+|++|++||...........+.... .....+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd06643 153 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232 (282)
T ss_pred ccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcc
Confidence 4322 22334568999999999842 22346789999999999999999999998876655555554332 2223456
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.++.++++||.+||+.||.+||++.+++++.+..
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 266 (282)
T cd06643 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266 (282)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence 6889999999999999999999999999987644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.76 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=191.1
Q ss_pred EEEecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 880 LQELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
..+||+|+||+||+|+.+ +..||+|.+..... ...+.+|+++++.++||||+++++++.......+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence 368999999999999874 35699998865321 1346789999999999999999999876556789
Q ss_pred EEEEEeecCCcchhhhcc--------ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 956 ATVTEYMVNGSLRHVLAR--------KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr--------~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||+..++...+.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 76 WLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 999999875 77666642 123478899999999999999999999999999999999996444467799999
Q ss_pred ecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---------HH
Q 001103 1028 DFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---------AI 1094 (1157)
Q Consensus 1028 DFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---------ei 1094 (1157)
|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|||++|++||...... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999997643321 22345689999999998753 35789999999999999999999999753321 01
Q ss_pred HHHhhhc-----------------------CC-------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHH
Q 001103 1095 IGGILSN-----------------------TL-------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138 (1157)
Q Consensus 1095 l~~Il~~-----------------------~l-------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe 1138 (1157)
+..+... .+ ........+..+.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 1111000 00 00011123566889999999999999999999998
Q ss_pred HHH
Q 001103 1139 RLR 1141 (1157)
Q Consensus 1139 ~Lr 1141 (1157)
+.|
T Consensus 314 hp~ 316 (317)
T cd07867 314 DPY 316 (317)
T ss_pred CCC
Confidence 765
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=322.81 Aligned_cols=256 Identities=28% Similarity=0.529 Sum_probs=204.3
Q ss_pred CCeeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 875 SDLEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.-|++++.||+|+||.||++++ .+..||+|.++... .......+.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 4578899999999999999975 25669999886431 1122467889999999999999999999987
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
.......++||||+++++|.+++.+....+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----CCCCEEECC
Confidence 7545678999999999999999876555689999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------------
Q 001103 1029 FGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-------------- 1090 (1157)
Q Consensus 1029 FGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-------------- 1090 (1157)
||++....... ......++..|+|||.+.+. .++.++|||||||++|+|++++.|+....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 99987543321 12234577889999998754 57889999999999999999876643211
Q ss_pred hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1091 ~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.................+..+++.+.+||.+||+.+|.+||+++++++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00111111222233345667899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.85 Aligned_cols=253 Identities=32% Similarity=0.559 Sum_probs=209.9
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
.+...+|++.++||+|+||.||++.+. +..+|+|.+.... .....+.+|+++++.++|+||+++++.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 456679999999999999999999874 5669999876431 123578889999999999999999999866
Q ss_pred CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
...+++|||+++++|.+++.+. ...+++..++.++.|++.||.|||++|++||||||+||+++ ..+.+||+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d 145 (260)
T cd05073 73 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIAD 145 (260)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECC
Confidence 4679999999999999998653 45578889999999999999999999999999999999998 678999999
Q ss_pred cCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
||++....... ......++..|+|||++.+. .++.++|+|||||++|+|++ |+.||...........+. .....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05073 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRM 222 (260)
T ss_pred CcceeeccCCCcccccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCC
Confidence 99987543221 12223456789999998754 57889999999999999998 999999877666655544 33444
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+...+.++.+++.+||..+|++||++.++++.|..
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 5566788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.99 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=199.1
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++++.||+|+||.||++++ .|..||+|+++..... +.....+.+|+.++++++||||+++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~ 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLYDVLHS--DK 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc------ccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CC
Confidence 488999999999999999998 4778999998764211 1122456789999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.++++|||+.+ +|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 73 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~----~~~~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc----CCCcEEECccchhh
Confidence 89999999975 78777766556689999999999999999999999999999999999998 67789999999987
Q ss_pred cccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCC-CCChhHHHHHhhhcC---------
Q 001103 1034 IKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA-NMHCGAIIGGILSNT--------- 1102 (1157)
Q Consensus 1034 l~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~-g~~~eeil~~Il~~~--------- 1102 (1157)
..... .......++..|+|||++.+. ..++.++|||||||++|+|++|..||. +....+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 54322 222334678999999998764 346889999999999999999988854 333333322221100
Q ss_pred ---------CCC---------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 ---------LRP---------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 ---------lrp---------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+ +....+++++++||.+||+.||.+|||+++++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 000 112346789999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.29 Aligned_cols=244 Identities=34% Similarity=0.615 Sum_probs=202.4
Q ss_pred EecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 882 ELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
.||+|+||.||++... ++.+|+|++.... .......+.+|+++++.++||||+++++++.. ....++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEE
Confidence 6899999999999874 5679999876531 12223568899999999999999999999877 557899999
Q ss_pred eecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcc
Q 001103 961 YMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV 1040 (1157)
Q Consensus 961 YmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~ 1040 (1157)
|+++++|.+++......+++..++.++.|++.+|.|||++|++||||||+||+++ ..+.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc----CCCeEEECCCccceecccccc
Confidence 9999999999876656688999999999999999999999999999999999998 677899999999865333221
Q ss_pred c--CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHH
Q 001103 1041 S--GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRK 1117 (1157)
Q Consensus 1041 s--ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrd 1117 (1157)
. ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...........+. ...+...+..++..+.+
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYK 225 (250)
T ss_pred ccCCCCCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 1 112346679999998754 57889999999999999998 999998877666555544 34445566778999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1118 LMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1118 LIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
|+.+||+.+|.+||++.++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=318.30 Aligned_cols=253 Identities=34% Similarity=0.564 Sum_probs=210.3
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
..+|++++.||+|+||.||+++.+ ...+|+|.+... ..+.....+.+|++++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-------cchHHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 468899999999999999999873 345888876543 112345678899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhcccc--------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKD--------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~g--------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd 1018 (1157)
+.+ ....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||++
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~--- 151 (275)
T cd05046 77 CRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS--- 151 (275)
T ss_pred ECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---
Confidence 877 567899999999999999986543 1589999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 001103 1019 PQRPICKVGDFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAII 1095 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil 1095 (1157)
..+.++|+|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.........
T Consensus 152 -~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~ 228 (275)
T cd05046 152 -SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228 (275)
T ss_pred -CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH
Confidence 67789999999986433221 22334567789999998754 46889999999999999998 89999877766666
Q ss_pred HHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1096 GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1096 ~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+.........+..++..+.++|.+||+.+|.+||++.++++.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 6665555555556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=323.38 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=212.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++.+.||+|+||.||++.+ .++.+|+|++.+.... .......+.+|++++++++||||+++++++.+ .
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--D 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--C
Confidence 3789999999999999999988 4678999998764221 12234678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+.+++|.+++.+. ..+++..+..++.|++.||.|||++||+|+||||.|||++ .++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~dfg~~ 148 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFA 148 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 6899999999999999998765 4589999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
...... .....|++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+... ...++..++
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 222 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVRFPSFFS 222 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CccCCccCC
Confidence 765444 3345799999999998754 5688999999999999999999999887766666655533 335667789
Q ss_pred HHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
+.++++|.+||..||.+|+ ++++++++.+.
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 257 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence 9999999999999999998 89999988663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.65 Aligned_cols=253 Identities=21% Similarity=0.370 Sum_probs=198.4
Q ss_pred EEEEeccc--CcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 879 ELQELGSG--TFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 879 ILrkLGsG--sFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
++++||+| +|++||++++ +|..||||+++.... .......+.+|+.+++.++||||+++++++.. .+.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNE 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCE
Confidence 56789999 7899999987 467799999875421 12234567789999999999999999999987 568
Q ss_pred EEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 955 MATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
+++||||+++++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++ .++.++|+||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~----~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe----cCCcEEEcccchhh
Confidence 99999999999999998653 34588999999999999999999999999999999999998 66789999998654
Q ss_pred cccCC--------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC-
Q 001103 1034 IKCNT--------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR- 1104 (1157)
Q Consensus 1034 l~~~~--------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr- 1104 (1157)
..... .......++..|+|||++.+....++.++|||||||++|+|++|+.||.................+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 32111 011123467889999999754345789999999999999999999999865543332222211110
Q ss_pred -------------------------------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1105 -------------------------------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1105 -------------------------------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
......+++++.+||.+||+.||.+|||+++++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0112235678999999999999999999999999877
Q ss_pred HH
Q 001103 1142 VM 1143 (1157)
Q Consensus 1142 ~L 1143 (1157)
..
T Consensus 310 f~ 311 (327)
T cd08227 310 FK 311 (327)
T ss_pred hh
Confidence 64
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.84 Aligned_cols=261 Identities=30% Similarity=0.530 Sum_probs=212.5
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCce
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR---------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNV 940 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k---------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNI 940 (1157)
.+...+|.+.+.||+|+||.||++++. ...+|+|.++... . ......+.+|+++++.+ +||||
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~---~~~~~~~~~E~~~l~~l~~h~~i 80 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----T---DKDLADLISEMELMKLIGKHKNI 80 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----C---hHHHHHHHHHHHHHHhccCCCCe
Confidence 445578999999999999999999762 2358999876431 1 12245678899999999 69999
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhhhccc---------------cccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK---------------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~---------------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
+++++++.. .+.++++|||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||
T Consensus 81 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 81 INLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred eeEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999876 56789999999999999988642 1347888999999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 159 dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 159 DLAARNVLVT----EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred cccceeEEEc----CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhC
Confidence 9999999998 677899999999975432211 1112345679999998754 57889999999999999999
Q ss_pred CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1082 GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1082 Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
|..||...........+... .....+..++.++++||.+||+.+|.+|||+.++++.|..+....
T Consensus 233 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 233 GGSPYPGIPVEELFKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 89999887776666655443 334566778899999999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=320.07 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=204.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPN 949 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~d 949 (1157)
...+|++++.||+|+||.||++++ .++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 346899999999999999999988 46789999876421 1124567899999999 69999999998743
Q ss_pred ---CCCCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 950 ---GPGGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 950 ---e~~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
......++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++ ..+.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----TEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC----CCCC
Confidence 224578999999999999988753 234588899999999999999999999999999999999998 6678
Q ss_pred EEEEecCCcccccCC-cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhh
Q 001103 1024 CKVGDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il 1099 (1157)
+||+|||++...... .......|++.|+|||++... ...++.++|||||||++|+|++|+.||........+..+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 999999998754322 223345699999999998532 2347889999999999999999999998766544433332
Q ss_pred hcC-CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1100 SNT-LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1100 ~~~-lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
... .....+..++..+.+||.+||+.||.+|||+.+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 221 122234556789999999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.62 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=207.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
..+|++.+.||+|+||.||+|.++ +..+++|++..... ....+.+|+.+++++ .||||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 368999999999999999999984 56799998875411 135678999999999 799999999998763
Q ss_pred C----CCcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 951 P----GGTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 951 ~----~~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
. ...+++||||+++++|.+++... ...+++..++.++.|++.||.|||+++|+|+||+|+||+++ .++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~----~~~~ 151 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAE 151 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc----cCCe
Confidence 3 34689999999999999888653 35689999999999999999999999999999999999998 6778
Q ss_pred EEEEecCCcccccCC-cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhh
Q 001103 1024 CKVGDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il 1099 (1157)
+||+|||++...... .......|+..|+|||++.+. ...++.++|||||||+||+|++|+.||...........+.
T Consensus 152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231 (275)
T ss_pred EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence 999999998754322 222345689999999987542 2346788999999999999999999998766555555554
Q ss_pred hcCCCC-CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1100 SNTLRP-QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1100 ~~~lrp-eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
...... ..+..+++++++||.+||..||.+|||+.+++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 332211 223347889999999999999999999999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.35 Aligned_cols=260 Identities=25% Similarity=0.464 Sum_probs=212.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
+...+|++.+.||+|+||.||+|.+.. ..|++|+++... .......+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 345789999999999999999998843 568999876421 1223467889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhcccc-------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKD-------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~g-------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd 1018 (1157)
++... ....+++++|+.+++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|||++
T Consensus 76 ~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~--- 151 (280)
T cd05043 76 VCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--- 151 (280)
T ss_pred EEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---
Confidence 87654 456889999999999999886532 4588999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 001103 1019 PQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAI 1094 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eei 1094 (1157)
+.+.+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|+|++ |++||........
T Consensus 152 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 152 -EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred -CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 66899999999997543221 11223467789999998753 57899999999999999999 9999987766555
Q ss_pred HHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1095 l~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
...+. ...+...+..+++++++++.+||..||++|||+.++++.|..+...
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 229 AAYLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 54443 3444445666789999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=341.62 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=199.9
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
...+|++++.||+|+||.||++... +..||+|.+... ....+|+++|+.|+|||||++++++.
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~~ 156 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAYR 156 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeEe
Confidence 4468999999999999999999764 355888887643 22457999999999999999999988
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ....|++||++. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|
T Consensus 157 ~--~~~~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~----~~~~~~l~D 228 (392)
T PHA03207 157 W--KSTVCMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD----EPENAVLGD 228 (392)
T ss_pred e--CCEEEEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcc
Confidence 7 568999999996 57888874 345689999999999999999999999999999999999998 677999999
Q ss_pred cCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---HHHHHhhhc-
Q 001103 1029 FGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGILSN- 1101 (1157)
Q Consensus 1029 FGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---eil~~Il~~- 1101 (1157)
||++....... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.... ..+..+...
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~ 306 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence 99987543321 22346799999999999754 5789999999999999999999999765421 111111110
Q ss_pred ------------------------CCCCC--CC-----CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1102 ------------------------TLRPQ--IP-----ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1102 ------------------------~lrpe--ip-----~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
..++. ++ ...+.++++||.+||..||.+|||+.+++.+.++.....
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00110 11 234678899999999999999999999999998865443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.57 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=212.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||+||++... +..||+|.+.+.... .......+.+|+++++.++||||+++++.+.. .
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQT--E 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeec--C
Confidence 37899999999999999999884 678999998765221 12235678899999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...|+||||+.+++|.+++.+. ...+++..++.++.|++.||.|||++|++|+||||+|||++ .++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~ 149 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH----ESGHIMLSDFDL 149 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc----CCCCEEEeecch
Confidence 6899999999999999998753 35689999999999999999999999999999999999998 677899999998
Q ss_pred cccccCCc------------------------------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1032 SRIKCNTL------------------------------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1032 Akl~~~~~------------------------------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
+....... ....+.||..|+|||++.+. .++.++||||||+++|+|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhh
Confidence 86432110 11234689999999999754 56889999999999999999
Q ss_pred CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCC----HHHHHHHHHHH
Q 001103 1082 GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPS----FTEITNRLRVM 1143 (1157)
Q Consensus 1082 Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPS----aeELLe~Lr~L 1143 (1157)
|+.||........+..+............+++.+++||.+||..||++||+ +++++++.+.-
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 228 GTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred CCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 999999888777776666554433333347899999999999999999999 99999986653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.45 Aligned_cols=259 Identities=31% Similarity=0.549 Sum_probs=214.3
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--Cc----eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GT----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt----~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
.++..+|++++.||+|+||+||+|.++ |. .+|+|++..... ......+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456678999999999999999999873 32 488888765421 22346788999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+++.. ...+++|||+.+|+|.+++.+....+++..++.++.|++.||+|||+++|+||||||+|||++ ..+.+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~----~~~~~ 148 (279)
T cd05057 76 GICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK----TPQHV 148 (279)
T ss_pred EEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc----CCCeE
Confidence 99876 468899999999999999987666689999999999999999999999999999999999998 66789
Q ss_pred EEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1025 KVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
||+|||+++....... .....++..|+|||.+.. ..++.++|+||||+++|||++ |+.||......+....+..
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Confidence 9999999975433221 112224568999998864 357889999999999999998 9999998877666555543
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
......+..++..+.+++.+||..+|.+||++.++++.|..+...
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 -GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 333455666889999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=346.19 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=210.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN-- 949 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d-- 949 (1157)
...|..++.||+|+||.|..+.+ +|..||||.+... + +.....++..||+++|+.++|+||+.+++++..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F-----~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-F-----ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-h-----hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 34566689999999999999888 4778999988743 1 123345788899999999999999999999866
Q ss_pred -CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 -GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 -e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+.-.-+|+|+|+| +.+|..+++.. +.++...+..++.||++||+|+|+.+|+||||||.|+|++ .+..+||||
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n----~~c~lKI~D 168 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN----ADCDLKICD 168 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec----cCCCEEecc
Confidence 2244689999999 44898888654 4489999999999999999999999999999999999999 777899999
Q ss_pred cCCcccccC---CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc----
Q 001103 1029 FGLSRIKCN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---- 1101 (1157)
Q Consensus 1029 FGLAkl~~~---~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~---- 1101 (1157)
||+|+.... ....+..+.|.+|.|||++... ..|+..+||||+||||.||++|++.|.+.+....+..|+.-
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 999997653 4455678899999999998754 57899999999999999999999999987765555444321
Q ss_pred --------------------CCCCC-----CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1102 --------------------TLRPQ-----IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1102 --------------------~lrpe-----ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
...+. +-...++.+.+|+++||.+||.+|+|+++.|.|+...
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 11111 1135788999999999999999999999999987543
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.26 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=202.9
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++++ .++.||+|+++.... .....+.+|+.+++.++||||+++++.+.. .
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~ 78 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--R 78 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--C
Confidence 4788889999999999999988 467799999875411 112456789999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+..+++|||+++++|.+++...+ .+++..++.++.|++.||.|||++||+|+||||+|||++ ..+.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~~l~dfg~~ 153 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVS 153 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcceee
Confidence 68999999999999999986544 589999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC-C--
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ-I-- 1107 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe-i-- 1107 (1157)
....... ......|+..|+|||++... ...++.++|+|||||++|+|++|..||........+.........+. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 6543221 22345799999999987421 23478899999999999999999999976654444333332222221 1
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
...++..+++||.+||+.+|.+||++++|+++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 124678899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.17 Aligned_cols=247 Identities=33% Similarity=0.619 Sum_probs=207.9
Q ss_pred cCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
...+|++.+.||+|+||.||++...+..||+|.++... ....+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-- 71 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--
Confidence 34679999999999999999999999999999886431 125678899999999999999999998652
Q ss_pred CcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
..+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++ .++.+||+|||+
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----~~~~~kl~Dfg~ 146 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGL 146 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCcEEECCCcc
Confidence 4689999999999999987543 4588999999999999999999999999999999999998 677899999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
+...... ......+..|+|||.+.+. .++.++|+|||||++|+|++ |++||...........+.. ...+..+..
T Consensus 147 ~~~~~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 221 (254)
T cd05083 147 ARVGSMG--VDNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEG 221 (254)
T ss_pred ceecccc--CCCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCc
Confidence 8754322 1223356789999998753 57889999999999999997 9999988877666555543 344555667
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+++.+.+||.+||+.+|.+||++++|+..|+
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 8999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=376.15 Aligned_cols=266 Identities=20% Similarity=0.300 Sum_probs=214.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
......+|++++.||+|+||+||++++. +..+|+|++...... ......+.+|+.+|+.|+|||||+++++|
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK------EREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 3445579999999999999999999984 556999998764221 22346788999999999999999999998
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHC-------CceeccCCccceeeccC
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMK-------NIVHFDLKCDNLLVNLR 1017 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSk-------GIIHRDLKPENILLd~d 1017 (1157)
.+.....+||||||+.+++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 776567899999999999999988652 34689999999999999999999985 49999999999999632
Q ss_pred C-------------CCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCC
Q 001103 1018 D-------------PQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEE 1084 (1157)
Q Consensus 1018 d-------------~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~ 1084 (1157)
. .....+||+|||++.............||+.|+|||++.+....++.++||||||||||+|++|+.
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 1 123469999999998655444444567999999999987655568899999999999999999999
Q ss_pred CCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1085 PYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1085 PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
||........+...+....... ....++++.+||..||..+|.+||++.++|.+.+.
T Consensus 242 PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 9987665444444333322222 23468999999999999999999999999987554
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.82 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=204.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC-
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG- 950 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de- 950 (1157)
..|++.+.||+|+||.||++++ .+..+|+|++.... .....+..|+.+++++ +||||+++++++...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 5788899999999999999998 46779999886531 1235577899999998 799999999998542
Q ss_pred ---CCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 951 ---PGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 951 ---~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
....+|++|||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++ ..+.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEE
Confidence 245789999999999999988653 34578888999999999999999999999999999999998 6778999
Q ss_pred EecCCcccccCC-cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1027 GDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
+|||++...... .......|++.|+|||.+... ...++.++|+|||||++|+|++|..||........+..+....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 242 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC
Confidence 999998754322 223345689999999987532 2357889999999999999999999997765544443333332
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
........++.++.+||.+||+.||.+||++.+|+++.|
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 333334568899999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=345.97 Aligned_cols=260 Identities=30% Similarity=0.477 Sum_probs=213.7
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIV 941 (1157)
+.+...+|.+.+.||+|+||.||+|++.+ ..||||+++.... ......+.+|+++|.++. |||||
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~~H~niv 104 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------SSEKQALMSELKIMSHLGPHLNIV 104 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------hhHHHHHHHHHHHHHhcCCCCCeE
Confidence 34455678889999999999999998743 4699999975311 112356789999999997 99999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------------------------------------------
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------------------------------------- 975 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------------------------------------- 975 (1157)
++++++.. .+.+++||||+.+|+|.+++.+..
T Consensus 105 ~~~~~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 105 NLLGACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred EEEEEEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 99999987 457999999999999999885431
Q ss_pred ---------------------------------------------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 001103 976 ---------------------------------------------------RILDRRKKLMLMMDAAFGMEYLHMKNIVH 1004 (1157)
Q Consensus 976 ---------------------------------------------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIH 1004 (1157)
..+++..++.++.||+.||.|||+++|+|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 23567778899999999999999999999
Q ss_pred ccCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1005 FDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1005 RDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
|||||+|||++ ..+.+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++
T Consensus 263 rdlkp~NiLl~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 263 RDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred ccCCcceEEEe----CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHH
Confidence 99999999998 67789999999997532211 12234578899999998754 57899999999999999998
Q ss_pred -CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1082 -GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
|..||......+.....+....++..+..++.++.+||.+||..+|.+||++++|++.|+.+.
T Consensus 337 ~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 337 LGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred cCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 899998776666555555556666677788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=324.54 Aligned_cols=254 Identities=30% Similarity=0.508 Sum_probs=203.2
Q ss_pred cCCCeeEEEEecccCcEEEEEEEECC----------------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWRG----------------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~kG----------------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~ 936 (1157)
...+|++.++||+|+||.||++++.+ ..||+|+++... . ......+.+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----T---KTARNDFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----C---HHHHHHHHHHHHHHHhCC
Confidence 44689999999999999999987632 238999886531 1 223467889999999999
Q ss_pred CCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc-----------ccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-----------RILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 937 HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g-----------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
||||+++++++.. ....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++||
T Consensus 76 h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 76 NPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred CCCcCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 9999999999877 567899999999999999885432 236788899999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ .++.+||+|||++....... ......++..|+|||++.+. .++.++|+|||||++|+|++
T Consensus 154 dlkp~Nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 154 DLATRNCLVG----NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred ccChhhEEEc----CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHc
Confidence 9999999998 66789999999987533221 12223457789999998754 57899999999999999988
Q ss_pred -CCCCCCCCChhHHHHHhhh------cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1082 -GEEPYANMHCGAIIGGILS------NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~------~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
|..||........+..+.. .......+..+++.+++||.+||+.||.+|||++++++.|+
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 228 CKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6789987766555544321 11112334557899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.83 Aligned_cols=259 Identities=27% Similarity=0.476 Sum_probs=208.4
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCC--ChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGR--SSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r--~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
+|.+.+.||+|+||.||+|.. .+..+|+|.++....... ........+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 577889999999999999977 477899998865322111 12223345678899999999999999999999877
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....++||||+.+++|.+++.+.+ .+++..+..++.|++.||.|||+++++||||||+||+++ .++.++|+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~----~~~~~~l~d~~~ 154 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD----ADGICKISDFGI 154 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc----CCCeEEEeeccc
Confidence 568899999999999999987654 588899999999999999999999999999999999998 678999999999
Q ss_pred cccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--
Q 001103 1032 SRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ-- 1106 (1157)
Q Consensus 1032 Akl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe-- 1106 (1157)
+...... .......|+..|+|||.+......++.++|+||||+++|+|++|..||...........+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence 8754322 11233568899999999875444578899999999999999999999976655444433332322222
Q ss_pred --CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1107 --IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1107 --ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
....++.+++++|.+||..+|.+||++++++++.+
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 23346889999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.63 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=202.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||.||+++++ +..||+|++....... ...+.+.+|++++++++||||+++++++.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 72 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP------VIKKIALREIRMLKQLKHPNLVNLIEVFRR--K 72 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc------cccHHHHHHHHHHHhCCCCCEeeeeeEEee--C
Confidence 36899999999999999999984 7789999987542111 112457789999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||++++.|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~ 147 (286)
T cd07847 73 RKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT----KQGQIKLCDFGFA 147 (286)
T ss_pred CEEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc----CCCcEEECccccc
Confidence 6889999999998888776543 3489999999999999999999999999999999999998 6778999999999
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC---------
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT--------- 1102 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~--------- 1102 (1157)
....... ......++..|+|||++.+. ..++.++|+||||+++|+|++|+.||.+....+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 7654432 23345688999999998753 346889999999999999999999998776544333321100
Q ss_pred ------------CCCC--------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 ------------LRPQ--------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 ------------lrpe--------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+.. ....++..+.+||.+||+.+|++||++.+++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 0000 01245788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=313.29 Aligned_cols=249 Identities=28% Similarity=0.504 Sum_probs=208.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++.+.||+|+||.||++++. +..+|+|.+.... ..+.+.+|++++++++||||+++++.+.. .
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~ 70 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----------DLQEIIKEISILKQCDSPYIVKYYGSYFK--N 70 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----------HHHHHHHHHHHHHhCCCCcEeeeeeeeec--C
Confidence 57899999999999999999985 5779999886531 14678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|++|||+.+++|.+++......+++..++.++.|++.||.|||+.+|+||||+|+||+++ ..+.+||+|||++
T Consensus 71 ~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~----~~~~~~l~dfg~~ 146 (256)
T cd06612 71 TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVS 146 (256)
T ss_pred CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----CCCcEEEcccccc
Confidence 689999999999999999976667789999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-CCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-LRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~-lrpeip~~ 1110 (1157)
....... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+.... .....+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224 (256)
T ss_pred hhcccCccccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhh
Confidence 7654332 22334588999999998754 57899999999999999999999998766544433332211 12223445
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
++.++.+||.+||+.+|.+|||+.+++++.+
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 7789999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.12 Aligned_cols=249 Identities=31% Similarity=0.553 Sum_probs=200.1
Q ss_pred EEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 881 QELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
+.||+|+||.||+|.+. ...+|+|.+.... .......+.+|+.+++.++||||+++++++... ++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 72 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSP 72 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCc
Confidence 36899999999999863 2358999875321 112246788899999999999999999976543 4567
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
+++|||+.+++|.+++.+....+++..++.++.|++.||.|||+++|+||||||+|||++ ..+.+||+|||++...
T Consensus 73 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~----~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 73 LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDI 148 (262)
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCccccccc
Confidence 899999999999999976555577788889999999999999999999999999999998 6778999999998753
Q ss_pred cCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1036 CNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1036 ~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
.... ......++..|+|||.+.+. .++.++|||||||++|||++ |.+||...........+.. ...+..+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPE 225 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCCCCC
Confidence 3211 11233467789999998753 57899999999999999999 5677877666555554433 33344566
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+++.+.+++.+||+.+|++||++.++++.|..+.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 67899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=371.55 Aligned_cols=266 Identities=35% Similarity=0.592 Sum_probs=230.6
Q ss_pred cccccccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc
Q 001103 867 YGLQIIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN 939 (1157)
Q Consensus 867 y~i~~I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN 939 (1157)
....++...+.+..++||+|+||+||+|+..+ +-||||.++... .....++|.||++++..|+|||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-------~~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-------ENQARQDFRREAELLAELQHPN 550 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-------cHHHHHHHHHHHHHHHhccCCC
Confidence 34566778889999999999999999998742 239999988652 2335689999999999999999
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCcchhhhccc---------ccc----ccHHHHHHHHHHHHHHHHHHHHCCceecc
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK---------DRI----LDRRKKLMLMMDAAFGMEYLHMKNIVHFD 1006 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~---------gr~----L~e~qVlkIa~QLa~ALeYLHSkGIIHRD 1006 (1157)
||+|+|++.+ ++.+|+|+|||..|||.++|... +.. ++..+.+.|+.||+.|+.||-++.+||||
T Consensus 551 IVrLlGVC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRD 628 (774)
T KOG1026|consen 551 IVRLLGVCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRD 628 (774)
T ss_pred eEEEEEEEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccc
Confidence 9999999988 67899999999999999998632 222 78899999999999999999999999999
Q ss_pred CCccceeeccCCCCCCeEEEEecCCcccccCCcccC---CCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-C
Q 001103 1007 LKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG---GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-G 1082 (1157)
Q Consensus 1007 LKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~st---s~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-G 1082 (1157)
|-..|+||+ ++..|||+|||+++......... ...-..+|||||.|+ ..+++.++||||+||+|||+++ |
T Consensus 629 LATRNCLVg----e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl--y~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 629 LATRNCLVG----ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL--YGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred hhhhhceec----cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh--cCcccchhhhhhhhhhhhhhhccc
Confidence 999999998 88999999999998544332221 122456899999998 4579999999999999999999 9
Q ss_pred CCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1083 k~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
+.||.+....++++.+..+.+ .+.|+.+|.++++||..||+.+|.+||++++|-..|+.+..+-.
T Consensus 703 ~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred cCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 999999999999999988877 78899999999999999999999999999999999998876543
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.47 Aligned_cols=247 Identities=34% Similarity=0.591 Sum_probs=199.6
Q ss_pred EecccCcEEEEEEEECC--c--eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEE
Q 001103 882 ELGSGTFGTVYRGKWRG--T--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~kG--t--~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~Ly 956 (1157)
.||+|+||.||++++++ . .+|+|.++... .......+.+|+++++++ +||||+++++++.. .+..+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCce
Confidence 58999999999998843 2 36888776421 112245678899999999 89999999999877 56789
Q ss_pred EEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCC
Q 001103 957 TVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~ 1021 (1157)
++|||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||++ .+
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----~~ 148 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----EN 148 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----CC
Confidence 9999999999999886432 2478899999999999999999999999999999999998 77
Q ss_pred CeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1022 PICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1022 g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
+.+||+|||++..............+..|+|||++.+. .++.++|+|||||++|+|++ |..||...........+..
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~ 226 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC
Confidence 89999999998632222111122346679999998743 57899999999999999997 9999988776666555543
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
......+..++.++.+|+.+||..+|.+|||+.+++..|..+.
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2344456668899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.88 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=210.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||.|+||.||++++ .+..||+|++..... ......+.+|+++++.++||||+++++.+.+ .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--G 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--C
Confidence 3688899999999999999988 467799999875421 1123567889999999999999999999887 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++|+||+.+++|.+++... .+++..++.++.|++.||.|||+++++||||+|+||+++ .++.++|+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 145 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVS 145 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEcccccc
Confidence 6899999999999999998754 689999999999999999999999999999999999998 6788999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC-
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER- 1110 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~- 1110 (1157)
+..... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+... ..+.++..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNK 222 (274)
T ss_pred eeecccccccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccc
Confidence 765443 223345789999999999864 4789999999999999999999999877655554444333 33444444
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++++.++|.+||..+|.+||++++++++.+..
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~ 255 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhc
Confidence 889999999999999999999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=357.43 Aligned_cols=267 Identities=37% Similarity=0.625 Sum_probs=232.2
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEEC---C--ce-EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeE
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR---G--TD-IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~k---G--t~-VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVk 942 (1157)
-|++..++..+.++||+|+||.||+|+++ + .. ||||..+... ...+..+.++.+|+++|++++|||||+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-----~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-----ELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-----cccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 35666778888899999999999999883 1 13 8999877522 122445788999999999999999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
+||+... ...+++|||+|.||+|.++|++.+..++..+.+.++.+++.||+|||++++|||||-.+|+|++ ...
T Consensus 226 ~yGVa~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~----~~~ 299 (474)
T KOG0194|consen 226 FYGVAVL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS----KKG 299 (474)
T ss_pred EEEEEcC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec----CCC
Confidence 9999888 5689999999999999999998877799999999999999999999999999999999999998 666
Q ss_pred eEEEEecCCcccccCCcccCCC-CCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1023 ICKVGDFGLSRIKCNTLVSGGV-RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~~sts~-~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
.+||+|||+++........... .-...|+|||.+... .|+.++|||||||++||+++ |..||.+....++...+..
T Consensus 300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred eEEeCccccccCCcceeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 7999999999865433332212 256789999999843 78999999999999999999 8999999999999999988
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
..++...+...+.++..++.+|+..+|++||++.++.+.+..+.....
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 889999999999999999999999999999999999999998887655
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.49 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=202.2
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHH-HHhCCCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI-ISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkI-LK~L~HPNIVkLygvf~de~ 951 (1157)
.+|++++.||+|+||.||+++++ |..||+|+++..... .. ...+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~---~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-- 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS----QE---QKRLLMDLDISMRSVDCPYTVTFYGALFR-- 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc----HH---HHHHHHHHHHHHHHcCCCCeeeeeEEEec--
Confidence 37899999999999999999984 778999998764211 11 1334455554 667799999999999977
Q ss_pred CCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 GGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.+..|++|||++ ++|.+++.. ....+++..++.++.|++.||.|||++ +++||||||+|||++ .++.+||+
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----~~~~~kl~ 146 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----RNGQVKLC 146 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEEe
Confidence 567999999997 577776643 234689999999999999999999998 999999999999998 67799999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhHHHHHhhhcCCC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGS--NNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAIIGGILSNTLR 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~--~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-~eeil~~Il~~~lr 1104 (1157)
|||++.............|+..|+|||.+.+. ...++.++|+|||||++|+|++|+.||.... ..+.+..+.....
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 225 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS- 225 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-
Confidence 99998765443333345689999999988642 1346889999999999999999999997533 2233333333322
Q ss_pred CCC-CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1105 PQI-PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1105 pei-p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
+.+ ...+++++.+||.+||..+|.+||++.+++++.+.....
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 223 345789999999999999999999999999988776643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.23 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=200.2
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCC
Q 001103 877 LEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~ 953 (1157)
|++++.||+|+||.||+++. .+..||+|++++... . .. .....+|+.+++++. ||||+++++++.+...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~-~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-S-LE-----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-C-ch-----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 67889999999999999987 467799998875421 1 11 123457888899885 99999999999886557
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+++||||+.+ +|.+.+......+++..++.++.|++.||+|||+++|+||||||+||+++ . +.+||+|||++.
T Consensus 74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~----~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK----D-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc----C-CCeEEEeccccc
Confidence 89999999975 77777766555689999999999999999999999999999999999998 5 899999999998
Q ss_pred cccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-----------
Q 001103 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT----------- 1102 (1157)
Q Consensus 1034 l~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~----------- 1102 (1157)
............++..|+|||.+.+. ..++.++|||||||++|||++|+.||...+..+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 65444433445689999999987543 346889999999999999999999998776554443332110
Q ss_pred -----CCCCC-----------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 -----LRPQI-----------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 -----lrpei-----------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
....+ ...++..+++||.+||..+|.+||++++++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 00011 1246789999999999999999999999998754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.96 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=209.2
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 883 LGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
||.|+||.||+++++ +..||+|++.+..... ....+.+.+|+++++.++||||+++++.+.+ ...++++||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-----TGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-----hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEe
Confidence 799999999999996 7789999997653211 2234678899999999999999999999877 568999999
Q ss_pred eecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcc
Q 001103 961 YMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV 1040 (1157)
Q Consensus 961 YmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~ 1040 (1157)
|+++++|.+++.+.. .+++..+..++.|++.||+|||+++++|+||||+||+++ .++.++|+|||++........
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~----~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc----CCCCEEEeeCCcccccCcccc
Confidence 999999999997543 488999999999999999999999999999999999998 677899999999986554433
Q ss_pred cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hhHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 001103 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH--CGAIIGGILSNTLRPQIPERCDPEWRKL 1118 (1157)
Q Consensus 1041 sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~--~eeil~~Il~~~lrpeip~~iSpeLrdL 1118 (1157)
.....|++.|++||.+.+. .++.++|+||||+++|+|++|..||.... .......+........++...++++++|
T Consensus 149 ~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 3345789999999998743 57889999999999999999999998776 5555566654445556677779999999
Q ss_pred HHHHhccCCCCCCC-----HHHHHHHHHHH
Q 001103 1119 MEECWSFNPAARPS-----FTEITNRLRVM 1143 (1157)
Q Consensus 1119 IkrCLqkDPskRPS-----aeELLe~Lr~L 1143 (1157)
|.+||+.+|.+||+ +++++++.|.-
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 99999999999999 99999988754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.75 Aligned_cols=248 Identities=39% Similarity=0.682 Sum_probs=206.8
Q ss_pred eeEEEEecccCcEEEEEEEECC------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 877 LEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~kG------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
+++.+.||.|+||.||++++.. ..||+|+++.... ......+.+|+.+++.++|+||+++++++.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------EQQIEEFLREARIMRKLDHPNIVKLLGVCTE- 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------hHHHHHHHHHHHHHHhcCCCchheEEEEEcC-
Confidence 3567889999999999999854 6699999865421 1134678899999999999999999999887
Q ss_pred CCCcEEEEEEeecCCcchhhhcccccc-ccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~-L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+..+++|||+++++|.+++...... +++..++.++.|++.||.|||+++++||||||+||+++ ..+.++|+||
T Consensus 73 -~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~----~~~~~~l~df 147 (258)
T smart00219 73 -EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDF 147 (258)
T ss_pred -CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc----cCCeEEEccc
Confidence 46899999999999999999765444 89999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccCCcccC--CCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTLVSG--GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~~st--s~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|++.......... ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||...........+.... ...
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 224 (258)
T smart00219 148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLP 224 (258)
T ss_pred CCceecccccccccccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCC
Confidence 9997654332211 1237789999999864 357899999999999999998 899998877766666655443 344
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
.+...+.++.+++.+||..||.+|||+.++++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 5666899999999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.32 Aligned_cols=253 Identities=32% Similarity=0.573 Sum_probs=207.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
...+|++++.||+|+||.||++++. +..||+|++.... .......+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 3468999999999999999999874 4569999886531 1123466889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhcccc---------------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------------RILDRRKKLMLMMDAAFGMEYLHMKNIVH 1004 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIH 1004 (1157)
++.. ....+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++|
T Consensus 76 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H 153 (288)
T cd05050 76 VCAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVH 153 (288)
T ss_pred EEcC--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 9877 457899999999999998886321 24678889999999999999999999999
Q ss_pred ccCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1005 FDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1005 RDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
|||||+|||++ .++.+||+|||++....... .......+..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 154 ~dl~p~nil~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 154 RDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred ccccHhheEec----CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHh
Confidence 99999999998 67789999999987432221 11223356679999998754 57899999999999999997
Q ss_pred -CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1082 -GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
|..||.+....+....+..... ...+..++.++.+||.+||+.+|.+|||+.++++.|+
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 228 YGMQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 8899988777666666554433 3345678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=346.88 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=208.2
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|+..+.+|.|+||.||+|... +..||||+..... +.-.+|+++|+.++|||||++..+|......
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------------RYKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 5778899999999999999884 5679999876541 1123799999999999999998887654443
Q ss_pred ---cEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 954 ---TMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 954 ---~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
++.+|||||+. +|..+++. .++.++...+.-+.+||.+||.|||+.||+||||||.|||+| ++.+.+|||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKIC 168 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEec
Confidence 67799999987 89888874 356688888999999999999999999999999999999998 577999999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC---
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--- 1104 (1157)
|||.|+.........+...|..|+|||.+.|. ..|+.+.||||.||++.||+-|++-|.+......+..|..-.-.
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99999987766665667789999999999987 46899999999999999999999999998877766665431000
Q ss_pred ---------------C---------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1105 ---------------P---------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1105 ---------------p---------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+ -+....++++.+|+.++|+.+|.+|.++.+++.+..
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 0 123457899999999999999999999999998754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.73 Aligned_cols=257 Identities=30% Similarity=0.525 Sum_probs=209.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
..+|++++.||+|+||.||++++. +..+|||+++.... ......+.+|+++++.+.||||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-------EQHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc-------hHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 457888999999999999999874 56799999876421 12346788999999999999999999998
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
........+++|||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++ .++.++|+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE----SEDLVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEc
Confidence 77556678999999999999999977665689999999999999999999999999999999999998 66899999
Q ss_pred ecCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-----------
Q 001103 1028 DFGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG----------- 1092 (1157)
Q Consensus 1028 DFGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e----------- 1092 (1157)
|||++........ .....++..|++||.+.+. .++.++|+||||+++|+|++|..||......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 9999986542211 1122356679999998754 5788999999999999999999998653221
Q ss_pred ---HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1093 ---AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1093 ---eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+...+........+..++.++.+|+.+||+.+|.+||++.++++.|..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112222333334444566788999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.28 Aligned_cols=245 Identities=34% Similarity=0.587 Sum_probs=202.0
Q ss_pred EEecccCcEEEEEEEECC-----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 881 QELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~kG-----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
++||+|+||.||+|++.. ..+|+|.+...... ...+.+.+|+++++.+.||||+++++++.. ...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---Cce
Confidence 469999999999998732 46999988764221 234678899999999999999999998754 357
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
++||||+.+++|.+++.+.. .+++..++.++.|++.||+|||.++++||||||+|||++ .++.+||+|||++...
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~----~~~~~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV----NRHQAKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc----CCCcEEecccccccee
Confidence 99999999999999997654 588999999999999999999999999999999999998 6778999999998754
Q ss_pred cCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1036 CNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1036 ~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||...........+.. ......+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEE 222 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCC
Confidence 32221 1111235679999998754 57889999999999999998 9999988777666555543 334456777
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++.+++||.+||..+|.+||++.+|++.|+.+
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=335.50 Aligned_cols=270 Identities=23% Similarity=0.319 Sum_probs=236.8
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~ 951 (1157)
..|+..+.||.|..++|-++.. .|.++|+|++.........+....+.+.-.+|+.||+++ .||+|+++.++++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 3566778899999999998877 477899999987665555555677788889999999999 59999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+++|+|.|+.|.|.++|...- .++++..++|++|+..|++|||.++||||||||+|||++ ++.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld----dn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD----DNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec----cccceEEeccce
Confidence 668999999999999999997654 389999999999999999999999999999999999999 888999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGS----NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~----~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
|+...........||||+|+|||.+... ...|+..+|+|++|||||.|+.|.+||-.......+..|+.+.+....
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 9998888888889999999999998642 235889999999999999999999999988888888888888776554
Q ss_pred C--CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 001103 1108 P--ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKR 1151 (1157)
Q Consensus 1108 p--~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesks 1151 (1157)
| .+++...++||.+||+.||.+|.|+++.|.|.++...+.+..+
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 4 4578899999999999999999999999999999877665543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.02 Aligned_cols=259 Identities=24% Similarity=0.319 Sum_probs=208.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||.||+|.+ .|..||+|+++....... ....+.+|+.++++++|+||+++++++....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------IPISSLREITLLLNLRHPNIVELKEVVVGKH 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------CcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence 36899999999999999999988 477899999875422111 1234567999999999999999999998755
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+++||||+.+ +|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ ..+.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~kL~dfg~ 154 (309)
T cd07845 80 LDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGL 154 (309)
T ss_pred CCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEECccce
Confidence 5678999999975 78888776556689999999999999999999999999999999999998 677999999999
Q ss_pred cccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC------
Q 001103 1032 SRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR------ 1104 (1157)
Q Consensus 1032 Akl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr------ 1104 (1157)
+....... ......+++.|+|||++.+. ..++.++|+|||||++|+|++|++||........+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 155 ARTYGLPAKPMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred eeecCCccCCCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 87644321 22223468889999998753 35788999999999999999999999987766655554331100
Q ss_pred -----------CCC-----------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1105 -----------PQI-----------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1105 -----------pei-----------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+ ....++++.+||.+||..||.+|||+++++.+.|.-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 0125788999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.15 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=212.6
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++++ .+..||+|++...... .........+.+|++++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS---QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc---chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 4789999999999999999987 4678999987543111 1112335678899999999999999999999877656
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++++|||+++++|.+++...+ .+++..++.++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECccccc
Confidence 67899999999999999886544 478889999999999999999999999999999999998 6678999999998
Q ss_pred ccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1033 RIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1033 kl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
...... .......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+.....++.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC
Confidence 754321 112345689999999999754 56889999999999999999999998877666666666555666788
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
..++++++++|.+||+ +|.+||++.++++++
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 8899999999999999 579999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.96 Aligned_cols=258 Identities=23% Similarity=0.420 Sum_probs=211.3
Q ss_pred CeeEEEEecccCcEEEEEEEECC---ceEEEEEEecccccCC--ChhHHHHHHHHHHHHHHHHh-CCCCceeEEeeeeec
Q 001103 876 DLEELQELGSGTFGTVYRGKWRG---TDIAIKRIKKSCFLGR--SSEQEWLIKEFWREAHIISN-LHHPNVVAFYGVVPN 949 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kG---t~VAVKVIkk~~l~~r--~~e~e~likqflrEIkILK~-L~HPNIVkLygvf~d 949 (1157)
+|++.+.||+|+||.||++++++ ..+|+|.+........ ..........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999854 6699998875432211 11223345667889998875 799999999999877
Q ss_pred CCCCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEE
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
.+..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+|||++ .++.+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~----~~~~~~ 154 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG----EDDKVT 154 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC----CCCcEE
Confidence 5689999999999999888743 34568899999999999999999996 6899999999999998 677999
Q ss_pred EEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1026 VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
|+|||++.............|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 9999999865544344456789999999999854 57899999999999999999999998777666666665554444
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.....+++++.+||.+||+.||.+||++.++..++.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 334467899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.79 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=208.1
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|+..+.||+|+||.||+++. .+..||+|++.... ......+...+.+.+|++++++++||||+++++++.+ .+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR--NTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeeccc--CCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CC
Confidence 477889999999999999987 57789999987542 1112233456788999999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..++||||+.+++|.+++.+.+ .+++..++.++.|++.||.|||++|++|+||||+||+++. ....+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~---~~~~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS---TGQRLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccccccc
Confidence 8899999999999999987544 5889999999999999999999999999999999999971 23469999999987
Q ss_pred cccCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---HHHHHhhhcCCCC
Q 001103 1034 IKCNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGILSNTLRP 1105 (1157)
Q Consensus 1034 l~~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---eil~~Il~~~lrp 1105 (1157)
...... ......|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... .....+......+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 644321 12234688999999998754 5688999999999999999999999754432 2222333334455
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.++..+++++.++|.+||..+|.+||++.+++++.+
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 677778999999999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.79 Aligned_cols=255 Identities=29% Similarity=0.420 Sum_probs=206.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
..+|++.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 46899999999999999999988 46789999986531 1124567899999999 899999999998653
Q ss_pred C---CCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 951 P---GGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 951 ~---~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+ .+..++||||+++++|.++++. ....+++..++.++.|++.||+|||+++|+||||||+||+++ ..+.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~----~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT----TEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCE
Confidence 2 2468999999999999988753 345689999999999999999999999999999999999998 66789
Q ss_pred EEEecCCcccccCCc-ccCCCCCCCcccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh
Q 001103 1025 KVGDFGLSRIKCNTL-VSGGVRGTLPWMAPELLNGSN---NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~---~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~ 1100 (1157)
||+|||++....... ......|+..|+|||.+.... ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 999999987543322 223456899999999986431 2367899999999999999999999988766555544433
Q ss_pred cCC-CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1101 NTL-RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1101 ~~l-rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
... ....+..++..+.+||.+||+++|.+||++.+++++.+
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 221 12234567788999999999999999999999999865
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.61 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=201.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEECC------------------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRG------------------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kG------------------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L 935 (1157)
..+|++.+.||+|+||.||++++.+ ..+|+|++.... .......+.+|+++++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~l 76 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSRL 76 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhC
Confidence 4579999999999999999986532 248899876431 122346788999999999
Q ss_pred CCCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------ccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD----------RILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 936 ~HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g----------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
+||||+++++++.. ....+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||++||+||
T Consensus 77 ~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~ 154 (296)
T cd05095 77 KDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154 (296)
T ss_pred CCCCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 99999999999877 557899999999999998886532 236778899999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ .++.++|+|||++....... ......++..|++||...+. .++.++|+|||||++|||++
T Consensus 155 dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 155 DLATRNCLVG----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred cCChheEEEc----CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHh
Confidence 9999999998 67789999999987543221 11223356789999987653 57899999999999999998
Q ss_pred -CCCCCCCCChhHHHHHhhh------cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1082 -GEEPYANMHCGAIIGGILS------NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~------~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
|..||......+.+..... .......+..+++.+++||.+||+.||.+||++.+|++.|+
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 229 CKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7899987665554433211 11112334567899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=343.53 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=223.3
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+.-++|+.++.||+|.||+|.+++-+ ++.||||++++.....+.+ +..-+-|-++|+..+||.+..+--.|+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE-----VAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE-----VAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH-----hhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 345578999999999999999999874 6779999999986655432 455667999999999999998877777
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. +.++|+||||..||.|...|.+. +.+++...+.+..+|+.||.|||+++||+||||.+|+|++ .++++||+|
T Consensus 239 t--~drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD----kDGHIKitD 311 (516)
T KOG0690|consen 239 T--QDRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD----KDGHIKITD 311 (516)
T ss_pred c--CceEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec----cCCceEeee
Confidence 7 67899999999999999888764 4588999999999999999999999999999999999999 889999999
Q ss_pred cCCcccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++.... ...+.++||||.|+|||++. +..|+..+|||.+||+||||++|++||.+.+.+.++..|+...+ .+
T Consensus 312 FGLCKE~I~~g~t~kTFCGTPEYLAPEVle--DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kF 387 (516)
T KOG0690|consen 312 FGLCKEEIKYGDTTKTFCGTPEYLAPEVLE--DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KF 387 (516)
T ss_pred cccchhcccccceeccccCChhhcCchhhc--cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cC
Confidence 999986443 44566799999999999998 45789999999999999999999999999999998888887665 47
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRVM 1143 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~L 1143 (1157)
|..++++.+.|+..+|.+||.+|- .+++|.++-.+.
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~ 428 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA 428 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence 889999999999999999999993 577777765443
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.23 Aligned_cols=246 Identities=25% Similarity=0.499 Sum_probs=192.9
Q ss_pred EEecccCcEEEEEEEEC-C---ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 881 QELGSGTFGTVYRGKWR-G---TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k-G---t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
++||+|+||+||+|+.. + ..+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ....+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~ 71 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYL 71 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceE
Confidence 36999999999999763 2 346777654321 12224567889999999999999999999877 56799
Q ss_pred EEEEeecCCcchhhhcccc----ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 957 TVTEYMVNGSLRHVLARKD----RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~g----r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+||||+.+|+|.+++.... ...++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~dfg~~ 147 (269)
T cd05042 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLA 147 (269)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----CCCcEEEeccccc
Confidence 9999999999999986532 2346778889999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc---ccCCCCCCCcccCcccccCC-----CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC-
Q 001103 1033 RIKCNTL---VSGGVRGTLPWMAPELLNGS-----NNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT- 1102 (1157)
Q Consensus 1033 kl~~~~~---~sts~~GTp~YmAPEVL~G~-----~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~- 1102 (1157)
....... ......++..|+|||++... ...++.++|||||||++|||++ |..||........+.......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence 6432211 12233467789999987531 2346889999999999999999 889998877665555443322
Q ss_pred ---CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1103 ---LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1103 ---lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
..+.++..+++.+.+++..|+ .||.+|||+++|++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 228 IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 223455678899999999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.16 Aligned_cols=245 Identities=37% Similarity=0.651 Sum_probs=203.2
Q ss_pred EEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEE
Q 001103 881 QELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVT 959 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVM 959 (1157)
++||+|+||.||++.+. ++.||+|.++.... ......+.+|++++++++||||+++++++.. ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVM 71 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEE
Confidence 36999999999999885 78899998875421 1234678899999999999999999999877 56889999
Q ss_pred EeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc
Q 001103 960 EYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039 (1157)
Q Consensus 960 EYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~ 1039 (1157)
||+.+++|.+++.+....+++..++.++.+++.+|.|||+++++||||||+|||++ .++.+||+|||++.......
T Consensus 72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~----~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc----CCCcEEEeeccccccccCCc
Confidence 99999999999876555688999999999999999999999999999999999998 67789999999987543211
Q ss_pred cc---CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHH
Q 001103 1040 VS---GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEW 1115 (1157)
Q Consensus 1040 ~s---ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeL 1115 (1157)
.. ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+.. ......+...+.++
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 224 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEI 224 (251)
T ss_pred ceeccccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHH
Confidence 11 112345679999998754 57899999999999999998 8999988776555554433 33445567788999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1116 RKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1116 rdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+||.+||..+|.+||++.++++.|.
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=303.31 Aligned_cols=253 Identities=31% Similarity=0.494 Sum_probs=212.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|.+.+.||+|++|.||+|... +..+++|++...... ....+.+.+|+.++++++||||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4778899999999999999985 778999998765221 23357788999999999999999999998874337
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..+++|||+.+++|.+++.+.. .+++..++.++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD----SDGVVKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcccccEE
Confidence 8999999999999999987654 689999999999999999999999999999999999998 67899999999988
Q ss_pred cccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhHHHHHhhhcCCCCCCCC
Q 001103 1034 IKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1034 l~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-~eeil~~Il~~~lrpeip~ 1109 (1157)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.... .......+......+.++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence 6554432 3446689999999998754 47889999999999999999999998765 2233333333344556777
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+++.+++||.+||+.+|.+||++.+++++.+
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 88999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.55 Aligned_cols=253 Identities=29% Similarity=0.493 Sum_probs=206.5
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||++.. .+..||+|+++..... ......+.+|+.+++.++|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND------PKTIKEIADEMKVLELLKHPNLVKYYGVEVH--RE 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc------hHHHHHHHHHHHHHHhCCCCChhheeeeEec--CC
Confidence 588899999999999999987 4678999998765211 3346788999999999999999999999876 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+++|+||+.+++|.+++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++ ..+.+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccccccc
Confidence 899999999999999998754 3478889999999999999999999999999999999998 67789999999987
Q ss_pred cccCCcc-----cCCCCCCCcccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1034 IKCNTLV-----SGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1034 l~~~~~~-----sts~~GTp~YmAPEVL~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
....... .....++..|+|||++.+.. ..++.++||||||+++|+|++|+.||..................+.+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 6433222 12356889999999987543 33788999999999999999999999766433322222222334444
Q ss_pred CCC--CcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1108 PER--CDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1108 p~~--iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+.. +++.+.+||.+||+.+|.+||++.+++.+.|
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 544 4899999999999999999999999987643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=316.79 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=209.5
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||+++++ +..||+|++.+..... ....+.+.+|++++++++||||+++++.+.+ ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-----KGSVRNVLNERRILQELNHPFLVNLWYSFQD--EE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-----hhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CC
Confidence 4889999999999999999985 7889999998643211 1235678899999999999999999999876 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..++||||+.+++|..++... ..+++..+..++.|++.||.|||+++|+|+||||+||+++ +++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~----~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc----CCCCEEEeeccccc
Confidence 899999999999999998765 4688999999999999999999999999999999999998 67789999999987
Q ss_pred cccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--hHHHHHhhhcCCCCCCCCCC
Q 001103 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC--GAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1034 l~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~--eeil~~Il~~~lrpeip~~i 1111 (1157)
............|+..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ...+...... .....+..+
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATW 225 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccC
Confidence 65544344456789999999998754 478899999999999999999999987764 2222222221 445677788
Q ss_pred cHHHHHHHHHHhccCCCCCCCH--HHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSF--TEITNRL 1140 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSa--eELLe~L 1140 (1157)
+..+.++|.+||+.||.+||++ .+++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~ 256 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKNHP 256 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence 9999999999999999999999 8877654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=315.51 Aligned_cols=250 Identities=33% Similarity=0.535 Sum_probs=208.2
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||.|+||.||++.++ +..+|+|++..... ......+.+|+++++.++||||+++++.+.. ..
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-------EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NG 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-------hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CC
Confidence 6788899999999999999985 67799998876421 1234678899999999999999999999877 57
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
.++++|||+.+++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++ ..+.++|+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~----~~~~~~l~d~g~~ 148 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDFGVS 148 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC----CCCCEEEeecccc
Confidence 8999999999999999997655678999999999999999999999 9999999999999998 6778999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----hhHHHHHhhhcCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-----CGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-----~eeil~~Il~~~lrpei 1107 (1157)
.......... ..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.... .......+... ..+.+
T Consensus 149 ~~~~~~~~~~-~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 224 (265)
T cd06605 149 GQLVNSLAKT-FVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPRL 224 (265)
T ss_pred hhhHHHHhhc-ccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCCC
Confidence 7543332222 6789999999999764 67899999999999999999999997652 22233333322 23334
Q ss_pred CCC-CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1108 PER-CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~-iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+.. +++++++||.+||..+|.+|||+.+++.+.+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 444 88999999999999999999999999998776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.38 Aligned_cols=262 Identities=29% Similarity=0.510 Sum_probs=213.3
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC---------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCc
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPN 939 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG---------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPN 939 (1157)
+.+...+|++.+.||+|+||.||++++.+ ..||+|.++... .......+.+|+++++++ +|||
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCCC
Confidence 34555689999999999999999997621 258999876431 112246788999999999 7999
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCcchhhhccc---------------cccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK---------------DRILDRRKKLMLMMDAAFGMEYLHMKNIVH 1004 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~---------------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIH 1004 (1157)
|+++++++.. .+.++++|||+.+++|.+++.+. ...+++..++.++.|++.||.|||++||+|
T Consensus 80 iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 80 IINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred eeeeeEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 9999999877 56789999999999999998642 234778889999999999999999999999
Q ss_pred ccCCccceeeccCCCCCCeEEEEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1005 FDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1005 RDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
|||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||+||||++
T Consensus 158 ~dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 158 RDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred cccccceEEEc----CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHh
Confidence 99999999998 667899999999875433211 1222345679999999754 57889999999999999998
Q ss_pred -CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1082 -GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
|..||......+....+.. ......+..++.++.+||.+||+.+|.+|||+.++++.|+.+....
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 232 LGGSPYPGIPVEELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred cCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 8999998877776665543 3444566778899999999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.66 Aligned_cols=252 Identities=28% Similarity=0.465 Sum_probs=207.5
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++.+.||.|+||+||++.+ .+..+|+|++...... . ....+.+|+++++.++|+||+++++.+.. .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ------T-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--G 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc------h-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--C
Confidence 3789999999999999999987 4667999998753211 1 34678899999999999999999998877 5
Q ss_pred CcEEEEEEeecCCcchhhhccc--cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 953 GTMATVTEYMVNGSLRHVLARK--DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~--gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
...+++||++++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++ +++.+||+|||
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~----~~~~~~l~df~ 147 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFG 147 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEcccc
Confidence 6899999999999999998653 24689999999999999999999999999999999999998 66789999999
Q ss_pred CcccccCCcc-----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1031 LSRIKCNTLV-----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1031 LAkl~~~~~~-----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
++........ .....|+..|+|||++... ..++.++|+|||||++|+|++|+.||........+........ +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 225 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-P 225 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-C
Confidence 9875443221 1334689999999998754 3578899999999999999999999987766555555443321 1
Q ss_pred CCC-----CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1106 QIP-----ERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1106 eip-----~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.++ ..+++.+.+||.+||.+||.+||++.+|+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 111 256789999999999999999999999998754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.97 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=202.8
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.+.....||+|+||.||++++. +..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. ..
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 78 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NG 78 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CC
Confidence 3444568999999999999874 5669999876531 1124578899999999999999999999887 56
Q ss_pred cEEEEEEeecCCcchhhhccccccc--cHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRIL--DRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L--~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
..+++|||+.+++|.+++......+ ++..+..++.|++.||.|||++||+||||||+|||++. ..+.+||+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~---~~~~~~l~dfg~ 155 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT---YSGVVKISDFGT 155 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCeEEEecchh
Confidence 8999999999999999987654445 78888999999999999999999999999999999972 356899999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCCCCCCCC
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~lrpeip~ 1109 (1157)
+...... .......|++.|+|||.+.+....++.++|+||||+++|+|++|+.||....... ...........+.++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE 235 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCc
Confidence 8754322 2223346899999999987554457889999999999999999999997654322 1112211223345677
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+++++++||.+||+.+|.+|||+.+++.+.+
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 78999999999999999999999999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=302.72 Aligned_cols=248 Identities=30% Similarity=0.534 Sum_probs=207.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|+..+.||+|++|.||++.+. +..+++|++..... .....+.+|+.+++.++||+|+++++++.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KD 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CC
Confidence 5788999999999999999985 77799999876421 234678899999999999999999999887 46
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..+++|||+++++|.+++....+.+++..++.++.|++.||.|||++|++||||+|+||+++ ..+.++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----cCCeEEEeeccccc
Confidence 78999999999999999877656789999999999999999999999999999999999998 67899999999987
Q ss_pred cccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--CCC
Q 001103 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--ERC 1111 (1157)
Q Consensus 1034 l~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~~i 1111 (1157)
............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||................ .+.++ ..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 223 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PPGLRNPEKW 223 (253)
T ss_pred cccccccccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-CCCcCccccc
Confidence 65544323446789999999998754 46889999999999999999999998775544444433322 22222 234
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
+..+.++|.+||+.||.+|||+.+++++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 88999999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=322.04 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=209.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||+||++++. +..||+|++.... .......+.+|+++++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 74 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLN- 74 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEec-
Confidence 3468889999999999999999985 7789999887531 12234678899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+++||||+++++|..++.+. +.+++..++.++.+++.+|.|||+ .+|+||||||+||+++ ..+.++|+||
T Consensus 75 -~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~d~ 148 (284)
T cd06620 75 -ENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCDF 148 (284)
T ss_pred -CCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC----CCCcEEEccC
Confidence 46899999999999999888654 358899999999999999999997 5899999999999998 6778999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-----------HHHHHh
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-----------AIIGGI 1098 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-----------eil~~I 1098 (1157)
|++....... .....|+..|+|||++.+. .++.++|+|||||++|+|++|+.||...... ..+..+
T Consensus 149 gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 149 GVSGELINSI-ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred Ccccchhhhc-cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 9986532222 2345799999999998754 5788999999999999999999999865432 222333
Q ss_pred hhcCCCCCCCC-CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1099 LSNTLRPQIPE-RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1099 l~~~lrpeip~-~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.... .+.++. .++.++.+||.+||+.||.+|||+.+++++++.+....
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 226 VQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred hhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 2222 222333 37889999999999999999999999999987766443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=320.24 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=207.0
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||++.+ .+..||+|.+...... ....+.+|+.+++.+.||||+++++.+.. .
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~ 89 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV--G 89 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--C
Confidence 5899999999999999999987 4678999988754211 13567889999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...|+||||+++++|.+++.+ ..+++.+++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----~~~~~kl~dfg~~ 163 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 163 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCCCEEECccccc
Confidence 689999999999999998854 3478889999999999999999999999999999999998 6678999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpeip~~ 1110 (1157)
....... ......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+... ......+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 7533221 22335689999999998753 4688999999999999999999999876654333333222 222234566
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+++.+.+||.+||..+|.+||++.+++++.+...
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 8899999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.18 Aligned_cols=251 Identities=22% Similarity=0.425 Sum_probs=210.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++++.||+|+||.||+++. .++.||+|++...... ......+.+|+.++++++||||+++++++.. .+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEE--NG 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CC
Confidence 588999999999999999987 4678999998754221 1123577899999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++++|+||+|+|||++ .++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~----~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEEeeccce
Confidence 899999999999999888653 34578999999999999999999999999999999999998 6678999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
....... ......|++.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+..... +..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHY 225 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccC
Confidence 7543322 12234588999999998754 568899999999999999999999988777666666654433 3456778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+.+++++|.+||+.+|.+||++.+++++.+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.81 Aligned_cols=255 Identities=28% Similarity=0.379 Sum_probs=205.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||+|+++ ++.+|+|.++..... +.....+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 47889999999999999999984 677999998765221 1123456789999999999999999999877545
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...|+||||+.+ +|.+++......+++..++.++.|++.||+|||+++|+|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCcEEEeecCce
Confidence 789999999975 89888876666789999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc----------
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---------- 1101 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~---------- 1101 (1157)
...... .......+++.|+|||.+.+. ..++.++|+||||+++|+|++|.+||........+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eeccCCccccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 765443 223334588999999998754 24688999999999999999999999876655444333211
Q ss_pred -------------------CCCCCCCCC-CcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1102 -------------------TLRPQIPER-CDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1102 -------------------~lrpeip~~-iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.....++.. +++.+++||.+||+.+|++|||+++++++-|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 001112222 5888999999999999999999999998744
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.36 Aligned_cols=247 Identities=26% Similarity=0.470 Sum_probs=192.7
Q ss_pred EEecccCcEEEEEEEECC----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 881 QELGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~kG----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
+.||+|+||.||+|++.+ ..+|+|.++.... ......+.+|+.++++++||||+++++++.+ ....+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 71 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYL 71 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcE
Confidence 368999999999998743 3589998765421 1123467889999999999999999999877 45789
Q ss_pred EEEEeecCCcchhhhcccc----ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 957 TVTEYMVNGSLRHVLARKD----RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~g----r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++++||||||+|||++ ..+.+||+|||++
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----~~~~~kL~dfg~~ 147 (269)
T cd05087 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLS 147 (269)
T ss_pred EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEECCcccc
Confidence 9999999999999986432 2356677888999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc---ccCCCCCCCcccCcccccCCC-----CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC-
Q 001103 1033 RIKCNTL---VSGGVRGTLPWMAPELLNGSN-----NRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT- 1102 (1157)
Q Consensus 1033 kl~~~~~---~sts~~GTp~YmAPEVL~G~~-----~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~- 1102 (1157)
....... ......++..|+|||++.+.. ..++.++|+||||+++|||++ |+.||................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc
Confidence 7543322 122345788999999986421 135789999999999999996 999998776555443332221
Q ss_pred ---CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 ---LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 ---lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+.+....++.+.++|..|+ .+|.+|||+++|+..|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122333456788999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.12 Aligned_cols=260 Identities=31% Similarity=0.566 Sum_probs=210.1
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCc----eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGT----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt----~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
.++..+|++++.||+|+||.||++.+ .+. .+|+|++.... .......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 45667899999999999999999987 343 36778765431 112234678899999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+++... ..++++||+++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~----~~~~~ 148 (303)
T cd05110 76 GVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK----SPNHV 148 (303)
T ss_pred EEEcCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec----CCCce
Confidence 998652 36789999999999999877666688999999999999999999999999999999999998 66789
Q ss_pred EEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1025 KVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++ |..||.+......... ..
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-~~ 225 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-LE 225 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HH
Confidence 999999997543221 12233467789999998754 57899999999999999997 9999987665444333 33
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.......+..++..+.++|..||..+|++||+++++++.|+.+....
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 33444455667899999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=315.92 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=212.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|+.++.||+|+||.||+|.++ +..||||++..... ......+.+|+.+++.+.||||+++++.+.+ .
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--G 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--C
Confidence 35778899999999999999874 67799999875411 1224678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+.+++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++ ..+.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~----~~~~~~l~dfg~~ 148 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS----EQGDVKLADFGVA 148 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc----CCCCEEEcccccc
Confidence 689999999999999998864 3478889999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
....... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+ .....+.++..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEF 225 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhh
Confidence 7543322 22334688899999998754 5789999999999999999999999877665554443 233345566678
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
+..+.+||.+||+.+|.+||++.+++++.+......
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 899999999999999999999999999977765544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=320.06 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=207.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||++++. ++.||+|.+.+... ........+.+|+++++.++||||+++++.+.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFET--K 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--C
Confidence 37899999999999999999884 56799998876421 112234677899999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~----~~~~~~l~dfg~~ 148 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLS 148 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC----CCCCEEEeeCCCc
Confidence 6899999999999999999655 4588999999999999999999999999999999999998 6779999999988
Q ss_pred ccccCC----------------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 001103 1033 RIKCNT----------------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096 (1157)
Q Consensus 1033 kl~~~~----------------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~ 1096 (1157)
+..... .......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.+....+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 631110 011124578899999998753 57899999999999999999999999877777666
Q ss_pred HhhhcCCC-CCCCCCCcHHHHHHHHHHhccCCCCCCC---HHHHHHHHHH
Q 001103 1097 GILSNTLR-PQIPERCDPEWRKLMEECWSFNPAARPS---FTEITNRLRV 1142 (1157)
Q Consensus 1097 ~Il~~~lr-peip~~iSpeLrdLIkrCLqkDPskRPS---aeELLe~Lr~ 1142 (1157)
.+...... +.....+++++++||.+||+.+|.+||+ +.+++++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 66554332 2223357899999999999999999998 6788887654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.29 Aligned_cols=242 Identities=28% Similarity=0.472 Sum_probs=190.9
Q ss_pred EEecccCcEEEEEEEECCce------------EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 881 QELGSGTFGTVYRGKWRGTD------------IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~kGt~------------VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+.||+|+||.||++.+.... +++|++.... . ....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH--------R-DSLAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch--------h-hHHHHHHHHHHHHcCCCcchhheeeEEe
Confidence 36899999999999985333 6777655431 1 1467889999999999999999999887
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC---CCCCeEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD---PQRPICK 1025 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd---~e~g~VK 1025 (1157)
. ...++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .....+|
T Consensus 72 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 72 R---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred c---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 6 346899999999999999977665689999999999999999999999999999999999998322 1123799
Q ss_pred EEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1026 VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|+|||++..... .....++..|+|||++.+....++.++|+|||||++|+|++ |..||...............
T Consensus 149 l~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~--- 222 (259)
T cd05037 149 LSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ--- 222 (259)
T ss_pred eCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC---
Confidence 999999876443 22345778899999987653467899999999999999999 68888766533332222211
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
...+......+.+||.+||..+|.+|||+.++++.|
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112222347899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.66 Aligned_cols=251 Identities=31% Similarity=0.519 Sum_probs=210.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|++|.||++++. +..|+||++..... ......+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-------EEFRKQLLRELKTLRSCESPYVVKCYGAFYK--E 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--C
Confidence 37899999999999999999884 77799998876421 1234678899999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
..++++|||+++++|.+++... ..+++..++.++.|++.||.|||+ ++++||||+|+||+++ .++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~----~~~~~~l~df~~ 146 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGI 146 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC----CCCCEEEccCcc
Confidence 6899999999999999999755 458999999999999999999999 9999999999999998 678999999999
Q ss_pred cccccCCccc-CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hhHHHHHhhhcCCCCCC
Q 001103 1032 SRIKCNTLVS-GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH---CGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1032 Akl~~~~~~s-ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~---~eeil~~Il~~~lrpei 1107 (1157)
+......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.... .......+.. ...+.+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 223 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPPPSL 223 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CCCCCC
Confidence 8765433322 245688999999998754 67889999999999999999999998774 3344444443 333445
Q ss_pred CCC-CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1108 PER-CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~-iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+.. ++..+.++|.+||..+|.+||++.+++++.+.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence 555 88999999999999999999999999998665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.23 Aligned_cols=242 Identities=28% Similarity=0.525 Sum_probs=193.6
Q ss_pred EecccCcEEEEEEEECC---------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 882 ELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~kG---------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.||+|+||.||+|.++. ..+|+|.+... .....+.+.+|..+++.++||||+++++++.. .
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~ 71 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--G 71 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--C
Confidence 59999999999998742 23777766432 12234678889999999999999999999987 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC----CCCCeEEEEe
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD----PQRPICKVGD 1028 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd----~e~g~VKLiD 1028 (1157)
...++||||+.+|+|..++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++ .....++|+|
T Consensus 72 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 72 DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 568899999999999999987666789999999999999999999999999999999999998432 1223489999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG-EEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG-k~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||++...... ....++..|+|||++.+. ..++.++|||||||++|+|++| ..||.......... .... ...+
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~~ 224 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQL 224 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--cccC
Confidence 9998654332 224688899999998753 3468899999999999999998 56776655443332 2222 2345
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
+...+.++.+||.+||+.||.+|||+++|++.|
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 666778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=355.37 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=212.0
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-C-----CceeEEeeee
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-H-----PNVVAFYGVV 947 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-H-----PNIVkLygvf 947 (1157)
+|++++.||+|+||.|.+|.+. +..||||++++.. ....+...|+++|+.|+ | -|+|+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 8899999999999999999884 6679999999752 23456678999999997 4 3899999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.. .+++|||+|.+.. +|+++|+.+ ...++...++.++.||+.||.+||+.||||+|||||||||.. .....|||
T Consensus 258 ~f--r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~--~~r~~vKV 332 (586)
T KOG0667|consen 258 YF--RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD--PKRSRIKV 332 (586)
T ss_pred cc--ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc--CCcCceeE
Confidence 88 7799999999855 999999875 366999999999999999999999999999999999999973 34558999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC----
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT---- 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~---- 1102 (1157)
+|||.|........ ..+-+..|+|||++.|. +|+.+.|+||||||++||++|.+.|.+....+.+..|+.-.
T Consensus 333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY--TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred EecccccccCCcce--eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99999987555443 46789999999999976 68999999999999999999999999998887777665300
Q ss_pred -------------CC-----C----------------------------CCC-----------CCCcHHHHHHHHHHhcc
Q 001103 1103 -------------LR-----P----------------------------QIP-----------ERCDPEWRKLMEECWSF 1125 (1157)
Q Consensus 1103 -------------lr-----p----------------------------eip-----------~~iSpeLrdLIkrCLqk 1125 (1157)
+. + ..| ......+.+||++||.+
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 00 0 011 01124578999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1126 NPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1126 DPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
||.+|+|+.+.++|.+.-.....
T Consensus 489 dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred CchhcCCHHHHhcCccccccccc
Confidence 99999999999999887754443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=338.45 Aligned_cols=258 Identities=27% Similarity=0.363 Sum_probs=211.6
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN-VVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN-IVkLygvf~de~ 951 (1157)
..|+.+++||+|+||+||+|+. .|..||+|+++..... +-......+|+.+|+.|+|+| ||.+++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence 3567778899999999999988 5778999999865321 112355679999999999999 999999998743
Q ss_pred ----CCcEEEEEEeecCCcchhhhcccc---ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKD---RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~g---r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
.+.+++||||+.. +|..++.... +.++...+..++.||+.||.|||+++|+||||||+||||+ +.+.+
T Consensus 85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----~~G~l 159 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----SSGVL 159 (323)
T ss_pred cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC----CCCcE
Confidence 2479999999966 8988887655 4688899999999999999999999999999999999999 78899
Q ss_pred EEEecCCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC
Q 001103 1025 KVGDFGLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1025 KLiDFGLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l 1103 (1157)
||+|||+|+... +....+..++|.+|.|||++.|.. .|+..+||||+|||++||++++..|.+....+.+..|....-
T Consensus 160 KlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG 238 (323)
T KOG0594|consen 160 KLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG 238 (323)
T ss_pred eeeccchHHHhcCCcccccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC
Confidence 999999998655 333456677999999999999874 489999999999999999999999999988777777643111
Q ss_pred CC----------------CCC------------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1104 RP----------------QIP------------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1104 rp----------------eip------------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+ .++ ...++...+++.+||+.+|.+|.|++..+.|..+..
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 11 111 112347889999999999999999999999855443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.98 Aligned_cols=255 Identities=32% Similarity=0.538 Sum_probs=201.2
Q ss_pred CCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.+|..-..||+|+||.||+|...+ +.||||++...... . ..+|.+|+.++.+++|||+|+|+|+|.+...
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~------~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ------G--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc------c--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 467777889999999999999964 88999987764211 0 2459999999999999999999999988322
Q ss_pred cEEEEEEeecCCcchhhhccccc-cccHHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeeccCCCCCCeEEEEec
Q 001103 954 TMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDAAFGMEYLHMKN---IVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr-~L~e~qVlkIa~QLa~ALeYLHSkG---IIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
..+||+|||++|+|.+.|..... .++|.++++|+.+++.||+|||+.. |||||||++|||+| ++...||+||
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD----~~~~aKlsDF 221 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD----EDFNAKLSDF 221 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC----CCCCEEccCc
Confidence 58999999999999999987665 8999999999999999999999864 99999999999999 8889999999
Q ss_pred CCcccccC-CcccCCC-CCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hhHHHH---Hh---
Q 001103 1030 GLSRIKCN-TLVSGGV-RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH---CGAIIG---GI--- 1098 (1157)
Q Consensus 1030 GLAkl~~~-~~~sts~-~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~---~eeil~---~I--- 1098 (1157)
|+|+.... ....... .||.+|+|||.++. ..++.|+|||||||+|+||++|+.|..... ...+.. ..
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99976544 3222222 79999999999974 368999999999999999999998876432 111111 11
Q ss_pred --hhcCCCCCCC-CCCc--HH---HHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1099 --LSNTLRPQIP-ERCD--PE---WRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1099 --l~~~lrpeip-~~iS--pe---LrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+.....+.+. ...+ .+ +..+..+|++.+|.+||+|.++.+.|..+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1122223332 2223 23 567888999999999999999988885443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.82 Aligned_cols=258 Identities=26% Similarity=0.340 Sum_probs=206.4
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||+|.++ ++.||||+++....... .......+.+|+++++.++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA---KDGINFTALREIKLLQELKHPNIIGLLDVFGH--KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc---cchhhHHHHHHHHHHhhcCCCCChhhhheeec--CC
Confidence 4788899999999999999884 67899999986533211 12234567789999999999999999999987 66
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+++||||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----CCCCEEEccceeee
Confidence 899999999 8899999976554689999999999999999999999999999999999998 67789999999997
Q ss_pred cccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC-------
Q 001103 1034 IKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP------- 1105 (1157)
Q Consensus 1034 l~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp------- 1105 (1157)
...... ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||........+..+......+
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 644332 22334578899999998653 356889999999999999999988888766544443332110000
Q ss_pred -------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1106 -------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1106 -------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
......+.++.+||.+||++||.+|||+.+++++-+.-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 011235678999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.18 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=209.6
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||.|+||.||++.+ .++.||+|.+..... .....+.+|+.+++.++||||+++++++.. .
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 88 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--------PKKELIINEILVMKELKNPNIVNFLDSFLV--G 88 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--------chHHHHHHHHHHHHhcCCCceeeeeeeEec--C
Confidence 5799999999999999999986 577899998865321 113567889999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+.+++|..++... .+++.+++.++.|++.||.|||++|++||||||+||+++ ..+.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~----~~~~~kl~dfg~~ 162 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG----MDGSVKLTDFGFC 162 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccc
Confidence 6899999999999999988643 488999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-CCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-LRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~-lrpeip~~ 1110 (1157)
....... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+.... .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCccc
Confidence 7543322 22335689999999998754 57889999999999999999999998876655444443322 22334567
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+++.+.+||.+||..||.+||++.+++++.+.-.
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 8899999999999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=314.78 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=199.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.++|++.+.||+|+||.||+++. .++.||||.+....... ....+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 74 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-------APFTAIREASLLKDLKHANIVTLHDIIHT-- 74 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-------CchhHHHHHHHHhhCCCcceeeEEEEEec--
Confidence 36899999999999999999988 46789999987642111 11345689999999999999999999887
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....++||||+.+ +|.+++.+....+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~ 149 (291)
T cd07844 75 KKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGL 149 (291)
T ss_pred CCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----CCCCEEECcccc
Confidence 5689999999985 89988877666789999999999999999999999999999999999998 677899999999
Q ss_pred cccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhHHHHHhhhc---C----
Q 001103 1032 SRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAIIGGILSN---T---- 1102 (1157)
Q Consensus 1032 Akl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-~eeil~~Il~~---~---- 1102 (1157)
+....... ......++..|+|||++.+. ..++.++||||||+++|+|++|+.||.... ..+.+..+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 87543221 12233578899999998753 346889999999999999999999997655 22222211100 0
Q ss_pred --------------CC---C----CCCCCCc--HHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 --------------LR---P----QIPERCD--PEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 --------------lr---p----eip~~iS--peLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.. . .....++ +.+.++|.+||+.+|.+|||+.+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 00 0 0001233 78899999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=318.71 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=207.7
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|++.+.||+|+||+||++++ .+..||+|++...... .......+.+|+++++.++||||+++++++.. .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~ 87 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--E 87 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--C
Confidence 4688899999999999999987 4778999988654211 12224568899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+.+ +|.+++......+++..+..++.|++.||.|||+++|+||||+|+||+++ .++.+||+|||++
T Consensus 88 ~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----~~~~~kL~dfg~~ 162 (307)
T cd06607 88 HTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGSA 162 (307)
T ss_pred CeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----CCCCEEEeecCcc
Confidence 578999999974 77777655555689999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
...... ....++..|+|||++.+ ....++.++||||||+++|+|++|+.||...........+.........+..+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (307)
T cd06607 163 SLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW 239 (307)
T ss_pred eecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence 754332 23568899999998753 12457889999999999999999999998877655555444333322234457
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
++.++++|.+||+.+|.+||++.+++.+.+...
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 889999999999999999999999999877644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.47 Aligned_cols=242 Identities=27% Similarity=0.444 Sum_probs=192.0
Q ss_pred EecccCcEEEEEEEEC--------------------------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC
Q 001103 882 ELGSGTFGTVYRGKWR--------------------------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~k--------------------------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L 935 (1157)
.||+|+||.||+|.+. ...||+|++... .......+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 5999999999998752 123788877542 122346688899999999
Q ss_pred CCCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Q 001103 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVN 1015 (1157)
Q Consensus 936 ~HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd 1015 (1157)
+||||+++++++.. ....++||||+++++|..++.+..+.+++..++.++.|++.||+|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 99999999999887 5578999999999999999876666789999999999999999999999999999999999997
Q ss_pred cCC---CCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCCh
Q 001103 1016 LRD---PQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII-TGEEPYANMHC 1091 (1157)
Q Consensus 1016 ~dd---~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELL-TGk~PF~g~~~ 1091 (1157)
..+ .....+||+|||++...... ....++..|+|||.+.+. ..++.++|+|||||++|||+ +|+.||.....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 322 12345899999987543221 223578889999988753 45789999999999999985 69999987654
Q ss_pred hHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1092 eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
...... ... ...++...++.+.+||.+||+.+|.+|||+.++++.|
T Consensus 228 ~~~~~~-~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERF-YEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH-HHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 433222 222 1223444667899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=313.30 Aligned_cols=243 Identities=25% Similarity=0.428 Sum_probs=190.2
Q ss_pred EEecccCcEEEEEEEECC--------------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 881 QELGSGTFGTVYRGKWRG--------------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~kG--------------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+.||+|+||.||+|++.. ..+|+|++... .......+.+|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 368999999999998631 23777776542 12234578889999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCC---CCCe
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP---QRPI 1023 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~---e~g~ 1023 (1157)
+.. ....+++|||+++++|..++.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++. ....
T Consensus 73 ~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 73 CVR--DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred Eec--CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 877 45678999999999999888766667899999999999999999999999999999999999973221 1224
Q ss_pred EEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCChhHHHHHhhhcC
Q 001103 1024 CKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII-TGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELL-TGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
+||+|||++...... ....++..|+|||.+... ..++.++|||||||++|+|+ .|..||......+.. ......
T Consensus 151 ~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~ 225 (262)
T cd05077 151 IKLSDPGIPITVLSR---QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ 225 (262)
T ss_pred eEeCCCCCCccccCc---ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC
Confidence 899999998654322 234588899999988633 35788999999999999998 589998765543332 222222
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
. ......++++++||.+||+.||.+||++.+|++.+
T Consensus 226 ~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2 12233467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=318.57 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=200.0
Q ss_pred CeeEEEEecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.|++.+.||+|+||.||+|.+. +..||+|++...... .......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 4788999999999999999983 577999998864211 1112355678999999999999999999998865
Q ss_pred CCcEEEEEEeecCCcchhhhccc----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 GGTMATVTEYMVNGSLRHVLARK----DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~----gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
...+++||||+++ +|..++... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++...+.+||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 5789999999976 666655422 23688999999999999999999999999999999999998544448899999
Q ss_pred ecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH---------H
Q 001103 1028 DFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA---------I 1094 (1157)
Q Consensus 1028 DFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee---------i 1094 (1157)
|||++....... ......++..|+|||++.+. ..++.++|+|||||+||+|++|++||....... .
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999987543322 22345688999999988754 346889999999999999999999997654321 1
Q ss_pred HHHhhh------------------------cCCCCCCC-----------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1095 IGGILS------------------------NTLRPQIP-----------ERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1095 l~~Il~------------------------~~lrpeip-----------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
+..+.. ......++ ...+.++.++|.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111100 00001111 1456789999999999999999999999987
Q ss_pred HH
Q 001103 1140 LR 1141 (1157)
Q Consensus 1140 Lr 1141 (1157)
.+
T Consensus 314 ~~ 315 (316)
T cd07842 314 PY 315 (316)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=311.21 Aligned_cols=248 Identities=35% Similarity=0.606 Sum_probs=198.8
Q ss_pred EecccCcEEEEEEEECC--------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 882 ELGSGTFGTVYRGKWRG--------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~kG--------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.||+|+||.||++++.. ..+|||.+.+... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NE 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CC
Confidence 58999999999998742 4589998764311 1124568889999999999999999999876 55
Q ss_pred cEEEEEEeecCCcchhhhccc------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-CCCCeEEE
Q 001103 954 TMATVTEYMVNGSLRHVLARK------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICKV 1026 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd-~e~g~VKL 1026 (1157)
..+++|||+++++|.+++.+. ...+++..++.++.|++.||+|||+++++|+||||+|||++.++ .....+||
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 789999999999999988642 23478899999999999999999999999999999999998321 11238999
Q ss_pred EecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC
Q 001103 1027 GDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~ 1102 (1157)
+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...........+. ..
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 229 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AG 229 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cC
Confidence 99999875432211 1223467889999998754 57899999999999999998 999998777666555443 33
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.....+..++..+.+||.+||..+|.+||+++++++.|.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 344556678899999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.95 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=204.8
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||.|++|.||++.+ .++.+|+|.+..... ......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 3689999999999999999998 467799998875411 1234678899999999999999999999877666
Q ss_pred CcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 GTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
..+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+++|+||+|+||+++ ..+.++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----~~~~~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----RKGQVKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe----cCCeEEEeec
Confidence 789999999999999887643 345588899999999999999999999999999999999998 6678999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----hhHHHHHhhhcCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-----CGAIIGGILSNTLR 1104 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-----~eeil~~Il~~~lr 1104 (1157)
|++........ ....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.... ..+....+... ..
T Consensus 150 g~~~~~~~~~~-~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 225 (287)
T cd06621 150 GVSGELVNSLA-GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PN 225 (287)
T ss_pred ccccccccccc-ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-Cc
Confidence 99875433222 235688899999998754 57889999999999999999999998652 12233332221 11
Q ss_pred CCCC------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1105 PQIP------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 peip------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+.++ ..+++.+++||.+||+.+|.+|||+.+++++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 1111 2356789999999999999999999999998876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.48 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=207.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|++++.||+|+||.||+|.+ .+..||+|++.... .....+.+.+|++++++++||||+++++.+.. ..
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhccccc--CC
Confidence 456677899999999999987 46779999886431 11234678899999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe----CCCCEEEccccccc
Confidence 89999999999999988854 3578899999999999999999999999999999999998 67789999999987
Q ss_pred cccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1034 IKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1034 l~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
...... ......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+. ....+.++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYS 226 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccC
Confidence 544322 22335688999999999754 57889999999999999999999998766555444332 233445566788
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.++.+||.+||+.+|.+||++.+++++.+...
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 99999999999999999999999999877543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=318.82 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=206.5
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||++.. .+..||+|.+...... ..+.+.+|+.+++.++||||+++++++.. .
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 88 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV--G 88 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 6899999999999999999987 4778999988753211 12557889999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++ .++.++|+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~----~~~~~~l~Dfg~~ 162 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 162 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEECcCccc
Confidence 689999999999999998854 3478889999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpeip~~ 1110 (1157)
....... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 7543322 22335689999999998754 5688999999999999999999999765543333222222 222234566
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++.+++||.+||..+|.+||++++++++.+.-
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 273 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence 888999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=311.55 Aligned_cols=251 Identities=25% Similarity=0.472 Sum_probs=205.5
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC---CCceeEEeeeeecC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH---HPNVVAFYGVVPNG 950 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~---HPNIVkLygvf~de 950 (1157)
.|++++.||+|+||.||+|.+ .+..||+|+++.... ......+.+|+.+++.+. |||++++++++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~- 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK- 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-
Confidence 477889999999999999998 467899999875311 112456778999999996 9999999999876
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....+++|||+.+++|.+++... .+++..++.++.|++.||.|||++||+|+||+|+||+++ ..+.++|+|||
T Consensus 74 -~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~----~~~~~~l~dfg 146 (277)
T cd06917 74 -GPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT----NTGNVKLCDFG 146 (277)
T ss_pred -CCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc----CCCCEEEccCC
Confidence 56889999999999999988653 588999999999999999999999999999999999998 67799999999
Q ss_pred CcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
++....... ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||...........+... ..+.++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLED 224 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCc
Confidence 987543322 22335689999999998643 34688999999999999999999999877655444333222 2333443
Q ss_pred -CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1110 -RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1110 -~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+.++.++|.+||+.||.+||++.+++++.+..
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~ 259 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence 3788999999999999999999999999987763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.05 Aligned_cols=251 Identities=27% Similarity=0.498 Sum_probs=213.0
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||.|+||.||++.+. +..+|+|++...... ......+.+|+++++.++|||++++++.+.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS------EKEREDALNEVKILKKLNHPNIIKYYESFEE--KG 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC------hHHHHHHHHHHHHHHhcCCCChhheEEEEec--CC
Confidence 5889999999999999999985 778999998764221 2234667899999999999999999999887 47
Q ss_pred cEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 954 TMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
..+++|||+++++|.+++.+. +..+++..++.++.+++.||.|||++|++|+||+|+|||++ ..+.++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~----~~~~~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc----CCCcEEECCcc
Confidence 899999999999999988764 36789999999999999999999999999999999999998 67789999999
Q ss_pred CcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
++....... ......|++.|+|||.+.+. .++.++|+||||+++|+|++|+.||................ ...++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 225 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPS 225 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCC
Confidence 987654432 23345689999999998754 47889999999999999999999998877666666555443 445667
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.++..+.++|.+||..+|.+||++.+++++.+
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 88999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=326.09 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=202.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||++++ .++.||||++.+... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 46899999999999999999987 577899998865311 1112356778999999999999999999886432
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
....|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~----~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEc
Confidence 2357999999965 787777533 78889999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC---
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--- 1104 (1157)
|||++.............++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999876554444456789999999999754 5789999999999999999999999876644333322110000
Q ss_pred -----------------C---------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1105 -----------------P---------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1105 -----------------p---------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+ ..+...++++++||.+||+.||++|||+.+++++.|.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0 00113456789999999999999999999999987753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=312.51 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=200.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++++.||.|+||.||+|++ .+..||||+++...... .....+.+|++++++++||||+++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHT--EN 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc------ccchHHHHHHHHHHhcCCCCCcchhhhccc--CC
Confidence 488999999999999999988 46789999887542111 123567889999999999999999999876 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++||||+. ++|..++... ...+++..++.++.|++.||+|||+++++||||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~----~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEeeccch
Confidence 8999999996 5788777543 35689999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC------
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP------ 1105 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp------ 1105 (1157)
....... ......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||...........+......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hhcccCccccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 7543222 22334578899999988754 345889999999999999999999998766544333332110000
Q ss_pred ---------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1106 ---------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1106 ---------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+...+++++++||.+||+.||.+||++++++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 012246788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.31 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=202.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||.||+|.++ ++.||+|++.+.... ....+.+.+|+++++.++||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRR--K 72 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhccc--C
Confidence 37899999999999999999984 678999987654211 1223567789999999999999999999876 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+.+++|..+.... ..+++..++.++.|++.||.|||+++|+|+||+|+||+++ .++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~----~~~~~~l~dfg~~ 147 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFA 147 (286)
T ss_pred CeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCcEEEEeeeee
Confidence 6899999999999888776543 3488999999999999999999999999999999999998 6779999999998
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc----------
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---------- 1101 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~---------- 1101 (1157)
...... .......++..|+|||++.+. ..++.++||||||+++|+|++|++||......+....+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 764332 222345688999999998753 34678999999999999999999999765543332222110
Q ss_pred ----------CCCC---------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1102 ----------TLRP---------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1102 ----------~lrp---------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
...+ .....++..+.+||.+||..+|.+||++.+++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 0000 012356788999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.57 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=195.7
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|.+++.||+|+||.||+|.. .+..||+|++....... ....+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~ 75 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-------VPFTAIREASLLKGLKHANIVLLHDIIHT--K 75 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-------CcHHHHHHHHHHHhcCCCCEeEEEEEEec--C
Confidence 5799999999999999999987 47789999987542111 12345689999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...|+||||+. ++|...+......+++..+..++.|++.||.|||++||+||||||+|||++ ..+.+||+|||++
T Consensus 76 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Dfg~~ 150 (291)
T cd07870 76 ETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS----YLGELKLADFGLA 150 (291)
T ss_pred CeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc----CCCcEEEeccccc
Confidence 68899999996 577666655445578888899999999999999999999999999999998 6778999999998
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhh----------
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILS---------- 1100 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~---------- 1100 (1157)
+..... .......+++.|+|||.+.+. ..++.++|+|||||++|+|++|+.||...... +.+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 151 RAKSIPSQTYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred cccCCCCCCCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 754322 122334579999999998753 24678999999999999999999999765432 11111110
Q ss_pred -----------cCCCCCCC---------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1101 -----------NTLRPQIP---------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1101 -----------~~lrpeip---------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.......+ ...++.+.++|.+||..||.+|||+.+++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 00000000 012568899999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=348.55 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=211.4
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGV 946 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygv 946 (1157)
+..++...|+++++||+|+.+.||++... .+.||+|++.... .....+.-+.+|+.+|.+|+ |.+||+||++
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE------ADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh------cCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 44577889999999999999999999874 4558888765431 22345688999999999995 9999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
-.. ++++||||||= ..+|..+|++....++...++.+..||+.+++++|+.||||.||||.|+|+ -.|.+||
T Consensus 429 Ev~--d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-----VkG~LKL 500 (677)
T KOG0596|consen 429 EVT--DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-----VKGRLKL 500 (677)
T ss_pred ecc--CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-----EeeeEEe
Confidence 777 78999999975 459999998877666656888899999999999999999999999999999 4689999
Q ss_pred EecCCcccccCCcc---cCCCCCCCcccCcccccCCC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhH
Q 001103 1027 GDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSN---------NRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGA 1093 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~---------~~yS~KSDIWSLGVILYELLTGk~PF~g~~-~ee 1093 (1157)
+|||+|.......+ ..+.+||+.||+||.+.... -+.+.++||||||||||+|+.|++||.... ...
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a 580 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA 580 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH
Confidence 99999986554433 45678999999999986422 226789999999999999999999998765 345
Q ss_pred HHHHhhhcCCCCCCCCCCcH-HHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1094 IIGGILSNTLRPQIPERCDP-EWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1094 il~~Il~~~lrpeip~~iSp-eLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+.+|.+.....++|.--+. ++.++++.||++||.+||++.+||++..
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 55566555444455544333 3999999999999999999999999754
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.28 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=201.9
Q ss_pred ecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 883 LGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 883 LGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
||+|+||+||++.+ +|+.||+|++.+..... ......+.+|+++++.++||||+++++.+.. .+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-----RKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-----hhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEe
Confidence 69999999999987 47789999987642211 1223556789999999999999999999877 568999999
Q ss_pred eecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc
Q 001103 961 YMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039 (1157)
Q Consensus 961 YmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~ 1039 (1157)
|+++++|.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~----~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccCcchhhhccCC
Confidence 999999998886544 3589999999999999999999999999999999999998 67789999999987654433
Q ss_pred ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh--cCCCCCCCCCCcHHHHH
Q 001103 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS--NTLRPQIPERCDPEWRK 1117 (1157)
Q Consensus 1040 ~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~--~~lrpeip~~iSpeLrd 1117 (1157)
......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+.. .......+..+++.+++
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 33445688999999998754 478899999999999999999999976543211111111 12233456678999999
Q ss_pred HHHHHhccCCCCCC-----CHHHHHHHHHHHH
Q 001103 1118 LMEECWSFNPAARP-----SFTEITNRLRVMS 1144 (1157)
Q Consensus 1118 LIkrCLqkDPskRP-----SaeELLe~Lr~Lk 1144 (1157)
+|.+||+.+|.+|| ++.+++++.+...
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 99999999999999 8888999877644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.92 Aligned_cols=251 Identities=28% Similarity=0.408 Sum_probs=201.3
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++++.||.|++|.||+|++. |..||||+++...... ....+.+|+.+++.++||||+++++.+.. .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-------TPSTAIREISLMKELKHENIVRLHDVIHT--EN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-------chHHHHHHHHHHHhhcCCCEeeeeeeEee--CC
Confidence 5889999999999999999984 7789999987642211 12456789999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhcccc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 954 TMATVTEYMVNGSLRHVLARKD--RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~g--r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
..++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~----~~~~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGL 146 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCcEEEeecch
Confidence 78999999986 8888776543 4589999999999999999999999999999999999998 677899999999
Q ss_pred cccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-------
Q 001103 1032 SRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL------- 1103 (1157)
Q Consensus 1032 Akl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l------- 1103 (1157)
+....... ......++..|++||++.+. ..++.++|+|||||++|+|++|+.||......+....+.....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 87543321 22234578899999998754 3468899999999999999999999987765554444322110
Q ss_pred ---------CCC-----------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1104 ---------RPQ-----------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1104 ---------rpe-----------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
... +...+++.++++|.+||+.||.+||++.+++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 000 11235778999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=352.43 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=226.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
...|.+.+.||+|.|++|.++++ +++.||||.+.+.... ...+.++.+|+++|+.|+|||||++|.+...
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln------~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-- 126 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN------PSKRQKLGREVDIMKSLNHPNIVKLFSVIET-- 126 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC------hHHHHHHHHHHHHHHhcCCcceeeeeeeeee--
Confidence 35789999999999999999988 6889999999886322 2234568999999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+|+||||+.+|.+.+++.+.++ +.+..+..++.|++.|++|||+++|+|||||++|||++ .+.++||+|||+
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~----~~mnikIaDfgf 201 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD----ENMNIKIADFGF 201 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc----cccceeeecccc
Confidence 5689999999999999999998876 45588999999999999999999999999999999999 778899999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
+..........++||++.|+|||+++|..+ -+.++|+||||++||.|+.|.+||.+..........+.+.++ ++.-+
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y-~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~m 278 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKY-DGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYM 278 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCccc-CCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--cccee
Confidence 998887778888999999999999998754 478999999999999999999999988877777777666665 55567
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+.+..++|+++|-++|.+|++.+++.++-|....
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 8899999999999999999999999998776544
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.95 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=211.0
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|+..+.||+|+||.||++++ .+..+|+|++...... .......+.+|+++++.++|||++++++++.+ .
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--E 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-----chHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--C
Confidence 3477889999999999999987 4677999988754211 12234678899999999999999999999887 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+.+ +|.+++......+++..+..++.|++.||.|||+++|+||||+|+||+++ .++.+||+|||++
T Consensus 98 ~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~----~~~~~kl~dfg~~ 172 (317)
T cd06635 98 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSA 172 (317)
T ss_pred CeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC----CCCCEEEecCCCc
Confidence 578999999975 77777766566689999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
...... ....|+..|+|||.+.. ....++.++|+|||||++|+|++|+.||...........+............+
T Consensus 173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T cd06635 173 SIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 249 (317)
T ss_pred cccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccc
Confidence 654322 23568999999998742 12357889999999999999999999998877666666665555444445567
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
++.+++||.+||+.+|.+||++.+++++++.+..
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 8899999999999999999999999998776543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.35 Aligned_cols=249 Identities=24% Similarity=0.457 Sum_probs=209.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||++++ .+..+|+|++...... ......+.+|+++++.++||||+++++++.. ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS------QKEREDAVNEIRILASVNHPNIISYKEAFLD--GN 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc------HHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CC
Confidence 588999999999999999987 4667999998764221 1224567789999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 954 TMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
..++||||+++++|..++.+. ...+++..++.++.|++.||.|||++|++|+||+|+||+++ ..+.+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~----~~~~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV----ANDLVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe----cCCcEEEeecc
Confidence 899999999999999888652 34588999999999999999999999999999999999998 56789999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
++...... ......+++.|++||.+.+. .++.++|+||||+++|+|++|+.||...........+..... +.++..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 224 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-PPIPPI 224 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCchh
Confidence 99765544 33345689999999999754 568899999999999999999999998877666555554433 345567
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
++.+++++|.+||+.+|.+||++.++++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.59 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=202.3
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||+|.++ +..||||+++.... .......+.+|++++++++|+||+++++++.. .+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 73 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KG 73 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc------cccchhHHHHHHHHHHhcCCCCeeehhheEEE--CC
Confidence 6899999999999999999884 66799998875421 11234678899999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..+++|||+.++.+..++. ....+++..++.++.|++.||.|||+++|+||||||+||+++ ..+.+||+|||++.
T Consensus 74 ~~~iv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~----~~~~~kl~d~g~~~ 148 (288)
T cd07833 74 RLYLVFEYVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFAR 148 (288)
T ss_pred EEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEEeeeccc
Confidence 8999999999877665554 344589999999999999999999999999999999999998 67899999999987
Q ss_pred cccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc----------
Q 001103 1034 IKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---------- 1101 (1157)
Q Consensus 1034 l~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~---------- 1101 (1157)
...... ......++..|+|||++.+. ..++.++|+||||+++|+|++|++||........+..+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 149 ALRARPASPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred ccCCCccccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 654432 33346688999999998754 25789999999999999999999999876544332222110
Q ss_pred ------CC--------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1102 ------TL--------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1102 ------~l--------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+ ....+..+++++++||++||..+|.+||++++++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 00 00123345889999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.82 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=209.5
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
-|++++.||+|+||.||++.+ .+..||||++.... .......+.+|+.++++++||||+++++.+.. ..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CC
Confidence 467889999999999999987 46779999876431 11224678899999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..++||||+.+++|..++.. ..+++..++.++.|++.+|.|||++|++|+||||+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC----CCCCEEEeecccce
Confidence 89999999999999988864 3478999999999999999999999999999999999998 66789999999987
Q ss_pred cccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1034 IKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1034 l~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+. ....+.++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYS 226 (277)
T ss_pred ecccchhhhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccC
Confidence 543322 22335689999999998753 56889999999999999999999998766555555443 333455667789
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.++.++|.+||+.+|.+||++.+++++.+....
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999999999998766544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.04 Aligned_cols=246 Identities=23% Similarity=0.468 Sum_probs=192.1
Q ss_pred EecccCcEEEEEEEEC-Cce---EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 882 ELGSGTFGTVYRGKWR-GTD---IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~k-Gt~---VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+||+|+||.||++++. +.. +++|.++... .......+.+|+.+++.++||||+++++.+.. ....|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEE
Confidence 5999999999999763 333 4455544321 11224678899999999999999999999887 557899
Q ss_pred EEEeecCCcchhhhcccc---ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 958 VTEYMVNGSLRHVLARKD---RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~g---r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
||||+++|+|.+++.+.. ..+++..++.++.|++.||+|||+++|+||||||+|||++ .++.+||+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~----~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----CCccEEecccccccc
Confidence 999999999999987532 3466777889999999999999999999999999999998 677899999999864
Q ss_pred ccCC---cccCCCCCCCcccCcccccCC-----CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC---
Q 001103 1035 KCNT---LVSGGVRGTLPWMAPELLNGS-----NNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT--- 1102 (1157)
Q Consensus 1035 ~~~~---~~sts~~GTp~YmAPEVL~G~-----~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~--- 1102 (1157)
.... .......++..|+|||++... ...++.++|||||||++|||++ |..||......+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc
Confidence 2211 112345688999999998532 1245788999999999999997 678998776655555543332
Q ss_pred -CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 -LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 -lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.++.++...++.+.+++..|| .+|.+||+++++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 334555668899999999999 67999999999988773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.17 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=201.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++.+.||+|++|+||+++++ ++.||+|.+...... +.....+.+|++++++++||||+++++++.. .
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 73 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHS--E 73 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc------ccchHHHHHHHHHHHhccCCCEeeEEEEEec--C
Confidence 47999999999999999999884 677999988654211 1123567789999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...|+||||+.+ +|...+... ...+++..++.++.||+.||+|||+++|+||||||+|||++. ....+||+|||+
T Consensus 74 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~dfg~ 149 (294)
T PLN00009 74 KRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGL 149 (294)
T ss_pred CeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEccccc
Confidence 689999999965 777666443 333678888999999999999999999999999999999972 345799999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-------
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL------- 1103 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l------- 1103 (1157)
+...... .......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||........+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9754322 222334678999999998753 3578899999999999999999999987665544443321100
Q ss_pred ----------------CC----CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1104 ----------------RP----QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 ----------------rp----eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+. .....+++++.++|.+||+.+|.+||++.+++++.+.-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 00 01234678899999999999999999999999986653
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.70 Aligned_cols=256 Identities=25% Similarity=0.302 Sum_probs=198.7
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~ 951 (1157)
++|++.+.||+|+||.||++++ .++.||||+++..... ......+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE------EGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc------cCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 3689999999999999999998 4678999987654211 112356778999999995 699999999886632
Q ss_pred C---CcEEEEEEeecCCcchhhhccc----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 952 G---GTMATVTEYMVNGSLRHVLARK----DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 952 ~---~~LyLVMEYmeGGSL~dlLkr~----gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
. ..+|++|||+.+ +|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ..+.+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~---~~~~~ 150 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK---QKGLL 150 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec---CCCeE
Confidence 2 248999999986 787777542 245899999999999999999999999999999999999982 26789
Q ss_pred EEEecCCcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC
Q 001103 1025 KVGDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l 1103 (1157)
||+|||++...... .......+++.|+|||++.+. ..++.++|+||||+++|+|++|..||.+.........+.....
T Consensus 151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EEeecccceecCCCccccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998754322 122233578899999988653 3468899999999999999999999987665544433322100
Q ss_pred ----------------------CC----CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1104 ----------------------RP----QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1104 ----------------------rp----eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+ .....+++++.+||.+||..||.+||++++++.+.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 00 011347888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=313.80 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=199.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~ 951 (1157)
.+|+..+.||+|+||.||++++. +..+|+|.+...... .....+.+|+.++.++. ||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-- 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-- 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--
Confidence 46677788999999999999884 677999988754211 22456788999999996 9999999999877
Q ss_pred CCcEEEEEEeecCCcchhhh---c-cccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEEE
Q 001103 952 GGTMATVTEYMVNGSLRHVL---A-RKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlL---k-r~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
....+++|||+.. +|.++. . .....+++..+..++.|++.||+|||+. +|+||||||+|||++ ..+.+||
T Consensus 75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl 149 (288)
T cd06616 75 EGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKL 149 (288)
T ss_pred CCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc----cCCcEEE
Confidence 4578899999865 544332 2 2235689999999999999999999975 999999999999998 6778999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhcC--
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSNT-- 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~~-- 1102 (1157)
+|||++.............|+..|+|||++.+.. ..++.++|||||||++|+|++|++||...... ..+..+....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 9999987654443334456899999999987531 35788999999999999999999999865421 2222222111
Q ss_pred -CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1103 -LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1103 -lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.....+..++.++.+||.+||+.+|.+|||+++++++.+.-.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 111223357899999999999999999999999999877644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=375.11 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=228.1
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+..+||++++.||+|+||.|.+++++ ++.||+|++.+..+..+. ....|+.|..+|..-+.+=|++++..|++
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~-----~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA-----ETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch-----hHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 56789999999999999999999985 456999999986554432 24678899999999999999999999998
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
..++|+|||||+||+|..+|.+.+ .+++..+++|+.+|+.||.-||+.|+|||||||+||||+ ..|++||+||
T Consensus 147 --~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld----~~GHikLADF 219 (1317)
T KOG0612|consen 147 --ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD----KSGHIKLADF 219 (1317)
T ss_pred --ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec----ccCcEeeccc
Confidence 679999999999999999999888 799999999999999999999999999999999999999 8899999999
Q ss_pred CCcccccCC--cccCCCCCCCcccCcccccC--CC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1030 GLSRIKCNT--LVSGGVRGTLPWMAPELLNG--SN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1030 GLAkl~~~~--~~sts~~GTp~YmAPEVL~G--~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|-+-..... ..+...+|||.|.+||+++. .+ ..|+..+|||||||++|||+.|..||......+.+..|+...-.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 987655432 34556789999999999853 22 67899999999999999999999999999999999999887555
Q ss_pred CCCC--CCCcHHHHHHHHHHhccCCCCCCC---HHHHHHHHHHHHHHH
Q 001103 1105 PQIP--ERCDPEWRKLMEECWSFNPAARPS---FTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1105 peip--~~iSpeLrdLIkrCLqkDPskRPS---aeELLe~Lr~Lk~aL 1147 (1157)
..+| ..+|+++++||.+++. +|..|-. ++++.+|+++--..+
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 5666 5689999999999997 6888876 999999887654433
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.55 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=203.9
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|++++.||.|+||.||++++. +..+|+|++.... . .......+.+|+++++.++|||++++++++.....+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--E----KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--c----cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678999999999999999985 5789999998652 1 1112356778999999999999999999998743478
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.++||||+.+ +|..++.+....+++..++.++.|++.||+|||++|++|+||||+|||++ +++.+||+|||++..
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~----~~~~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARP 149 (287)
T ss_pred EEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc----CCCCEEEccccceee
Confidence 9999999975 88888876656789999999999999999999999999999999999998 678999999999876
Q ss_pred ccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC--------
Q 001103 1035 KCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR-------- 1104 (1157)
Q Consensus 1035 ~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr-------- 1104 (1157)
..... ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred ccCCCcccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 54432 23334578899999987653 34688999999999999999999999877655444443321000
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1105 ---------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1105 ---------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+...+++.+.++|.+||+.+|.+||++.+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 0011113788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.07 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=198.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~- 951 (1157)
.+|++++.||+|+||.||+++.+ +..||||++....... .....+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------CchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 57999999999999999999984 6789999887542111 11234567999999999999999999876532
Q ss_pred -----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 952 -----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 952 -----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
....++||||+.+ +|.+++......+++..++.++.|++.||+|||++||+|+||||+|||++ ..+.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl 160 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT----KDGILKL 160 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC----CCCcEEE
Confidence 2357999999965 78877766555689999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh-
Q 001103 1027 GDFGLSRIKCNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS- 1100 (1157)
Q Consensus 1027 iDFGLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~- 1100 (1157)
+|||++....... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999987543221 12234678899999988653 3467899999999999999999999987664433222211
Q ss_pred -cCCCCC---------------C-------------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1101 -NTLRPQ---------------I-------------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1101 -~~lrpe---------------i-------------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+..++. + +...+..+++||.+||..||.+|||+++++++.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 000000 0 1113567889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.20 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=203.8
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 883 LGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
||+|+||.||++++. +..+|+|++...... .......+.+|++++++++||||+++++.+.. ....|++||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-----RKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh-----hhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEe
Confidence 689999999999985 788999998764221 12335678899999999999999999998876 668999999
Q ss_pred eecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc-
Q 001103 961 YMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL- 1039 (1157)
Q Consensus 961 YmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~- 1039 (1157)
|+.+++|.+++.+.+ .+++..++.++.|++.||.|||+++|+|+||+|+|||++ .++.++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~----~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc----CCCCEEEEecccchhcccCcc
Confidence 999999999997654 589999999999999999999999999999999999998 67799999999987543321
Q ss_pred --------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1040 --------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1040 --------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+............+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccC
Confidence 22335688899999998754 46889999999999999999999999888777776666544332222234
Q ss_pred cHHHHHHHHHHhccCCCCCCCH---HHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSF---TEITNRLRV 1142 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSa---eELLe~Lr~ 1142 (1157)
+..+.+||.+||+.+|.+|||+ .+++++.+.
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 8999999999999999999999 777776554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.03 Aligned_cols=252 Identities=23% Similarity=0.456 Sum_probs=207.0
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|+||.||++.++ |..+|+|.+....... ...+.+.+|+++++.++|+||+++++.+.. ..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQE--NG 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheecc--CC
Confidence 4789999999999999999884 6779999987642211 113567789999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++|||+.+++|.+++.+. ...+++..++.++.|++.||.|||+++|+|+||||+|||++. ....+||+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK---NGMVAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC---CCCeEEecccccc
Confidence 899999999999999988653 335789999999999999999999999999999999999982 2346799999998
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
....... ......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||........+..+..... ......+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNF 226 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCCC
Confidence 7544332 22234589999999998743 578899999999999999999999987776666655554433 3445567
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+.+++++|.+||..+|++|||+.+++++.|
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 227 SRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=339.48 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=195.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
....|.+.+.||+|+||.||++++. ++.||||.... ..+.+|+++|++|+|||||++++++..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~- 231 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVV- 231 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEE-
Confidence 3457999999999999999999984 56799995332 234689999999999999999999877
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.+..++|||++. ++|..++....+.+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||
T Consensus 232 -~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~----~~~~vkL~DFG 305 (461)
T PHA03211 232 -GGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN----GPEDICLGDFG 305 (461)
T ss_pred -CCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC----CCCCEEEcccC
Confidence 567899999995 688888876556799999999999999999999999999999999999998 66789999999
Q ss_pred CcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------hHHHHHhhh
Q 001103 1031 LSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-------GAIIGGILS 1100 (1157)
Q Consensus 1031 LAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~-------eeil~~Il~ 1100 (1157)
+++...... ......||+.|+|||++.+. .++.++|||||||+||||++|..|+..... ...+..++.
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 997543221 22346799999999999864 578999999999999999998765432110 111111111
Q ss_pred c-CCC-CCCC-------------------------------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1101 N-TLR-PQIP-------------------------------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1101 ~-~lr-peip-------------------------------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
. ... ..++ ...++.+.+||.+||+.||.+|||+.++|++.++
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 1 000 0000 1245688999999999999999999999999775
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.70 Aligned_cols=254 Identities=31% Similarity=0.540 Sum_probs=202.6
Q ss_pred eeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 877 LEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
|.+.+.||+|+||.||+|.++ +..||||+++.... .....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF------SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC------ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567789999999999999863 46799999875421 1122466889999999999999999999876532
Q ss_pred C----CcEEEEEEeecCCcchhhhccc-----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 952 G----GTMATVTEYMVNGSLRHVLARK-----DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 952 ~----~~LyLVMEYmeGGSL~dlLkr~-----gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
. ...+++++|+.+|+|..++... ...+++..++.++.|++.||+|||+++|+||||||+|||++ ..+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~----~~~ 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN----ENM 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc----CCC
Confidence 2 2347899999999998776421 12478889999999999999999999999999999999998 677
Q ss_pred eEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHh
Q 001103 1023 ICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~I 1098 (1157)
.+||+|||++....... ......+++.|++||.+.+. .++.++|||||||++|+|++ |++||...........+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 89999999987543222 11223456789999998754 56889999999999999999 99999887766655555
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1099 l~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.... ....+...++.+.+++.+||+.+|.+|||+.++++.|..+
T Consensus 229 ~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4332 2334556789999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.89 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=205.9
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVV 947 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf 947 (1157)
.+...+|++.+.||+|+||.||+++++ ++.||||++++... ......+.+|+.++.++ .||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-------KEENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-------hHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 345678999999999999999999996 78899999875421 11134556677766666 599999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.+ ....|++|||+.+ +|.+++......+++..+..++.|++.||.|||+ .+|+||||+|+|||++ .++.+||
T Consensus 84 ~~--~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~----~~~~~kL 156 (296)
T cd06618 84 IT--DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKL 156 (296)
T ss_pred ec--CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc----CCCCEEE
Confidence 87 5689999999854 7777776655678999999999999999999997 5999999999999998 6779999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hHHHHHhhhcCC
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSN--NRVSEKVDVYSFGIAMWEIITGEEPYANMHC-GAIIGGILSNTL 1103 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~--~~yS~KSDIWSLGVILYELLTGk~PF~g~~~-eeil~~Il~~~l 1103 (1157)
+|||++.............++..|+|||.+.+.. ..++.++|+||||+++|+|++|+.||..... .+.+..+.....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (296)
T cd06618 157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236 (296)
T ss_pred CccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC
Confidence 9999987654433333445888999999987542 3478899999999999999999999976433 233444433321
Q ss_pred -CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1104 -RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1104 -rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.......++.++++||.+||..||.+||++++++++.+...
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 11222347889999999999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=339.68 Aligned_cols=244 Identities=24% Similarity=0.428 Sum_probs=213.1
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECCce--EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kGt~--VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
+...+|.++..||+|+||.|.++..+|+. ||||++++........ ++--..|.++|... +-|.+++++.+|+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD-----vectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD-----VECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc-----ccceehhhhheecCCCCchHHHHHHHhh
Confidence 45578999999999999999999998876 9999999886654432 22234566777655 5789999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ..++|+||||+.||+|...+++-++ +.+..+..++.+|+.||-|||++|||+||||.+|||++ .++++||+|
T Consensus 421 T--mDRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd----~eGHiKi~D 493 (683)
T KOG0696|consen 421 T--MDRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIAD 493 (683)
T ss_pred h--hhheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec----cCCceEeee
Confidence 8 6789999999999999998877665 77888888999999999999999999999999999999 888999999
Q ss_pred cCCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++... ...++.++||||.|+|||++. +++|+..+||||+||+|||||.|++||.+.+.+++++.|++.... +
T Consensus 494 FGmcKEni~~~~TTkTFCGTPdYiAPEIi~--YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs--y 569 (683)
T KOG0696|consen 494 FGMCKENIFDGVTTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS--Y 569 (683)
T ss_pred cccccccccCCcceeeecCCCcccccceEE--ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--C
Confidence 99998643 445667799999999999997 457899999999999999999999999999999999999987664 6
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCC
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARP 1131 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRP 1131 (1157)
|..+|.++.++.+..|.+.|.+|-
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cccccHHHHHHHHHHhhcCCcccc
Confidence 888999999999999999999994
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.09 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=194.5
Q ss_pred EecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHH---HHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 882 ELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA---HIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEI---kILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
.||+|+||.||++++ .++.+|+|.+.+........ . ..+.+|. .++...+||+|+.+++.+.. .+..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--E---TLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--H---HHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEE
Confidence 389999999999988 46789999987653221111 1 1222333 34445589999999999887 55789
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
+||||+.+++|.+++...+ .+++..+..++.|++.||.|||+++|+||||||+|||++ .++.++|+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~----~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC----CCCCEEEccCCcceecc
Confidence 9999999999998886544 489999999999999999999999999999999999998 67789999999986543
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--HHHHHhhhcCCCCCCCCCCcHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG--AIIGGILSNTLRPQIPERCDPE 1114 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e--eil~~Il~~~lrpeip~~iSpe 1114 (1157)
... .....||..|+|||.+... ..++.++|+|||||++|+|++|..||...... ..+... .......++..++++
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPE 225 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHH
Confidence 322 2235699999999998632 34788999999999999999999999754322 122211 223344567778999
Q ss_pred HHHHHHHHhccCCCCCC-----CHHHHHHHHHHHH
Q 001103 1115 WRKLMEECWSFNPAARP-----SFTEITNRLRVMS 1144 (1157)
Q Consensus 1115 LrdLIkrCLqkDPskRP-----SaeELLe~Lr~Lk 1144 (1157)
++++|.+||..||.+|| |+++++++.++-.
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 99999999999999999 6999999877644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=296.17 Aligned_cols=248 Identities=29% Similarity=0.536 Sum_probs=209.1
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|++.+.||+|++|.||++++ .+..||+|.+...... +.....+.+|++++++++|||++++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SD 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CC
Confidence 578899999999999999987 4667999998765321 2335678999999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..+++|||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++ ..+.++|+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT----KDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC----CCCCEEEeccccce
Confidence 899999999999999998765 4589999999999999999999999999999999999998 57799999999987
Q ss_pred cccCCcc-cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1034 IKCNTLV-SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1034 l~~~~~~-sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
....... .....++..|+|||.+.+. .++.++|+|+||+++|+|++|+.||...........+.. ...+.++..++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGIS 224 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCC
Confidence 6543322 2335689999999998754 378899999999999999999999987665554444432 33345677789
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
+.++++|.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=302.70 Aligned_cols=245 Identities=28% Similarity=0.411 Sum_probs=197.1
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHH-HHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI-ISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkI-LK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||.||+|.+ .++.||||++.+..... ......+..|..+ ...++||||+++++++.. ....|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-----KNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-----HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEE
Confidence 5699999999999988 46789999987542111 1112333445444 445689999999999977 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
+|||+.+++|..++...+ .+++..+..++.|++.||.|||+.+|+||||+|+|||++ ..+.+||+|||++.....
T Consensus 75 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEeecccceeccc
Confidence 999999999999986543 588999999999999999999999999999999999998 677899999999875433
Q ss_pred CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC--CCCCCCCCcHHH
Q 001103 1038 TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL--RPQIPERCDPEW 1115 (1157)
Q Consensus 1038 ~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l--rpeip~~iSpeL 1115 (1157)
.....|+..|+|||.+.+. .++.++||||||+++|+|++|..||...........+..... .......+++.+
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224 (260)
T ss_pred ---cccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHH
Confidence 2235688999999998764 378999999999999999999999988777666665544332 233445678999
Q ss_pred HHHHHHHhccCCCCCCCH---HHHHHHHHH
Q 001103 1116 RKLMEECWSFNPAARPSF---TEITNRLRV 1142 (1157)
Q Consensus 1116 rdLIkrCLqkDPskRPSa---eELLe~Lr~ 1142 (1157)
.++|.+||+.+|++||++ .+++++.+.
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 999999999999999954 688777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=354.04 Aligned_cols=258 Identities=22% Similarity=0.314 Sum_probs=210.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-C-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeee-e
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-G-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGV-V 947 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-G-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygv-f 947 (1157)
+...++++.+.|.+|+|+.||+++.. + ..||+|++-.. .+...+.+.+|+++||.|. |+|||.+++. .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 45567889999999999999999984 3 78999998754 2345688899999999997 9999999993 3
Q ss_pred ecC--CC--CcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCC
Q 001103 948 PNG--PG--GTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQ 1020 (1157)
Q Consensus 948 ~de--~~--~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e 1020 (1157)
... .. -.++|+||||.||.|.++|... ...|++..+++|+.|+++|+.+||..+ |||||||-|||||. .
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls----~ 181 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS----A 181 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc----C
Confidence 221 11 2468999999999999999742 344999999999999999999999998 99999999999999 7
Q ss_pred CCeEEEEecCCcccccCCccc-C---------CCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 001103 1021 RPICKVGDFGLSRIKCNTLVS-G---------GVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANM 1089 (1157)
Q Consensus 1021 ~g~VKLiDFGLAkl~~~~~~s-t---------s~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~ 1089 (1157)
+++.||||||-+......... . ...-|+.|+|||++.- ....++.|+|||+|||+||-|+...+||+..
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 789999999988743322211 0 1237999999998742 2346899999999999999999999999865
Q ss_pred ChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1090 HCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1090 ~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.. .+|+...+..+-....+..|++||+.||+.||.+||++-+++..+..+..
T Consensus 262 g~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 262 GK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred cc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 33 34566666655556789999999999999999999999999999888764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.23 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=199.8
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|++++.||.|++|.||++.+ .|..||+|++...... +.....+.+|+++++.++||||+++++++.+ ...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED------EGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc------ccchhHHHHHHHHHHhcCCCCccCHhheecc--CCe
Confidence 57789999999999999987 4788999998764211 1123456789999999999999999999877 578
Q ss_pred EEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 955 MATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.|++|||+. ++|.+++.... ..+++..++.++.|++.||+|||+++++||||+|+|||++ .++.++|+|||++.
T Consensus 73 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLAR 147 (283)
T ss_pred EEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCcEEEeeccccc
Confidence 999999995 58988886543 4589999999999999999999999999999999999998 67799999999987
Q ss_pred cccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC---------
Q 001103 1034 IKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL--------- 1103 (1157)
Q Consensus 1034 l~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l--------- 1103 (1157)
...... ......++..|+|||++.+. ..++.++|+||||+++|+|++|++||........+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 543222 22233578899999988653 2468899999999999999999999987665443333221100
Q ss_pred ------------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1104 ------------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1104 ------------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.......+++.+.++|.+||+.||.+||++++++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 00112446788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=351.95 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=219.4
Q ss_pred CCeeEEEEecccCcEEEEEEEECCce--EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kGt~--VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
+-|+|++.||.|+||.||++..+.+. .|-|+|... .+..++.++-|+.||..++||+||+||+.|.. .
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~--e 101 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--E 101 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--c
Confidence 45789999999999999999886443 566776643 12335778889999999999999999998877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.++|+.|||.||-+..++-.-++.|.+.++..+++|++.||.|||+++|||||||..|||++ .+|.++|+|||.+
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T----ldGdirLADFGVS 177 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT----LDGDIRLADFGVS 177 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE----ecCcEeeeccccc
Confidence 689999999999999999988899999999999999999999999999999999999999999 7789999999987
Q ss_pred ccc-cCCcccCCCCCCCcccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-CCCC
Q 001103 1033 RIK-CNTLVSGGVRGTLPWMAPELLNG---SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-RPQI 1107 (1157)
Q Consensus 1033 kl~-~~~~~sts~~GTp~YmAPEVL~G---~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-rpei 1107 (1157)
... ..-....+|.|||.|||||+++. .+.+|+.++||||||++|.||..+.+|........++-.|..... ...-
T Consensus 178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred ccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC
Confidence 543 23344567899999999999865 356799999999999999999999999998888887777755433 3345
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
|..++..|.+|+++||.+||..||++.+|++|.+.-
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 778999999999999999999999999999987654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.96 Aligned_cols=256 Identities=27% Similarity=0.362 Sum_probs=199.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||.||+++++ +..+|||++........ ....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG------FPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC------cchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 368999999999999999999984 67799999876432111 1134568999999999999999999875533
Q ss_pred ------CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 952 ------GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 952 ------~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
...+++||||+.+ +|...+......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~----~~~~~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQGILK 155 (311)
T ss_pred ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEE
Confidence 2367999999975 67666655555699999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCCc------------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH
Q 001103 1026 VGDFGLSRIKCNTL------------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA 1093 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~------------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee 1093 (1157)
|+|||++....... ......+++.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999987533211 11234578899999988653 347889999999999999999999998766554
Q ss_pred HHHHhhhcCCC---------------------CCC-------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1094 IIGGILSNTLR---------------------PQI-------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1094 il~~Il~~~lr---------------------pei-------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
....+...... ... ...+++.+.+||.+||+.||.+|||+.+++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 44433221000 000 0234567899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=309.28 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=201.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||.||+|.++ ++.||||+++...... .....+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE------GFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc------CchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 468999999999999999999984 6789999987642111 11245678999999999999999999987643
Q ss_pred --------CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 952 --------GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 952 --------~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
.+.+++||||+.+ ++...+......+++..++.++.|++.||.|||+.||+||||||+||+++ .++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~ 154 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN----NKGQ 154 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCc
Confidence 3478999999986 67676665555689999999999999999999999999999999999998 7789
Q ss_pred EEEEecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc
Q 001103 1024 CKVGDFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~ 1101 (1157)
+||+|||++....... ......++..|+|||.+.+. ..++.++|||||||++|+|++|++||........+..+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999999987543322 22233568889999988643 34688999999999999999999999876554433333221
Q ss_pred ---CCCC-------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1102 ---TLRP-------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1102 ---~lrp-------------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.... .....++..+.+||.+||+.||.+||++++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0000 012246889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=307.90 Aligned_cols=253 Identities=29% Similarity=0.500 Sum_probs=211.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|++.+.||+|+||.||++.++ +..+|+|++..... ....+.+|+++++.++|+||+++++.+.. .
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 87 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLV--G 87 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--C
Confidence 46888899999999999999985 77899999875421 24567889999999999999999999887 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...+++|||+++++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----~~~~~~l~d~~~~ 163 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----KDGSVKLADFGFA 163 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----CCCCEEECccchh
Confidence 689999999999999999987654689999999999999999999999999999999999998 6778999999987
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC-CCCCC
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP-QIPER 1110 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp-eip~~ 1110 (1157)
....... ......++..|++||.+.+. .++.++|+||||+++|+|++|+.||...........+....... ..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEK 241 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhh
Confidence 6433221 22334588999999998754 57899999999999999999999998877665555544333322 22334
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
++..+++||.+||+.+|.+||++.+++++.+...
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 7889999999999999999999999999877665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.95 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=209.8
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~ 951 (1157)
.+|++.+.||+|+||.||+++. .+..||+|++.+..... +.....+.+|.++++++. ||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-- 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-----EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-- 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-----hHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--
Confidence 3789999999999999999988 57789999987642211 122366788999999998 9999999999877
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....+++|||+.+++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||||+||+++ .++.++|+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~----~~~~~~l~df~~ 148 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGT 148 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEecCCcc
Confidence 568999999999999999997654 589999999999999999999999999999999999998 677899999999
Q ss_pred cccccCCc---------------------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 001103 1032 SRIKCNTL---------------------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090 (1157)
Q Consensus 1032 Akl~~~~~---------------------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~ 1090 (1157)
+....... ....+.++..|+|||++.+. .++.++|+||||+++++|++|+.||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 87543221 12234688999999998753 47889999999999999999999999877
Q ss_pred hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCH----HHHHHHHH
Q 001103 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSF----TEITNRLR 1141 (1157)
Q Consensus 1091 ~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSa----eELLe~Lr 1141 (1157)
....+..+.. ....++..+++.+.+||.+||+.+|.+||++ ++++++.+
T Consensus 227 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 227 EYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 6555555543 2335667789999999999999999999999 89988754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.28 Aligned_cols=256 Identities=22% Similarity=0.371 Sum_probs=204.7
Q ss_pred CeeEEEEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 001103 876 DLEELQELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPN 949 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~d 949 (1157)
.|++.+.||+|+||.||+++. +|..||+|+++...... .....+.+.+|+++++.+ +|++|+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh----cchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478899999999999999987 46779999987642211 112235677899999999 69999999999877
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df 149 (290)
T cd05613 77 --DTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDF 149 (290)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC----CCCCEEEeeC
Confidence 56889999999999999998754 3588889999999999999999999999999999999998 6779999999
Q ss_pred CCcccccCC--cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHhhhcCC
Q 001103 1030 GLSRIKCNT--LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGGILSNTL 1103 (1157)
Q Consensus 1030 GLAkl~~~~--~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~Il~~~l 1103 (1157)
|++...... .......|+..|+|||.+.+....++.++||||||+++|+|++|..||..... ......+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~ 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--c
Confidence 998754332 12224568999999999875444567889999999999999999999974322 222222222 2
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRVMS 1144 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~Lk 1144 (1157)
.+.++..+++.+.+|+.+||+.||.+|| ++++++++.+...
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 2345667899999999999999999997 8899998755433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=360.36 Aligned_cols=266 Identities=33% Similarity=0.605 Sum_probs=227.3
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEEC---Cc----eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCcee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR---GT----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~k---Gt----~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIV 941 (1157)
+..+.....+..+.||+|+||.||.|... |. .||||.+++.. .+.....|.+|..+|++++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCccee
Confidence 34466778889999999999999999873 33 38888887642 123367899999999999999999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhccc------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVN 1015 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd 1015 (1157)
+++|++.+ .+..+|++|||+||+|..+|++. ...+.....+.++.|+++|++||+++++|||||-..|+|++
T Consensus 759 ~liGv~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~ 836 (1025)
T KOG1095|consen 759 SLIGVCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD 836 (1025)
T ss_pred eEEEeecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec
Confidence 99999988 56788999999999999999876 56799999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEEEecCCcccccCCc--ccCCC-CCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001103 1016 LRDPQRPICKVGDFGLSRIKCNTL--VSGGV-RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHC 1091 (1157)
Q Consensus 1016 ~dd~e~g~VKLiDFGLAkl~~~~~--~sts~-~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~ 1091 (1157)
....|||+|||+|+-..... ..... .-...|||||.++. +.++.|+|||||||+|||+++ |..||.+..+
T Consensus 837 ----~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 837 ----ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred ----ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 66899999999998332221 22222 23467999999984 578999999999999999999 9999999999
Q ss_pred hHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1092 eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
.+++...+.+. +.+.|..|+..+.+||..||+.+|++||++..|++.+..+.......
T Consensus 911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 99888777666 77889999999999999999999999999999999888877765443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.75 Aligned_cols=256 Identities=22% Similarity=0.369 Sum_probs=198.7
Q ss_pred EEeccc--CcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 881 QELGSG--TFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 881 rkLGsG--sFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
..||+| +||+||++++ .|+.||||++..... . ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~----~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~ 75 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC----T--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLW 75 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC----C--HHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceE
Confidence 346666 9999999988 578899999875421 1 1234678899999999999999999999987 56789
Q ss_pred EEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 957 TVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
+||||+.+++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++ ..+.+|++||+.+...
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~----~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS----GDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe----CCCcEEEechHHHhhh
Confidence 9999999999999887642 4588999999999999999999999999999999999998 6678999999854322
Q ss_pred cCCcc--------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-----
Q 001103 1036 CNTLV--------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT----- 1102 (1157)
Q Consensus 1036 ~~~~~--------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~----- 1102 (1157)
..... .....++..|+|||++.+....++.++|||||||++|+|++|++||................
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence 11100 01123566799999997654567899999999999999999999998765443332222110
Q ss_pred ----------------------------------------CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 ----------------------------------------LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 ----------------------------------------lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.....+..+++.+++||.+||+.||.+|||+++++++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 0011122356789999999999999999999999999887
Q ss_pred HHHHHh
Q 001103 1143 MSTALQ 1148 (1157)
Q Consensus 1143 Lk~aLe 1148 (1157)
-...-+
T Consensus 312 ~~~~~~ 317 (328)
T cd08226 312 KQVKEQ 317 (328)
T ss_pred HHHHHh
Confidence 554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=313.81 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=203.6
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|.....||+|+||.||++.. .+..||||.+.... ....+.+.+|+.+++.++||||+++++.+.. .+.
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~ 93 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--------QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDE 93 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--------HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCe
Confidence 44457799999999999987 46779999886431 1224668899999999999999999999877 568
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.++||||+++++|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kL~dfg~~~~ 167 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccCcchhh
Confidence 99999999999999888543 478899999999999999999999999999999999998 667899999999865
Q ss_pred ccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--CCCCC
Q 001103 1035 KCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ--IPERC 1111 (1157)
Q Consensus 1035 ~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe--ip~~i 1111 (1157)
.... .......|+..|+|||.+.+. .++.++|+||||+++|||++|+.||........+..+.. ..... .....
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKV 244 (292)
T ss_pred cccccccCceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCcccccccc
Confidence 3222 122335689999999998753 578899999999999999999999987766555444332 22222 22356
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+..+.++|.+||..||.+|||+++++++.+....
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 8899999999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=305.19 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=203.2
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|++.+.||+|++|.||++.. .+..+|+|.++..... ......+.+|++++++++||+|+++++++.. ...
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES------EGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGD 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc------chhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCC
Confidence 56788999999999999988 4677999988764221 1224577889999999999999999999877 568
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.+++|||+.+ +|.+++......+++..++.++.|++.||.|||+++|+|+||||+|||++ .++.+||+|||.+..
T Consensus 73 ~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLARS 147 (283)
T ss_pred EEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----CCCcEEEeeeeeeEe
Confidence 9999999976 88888776556789999999999999999999999999999999999998 677899999999876
Q ss_pred ccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC---------
Q 001103 1035 KCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--------- 1104 (1157)
Q Consensus 1035 ~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--------- 1104 (1157)
..... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||......+.+..+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 54433 22335688899999998754 35789999999999999999999999877655444333221000
Q ss_pred -------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1105 -------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1105 -------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
......++.++++||.+||+.||.+||++.+++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0112246788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=355.76 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=204.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|+++++||+|+||.||+|++. ++.||||+++.... ......+++.+|+++++.++||||+++++++.+ .
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--G 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--C
Confidence 47999999999999999999884 77899999875421 112345678899999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccc----------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARK----------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~----------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
+..+++|||++|++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++ ..+
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd----~dg 150 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG----LFG 150 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc----CCC
Confidence 6899999999999999988631 12345677889999999999999999999999999999998 677
Q ss_pred eEEEEecCCcccccCC-------------------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCC
Q 001103 1023 ICKVGDFGLSRIKCNT-------------------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~-------------------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk 1083 (1157)
.+||+|||+++..... ......+||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCC
Confidence 8999999999754110 011235699999999999864 5789999999999999999999
Q ss_pred CCCCCCChhHHHHHhh-hcCCCCCCCCCCcHHHHHHHHHHhccCCCCCC-CHHHHHHHHHHHHH
Q 001103 1084 EPYANMHCGAIIGGIL-SNTLRPQIPERCDPEWRKLMEECWSFNPAARP-SFTEITNRLRVMST 1145 (1157)
Q Consensus 1084 ~PF~g~~~eeil~~Il-~~~lrpeip~~iSpeLrdLIkrCLqkDPskRP-SaeELLe~Lr~Lk~ 1145 (1157)
.||............. ...........+++.+.+++.+||+.||++|| +++++++.|..+..
T Consensus 229 ~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 229 FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9998755443322211 11111111235788999999999999999995 67778777777654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=307.35 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=196.3
Q ss_pred EecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEE
Q 001103 882 ELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVT 959 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVM 959 (1157)
.||+|+||.||+++. .++.||+|.+.+........ +.........+++++...||+|+++++.+.. ....++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh--HHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEE
Confidence 389999999999987 46789999987653322111 1111122233445666789999999999887 56899999
Q ss_pred EeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc
Q 001103 960 EYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039 (1157)
Q Consensus 960 EYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~ 1039 (1157)
||+.|++|..++.+. ..+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++.......
T Consensus 77 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~----~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 77 DLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC----CCCCEEEccCcCccccCccC
Confidence 999999999888654 4589999999999999999999999999999999999998 66789999999987543222
Q ss_pred ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC---GAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1040 ~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~---eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
.....|+..|+|||.+.+. ..++.++||||+||++|+|++|+.||..... ....... ......++..+++++.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELR 227 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHH
Confidence 2235699999999998743 2478899999999999999999999986532 2222112 2234456677899999
Q ss_pred HHHHHHhccCCCCCC-----CHHHHHHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARP-----SFTEITNRLRVMST 1145 (1157)
Q Consensus 1117 dLIkrCLqkDPskRP-----SaeELLe~Lr~Lk~ 1145 (1157)
++|.+||..+|.+|| ++.+++++.+.-..
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 999999999999999 99999998766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.97 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=198.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||.||+|++ .|..||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 36899999999999999999987 47789999986421 1122456778999999999999999998875432
Q ss_pred ---CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 952 ---GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 952 ---~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
...++++|||+.+ +|..++.. +.+++..++.++.|++.||.|||++||+||||||+|||++ ..+.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~----~~~~~kl~d 149 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICD 149 (336)
T ss_pred ccccceEEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEECc
Confidence 2358999999975 77777643 3588999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh----
Q 001103 1029 FGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS---- 1100 (1157)
Q Consensus 1029 FGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~---- 1100 (1157)
||++....... ......||..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99987543221 12235689999999987543 3578999999999999999999999976554332222111
Q ss_pred -----------cC---------CCCC-----CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1101 -----------NT---------LRPQ-----IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1101 -----------~~---------lrpe-----ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.. .... .....++++.+||.+||+.+|.+|||+.+++++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~ 295 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 00 0000 112357789999999999999999999999998554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=313.22 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=205.6
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|+....||+|+||.||++.. .++.||+|++..... .....+.+|+.+++.+.||||+++++.+.. ..
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~ 91 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GE 91 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--------chHHHHHHHHHHHHhCCCCchhhhhhheee--CC
Confidence 344556799999999999987 477899999865321 113557889999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..+++|||+++++|..++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 92 ~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~----~~~~~kL~dfg~~~ 165 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT----LDGRVKLSDFGFCA 165 (297)
T ss_pred eEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc----cCCcEEEeechhHh
Confidence 89999999999999987754 3478999999999999999999999999999999999998 67899999999986
Q ss_pred cccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-CCCCCCCC
Q 001103 1034 IKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-RPQIPERC 1111 (1157)
Q Consensus 1034 l~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-rpeip~~i 1111 (1157)
...... ......|+..|+|||++.+. .++.++|+|||||++|+|++|+.||...........+..... .......+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06659 166 QISKDVPKRKSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243 (297)
T ss_pred hcccccccccceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCC
Confidence 433221 22345689999999999754 578899999999999999999999987765555544432211 12233457
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
++.+.++|.+||+.+|.+||++++++++.+....
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 8899999999999999999999999998776654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.01 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=205.3
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|...++||+|+||+||+|++ .+..||+|++...... .......+.+|+++++.++|||++++++++.+ ...
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHT 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-----chHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCE
Confidence 66678899999999999987 4778999998754211 12234567889999999999999999999987 567
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.|+||||+. ++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~----~~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC----CCCCEEEeecCCCcc
Confidence 899999996 477777766566789999999999999999999999999999999999998 677899999999864
Q ss_pred ccCCcccCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcH
Q 001103 1035 KCNTLVSGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113 (1157)
Q Consensus 1035 ~~~~~~sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSp 1113 (1157)
... .....|+..|+|||++.. ....++.++|+|||||++|+|++|..||...........+............++.
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247 (313)
T ss_pred cCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence 322 223568999999999853 1235788999999999999999999999887766655555444333334455778
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1114 EWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1114 eLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+++||.+||+.+|.+||++.+++.+.+.
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 89999999999999999999999987443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.71 Aligned_cols=255 Identities=20% Similarity=0.294 Sum_probs=197.5
Q ss_pred eEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEE
Q 001103 878 EELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyL 957 (1157)
.+.+.+|.|+++.||+++.+++.||||+++.... .......+.+|+++++.++||||+++++++.. ....++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYV 76 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEecccc------chhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEE
Confidence 3445566666777777777789999999876421 11234678899999999999999999999887 567899
Q ss_pred EEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 958 VTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
+|||+.+++|.+++.+. ...+++..+..++.|++.||+|||+++|+||||||+|||++ .++.+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~----~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS----GDGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe----cCCceEEecCccceeec
Confidence 99999999999998753 34588999999999999999999999999999999999998 66789999999886432
Q ss_pred CC--------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC----
Q 001103 1037 NT--------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR---- 1104 (1157)
Q Consensus 1037 ~~--------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr---- 1104 (1157)
.. .......++..|+|||++.+....++.++|+|||||++|+|++|+.||..................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence 11 112234578889999998754345788999999999999999999999876543332211111000
Q ss_pred ----------------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1105 ----------------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1105 ----------------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
......++.++.+||.+||++||++|||+++++++.+.-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0011223467889999999999999999999999988653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=347.41 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=217.3
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|.-++.||.|+||.||-+++. ...||||.+...... . ....+.++.|+++|++|.|||+|.+-|+|.. ...
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ----s-~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ----S-NEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHT 100 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccc----c-HHHHHHHHHHHHHHHhccCCCcccccceeec--cch
Confidence 566788999999999999883 456999998865321 1 2234778999999999999999999999987 457
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.|+|||||-| +-.+++.-..+++.+..+..|..+.+.||.|||+++.||||||..|||++ +.+.|||+|||.|..
T Consensus 101 aWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs----e~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 101 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS----EPGLVKLADFGSASI 175 (948)
T ss_pred HHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec----CCCeeeeccccchhh
Confidence 8999999966 77788777778899999999999999999999999999999999999999 889999999999876
Q ss_pred ccCCcccCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcH
Q 001103 1035 KCNTLVSGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113 (1157)
Q Consensus 1035 ~~~~~~sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSp 1113 (1157)
..+. .+|+|||.|||||++.. ..+.|+-++||||||++-.||...++|+.+++....+..|..+.-+..-...++.
T Consensus 176 ~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~ 252 (948)
T KOG0577|consen 176 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 252 (948)
T ss_pred cCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHH
Confidence 5543 34789999999999853 2356899999999999999999999999999999988888877665555667999
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1114 EWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1114 eLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.|+.|+..||++-|.+|||.++++.+...+
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence 999999999999999999999999875543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.69 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=202.1
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||++++ ++..||||.+...... ......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN------RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 5799999999999999999987 4678999998753211 1113456789999999999999999998765322
Q ss_pred ---CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 ---GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ---~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...|++|||+. ++|.+++... +.+++..++.++.|++.||.|||+++++||||||+|||++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----~~~~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDF 152 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECcC
Confidence 35899999996 5888888654 4589999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-------
Q 001103 1030 GLSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN------- 1101 (1157)
Q Consensus 1030 GLAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~------- 1101 (1157)
|++...... .......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.........+...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 999764433 223345689999999988643 24788999999999999999999999865433222211100
Q ss_pred -------------------CCCC---CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1102 -------------------TLRP---QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1102 -------------------~lrp---eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.... .....+++++.+||.+||+.+|++|||+++++++.+.-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000 112357889999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=312.24 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=207.2
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|+..+.||+|+||.||++++ .+..+|+|.+...... .......+.+|+++++.++|+|++++++++.. .
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 87 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--E 87 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--C
Confidence 3577788999999999999998 4667999988653111 12224567889999999999999999999887 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+. ++|.+++......+++..++.++.|++.||.|||+++++||||||+|||++ .++.+||+|||++
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~ 162 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 162 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC----CCCcEEECCcccc
Confidence 67899999996 578777765556689999999999999999999999999999999999998 6678999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
...... ....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...........+............+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06634 163 SIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (308)
T ss_pred eeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence 754332 235689999999997531 2346889999999999999999999998776655555554444433345568
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+..+++||.+||+.+|.+||++.+++++.+...
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 889999999999999999999999999877543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.19 Aligned_cols=248 Identities=24% Similarity=0.442 Sum_probs=203.7
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|...+.||+|++|.||++.+ .+..+++|++.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~ 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GD 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--------hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CC
Confidence 456678999999999999987 46779999876431 1123567899999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..++++||+.+++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++ .++.++|+|||++.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc----CCCcEEEcccccch
Confidence 88999999999999998876 3588899999999999999999999999999999999998 67899999999876
Q ss_pred cccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--CCCC
Q 001103 1034 IKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ--IPER 1110 (1157)
Q Consensus 1034 l~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe--ip~~ 1110 (1157)
...... ......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+.... .+. .+..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKLKNLHK 240 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCCccccc
Confidence 533221 22335689999999998754 57889999999999999999999998776655555544332 222 2334
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
++..+.+||.+||+.+|.+||++.+++++.+.
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence 78899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.98 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=204.5
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||++.. .+..||+|.+.... ....+.+.+|+.+++.++||||+++++.+.. .
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~ 88 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKHPNIVNYLDSYLV--G 88 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--------chHHHHHHHHHHHHhhcCCCCeeehhheeee--C
Confidence 6899999999999999999986 46779999876431 1113567889999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...|+||||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++ ..+.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~----~~~~~kL~dfg~~ 162 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 162 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc----CCCCEEEccCcce
Confidence 5789999999999999988653 378889999999999999999999999999999999998 6678999999988
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCCCCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpeip~~ 1110 (1157)
...... .......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (293)
T ss_pred ecccccccccccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence 643322 222335688999999998753 5688999999999999999999999876554433322211 112223445
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
++..++++|.+||..+|.+||++++++.+.+.-
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~ 273 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 688899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.81 Aligned_cols=252 Identities=28% Similarity=0.335 Sum_probs=198.4
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC---CCCceeEEeeeeecCC
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL---HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L---~HPNIVkLygvf~de~ 951 (1157)
|++.+.||+|+||.||+++++ +..||+|+++..... ......+.+|+.+++++ +||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc------chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678999999999999999984 678999998754211 11123455677777665 6999999999987643
Q ss_pred C---CcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 G---GTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ~---~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. ...+++|||+.+ +|.+++.+.. ..+++..++.++.|++.||.|||+++++|+||||+|||++ .++.+||+
T Consensus 75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~----~~~~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIA 149 (287)
T ss_pred CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc----cCCCEEEe
Confidence 2 238999999975 7888876533 3589999999999999999999999999999999999998 66899999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC---
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--- 1104 (1157)
|||++.............++..|+|||++.+. .++.++|+|||||++|+|++|++||......+.+..+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 99998765444333445688999999999764 5788999999999999999999999887766555544331100
Q ss_pred ---------------C-------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1105 ---------------P-------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1105 ---------------p-------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
. .....+++.+.+||.+||+.||.+||++.+++.+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 0 001134577899999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.91 Aligned_cols=257 Identities=26% Similarity=0.339 Sum_probs=208.1
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC--
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP-- 951 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~-- 951 (1157)
+|++.+.||+|+||.||+++.. +..||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 5889999999999999999984 67899998876421 1122467889999999999999999999987642
Q ss_pred -CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 952 -GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 952 -~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
...+|++|||+.+ +|..++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||
T Consensus 75 ~~~~~~lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~----~~~~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNCDLKICDFG 148 (330)
T ss_pred cccceEEEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEcccC
Confidence 2368999999985 8888886544 689999999999999999999999999999999999998 66899999999
Q ss_pred CcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC-
Q 001103 1031 LSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP- 1105 (1157)
Q Consensus 1031 LAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp- 1105 (1157)
++....... ......++..|+|||++.+.. .++.++|+||||+++|+|++|++||......+.+..+....-.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998654432 233456899999999998642 57899999999999999999999998877655544443311100
Q ss_pred ----------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1106 ----------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1106 ----------------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.....+++++.+||.+||+++|.+||++.+++.+.+.-..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0123367889999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.02 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=203.8
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|.+.+.||+|+||.||++++. +..+++|+++......... .....+.+|+.+++.++||||+++++++.+ ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP---NETVQANQEAQLLSKLDHPAIVKFHASFLE--RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc---chHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CC
Confidence 4788999999999999999885 3447777766532211111 112456678999999999999999999877 45
Q ss_pred cEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 954 TMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++ . +.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~-~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----N-NLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----c-CCEeecccC
Confidence 78999999999999988753 345689999999999999999999999999999999999996 2 459999999
Q ss_pred CcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
++...... .......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.. ...+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 227 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPE 227 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcc
Confidence 98764332 223345689999999998643 467899999999999999999999987666555555543 33444567
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.++.++.++|.+||+.+|++||++.+++++.+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred hhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 78899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.53 Aligned_cols=256 Identities=18% Similarity=0.222 Sum_probs=186.2
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECCc-----eEEEEEEecccccCCChhHHHH------HHHHHHHHHHHHhCCCCc
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRGT-----DIAIKRIKKSCFLGRSSEQEWL------IKEFWREAHIISNLHHPN 939 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kGt-----~VAVKVIkk~~l~~r~~e~e~l------ikqflrEIkILK~L~HPN 939 (1157)
.+...+|++.+.||+|+||+||+|++.+. .+|+|+..... .....+.. ......++..+..+.|++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---CchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34557899999999999999999998543 46666543221 11101100 112334455566789999
Q ss_pred eeEEeeeeecCCC--CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccC
Q 001103 940 VVAFYGVVPNGPG--GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLR 1017 (1157)
Q Consensus 940 IVkLygvf~de~~--~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~d 1017 (1157)
|+++++....... ...+++|+++.. ++.++++.. ...++..++.++.|++.||.|||+++|+||||||+|||++
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~-- 160 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD-- 160 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--
Confidence 9999987654322 234677777643 555555443 2357788899999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCcccccCC--------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 001103 1018 DPQRPICKVGDFGLSRIKCNT--------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM 1089 (1157)
Q Consensus 1018 d~e~g~VKLiDFGLAkl~~~~--------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~ 1089 (1157)
..+.++|+|||+|+..... .......||+.|+|||++.+. .++.++|||||||+||||++|++||...
T Consensus 161 --~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 161 --GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred --CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 6678999999999754211 112235699999999998864 5799999999999999999999999876
Q ss_pred Ch-hHHH--------HHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1090 HC-GAII--------GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1090 ~~-eeil--------~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
.. ...+ ..+..... ....+++++.++++.|++++|.+||++.+|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 32 2211 22211111 1234688999999999999999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=315.75 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=203.7
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG-- 950 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de-- 950 (1157)
.+|++.+.||+|+||.||++.. .+..||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc------ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 6899999999999999999987 4778999998754211 11245677899999999999999999987643
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....+++||||+. ++|.+++.... .+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEecccc
Confidence 2357899999996 58888886544 489999999999999999999999999999999999998 77899999999
Q ss_pred CcccccCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc----
Q 001103 1031 LSRIKCNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---- 1101 (1157)
Q Consensus 1031 LAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~---- 1101 (1157)
++....... ......|+..|+|||.+.+. ..++.++|||||||++|+|++|+.||........+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 987543221 12345789999999998653 34789999999999999999999999876543322221110
Q ss_pred ------------------CC--CCC-----CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1102 ------------------TL--RPQ-----IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1102 ------------------~l--rpe-----ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+ ... +....++++.++|.+||+.+|.+||++.+++.+.|.-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 00 001 11346889999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.40 Aligned_cols=260 Identities=25% Similarity=0.330 Sum_probs=201.9
Q ss_pred CCeeE-EEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHH------HHHHHHHHHHHHHhCCCCceeEEee
Q 001103 875 SDLEE-LQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEW------LIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 875 sdYeI-LrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~------likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+|.. .+.||.|+||+||++++ .++.||||+++............. ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 46799999999999987 477899999876532211100000 1124678999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.. ....+++|||+. ++|.+++... ..+++..++.++.|++.||+|||++||+|+||||+|||++ ..+.+|
T Consensus 88 ~~~~--~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~----~~~~~k 159 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN----SKGICK 159 (335)
T ss_pred EEec--CCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC----CCCCEE
Confidence 9877 568999999997 5888888654 3488999999999999999999999999999999999998 677999
Q ss_pred EEecCCcccccC---------------CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 001103 1026 VGDFGLSRIKCN---------------TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090 (1157)
Q Consensus 1026 LiDFGLAkl~~~---------------~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~ 1090 (1157)
|+|||++..... ........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999875431 1112234578899999998764 346889999999999999999999998877
Q ss_pred hhHHHHHhhhcCC---CC-----------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1091 CGAIIGGILSNTL---RP-----------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1091 ~eeil~~Il~~~l---rp-----------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+.+..+..... .. ......+.++.+||.+||+.+|.+|||+++++.+.|.-
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 6655544432110 00 01123578899999999999999999999999988764
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.05 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=200.6
Q ss_pred CeeEEEEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 001103 876 DLEELQELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPN 949 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~d 949 (1157)
+|++.+.||+|+||.||++++ +++.||||++++.... ........+.+|+++++++ +||+|+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 478899999999999999875 3567999998754211 1122346778999999999 69999999999876
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++||||+.+++|..++... ..+++..++.++.|++.+|.|||+++++||||||.||+++ .++.++|+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df 149 (288)
T cd05583 77 --DTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDF 149 (288)
T ss_pred --CCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEEEC
Confidence 56889999999999999888654 3588889999999999999999999999999999999998 6678999999
Q ss_pred CCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHhhhcCC
Q 001103 1030 GLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGGILSNTL 1103 (1157)
Q Consensus 1030 GLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~Il~~~l 1103 (1157)
|++....... ......|+..|+|||.+.+.....+.++|+||||+++|+|++|..||..... ......+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~ 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--S 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--c
Confidence 9987543222 1223568999999999876533468899999999999999999999964322 222222222 2
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHH---HHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFT---EITNRLR 1141 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSae---ELLe~Lr 1141 (1157)
....+..+++.++++|.+||+.||++|||+. +++++++
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 2345667889999999999999999999854 5566554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.52 Aligned_cols=250 Identities=27% Similarity=0.374 Sum_probs=199.6
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCC
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~ 953 (1157)
|++.+.||+|+||+||+|+.. +..||||++...... . ......+|+..++++. ||||+++++++.. ..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----W---EECMNLREVKSLRKLNEHPNIVKLKEVFRE--ND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----h---hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CC
Confidence 678899999999999999984 667999988754211 0 1123457899999999 9999999999877 66
Q ss_pred cEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 954 TMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++||||+ +++|.+++.... ..+++..++.++.|++.+|.|||+++|+|+||||+||+++ ..+.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~----~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCCEEEeecccc
Confidence 899999999 779988886643 5689999999999999999999999999999999999998 6789999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-----------
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN----------- 1101 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~----------- 1101 (1157)
.............++..|+|||++.+. ..++.++|+||||+++|+|++|++||......+.+..+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 866554444456689999999988643 34788999999999999999999999876554433322110
Q ss_pred ------CCCC-----------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1102 ------TLRP-----------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1102 ------~lrp-----------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.... ......+..+++||.+||+.+|.+||++++++.+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 0000 001123678999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=345.78 Aligned_cols=251 Identities=30% Similarity=0.468 Sum_probs=210.6
Q ss_pred EEecccCcEEEEEEEECCce--EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~kGt~--VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLV 958 (1157)
-.||+|.||+||.|++..++ +|||.+.... ....+-+..|+.+-++|+|.|||+++|.+.. ++++-|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIF 650 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--------SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIF 650 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--------chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEE
Confidence 46999999999999996554 7888776531 1224667889999999999999999999876 7799999
Q ss_pred EEeecCCcchhhhccccccc--cHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc-
Q 001103 959 TEYMVNGSLRHVLARKDRIL--DRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK- 1035 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L--~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~- 1035 (1157)
||-++||+|..+|..+=+++ .+..+-.+.+||++||+|||++.|||||||-+|||++ --.|.+||+|||-++..
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN---TySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN---TYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe---eccceEEecccccchhhc
Confidence 99999999999998765566 6778888999999999999999999999999999997 24579999999998854
Q ss_pred cCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhcCCCCCCCCCCcHH
Q 001103 1036 CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSNTLRPQIPERCDPE 1114 (1157)
Q Consensus 1036 ~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~~lrpeip~~iSpe 1114 (1157)
.-...+.++.||..|||||++-.+...|+.++|||||||++.||.||++||...... ..+.++-.-..-|++|..++.+
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae 807 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE 807 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence 334455668999999999999877788999999999999999999999999866543 2222332234456789999999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1115 WRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1115 LrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+.||.+|+..||.+||++.++|.......
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 999999999999999999999998765443
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.95 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=202.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
..+|++.+.||+|+||.||+|.+ .+..+|||++.+... . ......+.+|+.+++++ +||||+++++++...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~-----~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-N-----ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-c-----chhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 35788999999999999999988 467799998864311 1 11134567899999999 999999999998765
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....+|+||||+.+ +|..++... .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~----~~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN----SDCRVKLADFG 152 (337)
T ss_pred CCceEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeecc
Confidence 55678999999974 888888654 678889999999999999999999999999999999998 77899999999
Q ss_pred CcccccCC------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-
Q 001103 1031 LSRIKCNT------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL- 1103 (1157)
Q Consensus 1031 LAkl~~~~------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l- 1103 (1157)
++...... .......||..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 98754322 122335689999999988653 3568899999999999999999999986654433332211100
Q ss_pred ----------------------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1104 ----------------------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1104 ----------------------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.......++.++.+||.+||+.||.+|||+.+++++.+.-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 00112236889999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=333.15 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=214.9
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
+.+....|..-+.||+|+||.||-++. +|+-||.|.+.++....+.. ....+.|..||++++.+.||.+--.|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g-----e~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG-----ETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh-----hHHhhHHHHHHHHhccCcEEEEeeee
Confidence 345667889999999999999998766 57779999988765443333 24457899999999999999997777
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.. ...+|+||..|+||+|...|.+.+ ..+++..++.++.+|+.||++||..+||+|||||+|||+| +.|+++|
T Consensus 255 eT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD----d~GhvRI 328 (591)
T KOG0986|consen 255 ET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD----DHGHVRI 328 (591)
T ss_pred cC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec----cCCCeEe
Confidence 76 668999999999999998777654 5699999999999999999999999999999999999999 8899999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh----HHHHHhhhcC
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG----AIIGGILSNT 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e----eil~~Il~~~ 1102 (1157)
+|+|+|..........+.+||.+|||||+++.. .|+..+|||||||+||||+.|+.||...... ++-+.+. .
T Consensus 329 SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--~ 404 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--E 404 (591)
T ss_pred eccceEEecCCCCccccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--c
Confidence 999999988777777777999999999999965 5888899999999999999999999865533 2222222 2
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARP-----SFTEITNRL 1140 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~L 1140 (1157)
.+..++...++++++|.+.+|++||.+|- .+.++.+|.
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 33457788999999999999999999984 455666654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=294.18 Aligned_cols=243 Identities=27% Similarity=0.407 Sum_probs=204.1
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 883 LGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
||+|+||.||++.++ +..+|+|++.+..... ......+.+|+++++.++||||+++++.+.. ....+++||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-----RKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-----hHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEe
Confidence 699999999999984 6789999988753221 1235678889999999999999999999876 668999999
Q ss_pred eecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCC-c
Q 001103 961 YMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT-L 1039 (1157)
Q Consensus 961 YmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~-~ 1039 (1157)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++ ..+.++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~----~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc----CCCcEEEeecCcceecccCCC
Confidence 999999999987654 488999999999999999999999999999999999998 6678999999998765443 2
Q ss_pred ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHH
Q 001103 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLM 1119 (1157)
Q Consensus 1040 ~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLI 1119 (1157)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+.. ....++...+..+.++|
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i 224 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLI 224 (250)
T ss_pred cccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHH
Confidence 33446689999999998754 468899999999999999999999987776555555554 33457777899999999
Q ss_pred HHHhccCCCCCCCH---HHHHHHHH
Q 001103 1120 EECWSFNPAARPSF---TEITNRLR 1141 (1157)
Q Consensus 1120 krCLqkDPskRPSa---eELLe~Lr 1141 (1157)
++||..||.+||++ ++++++.+
T Consensus 225 ~~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 225 SGLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred HHHhcCCHhhCCCcccHHHHHhCCC
Confidence 99999999999999 77777643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.53 Aligned_cols=247 Identities=26% Similarity=0.458 Sum_probs=216.3
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
-|.++++||+|+||.||++.+ .|..+|||.+.... .+++++.|+.|+++++.|++|++||.+.. +.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~s 101 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----------DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HS 101 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----------hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CC
Confidence 466789999999999999977 47889999887541 25788999999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
-+|||||||..|++.+++....+.+.+..+..++...+.||+|||...=||||||..|||++ .+++.||+|||.|.
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN----T~G~AKLADFGVAG 177 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN----TDGIAKLADFGVAG 177 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc----ccchhhhhhccccc
Confidence 79999999999999999988888999999999999999999999999999999999999999 88899999999998
Q ss_pred cccCCcc-cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCCCCCCC
Q 001103 1034 IKCNTLV-SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPERC 1111 (1157)
Q Consensus 1034 l~~~~~~-sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpeip~~i 1111 (1157)
...+... ..+..|||.|||||+++.- .|..++||||||++..||..|++||...+....+..|-.+ ...+..|+.+
T Consensus 178 QLTDTMAKRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 178 QLTDTMAKRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEW 255 (502)
T ss_pred hhhhhHHhhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhh
Confidence 7655432 3457899999999999854 5789999999999999999999999998887666555433 2233567789
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
+.++.+||++||-+.|++|.|+.+|++|.
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 99999999999999999999999999974
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=311.46 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=203.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||++.+ .+..||||++..... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 45799999999999999999987 477899998865311 1223456789999999999999999999986532
Q ss_pred C----CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 G----GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ~----~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. ..+++||||+ +++|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~----~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN----EDCELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEe
Confidence 2 2468999998 6788888754 3588999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC---
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--- 1104 (1157)
|||++...... .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|+.||...........+......
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99998754332 2335689999999998753 24788999999999999999999999876654433332221100
Q ss_pred --------------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1105 --------------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1105 --------------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+...+++++.++|.+||..||.+|||+.+++.+.+.-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 0122457788999999999999999999999998876544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.39 Aligned_cols=242 Identities=21% Similarity=0.336 Sum_probs=189.6
Q ss_pred CeeEEEE--ecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 876 DLEELQE--LGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 876 dYeILrk--LGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
+|++.+. ||+|+||.||+++. .+..+|+|++....... .|+.....+ +||||+++++.+..
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 4555555 49999999999987 46779999987642110 012122212 79999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC-eEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP-ICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g-~VKLiDF 1029 (1157)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++ ..+ .++|+||
T Consensus 81 -~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~~l~df 154 (267)
T PHA03390 81 -LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----RAKDRIYLCDY 154 (267)
T ss_pred -CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----CCCCeEEEecC
Confidence 458999999999999999997654 689999999999999999999999999999999999998 455 8999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH-HHhhh-cCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII-GGILS-NTLRPQI 1107 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil-~~Il~-~~lrpei 1107 (1157)
|++....... ...|+..|+|||++.+. .++.++|+||||+++|+|++|+.||......... ..+.. .......
T Consensus 155 g~~~~~~~~~---~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T PHA03390 155 GLCKIIGTPS---CYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229 (267)
T ss_pred ccceecCCCc---cCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence 9987654322 24689999999999754 5688999999999999999999999865433211 11111 1222344
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCC-HHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPS-FTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPS-aeELLe~Lr~ 1142 (1157)
+..+++.+++||.+||+.+|.+||+ +++++++.|.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 5578999999999999999999995 6999987653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=334.79 Aligned_cols=260 Identities=17% Similarity=0.251 Sum_probs=187.3
Q ss_pred CCeeEEEEecccCcEEEEEEEECCc---eEEEEEEeccc---------ccCCChhHHHHHHHHHHHHHHHHhCCCCceeE
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRGT---DIAIKRIKKSC---------FLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kGt---~VAVKVIkk~~---------l~~r~~e~e~likqflrEIkILK~L~HPNIVk 942 (1157)
.+|+++++||+|+||+||++.++.. .+++|.+.... ..............+.+|+.+|++|+|||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 5899999999999999999876421 12222111000 00000111223456889999999999999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhccc----cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARK----DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~----gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd 1018 (1157)
+++++.. ....|++|+++.+ +|..++... ........++.++.||+.||+|||++|||||||||+|||++
T Consensus 228 l~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~--- 301 (501)
T PHA03210 228 IEEILRS--EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN--- 301 (501)
T ss_pred EeEEEEE--CCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---
Confidence 9999987 5578999999854 666665432 12234567788999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCC--hhH
Q 001103 1019 PQRPICKVGDFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP-YANMH--CGA 1093 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~P-F~g~~--~ee 1093 (1157)
.++.+||+|||++....... .....+||..|+|||++.+. .++.++|||||||+||||++|..+ |.... ...
T Consensus 302 -~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 302 -CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred -CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 67899999999997654322 23346799999999999864 578999999999999999998754 43322 111
Q ss_pred HHHHhhhc------CCC-------------------CCC-----CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1094 IIGGILSN------TLR-------------------PQI-----PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1094 il~~Il~~------~lr-------------------pei-----p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+..++.. .++ ..+ ...++..+.++|.+||++||.+|||+.+++++.++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 11111110 000 000 112456788899999999999999999999988764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=367.70 Aligned_cols=251 Identities=30% Similarity=0.451 Sum_probs=215.4
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
+|+....||.|.||.||.|.. +|...|||-++..... ....+.+.+|+.+|..|+|||+|++||+-.+ ..
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Re 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--RE 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeec--HH
Confidence 567778899999999999877 5777999987754211 3345678899999999999999999999766 55
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.++|.||||++|+|.+++. .++..++.....+..|++.|+.|||++|||||||||+|||++ .++.+|++|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld----~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD----FNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee----cCCcEEeeccccee
Confidence 7899999999999999985 566788888888899999999999999999999999999999 77899999999998
Q ss_pred cccCCc-----ccCCCCCCCcccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1034 IKCNTL-----VSGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1034 l~~~~~-----~sts~~GTp~YmAPEVL~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
...+.. ......||+.|||||++.|.+ ..-..++|||||||++.||+||+.||...+.+-.+..-+.....|++
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 655442 123467999999999998754 23456899999999999999999999998877666666667778899
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
|..++++-++||..||..||++|.++.||+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99999999999999999999999999998876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=339.50 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=235.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECCce--EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kGt~--VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+++++..||-|+||.|=+++.++.. +|+|++++....+.+. .+.+..|.+||..+..|.||++|..|.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ-----qeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ-----QEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH-----HHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 34568888999999999999999887665 8999999876655433 3567889999999999999999999998
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
..++|++||-|-||.|..+|...+ .|+......++..+++|++|||++|||+|||||+|+|++ .+|.+||.||
T Consensus 492 --~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----~~Gy~KLVDF 564 (732)
T KOG0614|consen 492 --SKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----NRGYLKLVDF 564 (732)
T ss_pred --chhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec----cCCceEEeeh
Confidence 679999999999999999997655 588899999999999999999999999999999999999 8899999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
|+|+.......+.++||||.|.|||++..+ ..+.++|.||||+++||||+|.+||.+.+....+..|+.+.-...+|.
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr 642 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR 642 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc
Confidence 999998888888889999999999999854 458899999999999999999999999999999999998888888999
Q ss_pred CCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~Lk~aL 1147 (1157)
.++....+||+++...+|.+|- .+.+|-+|-|+.--.+
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 9999999999999999999995 4789999988765443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.97 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=203.6
Q ss_pred EEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 879 ELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
....||+|+||.||++.. ++..||||++.... ......+.+|+.+++.++||||+++++.+.. ....+
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 93 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELW 93 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEE
Confidence 346799999999999988 46789999875421 1124568899999999999999999999987 56899
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
++|||+++++|.+++... .+++..++.++.|++.||+|||++||+|+||||+||+++ .++.++|+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~----~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 94 VVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVS 167 (292)
T ss_pred EEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEcccccceecc
Confidence 999999999999887543 478889999999999999999999999999999999998 66789999999886543
Q ss_pred CCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--CCCCCcH
Q 001103 1037 NTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ--IPERCDP 1113 (1157)
Q Consensus 1037 ~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe--ip~~iSp 1113 (1157)
... ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.. ..+.. ....+++
T Consensus 168 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 244 (292)
T cd06657 168 KEVPRRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSP 244 (292)
T ss_pred cccccccccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-hCCcccCCcccCCH
Confidence 221 22335689999999998643 568899999999999999999999987765554444332 22222 2345788
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1114 EWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1114 eLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.+.++|.+||+.+|.+||++.+++++.+......
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 9999999999999999999999999877766554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=310.42 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=199.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||.|+||.||+|.++ +..||+|++..... ...+.+.+|+++++.++||||+++++.+.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 68999999999999999999884 67899998875421 123567789999999999999999987765322
Q ss_pred ------------CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCC
Q 001103 953 ------------GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQ 1020 (1157)
Q Consensus 953 ------------~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e 1020 (1157)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. .
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~---~ 150 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT---E 150 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---C
Confidence 35789999997 488887753 34889999999999999999999999999999999999972 3
Q ss_pred CCeEEEEecCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 001103 1021 RPICKVGDFGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096 (1157)
Q Consensus 1021 ~g~VKLiDFGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~ 1096 (1157)
...+||+|||++........ .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||..........
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 45789999999875432211 1223578899999987543 357889999999999999999999998766544433
Q ss_pred HhhhcC-----------------------CCC-----CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1097 GILSNT-----------------------LRP-----QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1097 ~Il~~~-----------------------lrp-----eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+.... ... .+...++.++++||.+||+.||.+|||+.+++++.+.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 332110 000 01234678899999999999999999999999987764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=297.22 Aligned_cols=251 Identities=30% Similarity=0.420 Sum_probs=201.8
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|++.+.||+|.||.||+|+.. ++.||+|++..... .+.....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCc
Confidence 567788999999999999984 67899999886531 11223566789999999999999999999887 468
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.++||||+.+ +|.+++.+....+++..++.++.|++.||.|||++||+||||+|+||+++ .++.+||+|||++..
T Consensus 73 ~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~----~~~~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARA 147 (282)
T ss_pred eEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc----CCCCEEEecCCcccc
Confidence 9999999984 89999987645689999999999999999999999999999999999998 678999999999876
Q ss_pred ccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-----------
Q 001103 1035 KCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT----------- 1102 (1157)
Q Consensus 1035 ~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~----------- 1102 (1157)
..... ......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||........+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 43332 22334567889999998754 357889999999999999999999998766554443332100
Q ss_pred ---------CCC-------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 ---------LRP-------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 ---------lrp-------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+.. ..-...+..+.++|.+||..+|.+||++.+++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 000 001124778999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.06 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=197.5
Q ss_pred CeeEEEEecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
+|++.+.||+|+||.||++++. +..||||++.... .. ....+.+.+|+.+++++ +||||+++++.....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SK----KILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--cc----chhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4788999999999999999985 4579999987431 11 11245677899999999 599999999875432
Q ss_pred --CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 951 --PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 951 --~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
....++++|+|+. ++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|
T Consensus 75 ~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~----~~~~~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN----ADCELKICD 148 (332)
T ss_pred cccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----CCCCEEeCc
Confidence 2346788999986 5888888543 4588999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-
Q 001103 1029 FGLSRIKCNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT- 1102 (1157)
Q Consensus 1029 FGLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~- 1102 (1157)
||++....... ......||..|+|||.+.+. ..++.++|+|||||++|+|++|++||........+..++...
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99997533211 12335689999999987643 357899999999999999999999998765443333222100
Q ss_pred -------------------------CCC---CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 -------------------------LRP---QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 -------------------------lrp---eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
... ......+..+++||.+||+.||.+|||+.+++.+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 000 1122357889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=338.78 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=211.9
Q ss_pred CCe-eEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 875 SDL-EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdY-eILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.+| +...+||+|+|-+||+|.+. |-.||=-.++...+. ....-.++|..|+.+|+.|+|||||++|..|.+..
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~----q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT----QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhh----cChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 344 44678999999999999985 444542222222111 11223578999999999999999999999999877
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCCCCeEEEEec
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
..++.+|+|.+..|+|..++++.++ +..+.+..|++||++||.|||++. |||||||.+||+|+ +..|.|||+|+
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKIGDL 190 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKIGDL 190 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceeecch
Confidence 7889999999999999999988765 888999999999999999999995 99999999999998 47899999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhcCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~~lrpeip 1108 (1157)
|||+......... ..|||.|||||+.. ..|...+||||||++|+||+|+..||...... .+++.+..+..+..+.
T Consensus 191 GLAtl~r~s~aks-vIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 191 GLATLLRKSHAKS-VIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred hHHHHhhccccce-eccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence 9999876665544 78999999999986 46899999999999999999999999987655 4555565555555566
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.--.+++++||.+||.. ..+|+|+.+||++..+-
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~ 300 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFD 300 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhc
Confidence 66689999999999998 99999999999975543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=306.67 Aligned_cols=254 Identities=24% Similarity=0.435 Sum_probs=211.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
..+++.+..||.|+.|.|++++.+ |...|||.+.+.. . ....+++++.+.++... ++|+||+.||+|..
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---N----kee~kRILmDldvv~~s~dcpyIV~c~GyFi~- 162 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---N----KEENKRILMDLDVVLKSHDCPYIVQCFGYFIT- 162 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC---C----HHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-
Confidence 456778899999999999999885 5779999998752 1 12246777788776655 59999999999988
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
+.-.+|.||.|.. .+..++++-.+++++..+-++..-++.||.||.++ ||||||+||+|||++ +.|++|||||
T Consensus 163 -n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD----e~GniKlCDF 236 (391)
T KOG0983|consen 163 -NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGNIKLCDF 236 (391)
T ss_pred -CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc----cCCCEEeecc
Confidence 3457778998854 67778877778899999999999999999999976 899999999999999 8889999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hHHHHHhhhcCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-GAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~-eeil~~Il~~~lrpei 1107 (1157)
|++....+....+...|-+.|||||.+... ...|+.++||||||++|+||.||+.||.+.+. .+.+..++. ..++.+
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L 315 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLL 315 (391)
T ss_pred cccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCC
Confidence 999988887776667899999999999754 45689999999999999999999999998654 455555555 444555
Q ss_pred CC--CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1108 PE--RCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p~--~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+. .+++.+.+|++.||++|+.+||.+.+|+++...
T Consensus 316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi 352 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI 352 (391)
T ss_pred CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence 43 389999999999999999999999999997543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.49 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=200.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||++.+ .+..||+|++++... .......+.+|+.++++++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 36899999999999999999986 477899998875311 1112356778999999999999999999875421
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
....|++++++ +++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc----CCCCEEEe
Confidence 23578888887 77898877543 488999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-----
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT----- 1102 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~----- 1102 (1157)
|||++...... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||........+..+....
T Consensus 163 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 163 DFGLARHTDDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred ccccccccccc--ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99998754332 2345689999999998653 357889999999999999999999998765544333221110
Q ss_pred -------------------CCC-----CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1103 -------------------LRP-----QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1103 -------------------lrp-----eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+ ......++++++||.+||+.||.+||++.+++++.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 000 011235788999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.02 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=197.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|.+.+.||+|+||.||+|++ ++..||||++.+.... +.....+.+|+.+++.+.||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS------EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc------ccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 5899999999999999999987 4778999998754211 1123567789999999999999999999865321
Q ss_pred ----CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 953 ----GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 953 ----~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
...++||||+.. +|..++. ..+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~----~~~~~kL~d 160 (342)
T cd07879 89 GDEFQDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN----EDCELKILD 160 (342)
T ss_pred CCCCceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEee
Confidence 346899999964 6655542 3478899999999999999999999999999999999998 678999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-----
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL----- 1103 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l----- 1103 (1157)
||++...... .....++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+......+..+....-
T Consensus 161 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 161 FGLARHADAE--MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCCCcCCCCC--CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998754322 2345688999999998753 3478899999999999999999999987665444333322100
Q ss_pred ----------------CCCC--------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 ----------------RPQI--------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 ----------------rpei--------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+.. ....++.+.+||.+||+.||.+||++.+++.+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 0000 12367789999999999999999999999988554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=310.47 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=203.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||.||+|++. +..||||++..... .......+.+|+.+++.+.||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ------SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 458999999999999999999984 67799998865311 1112356778999999999999999998876532
Q ss_pred C----CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 G----GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ~----~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. ..+++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++ ..+.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~----~~~~~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN----EDCELKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEc
Confidence 2 3489999998 5699888865 3589999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP-- 1105 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp-- 1105 (1157)
|||++...... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||........+..+......+
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 99998765433 2345689999999998653 256889999999999999999999998776555444433211000
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1106 ---------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1106 ---------------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
......++++.+||.+||..+|.+|||+.+|+++.+.-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 011235889999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.39 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=210.3
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYG 945 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLyg 945 (1157)
.+-+...+|..++.||+|+|.+|.+++++ .+.||+|++++..+.. .+ .+..+..|..+..+. +||.+|.++.
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-de----didwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DE----DIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cc----cchhHHhhHHHHHhccCCCeEEehhh
Confidence 34456689999999999999999999885 4559999999874432 22 245566788887766 7999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
+|+. ...+++|.||++||+|...+.+. +.++++.++.+..+|+.||.|||++|||+||||.+|+|++ .++++|
T Consensus 319 cfqt--esrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld----aeghik 391 (593)
T KOG0695|consen 319 CFQT--ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD----AEGHIK 391 (593)
T ss_pred hhcc--cceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc----cCCcee
Confidence 9998 66899999999999999888654 4599999999999999999999999999999999999999 888999
Q ss_pred EEecCCcccc-cCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC--C-----ChhH-HHH
Q 001103 1026 VGDFGLSRIK-CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN--M-----HCGA-IIG 1096 (1157)
Q Consensus 1026 LiDFGLAkl~-~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g--~-----~~ee-il~ 1096 (1157)
|+|+|+++.. .+...+.++||||.|.|||+++|. .|+..+|||+|||+||||+.|+.||.. + +.++ +++
T Consensus 392 ltdygmcke~l~~gd~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq 469 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ 469 (593)
T ss_pred ecccchhhcCCCCCcccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence 9999999864 344566779999999999999986 567889999999999999999999963 2 2223 344
Q ss_pred HhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCC------CHHHHHHHH
Q 001103 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARP------SFTEITNRL 1140 (1157)
Q Consensus 1097 ~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRP------SaeELLe~L 1140 (1157)
-|+.... .+|..++-....+++..|.+||.+|- .+.++..+.
T Consensus 470 vilekqi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ 517 (593)
T KOG0695|consen 470 VILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHA 517 (593)
T ss_pred HHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcch
Confidence 4444433 47788888899999999999999983 345555543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=336.15 Aligned_cols=147 Identities=26% Similarity=0.490 Sum_probs=129.2
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|+++++||+|+||+||+|++. ++.||||++++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~ 76 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQS--A 76 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--C
Confidence 58999999999999999999996 788999999764321 12335678899999999999999999998877 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+||||||+.+++|..++...+ .+++..++.++.||+.||.|||+++||||||||+|||++ ..+.+||+|||++
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~----~~g~vkL~DFGls 151 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGLS 151 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc----CCCCEEEEeCCCC
Confidence 68999999999999999986543 588899999999999999999999999999999999998 6678999999987
Q ss_pred c
Q 001103 1033 R 1033 (1157)
Q Consensus 1033 k 1033 (1157)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=273.82 Aligned_cols=95 Identities=62% Similarity=1.078 Sum_probs=91.0
Q ss_pred EeecCCccccCCCCCCceeecCceEEEEccCCCCHHHHHHHHHhhcCCC--ceEEEeCCCCCCCcEEeecChhHHHHHHH
Q 001103 188 LCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQP--HTIKYQLPGEDLDALISVCSDEDLHHMIE 265 (1157)
Q Consensus 188 mcSyGG~I~pr~~d~~l~YvGG~triv~v~r~~~f~~l~~kl~~~~~~~--~~lkYqLP~edLD~LisV~~DeDL~~m~~ 265 (1157)
||||||+|+|||+||+|+|+||+|||++|+|++||+||+.||+++++.. ++||||||+||||+||||++||||+|||+
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp~edld~Lisv~~DeDl~~M~~ 80 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPDEDLDALISVSNDEDLKNMME 80 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcCCCCcceeEEecCcHHHHHHHH
Confidence 7999999999999999999999999999999999999999999999865 49999999999999999999999999999
Q ss_pred HHHHhhhcCCCCeEEEEEe
Q 001103 266 EYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 266 eydr~~~~~~~~rlR~FLF 284 (1157)
||+|+ ...++|+|||||
T Consensus 81 e~~~~--~~~~~rirvflf 97 (97)
T cd06410 81 EYDRL--SGGSARLRVFLF 97 (97)
T ss_pred hhccc--cCCCceEEEEEC
Confidence 99998 456789999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=302.48 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=198.7
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||.|+||.||++++ .+..||||++.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST------PVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 346899999999999999999987 4677999988754211 11235677899999999999999999988653
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....+++|||+ +++|..+++. ..+++..+..++.|++.||.|||+++|+||||||.|||++ ..+.+||+|||
T Consensus 82 -~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~----~~~~~~l~dfg 153 (328)
T cd07856 82 -LEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN----ENCDLKICDFG 153 (328)
T ss_pred -CCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC----CCCCEEeCccc
Confidence 44788999998 5588888754 2478888889999999999999999999999999999998 67789999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh----------
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS---------- 1100 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~---------- 1100 (1157)
++...... .....++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||...........+..
T Consensus 154 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 154 LARIQDPQ--MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccccCCC--cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98754322 2335688899999987642 3578999999999999999999999976554222111110
Q ss_pred --------------cCCCCC-----CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1101 --------------NTLRPQ-----IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1101 --------------~~lrpe-----ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...... ....++++++++|.+||+.+|++||++.+++.+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 000000 113467899999999999999999999999998655
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.10 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=209.3
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
-.+...+|.+.++||+|+|+.||+++. ++..||+|++.... ..-++...+|++..++++|||+++++++.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 347788999999999999999999885 57779999987652 11256788999999999999999999886
Q ss_pred ecCC---CCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCC
Q 001103 948 PNGP---GGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 948 ~de~---~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~ 1019 (1157)
..+. ....||++.|...|+|.+.+.. ++..+++.+++.|+.++++||++||+.. ++||||||.|||+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---- 163 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---- 163 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec----
Confidence 4322 3368999999999999988754 4567999999999999999999999998 99999999999998
Q ss_pred CCCeEEEEecCCcccccCCc----------ccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 001103 1020 QRPICKVGDFGLSRIKCNTL----------VSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088 (1157)
Q Consensus 1020 e~g~VKLiDFGLAkl~~~~~----------~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g 1088 (1157)
+.+.++|.|||.+....-.. .......|..|.|||.+.-+ ....+.++|||||||+||+|+.|..||..
T Consensus 164 ~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 164 DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 67799999999887532211 11223478899999998642 34578999999999999999999999964
Q ss_pred CC--hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1089 MH--CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1089 ~~--~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.- ...+.-++....+..+-....++.+.+||++||+.||.+||++.+++.++..+
T Consensus 244 ~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 244 IYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 22 11111122222333333345899999999999999999999999999998765
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.80 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=211.3
Q ss_pred CCeeE-EEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 875 SDLEE-LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 875 sdYeI-LrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
++|.+ -+.||-|-.|.|..+..+ +..+|+|++... .+.++|+++--.. .|||||.++++|.+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 46655 367999999999999874 667999987643 4456777764433 699999999998753
Q ss_pred C--CCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 P--GGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 ~--~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
- ..++.+|||.|+||.|...+...+ +.++++++-.|+.||..|+.|||+.+|.||||||+|+|+.... .+..+||+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLt 206 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLT 206 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEec
Confidence 3 457889999999999999997654 6699999999999999999999999999999999999998544 67789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh----HHHHHhhhcCC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG----AIIGGILSNTL 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e----eil~~Il~~~l 1103 (1157)
|||+|+.........+.|-||.|.|||++.. .+|+..+|+|||||+||-||.|.+||...+.. ....+|..+.+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 9999998776666677899999999999974 46899999999999999999999999887653 34455555544
Q ss_pred CCC--CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1104 RPQ--IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1104 rpe--ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.++ -+..+|+..+++|+.+|+.+|.+|.|+.+++++.|...
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 433 33458899999999999999999999999999988643
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=327.57 Aligned_cols=254 Identities=33% Similarity=0.594 Sum_probs=218.5
Q ss_pred CCeeEEEEecccCcEEEEEEEEC----Cc--eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR----GT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k----Gt--~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+.....+.||.|-||.||+|... |. .||||.-+..+..+ ..+.|..|..+|++++|||||+++|++.
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-------~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-------DTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-------hHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 34445578999999999999873 33 28999887754322 2578999999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+. .+|||||.++.|.|.++|+.....++......++.||+.||.|||++.+|||||-..|||+. ...-|||+|
T Consensus 462 e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs----Sp~CVKLaD 534 (974)
T KOG4257|consen 462 EQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS----SPQCVKLAD 534 (974)
T ss_pred cc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec----Ccceeeecc
Confidence 75 58999999999999999998888899999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccCCcccCCCC--CCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTLVSGGVR--GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~--GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
||+++..........-. -...|||||-++- ..++.++|||.|||+|||++. |..||.+..+.+++..+. ++-+.
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRl 611 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERL 611 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCC
Confidence 99999876665443333 3456999999973 468999999999999999887 999999988877776664 55667
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+.|..|++.|..|+.+||..||.+||.+.+|...|..+..
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 8899999999999999999999999999999988877765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.80 Aligned_cols=249 Identities=29% Similarity=0.446 Sum_probs=213.4
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLV 958 (1157)
+.||+|-||+||-|++ +|+.||||++.+..+.... ..++++|+.||+++.||.||.+-.+|+. .+.++.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq------esqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ------ESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch------HHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEE
Confidence 6799999999998877 5889999999987665432 2678899999999999999999999988 5689999
Q ss_pred EEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCC
Q 001103 959 TEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT 1038 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~ 1038 (1157)
||-+.|.-|+-+|....+.+++.....++.||+.||+|||-++|+|+||||+|||+...+ .-..+||||||+|+...+.
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchh
Confidence 999988667677777777799999999999999999999999999999999999998443 6678999999999999888
Q ss_pred cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc--CCCCCCCCCCcHHHH
Q 001103 1039 LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--TLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1039 ~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~--~lrpeip~~iSpeLr 1116 (1157)
....+.+|||.|+|||+++.+ .|...-|+||+|||+|.-|+|..||.... ++..+|-.. -+++.-+.+++++..
T Consensus 721 sFRrsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHH
Confidence 888889999999999999854 57888999999999999999999997543 333333322 344555677999999
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+||..+|+..-++|.|++.-+.+.|.
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhh
Confidence 99999999999999999988887553
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=347.69 Aligned_cols=251 Identities=31% Similarity=0.506 Sum_probs=197.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG-- 950 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de-- 950 (1157)
.+|++++.||+|+||.||+++. +|+.||||+|.... ....-.++.+|+++|.+|+|||||++|..|.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 4788899999999999999987 69999999998652 233457789999999999999999998654320
Q ss_pred --------------------------------------------------------------------------------
Q 001103 951 -------------------------------------------------------------------------------- 950 (1157)
Q Consensus 951 -------------------------------------------------------------------------------- 950 (1157)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred ---------------------------CC--------CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHH
Q 001103 951 ---------------------------PG--------GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995 (1157)
Q Consensus 951 ---------------------------~~--------~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALe 995 (1157)
.. .++||.||||+...|.+++.++...-.....|++++||+.||.
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 00 3579999999998888888764422256788999999999999
Q ss_pred HHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc-------------------CCcccCCCCCCCcccCcccc
Q 001103 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC-------------------NTLVSGGVRGTLPWMAPELL 1056 (1157)
Q Consensus 996 YLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~-------------------~~~~sts~~GTp~YmAPEVL 1056 (1157)
|+|++|||||||||.||+++ ....|||+|||+|+... +....++.+||..|+|||++
T Consensus 712 YIH~~giIHRDLKP~NIFLd----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLD----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHhCceeeccCCcceeEEc----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99999999999999999999 77899999999998511 12234567899999999999
Q ss_pred cCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHHhccCCCCCCC
Q 001103 1057 NGSN-NRVSEKVDVYSFGIAMWEIITGEEPYAN-MHCGAIIGGILSNTLRPQ--IPERCDPEWRKLMEECWSFNPAARPS 1132 (1157)
Q Consensus 1057 ~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g-~~~eeil~~Il~~~lrpe--ip~~iSpeLrdLIkrCLqkDPskRPS 1132 (1157)
.+.. ..|+.|+|+||||++||||+. ||.. |.-..++..+....++.+ +...--+.-+.+|.+||+.||.+|||
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence 8653 268999999999999999985 4653 333444555544444333 11122345578999999999999999
Q ss_pred HHHHHHH
Q 001103 1133 FTEITNR 1139 (1157)
Q Consensus 1133 aeELLe~ 1139 (1157)
+.+||+.
T Consensus 865 A~eLL~s 871 (1351)
T KOG1035|consen 865 ATELLNS 871 (1351)
T ss_pred HHHHhhc
Confidence 9999973
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=322.22 Aligned_cols=261 Identities=34% Similarity=0.641 Sum_probs=225.0
Q ss_pred cccccccCCCeeEEEEecccCcEEEEEEEECC--ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 867 YGLQIIKDSDLEELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 867 y~i~~I~~sdYeILrkLGsGsFGtVYlAr~kG--t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
+..|++...++.+..+||-|-||.||.|.|+. -.||||.++... ..+++|+.|+.+|+.++|||+|+|+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---------MeveEFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---------hhHHHHHHHHHHHHhhcCccHHHHh
Confidence 34566777788889999999999999999964 459999887642 2367899999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccc-cccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr-~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
|+|.. ...+|||.|||..|+|.++|.+..+ .++.-..++++.||..|++||..+++|||||-..|.|+. ++..
T Consensus 330 GVCT~--EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg----Enhi 403 (1157)
T KOG4278|consen 330 GVCTH--EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHI 403 (1157)
T ss_pred hhhcc--CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc----ccce
Confidence 99988 4479999999999999999988653 466677788999999999999999999999999999998 8889
Q ss_pred EEEEecCCcccccCCccc--CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1024 CKVGDFGLSRIKCNTLVS--GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~~s--ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
||++||||++++..+..+ .+..-...|.|||-+. .+.++.|+|||+|||+|||+.| |..||.+.+.-.+ ..++.
T Consensus 404 VKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA--yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLE 480 (1157)
T KOG4278|consen 404 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA--YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLE 480 (1157)
T ss_pred EEeeccchhhhhcCCceecccCccCcccccCccccc--ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHh
Confidence 999999999987655432 2233456799999986 5678999999999999999999 9999999886554 45667
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
..++..-|+.|++...+||+.||++.|.+||++.+|-+.++.+..
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 888999999999999999999999999999999999998887654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=287.14 Aligned_cols=226 Identities=22% Similarity=0.256 Sum_probs=182.2
Q ss_pred cCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEEeec
Q 001103 886 GTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMV 963 (1157)
Q Consensus 886 GsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVMEYme 963 (1157)
|.||.||++++ .++.||+|++++.. .+.+|...+....||||+++++++.. ....+++|||+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCC
Confidence 89999999988 46779999987641 12344555566679999999999887 568999999999
Q ss_pred CCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCC
Q 001103 964 NGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG 1043 (1157)
Q Consensus 964 GGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts 1043 (1157)
+++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|||++ .++.++|+|||++...... ...
T Consensus 69 ~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~df~~~~~~~~~--~~~ 141 (237)
T cd05576 69 GGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWSEVEDS--CDG 141 (237)
T ss_pred CCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEEEecccchhccccc--ccc
Confidence 999999886543 488999999999999999999999999999999999998 6778999999987654332 223
Q ss_pred CCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHh
Q 001103 1044 VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECW 1123 (1157)
Q Consensus 1044 ~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCL 1123 (1157)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ........++..+++.+++||.+||
T Consensus 142 ~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 142 EAVENMYCAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCcCccccCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHc
Confidence 4577889999998643 5688999999999999999999987643211 1111223456778999999999999
Q ss_pred ccCCCCCCCH-----HHHHHHHH
Q 001103 1124 SFNPAARPSF-----TEITNRLR 1141 (1157)
Q Consensus 1124 qkDPskRPSa-----eELLe~Lr 1141 (1157)
+.||.+||++ ++++++.+
T Consensus 214 ~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 214 QFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred cCCHHHhcCCCccchHHHHcCCC
Confidence 9999999985 77776543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=332.29 Aligned_cols=260 Identities=34% Similarity=0.599 Sum_probs=226.4
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--C---ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--G---TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--G---t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
+|......|.+.||.|.||.|++|+++ | ..||||.++... .+.....|+.|+.||-+++||||++|-|
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------tekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------cHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 355567788999999999999999985 3 349999998652 1334578999999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
+... ...+.||.|||++|+|..+|.++++.|...+...+++.|+.|++||-+.++|||||-..|||++ .+..+|
T Consensus 698 VVTk--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN----snLvCK 771 (996)
T KOG0196|consen 698 VVTK--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN----SNLVCK 771 (996)
T ss_pred EEec--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec----cceEEE
Confidence 9987 5688999999999999999999888899999999999999999999999999999999999999 888999
Q ss_pred EEecCCcccccCCc--c--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1026 VGDFGLSRIKCNTL--V--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~--~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
++|||+++...+.. . +.+-.-...|.|||.+. ..+++.++||||+|++|||.++ |..||-.+.+.+++..|.
T Consensus 772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa--~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe- 848 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE- 848 (996)
T ss_pred eccccceeecccCCCccccccCCccceeecChhHhh--hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-
Confidence 99999999764433 1 22223456899999997 4578999999999999999887 999999999999998886
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
..++.+-|.++|..|.+||..||++|..+||.+.+|...|.++...
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 4566677889999999999999999999999999999999887643
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=330.96 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=202.9
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~- 951 (1157)
..|+.-+.||+|+||.||+++. .|+.||||.+++..... .++...+|+++|++|+|||||+++++-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r-------~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR-------PRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc-------hHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 3566778899999999999997 48889999998764221 2467789999999999999999998865533
Q ss_pred ---CCcEEEEEEeecCCcchhhhccc--cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 952 ---GGTMATVTEYMVNGSLRHVLARK--DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 952 ---~~~LyLVMEYmeGGSL~dlLkr~--gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
...-.+|||||.||+|+.+|.+. -..|++...+.++.++..||.|||++||+||||||.||++-...+.....||
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence 33457999999999999999763 3559999999999999999999999999999999999999744446677899
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH----HHHHhhhcC
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA----IIGGILSNT 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee----il~~Il~~~ 1102 (1157)
+|||.|+...+.....++.||+.|++||+...+ ..|+..+|.|||||++|+++||.+||....... +...+..+.
T Consensus 166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ecccccccCCCCCeeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 999999988888888889999999999998742 357888999999999999999999997654432 222222110
Q ss_pred ---------------C----CCCCCCCCcHH----HHHHHHHHhccCCCCCC--CHHHHHHHH
Q 001103 1103 ---------------L----RPQIPERCDPE----WRKLMEECWSFNPAARP--SFTEITNRL 1140 (1157)
Q Consensus 1103 ---------------l----rpeip~~iSpe----LrdLIkrCLqkDPskRP--SaeELLe~L 1140 (1157)
. ..+.+..+++. +-..+..+|.++|++|. .+.+....+
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence 0 01123333333 45688889999999998 555444433
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=325.56 Aligned_cols=250 Identities=33% Similarity=0.592 Sum_probs=213.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC---Cc--eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR---GT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k---Gt--~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+++...++||+|.||+|++|.|+ |+ .||||.++..... .....|++|+.+|.+|+|||+|+|||+..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------~~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------AIMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------hhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 345556688999999999999995 33 4999999865322 14688999999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhcc-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr-~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
+. .+.+|||+++.|+|.+.|.+ ....|.......++.||+.||.||.++++|||||-..|||+. ....|||+
T Consensus 182 ~q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----sprtVKI~ 254 (1039)
T KOG0199|consen 182 DQ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----SPRTVKIC 254 (1039)
T ss_pred cc---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----ccceeeee
Confidence 73 47889999999999999977 556788888899999999999999999999999999999998 67799999
Q ss_pred ecCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC
Q 001103 1028 DFGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1028 DFGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~ 1102 (1157)
||||.+.+..... .....-...|+|||.++. ..++.++|+|++||+||||++ |+.||.+.....+++.|. ..
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~ 331 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AG 331 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cc
Confidence 9999986543322 122334567999999984 468999999999999999999 899999999999999887 55
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
.+..-|..|++.+.++++.||+.+|++||++..|.+.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 66677888999999999999999999999999997544
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.90 Aligned_cols=265 Identities=26% Similarity=0.376 Sum_probs=210.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
..|+.++.||+|.||.||+|..+ ...+|||.++...-. .-......||+.+++.|+||||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~------tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG------TGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC------CCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 47889999999999999999552 225899988754211 112345679999999999999999999987
Q ss_pred cCCCCcEEEEEEeecCCcchhhhcc----ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLAR----KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr----~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
.. +..+++++||.+. +|.++++- ..+.++...+..|++||+.|+.|||++.|+||||||.|||+..++++.|.|
T Consensus 98 ~~-d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 98 SH-DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cc-CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 64 6789999999987 88888863 235689999999999999999999999999999999999999888899999
Q ss_pred EEEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--------
Q 001103 1025 KVGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-------- 1092 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-------- 1092 (1157)
||+|||+++...++. .....+-|.+|.|||.+.|. ..|+.+.|+|++|||+.||++-++.|.+....
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 999999999765543 23456789999999999987 57999999999999999999998888653321
Q ss_pred -HHHHHhhhcCCCC---C------CC--------------------------CCCcHHHHHHHHHHhccCCCCCCCHHHH
Q 001103 1093 -AIIGGILSNTLRP---Q------IP--------------------------ERCDPEWRKLMEECWSFNPAARPSFTEI 1136 (1157)
Q Consensus 1093 -eil~~Il~~~lrp---e------ip--------------------------~~iSpeLrdLIkrCLqkDPskRPSaeEL 1136 (1157)
..+.+|..-.-.+ . .| ..-++...+|+.+||+.||-+|.|+++.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 2223332210000 0 00 1124457789999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 001103 1137 TNRLRVMSTALQ 1148 (1157)
Q Consensus 1137 Le~Lr~Lk~aLe 1148 (1157)
+++..+....+.
T Consensus 335 leh~yF~~d~lp 346 (438)
T KOG0666|consen 335 LEHPYFTEDPLP 346 (438)
T ss_pred hcccccccCCCC
Confidence 999888776554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=314.40 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=216.2
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
+.++..+.+.+.++||+|-||.|.+|+..+ ..||||.++... ....+..|.+|+++|.+|+|||||.++++|
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 445666778899999999999999999987 889999988642 233468899999999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhcccccc-ccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~-L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.. ++.+++|+|||++|+|..++.++..+ +.-.....|+.||+.||+||.+.++|||||.+.|+|++ .+.++||
T Consensus 605 ~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~----~e~~iKi 678 (807)
T KOG1094|consen 605 VQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD----GEFTIKI 678 (807)
T ss_pred ec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec----CcccEEe
Confidence 87 56799999999999999999877433 35566778999999999999999999999999999999 8899999
Q ss_pred EecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChhHHHHHhhh-
Q 001103 1027 GDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT--GEEPYANMHCGAIIGGILS- 1100 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT--Gk~PF~g~~~eeil~~Il~- 1100 (1157)
+|||+++-...... ....+-...|||+|.+.- .+++.++|+|+||++|||+++ ...||.....+.++...-.
T Consensus 679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~ 756 (807)
T KOG1094|consen 679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF 756 (807)
T ss_pred cCcccccccccCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh
Confidence 99999985433222 223456778999998763 468999999999999999877 7899998888776655421
Q ss_pred --c---CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1101 --N---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1101 --~---~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
. ..-+..|.-++..+.++|.+||..|-.+||++++|-.+|....
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1 1122346678999999999999999999999999998887653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.79 Aligned_cols=254 Identities=21% Similarity=0.300 Sum_probs=207.3
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+|+.|--+.. +|..||||++.+.. ...+.++.||++++.+++ |+||++++++|++ +..+||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------GHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEE
Confidence 5699999999998766 68889999998752 233578899999999995 9999999999998 668999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
|||-|.||+|...|.+. +.+.+..+.++.++|+.||.|||.+||.||||||+|||-...+ .-.-||||||.++.....
T Consensus 154 VfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-KVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-CcCceeeecccccccccc
Confidence 99999999999888643 4689999999999999999999999999999999999997333 445689999998763211
Q ss_pred --------CcccCCCCCCCcccCccccc---CCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---------------
Q 001103 1038 --------TLVSGGVRGTLPWMAPELLN---GSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC--------------- 1091 (1157)
Q Consensus 1038 --------~~~sts~~GTp~YmAPEVL~---G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~--------------- 1091 (1157)
.....+.+|+..|||||++. +....|+.++|+||||||||-||.|.+||.++-.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 11123467999999999863 4445689999999999999999999999986432
Q ss_pred hHHHHHhhhcCCCCC--CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1092 GAIIGGILSNTLRPQ--IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1092 eeil~~Il~~~lrpe--ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
..++..|-++.+.++ -+..+|.+.+++|..+|..|+..|-++.++++++|.-.-+
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 245666666655432 2345899999999999999999999999999988765443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=322.21 Aligned_cols=244 Identities=26% Similarity=0.345 Sum_probs=201.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
..+|++...+|.|+|+.|-.+.+ +++..++|++.+.. ....+|+.++... +||||+++++.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------------~~~~~e~~~~~~~~~h~niv~~~~v~~~- 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------------DDNQDEIPISLLVRDHPNIVKSHDVYED- 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------------cccccccchhhhhcCCCcceeecceecC-
Confidence 46788888899999999999988 46779999998751 1122455444444 79999999999988
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....|+|||++.|+-|.+.+..... +. ..+..|+++|+.|+.|||++|||||||||+|||++ ...++++|+|||
T Consensus 388 -~~~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~lrltyFG 461 (612)
T KOG0603|consen 388 -GKEIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHLRLTYFG 461 (612)
T ss_pred -CceeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---CCCCcEEEEEec
Confidence 6789999999999988877755432 22 67778999999999999999999999999999994 277899999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~~lrpeip~ 1109 (1157)
.++..... ..+.+-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... ++...+ ..+.+..
T Consensus 462 ~a~~~~~~--~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~ 533 (612)
T KOG0603|consen 462 FWSELERS--CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSE 533 (612)
T ss_pred hhhhCchh--hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCcccc
Confidence 99876655 334567999999999984 47899999999999999999999999877665 333333 3445558
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+|.++++||.+||+.||.+|+++.+++.+.|.+.
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 89999999999999999999999999999999843
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=267.02 Aligned_cols=238 Identities=30% Similarity=0.457 Sum_probs=195.3
Q ss_pred CcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEEeecC
Q 001103 887 TFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVN 964 (1157)
Q Consensus 887 sFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVMEYmeG 964 (1157)
+||.||++.+. +..+|+|++....... ..+.+.+|++.+++++|++|+++++.+.. ....+++|||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-------KRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-------HHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCC
Confidence 58999999995 5789999987642211 04678899999999999999999999877 4688999999999
Q ss_pred CcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCC
Q 001103 965 GSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044 (1157)
Q Consensus 965 GSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~ 1044 (1157)
++|.+++..... +++..++.++.+++.+|.|||+.+|+|+||+|.||+++ .++.++|+|||.+............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~----~~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD----EDGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC----CCCcEEEccccceeeeccccccccc
Confidence 999999875443 78899999999999999999999999999999999998 6689999999999876554444556
Q ss_pred CCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhHHHHHhhhcCCCCCCCCC-CcHHHHHHHHHH
Q 001103 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN-MHCGAIIGGILSNTLRPQIPER-CDPEWRKLMEEC 1122 (1157)
Q Consensus 1045 ~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g-~~~eeil~~Il~~~lrpeip~~-iSpeLrdLIkrC 1122 (1157)
.++..|++||.+.+. .++.++|+|+||+++|+|++|..||.. .........+............ ++.++.+++.+|
T Consensus 147 ~~~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 147 VGTPEYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred cCCcCCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 789999999998743 568899999999999999999999987 4444444433332222211111 788999999999
Q ss_pred hccCCCCCCCHHHHHHHH
Q 001103 1123 WSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1123 LqkDPskRPSaeELLe~L 1140 (1157)
|..+|.+||++.+++++.
T Consensus 225 l~~~p~~Rp~~~~~~~~~ 242 (244)
T smart00220 225 LVKDPEKRLTAEEALQHP 242 (244)
T ss_pred ccCCchhccCHHHHhhCC
Confidence 999999999999999854
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=322.71 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=215.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
...|++.+.||.|.+|.||+++. .++..|+|++..... .-+++..|.++|+.+ +|||++.+|++|...
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---------~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---------EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---------ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 35789999999999999998876 688899998876421 124456788888887 699999999998532
Q ss_pred ---CCCcEEEEEEeecCCcchhhhcc-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 951 ---PGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 951 ---~~~~LyLVMEYmeGGSL~dlLkr-~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.++.+|||||||.||+.-++++. .+..+.|..+.+|+.+++.||.+||.+.+||||||-.|||++ .++.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT----~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT----ENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----ccCcEEE
Confidence 24589999999999999999876 367799999999999999999999999999999999999999 8899999
Q ss_pred EecCCcccccCC-cccCCCCCCCcccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1027 GDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNG---SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G---~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
+|||++...... ....+++|||.|||||++.. ....|+.++|+||||++..||..|.+|+-.++....+..|-.+.
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP 244 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence 999998765443 34556789999999999854 34567889999999999999999999999999988877775543
Q ss_pred CCCC-CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1103 LRPQ-IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1103 lrpe-ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+.. -|..+++++.+||..||.+|..+||++.++++|..
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 3322 36789999999999999999999999999998743
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-33 Score=300.31 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=210.6
Q ss_pred ccccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHH-hCCCCceeEEe
Q 001103 868 GLQIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS-NLHHPNVVAFY 944 (1157)
Q Consensus 868 ~i~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK-~L~HPNIVkLy 944 (1157)
.+..+...+++.+..||.|+||+|++..++ |+..|||+++.... +...++++.|.+... .-+.||||++|
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-------~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-------EKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-------hHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 345677778888999999999999998885 77899999987532 222467778887654 45799999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhcc----ccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCC
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLAR----KDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr----~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~ 1019 (1157)
|.... ++-+||.||.|.- +|..+.+. ....+++..+-.|..-.+.||.||.+. +|||||+||+|||++
T Consensus 130 Ga~F~--EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld---- 202 (361)
T KOG1006|consen 130 GALFS--EGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD---- 202 (361)
T ss_pred hhhhc--CCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe----
Confidence 99877 5679999999954 66555432 345588888888888999999999975 899999999999999
Q ss_pred CCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hHHHHHh
Q 001103 1020 QRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-GAIIGGI 1098 (1157)
Q Consensus 1020 e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~-eeil~~I 1098 (1157)
..|.+||||||.+....+....+...|-..|||||.+......|+.++|+||||++|||+.||+.|+..... .+.+..+
T Consensus 203 r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V 282 (361)
T KOG1006|consen 203 RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV 282 (361)
T ss_pred cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH
Confidence 788999999999988777776666778899999999987666799999999999999999999999987553 3344444
Q ss_pred hhcCCCCC-CC---CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1099 LSNTLRPQ-IP---ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1099 l~~~lrpe-ip---~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+..+.. .+ ...+..+..+|..||.+|...||.+.+|+++...
T Consensus 283 v~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy 330 (361)
T KOG1006|consen 283 VIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY 330 (361)
T ss_pred HcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence 44433322 22 2378899999999999999999999999986543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=329.11 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=183.3
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
+...+.||+|+||.||+|++ .+..||||+++.... ....|++++++++|||||++++++.+ ...
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~ 757 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRS--EKG 757 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEc--CCC
Confidence 45567899999999999997 477899998864311 11245788999999999999999987 457
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH---MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLH---SkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.|+||||+++|+|.++++. +++..+..++.|++.||+||| +.+|+||||||+|||++ .....++. ||.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~----~~~~~~~~-~~~ 828 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----GKDEPHLR-LSL 828 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC----CCCceEEE-ecc
Confidence 8999999999999999953 788999999999999999999 66999999999999998 44455554 665
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--HHHHH---hh-----hc
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG--AIIGG---IL-----SN 1101 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e--eil~~---Il-----~~ 1101 (1157)
....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..... .. ..
T Consensus 829 ~~~~~~~---~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 829 PGLLCTD---TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccccC---CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence 4332221 223689999999998754 5799999999999999999999998542211 11110 00 00
Q ss_pred CCCCCCC------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1102 TLRPQIP------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1102 ~lrpeip------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
...+.+. .....++.+++.+||+.||++||+++++++.|+.+..
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 1111111 1122356789999999999999999999999988765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=313.72 Aligned_cols=260 Identities=32% Similarity=0.534 Sum_probs=218.2
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCC
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR---------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHP 938 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~k---------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HP 938 (1157)
.+++....+.+.+.||+|.||.|++|..+ ...||||.++..... ...+.+..|+++|+.+ .||
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-------~~~~~~~~El~~m~~~g~H~ 362 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-------SEKKDLMSELNVLKELGKHP 362 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-------HHHHHHHHHHHHHHHhcCCc
Confidence 45566666777789999999999998753 234999988765321 2257788999999999 699
Q ss_pred ceeEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCce
Q 001103 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIV 1003 (1157)
Q Consensus 939 NIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGII 1003 (1157)
||+.+.|++.. .+.+++|+||+..|+|.+++...+ ..+.....+.++.||+.|++||+++.+|
T Consensus 363 niv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 363 NIVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred chhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 99999999988 778999999999999999998765 3488899999999999999999999999
Q ss_pred eccCCccceeeccCCCCCCeEEEEecCCcccccCCccc--CCCCC--CCcccCcccccCCCCCCCchhHHHHHHHHHHHH
Q 001103 1004 HFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS--GGVRG--TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEI 1079 (1157)
Q Consensus 1004 HRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~s--ts~~G--Tp~YmAPEVL~G~~~~yS~KSDIWSLGVILYEL 1079 (1157)
||||-..|||++ .+..+||+|||+|+........ ..-.| ...|||||.+.. ..|+.++||||+|++||||
T Consensus 441 HRDLAaRNVLi~----~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~Ei 514 (609)
T KOG0200|consen 441 HRDLAARNVLIT----KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEI 514 (609)
T ss_pred chhhhhhhEEec----CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHH
Confidence 999999999998 7789999999999854332221 21222 345999999985 5789999999999999999
Q ss_pred Hc-CCCCCCCCC-hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1080 IT-GEEPYANMH-CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1080 LT-Gk~PF~g~~-~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
++ |..||.+.. ..++ ...+..+.+...|..+++++.++|+.||+.+|.+||++.++.+.+....
T Consensus 515 fsLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 515 FTLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred hhCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 99 999999876 4445 4466677888899999999999999999999999999999999998854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=311.51 Aligned_cols=264 Identities=20% Similarity=0.320 Sum_probs=208.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...-|..++.||-|+||.|.+++.. ...||+|.+++...+.+ .-+..+..|..||..-+.+-||+||..|++
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~r-----nQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMR-----NQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhh-----hhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 44566888999999999999998764 34499999887654433 234567789999999999999999999998
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+||||++||++..+|-+.+ .|++..++.++.+|..|+++.|..|+|||||||+||||| .+|++||+||
T Consensus 701 --kdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID----rdGHIKLTDF 773 (1034)
T KOG0608|consen 701 --KDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDF 773 (1034)
T ss_pred --CCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc----cCCceeeeec
Confidence 679999999999999999997665 589999999999999999999999999999999999999 7889999999
Q ss_pred CCcccc---c------C----------------------------------CcccCCCCCCCcccCcccccCCCCCCCch
Q 001103 1030 GLSRIK---C------N----------------------------------TLVSGGVRGTLPWMAPELLNGSNNRVSEK 1066 (1157)
Q Consensus 1030 GLAkl~---~------~----------------------------------~~~sts~~GTp~YmAPEVL~G~~~~yS~K 1066 (1157)
||++-. . + .......+||+.|+|||++... .|+..
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~ 851 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQL 851 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--Ccccc
Confidence 998620 0 0 0011235799999999999743 57888
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhh--hcCCCCCCCCCCcHHHHHHHHHHhccCCCCCC---CHHHHHHHHH
Q 001103 1067 VDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL--SNTLRPQIPERCDPEWRKLMEECWSFNPAARP---SFTEITNRLR 1141 (1157)
Q Consensus 1067 SDIWSLGVILYELLTGk~PF~g~~~eeil~~Il--~~~lrpeip~~iSpeLrdLIkrCLqkDPskRP---SaeELLe~Lr 1141 (1157)
+||||.|||||||+.|+.||-.....+....++ ...+.......++++..+||.++.. +++.|- .++++-.|.+
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpf 930 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPF 930 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcc
Confidence 999999999999999999998766554433332 2234445567799999999988664 566663 4566777766
Q ss_pred HHHHHHhhc
Q 001103 1142 VMSTALQTK 1150 (1157)
Q Consensus 1142 ~Lk~aLesk 1150 (1157)
+-...+...
T Consensus 931 FkgIDfssl 939 (1034)
T KOG0608|consen 931 FKGIDFSSL 939 (1034)
T ss_pred ccccchHhh
Confidence 554444443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=305.49 Aligned_cols=270 Identities=23% Similarity=0.369 Sum_probs=216.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|-++..||+|+|+.||++.+ ..+.||||+-....-+. .+..+.+.+...+|.+|-+.|+||.||++|++|.-+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD- 539 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh-hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-
Confidence 35677889999999999999987 45679999866543332 334456778889999999999999999999999764
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCCCCeEEEEec
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|.|+|||+|.+|..+|+.+. .++++.++.|+.||+.||.||.+.. |||.||||.|||+- ++..-+.+||+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv-~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV-NGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe-cCcccceeEeeec
Confidence 457899999999999999997654 5899999999999999999999885 99999999999996 3336688999999
Q ss_pred CCcccccCCc--------ccCCCCCCCcccCcccccC--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHH-
Q 001103 1030 GLSRIKCNTL--------VSGGVRGTLPWMAPELLNG--SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGG- 1097 (1157)
Q Consensus 1030 GLAkl~~~~~--------~sts~~GTp~YmAPEVL~G--~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~- 1097 (1157)
|+++.+.... .+.-..||.+|++||.+-- .+.+++.|+||||+|||+|.++.|+.||...... ++++.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 9998754321 2334679999999997642 3567899999999999999999999999875533 22222
Q ss_pred -hhh-cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1098 -ILS-NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1098 -Il~-~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
|+. ....++....++.+.++||++||++..+.|..+.+|..+...+....
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 111 12223344568999999999999999999999999998877665443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=298.44 Aligned_cols=261 Identities=23% Similarity=0.272 Sum_probs=206.7
Q ss_pred cccccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC--C----
Q 001103 867 YGLQIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--P---- 938 (1157)
Q Consensus 867 y~i~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H--P---- 938 (1157)
|....+...+|+++..||+|.||.|..+.++ +..||||+++.. ..+.+...-|+++|+++.+ |
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---------~kYreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---------DKYREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---------HHHhhHHHHHHHHHHHHHhcCCCCce
Confidence 4444555689999999999999999999874 567999998864 2334556679999999942 2
Q ss_pred ceeEEeeeeecCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccC
Q 001103 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLR 1017 (1157)
Q Consensus 939 NIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~d 1017 (1157)
-+|++.+||.. .+++|||+|.+ |.+++++|+.+ ..+++..+++.+++||+.+++|||+.+++|.||||||||+...
T Consensus 152 rcv~m~~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 152 RCVQMRDWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSS 228 (415)
T ss_pred EEEeeehhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEecc
Confidence 37788888877 78999999988 56999999874 4779999999999999999999999999999999999998522
Q ss_pred C----------------CCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1018 D----------------PQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1018 d----------------~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
. .+...|||+|||.|+...... ...+.|..|.|||++.|. .++.++||||+||||+||.+
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeec
Confidence 1 235679999999998765544 447789999999999976 68999999999999999999
Q ss_pred CCCCCCCCChhH---HHHHhhhcCCC-----------------CCCCC-------------------------CCcHHHH
Q 001103 1082 GEEPYANMHCGA---IIGGILSNTLR-----------------PQIPE-------------------------RCDPEWR 1116 (1157)
Q Consensus 1082 Gk~PF~g~~~ee---il~~Il~~~lr-----------------peip~-------------------------~iSpeLr 1116 (1157)
|...|+...+.+ +++.|+. .++ ..++. ....+|.
T Consensus 305 G~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred cceecccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 999999877554 2233321 100 00010 0123478
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+||++||..||.+|+|+.|++.+..+-.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHHHHHHccCccccccHHHHhcCHHhhc
Confidence 9999999999999999999999987643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=272.96 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=207.9
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|...++||+|.||+||+++.+ +..||+|+++...- .+.......+|+-+|+.|+|.|||+++++... +.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd------degvpssalreicllkelkhknivrl~dvlhs--dk 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHS--DK 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC------CCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--Cc
Confidence 4566788999999999999874 56699999886421 12223566799999999999999999999877 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+-+|+|||.. +|..+.....+.++.+.++.++.|+++||.|+|++++.||||||.|+||+ .++.+||+|||+++
T Consensus 75 kltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin----~ngelkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN----RNGELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec----cCCcEEecccchhh
Confidence 78999999965 88888877777799999999999999999999999999999999999999 88999999999998
Q ss_pred cccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCC---CCC
Q 001103 1034 IKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP---QIP 1108 (1157)
Q Consensus 1034 l~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrp---eip 1108 (1157)
...-+. .....+-|.+|.+|.++.|. .-|+...|+||.|||+.|+.. |++.|++.+..+.+.+|....-.+ ++|
T Consensus 150 afgipvrcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 765554 34456789999999999986 368999999999999999987 888899999888887775321111 011
Q ss_pred ------------------------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1109 ------------------------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1109 ------------------------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+...-++|++++|..+|.+|.++++.+++..+
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 1123345789999999999999999999987653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=305.50 Aligned_cols=256 Identities=18% Similarity=0.183 Sum_probs=171.1
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
+..++|++.+.||+|+||.||+|++. +..||||++.... ..+ ....| .++...+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e----~~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVE----IWMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhH----HHHHH--HHHhhchhhHHHHHH
Confidence 34578999999999999999999984 5679999876431 111 11111 112222222222221
Q ss_pred ee----ecCCCCcEEEEEEeecCCcchhhhcccccc-------------------ccHHHHHHHHHHHHHHHHHHHHCCc
Q 001103 946 VV----PNGPGGTMATVTEYMVNGSLRHVLARKDRI-------------------LDRRKKLMLMMDAAFGMEYLHMKNI 1002 (1157)
Q Consensus 946 vf----~de~~~~LyLVMEYmeGGSL~dlLkr~gr~-------------------L~e~qVlkIa~QLa~ALeYLHSkGI 1002 (1157)
.+ .......+++||||+.+++|.+++...... .....+..++.||+.||.|||+++|
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 11 112355789999999999999888643211 1234466789999999999999999
Q ss_pred eeccCCccceeeccCCCCCCeEEEEecCCcccccC--CcccCCCCCCCcccCcccccCCCC-------------------
Q 001103 1003 VHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN--TLVSGGVRGTLPWMAPELLNGSNN------------------- 1061 (1157)
Q Consensus 1003 IHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~--~~~sts~~GTp~YmAPEVL~G~~~------------------- 1061 (1157)
+||||||+|||++. ..+.+||+|||+|+.... ......+++|+.|+|||.+....+
T Consensus 277 iHRDLKP~NILl~~---~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 277 VHRDVKPQNIIFSE---GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred EeCcCCHHHEEEeC---CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 99999999999972 346899999999975432 222345679999999997643211
Q ss_pred -CCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh-c-------------CCCCC------CCCCCcHHHHHHHH
Q 001103 1062 -RVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS-N-------------TLRPQ------IPERCDPEWRKLME 1120 (1157)
Q Consensus 1062 -~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~-~-------------~lrpe------ip~~iSpeLrdLIk 1120 (1157)
.+..++|||||||+||||+++..|+... ...+..++. . ..... +.........+||.
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 2345679999999999999987765432 111111111 0 00000 00112234558999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1121 ECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1121 rCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+||++||.+|||++++++|.+...
T Consensus 432 ~mL~~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred HHccCCcccCCCHHHHhCCcCcCC
Confidence 999999999999999999987643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=295.55 Aligned_cols=267 Identities=19% Similarity=0.183 Sum_probs=186.6
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE------------------CCceEEEEEEecccccCCChhH------HHHHHHHHHH
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW------------------RGTDIAIKRIKKSCFLGRSSEQ------EWLIKEFWRE 928 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~------------------kGt~VAVKVIkk~~l~~r~~e~------e~likqflrE 928 (1157)
..++|++.++||+|+||+||+|.+ .++.||||+++........... ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999864 2456999998653110000000 0011233457
Q ss_pred HHHHHhCCCCce-----eEEeeeeecC------CCCcEEEEEEeecCCcchhhhcccc----------------------
Q 001103 929 AHIISNLHHPNV-----VAFYGVVPNG------PGGTMATVTEYMVNGSLRHVLARKD---------------------- 975 (1157)
Q Consensus 929 IkILK~L~HPNI-----VkLygvf~de------~~~~LyLVMEYmeGGSL~dlLkr~g---------------------- 975 (1157)
+.++.+++|.++ +++++++... ..+..++||||+.+++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 5666666432 1346899999999999998886321
Q ss_pred -ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCC--CCCCCcccC
Q 001103 976 -RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG--VRGTLPWMA 1052 (1157)
Q Consensus 976 -r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts--~~GTp~YmA 1052 (1157)
..+++..++.++.|++.+|.|||+++|+||||||+|||++ .++.+||+|||++........... ..+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~----~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT----VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC----CCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1235667888999999999999999999999999999998 667899999999975433222222 235889999
Q ss_pred cccccCCC--------------------CCCCchhHHHHHHHHHHHHHcCCC-CCCCCChhH-----------HHHHhhh
Q 001103 1053 PELLNGSN--------------------NRVSEKVDVYSFGIAMWEIITGEE-PYANMHCGA-----------IIGGILS 1100 (1157)
Q Consensus 1053 PEVL~G~~--------------------~~yS~KSDIWSLGVILYELLTGk~-PF~g~~~ee-----------il~~Il~ 1100 (1157)
||.+.... +....+.|+||+||+||+|++|.+ ||....... ....+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875321 111234799999999999999986 775422111 1111111
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCC---CCCCCHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNP---AARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDP---skRPSaeELLe~Lr~L 1143 (1157)
..+........++..++||.+||.++| .+|+|++++|+|.|+.
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 223333445678999999999999876 6899999999998763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=288.29 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=206.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
....|+.+.+||+|.||.||+|+.+ |+.||+|++...... +-.-...++|+++|+.|+|+|++.++.++...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK------eGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc------cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 3456788899999999999999874 566888765432111 11123456899999999999999998887532
Q ss_pred ------CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 951 ------PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 951 ------~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
....+|+||++|+. +|.-+|......++...+.+++.++..||.|+|...|+|||+|++|+||+ .++.+
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt----~dgil 163 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT----KDGIL 163 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc----CCceE
Confidence 23469999999987 88888887767799999999999999999999999999999999999999 78899
Q ss_pred EEEecCCcccccC-----CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhh
Q 001103 1025 KVGDFGLSRIKCN-----TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1025 KLiDFGLAkl~~~-----~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il 1099 (1157)
||+|||+++.... ....+..+-|.+|++||.+.|. ..|+.+.|||+.|||+.||+++.+.|.+......+..|.
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999999964322 2234455679999999999986 578999999999999999999999998877655444432
Q ss_pred h--cCCCCC------------------CCC-------------CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1100 S--NTLRPQ------------------IPE-------------RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1100 ~--~~lrpe------------------ip~-------------~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
. +...++ ++. .-+++..+|+..||..||.+|+++++.+++.++.+..
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 1 111111 111 1135677999999999999999999999998877654
Q ss_pred H
Q 001103 1147 L 1147 (1157)
Q Consensus 1147 L 1147 (1157)
.
T Consensus 323 ~ 323 (376)
T KOG0669|consen 323 M 323 (376)
T ss_pred c
Confidence 3
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=281.98 Aligned_cols=273 Identities=21% Similarity=0.279 Sum_probs=205.9
Q ss_pred HHHHhhcccc---ccc-ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHH
Q 001103 859 MAEMEAGIYG---LQI-IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932 (1157)
Q Consensus 859 l~e~ea~~y~---i~~-I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkIL 932 (1157)
..++..+.|. +.. +...+|.++++||+|.|++||++.+. .+.||+|+.+.. +.+.+..+.|+++|
T Consensus 58 ~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL 128 (590)
T KOG1290|consen 58 PEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLL 128 (590)
T ss_pred hhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHH
Confidence 3445555553 333 34489999999999999999999884 566999998853 44567778999999
Q ss_pred HhCC-----C---CceeEEeeeeec--CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHC-
Q 001103 933 SNLH-----H---PNVVAFYGVVPN--GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMK- 1000 (1157)
Q Consensus 933 K~L~-----H---PNIVkLygvf~d--e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSk- 1000 (1157)
+++. | .+||+|++.|.. ..+.++|||+|++ |.+|..+|+.. -+.++...+..|++|++.||.|||.+
T Consensus 129 ~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec 207 (590)
T KOG1290|consen 129 QQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC 207 (590)
T ss_pred HHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc
Confidence 9983 3 479999999964 3355899999998 66888888764 46799999999999999999999976
Q ss_pred CceeccCCccceeeccCC--------------------------------------------------------------
Q 001103 1001 NIVHFDLKCDNLLVNLRD-------------------------------------------------------------- 1018 (1157)
Q Consensus 1001 GIIHRDLKPENILLd~dd-------------------------------------------------------------- 1018 (1157)
||||.||||+|||+...+
T Consensus 208 gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~ 287 (590)
T KOG1290|consen 208 GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEAS 287 (590)
T ss_pred CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhh
Confidence 999999999999982210
Q ss_pred ----------------------------------C--------------C------------------------------
Q 001103 1019 ----------------------------------P--------------Q------------------------------ 1020 (1157)
Q Consensus 1019 ----------------------------------~--------------e------------------------------ 1020 (1157)
+ .
T Consensus 288 l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s 367 (590)
T KOG1290|consen 288 LAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSS 367 (590)
T ss_pred hcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccC
Confidence 0 0
Q ss_pred ----------------------CCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHH
Q 001103 1021 ----------------------RPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWE 1078 (1157)
Q Consensus 1021 ----------------------~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYE 1078 (1157)
.-.|||+|||.|.......+. ..-|..|+|||++.|. .|+..+||||++|++||
T Consensus 368 ~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~--DIQTRQYRapEVllGs--gY~~~ADiWS~AC~~FE 443 (590)
T KOG1290|consen 368 PSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTE--DIQTRQYRAPEVLLGS--GYSTSADIWSTACMAFE 443 (590)
T ss_pred cCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhch--hhhhhhccCcceeecC--CCCCchhHHHHHHHHHH
Confidence 014788888888765544333 4578899999999987 57899999999999999
Q ss_pred HHcCCCCCCCCCh------hHHHHHhhh------------cC-----------CC----C-------------CCCCCCc
Q 001103 1079 IITGEEPYANMHC------GAIIGGILS------------NT-----------LR----P-------------QIPERCD 1112 (1157)
Q Consensus 1079 LLTGk~PF~g~~~------eeil~~Il~------------~~-----------lr----p-------------eip~~iS 1112 (1157)
|+||...|..... ++.+..|+. +. ++ . .++..-.
T Consensus 444 LaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A 523 (590)
T KOG1290|consen 444 LATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDA 523 (590)
T ss_pred hhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHH
Confidence 9999998864322 222222221 00 00 0 1112223
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.++.+|+.-||+++|++|||+.+.+++.|....
T Consensus 524 ~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 524 QQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPV 556 (590)
T ss_pred HHHHHHHHHHHhcCccccccHHHHhcCccccCC
Confidence 568899999999999999999999999987643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=301.36 Aligned_cols=258 Identities=31% Similarity=0.548 Sum_probs=216.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCc----eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGT----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt----~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+..+....++||+|+||+||+|.| +|. +||||++..... .....+++.|+-+|.+|+|||++++++
T Consensus 693 ~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-------~~~s~e~LdeAl~masldHpnl~RLLg 765 (1177)
T KOG1025|consen 693 LKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-------PKASIELLDEALRMASLDHPNLLRLLG 765 (1177)
T ss_pred chhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-------chhhHHHHHHHHHHhcCCCchHHHHhh
Confidence 3444556678999999999999998 443 489998876422 112467889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++... .+.||++||++|.|.++++.++..+..+..+.|..||++||.|||.++++||||-..|||+. +-.++|
T Consensus 766 vc~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk----sP~hvk 838 (1177)
T KOG1025|consen 766 VCMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK----SPNHVK 838 (1177)
T ss_pred hcccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec----CCCeEE
Confidence 99874 37889999999999999998888899999999999999999999999999999999999998 777999
Q ss_pred EEecCCcccccCCcc---cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhc
Q 001103 1026 VGDFGLSRIKCNTLV---SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~---sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~ 1101 (1157)
|.|||+++....... ..+..-.+.|||-|.+.. ..|+.++||||+||++||+|| |..|+.+....++-. ++..
T Consensus 839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-lle~ 915 (1177)
T KOG1025|consen 839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-LLEK 915 (1177)
T ss_pred EEecchhhccCcccccccccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-HHhc
Confidence 999999997554332 222334567999998874 478999999999999999999 999999988766544 4445
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
..+..-|..++.++.-++.+||..|+..||+++++...+..+...
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 556777888999999999999999999999999999988776643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=271.05 Aligned_cols=257 Identities=20% Similarity=0.289 Sum_probs=209.6
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeec
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPN 949 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~d 949 (1157)
..++|++++++|+|.|+.||.|.. +...++||+++... .+++.||++||+.|. ||||++++++..+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 457899999999999999999985 56779999998641 367899999999997 9999999999999
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
+......+|+||+++.+...+.. .+....++.++.|++.||.|||++||+|||+||.|++|+ .....++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId---h~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID---HELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec---hhhceeeeeec
Confidence 88888899999999988766653 366778899999999999999999999999999999998 56778999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCC-CCChhHHHHHhhh--------
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA-NMHCGAIIGGILS-------- 1100 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~-g~~~eeil~~Il~-------- 1100 (1157)
|+|.+........-.+.+..|--||.+-.. ..|+..-|+|||||+|..|+..+.||- +.++.+.+..|..
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 999987766665556678889999998753 457888999999999999999999974 3344333333321
Q ss_pred -------cCCCC--------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1101 -------NTLRP--------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1101 -------~~lrp--------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
-.+.+ .-....++++.+|+.++|..|-.+|+|+++.+.|..+....-.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 00111 1112256899999999999999999999999999887765433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=236.12 Aligned_cols=211 Identities=38% Similarity=0.648 Sum_probs=181.0
Q ss_pred ecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 883 LGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
||+|.+|.||+++.. +..+++|++....... ....+.+|++.++.+.|++|+++++++.. ....+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEe
Confidence 689999999999996 7889999988652111 24678899999999999999999999887 468899999
Q ss_pred eecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCC-CCeEEEEecCCcccccCCc
Q 001103 961 YMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQ-RPICKVGDFGLSRIKCNTL 1039 (1157)
Q Consensus 961 YmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e-~g~VKLiDFGLAkl~~~~~ 1039 (1157)
++.+++|.+++......+++..++.++.+++.+|.+||++|++|+||+|.||+++ . .+.++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~----~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD----SDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe----CCCCcEEEecCCceEEccCCc
Confidence 9999999999876534588999999999999999999999999999999999998 4 6789999999987654432
Q ss_pred -ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHH
Q 001103 1040 -VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKL 1118 (1157)
Q Consensus 1040 -~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdL 1118 (1157)
......+...|++||.+... ..++.+.|+|+||+++++| ..+.++
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~ 193 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL---------------------------------PELKDL 193 (215)
T ss_pred chhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------HHHHHH
Confidence 12235588899999998753 2568899999999999999 688999
Q ss_pred HHHHhccCCCCCCCHHHHHHHH
Q 001103 1119 MEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1119 IkrCLqkDPskRPSaeELLe~L 1140 (1157)
+.+|++.+|.+||++.++++++
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=293.77 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=208.8
Q ss_pred ccccccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC------CCc
Q 001103 868 GLQIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH------HPN 939 (1157)
Q Consensus 868 ~i~~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~------HPN 939 (1157)
.+.++-..+|.+....|+|-|++|.+|++ .|..||||+|.... ...+.-++|++||++|+ --+
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---------~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---------VMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---------HHhhhhhHHHHHHHHhhccCchhhhH
Confidence 45566778999999999999999999998 47789999999863 33456678999999996 247
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccc--cccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccC
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR--ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLR 1017 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr--~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~d 1017 (1157)
+++|+..|.. .+++|||+|.+. .+|.++|++.++ .|....+..++.||..||+.|...||+|.||||+|||++
T Consensus 496 clrl~r~F~h--knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN-- 570 (752)
T KOG0670|consen 496 CLRLFRHFKH--KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN-- 570 (752)
T ss_pred HHHHHHHhhh--cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--
Confidence 8899988887 779999999884 489999988653 377889999999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 001103 1018 DPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGG 1097 (1157)
Q Consensus 1018 d~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~ 1097 (1157)
+....+||||||.|........+ .+.-+..|.|||++.|. .|+...|+||+||+||||.||+..|++..+..++..
T Consensus 571 -E~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 571 -ESKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred -cCcceeeeccCcccccccccccc-HHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 46778999999999876655443 34567789999999987 467789999999999999999999999877665544
Q ss_pred hhhc--CCCC-----------------------------------------------------CCCCC---CcHHHHHHH
Q 001103 1098 ILSN--TLRP-----------------------------------------------------QIPER---CDPEWRKLM 1119 (1157)
Q Consensus 1098 Il~~--~lrp-----------------------------------------------------eip~~---iSpeLrdLI 1119 (1157)
.+.. .++. .++.. .-.+|++|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 4321 1100 00000 114588999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHH
Q 001103 1120 EECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1120 krCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..||.+||++|.|..+.|.|+.+
T Consensus 727 dkml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred HHHhccChhhcCCHHHHhcCCcc
Confidence 99999999999999999988654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=279.01 Aligned_cols=255 Identities=33% Similarity=0.581 Sum_probs=203.7
Q ss_pred CCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHh--CCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN--LHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~--L~HPNIVkLygvf~de~ 951 (1157)
..+..+++.||+|.||.||+|+|+|..||||++.... ...+.||.+|++. |+|+||+.+++.-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----------ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc-----------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 4678899999999999999999999999999987541 2456788888885 48999999997754432
Q ss_pred --CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC--------CceeccCCccceeeccCCCCC
Q 001103 952 --GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK--------NIVHFDLKCDNLLVNLRDPQR 1021 (1157)
Q Consensus 952 --~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk--------GIIHRDLKPENILLd~dd~e~ 1021 (1157)
-..+|||.+|-+.|+|+++|.+ ..++....++++..++.||++||.. .|.|||||..|||+. ++
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK----kn 352 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KN 352 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc----cC
Confidence 2368999999999999999987 4488899999999999999999964 399999999999999 88
Q ss_pred CeEEEEecCCcccccCC-----cccCCCCCCCcccCcccccCCCCC----CCchhHHHHHHHHHHHHHcC----------
Q 001103 1022 PICKVGDFGLSRIKCNT-----LVSGGVRGTLPWMAPELLNGSNNR----VSEKVDVYSFGIAMWEIITG---------- 1082 (1157)
Q Consensus 1022 g~VKLiDFGLAkl~~~~-----~~sts~~GTp~YmAPEVL~G~~~~----yS~KSDIWSLGVILYELLTG---------- 1082 (1157)
+.+.|+|+|||...... ......+||..|||||++...-+. .-..+||||||+++||++-.
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999754332 123456899999999998642110 11358999999999998762
Q ss_pred CCCCCCCC-----hhHHHHHhhhcCCCCCCCCCCc--H---HHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1083 EEPYANMH-----CGAIIGGILSNTLRPQIPERCD--P---EWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1083 k~PF~g~~-----~eeil~~Il~~~lrpeip~~iS--p---eLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
++||.+.. .+++..-+-...++|.+|..+. + .+.+||+.||..+|.-|-|+-.|-+.|.++..
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 57886532 2344444556678888776653 2 36689999999999999999999888888774
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=280.90 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=207.3
Q ss_pred cCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHh--CCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN--LHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~--L~HPNIVkLygvf~de 950 (1157)
.....+.++.||+|.||.||+|+++++.||||++... ..+.+..|.+|++. ++|+||+++++.-...
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 3455677889999999999999999999999998753 24678888888875 5899999998874432
Q ss_pred C--CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC---------CceeccCCccceeeccCCC
Q 001103 951 P--GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK---------NIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 951 ~--~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk---------GIIHRDLKPENILLd~dd~ 1019 (1157)
. ...++||++|.+.|+|.++|+.+- ++|....+++.-|++||+|||+- .|+|||||..|||+.
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK---- 350 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK---- 350 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc----
Confidence 2 336899999999999999998654 78999999999999999999974 399999999999998
Q ss_pred CCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCC----CCCchhHHHHHHHHHHHHHcCC---------
Q 001103 1020 QRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNN----RVSEKVDVYSFGIAMWEIITGE--------- 1083 (1157)
Q Consensus 1020 e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~----~yS~KSDIWSLGVILYELLTGk--------- 1083 (1157)
++....|+|||+|...... ....+.+||..|||||++.|.-+ ..-.+.||||+|.+||||++.-
T Consensus 351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 7889999999999764432 22344789999999999987422 1224689999999999999853
Q ss_pred ---CCCCC-----CChhHHHHHhhhcCCCCCCCCCC-----cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1084 ---EPYAN-----MHCGAIIGGILSNTLRPQIPERC-----DPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1084 ---~PF~g-----~~~eeil~~Il~~~lrpeip~~i-----SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
+||.. ...+++...++....+|.++..+ ...+++.+..||..|++-|-|+.=+.++++.+....+.
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 34431 11234445556677788777543 35688999999999999999999999999998876543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=298.17 Aligned_cols=241 Identities=27% Similarity=0.451 Sum_probs=185.8
Q ss_pred EEecccCcEE-EEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGT-VYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGt-VYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~LyLV 958 (1157)
+.+|.|+-|+ ||+|...|+.||||++-... .....+|+..|+.- +|||||++|+.-.+ ...+||.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----------~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF~YIa 581 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----------FDFAQREIQLLQESDEHPNVIRYYCSEQD--RQFLYIA 581 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhHh-----------HHHHHHHHHHHHhccCCCceEEEEeeccC--CceEEEE
Confidence 5589999886 88999999999999876542 24567899999988 69999999887555 7799999
Q ss_pred EEeecCCcchhhhccccccccH---HHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCC-CCCeEEEEecCCccc
Q 001103 959 TEYMVNGSLRHVLARKDRILDR---RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP-QRPICKVGDFGLSRI 1034 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L~e---~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~-e~g~VKLiDFGLAkl 1034 (1157)
.|.|.. +|.+++...+...+. ...+.+..|++.||++||+.+||||||||.||||+..+. ....++|+|||+++.
T Consensus 582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 999966 999999764211111 234667899999999999999999999999999985432 346899999999997
Q ss_pred ccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhHHHHHhhhcCCCC-CCC
Q 001103 1035 KCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG-EEPYANMHCGAIIGGILSNTLRP-QIP 1108 (1157)
Q Consensus 1035 ~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG-k~PF~g~~~eeil~~Il~~~lrp-eip 1108 (1157)
...... ..+..||.+|+|||++.... -+.++|||||||++|+.++| .+||...-..+ ..|+.+.... .+.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLE 736 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccc--cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeec
Confidence 544322 34567999999999998653 35689999999999999995 99998644322 2333332211 111
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
.....++++||.+|+..+|..||++.+++.|
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1112288999999999999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=257.51 Aligned_cols=215 Identities=28% Similarity=0.421 Sum_probs=175.7
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPN 949 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~d 949 (1157)
...++..+..||+|+||.|-+.++ .|+-.|+|.+.... . ....+++++|+.+..+. .+|.+|++||.+..
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n-----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--N-----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--C-----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 345666778899999999988777 68889999988642 1 22346778888876655 79999999998776
Q ss_pred CCCCcEEEEEEeecCCcchhhhc---cccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEE
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLA---RKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLk---r~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
.+..+|.||.|.. +|..+.+ ++++.+++..+-+|+..++.||.|||++ .|||||+||.|||++ ..++||
T Consensus 117 --egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn----~~GqVK 189 (282)
T KOG0984|consen 117 --EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN----YDGQVK 189 (282)
T ss_pred --cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc----cCCcEE
Confidence 5679999999965 7755543 3567799999999999999999999987 899999999999999 778999
Q ss_pred EEecCCcccccCCcccCCCCCCCcccCcccccCC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChhHHHHHhhhc
Q 001103 1026 VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGS--NNRVSEKVDVYSFGIAMWEIITGEEPYANM-HCGAIIGGILSN 1101 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~--~~~yS~KSDIWSLGVILYELLTGk~PF~g~-~~eeil~~Il~~ 1101 (1157)
+||||.+....+....+...|-..|||||++..+ ...|+.++||||||++++||.+++.||..- ...+.+.+++..
T Consensus 190 iCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred EcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 9999999888777766656788899999998753 236899999999999999999999999864 445666666544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=235.00 Aligned_cols=205 Identities=34% Similarity=0.551 Sum_probs=171.4
Q ss_pred eeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
|.+.+.||+|++|+||++... +..+|+|.+...... ...+.+.+|++.++.++|+|++++++++.. ...
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFED--PEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCc
Confidence 567889999999999999985 578999998865321 235678899999999999999999999876 467
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.++++||+.+++|.+++......+++..++.++.+++.+|.|||+++++|+||+|.||+++ ..+.++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~----~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG----MDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeeCceeeE
Confidence 8999999999999999876543378899999999999999999999999999999999998 568999999999886
Q ss_pred ccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhHHH
Q 001103 1035 KCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN-MHCGAII 1095 (1157)
Q Consensus 1035 ~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g-~~~eeil 1095 (1157)
..... ......++..|++||.+. ....++.++|+|+||+++|+|++|+.||.. ......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~ 210 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL 210 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence 54432 333456888999999984 334677899999999999999999999977 4444333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=285.15 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=211.8
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|+.+.++|.|+||.||++++ ++...|||+++...-. ...-+.+|+-+++.++|||||.+++.+..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--------d~~~iqqei~~~~dc~h~nivay~gsylr-- 83 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--------DFSGIQQEIGMLRDCRHPNIVAYFGSYLR-- 83 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--------cccccccceeeeecCCCcChHHHHhhhhh--
Confidence 36899999999999999999998 4777999999875321 13556789999999999999999999877
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...++|.||||.+|+|.++..-.+ ++++.++.+.+++.++||+|||++|=+|||||-.|||++ +.+.+||+|||.
T Consensus 84 ~dklwicMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt----d~gDvklaDfgv 158 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT----DEGDVKLADFGV 158 (829)
T ss_pred hcCcEEEEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceeec----ccCceeecccCc
Confidence 557999999999999999886554 599999999999999999999999999999999999999 888999999999
Q ss_pred cccccCCc-ccCCCCCCCcccCccccc-CCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC---
Q 001103 1032 SRIKCNTL-VSGGVRGTLPWMAPELLN-GSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ--- 1106 (1157)
Q Consensus 1032 Akl~~~~~-~sts~~GTp~YmAPEVL~-G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe--- 1106 (1157)
+....... ....+.||+.|||||+-. +....|...+|+|++|++..|+-.-++|-...+....+.-+....+.+.
T Consensus 159 saqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 159 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 87654432 345688999999999852 2345678899999999999999999999777776666666655544332
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
-+..+++.|.+|++.+|.++|.+||+++.+|.+
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 345689999999999999999999999999885
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=265.15 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=195.9
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+.+--+.||-|+||+||.+.+ +|+.||+|++.... ..-...+.+.+|+++|..++|.|++..+++.+-..-
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf------q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF------QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHH------HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 4556668899999999999887 68889999876531 112235788999999999999999998887654322
Q ss_pred C---cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 G---TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~---~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
. .+|.+.|.|.. +|..++-. .+.++...+.-++.||++||+|||+.+|.||||||.|+|++ .+-.+|||||
T Consensus 127 dfFqEiYV~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN----SNCvLKICDF 200 (449)
T KOG0664|consen 127 SFFQELYVLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN----SNCILKICDF 200 (449)
T ss_pred hHHHHHHHHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec----cCceEEeccc
Confidence 2 35777887744 77777654 44588888888999999999999999999999999999999 8889999999
Q ss_pred CCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc------
Q 001103 1030 GLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN------ 1101 (1157)
Q Consensus 1030 GLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~------ 1101 (1157)
|+++...... ..+..+-|-.|.|||+++|. ..|+..+||||+|||+.||+..+..|......+.++.|.+.
T Consensus 201 GLARvee~d~~~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 201 GLARTWDQRDRLNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred ccccccchhhhhhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 9998654332 22334578899999999987 57999999999999999999999999877665555444321
Q ss_pred -----------------CCC-CCCC--------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1102 -----------------TLR-PQIP--------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1102 -----------------~lr-peip--------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+ +.++ ..-..+...++..||..||++|.+.++.+.++.
T Consensus 280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111 1111 112345678899999999999999998887654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-28 Score=276.98 Aligned_cols=207 Identities=26% Similarity=0.384 Sum_probs=171.8
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC---CCceeEEeeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH---HPNVVAFYGVV 947 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~---HPNIVkLygvf 947 (1157)
+..+|..++.||.|+||.|++|.++ ...|+||.+.+.......=-.....-.+..|++||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4578999999999999999999985 445999998876443211000111234567999999998 99999999999
Q ss_pred ecCCCCcEEEEEEee-cCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYM-VNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYm-eGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
++ ++++||+||.- +|-+|.+++..+. .+++..+..|++|++.|+++||++||||||||-+||.++ .+|-+||
T Consensus 639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd----~~g~~kl 711 (772)
T KOG1152|consen 639 ED--DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD----SNGFVKL 711 (772)
T ss_pred ec--CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEe----cCCeEEE
Confidence 98 67999999976 3458889986554 489999999999999999999999999999999999999 8899999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN 1088 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g 1088 (1157)
+|||.|.+..... ...++||..|+|||++.|..| .+..-|||+||++||.++...-||.+
T Consensus 712 idfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhcCCC-cceeeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999887654443 445889999999999998765 47889999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=259.25 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=198.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|.-++.+|.|+- .|..+.+ .+++||+|.+..+ +..... .++..+|+.++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~-----akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTH-----AKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCcc-----chhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 457888899999998 5655655 5888999988766 333222 356678999999999999999999986532
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
-...|+|||+|.. +|..++. -.++-..+.+++.|++.|++|||+.||+||||||+||++. ....+||.
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~----~~~~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN----SDCTLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec----chhheeec
Confidence 1257899999966 7877765 2367788999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-----
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT----- 1102 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~----- 1102 (1157)
|||+|.........+..+.|..|.|||++.|.. |...+||||+||++.||++|+..|.+.+.-+.+..+....
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 999999877776667788999999999998763 7889999999999999999999998765433332222100
Q ss_pred ------------------------CCCCCC-----------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 ------------------------LRPQIP-----------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 ------------------------lrpeip-----------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+...+| ..-...+++++.+||..||++|.|++++|+|+..
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 000011 0113457899999999999999999999998654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-24 Score=214.66 Aligned_cols=251 Identities=28% Similarity=0.469 Sum_probs=199.7
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC-ceeEEeeeeecCCCCcE
Q 001103 877 LEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP-NVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP-NIVkLygvf~de~~~~L 955 (1157)
|.+.+.||.|+||.||++.+. ..+++|++........ .....+.+|+.++..+.|+ +|+++++.+.. ....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEE
Confidence 678899999999999999988 7789999887532211 2357788999999999988 79999999955 4458
Q ss_pred EEEEEeecCCcchhhhcccc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC-eEEEEecCCc
Q 001103 956 ATVTEYMVNGSLRHVLARKD--RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP-ICKVGDFGLS 1032 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~g--r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g-~VKLiDFGLA 1032 (1157)
+++++++.++++.+++.... ..+.......++.|++.++.|+|+.+++||||||+|||++ ... .++++|||.+
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~----~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD----RDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----CCCCeEEEeccCcc
Confidence 99999999999997776544 2688999999999999999999999999999999999998 555 7999999998
Q ss_pred ccccCCc-------ccCCCCCCCcccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHhhh
Q 001103 1033 RIKCNTL-------VSGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGGILS 1100 (1157)
Q Consensus 1033 kl~~~~~-------~sts~~GTp~YmAPEVL~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~Il~ 1100 (1157)
....... ......||..|++||.+.+.. ..++...|+|++|+++++++.|..||..... ......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 7543322 235678999999999998632 3568899999999999999999999887763 333333333
Q ss_pred cCCC---CCCCCCC----cHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1101 NTLR---PQIPERC----DPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1101 ~~lr---peip~~i----SpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
.... ....... ...+.+++..|+..+|..|.+..+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 3322 1122211 2578999999999999999998887765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=247.37 Aligned_cols=261 Identities=26% Similarity=0.446 Sum_probs=211.7
Q ss_pred CCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
..+++..-.+-+|.||.||+|.|.. +.|-+|.++... .+--...+..|..++..+.|||+..+.++
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-------S~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-------SQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-------cHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3456777788999999999998742 235566554331 12235678889999999999999999998
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhcc-------ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCC
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLAR-------KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr-------~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~ 1019 (1157)
..++ ....+.++.++.-|+|+.+|.. ..+.+...+...++.|++.|++|||.+||||.||-..|.+|+
T Consensus 356 ~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId---- 430 (563)
T KOG1024|consen 356 SIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID---- 430 (563)
T ss_pred Eeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh----
Confidence 7664 4566788999999999999872 234567778888999999999999999999999999999999
Q ss_pred CCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 001103 1020 QRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAII 1095 (1157)
Q Consensus 1020 e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil 1095 (1157)
+...|||+|=.+++-.-+. ...........||+||.+.. ..|+..+|+|||||+||||+| |+.|+...++.++.
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 7789999999998853322 12223345668999999984 478999999999999999999 99999999888776
Q ss_pred HHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1096 GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1096 ~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
..+. .+++..-|-.+|.++..+|..||..+|++||++.|+..-|......+..
T Consensus 509 ~ylk-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~ 561 (563)
T KOG1024|consen 509 HYLK-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR 561 (563)
T ss_pred HHHh-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence 5554 5666777889999999999999999999999999999999988876643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=280.95 Aligned_cols=205 Identities=20% Similarity=0.210 Sum_probs=149.5
Q ss_pred hCCC-CceeEEeeeeecC-----CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 001103 934 NLHH-PNVVAFYGVVPNG-----PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDL 1007 (1157)
Q Consensus 934 ~L~H-PNIVkLygvf~de-----~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDL 1007 (1157)
.+.| .||+++++.+... ....++++||++ +++|.++|....+.+++..++.++.||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4445 5777777776221 134677889987 55999999766667999999999999999999999999999999
Q ss_pred CccceeeccCC---------------CCCCeEEEEecCCcccccCC-----------------cccCCCCCCCcccCccc
Q 001103 1008 KCDNLLVNLRD---------------PQRPICKVGDFGLSRIKCNT-----------------LVSGGVRGTLPWMAPEL 1055 (1157)
Q Consensus 1008 KPENILLd~dd---------------~e~g~VKLiDFGLAkl~~~~-----------------~~sts~~GTp~YmAPEV 1055 (1157)
||+||||+..+ ...+.+||+|||+++..... ......+||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996211 13456788888877632110 00112468999999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHH
Q 001103 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTE 1135 (1157)
Q Consensus 1056 L~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeE 1135 (1157)
+.+. .|+.++|||||||+||||++|.+||.... ..+..+....+++... ...+....++.+||.++|.+||++.+
T Consensus 187 ~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 187 DNGS--SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hccC--CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcChHH
Confidence 9865 57899999999999999999998876432 1222222222222211 12456778999999999999999999
Q ss_pred HHHHHHHHH
Q 001103 1136 ITNRLRVMS 1144 (1157)
Q Consensus 1136 LLe~Lr~Lk 1144 (1157)
++++.+...
T Consensus 262 il~h~~~~~ 270 (793)
T PLN00181 262 LLQSEFINE 270 (793)
T ss_pred Hhhchhhhh
Confidence 999887643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-24 Score=236.69 Aligned_cols=260 Identities=19% Similarity=0.246 Sum_probs=201.4
Q ss_pred CeeEEEEecccCcEEEEEEEECCc---eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC----CceeEEeeeee
Q 001103 876 DLEELQELGSGTFGTVYRGKWRGT---DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH----PNVVAFYGVVP 948 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kGt---~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H----PNIVkLygvf~ 948 (1157)
.|.+.+.||+|+||.||++..... .+|+|+......... ..+..|..++..+.. +++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999998543 589998776422111 145668888888862 58888888874
Q ss_pred cCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-CCCCeEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICKV 1026 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd-~e~g~VKL 1026 (1157)
....+-++||+.+ |.+|.++.+... +.++...++.++.|++.+|++||+.|++||||||+|+++.... .....+.|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 2256789999987 779999886554 7799999999999999999999999999999999999998543 23367999
Q ss_pred EecCCcc--ccc-CC------c-c-cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 001103 1027 GDFGLSR--IKC-NT------L-V-SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII 1095 (1157)
Q Consensus 1027 iDFGLAk--l~~-~~------~-~-sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil 1095 (1157)
.|||+++ ... .. . . ...+.||..|+++.+..+. ..+.+.|+|||++++.+|+.|.+||.........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 9999998 311 11 1 1 2345699999999999865 5689999999999999999999999876643333
Q ss_pred HHhhh---cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1096 GGILS---NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1096 ~~Il~---~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
..... ...........+.++.++...+-..+...+|.+..+...++......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 22222 11111133456678999999999999999999999999988777653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=219.43 Aligned_cols=164 Identities=24% Similarity=0.330 Sum_probs=130.3
Q ss_pred CcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCC
Q 001103 965 GSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044 (1157)
Q Consensus 965 GSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~ 1044 (1157)
|+|.+++...++.+++..++.++.|++.||.|||+++ ||+|||++ .++.+|+ ||++....... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~----~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT----WDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc----Cccceee--ccceEeecccc----C
Confidence 6889999876677999999999999999999999999 99999998 6778888 99987654322 2
Q ss_pred CCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhcCCCC-----CCCCCCcH--HHH
Q 001103 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSNTLRP-----QIPERCDP--EWR 1116 (1157)
Q Consensus 1045 ~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~~lrp-----eip~~iSp--eLr 1116 (1157)
.||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+....... ..+..++. +++
T Consensus 65 ~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 65 RVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 589999999999864 5788999999999999999999999765432 2222322221111 11222333 699
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1117 KLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
++|.+||..+|.+||++.+++++++.....
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999999888654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-25 Score=237.58 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=189.8
Q ss_pred CCeeEEEEecccCcEEEEEEEECCc--eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kGt--~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~ 951 (1157)
+.|.+.+.||+|.||.+.+++++++ .+++|.+.+. ......|.+|...--.| .|.||+.-|+.....
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---------~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt- 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---------QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT- 93 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---------hhhHHHHHHHhccceeeccchhhhHHHHHHhhc-
Confidence 4688899999999999999999754 5899988765 22357788998876666 589999988764332
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+.++|||++.|+|..-+...+ +-+....+++.|++.||.|+|++++||||||.+||||-.. +...|||||||+
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~--df~rvKlcDFG~ 169 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA--DFYRVKLCDFGL 169 (378)
T ss_pred CceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC--CccEEEeeeccc
Confidence 558889999999999988776543 7788889999999999999999999999999999999733 455999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHhhhcCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNG---SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGGILSNTLR 1104 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G---~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~Il~~~lr 1104 (1157)
.+..+..... ..-+..|.+||+... ......+..|+|.||+++|.+|+|++||+.... ...+.+.. +...
T Consensus 170 t~k~g~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~-~rk~ 246 (378)
T KOG1345|consen 170 TRKVGTTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL-KRKN 246 (378)
T ss_pred ccccCceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh-cccC
Confidence 8754433222 335667999997642 234456779999999999999999999984322 12222222 2222
Q ss_pred CCCC---CCCcHHHHHHHHHHhccCCCCC---CCHHHHHHHHHH
Q 001103 1105 PQIP---ERCDPEWRKLMEECWSFNPAAR---PSFTEITNRLRV 1142 (1157)
Q Consensus 1105 peip---~~iSpeLrdLIkrCLqkDPskR---PSaeELLe~Lr~ 1142 (1157)
+..| ..+++.+..+.++-|..++.+| .+++.....+|.
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 2333 3478889999999999999999 455555554443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=244.68 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=190.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
..|..+.+||.|+|++||++.+. ...||+|.+..... ...+..|+++|..+ -+.||+++.+++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 57888999999999999998763 45699998876532 24588999999999 5999999999988
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ++...+||||++.....+++.. ++...+..+++.++.||+++|.+|||||||||.|+|++ ...+.-.|+|
T Consensus 106 n--nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n---~~t~rg~LvD 176 (418)
T KOG1167|consen 106 N--NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN---RRTQRGVLVD 176 (418)
T ss_pred c--CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc---cccCCceEEe
Confidence 7 6689999999999888888754 56778999999999999999999999999999999998 3556778999
Q ss_pred cCCcccccC---------------Cc------------------------------ccCCCCCCCcccCcccccCCCCCC
Q 001103 1029 FGLSRIKCN---------------TL------------------------------VSGGVRGTLPWMAPELLNGSNNRV 1063 (1157)
Q Consensus 1029 FGLAkl~~~---------------~~------------------------------~sts~~GTp~YmAPEVL~G~~~~y 1063 (1157)
||+|..... .. ..-...||++|.|||++.... .-
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~Q 255 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-RQ 255 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-Cc
Confidence 999871000 00 000135999999999998653 34
Q ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhh--------------cC---------------------C----
Q 001103 1064 SEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILS--------------NT---------------------L---- 1103 (1157)
Q Consensus 1064 S~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~--------------~~---------------------l---- 1103 (1157)
+.++||||.|||++.+++++.||-....+ ..+..+.. +. +
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 78899999999999999999998543221 11111100 00 0
Q ss_pred ----------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 ----------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 ----------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+.......+..+.+|+.+||..||.+|.|+++.|+|..+
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF 384 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF 384 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence 000111234578899999999999999999999997544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-23 Score=225.21 Aligned_cols=262 Identities=17% Similarity=0.248 Sum_probs=213.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~ 948 (1157)
+..-.|.+.++||+|+||..|+|+. ++.+||||.-..+. + ..++..|.+.++.|. .+.|...|-+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~----APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------E----APQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC------C----cchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 4566899999999999999999986 78999999765442 1 246677888888884 789999987765
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-CCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd-~e~g~VKLi 1027 (1157)
+ +.+-.||||++ |.+|++++.-.++.|+.+.+..++.||+.-++|+|++.+|+|||||+|+||...+ .....+.|+
T Consensus 95 e--G~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 E--GKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred c--cchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 5 55667899987 7799999988999999999999999999999999999999999999999998654 345679999
Q ss_pred ecCCcccccCCcc--------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---HHHH
Q 001103 1028 DFGLSRIKCNTLV--------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIG 1096 (1157)
Q Consensus 1028 DFGLAkl~~~~~~--------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---eil~ 1096 (1157)
|||+|+...++.+ ..+..||..||+-....|. .-+.+.|+-|||-+++++|-|.+||.+.... +.++
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 9999997554433 2356799999999988875 3489999999999999999999999986643 3334
Q ss_pred HhhhcCC---CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1097 GILSNTL---RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1097 ~Il~~~l---rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
.|-+... ...+...+|.++...+...-..+-.+-|+++-+...+..+...+.
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 4422211 123567789999999999999999999999999988887776543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=219.12 Aligned_cols=259 Identities=19% Similarity=0.293 Sum_probs=208.8
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC-CceeEEeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH-PNVVAFYGVV 947 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H-PNIVkLygvf 947 (1157)
.+....|.++++||+|+||.+|+|.. .|..||||+-..... ..++..|.++.+.|++ ..|+.++.+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----------hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----------HPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----------CcchhHHHHHHHHhccCCCCchhhhhc
Confidence 35567899999999999999999987 688999998876532 2456778999999974 5677777666
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.+ ..+-.+|||.+ |.+|++++.-..+.++...++.++-|++.-++|+|.+++|||||||+|+|..... ....+.|+
T Consensus 81 ~e--~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LI 156 (341)
T KOG1163|consen 81 TE--KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLI 156 (341)
T ss_pred cc--cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEE
Confidence 66 55778899987 7799999987888899999999999999999999999999999999999998544 45679999
Q ss_pred ecCCcccccCC--------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH---HHH
Q 001103 1028 DFGLSRIKCNT--------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA---IIG 1096 (1157)
Q Consensus 1028 DFGLAkl~~~~--------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee---il~ 1096 (1157)
|||+|+...+. .......||..|++-....|. .-+.+.|+-|+|++|.++.-|.+||++..... ..+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 99999853321 122346799999998877654 34788999999999999999999999876432 233
Q ss_pred HhhhcCC---CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1097 GILSNTL---RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1097 ~Il~~~l---rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.|.+... ...+....|.++.-.+..|-..--++-|++..|.+..+.+.-
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 3433322 234667889999999999999999999999999888777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=241.30 Aligned_cols=255 Identities=25% Similarity=0.306 Sum_probs=189.1
Q ss_pred EEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 879 ELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
....+|.|++|.|+..... ...++.|..... .. .....+.....+..|+-+-..|.|||++.....+.+.. ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~ 397 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GIL 397 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cch
Confidence 4577999999988876552 333444433321 11 11222333344788888899999999988877766532 233
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
-.||||++ +|..++.+. ..+....+-.++.||+.||+|+|+.||.||||||+|+++. ..+.+||+|||.+....
T Consensus 398 ~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~----~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT----ENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe----cCCceEEeecCcceeec
Confidence 34999999 999999765 3477888889999999999999999999999999999999 77899999999987532
Q ss_pred C---C--cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH-HHhh-hc-----CCC
Q 001103 1037 N---T--LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII-GGIL-SN-----TLR 1104 (1157)
Q Consensus 1037 ~---~--~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil-~~Il-~~-----~lr 1104 (1157)
. . ....+++|+..|+|||++.+..+. ...+||||.|++++.|.+|+.||......+.. .... .. .-.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd-pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYD-PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccC-cchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 2 2 345678999999999999876433 35699999999999999999999865544321 1110 00 011
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+...++.+.+.+|.+||+.||.+|.|+++|++.-|.-.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 1233457788899999999999999999999999877643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=218.43 Aligned_cols=164 Identities=21% Similarity=0.162 Sum_probs=124.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC---CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeE-Eeeeeec
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA-FYGVVPN 949 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k---Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVk-Lygvf~d 949 (1157)
..+|.+.+.||+|+||+||+|+++ ++.+|||++......... ......+.+|+++|++|+|+|++. +++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~---~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSK---PLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccccc---HHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 357999999999999999999873 556899987532110011 123466899999999999999985 5442
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccC-CccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDL-KCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDL-KPENILLd~dd~e~g~VKLiD 1028 (1157)
+..|+||||++|++|... ... . ...++.|++.+|.|||++||+|||| ||+|||++ .++.+||+|
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~----~~~~ikLiD 155 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG----PDGEAAVID 155 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc----CCCCEEEEE
Confidence 247999999999999632 111 1 1457889999999999999999999 99999997 567899999
Q ss_pred cCCcccccCCc---------ccCCCCCCCcccCcccccC
Q 001103 1029 FGLSRIKCNTL---------VSGGVRGTLPWMAPELLNG 1058 (1157)
Q Consensus 1029 FGLAkl~~~~~---------~sts~~GTp~YmAPEVL~G 1058 (1157)
||+|+...... ......+++.|+|||.+..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99998543221 1134578889999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-22 Score=235.32 Aligned_cols=224 Identities=26% Similarity=0.432 Sum_probs=187.1
Q ss_pred ecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCcEE
Q 001103 883 LGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 883 LGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~Ly 956 (1157)
+|+|+||.|++++- .|.-||+|++++.....+.. .....|..++..++ ||.+|+++-.++. .+.++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~------~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR------THTKQERIILAFVHNTPFLVKLHYAFQT--DGKLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc------cccccHHHHHhhccCCCceeeeeeeecc--ccchh
Confidence 79999999997543 46669999998875544332 14456788899887 9999999999887 66789
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
+++++..||+|...+++... +.+.....+..+++.+++++|+.+|+|||+|++||+++ .+|++++.|||+++...
T Consensus 74 l~ld~~rgg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld----~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL----LEGHIKLTDFGLSKEAV 148 (612)
T ss_pred HhhhhcccchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec----ccCccccCCchhhhHhH
Confidence 99999999999888876554 66777777889999999999999999999999999999 88899999999998766
Q ss_pred CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHH
Q 001103 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWR 1116 (1157)
Q Consensus 1037 ~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLr 1116 (1157)
+.... |||..|||||+++| ....+|+||||+++|||++|..||.. ++...|... .+..|..++..++
T Consensus 149 ~~~~~---cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~ 215 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEAR 215 (612)
T ss_pred hhhhc---ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHH
Confidence 55443 89999999999983 36779999999999999999999997 555555543 3357888899999
Q ss_pred HHHHHHhccCCCCCCC
Q 001103 1117 KLMEECWSFNPAARPS 1132 (1157)
Q Consensus 1117 dLIkrCLqkDPskRPS 1132 (1157)
+++.+++..+|..|--
T Consensus 216 ~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 216 SLFRQLFKRNPENRLG 231 (612)
T ss_pred HHHHHHHhhCHHHHhc
Confidence 9999999999999943
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-21 Score=232.80 Aligned_cols=250 Identities=19% Similarity=0.214 Sum_probs=181.2
Q ss_pred CeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
++...+.||++.|=+|.+|+++...|+||++-+..- ....+.. .+.++|++ ...+++||.+.+..+... ....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p---~~sL~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDP---TISLRPF-KQRLEEIK-FALMKAPNCLPFQKVLVT--DKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCC---CCCchHH-HHHHHHHH-HHhhcCCcccchHHHHHh--hHHH
Confidence 678889999999999999999766699999877531 1111222 23334555 666789999999887655 4567
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc-
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI- 1034 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl- 1034 (1157)
|||-+|+.. +|++.+. .+.++.......|+.||+.||+.+|..||+|+|||.|||||+ ...++.|+||.--+.
T Consensus 97 ylvRqyvkh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT----SWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT----SWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHHhh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe----eechhhhhcccccCCc
Confidence 888888855 9999985 455678888889999999999999999999999999999999 888999999986552
Q ss_pred ---ccCCcc----cCCCCCCCcccCcccccC--------CCCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 001103 1035 ---KCNTLV----SGGVRGTLPWMAPELLNG--------SNNR-VSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGG 1097 (1157)
Q Consensus 1035 ---~~~~~~----sts~~GTp~YmAPEVL~G--------~~~~-yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~ 1097 (1157)
..++.. ..+-..-.+|.|||.+-. ++.. .+++.||||+||+++||++ |++||.-.+..+....
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~ 250 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG 250 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence 122222 122234457999998753 1222 6788999999999999988 7999863222111110
Q ss_pred hhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1098 ILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1098 Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
- .......+..--+..+++||..|++.||.+|-|++++|+.
T Consensus 251 ~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 N-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred C-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 0000000111124478999999999999999999999986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-20 Score=205.07 Aligned_cols=263 Identities=24% Similarity=0.284 Sum_probs=186.2
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC--c-----------------------------------eEEEEEEecccccCC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG--T-----------------------------------DIAIKRIKKSCFLGR 914 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG--t-----------------------------------~VAVKVIkk~~l~~r 914 (1157)
+..++|+|...||+|.-..||.++... . +.|||.+......
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~-- 231 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD-- 231 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC--
Confidence 455789999999999999999775521 0 1355655433211
Q ss_pred ChhHHHHHHHHHHHHH------H--------HHh--------CCCCceeEEeeeeecC----------------------
Q 001103 915 SSEQEWLIKEFWREAH------I--------ISN--------LHHPNVVAFYGVVPNG---------------------- 950 (1157)
Q Consensus 915 ~~e~e~likqflrEIk------I--------LK~--------L~HPNIVkLygvf~de---------------------- 950 (1157)
.....+.+...+|+- + .+. -+|||||+++++|.++
T Consensus 232 -s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 232 -SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred -CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 222333444444431 1 111 2499999998887652
Q ss_pred ---CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 ---PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 ---~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
+...+|+||..+.. +|..++-... .+.....-++.|+++|+.|||++||.|||+|.+|||+..++..-..+.|+
T Consensus 311 g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred ccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 23478999998865 8888885433 45667777899999999999999999999999999999887677899999
Q ss_pred ecCCcccccCC-----cc--cCCCCCCCcccCcccccCCCCCC----CchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 001103 1028 DFGLSRIKCNT-----LV--SGGVRGTLPWMAPELLNGSNNRV----SEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096 (1157)
Q Consensus 1028 DFGLAkl~~~~-----~~--sts~~GTp~YmAPEVL~G~~~~y----S~KSDIWSLGVILYELLTGk~PF~g~~~eeil~ 1096 (1157)
|||.+-..... .. .-..-|....||||+....+.+. -.|+|.|+.|.+.||++...-||.+.....+-.
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 99987532221 01 11134788899999986433221 147999999999999999999998743322222
Q ss_pred HhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1097 ~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
+-......+.++..+++.+++|+..+|+.||++|+++.-..+.|
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 22334445678899999999999999999999999876555543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-20 Score=197.71 Aligned_cols=251 Identities=28% Similarity=0.496 Sum_probs=202.6
Q ss_pred CCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
.++.++.+|.+...|..|+|+|+|..+++|+++......+ ....|..|.-.|+-+.||||+.+++.+..++ .
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~r------isrdfneefp~lrifshpnilpvlgacnspp--n 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTAR------ISRDFNEEFPALRIFSHPNILPVLGACNSPP--N 261 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchh------hcchhhhhCcceeeecCCchhhhhhhccCCC--C
Confidence 4556677899999999999999999999998876543322 2356778888888889999999999998854 6
Q ss_pred EEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCCCCeEEE--Eec
Q 001103 955 MATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKV--GDF 1029 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e~g~VKL--iDF 1029 (1157)
+.++..||+.|+|+.+|... .-..+..++.+++.++++|+.|||+.. |.---|....++++ ++.+.+| +|-
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid----edltarismad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID----EDLTARISMADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec----chhhhheecccc
Confidence 88899999999999999764 334677899999999999999999985 33346888899998 4444433 343
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRV-SEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~y-S~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
-++.. ..+..-.|.||+||.++..+... -..+|+|||.++||||.|...||......+.-..+.-..++..+|
T Consensus 338 kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 338 KFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred eeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 33211 12234578899999998654332 356999999999999999999999988888878888888999999
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+++..+.+||.-|+..||.+||.++.|.-.|+.+
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 99999999999999999999999999998888765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=183.46 Aligned_cols=146 Identities=19% Similarity=0.140 Sum_probs=107.8
Q ss_pred EEEecccCcEEEEEEEE-CCceEEEEEEecccccCCCh------------------hHHHHHHHHHHHHHHHHhCCCCce
Q 001103 880 LQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSS------------------EQEWLIKEFWREAHIISNLHHPNV 940 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~------------------e~e~likqflrEIkILK~L~HPNI 940 (1157)
.+.||+|+||.||+|.. +|+.||||+++......... ..........+|++++++|.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 58899999998653211110 000112234569999999987776
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHH-HHCCceeccCCccceeeccCCC
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL-HMKNIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYL-HSkGIIHRDLKPENILLd~dd~ 1019 (1157)
...+..... ..+|||||++|+++...+.. ...++...++.++.|++.+|.|| |+.||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 82 PCPEPILLK----SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCcEEEec----CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 433222222 23899999999877654332 34588999999999999999999 799999999999999997
Q ss_pred CCCeEEEEecCCcccc
Q 001103 1020 QRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 1020 e~g~VKLiDFGLAkl~ 1035 (1157)
. +.++|+|||+|...
T Consensus 153 ~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 D-GKLYIIDVSQSVEH 167 (190)
T ss_pred C-CcEEEEEccccccC
Confidence 2 57999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-20 Score=222.05 Aligned_cols=203 Identities=31% Similarity=0.500 Sum_probs=153.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|+.++.|-.|+||.||+.+++ .+.+|+| +.+..+. .|- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------------lRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------------LRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------------hhc--cccccCCccee----------
Confidence 468999999999999999999886 5668884 4432111 110 22222333333
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
|+-...++.-+ .++.. ++.+++|||+.||+|||+||+|+||+ .-+++|++|||+
T Consensus 136 -------------gDc~tllk~~g-~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT----~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 -------------GDCATLLKNIG-PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT----SMGHIKLTDFGL 189 (1205)
T ss_pred -------------chhhhhcccCC-CCcch--------hhHHhHhhccCCeecCCCCCCcceee----ecccccccchhh
Confidence 45555565433 24322 27789999999999999999999999 889999999999
Q ss_pred cccccCC----------------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 001103 1032 SRIKCNT----------------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII 1095 (1157)
Q Consensus 1032 Akl~~~~----------------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil 1095 (1157)
++..... ......|||+.|.|||++.. +.|+..+|||++|+|+||++-|..||.+...++++
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 8742111 11234589999999999874 46899999999999999999999999999999988
Q ss_pred HHhhhcCCC-CCCCCCCcHHHHHHHHHHhccCCCCC
Q 001103 1096 GGILSNTLR-PQIPERCDPEWRKLMEECWSFNPAAR 1130 (1157)
Q Consensus 1096 ~~Il~~~lr-peip~~iSpeLrdLIkrCLqkDPskR 1130 (1157)
..++..... ++-...++++++++|.++|..+|..|
T Consensus 268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 887665332 23355578999999999999999999
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=191.01 Aligned_cols=176 Identities=11% Similarity=0.055 Sum_probs=133.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHH------HHHHHHHHHHhCCCCceeEEeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIK------EFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~lik------qflrEIkILK~L~HPNIVkLygv 946 (1157)
-..+|++++.||.|+||.||+...++..+|||++...... .+.... .+.+|++.+.+|.||+|....++
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 3579999999999999999998777788999998765211 122222 26799999999999999999888
Q ss_pred eecCC------CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCC
Q 001103 947 VPNGP------GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQ 1020 (1157)
Q Consensus 947 f~de~------~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e 1020 (1157)
+.... .+..+|+|||++|.+|.++.. +++ ....+++.+|..||+.|++||||||.|||++ .
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~----~ 170 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS----K 170 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe----C
Confidence 65432 235789999999999987742 222 2356899999999999999999999999998 4
Q ss_pred CCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHH
Q 001103 1021 RPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII 1080 (1157)
Q Consensus 1021 ~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELL 1080 (1157)
.+ ++|+|||............ .++.. ..|..++|+|+||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d-----------~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKD-----------RIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhHH-----------HHHHH--hHhcccccccceeEeehHHH
Confidence 55 9999999876443222211 12222 23567899999999987665
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=183.52 Aligned_cols=190 Identities=16% Similarity=0.066 Sum_probs=141.4
Q ss_pred eEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCcEE
Q 001103 878 EELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~Ly 956 (1157)
.+...|++|+||+||++...+..++.+.+.....+.+ ......+.+|+++|++|. |+++++++++ . ..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~----~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~----~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLR----GVAWWLARREALALRQLDGLPRTPRLLHW--D----GRH 74 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhh----hHHHHHHHHHHHHHHhcCCCCCCCEEEEE--c----CEE
Confidence 3567899999999998887778888776665432211 111235789999999995 5889999886 2 368
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccC-CccceeeccCCCCCCeEEEEecCCcccc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDL-KCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDL-KPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
++|||+.|.+|...+.. ....++.|++.+|+++|++||+|||| ||+|||++ .++.++|+|||+|...
T Consensus 75 lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~----~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ----EDGSPAVIDFQLAVRG 142 (218)
T ss_pred EEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc----CCCCEEEEECCCceec
Confidence 99999999998654321 11346789999999999999999999 79999998 5678999999999853
Q ss_pred cCCcc--------------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 001103 1036 CNTLV--------------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM 1089 (1157)
Q Consensus 1036 ~~~~~--------------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~ 1089 (1157)
..... ......++.|++|+........--...++++.|+-+|.++|+..|+-+.
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 33221 0112368889999865543222236789999999999999999886543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=189.94 Aligned_cols=237 Identities=19% Similarity=0.195 Sum_probs=148.5
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC----------CceeEE
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH----------PNVVAF 943 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H----------PNIVkL 943 (1157)
.+...+.||.|+++.||.+++. +..+|||+...... ......+++.+|.-....+.+ -.++.-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-----~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-----ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-----THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc-----cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 4567789999999999999994 68899999876541 111224555555544433322 111111
Q ss_pred eeeee---------cCCC-C-----cEEEEEEeecCCcchhhhcc---cc---ccccHHHHHHHHHHHHHHHHHHHHCCc
Q 001103 944 YGVVP---------NGPG-G-----TMATVTEYMVNGSLRHVLAR---KD---RILDRRKKLMLMMDAAFGMEYLHMKNI 1002 (1157)
Q Consensus 944 ygvf~---------de~~-~-----~LyLVMEYmeGGSL~dlLkr---~g---r~L~e~qVlkIa~QLa~ALeYLHSkGI 1002 (1157)
++... ...+ . ..+++|+-+ .++|..++.- .. ..+.....+.+..|+++.+++||.+||
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 11111 1101 1 235677776 4488776542 11 224445556677899999999999999
Q ss_pred eeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCC------CCCCCchhHHHHHHHHH
Q 001103 1003 VHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGS------NNRVSEKVDVYSFGIAM 1076 (1157)
Q Consensus 1003 IHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~------~~~yS~KSDIWSLGVIL 1076 (1157)
+|+||||+|+|++ .+|.++|+||+........... ...+..|.+||..... .-.++.+.|.|+||++|
T Consensus 167 VHgdi~~~nfll~----~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 167 VHGDIKPENFLLD----QDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred EecccceeeEEEc----CCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 9999999999999 7899999999977654443332 2356789999976431 23478899999999999
Q ss_pred HHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCC
Q 001103 1077 WEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130 (1157)
Q Consensus 1077 YELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskR 1130 (1157)
|.|.+|..||........... ....+..+++.++.||..||+++|.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999999987654322211 122333789999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=175.41 Aligned_cols=146 Identities=18% Similarity=0.108 Sum_probs=109.4
Q ss_pred EEEecccCcEEEEEEEEC-CceEEEEEEecccccCC------------------ChhHHHHHHHHHHHHHHHHhCCCCce
Q 001103 880 LQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGR------------------SSEQEWLIKEFWREAHIISNLHHPNV 940 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r------------------~~e~e~likqflrEIkILK~L~HPNI 940 (1157)
.+.||+|+||.||+|++. |+.||||+++....... ..........+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999884 88999999987521100 00111112345689999999999987
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhh-hccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCC
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHV-LARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dl-Lkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd 1018 (1157)
.....+... ..+|||||++|+++... +.. ..++...+..++.|++.+|.+||+ +||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--- 152 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--- 152 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence 543333322 13799999998865433 332 347788899999999999999999 9999999999999996
Q ss_pred CCCCeEEEEecCCccccc
Q 001103 1019 PQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl~~ 1036 (1157)
++.++|+|||++....
T Consensus 153 --~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 --DGKPYIIDVSQAVELD 168 (190)
T ss_pred --CCCEEEEEcccceecC
Confidence 3579999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=212.32 Aligned_cols=248 Identities=19% Similarity=0.232 Sum_probs=183.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC---CCceeEEeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH---HPNVVAFYGVV 947 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~---HPNIVkLygvf 947 (1157)
+....|.|-+.||+|+||+||+|.. +|+.||+|+-+....+.-.. -.+++.+|+ -+.|..++..+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----------~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----------CLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----------hHHHHHhhchhhhcchHHHHHHH
Confidence 4457899999999999999999987 67889999988775553321 122334443 23444444444
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecc---CCCCCCeE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNL---RDPQRPIC 1024 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~---dd~e~g~V 1024 (1157)
.. .+..++|+||.+.|+|.+++. ..+.+++..+..++.||+..|++||..+|||+||||+|+||.. ++....-+
T Consensus 764 ~~--~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 764 VF--QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cc--CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccce
Confidence 33 345789999999999999997 5567999999999999999999999999999999999999963 22345679
Q ss_pred EEEecCCccc---ccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc
Q 001103 1025 KVGDFGLSRI---KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1025 KLiDFGLAkl---~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~ 1101 (1157)
+|+|||.+.- ..+.....+.++|..+-.+|++.|. .|+..+|.|.|..+++.||.|+.- + . .+
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y~----------q-~-~~ 906 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKYM----------E-V-KN 906 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHHH----------H-h-cC
Confidence 9999998863 3444566778899999999999865 799999999999999999998652 1 1 11
Q ss_pred CCCCC----CCCCCcH-HHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1102 TLRPQ----IPERCDP-EWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1102 ~lrpe----ip~~iSp-eLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
..... ++..+.. -+.+|+..+|..|-..=|...+|...+......-
T Consensus 907 g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 907 GSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred CcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 11111 2222222 3578999999844444478888777776665543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.4e-18 Score=177.69 Aligned_cols=141 Identities=21% Similarity=0.216 Sum_probs=106.1
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-----CCCceeEEeeeeecCCC-
Q 001103 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-----HHPNVVAFYGVVPNGPG- 952 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-----~HPNIVkLygvf~de~~- 952 (1157)
-.+.||+|+||.||.....+. .+||++..... . ..+.+.+|+++++.| +||||+++|+++.++.+
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~----~----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD----G----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred CcceecCCCceEEEECCCCcC-eEEEEEecccc----c----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 357799999999996222333 46887765311 0 135688999999999 67999999999988542
Q ss_pred Cc-EEEEEEe--ecCCcchhhhccccccccHHHHHHHHHHHHHHH-HHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 953 GT-MATVTEY--MVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM-EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 953 ~~-LyLVMEY--meGGSL~dlLkr~gr~L~e~qVlkIa~QLa~AL-eYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+. +.+|||| +.+++|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+|||++..+.....++|+|
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 34 3478999 5579999999763 25555 35578888777 9999999999999999999985444556899999
Q ss_pred cCCc
Q 001103 1029 FGLS 1032 (1157)
Q Consensus 1029 FGLA 1032 (1157)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=166.84 Aligned_cols=142 Identities=20% Similarity=0.252 Sum_probs=111.7
Q ss_pred EEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEE
Q 001103 881 QELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTE 960 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVME 960 (1157)
+.||+|++|.||+|++.|..++||+...................+.+|+.++..+.|++|+....++.+ ....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEEE
Confidence 579999999999999999999999876442222111222233567889999999999887655555444 345789999
Q ss_pred eecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 961 YMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 961 YmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
|++|++|.+++.... . ....++.+++.+|.+||+.+++|+|++|.|||++ .+.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-----~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-----GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-----CCCEEEEECCcccC
Confidence 999999999886432 2 7788899999999999999999999999999997 35789999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=162.59 Aligned_cols=136 Identities=23% Similarity=0.325 Sum_probs=105.1
Q ss_pred EecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCcee--EEeeeeecCCCCcEEEEE
Q 001103 882 ELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV--AFYGVVPNGPGGTMATVT 959 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIV--kLygvf~de~~~~LyLVM 959 (1157)
.||+|+||.||++.+.+..+++|+..................++.+|+++++.+.|+++. .++.. . ....+++|
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV--D--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE--E--CCCCEEEE
Confidence 389999999999999999999998665422211111222246778999999999887543 44443 3 23468999
Q ss_pred EeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 960 EYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 960 EYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
||++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.|||++ .+.++|+|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-----DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-----CCcEEEEECCCCcC
Confidence 99999999888754221 6789999999999999999999999999996 35799999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=185.71 Aligned_cols=142 Identities=22% Similarity=0.231 Sum_probs=111.4
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 877 LEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
|...+.||+|+||+||++.+.+..+++|+...................+.+|+++++.++|++++..+.+... ....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCCE
Confidence 3557889999999999999988887777654332221111122234678899999999999998877666555 33568
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
+||||++|++|.+++. ....++.+++.+|.|||++||+||||||+|||++ .+.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-----~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-----DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-----CCcEEEEeCccccc
Confidence 9999999999988874 3466889999999999999999999999999994 35799999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-16 Score=167.31 Aligned_cols=148 Identities=17% Similarity=0.077 Sum_probs=111.4
Q ss_pred CeeEEEEecccCcEEEEEEE-E--CCceEEEEEEecccccCC---------------C-hhHHHHHHHHHHHHHHHHhCC
Q 001103 876 DLEELQELGSGTFGTVYRGK-W--RGTDIAIKRIKKSCFLGR---------------S-SEQEWLIKEFWREAHIISNLH 936 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr-~--kGt~VAVKVIkk~~l~~r---------------~-~e~e~likqflrEIkILK~L~ 936 (1157)
.|++.+.||+|+||.||+|. . +|+.||||+++....... . ...+.....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 3 688999999886432110 0 011112345678999999997
Q ss_pred C--CceeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC-ceeccCCcccee
Q 001103 937 H--PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN-IVHFDLKCDNLL 1013 (1157)
Q Consensus 937 H--PNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG-IIHRDLKPENIL 1013 (1157)
+ ..+++++.. . ..++||||+.|.+|...+... ..+....+..++.|++.+|.+||++| |+||||||+|||
T Consensus 109 ~~~i~~p~~~~~--~----~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--R----RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--c----CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 5 334555543 1 247999999998887655332 23566677889999999999999999 999999999999
Q ss_pred eccCCCCCCeEEEEecCCcccc
Q 001103 1014 VNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 1014 Ld~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
++ .+.++|+|||.+...
T Consensus 182 i~-----~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-----DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-----CCCEEEEEChhhhcc
Confidence 96 347999999998643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.1e-16 Score=183.08 Aligned_cols=208 Identities=35% Similarity=0.547 Sum_probs=165.7
Q ss_pred HHhCCCCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCc-eeccCCcc
Q 001103 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNI-VHFDLKCD 1010 (1157)
Q Consensus 932 LK~L~HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGI-IHRDLKPE 1010 (1157)
|+.+.|.|+.+++|.+.+. ..+++|.+||..|+|.+.+......+++.....++++++.||.|||.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4678899999999999884 68899999999999999999877779999999999999999999998866 99999999
Q ss_pred ceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCC--CC---CCchhHHHHHHHHHHHHHcC
Q 001103 1011 NLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSN--NR---VSEKVDVYSFGIAMWEIITG 1082 (1157)
Q Consensus 1011 NILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~--~~---yS~KSDIWSLGVILYELLTG 1082 (1157)
|.+++ ....+||+|||+....... .......-...|.|||.+.+.. .. .+.+.|+||+|++++|+++.
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999 8889999999998765421 1111122345699999998631 11 46789999999999999999
Q ss_pred CCCCCCCC----hhHHHHHhhh---cCCCCCCCC--CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1083 EEPYANMH----CGAIIGGILS---NTLRPQIPE--RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1083 k~PF~g~~----~eeil~~Il~---~~lrpeip~--~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+.||.... ..+++..+.. ..++|.+.. ...+++..+++.||..+|.+||+++++-..+..+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99997632 2345555444 123444331 456679999999999999999999999888776654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=155.27 Aligned_cols=142 Identities=18% Similarity=0.023 Sum_probs=106.6
Q ss_pred CeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCC-Ch-------------hHHHHHHHHHHHHHHHHhCCCC--
Q 001103 876 DLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGR-SS-------------EQEWLIKEFWREAHIISNLHHP-- 938 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r-~~-------------e~e~likqflrEIkILK~L~HP-- 938 (1157)
.|.+.+.||+|+||.||++.+ .|+.||||++........ .. ..........+|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 367788999999999999988 588999999875421000 00 0011123467899999999877
Q ss_pred ceeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC
Q 001103 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 939 NIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd 1018 (1157)
.++..++. ...+++|||++|++|..+... .....++.+++.++.++|+.||+||||||+|||++
T Consensus 96 ~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~--- 159 (198)
T cd05144 96 PVPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD--- 159 (198)
T ss_pred CCCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc---
Confidence 44444432 235899999999998765431 23456788999999999999999999999999998
Q ss_pred CCCCeEEEEecCCccc
Q 001103 1019 PQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl 1034 (1157)
.++.++|+|||++..
T Consensus 160 -~~~~~~liDfg~~~~ 174 (198)
T cd05144 160 -DDEKIYIIDWPQMVS 174 (198)
T ss_pred -CCCcEEEEECCcccc
Confidence 677999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-16 Score=185.34 Aligned_cols=171 Identities=26% Similarity=0.369 Sum_probs=132.1
Q ss_pred CcEEEEEEeecCCcchhhhcc--ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 953 GTMATVTEYMVNGSLRHVLAR--KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr--~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.++||.|++|...+|.++|.+ .....++...+.++.|++.|++| +|.+|||+||.||++. .+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~----~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS----DDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc----cchhhhhhhhh
Confidence 368999999999999999964 34456777889999999999999 9999999999999998 55689999999
Q ss_pred CcccccCCc-------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC
Q 001103 1031 LSRIKCNTL-------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1031 LAkl~~~~~-------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~ 1102 (1157)
+........ ..+..+||.+||+||.+.|. .|+.++||||||+|||||+. =..+|.. ...+..+.++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ 476 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGI 476 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCC
Confidence 987644433 34556899999999999965 68999999999999999997 2333322 22233333444
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeEL 1136 (1157)
+++.+....+ +-..|+.+||.+.|.+||++.+.
T Consensus 477 ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 477 IPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred CChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 4444444443 44689999999999999944433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=135.32 Aligned_cols=132 Identities=20% Similarity=0.147 Sum_probs=109.3
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC--CceeEEeeeeecCCCCcEE
Q 001103 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--PNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H--PNIVkLygvf~de~~~~Ly 956 (1157)
+++.||+|.++.||++...+..+++|+...... ...+.+|..+++.+.| ..+++++.+... .+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGES--DGWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccE
Confidence 467899999999999999888899998765421 2467789999999976 588999888765 46789
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK---NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk---GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
++|||+.++.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++ ..+.++|+|||.+.
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----~~~~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----DGKILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE----CCcEEEEEeccccc
Confidence 99999999888654 3445667789999999999985 699999999999998 56789999999885
Q ss_pred c
Q 001103 1034 I 1034 (1157)
Q Consensus 1034 l 1034 (1157)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 3
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-14 Score=153.11 Aligned_cols=144 Identities=15% Similarity=0.173 Sum_probs=106.3
Q ss_pred EEec-ccCcEEEEEEEECCceEEEEEEecccccCCChh-----HHHHHHHHHHHHHHHHhCCCCce--eEEeeeeecCCC
Q 001103 881 QELG-SGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSE-----QEWLIKEFWREAHIISNLHHPNV--VAFYGVVPNGPG 952 (1157)
Q Consensus 881 rkLG-sGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e-----~e~likqflrEIkILK~L~HPNI--VkLygvf~de~~ 952 (1157)
..|| .|+.|+||+++..+..++||.+.......+-.. .......+.+|++++.+|.|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 788999999988889999999875433211110 11234567899999999998775 667666433212
Q ss_pred C--cEEEEEEeecC-CcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 G--TMATVTEYMVN-GSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~--~LyLVMEYmeG-GSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
. ..++|||+++| .+|.+++... .+++. .+.+++.+|.+||++||+||||||+|||++ .++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~----~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD----PDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc----CCCCEEEEEC
Confidence 1 23599999997 6888887542 34443 356899999999999999999999999998 4568999999
Q ss_pred CCccc
Q 001103 1030 GLSRI 1034 (1157)
Q Consensus 1030 GLAkl 1034 (1157)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=143.55 Aligned_cols=141 Identities=18% Similarity=0.050 Sum_probs=96.7
Q ss_pred EEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHH----------------HHHHHHHHHHHHHHhCCCC--ce
Q 001103 880 LQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQE----------------WLIKEFWREAHIISNLHHP--NV 940 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e----------------~likqflrEIkILK~L~HP--NI 940 (1157)
.+.||+|+||+||++.+. ++.||||+++............ ........|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999886 8889999987642211110000 0001123566666666443 34
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchh-hhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCC
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRH-VLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~d-lLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd 1018 (1157)
.+.+++. ..++||||++++.+.. .+.... . ...+..++.+++.++.++|. ++|+||||||+|||++
T Consensus 82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--- 149 (187)
T cd05119 82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--- 149 (187)
T ss_pred CceEecC------CCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---
Confidence 5555431 2589999999965432 121111 1 15677889999999999999 9999999999999997
Q ss_pred CCCCeEEEEecCCccc
Q 001103 1019 PQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl 1034 (1157)
++.++|+|||.+..
T Consensus 150 --~~~~~liDfg~a~~ 163 (187)
T cd05119 150 --DGKVYIIDVPQAVE 163 (187)
T ss_pred --CCcEEEEECccccc
Confidence 45799999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-16 Score=186.43 Aligned_cols=257 Identities=23% Similarity=0.245 Sum_probs=194.3
Q ss_pred CCeeEEEEecccCcEEEEEEEECC---ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRG---TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNG 950 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kG---t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de 950 (1157)
..|.+.+.||+|+|+.|-+....+ ..+|+|.+.... ........+..|..+=+.+. |+|++++++....
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~- 92 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS- 92 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccCC-
Confidence 456777889999999998776632 236666655442 11122345556777777776 9999999999877
Q ss_pred CCCcEEEEEEeecCCcchhhh-ccccccccHHHHHHHHHHHHHHHHHHH-HCCceeccCCccceeeccCCCCCC-eEEEE
Q 001103 951 PGGTMATVTEYMVNGSLRHVL-ARKDRILDRRKKLMLMMDAAFGMEYLH-MKNIVHFDLKCDNLLVNLRDPQRP-ICKVG 1027 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlL-kr~gr~L~e~qVlkIa~QLa~ALeYLH-SkGIIHRDLKPENILLd~dd~e~g-~VKLi 1027 (1157)
....+++++|..|+++...+ .......+......++.|+..++.|+| ..++.||||||+|.+++ ..+ .+++.
T Consensus 93 -~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~----~s~~~l~~~ 167 (601)
T KOG0590|consen 93 -PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD----ESGSALKIA 167 (601)
T ss_pred -CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc----cCCCcccCC
Confidence 56788999999999999888 433325667778889999999999999 99999999999999998 555 89999
Q ss_pred ecCCcccccC----CcccCCCCC-CCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH-HHhhhc
Q 001103 1028 DFGLSRIKCN----TLVSGGVRG-TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII-GGILSN 1101 (1157)
Q Consensus 1028 DFGLAkl~~~----~~~sts~~G-Tp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil-~~Il~~ 1101 (1157)
|||+|..... .......+| ++.|+|||...+.. ......|+||.|+++.-|++|..||......... ......
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~-~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~ 246 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA-YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN 246 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchh-hcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence 9999986443 223344678 99999999998642 3467799999999999999999999764433211 111222
Q ss_pred C--CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1102 T--LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1102 ~--lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
. +.......++....+++.+++..+|..|.+.+++-...|...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1 123345667888999999999999999999999887766554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.7e-13 Score=156.61 Aligned_cols=250 Identities=23% Similarity=0.214 Sum_probs=188.7
Q ss_pred cCCCeeEEEEecc--cCcEEEEEEEE----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEee
Q 001103 873 KDSDLEELQELGS--GTFGTVYRGKW----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYG 945 (1157)
Q Consensus 873 ~~sdYeILrkLGs--GsFGtVYlAr~----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLyg 945 (1157)
....+.+.+.+|. |.+|.||.++. .+..+|+|.-+........ ...-.+|+...+.+ .|++.++.+.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~------~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD------SKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc------cccccchhhcccccCccccccccCc
Confidence 3456678889999 99999998766 4566898874433211111 12224566666666 4999999888
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHH----HHHHHHHCCceeccCCccceeeccCCCCC
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF----GMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~----ALeYLHSkGIIHRDLKPENILLd~dd~e~ 1021 (1157)
.+.. .+.+++-+|+|. .+|..+.......++...++..+.+... ||.++|+..|+|-|+||+||++. .+
T Consensus 186 ~~e~--~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~----~~ 258 (524)
T KOG0601|consen 186 AWEG--SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT----SD 258 (524)
T ss_pred cccc--CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc----cc
Confidence 8877 678999999985 6887777766677889999999999999 99999999999999999999998 55
Q ss_pred -CeEEEEecCCcccccCCcccCC------CCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHH
Q 001103 1022 -PICKVGDFGLSRIKCNTLVSGG------VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI 1094 (1157)
Q Consensus 1022 -g~VKLiDFGLAkl~~~~~~sts------~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eei 1094 (1157)
...+++|||+.....+...... ..|...|++||..++. ++...|+|+||.++.+...+..++..... ..
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~ 334 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEVILEAILGSHLPSVGKN-SS 334 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhhhHhhHhhcccccCCCC-CC
Confidence 7899999999886655443211 2588899999999864 68889999999999999998776654311 11
Q ss_pred HHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1095 l~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
..++.....+.++....+.++...+..|++.+|..|++...+.++
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 112222234455666677788889999999999999998887764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.1e-11 Score=139.33 Aligned_cols=145 Identities=21% Similarity=0.207 Sum_probs=96.3
Q ss_pred EEecccCcEEEEEEEE-CCceEEEEEEecccccCCC--------------------------hhHHHHHH------HHHH
Q 001103 881 QELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRS--------------------------SEQEWLIK------EFWR 927 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~--------------------------~e~e~lik------qflr 927 (1157)
+.||.|++|.||+|+. +|+.||||+.+......-. .-.+.... .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 6899999998654210000 00000111 2445
Q ss_pred HHHHHHhCC-----CCc--eeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHH-HHHHHHH
Q 001103 928 EAHIISNLH-----HPN--VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF-GMEYLHM 999 (1157)
Q Consensus 928 EIkILK~L~-----HPN--IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~-ALeYLHS 999 (1157)
|++.+.++. +++ ++++|..+. ...++||||++|++|.++........+ ...++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 666555552 232 334443222 245899999999999887643221122 2345555554 4788999
Q ss_pred CCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 1000 kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
.|++|+|+||.||+++ .++.++|+|||++....
T Consensus 276 ~g~~H~D~hPgNilv~----~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVL----KDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEEC----CCCcEEEEeCCCeeECC
Confidence 9999999999999998 66789999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.2e-11 Score=117.23 Aligned_cols=127 Identities=17% Similarity=0.114 Sum_probs=94.4
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCCCCcEEEE
Q 001103 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN-VVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN-IVkLygvf~de~~~~LyLV 958 (1157)
++.|+.|.++.||+++..+..|++|+...... ....+.+|+.+++.+.+.+ +++++..... ..++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---------LLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---------cccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEE
Confidence 57789999999999999989999998754311 0123457888888885544 3456555332 24789
Q ss_pred EEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 959 TEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNI-----VHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 959 MEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGI-----IHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
|||++|.++.... . ....++.+++.+|..||+.++ +|+|++|.|||++ .+.++|+|||.+.
T Consensus 70 ~e~i~G~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-----~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-----DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-----CCeEEEEeccccc
Confidence 9999998886531 1 112346789999999999985 9999999999997 2368999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.5e-11 Score=141.55 Aligned_cols=153 Identities=20% Similarity=0.255 Sum_probs=93.5
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEeccccc--------------------C--C----ChhHHHHHHHH-
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFL--------------------G--R----SSEQEWLIKEF- 925 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~--------------------~--r----~~e~e~likqf- 925 (1157)
.+|+. +.||+|++|.||+|+++ |+.||||++++.... . + ..-.+...+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 78999999999999984 889999999865210 0 0 00011122233
Q ss_pred -----HHHHHHHHhCC----CCceeEEeeeeecCCCCcEEEEEEeecCCcchhh--hcccc---ccccHHHHHHHHHHHH
Q 001103 926 -----WREAHIISNLH----HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHV--LARKD---RILDRRKKLMLMMDAA 991 (1157)
Q Consensus 926 -----lrEIkILK~L~----HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dl--Lkr~g---r~L~e~qVlkIa~QLa 991 (1157)
.+|+..+.++. +...+.+-.++.+- ....+|||||+.|+.+.++ +...+ +.+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 33444444432 33222222222111 2245799999999999764 22222 123333344444444
Q ss_pred HHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 992 ~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
...|++|+|+||.|||++.+++..+.++++|||++....
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 469999999999999998554455699999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.1e-11 Score=152.64 Aligned_cols=246 Identities=22% Similarity=0.268 Sum_probs=179.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.++.+.+-+-+|+++.++.++-. |...++|+..+........ .+.+.++-.++-...+|.++....-+.. .
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~-----~~s~r~~s~~~i~p~~P~v~~~~~s~~~--r 876 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND-----YESIRSKSNILITPRSPAVVRSFPSFPC--R 876 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhcccc-----ccccCCccCccccCCCCceecccCCCCC--C
Confidence 45666777888999999977654 3234555444322211110 1223334444444456777766544333 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...+++|+|..+++|...|+..+ ..+....+.++..+..+++|||...++|||++|.|+|+. ..++.+++|||..
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~----~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA----YDGHRPLTDFGTL 951 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhc----ccCCcccCccccc
Confidence 57899999999999999887655 456666677788899999999999999999999999998 7788999999833
Q ss_pred cccc-------C-------------------------CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHH
Q 001103 1033 RIKC-------N-------------------------TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII 1080 (1157)
Q Consensus 1033 kl~~-------~-------------------------~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELL 1080 (1157)
.... . ........||+.|.+||.+.+. .....+|||++|++++|.+
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhh
Confidence 2100 0 0112235699999999999875 3466799999999999999
Q ss_pred cCCCCCCCCChhHHHHHhhhcCCCC-CCCCCCcHHHHHHHHHHhccCCCCCCCHH
Q 001103 1081 TGEEPYANMHCGAIIGGILSNTLRP-QIPERCDPEWRKLMEECWSFNPAARPSFT 1134 (1157)
Q Consensus 1081 TGk~PF~g~~~eeil~~Il~~~lrp-eip~~iSpeLrdLIkrCLqkDPskRPSae 1134 (1157)
+|.+||.......+++.+......+ ..+...+.+.++++...|..+|.+|..+.
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999888888887665543 35667889999999999999999997654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.1e-10 Score=117.31 Aligned_cols=142 Identities=17% Similarity=0.076 Sum_probs=99.1
Q ss_pred EEecccCcEEEEEEEEC--------CceEEEEEEecccc--cCCC----------------hhHHHHHHHHHHHHHHHHh
Q 001103 881 QELGSGTFGTVYRGKWR--------GTDIAIKRIKKSCF--LGRS----------------SEQEWLIKEFWREAHIISN 934 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--------Gt~VAVKVIkk~~l--~~r~----------------~e~e~likqflrEIkILK~ 934 (1157)
..||.|--+.||.|... +..+|||+.+.... ..+. ...........+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 56899999999999764 36899998764321 1100 0011111233489999999
Q ss_pred CC--CCceeEEeeeeecCCCCcEEEEEEeecCCcch-hhhccccccccHHHHHHHHHHHHHHHHHH-HHCCceeccCCcc
Q 001103 935 LH--HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGMEYL-HMKNIVHFDLKCD 1010 (1157)
Q Consensus 935 L~--HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~-dlLkr~gr~L~e~qVlkIa~QLa~ALeYL-HSkGIIHRDLKPE 1010 (1157)
|. .-++++.+++. .-+|||||+.+..+. ..++. ..++......+..+++.+|..| |+.||||+||++.
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 85 35677777652 248899999775442 22322 1244556677789999999998 8999999999999
Q ss_pred ceeeccCCCCCCeEEEEecCCcccc
Q 001103 1011 NLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 1011 NILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
|||+. ++.+.|+|||.+...
T Consensus 155 NIL~~-----~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-----DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-----CCcEEEEECCCceeC
Confidence 99996 257999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-09 Score=114.04 Aligned_cols=136 Identities=22% Similarity=0.274 Sum_probs=101.7
Q ss_pred EecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--CCceeEEeeeeecCCCCcEEEEE
Q 001103 882 ELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--HPNVVAFYGVVPNGPGGTMATVT 959 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--HPNIVkLygvf~de~~~~LyLVM 959 (1157)
.+++|+-+.+|++.+.|.++.+|.-.++......-+..--..+..+|++++.++. --+.+.+|++... ...|+|
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~----~~~I~m 78 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD----NGLIVM 78 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC----CCEEEE
Confidence 5789999999999998888777765444333322222223456788999999885 4455667766443 457899
Q ss_pred EeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 960 EYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 960 EYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
||++|..|.+++... ...++..+-..+.-||..||+|+||.++||++. .+.+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~-----~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS-----GGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-----CCcEEEEECCcccc
Confidence 999999998888654 134566777778889999999999999999997 23489999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-10 Score=137.74 Aligned_cols=252 Identities=21% Similarity=0.214 Sum_probs=177.3
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC---CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k---Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
...+|..+..||.|.|+.|+....+ +..|++|.+.+..... ..+ ..-..|+-+...+ .|.+++.++..|.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~-~~d-----i~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF-ASD-----IFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch-Hhh-----hcchhhhhHhhHhhcccccCCCCCCcc
Confidence 4468899999999999999976543 4568988776652211 111 1223455555555 4888888887776
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ....|+-.|||+++++...+ .....+++..++.+..|++.++.++|++.++|+|+||+||++..++ +..++.|
T Consensus 337 ~--~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~~~~ 410 (524)
T KOG0601|consen 337 Q--LRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSKLGD 410 (524)
T ss_pred c--cccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhhccc
Confidence 6 33566899999999887655 2334477888899999999999999999999999999999998322 7789999
Q ss_pred cCCcccccCCcccCCCCCCCccc-CcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChhHHHHHhhhcCCCCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWM-APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP-YANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~Ym-APEVL~G~~~~yS~KSDIWSLGVILYELLTGk~P-F~g~~~eeil~~Il~~~lrpe 1106 (1157)
||.++...-. ...+....++. .+|++.. .+.+..+.|+++||..+.+.+++..- +.+.+.. .+..+ ..+.
T Consensus 411 ~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e-~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----~i~~~-~~p~ 482 (524)
T KOG0601|consen 411 FGCWTRLAFS--SGVFHHIDRLYPIAEILLE-DYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----TIRSG-DTPN 482 (524)
T ss_pred ccccccccee--cccccccccccccchhhcc-ccccccccccccccccccccccCcccCcccccce----eeecc-cccC
Confidence 9988641111 11123444555 3666654 35678899999999999999998653 3322221 11111 1222
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.+. ...++..+.+.++..++..||++.++..+...+..
T Consensus 483 ~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 483 LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred CCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 333 33788899999999999999999998887776654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.8e-10 Score=126.27 Aligned_cols=200 Identities=21% Similarity=0.282 Sum_probs=138.2
Q ss_pred HHHhCCCCceeEEeeeeecCC---CCcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCC--c
Q 001103 931 IISNLHHPNVVAFYGVVPNGP---GGTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKN--I 1002 (1157)
Q Consensus 931 ILK~L~HPNIVkLygvf~de~---~~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkG--I 1002 (1157)
-|-.+.|-|||+++.+|.+.. .....++.|||..|+|..+|++. ...+......+|+-||+.||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 445567999999999987632 34678999999999999999763 455778888899999999999999985 9
Q ss_pred eeccCCccceeeccCCCCCCeEEEEecCCcccc--cC---CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHH
Q 001103 1003 VHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK--CN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMW 1077 (1157)
Q Consensus 1003 IHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~--~~---~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILY 1077 (1157)
+|+.+..+-|++. .++.+|+.---..... .+ .....--.+-++|.+||.-.- ...+..+|||++|+...
T Consensus 200 ihgnlTc~tifiq----~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQ----HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCAL 273 (458)
T ss_pred ccCCcchhheeec----CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHH
Confidence 9999999999998 6677776432211110 00 000111246788999997432 23467899999999999
Q ss_pred HHHcCCCCCCC-CChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1078 EIITGEEPYAN-MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1078 ELLTGk~PF~g-~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+|..+..--.. ......-..+..-.+- + -...=+++|.+||+-.|..||++..++.|+.
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~i~~--l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANVIIG--L---ENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhheee--c---cCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 99988764222 1111111111111110 0 0112367999999999999999999998743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.8e-09 Score=105.68 Aligned_cols=144 Identities=22% Similarity=0.230 Sum_probs=103.0
Q ss_pred EEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC--CceeEEeeeeecCC-CCcE
Q 001103 880 LQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--PNVVAFYGVVPNGP-GGTM 955 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H--PNIVkLygvf~de~-~~~L 955 (1157)
++.|+.|.++.||+++..+ ..+++|+....... .....+.+|.++++.+.+ ..+++++.+..... .+..
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 3678999999999998865 78999987654211 013456789999999965 44567776654421 1356
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM------------------------------------ 999 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS------------------------------------ 999 (1157)
++||||++|.++.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 76 ~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred eEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 899999999988776532 235566666677777777777773
Q ss_pred --------------------CCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 1000 --------------------KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1000 --------------------kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
..++|+|++|.|||++.+ ..+.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~--~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD--EPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC--CCcEEEEEecccccc
Confidence 236999999999999821 145789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.4e-09 Score=111.00 Aligned_cols=151 Identities=18% Similarity=0.165 Sum_probs=108.4
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC--CceeEEeeeeecCCCCcEE
Q 001103 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--PNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H--PNIVkLygvf~de~~~~Ly 956 (1157)
.+..|-+|+-+.|+++.+.|+.+.||.-..+......-+..-...+..+|+++|.++.- -..+++|.+-.. .-.
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----GGQ 86 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC----CCe
Confidence 56789999999999999999998888654443333333333345677889999998853 233455443222 236
Q ss_pred EEEEeecC-Ccchhhhcccccccc-HHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 957 TVTEYMVN-GSLRHVLARKDRILD-RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 957 LVMEYmeG-GSL~dlLkr~gr~L~-e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
|+|||++| .++.+++......-. ......++.++-..+.-||..+|||+||..+||++..++ ....+.|+|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-NQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-CcCceEEEeecchhc
Confidence 78999987 467777755432222 223367788888999999999999999999999998554 555678999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.4e-08 Score=119.85 Aligned_cols=163 Identities=20% Similarity=0.272 Sum_probs=120.5
Q ss_pred CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccc
Q 001103 897 RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR 976 (1157)
Q Consensus 897 kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr 976 (1157)
.+.+|.|++.+...- .......+-++.|+.|+||||+++++.+.. .+++|||+|.+. .|..++++.+
T Consensus 36 ~~~~vsVF~~~~~~~--------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l~- 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--------EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKELG- 102 (690)
T ss_pred cCCceEEEEEeCCCc--------hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHHhH-
Confidence 567788888775421 123445667788999999999999999887 569999999984 5666666533
Q ss_pred cccHHHHHHHHHHHHHHHHHHH-HCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc-ccCCCCCCCcccCcc
Q 001103 977 ILDRRKKLMLMMDAAFGMEYLH-MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL-VSGGVRGTLPWMAPE 1054 (1157)
Q Consensus 977 ~L~e~qVlkIa~QLa~ALeYLH-SkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~-~sts~~GTp~YmAPE 1054 (1157)
...+...+.||+.||.||| +.+++|++|.-+-|+++ ..|..||++|.++....... ......--..|..|+
T Consensus 103 ---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn----~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 103 ---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN----ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc----CCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 4456667899999999998 56899999999999999 78899999999875432211 111111223477787
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHcCC
Q 001103 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083 (1157)
Q Consensus 1055 VL~G~~~~yS~KSDIWSLGVILYELLTGk 1083 (1157)
.+... ....|.|.|||++++++.|.
T Consensus 176 ~~~~s----~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 176 EIDPS----EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hcCcc----ccchhhhhHHHHHHHHhCcc
Confidence 76532 23479999999999999993
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.9e-08 Score=110.39 Aligned_cols=259 Identities=15% Similarity=0.166 Sum_probs=168.5
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeee-----eecCCC
Q 001103 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGV-----VPNGPG 952 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygv-----f~de~~ 952 (1157)
..+.||+|+-+.+|-.-.-+..|| |+..+..-.. ..+ -+..|.+. .||-+-.-+.| +-.+..
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~--------~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAA--------QAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred CCccccCCccceeeecchhhchhh-eeecCCCchH--------HHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 346799999999995433333344 7766542110 111 11222222 45543321111 111123
Q ss_pred CcEEEEEEeecCCcchhhhcc------ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 953 GTMATVTEYMVNGSLRHVLAR------KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr------~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
..+.++|..+.+..--..+.+ .-....|...++.++.|+.+...||..|.+-+|+.++|+|++ +.+.|.|
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs----d~~~V~L 158 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS----DDSKVVL 158 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee----cCceEEE
Confidence 347788888877533222211 223367889999999999999999999999999999999998 7788999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCccccc-CC--CCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChh-----HHHHH
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLN-GS--NNRVSEKVDVYSFGIAMWEIITG-EEPYANMHCG-----AIIGG 1097 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~-G~--~~~yS~KSDIWSLGVILYELLTG-k~PF~g~~~e-----eil~~ 1097 (1157)
.|-..-....+.......+|...|.+||..+ +. ...-+...|.|.||++||+||.| ++||.+.... ..-..
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 9866444444555555678999999999865 11 11235668999999999999986 9999875421 01011
Q ss_pred hhhcC----------CCC---CCC-CCCcHHHHHHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHhhcccc
Q 001103 1098 ILSNT----------LRP---QIP-ERCDPEWRKLMEECWSFN--PAARPSFTEITNRLRVMSTALQTKRRN 1153 (1157)
Q Consensus 1098 Il~~~----------lrp---eip-~~iSpeLrdLIkrCLqkD--PskRPSaeELLe~Lr~Lk~aLesksRn 1153 (1157)
|..+. +.+ .+| .-+++.+..|..+|+..- +.-|||++.++..|-.+...+.++-++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~ 310 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVS 310 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhc
Confidence 21111 110 111 236788999999999743 568999999999999999888776554
|
|
| >smart00666 PB1 PB1 domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.4e-08 Score=90.29 Aligned_cols=75 Identities=45% Similarity=0.709 Sum_probs=65.8
Q ss_pred CCceeecCceEEEEccCCCCHHHHHHHHHhhcCC---CceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCe
Q 001103 202 GKLRYVGGETRIISIRKSLTWEELMRKTSAICNQ---PHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQR 278 (1157)
Q Consensus 202 ~~l~YvGG~triv~v~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~r 278 (1157)
.+++| ||++|.+.|+++++|.+|+.++.+.++. .+.|||+ .||-| +|++++|+||..|++.+.+.. ...
T Consensus 4 vK~~~-~~~~~~~~~~~~~s~~dL~~~i~~~~~~~~~~~~l~Y~--Dedgd-~v~l~sd~Dl~~a~~~~~~~~----~~~ 75 (81)
T smart00666 4 VKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLTSDEDLEEAIEEYDSLG----SKK 75 (81)
T ss_pred EEEEE-CCEEEEEEECCCCCHHHHHHHHHHHhCCCCCCeEEEEE--CCCCC-EEEecCHHHHHHHHHHHHHcC----Cce
Confidence 35677 8999999999999999999999999875 6899999 77766 999999999999999987753 357
Q ss_pred EEEEEe
Q 001103 279 LRIFLV 284 (1157)
Q Consensus 279 lR~FLF 284 (1157)
||+++|
T Consensus 76 l~l~v~ 81 (81)
T smart00666 76 LRLHVF 81 (81)
T ss_pred EEEEeC
Confidence 999886
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-07 Score=100.33 Aligned_cols=133 Identities=24% Similarity=0.185 Sum_probs=82.3
Q ss_pred EEEEEEE-CCceEEEEEEeccccc-----------CC-------ChhHHHHHHHHHHHHHHHHhCCCC--ceeEEeeeee
Q 001103 890 TVYRGKW-RGTDIAIKRIKKSCFL-----------GR-------SSEQEWLIKEFWREAHIISNLHHP--NVVAFYGVVP 948 (1157)
Q Consensus 890 tVYlAr~-kGt~VAVKVIkk~~l~-----------~r-------~~e~e~likqflrEIkILK~L~HP--NIVkLygvf~ 948 (1157)
.||.|.. +|..+|||+.+..... .+ ............+|.+.|+++..- ++++.+.+..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 3898887 6888999987653111 00 112233345678899999999755 5777776632
Q ss_pred cCCCCcEEEEEEeec--CCcchhhhccccccccHHHHHHHHHHHHHHHHH-HHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 949 NGPGGTMATVTEYMV--NGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY-LHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 949 de~~~~LyLVMEYme--GGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeY-LHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
-+|||||++ |..+..+... . ++......++.+++..+.. +|..||+|+||.+.|||++ .. .+.
T Consensus 81 ------~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~-~~~ 146 (188)
T PF01163_consen 81 ------NVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DG-KVY 146 (188)
T ss_dssp ------TEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TT-CEE
T ss_pred ------CEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cc-eEE
Confidence 278999998 6555443322 1 1123445567777774444 6899999999999999997 33 899
Q ss_pred EEecCCccccc
Q 001103 1026 VGDFGLSRIKC 1036 (1157)
Q Consensus 1026 LiDFGLAkl~~ 1036 (1157)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=3e-07 Score=101.47 Aligned_cols=147 Identities=20% Similarity=0.090 Sum_probs=96.8
Q ss_pred CcEEEEEEEECCceEEEEEEecccccCC-Chh--HHHHHHHHHHHHHHHHhCCCC--ceeEEeeeeecCC---CCcEEEE
Q 001103 887 TFGTVYRGKWRGTDIAIKRIKKSCFLGR-SSE--QEWLIKEFWREAHIISNLHHP--NVVAFYGVVPNGP---GGTMATV 958 (1157)
Q Consensus 887 sFGtVYlAr~kGt~VAVKVIkk~~l~~r-~~e--~e~likqflrEIkILK~L~HP--NIVkLygvf~de~---~~~LyLV 958 (1157)
....|++..+.|+.|.||+......... +.. ...-...+.+|...+.+|..- ..+...++..... ....+||
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3344778888899999997754321100 000 000011367888888877422 2223333332211 2347899
Q ss_pred EEeecCC-cchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccC---CCCCCeEEEEecCCcc
Q 001103 959 TEYMVNG-SLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLR---DPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 959 MEYmeGG-SL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~d---d~e~g~VKLiDFGLAk 1033 (1157)
||++++. +|.+++... ....+......++.+++..+.-||..||+|+||++.|||++.+ ..+...+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999886 788887532 2334566777889999999999999999999999999999732 2245789999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.8e-07 Score=106.56 Aligned_cols=214 Identities=15% Similarity=0.167 Sum_probs=151.3
Q ss_pred CcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC--CCcEEEEEEee
Q 001103 887 TFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP--GGTMATVTEYM 962 (1157)
Q Consensus 887 sFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~--~~~LyLVMEYm 962 (1157)
--.+.|++.. +|..|.+|++........ .+...-+++++++.|+|+|++..+|.... +..+++|++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 3456888876 688899999843221111 12234467899999999999998886322 44789999999
Q ss_pred cC-Ccchhhhcc--------------ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 963 VN-GSLRHVLAR--------------KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 963 eG-GSL~dlLkr--------------~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
++ ++|+++... .+...++..+|.++.||+.||.++|+.|+.-+-|.|.+||++ .+.+++|.
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~----G~~RIriS 435 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT----GKMRIRIS 435 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee----CcceEEEe
Confidence 86 366655321 234578899999999999999999999999999999999998 55688998
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChhHH-HHHhhhcCCCC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP-YANMHCGAI-IGGILSNTLRP 1105 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~P-F~g~~~eei-l~~Il~~~lrp 1105 (1157)
..|......+... |.+++ -.+-|.=.||.+++.|.+|..- +........ +..
T Consensus 436 ~C~i~Dvl~~d~~-------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------- 489 (655)
T KOG3741|consen 436 GCGIMDVLQEDPT-------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------- 489 (655)
T ss_pred cccceeeecCCCC-------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------
Confidence 8887655443321 22322 2346999999999999999543 111111111 121
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~L 1140 (1157)
+....+.+++++|..+....+++ -++.+++.++
T Consensus 490 -I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 490 -ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 23346789999999999999987 6777777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.5e-07 Score=95.37 Aligned_cols=110 Identities=23% Similarity=0.166 Sum_probs=81.1
Q ss_pred HHHHHHHHHHHhCCC--CceeEEeeeeecCC--CCcEEEEEEeecCC-cchhhhccccccccHHHHHHHHHHHHHHHHHH
Q 001103 923 KEFWREAHIISNLHH--PNVVAFYGVVPNGP--GGTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997 (1157)
Q Consensus 923 kqflrEIkILK~L~H--PNIVkLygvf~de~--~~~LyLVMEYmeGG-SL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYL 997 (1157)
.+..+|...+..|.. -.+++.+++..... ....++|+|++++. +|.+++..... ++......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 456778887777742 22334444443321 12458999999884 78888865333 56667788899999999999
Q ss_pred HHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 998 HSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
|++||+|+|+++.|||++.++ ....+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 999999999999999998443 445899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF00564 PB1: PB1 domain; InterPro: IPR000270 The Phox and Bem1p domain, is present in many eukaryotic cytoplasmic signalling proteins | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.5e-06 Score=77.36 Aligned_cols=74 Identities=36% Similarity=0.609 Sum_probs=60.2
Q ss_pred eeecCceEEEEccCCCCHHHHHHHHHhhcCC---CceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEE
Q 001103 205 RYVGGETRIISIRKSLTWEELMRKTSAICNQ---PHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRI 281 (1157)
Q Consensus 205 ~YvGG~triv~v~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~ 281 (1157)
+|.|+.+|++.+++.++|.+|+.++++.++. .+.|+|+ .||- .+|++++|+||..|++.+.+. ...+|||
T Consensus 7 ~~~~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~Y~--D~dg-D~V~i~sd~Dl~~a~~~~~~~----~~~~lrl 79 (84)
T PF00564_consen 7 RYGGDIRRIISLPSDVSFDDLRSKIREKFGLLDEDFQLKYK--DEDG-DLVTISSDEDLQEAIEQAKES----GSKTLRL 79 (84)
T ss_dssp EETTEEEEEEEECSTSHHHHHHHHHHHHHTTSTSSEEEEEE--ETTS-SEEEESSHHHHHHHHHHHHHC----TTSCEEE
T ss_pred EECCeeEEEEEcCCCCCHHHHHHHHHHHhCCCCccEEEEee--CCCC-CEEEeCCHHHHHHHHHHHHhc----CCCcEEE
Confidence 3333344569999999999999999999885 6778887 5444 799999999999999999886 3358999
Q ss_pred EEee
Q 001103 282 FLVS 285 (1157)
Q Consensus 282 FLFp 285 (1157)
|+..
T Consensus 80 ~v~~ 83 (84)
T PF00564_consen 80 FVQD 83 (84)
T ss_dssp EEEE
T ss_pred EEEe
Confidence 9874
|
The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate.; GO: 0005515 protein binding; PDB: 1IPG_A 1IP9_A 2KFK_A 1WMH_A 1VD2_A 1WI0_A 1OEY_C 1PQS_A 1Q1O_A 1TZ1_A .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=4.1e-07 Score=109.82 Aligned_cols=146 Identities=21% Similarity=0.261 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcc----------cCCCCCCCcccCcccc
Q 001103 988 MDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV----------SGGVRGTLPWMAPELL 1056 (1157)
Q Consensus 988 ~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~----------sts~~GTp~YmAPEVL 1056 (1157)
.+++.||.|+|.. ++||+.|.|++|.++ ..+.+||+.|+++........ ..-..-...|.|||++
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~n----a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVN----ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeec----cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3455899999976 899999999999999 888999999998764332111 0111245679999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhH--HHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCH
Q 001103 1057 NGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGA--IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSF 1133 (1157)
Q Consensus 1057 ~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~ee--il~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSa 1133 (1157)
.+. ..+.++|+|||||++|.+.. |+.-+....... .......+.-.......+++++++=|.+++..++..||++
T Consensus 182 ~~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 182 LGT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccc--cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 863 56889999999999999994 555544332111 1111111222223456789999999999999999999988
Q ss_pred HHHHHH
Q 001103 1134 TEITNR 1139 (1157)
Q Consensus 1134 eELLe~ 1139 (1157)
..++..
T Consensus 260 ~~l~~~ 265 (700)
T KOG2137|consen 260 DLLLSI 265 (700)
T ss_pred hhhhcc
Confidence 877653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=7.3e-06 Score=91.23 Aligned_cols=141 Identities=20% Similarity=0.051 Sum_probs=98.3
Q ss_pred eEEEEecccCcEEEEEEEE-CCceEEEEEEecccccC--------------CChhHHHHHHHHHHHHHHHHhCCCC--ce
Q 001103 878 EELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLG--------------RSSEQEWLIKEFWREAHIISNLHHP--NV 940 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~--------------r~~e~e~likqflrEIkILK~L~HP--NI 940 (1157)
.+..+||-|--+.||.|.. +|.++|||.=+.....- ........+....+|.++|++|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3568899999999999998 59999999644321110 0111122334567899999999644 66
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCC
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQ 1020 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e 1020 (1157)
++-+++ +...+||||++|-.|...-- +....-.++..|+.-+.-+-..||||+|+.+=|||++ +
T Consensus 174 P~P~~~------nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~----~ 237 (304)
T COG0478 174 PKPIAW------NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT----E 237 (304)
T ss_pred CCcccc------ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe----c
Confidence 666654 35689999999977765431 1222333444555555555589999999999999999 7
Q ss_pred CCeEEEEecCCccc
Q 001103 1021 RPICKVGDFGLSRI 1034 (1157)
Q Consensus 1021 ~g~VKLiDFGLAkl 1034 (1157)
++.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 77899999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.2e-05 Score=84.83 Aligned_cols=146 Identities=17% Similarity=0.108 Sum_probs=101.2
Q ss_pred ecccCcEEEEEEEECCceEEEEEEecccccCCC-hhHHHHHHHHHHHHHHHHhCCCC--ceeEEe--eeeecCCCCcEEE
Q 001103 883 LGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRS-SEQEWLIKEFWREAHIISNLHHP--NVVAFY--GVVPNGPGGTMAT 957 (1157)
Q Consensus 883 LGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~-~e~e~likqflrEIkILK~L~HP--NIVkLy--gvf~de~~~~LyL 957 (1157)
-|+|+-+.|++....|..+-+|.-.......-. .. -...|.+|+..|++|..- .+++.. +.-.....-..+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~---g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPF---GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCC---CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence 356899999999888888888876532111100 11 136788999999988532 233333 2222222234678
Q ss_pred EEEeecC-Ccchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 958 VTEYMVN-GSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 958 VMEYmeG-GSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
|+|-+.+ -+|.+++.... ...+......++.+++..|.-||+.|+.|+|+-+.|||++.++ ...++++||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g--~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG--KAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC--CeeEEEEEhhccc
Confidence 9997764 47878775432 3456777788999999999999999999999999999997322 3459999999765
|
|
| >cd05992 PB1 The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.1e-05 Score=72.81 Aligned_cols=73 Identities=36% Similarity=0.623 Sum_probs=57.8
Q ss_pred ceeecCceEEEEcc-CCCCHHHHHHHHHhhcCC---CceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeE
Q 001103 204 LRYVGGETRIISIR-KSLTWEELMRKTSAICNQ---PHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRL 279 (1157)
Q Consensus 204 l~YvGG~triv~v~-r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rl 279 (1157)
++|- |++|.+.|+ ++++|.+|+.++.+.++. .+.|||. .||- .+|++++|+||..|++.+.+ ....++
T Consensus 5 ~~~~-~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~y~--D~e~-d~v~l~sd~Dl~~a~~~~~~----~~~~~l 76 (81)
T cd05992 5 VKYG-GEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP--DEDG-DLVTISSDEDLEEAIEEARR----SGSKKL 76 (81)
T ss_pred EEec-CCCEEEEEecCCCCHHHHHHHHHHHhCCCCCcEEEEee--CCCC-CEEEeCCHHHHHHHHHHHhh----cCCccE
Confidence 4444 566667776 999999999999999985 4556666 5554 78999999999999999977 335689
Q ss_pred EEEEe
Q 001103 280 RIFLV 284 (1157)
Q Consensus 280 R~FLF 284 (1157)
|+|++
T Consensus 77 ~l~v~ 81 (81)
T cd05992 77 RLFVF 81 (81)
T ss_pred EEEeC
Confidence 98875
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=9e-07 Score=106.29 Aligned_cols=234 Identities=15% Similarity=0.158 Sum_probs=153.9
Q ss_pred eeEEEEecccCcEEEEEEEECCce-EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKWRGTD-IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN-VVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~kGt~-VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN-IVkLygvf~de~~~~ 954 (1157)
++....+++|++++++|.+...+. ...|++... ....-++++|.+++||| .+..++-+ +.+.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccC--Ccccc
Confidence 456778999999999988764322 224443321 22345788999999999 44444433 33668
Q ss_pred EEEEEEeecCC-cchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 955 MATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 955 LyLVMEYmeGG-SL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.++.|+++.++ +....+....-.+..-+...+.+.-+++|++||+--=+||| |||.. ++..|+.||+...
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----EEEVKLLDFAVPP 379 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----ccccccccccCCc
Confidence 99999999887 33333333333355556667777888999999988778998 88885 3578999999887
Q ss_pred cccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--CCC
Q 001103 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--ERC 1111 (1157)
Q Consensus 1034 l~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~~i 1111 (1157)
..........+.+|+.++|||+.+.. .+..+.|.|++|+-..+|.-|.+|-... ......+-.+.-.+.+. ..+
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw 455 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAW 455 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhc
Confidence 66655555667899999999988743 5788899999999888888888775431 11111111111011111 112
Q ss_pred cHHHH-HHHHHHhccCCCCCCCHHHHHH
Q 001103 1112 DPEWR-KLMEECWSFNPAARPSFTEITN 1138 (1157)
Q Consensus 1112 SpeLr-dLIkrCLqkDPskRPSaeELLe 1138 (1157)
++.+. ++...|+...|..|+.....+.
T Consensus 456 ~~~~~~~~~~~~~~g~P~~pkv~mgacf 483 (829)
T KOG0576|consen 456 SPVFHRDFPAPCLNGLPPTPKVHMGACF 483 (829)
T ss_pred CcccccCCcccccCCCCCCCcchhhHHH
Confidence 22222 3667777777777776655544
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.5e-05 Score=80.34 Aligned_cols=135 Identities=22% Similarity=0.207 Sum_probs=94.8
Q ss_pred CCeeEEEEecccCc-EEEEEEEECCceEEEEEEecccccCC------Chh-------HHHHHHHHHHHHHHHHhCC---C
Q 001103 875 SDLEELQELGSGTF-GTVYRGKWRGTDIAIKRIKKSCFLGR------SSE-------QEWLIKEFWREAHIISNLH---H 937 (1157)
Q Consensus 875 sdYeILrkLGsGsF-GtVYlAr~kGt~VAVKVIkk~~l~~r------~~e-------~e~likqflrEIkILK~L~---H 937 (1157)
.+++.++.||.|.- |.||+++..|..||+|+.+.-..... ... ......-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 58899999999999 99999999999999999433211111 000 0133456788888777774 4
Q ss_pred Cce--eEEeeeeecCC----------------CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH
Q 001103 938 PNV--VAFYGVVPNGP----------------GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999 (1157)
Q Consensus 938 PNI--VkLygvf~de~----------------~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS 999 (1157)
..+ |+.|||+.-.. .....||.||+.... .+.. .-+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence 455 89999974321 113467888775533 1222 235667777899999
Q ss_pred CCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 1000 kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
.||+-+|+|+.|..=+ ||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~~G---------~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYRGG---------KLVDFSSS 206 (207)
T ss_pred CCeeeccCccccccCC---------EEEecccC
Confidence 9999999999998744 79999964
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00014 Score=79.26 Aligned_cols=144 Identities=16% Similarity=0.129 Sum_probs=93.3
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHH-----HHHHHHHHHHhC---CCCceeEE
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIK-----EFWREAHIISNL---HHPNVVAF 943 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~lik-----qflrEIkILK~L---~HPNIVkL 943 (1157)
+...+|.+++.+-......|.+-..+|..+.+|..+.... ..+ +.... ...+++..+.++ .-..+..+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~---r~e-r~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENR---RPE-RRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhh---hHH-HHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 4457899999999999999999999999999998765421 111 11111 112233333333 22233333
Q ss_pred eeeeecCC---CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCC
Q 001103 944 YGVVPNGP---GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQ 1020 (1157)
Q Consensus 944 ygvf~de~---~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e 1020 (1157)
|.+..-.. ....+++|||++|..|.++.. +++ .++..+..++.-||+.|+.|+|+.|.|++++ .
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~ 170 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----N 170 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----C
Confidence 32222111 124568999999988876542 222 2345667789999999999999999999997 3
Q ss_pred CCeEEEEecCCcc
Q 001103 1021 RPICKVGDFGLSR 1033 (1157)
Q Consensus 1021 ~g~VKLiDFGLAk 1033 (1157)
+.++++||+..+
T Consensus 171 -~~i~iID~~~k~ 182 (229)
T PF06176_consen 171 -NGIRIIDTQGKR 182 (229)
T ss_pred -CcEEEEECcccc
Confidence 348999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.8e-05 Score=92.12 Aligned_cols=146 Identities=21% Similarity=0.227 Sum_probs=92.5
Q ss_pred EEecccCcEEEEEEEEC-CceEEEEEEeccccc--------------------C--C----ChhHHHHHHH------HHH
Q 001103 881 QELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFL--------------------G--R----SSEQEWLIKE------FWR 927 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~--------------------~--r----~~e~e~likq------flr 927 (1157)
..|+.++-|.||+|+++ |+.||||+.+..... . + ....+...+. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999996 899999997654110 0 0 0011111222 344
Q ss_pred HHHHHHhCC-----CCc--eeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC
Q 001103 928 EAHIISNLH-----HPN--VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK 1000 (1157)
Q Consensus 928 EIkILK~L~-----HPN--IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk 1000 (1157)
|...+.++. .|. |+++|.-+.. .-.|+|||++|-.+.++..-....++.+.+.....++ -+..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccC----CcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhc
Confidence 555555442 232 3445433333 4578999999999988853322335533333332222 23444458
Q ss_pred CceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 1001 GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
|++|.|..|.||++. .++.+.+.|||+.....
T Consensus 285 gffHaDpHpGNi~v~----~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVR----SDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEe----cCCcEEEEcCcceecCC
Confidence 999999999999999 66899999999876533
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00029 Score=71.88 Aligned_cols=80 Identities=19% Similarity=0.197 Sum_probs=56.6
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC--ceeEEeeeeecC-CCCcEE
Q 001103 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP--NVVAFYGVVPNG-PGGTMA 956 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP--NIVkLygvf~de-~~~~Ly 956 (1157)
++.|+.|..+.||+....+..+++|+.... .....+.+|..+++.|... .+++++...... .....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 578999999999999998788999986532 2245667888888887422 356666543222 234578
Q ss_pred EEEEeecCCcchh
Q 001103 957 TVTEYMVNGSLRH 969 (1157)
Q Consensus 957 LVMEYmeGGSL~d 969 (1157)
++|++++|..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00025 Score=78.48 Aligned_cols=145 Identities=19% Similarity=0.075 Sum_probs=96.6
Q ss_pred EEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCC---------------hhHHHH-HHHHHHHHHHHHhCC--CCc
Q 001103 879 ELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRS---------------SEQEWL-IKEFWREAHIISNLH--HPN 939 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~---------------~e~e~l-ikqflrEIkILK~L~--HPN 939 (1157)
+...|.+|--+.||+|.. .+..+|||+.+......+. ...+.+ .....+|..-|+++. +-.
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 456788999999999886 5788999998764222111 111111 123456777788773 455
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCc-chhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccC
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGS-LRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLR 1017 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGS-L~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~d 1017 (1157)
+++-+.+... .|||||+...- -.-.|+.- .++......+..+++..+.-|-. .++||+||+.=|||+.
T Consensus 132 vP~Pi~~~~n------VLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-- 201 (268)
T COG1718 132 VPEPIAFRNN------VLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-- 201 (268)
T ss_pred CCCceeecCC------eEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE--
Confidence 5565655444 68999996541 11223221 13333566677788888887766 8999999999999996
Q ss_pred CCCCCeEEEEecCCccccc
Q 001103 1018 DPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 1018 d~e~g~VKLiDFGLAkl~~ 1036 (1157)
.+.+.|+|||.|....
T Consensus 202 ---~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 ---DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---CCeEEEEECccccccC
Confidence 4578999999986544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00019 Score=77.20 Aligned_cols=72 Identities=17% Similarity=0.253 Sum_probs=49.9
Q ss_pred EEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc--eeEEeeeeecCCCCcEEEE
Q 001103 881 QELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN--VVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN--IVkLygvf~de~~~~LyLV 958 (1157)
..||+|..+.||+. .+..+++|...... . ...+.+|.++++.+..-. +++.+++... .+...+|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-----~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-----D-----KETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-----C-----HHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeee
Confidence 67899999999984 35567788765421 0 134578898988885332 4566666554 4457889
Q ss_pred EEeecCCc
Q 001103 959 TEYMVNGS 966 (1157)
Q Consensus 959 MEYmeGGS 966 (1157)
||+++|.+
T Consensus 73 ~e~i~G~~ 80 (226)
T TIGR02172 73 YELIVGKR 80 (226)
T ss_pred eeecCCcc
Confidence 99999964
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd06407 PB1_NLP A PB1 domain is present in NIN like proteins (NLP), a key enzyme in a process of establishment of symbiosis betweeen legumes and nitrogen fixing bacteria (Rhizobium) | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00017 Score=67.31 Aligned_cols=71 Identities=23% Similarity=0.425 Sum_probs=60.9
Q ss_pred ecCceEEEEccCCCCHHHHHHHHHhhcC----CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEE
Q 001103 207 VGGETRIISIRKSLTWEELMRKTSAICN----QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIF 282 (1157)
Q Consensus 207 vGG~triv~v~r~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~F 282 (1157)
.||+++.+.++.+++|.+|..++++.++ ..++|||. .|| .-.|+++||+||+.-++-|... ...++|||
T Consensus 7 ~~~d~~r~~l~~~~~~~~L~~~i~~r~~~~~~~~f~LkY~--Dde-gd~v~ltsd~DL~eai~i~~~~----~~~~v~l~ 79 (82)
T cd06407 7 YGEEKIRFRLPPSWGFTELKQEIAKRFKLDDMSAFDLKYL--DDD-EEWVLLTCDADLEECIDVYRSS----GSHTIRLL 79 (82)
T ss_pred eCCeEEEEEcCCCCCHHHHHHHHHHHhCCCCCCeeEEEEE--CCC-CCeEEeecHHHHHHHHHHHHHC----CCCeEEEE
Confidence 3889999999999999999999999986 36899999 666 8899999999999888766553 45789999
Q ss_pred Ee
Q 001103 283 LV 284 (1157)
Q Consensus 283 LF 284 (1157)
+-
T Consensus 80 v~ 81 (82)
T cd06407 80 VH 81 (82)
T ss_pred ee
Confidence 74
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes like osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-inte |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00013 Score=77.41 Aligned_cols=131 Identities=27% Similarity=0.318 Sum_probs=92.4
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCcee-EEeeeeecCCCCcE
Q 001103 877 LEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV-AFYGVVPNGPGGTM 955 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIV-kLygvf~de~~~~L 955 (1157)
.+..+.||+|.+|.||++.|.|..+|+|+-+.... ...+..|+++|+.+.-.++- ++|.+-.+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----------r~~l~kEakiLeil~g~~~~p~vy~yg~~------ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----------RRNLEKEAKILEILAGEGVTPEVYFYGED------ 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----------hhhHHHHHHHHHHhhhcCCCceEEEechh------
Confidence 34567899999999999999999999998765421 35677899999999765543 56655333
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCc--cceeeccCCCCCCeEEEEecCCcc
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKC--DNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKP--ENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
++.|||+.|-.|.++-... +..+++ .+++.---|-..||-|..|.- .||++. ...+.|+||.-|+
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~-----~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVN-----DRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEec-----CCcEEEEEccchh
Confidence 5569999998887654321 223333 344444556777999988863 456664 4478999999887
Q ss_pred ccc
Q 001103 1034 IKC 1036 (1157)
Q Consensus 1034 l~~ 1036 (1157)
...
T Consensus 155 ~k~ 157 (201)
T COG2112 155 FKK 157 (201)
T ss_pred hcc
Confidence 443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00017 Score=86.79 Aligned_cols=150 Identities=19% Similarity=0.199 Sum_probs=93.5
Q ss_pred EEecccCcEEEEEEEEC-CceEEEEEEecccccC-------------------CChhH----HHHHHH------HHHHHH
Q 001103 881 QELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLG-------------------RSSEQ----EWLIKE------FWREAH 930 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~-------------------r~~e~----e~likq------flrEIk 930 (1157)
+.||.-+.|.||+|+.+ |..||||+-+...... ....- ++..+. |.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56999999999999984 7779999865431100 00000 111122 333443
Q ss_pred HHH----hCCCCc------eeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC
Q 001103 931 IIS----NLHHPN------VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK 1000 (1157)
Q Consensus 931 ILK----~L~HPN------IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk 1000 (1157)
-.. .+.|-+ |+++|..+.. ...|+||||+|..+.++-.-....++...+...+.++. ++.+=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 322 233555 6677665544 46899999999988766432233355554444433332 2334457
Q ss_pred CceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 1001 GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
|++|.|=.|.|||+..+......+.|.|||+.....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 899999999999998443456789999999986543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00034 Score=74.34 Aligned_cols=75 Identities=19% Similarity=0.108 Sum_probs=50.8
Q ss_pred EecccCc-EEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCcEEEEE
Q 001103 882 ELGSGTF-GTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGTMATVT 959 (1157)
Q Consensus 882 kLGsGsF-GtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~LyLVM 959 (1157)
.|-.|.. ..||+....+..+.||+..... ...+.+|+++++.+. +--+++++++... .+..++||
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~ 71 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLT 71 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEE
Confidence 3444555 7899987776678888765431 124557888888773 4446677777655 34678899
Q ss_pred EeecCCcchh
Q 001103 960 EYMVNGSLRH 969 (1157)
Q Consensus 960 EYmeGGSL~d 969 (1157)
|+++|.+|..
T Consensus 72 e~i~G~~l~~ 81 (244)
T cd05150 72 SAVPGVPAAA 81 (244)
T ss_pred EeeCCccHhH
Confidence 9999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=5e-06 Score=106.61 Aligned_cols=239 Identities=15% Similarity=0.078 Sum_probs=156.5
Q ss_pred EEEEEEECCc---eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEEeecCCc
Q 001103 890 TVYRGKWRGT---DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGS 966 (1157)
Q Consensus 890 tVYlAr~kGt---~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVMEYmeGGS 966 (1157)
.-++++|-++ -+.+|+.+...+ ....+.+.+....|...++...|+++...+.-.........+..++|+.+|.
T Consensus 1241 ~~~R~k~Lr~kid~Fk~~I~ke~d~---e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~ 1317 (2724)
T KOG1826|consen 1241 FHFRNKWLRSKIDWFKFSIYKEYDF---ENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGK 1317 (2724)
T ss_pred eeeccchHhhhhceeEEEeehhhhH---HHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhH
Confidence 3346666322 245565543321 1122333444555666677789999999888777666667899999999999
Q ss_pred chhhhcccc---ccccHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCccceeeccCCCCCCeEEEEecCCcccccCC
Q 001103 967 LRHVLARKD---RILDRRKKLMLMMDAAFGMEYLHMKN-----IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT 1038 (1157)
Q Consensus 967 L~dlLkr~g---r~L~e~qVlkIa~QLa~ALeYLHSkG-----IIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~ 1038 (1157)
+.+++-+.- ..+....+.....+.+.+..-+|++. .+|++||+-|.+|. .+..+|+.++|+.+...+.
T Consensus 1318 ~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIV----tny~v~~gk~gLdKIknp~ 1393 (2724)
T KOG1826|consen 1318 LFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIV----TNYNVKLGKGGLDKIKNPV 1393 (2724)
T ss_pred HHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhcccee----cCCcccccccccccccCch
Confidence 999886532 23444445444445466777777652 79999999999998 7788999999999843333
Q ss_pred -cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHH
Q 001103 1039 -LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRK 1117 (1157)
Q Consensus 1039 -~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrd 1117 (1157)
.......+++.|++|++.+.- .++.++|+|.+|+.+|++..|..+|...- ...+..++++.....++...|.+...
T Consensus 1394 ~sf~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~rs~~n~~fi~fl-q~~Lkgiidn~tf~sIe~l~pgdaNv 1470 (2724)
T KOG1826|consen 1394 LSFFGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLRSDGNAYFIFFL-QPALKGIIDNHTFFSIEKLKPGDANV 1470 (2724)
T ss_pred HhhhhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHHhcccHHHHHHH-HHHHcCcccccccccccccCCCcccH
Confidence 334556789999999998743 56778999999999999999988875321 22333333333333444444444444
Q ss_pred HHHHHhccCCCCCCCHHHHHH
Q 001103 1118 LMEECWSFNPAARPSFTEITN 1138 (1157)
Q Consensus 1118 LIkrCLqkDPskRPSaeELLe 1138 (1157)
+...+|-+....||.-...+.
T Consensus 1471 e~~~~Ll~K~~~rp~q~isls 1491 (2724)
T KOG1826|consen 1471 EALHRLLWKYMERPGQYISLS 1491 (2724)
T ss_pred HHHHHHHHHhhhcchhhhhcc
Confidence 445555555566666555444
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00096 Score=71.34 Aligned_cols=144 Identities=20% Similarity=0.179 Sum_probs=95.4
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEecccccCCChh--------HHHHHHHHHHHHHHHHhCC------CCceeEEee
Q 001103 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSE--------QEWLIKEFWREAHIISNLH------HPNVVAFYG 945 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e--------~e~likqflrEIkILK~L~------HPNIVkLyg 945 (1157)
...||+|+.-.||.--.+ ....||++.......+... ......+..+|+.....+. +..|.++||
T Consensus 6 ~~~i~~G~~R~cy~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 356999999999964433 3467898877641111000 0111345667777666665 889999999
Q ss_pred eeecCCCCcEEEEEEeecC------CcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCC
Q 001103 946 VVPNGPGGTMATVTEYMVN------GSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeG------GSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~ 1019 (1157)
+.++ .....+|+|.+.. .+|.+++++.. ++. .... .+-.-.+||-+.+|+.+||+|.||++...+.
T Consensus 85 ~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 85 FVET--NLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEec--CCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 9988 4467889998754 25777775433 444 3322 3334467889999999999999999986654
Q ss_pred CCCeEEEEe-cCCc
Q 001103 1020 QRPICKVGD-FGLS 1032 (1157)
Q Consensus 1020 e~g~VKLiD-FGLA 1032 (1157)
....+.|+| ||..
T Consensus 157 ~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 157 GEFRLVLIDGLGEK 170 (199)
T ss_pred CceEEEEEeCCCCc
Confidence 444788887 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0011 Score=83.57 Aligned_cols=82 Identities=16% Similarity=0.262 Sum_probs=56.6
Q ss_pred EEEEecccCcEEEEEEEECC----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCce--eEEeeeeecCC
Q 001103 879 ELQELGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNV--VAFYGVVPNGP 951 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kG----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNI--VkLygvf~de~ 951 (1157)
.++.|+.|.+..+|+....+ ..+++|+........ ....+.+|.++|+.|. |+++ ++++.++.+..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~ 114 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS 114 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence 46889999999999987754 357777654321111 0235778999999995 6654 78887765532
Q ss_pred -CCcEEEEEEeecCCcc
Q 001103 952 -GGTMATVTEYMVNGSL 967 (1157)
Q Consensus 952 -~~~LyLVMEYmeGGSL 967 (1157)
.+..|+||||++|..+
T Consensus 115 v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 115 VIGTAFYIMEYLEGRIF 131 (822)
T ss_pred cCCCceEEEEecCCccc
Confidence 2467899999998654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00025 Score=90.44 Aligned_cols=204 Identities=18% Similarity=0.178 Sum_probs=141.4
Q ss_pred HHHHHHHHHHHHhCCCCceeEEeeeeecCC-CC-cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH
Q 001103 922 IKEFWREAHIISNLHHPNVVAFYGVVPNGP-GG-TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM 999 (1157)
Q Consensus 922 ikqflrEIkILK~L~HPNIVkLygvf~de~-~~-~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS 999 (1157)
+....-|+..+.++.|+|++.++.+-.... .+ .+.+..++|..-++...+...+ ..+....+.+..+++.||.|+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHH
Confidence 444556788889999999999998865432 12 2334557777778877775443 47888888899999999999999
Q ss_pred CCceeccCCcc---ceeeccCCCCCCeEEEE--ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHH
Q 001103 1000 KNIVHFDLKCD---NLLVNLRDPQRPICKVG--DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074 (1157)
Q Consensus 1000 kGIIHRDLKPE---NILLd~dd~e~g~VKLi--DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGV 1074 (1157)
....|.-|... +-..+ ..+.+.++ ||+.++............-+..|.+||.........+...|+|.+|.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~----~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVD----GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred hccceeEEecccccccccC----ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 96555544433 22222 45566666 89888766665555556677788999988755444455579999999
Q ss_pred HHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1075 AMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1075 ILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
.+..+..|..+-... .....+ .+......+.+++.+|+..++++|+++.+++.+.-
T Consensus 381 l~~~~~~~~~i~~~~---~~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS---AVPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HHhhhhhcCcccccc---cchhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 999999876542211 111111 12222226788999999999999999999998754
|
|
| >cd06408 PB1_NoxR The PB1 domain is present in the Epichloe festucae NoxR protein (NADPH oxidase regulator), a key regulator of NADPH oxidase isoform, NoxA | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00054 Score=64.77 Aligned_cols=72 Identities=21% Similarity=0.354 Sum_probs=59.7
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcC--CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCC--CCeEEEEE
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICN--QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGG--SQRLRIFL 283 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~--~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~--~~rlR~FL 283 (1157)
+|++|++.||.+|+|.+|..|+.+.|+ ..++|||+ .| ...|++++++||+-.+.-+....+..+ -+|+-+.+
T Consensus 10 ~~Dv~~i~v~~~i~f~dL~~kIrdkf~~~~~~~iKyk--DE--GD~iti~sq~DLd~Ai~~a~~~~~~~~~~~~~~e~w~ 85 (86)
T cd06408 10 QDDTRYIMIGPDTGFADFEDKIRDKFGFKRRLKIKMK--DD--GDMITMGDQDDLDMAIDTARSEARKQGSDMGKLEIWV 85 (86)
T ss_pred cCcEEEEEcCCCCCHHHHHHHHHHHhCCCCceEEEEE--cC--CCCccccCHHHHHHHHHHHHHHHHhhcccccceeeec
Confidence 788999999999999999999999998 57899999 44 799999999999999988765444333 26766654
|
NoxA is essential for growth control of the fungal endophyte in plant tissue in the process of symbiotic interaction between a fungi and its plant host. The Epichloe festucae p67(phox)-like regulator, NoxR, dispensable in culture but essential in plants for the symbiotic interaction. Plants infected with a noxR deletion mutant show severe stunting and premature senescence, whereas hyphae in the meristematic tissues show increased branching leading to increased fungal colonization of pseudostem and leaf blade tissue. The PB1 domain is a modular domain mediating specific protein-protein interactions which a play role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0018 Score=69.02 Aligned_cols=76 Identities=16% Similarity=0.207 Sum_probs=45.5
Q ss_pred EEEecccCcE-EEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC---ceeEEeeeeecCCC-Cc
Q 001103 880 LQELGSGTFG-TVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP---NVVAFYGVVPNGPG-GT 954 (1157)
Q Consensus 880 LrkLGsGsFG-tVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP---NIVkLygvf~de~~-~~ 954 (1157)
++.|+.|+.. .||+. +..+.+|+..... ....+.+|.+++..|... -+++.+......+. ..
T Consensus 2 ~~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~ 68 (235)
T cd05155 2 IEPVDSGGTDNATFRL---GDDMSVRLPSAAG----------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPW 68 (235)
T ss_pred ceeccCCCcccceEEc---CCceEEEcCCccc----------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCc
Confidence 3567766666 58875 3456777543210 124677899998887531 34455544332211 24
Q ss_pred EEEEEEeecCCcch
Q 001103 955 MATVTEYMVNGSLR 968 (1157)
Q Consensus 955 LyLVMEYmeGGSL~ 968 (1157)
.+++|++++|.++.
T Consensus 69 ~~~l~~~i~G~~l~ 82 (235)
T cd05155 69 PWSVYRWLEGETAT 82 (235)
T ss_pred ceEEEEeecCCCCC
Confidence 58899999997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0016 Score=68.76 Aligned_cols=97 Identities=20% Similarity=0.135 Sum_probs=77.7
Q ss_pred HHHHHHHhCCC-CceeEEeeeeecCCCCcEEEEEEeecCCcchhh---hccccccccHHHHHHHHHHHHHHHHHHHH---
Q 001103 927 REAHIISNLHH-PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHV---LARKDRILDRRKKLMLMMDAAFGMEYLHM--- 999 (1157)
Q Consensus 927 rEIkILK~L~H-PNIVkLygvf~de~~~~LyLVMEYmeGGSL~dl---Lkr~gr~L~e~qVlkIa~QLa~ALeYLHS--- 999 (1157)
.|.-+++.+++ +++++++|.+-. +++.||...+++... +.+. ...+|..+.+|+.+++..+++|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 47788888976 699999999855 669999987766432 1111 126889999999999999999997
Q ss_pred CCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1000 kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
..+.-.|++|+|+-++ +++.+|++|...+..
T Consensus 81 ~~~~lcDv~~~nfgv~----~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVN----DDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEe----CCCcEEEEechhcch
Confidence 3577889999999998 677899999997654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0041 Score=65.60 Aligned_cols=73 Identities=16% Similarity=0.218 Sum_probs=47.0
Q ss_pred EEEecccCcEEEEEEEEC---CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCcE
Q 001103 880 LQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~k---Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~L 955 (1157)
++.|..|-...||+.... +..|++|+....... .-...+|+.+++.+. +.-.++++.....
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---------~~d~~~E~~~~~~l~~~gl~P~v~~~~~~------ 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---------IIDRERELRIHKLLSKHGLAPKLYATFQN------ 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---------eecHHHHHHHHHHHHhCCCCCeEEEEeCC------
Confidence 567888999999998875 467888866532110 011236788888774 3334555554322
Q ss_pred EEEEEeecCCcc
Q 001103 956 ATVTEYMVNGSL 967 (1157)
Q Consensus 956 yLVMEYmeGGSL 967 (1157)
.++|||++|.++
T Consensus 68 ~~l~e~i~G~~l 79 (235)
T cd05157 68 GLIYEFIPGRTL 79 (235)
T ss_pred cEEEEeeCCCcC
Confidence 379999999766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd06405 PB1_Mekk2_3 The PB1 domain is present in the two mitogen-activated protein kinase kinases MEKK2 and MEKK3 which are two members of the signaling kinase cascade involved in angiogenesis and early cardiovascular development | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0021 Score=59.39 Aligned_cols=70 Identities=30% Similarity=0.486 Sum_probs=60.5
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcCCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEe
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLF 284 (1157)
-||.||+.++|.+.|.||..|+...+|..+.+-|-.-. -||.+.|.|||+.-|+-.|+. +.-..||+.|-
T Consensus 8 ~gEKRIi~f~RPvkf~dl~~kv~~afGq~mdl~ytn~e----L~iPl~~Q~DLDkAie~ld~s---~~~ksLRilL~ 77 (79)
T cd06405 8 NGEKRIIQFPRPVKFKDLQQKVTTAFGQPMDLHYTNNE----LLIPLKNQEDLDRAIELLDRS---PHMKSLRILLS 77 (79)
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEeccc----EEEeccCHHHHHHHHHHHccC---ccccceeEeEe
Confidence 58999999999999999999999999999999998432 799999999999999999982 22245888775
|
The PB1 domain of MEKK2 (and/or MEKK3) interacts with the PB1 domain of another member of the kinase cascade Map2k5. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, f |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0073 Score=65.15 Aligned_cols=133 Identities=16% Similarity=0.119 Sum_probs=74.6
Q ss_pred ecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCCCCcEEEEEEe
Q 001103 883 LGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN-VVAFYGVVPNGPGGTMATVTEY 961 (1157)
Q Consensus 883 LGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN-IVkLygvf~de~~~~LyLVMEY 961 (1157)
+..|-...+|+....+..+++|+....... .--...+|..+++.+.... .++++.... -++||||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~--------~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKA--------LGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccc--------ccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEe
Confidence 556888899998877778888865432110 0012346778888875322 344544432 2689999
Q ss_pred ecCCcchhh--------------hc---cc---cccccHH-HHHHHHHHH---------HHHHHHHHHC--------Cce
Q 001103 962 MVNGSLRHV--------------LA---RK---DRILDRR-KKLMLMMDA---------AFGMEYLHMK--------NIV 1003 (1157)
Q Consensus 962 meGGSL~dl--------------Lk---r~---gr~L~e~-qVlkIa~QL---------a~ALeYLHSk--------GII 1003 (1157)
++|..+... +. .. +..++.. .+..+..++ ...++.+-.. .++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 998765321 11 10 1111111 111111111 1112222221 489
Q ss_pred eccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 1004 HFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1004 HRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
|+|+.|.|||++ .++ +.|+||..+..
T Consensus 150 H~Dl~~~Nil~~----~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVT----PQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEe----CCC-CEEEeccccCc
Confidence 999999999998 333 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.021 Score=62.54 Aligned_cols=141 Identities=17% Similarity=0.106 Sum_probs=82.6
Q ss_pred eEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC--ceeEEeeeeec----CC
Q 001103 878 EELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP--NVVAFYGVVPN----GP 951 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP--NIVkLygvf~d----e~ 951 (1157)
.-++.|..|....+|+....+..+++|+.... . ...+..|+++++.|.+- .+++.+..... .-
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~ 85 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTDSGRYVLTLFEKV-----S------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSEL 85 (296)
T ss_pred hheecccCccccceEEEEeCCCcEEEEEcCCC-----C------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeee
Confidence 34677888888999998877778999976531 1 13455677777777432 24454432110 11
Q ss_pred CCcEEEEEEeecCCcchh----hhc----------cc--c--------ccccHHHH--H--------HHHHHHHHHHHHH
Q 001103 952 GGTMATVTEYMVNGSLRH----VLA----------RK--D--------RILDRRKK--L--------MLMMDAAFGMEYL 997 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~d----lLk----------r~--g--------r~L~e~qV--l--------kIa~QLa~ALeYL 997 (1157)
.+..++||++++|..+.. .+. .. . ....+... . .....+..++.++
T Consensus 86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 165 (296)
T cd05153 86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQ 165 (296)
T ss_pred CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHH
Confidence 345689999999876532 100 00 0 00010000 0 0111122344555
Q ss_pred HH-------CCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 998 HM-------KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 998 HS-------kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+ .+++|+|+.|.|||++ .+..+.|+||+.+.
T Consensus 166 ~~~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~iIDfe~a~ 204 (296)
T cd05153 166 DAFDPSDLPRGVIHADLFRDNVLFD----GDELSGVIDFYFAC 204 (296)
T ss_pred HhhhhhcCCCcCCccCcCcccEEEe----CCceEEEeehhhhc
Confidence 53 3699999999999998 55567899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.013 Score=64.57 Aligned_cols=74 Identities=19% Similarity=0.345 Sum_probs=46.4
Q ss_pred EEEecccCcEEEEEEEEC--------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC-ceeEEeeeeecC
Q 001103 880 LQELGSGTFGTVYRGKWR--------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP-NVVAFYGVVPNG 950 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~k--------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP-NIVkLygvf~de 950 (1157)
++.|..|-...||+.... +..+++|+....... .....+|.++++.+... -.+++++.+..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC-
Confidence 466777888899988764 367888886543100 12345677777777422 23456655532
Q ss_pred CCCcEEEEEEeecCCcch
Q 001103 951 PGGTMATVTEYMVNGSLR 968 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~ 968 (1157)
.+||||++|..+.
T Consensus 73 -----~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -----GRIEEFIPSRTLT 85 (302)
T ss_pred -----CchhheeCCCcCC
Confidence 3589999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.028 Score=66.19 Aligned_cols=83 Identities=17% Similarity=0.107 Sum_probs=53.1
Q ss_pred EEEEecccCcEEEEEEEECC--ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC---CCceeEEeeeeecCCCC
Q 001103 879 ELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH---HPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kG--t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~---HPNIVkLygvf~de~~~ 953 (1157)
..+.||.|.+..||++...+ +.+.||.-........... .....+...|.+.|+.+. -..++++|.+.. .
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~w-pl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~ 104 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESW-PLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----E 104 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccc-cccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----C
Confidence 45789999999999998854 3799997542211000000 011345566777777762 346788887733 3
Q ss_pred cEEEEEEeecCCc
Q 001103 954 TMATVTEYMVNGS 966 (1157)
Q Consensus 954 ~LyLVMEYmeGGS 966 (1157)
..++||||+++..
T Consensus 105 ~~~lVME~L~~~~ 117 (401)
T PRK09550 105 LAVTVMEDLSDHK 117 (401)
T ss_pred CCEEEEecCCCcc
Confidence 4689999998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.02 Score=63.61 Aligned_cols=143 Identities=17% Similarity=0.129 Sum_probs=81.2
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC--CceeEEeeeee----cC
Q 001103 877 LEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--PNVVAFYGVVP----NG 950 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H--PNIVkLygvf~----de 950 (1157)
...++.++.|....||+.+..+..+.+|+..... . ...+..|.+++..|.. -.+++.+.... ..
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV----K------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCC----C------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 4456778888888999987766678888765421 0 1233456666666632 22444443211 11
Q ss_pred CCCcEEEEEEeecCCcchhh--------------hcccccc----------cc-HHHHH------------HHHHHHHHH
Q 001103 951 PGGTMATVTEYMVNGSLRHV--------------LARKDRI----------LD-RRKKL------------MLMMDAAFG 993 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dl--------------Lkr~gr~----------L~-e~qVl------------kIa~QLa~A 993 (1157)
-.+..+++|+|++|..+... ++..... ++ +.... .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 13467899999998654211 0100000 00 00000 001122334
Q ss_pred HHHHHH-------CCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 994 MEYLHM-------KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 994 LeYLHS-------kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
++++.. .+++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~----~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFD----GDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEE----CCceEEEeeccccc
Confidence 555543 5799999999999998 44567899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.032 Score=61.94 Aligned_cols=78 Identities=9% Similarity=0.021 Sum_probs=44.4
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC--CceeEEeeee----ecCCC
Q 001103 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--PNVVAFYGVV----PNGPG 952 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H--PNIVkLygvf----~de~~ 952 (1157)
.++.|+.|....+|+.+..+..+++|+.... . ...+..|..+++.|.. -.+++.+... ...-.
T Consensus 26 ~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~---~--------~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~ 94 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTTQGEYVLTLFERL---T--------AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELA 94 (319)
T ss_pred ccchhccccccceEEEEeCCCcEEEEEeccC---C--------hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeC
Confidence 3566888888899998876667899976521 0 1222334455555421 1133333211 00113
Q ss_pred CcEEEEEEeecCCcc
Q 001103 953 GTMATVTEYMVNGSL 967 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL 967 (1157)
+..+++|+|++|..+
T Consensus 95 g~~~~l~~~l~G~~~ 109 (319)
T PRK05231 95 GKPAAIVTFLEGKWP 109 (319)
T ss_pred CEEEEEEEecCCCCC
Confidence 457899999998754
|
|
| >cd06404 PB1_aPKC PB1 domain is an essential modular domain of the atypical protein kinase C (aPKC) which in complex with Par6 and Par3 proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.02 Score=54.06 Aligned_cols=72 Identities=26% Similarity=0.450 Sum_probs=58.4
Q ss_pred ecCceEEEEccCCCCHHHHHHHHHhhcC----CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEE
Q 001103 207 VGGETRIISIRKSLTWEELMRKTSAICN----QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIF 282 (1157)
Q Consensus 207 vGG~triv~v~r~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~F 282 (1157)
-+|+-+|..++.+++|.+|..|+..+|. .++++||- .||= -+|++++|++|+.-+..|.... .+-|-+-
T Consensus 7 y~gdi~it~~d~~~s~e~L~~~v~~~c~~~~~q~ft~kw~--DEEG-Dp~tiSS~~EL~EA~rl~~~n~----~~~l~ih 79 (83)
T cd06404 7 YNGDIMITSIDPSISLEELCNEVRDMCRFHNDQPFTLKWI--DEEG-DPCTISSQMELEEAFRLYELNK----DSELNIH 79 (83)
T ss_pred ecCcEEEEEcCCCcCHHHHHHHHHHHhCCCCCCcEEEEEE--CCCC-CceeecCHHHHHHHHHHHHhcC----cccEEEE
Confidence 3667789999999999999999999995 58999998 4333 4799999999988887776643 3467777
Q ss_pred Eee
Q 001103 283 LVS 285 (1157)
Q Consensus 283 LFp 285 (1157)
+||
T Consensus 80 vfp 82 (83)
T cd06404 80 VFP 82 (83)
T ss_pred ecC
Confidence 776
|
PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, |
| >cd06401 PB1_TFG The PB1 domain found in TFG protein, an oncogenic gene product and fusion partner to nerve growth factor tyrosine kinase receptor TrkA and to the tyrosine kinase ALK | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.016 Score=54.54 Aligned_cols=53 Identities=26% Similarity=0.450 Sum_probs=44.1
Q ss_pred cCceEEEEccC-CCCHHHHHHHHHhhcC------CCceEEEeCCCCCCCcEEeecChhHHHHH
Q 001103 208 GGETRIISIRK-SLTWEELMRKTSAICN------QPHTIKYQLPGEDLDALISVCSDEDLHHM 263 (1157)
Q Consensus 208 GG~triv~v~r-~~~f~~l~~kl~~~~~------~~~~lkYqLP~edLD~LisV~~DeDL~~m 263 (1157)
|||.|.+.++. .++|.+|+..+..++. .++.|||.=+. ..||+||+++||.--
T Consensus 8 g~DiR~~~~~~~~~t~~~L~~~v~~~F~~~~~~~~~flIKYkD~d---GDlVTIts~~dL~~A 67 (81)
T cd06401 8 GDDIRRIPIHNEDITYDELLLMMQRVFRGKLGSSDDVLIKYKDED---GDLITIFDSSDLSFA 67 (81)
T ss_pred CCeEEEEeccCccccHHHHHHHHHHHhccccCCcccEEEEEECCC---CCEEEeccHHHHHHH
Confidence 99999999997 5899999999987664 37889998332 358999999999754
|
The PB1 domain is a modular domain mediating specific protein-protein interaction in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The PB1 domains of TFG represent a type I/II PB1 domain. The physiological function of TFG remains unknown. |
| >cd06398 PB1_Joka2 The PB1 domain is present in the Nicotiana plumbaginifolia Joka2 protein which interacts with sulfur stress inducible UP9 protein | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.033 Score=53.30 Aligned_cols=71 Identities=21% Similarity=0.329 Sum_probs=55.3
Q ss_pred cCceEEEEccC-----CCCHHHHHHHHHhhcC----CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCe
Q 001103 208 GGETRIISIRK-----SLTWEELMRKTSAICN----QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQR 278 (1157)
Q Consensus 208 GG~triv~v~r-----~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~r 278 (1157)
||++|-+.++. +++|.+|..|+++.+. ..+.|||. .| =..+|.+++|+||+.-|+...+ .+...-
T Consensus 8 ~~~~rRf~l~~~~~~~d~~~~~L~~kI~~~f~l~~~~~~~l~Y~--De-dgd~V~l~~D~DL~~a~~~~~~---~~~~~~ 81 (91)
T cd06398 8 GGTLRRFTFPVAENQLDLNMDGLREKVEELFSLSPDADLSLTYT--DE-DGDVVTLVDDNDLTDAIQYFCS---GSRLNP 81 (91)
T ss_pred CCEEEEEEeccccccCCCCHHHHHHHHHHHhCCCCCCcEEEEEE--CC-CCCEEEEccHHHHHHHHHHHhc---cCCCce
Confidence 88899999985 7999999999999875 36889998 33 3479999999999988875322 333446
Q ss_pred EEEEEe
Q 001103 279 LRIFLV 284 (1157)
Q Consensus 279 lR~FLF 284 (1157)
||+++-
T Consensus 82 lrl~v~ 87 (91)
T cd06398 82 LRIDVT 87 (91)
T ss_pred EEEEEE
Confidence 888764
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.014 Score=70.29 Aligned_cols=158 Identities=20% Similarity=0.283 Sum_probs=99.0
Q ss_pred HHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCc
Q 001103 923 KEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNI 1002 (1157)
Q Consensus 923 kqflrEIkILK~L~HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGI 1002 (1157)
.++....++++.+.|+++.+++++.... ..+..+|||++. -+|++.++... +- ..++. .+++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~-~Sled~~~~~~--l~-------~~s~~-------~~~~ 88 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYT-MSLEDILKTGN--LK-------DESLL-------AHGV 88 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhhc-cchHHHHHhcc--cc-------hhhhc-------cccc
Confidence 4566778899999999999999887654 456889999994 48988886533 11 11111 2222
Q ss_pred eeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC
Q 001103 1003 VHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082 (1157)
Q Consensus 1003 IHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG 1082 (1157)
.| -|+ ++++| -++ ... |-. ..+|+|||++|.++.++.-|
T Consensus 89 ~~-----~~~-----------~~~td-~~~---t~~--------------~~~-------~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 89 LH-----LNI-----------IYITD-HFL---TKY--------------PSP-------IGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred ce-----ehh-----------hhccc-ccc---ccC--------------CCC-------CCcchhhhhHHHHHHHHHHh
Confidence 22 122 23334 111 000 111 12379999999999999999
Q ss_pred CCCCCCCChhHHHHHhhhcCCCCC----------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001103 1083 EEPYANMHCGAIIGGILSNTLRPQ----------IPERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139 (1157)
Q Consensus 1083 k~PF~g~~~eeil~~Il~~~lrpe----------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~ 1139 (1157)
...|......+....+..-...+. +-..++..+.++.+.|+...|..||...++.++
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~ 194 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKR 194 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcC
Confidence 888776555444444432222111 112356677889999999999999977666553
|
|
| >cd06396 PB1_NBR1 The PB1 domain is an essential part of NBR1 protein, next to BRCA1, a scaffold protein mediating specific protein-protein interaction with both titin protein kinase and with another scaffold protein p62 | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.072 Score=50.24 Aligned_cols=69 Identities=20% Similarity=0.312 Sum_probs=55.4
Q ss_pred cCceEEEEccC--CCCHHHHHHHHHhhcC-CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEe
Q 001103 208 GGETRIISIRK--SLTWEELMRKTSAICN-QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 208 GG~triv~v~r--~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLF 284 (1157)
||+++.+.++. +.+|.+|.+.+++.|+ ..++|||= .| =.--|+++||.||+.-++-|.|. + ..||+|+.
T Consensus 8 ~~d~~rf~~~~~~~~~~~~L~~ev~~rf~l~~f~lKYl--Dd-e~e~v~lssd~eLeE~~rl~~~~----~-~~l~~~v~ 79 (81)
T cd06396 8 NGESQSFLVSDSENTTWASVEAMVKVSFGLNDIQIKYV--DE-ENEEVSVNSQGEYEEALKSAVRQ----G-NLLQMNVY 79 (81)
T ss_pred CCeEEEEEecCCCCCCHHHHHHHHHHHhCCCcceeEEE--cC-CCCEEEEEchhhHHHHHHHHHhC----C-CEEEEEEe
Confidence 56788899988 7799999999999998 57889997 43 34689999999998777766663 2 47888875
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The NBR1 protein contains a type I PB1 domain. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.1 Score=57.29 Aligned_cols=29 Identities=24% Similarity=0.354 Sum_probs=24.5
Q ss_pred CCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 1000 kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+++|+|+.+.|||++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~----~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK----D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe----C-CcEEEEECcccc
Confidence 4799999999999997 3 457899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.11 Score=61.15 Aligned_cols=147 Identities=20% Similarity=0.151 Sum_probs=94.7
Q ss_pred eEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCC-----------------ChhHHHHH-HHHHHHHHHHHhCCCC
Q 001103 878 EELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGR-----------------SSEQEWLI-KEFWREAHIISNLHHP 938 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r-----------------~~e~e~li-kqflrEIkILK~L~HP 938 (1157)
++-..|..|--+-||.+.- .|..+|||+++...+.-+ ....+.++ -....|++-|++|+.-
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788899999998876 688899999876533211 11122222 2345688888888654
Q ss_pred ceeEEeeeeecCCCCcEEEEEEeecCCcch-hhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecc
Q 001103 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLR-HVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNL 1016 (1157)
Q Consensus 939 NIVkLygvf~de~~~~LyLVMEYmeGGSL~-dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~ 1016 (1157)
.|+----+... ...|||+|+.....- -.|+ .-.++...+..+-.+++.-+.-|-+ .++||.||.-=|+|+
T Consensus 227 GIP~PePIlLk----~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-- 298 (520)
T KOG2270|consen 227 GIPCPEPILLK----NHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-- 298 (520)
T ss_pred CCCCCCceeee----cceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE--
Confidence 43311111111 246899999643221 1222 2235555677777777777776654 589999999999999
Q ss_pred CCCCCCeEEEEecCCcccc
Q 001103 1017 RDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 1017 dd~e~g~VKLiDFGLAkl~ 1035 (1157)
..+.+.|+|-+.+...
T Consensus 299 ---hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 ---HDGKLYIIDVSQSVEH 314 (520)
T ss_pred ---ECCEEEEEEccccccC
Confidence 4679999999988643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.019 Score=66.35 Aligned_cols=140 Identities=19% Similarity=0.067 Sum_probs=92.3
Q ss_pred eeEEEEecccCcEEEEEEEE-CCceEEEEEEeccc--ccCCC------------hhHHHHHHHHHHHHHHHHhCC-CC-c
Q 001103 877 LEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSC--FLGRS------------SEQEWLIKEFWREAHIISNLH-HP-N 939 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~--l~~r~------------~e~e~likqflrEIkILK~L~-HP-N 939 (1157)
+.+..+||-|--+-||.+-+ .|++.++|.-+... +..-+ ....--+-...+|...|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 45678999999999999887 48998888532211 10000 000101123467888999884 32 2
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCC
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~ 1019 (1157)
+++-+++ ...++|||++.|..|..+-+-. .... +...+..-+--|-.+|+||+|+.-=||+++
T Consensus 174 VPkpiD~------~RH~Vvmelv~g~Pl~~v~~v~----d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---- 236 (465)
T KOG2268|consen 174 VPKPIDH------NRHCVVMELVDGYPLRQVRHVE----DPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVK---- 236 (465)
T ss_pred CCCcccc------cceeeHHHhhcccceeeeeecC----ChHH---HHHHHHHHHHHHHHcCceecccchheeEEe----
Confidence 4444443 3568999999998887654321 2222 333444445667889999999999999998
Q ss_pred CCCeEEEEecCCcc
Q 001103 1020 QRPICKVGDFGLSR 1033 (1157)
Q Consensus 1020 e~g~VKLiDFGLAk 1033 (1157)
+...++++||-...
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 66789999998654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.17 Score=56.81 Aligned_cols=109 Identities=13% Similarity=0.039 Sum_probs=74.7
Q ss_pred CeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC---CceeEEeeeeecCC-
Q 001103 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH---PNVVAFYGVVPNGP- 951 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H---PNIVkLygvf~de~- 951 (1157)
...-.+.||.|..+.||+....+..+.+|..+... . ...+.+|...|+.|.- ..++++++++....
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~--~--------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFS--T--------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccc--c--------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34456789999999999987755567777743210 0 1467789999988843 46788888765422
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK 1000 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk 1000 (1157)
.+..+||||+++|.++.+.. ........+..+++.+|.-||+.
T Consensus 85 ~g~~~LVmE~i~G~~~~~~~------~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 85 PGPDVLLLERLRGVSVEAPA------RTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred CCCeEEEEeccCCEecCCCC------CCHHHHHHHHHHHHHHHHHHhCC
Confidence 35689999999998886521 12233445566777888888874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.22 Score=55.54 Aligned_cols=31 Identities=19% Similarity=0.336 Sum_probs=24.3
Q ss_pred CceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1001 GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.++|+|+.|.|||++. .....-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~---~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDE---DARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeC---CCCEEEEECcHhccc
Confidence 3899999999999981 133467999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.43 Score=56.86 Aligned_cols=81 Identities=16% Similarity=0.096 Sum_probs=52.1
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC---CCceeEEeeeeecCCCCcE
Q 001103 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH---HPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~---HPNIVkLygvf~de~~~~L 955 (1157)
..+.||.|....||+....+..+.||.-............ ....+...|...|+.+. -..++++|.+..+ ..
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wp-l~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWP-MTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCcccc-CCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CC
Confidence 5788999999999998887777999975532111111000 01233344566666553 3478888888764 45
Q ss_pred EEEEEeecC
Q 001103 956 ATVTEYMVN 964 (1157)
Q Consensus 956 yLVMEYmeG 964 (1157)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 789999977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.36 Score=55.42 Aligned_cols=140 Identities=15% Similarity=0.232 Sum_probs=77.8
Q ss_pred eeEEEEecccCcEEEEEEEEC------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC-CceeEEeeeeec
Q 001103 877 LEELQELGSGTFGTVYRGKWR------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH-PNVVAFYGVVPN 949 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~k------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H-PNIVkLygvf~d 949 (1157)
...+..|-.|-.-.+|+..+. +..|.+|+..... +..+.+ .+|..+++.+.. ---+++++.+..
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--------~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~ 108 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--------ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN 108 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--------Ceeech-HHHHHHHHHHHHcCCCCceEEEECC
Confidence 334556656889999998763 2468888765431 111122 467778877743 333455666533
Q ss_pred CCCCcEEEEEEeecCCcchhh-------h----------ccc---cc--cccHHHHHHHHHH-----------------H
Q 001103 950 GPGGTMATVTEYMVNGSLRHV-------L----------ARK---DR--ILDRRKKLMLMMD-----------------A 990 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dl-------L----------kr~---gr--~L~e~qVlkIa~Q-----------------L 990 (1157)
+ .|++|+++.+|... + ++. +. ...+..+.++..+ +
T Consensus 109 ---g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l 182 (344)
T PLN02236 109 ---G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSL 182 (344)
T ss_pred ---c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHH
Confidence 2 47999988766311 0 010 00 1112222222211 1
Q ss_pred HHHHHHH----H----HCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 991 AFGMEYL----H----MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 991 a~ALeYL----H----SkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
...+..| . ...++|+|+++.|||++. ..+.+.|+||..+..
T Consensus 183 ~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~---~~~~~~lID~Eya~~ 231 (344)
T PLN02236 183 EDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDE---ETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeC---CCCcEEEEeehhccc
Confidence 1112222 2 125899999999999971 246799999998753
|
|
| >cd06397 PB1_UP1 Uncharacterized protein 1 | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.087 Score=49.65 Aligned_cols=56 Identities=27% Similarity=0.380 Sum_probs=45.6
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcCC---CceEEEeCCCCCCCcEEeecChhHHHHHHHH
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICNQ---PHTIKYQLPGEDLDALISVCSDEDLHHMIEE 266 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisV~~DeDL~~m~~e 266 (1157)
||+||=+++++..+|++|.+||..++.- ++.|+|- .||= -+|++++|+||+..+..
T Consensus 8 ~g~~RRf~~~~~pt~~~L~~kl~~Lf~lp~~~~~vtYi--DeD~-D~ITlssd~eL~d~~~~ 66 (82)
T cd06397 8 LGDTRRIVFPDIPTWEALASKLENLYNLPEIKVGVTYI--DNDN-DEITLSSNKELQDFYRL 66 (82)
T ss_pred CCceEEEecCCCccHHHHHHHHHHHhCCChhHeEEEEE--cCCC-CEEEecchHHHHHHHHh
Confidence 5667777799999999999999999863 5889997 4322 68999999999877653
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.5 Score=53.88 Aligned_cols=30 Identities=27% Similarity=0.270 Sum_probs=25.1
Q ss_pred ceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 1002 IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1002 IIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
++|.||-+.|||++. +.+.++|+||..|..
T Consensus 184 ~CHnDl~~~NiL~~~---~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNE---DEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeC---CCCcEEEEcccccCC
Confidence 799999999999971 345799999998753
|
|
| >cd06402 PB1_p62 The PB1 domain is an essential part of p62 scaffold protein (alias sequestosome 1,SQSTM) involved in cell signaling, receptor internalization, and protein turnover | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.26 Score=47.10 Aligned_cols=65 Identities=25% Similarity=0.445 Sum_probs=50.0
Q ss_pred ceEEEEc--cCCCCHHHHHHHHHhhc----CCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEE
Q 001103 210 ETRIISI--RKSLTWEELMRKTSAIC----NQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFL 283 (1157)
Q Consensus 210 ~triv~v--~r~~~f~~l~~kl~~~~----~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FL 283 (1157)
|-|-.++ +.+++|.+|+.++.++| +..++|||. .|| .-||++++||||.--+.... .+-||||+
T Consensus 15 EIRRf~l~~~~~~s~~~L~~~V~~~f~~l~~~~ftlky~--Dee-GDlvtIssdeEL~~A~~~~~-------~~~~RlyI 84 (87)
T cd06402 15 EIRRFAIDEDVSTSYEYLVEKVAAVFPSLRGKNFQLFWK--DEE-GDLVAFSSDEELVMALGSLN-------DDTFRIYI 84 (87)
T ss_pred ceEEEEecCCCCcCHHHHHHHHHHHccccCCCcEEEEEE--CCC-CCEEeecCHHHHHHHHHcCC-------CCcEEEEE
Confidence 5677777 44569999999999998 458999998 333 35899999999987766432 36799987
Q ss_pred e
Q 001103 284 V 284 (1157)
Q Consensus 284 F 284 (1157)
=
T Consensus 85 ~ 85 (87)
T cd06402 85 K 85 (87)
T ss_pred E
Confidence 3
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.20 E-value=0.29 Score=57.39 Aligned_cols=79 Identities=15% Similarity=0.097 Sum_probs=46.9
Q ss_pred EecccCcEEEEEEEECC--ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--CC-ceeEEeeeeecCCCCcEE
Q 001103 882 ELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--HP-NVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 882 kLGsGsFGtVYlAr~kG--t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--HP-NIVkLygvf~de~~~~Ly 956 (1157)
+||.|....||++...+ +.+.||.-........... .....+..-|...|+... -| .++++|.+-.+ ...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~w-pl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e----~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESW-PLTLDRARIESSALIRQGEHVPHLVPRIFHFDTE----MAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCC-CCCccHHHHHHHHHHHhhccCccccCeEEEEccc----cce
Confidence 58999999999998854 4699996442211100000 001233445667776653 23 56777776333 456
Q ss_pred EEEEeecCC
Q 001103 957 TVTEYMVNG 965 (1157)
Q Consensus 957 LVMEYmeGG 965 (1157)
+|||+++..
T Consensus 77 ~vMEdL~~~ 85 (370)
T TIGR01767 77 TVMEDLSHH 85 (370)
T ss_pred ehHhhCccc
Confidence 899998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1157 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-43 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-42 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-40 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-39 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-39 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-31 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-31 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-31 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-31 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-31 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-31 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-31 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-31 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-31 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-31 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-31 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-30 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-30 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-30 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-30 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-30 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-30 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-30 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-30 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-30 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-30 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-30 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-30 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-30 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-30 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-30 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-30 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-29 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-29 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-29 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-29 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-29 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-29 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-29 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-29 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-29 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-29 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-29 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-29 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-29 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-29 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-29 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-29 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-29 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-28 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-28 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-28 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-28 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-28 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-28 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-28 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-28 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-28 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-28 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-28 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-28 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-28 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-27 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-27 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-27 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-27 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-27 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-27 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-27 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-27 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-27 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-27 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-27 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-27 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-27 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-27 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-27 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-27 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-27 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-27 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-27 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-27 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-27 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-27 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-27 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-27 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-27 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-27 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-26 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-26 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-26 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-26 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-25 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-25 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-25 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-25 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-25 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-25 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-25 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-25 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-25 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-25 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-25 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-25 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-25 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-25 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-25 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-24 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-24 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-24 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-24 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-23 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-23 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-23 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-23 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-23 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-23 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-23 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-23 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-23 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-23 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-23 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-23 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-22 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-22 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-22 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-22 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-21 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-21 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-21 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-21 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-21 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-21 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-21 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-21 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-21 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-21 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-21 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-21 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-21 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-20 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-20 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-20 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-20 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-20 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-20 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-20 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-20 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-20 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-20 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-20 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-20 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-20 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-20 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-20 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-20 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-20 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-20 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-20 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-20 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-20 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-20 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-20 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-20 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-20 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-20 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-19 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-19 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-19 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-19 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-18 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-18 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-18 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-18 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-18 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-18 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-18 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-17 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-15 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-15 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-15 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-15 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-15 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-13 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-04 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-122
Identities = 106/294 (36%), Positives = 153/294 (52%), Gaps = 14/294 (4%)
Query: 857 AAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGR 914
AM E L + D+++E +++G G FG V++G+ + +AIK + G
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 915 SSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK 974
+ E +EF RE I+SNL+HPN+V YG++ N P V E++ G L H L K
Sbjct: 61 TEMIE-KFQEFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDK 115
Query: 975 DRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPIC-KVGDFGL 1031
+ KL LM+D A G+EY+ +N IVH DL+ N+ + D P+C KV DFGL
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
S+ ++ G+ G WMAPE + +EK D YSF + ++ I+TGE P+
Sbjct: 176 SQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233
Query: 1092 G--AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
G I I LRP IPE C P R ++E CWS +P RP F+ I L +
Sbjct: 234 GKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-119
Identities = 92/279 (32%), Positives = 140/279 (50%), Gaps = 18/279 (6%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
I ++L + +G G FG VYR W G ++A+K + + I+ +EA +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH----DPDEDISQTIENVRQEAKL 59
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ L HPN++A GV P + V E+ G L VL+ K + + + A
Sbjct: 60 FAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIA 115
Query: 992 FGMEYLHMKN---IVHFDLKCDNLLVN----LRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
GM YLH + I+H DLK N+L+ D I K+ DFGL+R T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104
G WMAPE++ S S+ DV+S+G+ +WE++TGE P+ + A+ G+ N L
Sbjct: 176 -GAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
IP C + KLME+CW+ +P +RPSFT I ++L +
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-118
Identities = 106/284 (37%), Positives = 159/284 (55%), Gaps = 19/284 (6%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
I DL +++G+G+FGTV+R +W G+D+A+K + + F + EF RE I
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE------RVNEFLREVAI 87
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD--RILDRRKKLMLMMD 989
+ L HPN+V F G V P ++ VTEY+ GSL +L + LD R++L + D
Sbjct: 88 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 990 AAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG-GVRG 1046
A GM YLH +N IVH +LK NLLV+ ++ KV DFGLSR+K +T +S G
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106
T WMAPE+L +EK DVYSFG+ +WE+ T ++P+ N++ ++ + R +
Sbjct: 202 TPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150
IP +P+ ++E CW+ P RPSF I + LR + +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 362 bits (931), Expect = e-117
Identities = 72/277 (25%), Positives = 120/277 (43%), Gaps = 18/277 (6%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
I L L +L G +++G+W+G DI +K +K + R ++F E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR------KSRDFNEECPR 60
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARKDRILDRRKKLMLMMDA 990
+ HPNV+ G + P +T +M GSL +VL + ++D+ + + +D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 991 AFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTL 1048
A GM +LH I L +++++ ++ + S G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----ARISMADVKFSF----QSPGRMYAP 172
Query: 1049 PWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
W+APE L + D++SF + +WE++T E P+A++ I + LRP I
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
P P KLM+ C + +PA RP F I L M
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-111
Identities = 87/281 (30%), Positives = 145/281 (51%), Gaps = 22/281 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
I D + Q +GSG+FGTVY+GKW G D+A+K + + + ++ F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT------APTPQQLQAFKNEVGV 73
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ H N++ F G +A VT++ SL H L + + +K + + A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS---GGVRGTL 1048
GM+YLH K+I+H DLK +N+ ++ + K+GDFGL+ K S + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 1049 PWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-GAIIGGILSNTLRP- 1105
WMAPE++ +N S + DVY+FGI ++E++TG+ PY+N++ II + +L P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 1106 --QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
++ C ++LM EC RPSF I + ++
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-109
Identities = 78/321 (24%), Positives = 123/321 (38%), Gaps = 35/321 (10%)
Query: 836 PDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGK 895
P+ + + S + + E + I LE + +G G FG VY G+
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWD--------IPFEQLEIGELIGKGRFGQVYHGR 53
Query: 896 WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955
W G ++AI+ I + E +K F RE H NVV F G + P +
Sbjct: 54 WHG-EVAIRLIDIE------RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--HL 104
Query: 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVN 1015
A +T +L V+ +LD K + + GM YLH K I+H DLK N+ +
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD 164
Query: 1016 LRDPQRPICKVGDFGLSRIKCNTLVSG------GVRGTLPWMAPELLNGS-------NNR 1062
+ DFGL I G L +APE++
Sbjct: 165 NGK-----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 1063 VSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEEC 1122
S+ DV++ G +E+ E P+ AII + + E ++ C
Sbjct: 220 FSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
Query: 1123 WSFNPAARPSFTEITNRLRVM 1143
W+F RP+FT++ + L +
Sbjct: 280 WAFEQEERPTFTKLMDMLEKL 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-109
Identities = 89/286 (31%), Positives = 135/286 (47%), Gaps = 27/286 (9%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
L +I ++E + +G G FG V + KWR D+AIK+I+ E K F E
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE----------SESERKAFIVE 51
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI--LDRRKKLML 986
+S ++HPN+V YG N + V EY GSL +VL + + +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 987 MMDAAFGMEYLH---MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG 1043
+ + G+ YLH K ++H DLK NLL+ + K+ DFG + + +
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLL---VAGGTVLKICDFGTACDIQTHMTNN- 163
Query: 1044 VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI-IGGILSNT 1102
+G+ WMAPE+ GS SEK DV+S+GI +WE+IT +P+ + A I + N
Sbjct: 164 -KGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148
RP + + LM CWS +P+ RPS EI + +
Sbjct: 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 9e-95
Identities = 85/323 (26%), Positives = 132/323 (40%), Gaps = 58/323 (17%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
+Q ++ ++++G G +G V+ GKWRG +A+K + ++RE
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE-----------ASWFRE 79
Query: 929 AHI--ISNLHHPNVVAFYGVVPNGPGGT--MATVTEYMVNGSLRHVLARKDRILDRRKKL 984
I + H N++ F G G + +T+Y NGSL L K LD + L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSML 137
Query: 985 MLMMDAAFGMEYLHMKN--------IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK- 1035
L + G+ +LH + I H DLK N+LV + C + D GL+
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVKFI 193
Query: 1036 ----CNTLVSGGVRGTLPWMAPELLNGSNNRVS----EKVDVYSFGIAMWEIITGEE--- 1084
+ GT +M PE+L+ S NR D+YSFG+ +WE+
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
Query: 1085 -------PYANM-----HCGAIIGGILSNTLRPQIPER-----CDPEWRKLMEECWSFNP 1127
PY ++ + + LRP P R C + KLM ECW+ NP
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 1128 AARPSFTEITNRLRVMSTALQTK 1150
A+R + + L MS + K
Sbjct: 314 ASRLTALRVKKTLAKMSESQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 5e-93
Identities = 85/296 (28%), Positives = 126/296 (42%), Gaps = 34/296 (11%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
I + SDL + LG G FG + R T + +K + + E + + F +E
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQ---RTFLKE 57
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
++ L HPNV+ F GV+ + +TEY+ G+LR ++ D +++
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---------- 1038
D A GM YLH NI+H DL N LV + V DFGL+R+ +
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 1039 -----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG- 1092
V G WMAPE++NG EKVDV+SFGI + EII +
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148
G + L P C P + + C +P RPSF ++ + L + L
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 9e-85
Identities = 91/362 (25%), Positives = 139/362 (38%), Gaps = 70/362 (19%)
Query: 836 PDSDHEDVRGDGREVDE------SISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFG 889
P D + D S S + + + Q + + +G G FG
Sbjct: 3 PSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLV------QRTIARTIVLQESIGKGRFG 56
Query: 890 TVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI--ISNLHHPNVVAFYGVV 947
V+RGKWRG ++A+K S +E + ++REA I L H N++ F
Sbjct: 57 EVWRGKWRGEEVAVKIFS--------SREE---RSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 948 --PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK----- 1000
NG + V++Y +GSL L + + L + A G+ +LHM+
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 1001 ---NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT-----LVSGGVRGTLPWMA 1052
I H DLK N+LV + C + D GL+ + + GT +MA
Sbjct: 164 GKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 1053 PELLNGSNN----RVSEKVDVYSFGIAMWEIITGEE----------PYANM-----HCGA 1093
PE+L+ S N ++ D+Y+ G+ WEI PY ++
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 1094 IIGGILSNTLRPQIPER-----CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148
+ + LRP IP R K+M ECW N AAR + I L +S
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339
Query: 1149 TK 1150
K
Sbjct: 340 IK 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 2e-80
Identities = 76/307 (24%), Positives = 131/307 (42%), Gaps = 54/307 (17%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
D+ L+ +G G +G V+RG W+G ++A+K E+ W +E E + L
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR------DEKSWF-RE--TELYNTVML 59
Query: 936 HHPNVVAFYGVVPNGPGGT--MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
H N++ F + + +T Y GSL L + LD L +++ A G
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASG 117
Query: 994 MEYLHMK--------NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT-----LV 1040
+ +LH++ I H DLK N+LV + C + D GL+ + + +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVK----KNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 1041 SGGVRGTLPWMAPELLNGSNN----RVSEKVDVYSFGIAMWEIITGEE----------PY 1086
+ GT +MAPE+L+ + ++VD+++FG+ +WE+ P+
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 1087 ANMHCGA-----IIGGILSNTLRPQIPER-----CDPEWRKLMEECWSFNPAARPSFTEI 1136
++ + + + RP IP R KLM+ECW NP+AR + I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 1137 TNRLRVM 1143
L +
Sbjct: 294 KKTLTKI 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 7e-71
Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 27/285 (9%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLI 922
L+I+K+++ ++++ LGSG FGTVY+G W +AIK ++++ +S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPKAN-- 61
Query: 923 KEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
KE EA++++++ +P+V G+ + +T+ M G L + + +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS 1041
L + A GM YL + +VH DL N+LV K+ DFGL++ +
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 1042 GGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
G +P WMA E + + + + DV+S+G+ +WE++T G +PY + I I
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 231
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
L R P C + +M +CW + +RP F E+ M
Sbjct: 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-70
Identities = 87/278 (31%), Positives = 130/278 (46%), Gaps = 22/278 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+ DL +++G G FG V+ G+ R T +A+K +++ + +F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----PPDL---KAKFLQEA 163
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
I+ HPN+V GV + V E + G L + L + L ++ D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGTL 1048
AA GMEYL K +H DL N LV ++ + K+ DFG+SR + G +
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQV 277
Query: 1049 P--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105
P W APE LN R S + DV+SFGI +WE + G PY N+ + R
Sbjct: 278 PVKWTAPEALN--YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRL 334
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
PE C +LME+CW++ P RPSF+ I L+ +
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 6e-69
Identities = 64/314 (20%), Positives = 115/314 (36%), Gaps = 58/314 (18%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ L+ L+ G FG V++ + +A+K +Q W + E +
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKI------FPIQDKQSW---QNEYEVYS 71
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMAT--VTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
+ + H N++ F G G + +T + GSL L K ++ + +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129
Query: 990 AAFGMEYLHMK----------NIVHFDLKCDNLLV--NLRDPQRPICKVGDFGLSRIKC- 1036
A G+ YLH I H D+K N+L+ NL + DFGL+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT------ACIADFGLALKFEA 183
Query: 1037 --NTLVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
+ + G GT +MAPE+L G+ ++D+Y+ G+ +WE+ +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 1092 G----------------AIIGGILSNTLRPQIPERCDPE-----WRKLMEECWSFNPAAR 1130
+ ++ RP + + + +EECW + AR
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 1131 PSFTEITNRLRVMS 1144
S + R+ M
Sbjct: 304 LSAGCVGERITQMQ 317
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-68
Identities = 84/283 (29%), Positives = 127/283 (44%), Gaps = 25/283 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
I D+ + LG G FG VY G + ++A+K KK + ++F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-----CTLDNK--EKFM 61
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
EA I+ NL HP++V G++ P + E G L H L R L ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG 1046
+ M YL N VH D+ N+LV + K+GDFGLSR +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 1047 TLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
LP WM+PE +N R + DV+ F + MWEI++ G++P+ + +IG +
Sbjct: 175 RLPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
P+ P+ C P LM CW ++P+ RP FTE+ L +
Sbjct: 233 LPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-68
Identities = 86/284 (30%), Positives = 127/284 (44%), Gaps = 24/284 (8%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEF 925
+I + DL L++LG G+FG V RG+W +A+K +K Q + +F
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD-----VLSQPEAMDDF 68
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
RE + + +L H N++ YGVV P M VTE GSL L +
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT----LVS 1041
+ A GM YL K +H DL NLL+ RD + K+GDFGL R ++
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQ 181
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100
+ W APE L S D + FG+ +WE+ T G+EP+ ++ I+ I
Sbjct: 182 EHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
R PE C + +M +CW+ P RP+F + + L
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-67
Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 25/283 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
I+ +E + +G G FG V++G + +AIK K S ++F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVR---EKFL 64
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
+EA + HP++V GV+ P + + E G LR L + LD ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG 1046
+ + YL K VH D+ N+LV+ D K+GDFGLSR ++ +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 1047 TLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
LP WMAPE +N R + DV+ FG+ MWEI+ G +P+ + +IG I +
Sbjct: 178 KLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
P P C P LM +CW+++P+ RP FTE+ +L +
Sbjct: 236 LPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 6e-67
Identities = 88/302 (29%), Positives = 129/302 (42%), Gaps = 33/302 (10%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
I + + LG G FG+V + + +A+K +K + + I+EF
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA----DIIASSD--IEEFL 73
Query: 927 REAHIISNLHHPNVVAFYGVV----PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
REA + HP+V GV G + +M +G L L RI +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPF 132
Query: 983 KL----MLMM--DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IK 1035
L ++ D A GMEYL +N +H DL N ++ + V DFGLSR I
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA----EDMTVCVADFGLSRKIY 188
Query: 1036 CNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCG 1092
G LP W+A E L +N + DV++FG+ MWEI+T G+ PYA +
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152
I ++ R + P C E LM +CWS +P RPSFT + L + L
Sbjct: 247 EIYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305
Query: 1153 NH 1154
+
Sbjct: 306 SQ 307
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 9e-67
Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 22/279 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I S+L +QE+GSG FG V+ G W +AIK I++ + +E +F EA
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEE----DFIEEAE 55
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
++ L HP +V YGV + VTE+M +G L L + + L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQA--PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP- 1049
GM YL ++H DL N LV + + KV DFG++R + + P
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 1050 -WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W +PE+ + +R S K DV+SFG+ MWE+ + G+ PY N ++ I + +
Sbjct: 170 KWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK- 226
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
P ++M CW P RP+F+ + +L ++ +
Sbjct: 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-66
Identities = 68/330 (20%), Positives = 113/330 (34%), Gaps = 69/330 (20%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ +L+ L+ +G G +G VY+G +A+K ++ Q ++ E + +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSF------ANRQNFI-NE--KNIYR 60
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
+ + H N+ F V EY NGSL L D L
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAH 118
Query: 989 DAAFGMEYLHM---------KNIVHFDLKCDNLLV--NLRDPQRPICKVGDFGLSRIKCN 1037
G+ YLH I H DL N+LV + C + DFGLS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT------CVISDFGLSMRLTG 172
Query: 1038 TLVSG---------GVRGTLPWMAPELLNGSNN-----RVSEKVDVYSFGIAMWEIITGE 1083
+ GT+ +MAPE+L G+ N ++VD+Y+ G+ WEI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 1084 E-------------PYANMHCGA-----IIGGILSNTLRPQIPERCDP------EWRKLM 1119
+ + + RP+ PE ++ +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 1120 EECWSFNPAARPSFTEITNRLRVMSTALQT 1149
E+CW + AR + R+ + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-66
Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 27/285 (9%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLI 922
L+I+K+++ ++++ LGSG FGTVY+G W +AIK ++++ +S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPKAN-- 61
Query: 923 KEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
KE EA++++++ +P+V G+ + +T+ M G L + + +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVS 1041
L + A GM YL + +VH DL N+LV K+ DFGL++ +
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 1042 GGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
G +P WMA E + + + + DV+S+G+ +WE++T G +PY + I I
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 231
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
L R P C + +M +CW + +RP F E+ M
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-66
Identities = 93/278 (33%), Positives = 133/278 (47%), Gaps = 26/278 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ +L+ LQ +G G FG V G +RG +A+K IK ++ Q F EA +
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQ-----AFLAEASV 67
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM-DA 990
++ L H N+V GV+ GG VTEYM GSL L + R + L+ D
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP- 1049
MEYL N VH DL N+LV+ + + KV DFGL++ S G LP
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTK----EASSTQDTGKLPV 178
Query: 1050 -WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W APE L + S K DV+SFGI +WEI + G PY + ++ +
Sbjct: 179 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA- 235
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145
P+ C P ++M+ CW + A RPSF ++ +L + T
Sbjct: 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-66
Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 27/293 (9%)
Query: 872 IKDSDLE-ELQELGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
+ L E +ELGSG FGTV +G ++ +A+K +K + E
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN----EANDPALK--DELL 66
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
EA+++ L +P +V G+ V E G L L +++R + + + L
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 122
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGV 1044
+ + GM+YL N VH DL N+L+ + K+ DFGLS+
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQT 178
Query: 1045 RGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101
G P W APE +N + S K DV+SFG+ MWE + G++PY M + +
Sbjct: 179 HGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNH 1154
P C E LM CW+++ RP F + RLR + + +H
Sbjct: 237 ERMGC-PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHH 288
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 3e-66
Identities = 90/280 (32%), Positives = 133/280 (47%), Gaps = 24/280 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+ L+ ++ LG+G FG V+ G + G T +A+K +K+ S + F EA+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-----SMSPD----AFLAEAN 60
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM-D 989
++ L H +V Y VV P + +TEYM NGSL L I KL+ M
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+R+ + + P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 1050 --WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
W APE +N + K DV+SFGI + EI+T G PY M +I + R
Sbjct: 174 IKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
P+ C E +LM CW P RP+F + + L TA
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 4e-66
Identities = 81/289 (28%), Positives = 128/289 (44%), Gaps = 26/289 (8%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+ +G G FG VY G++ AIK + + Q+ ++ F RE
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQ--VEAFLREG 73
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ L+HPNV+A G++ G + YM +G L + R + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCN--TLVSGGVRG 1046
A GMEYL + VH DL N +++ + KV DFGL+R I V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 1047 TLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
LP W A E L R + K DV+SFG+ +WE++T G PY ++ + +
Sbjct: 189 RLPVKWTALESLQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152
PQ PE C ++M++CW +PA RP+F + + + +AL
Sbjct: 247 LPQ-PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 4e-66
Identities = 90/273 (32%), Positives = 126/273 (46%), Gaps = 22/273 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I DL L+ELG+G FG V GKWRG D+AIK IK+ S ++ EF EA
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSED----EFIEEAK 71
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
++ NL H +V YGV + +TEYM NG L + L ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP- 1049
MEYL K +H DL N LVN + + KV DFGLSR + + V P
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 1050 -WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W PE+L ++ S K D+++FG+ MWEI + G+ PY I +
Sbjct: 186 RWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR- 242
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
P + +M CW RP+F + + +
Sbjct: 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-66
Identities = 88/296 (29%), Positives = 131/296 (44%), Gaps = 34/296 (11%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
I + L + LG G FG+V G + +A+K +K SS++E I+EF
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL----DNSSQRE--IEEFL 84
Query: 927 REAHIISNLHHPNVVAFYGVV----PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
EA + + HPNV+ GV G M + +M G L L R+ K
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM-VILPFMKYGDLHTYL-LYSRLETGPK 142
Query: 983 KL----MLMM--DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IK 1035
+ +L D A GMEYL +N +H DL N ++ V DFGLS+ I
Sbjct: 143 HIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR----DDMTVCVADFGLSKKIY 198
Query: 1036 CNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCG 1092
G +P W+A E L + + K DV++FG+ MWEI T G PY +
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148
+ +L R + PE C E ++M CW +P RP+F+ + +L + +L
Sbjct: 257 EMYDYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 9e-66
Identities = 86/276 (31%), Positives = 133/276 (48%), Gaps = 22/276 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+K ++ L+ELGSG FG V GKW+G D+A+K IK+ S ++ EF++EA
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-----SMSED----EFFQEAQ 55
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
+ L HP +V FYGV + VTEY+ NG L + L + L+ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEY--PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP- 1049
GM +L +H DL N LV+ + KV DFG++R + V P
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVD----RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 1050 -WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W APE+ + + S K DV++FGI MWE+ + G+ PY ++ + R
Sbjct: 170 KWSAPEVFH--YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYR 226
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
P ++M CW P RP+F ++ + + +
Sbjct: 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-65
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 26/287 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
+ + +G G FG VY G A+K + + E + +F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGE--VSQFL 74
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
E I+ + HPNV++ G+ G + V YM +G LR+ + + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT--LVSGG 1043
+ A GM+YL K VH DL N +++ ++ KV DFGL+R + V
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 1044 VRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100
LP WMA E L + + K DV+SFG+ +WE++T G PY +++ I +L
Sbjct: 190 TGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
Query: 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147
Q PE C ++M +CW RPSF+E+ +R+ + +
Sbjct: 248 GRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-65
Identities = 81/308 (26%), Positives = 139/308 (45%), Gaps = 42/308 (13%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
I ++ L+ + +LG G FG+V ++ +A+K+++ S +Q+ ++
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQ---RD 70
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
F RE I+ LH +V + GV ++ V EY+ +G LR L R LD + L
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT---LV 1040
+ GMEYL + VH DL N+LV K+ DFGL++ + + +V
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVE----SEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 1041 SGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHC-----G 1092
G P W APE L+ +N S + DV+SFG+ ++E+ T ++ + G
Sbjct: 187 REP--GQSPIFWYAPESLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 1093 AIIGGILSNTLRPQI--------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
+ L + P C E +LM+ CW+ +P RPSF+ + +L ++
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
Query: 1145 TALQTKRR 1152
+ +
Sbjct: 303 SGSRGCET 310
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 3e-65
Identities = 72/309 (23%), Positives = 126/309 (40%), Gaps = 43/309 (13%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQE 919
I++ DL + LG GTF +++G R T++ +K + K+
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYS 56
Query: 920 WLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD 979
+ F+ A ++S L H ++V YGV G V E++ GSL L + ++
Sbjct: 57 ---ESFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCIN 111
Query: 980 RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR----PICKVGDFGLSRIK 1035
KL + A M +L ++H ++ N+L+ + ++ P K+ D G+S
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT- 170
Query: 1036 CNTLVSGGVRGTLPWMAPELLNGSNNRV-SEKVDVYSFGIAMWEIIT-GEEPYANMHCGA 1093
L ++ +PW+ PE + N + + D +SFG +WEI + G++P + +
Sbjct: 171 --VLPKDILQERIPWVPPECIE--NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 1094 II-----GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148
+ L P E L+ C + P RPSF I L + T
Sbjct: 227 KLQFYEDRHQLP---AP-----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278
Query: 1149 TKRRNHAIR 1157
R +H
Sbjct: 279 VPRGSHHHH 287
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 3e-65
Identities = 86/278 (30%), Positives = 126/278 (45%), Gaps = 26/278 (9%)
Query: 882 ELGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
ELG G FG+V +G +R D+AIK +K+ G +E REA I+ L +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADT---EEMMREAQIMHQLDN 69
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
P +V GV + V E G L L K + L+ + GM+YL
Sbjct: 70 PYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGTLP--WMAP 1053
KN VH DL N+L+ R K+ DFGLS+ ++ + G P W AP
Sbjct: 127 EEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
E +N + S + DV+S+G+ MWE ++ G++PY M ++ I P C
Sbjct: 183 ECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECP 239
Query: 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150
PE LM +CW + RP F + R+R +L +K
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-65
Identities = 77/283 (27%), Positives = 128/283 (45%), Gaps = 27/283 (9%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
I K+++L +L+ LGSG FGTV++G W + IK I+ S Q +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQS--FQA 61
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
I +L H ++V G+ P + VT+Y+ GSL + + L + L
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLL 118
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGG 1043
+ A GM YL +VH +L N+L+ +V DFG++ + +
Sbjct: 119 NWGVQIAKGMYYLEEHGMVHRNLAARNVLLK----SPSQVQVADFGVADLLPPDDKQLLY 174
Query: 1044 VRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100
P WMA E ++ + + + DV+S+G+ +WE++T G EPYA + + +L
Sbjct: 175 SEAKTPIKWMALESIH--FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLE 231
Query: 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
R P+ C + +M +CW + RP+F E+ N M
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-65
Identities = 85/312 (27%), Positives = 130/312 (41%), Gaps = 38/312 (12%)
Query: 855 SDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIK 907
+ A + I L+ + ++ ++ LG G FG VY G+ G +A+K +
Sbjct: 10 PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 908 KSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL 967
+ C SEQ+ +F EA IIS +H N+V GV + E M G L
Sbjct: 70 EVC-----SEQDE--LDFLMEALIISKFNHQNIVRCIGVSLQS--LPRFILMELMAGGDL 120
Query: 968 RHVL------ARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021
+ L + L L + D A G +YL + +H D+ N L+ P R
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180
Query: 1022 PICKVGDFGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWE 1078
+ K+GDFG++R I + G LP WM PE + K D +SFG+ +WE
Sbjct: 181 -VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWE 237
Query: 1079 IIT-GEEPYANMH----CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSF 1133
I + G PY + + G R P+ C ++M +CW P RP+F
Sbjct: 238 IFSLGYMPYPSKSNQEVLEFVTSGG-----RMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 292
Query: 1134 TEITNRLRVMST 1145
I R+ +
Sbjct: 293 AIILERIEYCTQ 304
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 8e-65
Identities = 84/306 (27%), Positives = 134/306 (43%), Gaps = 45/306 (14%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
++ L+ LQ+LG G FG+V ++ +A+K+++ S +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLR----D 57
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
F RE I+ +L H N+V + GV + + + EY+ GSLR L + +D K L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTL---V 1040
GMEYL K +H DL N+LV K+GDFGL++ + + V
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 1041 SGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT----------------G 1082
G P W APE L ++ S DV+SFG+ ++E+ T G
Sbjct: 174 KEP--GESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
Query: 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142
+ M +I + +N P+ P+ C E +M ECW+ N RPSF ++ R+
Sbjct: 230 NDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 1143 MSTALQ 1148
+ +
Sbjct: 289 IRDNMA 294
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 1e-64
Identities = 83/352 (23%), Positives = 142/352 (40%), Gaps = 26/352 (7%)
Query: 807 SSSSVVPFVQDDVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGI 866
++ ++ D S T V +S ++A
Sbjct: 21 VAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQ 80
Query: 867 YGLQIIKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWL 921
+ + + + +G G FG VY G A+K + + E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGE-- 133
Query: 922 IKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR 981
+ +F E I+ + HPNV++ G+ G + V YM +G LR+ + + +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTVK 192
Query: 982 KKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCN--T 1038
+ + A GM++L K VH DL N +++ ++ KV DFGL+R +
Sbjct: 193 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFD 248
Query: 1039 LVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAII 1095
V LP WMA E L + + K DV+SFG+ +WE++T G PY +++ I
Sbjct: 249 SVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306
Query: 1096 GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147
+L Q PE C ++M +CW RPSF+E+ +R+ + +
Sbjct: 307 VYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-64
Identities = 89/276 (32%), Positives = 131/276 (47%), Gaps = 26/276 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
++ +D+ +LG G +G VY G W+ +A+K +K+ + E E EF +EA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEA 60
Query: 930 HIISNLHHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
++ + HPN+V GV P +TE+M G+L L +R L+ M
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 989 -DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGT 1047
+ MEYL KN +H DL N LV + + KV DFGLSR+ +
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 1048 LP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104
P W APE L N+ S K DV++FG+ +WEI T G PY + + + +
Sbjct: 174 FPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
+ PE C + +LM CW +NP+ RPSF EI
Sbjct: 232 ER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-64
Identities = 85/306 (27%), Positives = 140/306 (45%), Gaps = 45/306 (14%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
++ L+ LQ+LG G FG+V ++ +A+K+++ S +E+ +++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEH--LRD 88
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
F RE I+ +L H N+V + GV + + + EY+ GSLR L + +D K L
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT---LV 1040
GMEYL K +H DL N+LV + K+GDFGL++ + + V
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKV 204
Query: 1041 SGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT----------------G 1082
G P W APE L ++ S DV+SFG+ ++E+ T G
Sbjct: 205 KEP--GESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
Query: 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142
+ M +I + +N P+ P+ C E +M ECW+ N RPSF ++ R+
Sbjct: 261 NDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
Query: 1143 MSTALQ 1148
+ +
Sbjct: 320 IRDQMA 325
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-64
Identities = 91/278 (32%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ +L+ LQ +G G FG V G +RG +A+K IK ++ Q F EA +
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQ-----AFLAEASV 239
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM-DA 990
++ L H N+V GV+ GG VTEYM GSL L + R + L+ D
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP- 1049
MEYL N VH DL N+LV+ + + KV DFGL++ + ++ G LP
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTK-EASSTQDT---GKLPV 350
Query: 1050 -WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W APE L + S K DV+SFGI +WEI + G PY + ++ + +
Sbjct: 351 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145
P+ C P +M+ CW + A RP+F ++ +L + T
Sbjct: 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-64
Identities = 91/280 (32%), Positives = 123/280 (43%), Gaps = 24/280 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I L +LG G FG V+ G W G T +AIK +K + E F +EA
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 231
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM-D 989
++ L H +V Y VV P + VTEYM GSL L + R +L+ M
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
A GM Y+ N VH DL+ N+LV +CKV DFGL+R+ + + P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 1050 --WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
W APE R + K DV+SFGI + E+ T G PY M ++ + R
Sbjct: 345 IKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
P C LM +CW P RP+F + L T+
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 7e-64
Identities = 92/291 (31%), Positives = 131/291 (45%), Gaps = 26/291 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
I+ S + + +GSG G V G+ R +AIK +K + Q ++F
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQR---RDFL 98
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
EA I+ HPN++ GVV G VTEYM NGSL L D + + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGV 1044
+ GM YL VH DL N+LV+ +CKV DFGLSR+
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 1045 RGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101
G +P W APE + S DV+SFG+ MWE++ GE PY NM +I +
Sbjct: 213 GGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152
P P C +LM +CW + A RP F++I + L + + ++ R
Sbjct: 271 YRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-63
Identities = 73/300 (24%), Positives = 127/300 (42%), Gaps = 43/300 (14%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWR------GTDIAIKRIKKSCFLGRSSEQEWLIKE 924
+ L+ +++LG G FG V ++ G +A+K +K S +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----SGGNHI--AD 69
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
+E I+ NL+H N+V + G+ G + + E++ +GSL+ L + ++ +++L
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT---LV 1040
+ GM+YL + VH DL N+LV K+GDFGL++ I+ + V
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTV 185
Query: 1041 SGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT---------------GE 1083
P W APE L ++ DV+SFG+ + E++T
Sbjct: 186 KDD--RDSPVFWYAPECLM--QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 1084 EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+ M ++ + P P C E +LM +CW F P+ R SF + +
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-63
Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 38/295 (12%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
+ ++ ++ LG G FG VY G+ G +A+K + + C SEQ+ +
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LD 120
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL------ARKDRIL 978
F EA IIS +H N+V GV + E M G L+ L + L
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQS--LPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 979 DRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCN 1037
L + D A G +YL + +H D+ N L+ P R + K+GDFG++R I
Sbjct: 179 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRA 237
Query: 1038 TLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMH---- 1090
G LP WM PE + K D +SFG+ +WEI + G PY +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145
+ G R P+ C ++M +CW P RP+F I R+ +
Sbjct: 296 LEFVTSGG-----RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-63
Identities = 93/288 (32%), Positives = 135/288 (46%), Gaps = 31/288 (10%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKEF 925
I S + + +G+G FG VY+G + +AIK +K +E++ +F
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----TEKQR--VDF 93
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
EA I+ H N++ GV+ M +TEYM NG+L L KD + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR----IKCNTLVS 1041
++ A GM+YL N VH DL N+LVN +CKV DFGLSR T +
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 1042 GGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
G G +P W APE ++ + + DV+SFGI MWE++T GE PY + ++ I
Sbjct: 208 SG--GKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
P P C +LM +CW A RP F +I + L + A
Sbjct: 264 NDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 9e-63
Identities = 72/308 (23%), Positives = 128/308 (41%), Gaps = 47/308 (15%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
+ L+++++LG G FG V + +A+K +K + Q
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-----AGPQH--RSG 79
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
+ +E I+ L+H +++ + G + ++ V EY+ GSLR L + I +L
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSI--GLAQL 136
Query: 985 MLMM-DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT---L 1039
+L GM YLH ++ +H DL N+L++ + K+GDFGL++ +
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLD----NDRLVKIGDFGLAKAVPEGHEYYR 192
Query: 1040 VSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT---------------G 1082
V G P W APE L + DV+SFG+ ++E++T
Sbjct: 193 VRED--GDSPVFWYAPECLK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
Query: 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142
M + + P+ P++C E LM+ CW + RP+F + L+
Sbjct: 249 GIAQGQMTVLRLTELLERGERLPR-PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
Query: 1143 MSTALQTK 1150
+ Q +
Sbjct: 308 VHEKYQGQ 315
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-62
Identities = 82/282 (29%), Positives = 131/282 (46%), Gaps = 26/282 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
+ +++ + +G+G FG V G+ + +AIK +K +E++ ++F
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-----TEKQR--RDFL 94
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
EA I+ HPN++ GVV + VTEYM NGSL L + D + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGV 1044
+ A GM+YL VH DL N+L+N +CKV DFGL R+
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILIN----SNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 1045 RGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101
G +P W +PE + + + DV+S+GI +WE+++ GE PY M +I +
Sbjct: 209 GGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
P P C +LM +CW + RP F +I + L +
Sbjct: 267 YRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-62
Identities = 86/280 (30%), Positives = 128/280 (45%), Gaps = 24/280 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I L+ ++LG+G FG V+ + T +A+K +K S E F EA+
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVE----AFLAEAN 235
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM-D 989
++ L H +V + VV P + +TE+M GSL L + KL+
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+R+ + + P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 1050 --WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
W APE +N + K DV+SFGI + EI+T G PY M +I + R
Sbjct: 349 IKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
PE C E +M CW P RP+F I + L TA
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-62
Identities = 89/306 (29%), Positives = 133/306 (43%), Gaps = 53/306 (17%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
IK D+ +ELG G FG V+ + +A+K +K + K+
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAA--RKD 63
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL---------ARKD 975
F REA +++NL H ++V FYGV +G + V EYM +G L L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 976 RILDRRKKL----MLMM--DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029
+ + +L ML + A GM YL ++ VH DL N LV + K+GDF
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGDF 177
Query: 1030 GLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEP 1085
G+SR + G LP WM PE + + + + DV+SFG+ +WEI T G++P
Sbjct: 178 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 1086 YANMHCGAII-----GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
+ + +I G +L + P C E +M CW P R + EI L
Sbjct: 236 WFQLSNTEVIECITQGRVL------ERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
Query: 1141 RVMSTA 1146
+ A
Sbjct: 290 HALGKA 295
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-62
Identities = 85/280 (30%), Positives = 134/280 (47%), Gaps = 25/280 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
I+ +E + +G G FG V++G + +AIK K +S+ ++F
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-----TSDSVR--EKFL 439
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
+EA + HP++V GV+ P + + E G LR L + LD ++
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG 1046
+ + YL K VH D+ N+LV+ D K+GDFGLSR ++ +G
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 552
Query: 1047 TLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
LP WMAPE +N R + DV+ FG+ MWEI+ G +P+ + +IG I +
Sbjct: 553 KLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 610
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
P P C P LM +CW+++P+ RP FTE+ +L +
Sbjct: 611 LPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 6e-62
Identities = 89/281 (31%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
++ +D+ +LG G +G VY G W+ +A+K +K+ + E E EF +EA
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEA 267
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM- 988
++ + HPN+V GV +TE+M G+L L +R L+ M
Sbjct: 268 AVMKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTL 1048
+ MEYL KN +H +L N LV + + KV DFGLSR+ +
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 1049 P--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105
P W APE L N+ S K DV++FG+ +WEI T G PY + + + + R
Sbjct: 382 PIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM 438
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
+ PE C + +LM CW +NP+ RPSF EI M
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-62
Identities = 83/299 (27%), Positives = 124/299 (41%), Gaps = 44/299 (14%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKE 924
I S + ++ELG FG VY+G G +AIK +K +E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLR--EE 58
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--- 981
F EA + + L HPNVV GVV ++ + Y +G L L
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKD--QPLSMIFSYCSHGDLHEFL-VMRSPHSDVGST 115
Query: 982 ------------KKLMLMM-DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028
+ ++ A GMEYL ++VH DL N+LV + K+ D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNVKISD 171
Query: 1029 FGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEE 1084
GL R + LP WMAPE + + S D++S+G+ +WE+ + G +
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 1085 PYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
PY ++ I + + P P+ C LM ECW+ P+ RP F +I +RLR
Sbjct: 230 PYCGYSNQDVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 8e-62
Identities = 87/289 (30%), Positives = 130/289 (44%), Gaps = 40/289 (13%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
+ +ELG G+FG VY G +G T +AIK + ++ S +E EF
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----SMRER--IEFLN 77
Query: 928 EAHIISNLHHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDR---------- 976
EA ++ + +VV GVV P + E M G L+ L R R
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQP---TLVIMELMTRGDLKSYL-RSLRPAMANNPVLA 133
Query: 977 ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IK 1035
K + + + A GM YL+ VH DL N +V + K+GDFG++R I
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDIY 189
Query: 1036 CNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCG 1092
G +G LP WM+PE L + + DV+SFG+ +WEI T E+PY +
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
++ ++ P+ C +LM CW +NP RPSF EI + ++
Sbjct: 248 QVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-61
Identities = 91/280 (32%), Positives = 123/280 (43%), Gaps = 24/280 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I L +LG G FG V+ G W G T +AIK +K + E F +EA
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 314
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM-D 989
++ L H +V Y VV P + VTEYM GSL L + R +L+ M
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
A GM Y+ N VH DL+ N+LV +CKV DFGL+R+ + + P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 1050 --WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106
W APE R + K DV+SFGI + E+ T G PY M ++ + R
Sbjct: 428 IKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
P C LM +CW P RP+F + L T+
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-61
Identities = 88/291 (30%), Positives = 132/291 (45%), Gaps = 26/291 (8%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKE 924
L + +D+ L ELG G FG+V +G +R D+AIK +K+ G +E
Sbjct: 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADT---EE 382
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
REA I+ L +P +V GV + V E G L L K +
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVA 439
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSG 1042
L+ + GM+YL KN VH +L N+L+ R K+ DFGLS+ ++ +
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----YAKISDFGLSKALGADDSYYTA 495
Query: 1043 GVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099
G P W APE +N + S + DV+S+G+ MWE ++ G++PY M ++ I
Sbjct: 496 RSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150
P C PE LM +CW + RP F + R+R +L +K
Sbjct: 554 QGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 6e-61
Identities = 90/299 (30%), Positives = 139/299 (46%), Gaps = 43/299 (14%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+D++ +G G FG V + + + D AIKR+K+ +S+ + ++F E
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH--RDFAGELE 77
Query: 931 IISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR-------- 981
++ L HHPN++ G + G + EY +G+L L RK R+L+
Sbjct: 78 VLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANS 134
Query: 982 -------KKLMLMM-DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
++L+ D A GM+YL K +H DL N+LV + + K+ DFGLSR
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSR 190
Query: 1034 IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMH 1090
+ + G LP WMA E LN + + DV+S+G+ +WEI++ G PY M
Sbjct: 191 GQEVYVKKTM--GRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149
C + + + P CD E LM +CW P RPSF +I L M +T
Sbjct: 247 CAELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-60
Identities = 89/302 (29%), Positives = 131/302 (43%), Gaps = 52/302 (17%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
D+ ELG G FG V+ + +A+K +K++ SE ++F R
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESAR--QDFQR 92
Query: 928 EAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL--------------AR 973
EA +++ L H ++V F+GV G + V EYM +G L L
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEG--RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150
Query: 974 KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
L + L + A GM YL + VH DL N LV Q + K+GDFG+SR
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG----QGLVVKIGDFGMSR 206
Query: 1034 -IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANM 1089
I G R LP WM PE + + + + DV+SFG+ +WEI T G++P+ +
Sbjct: 207 DIYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264
Query: 1090 HCGAII-----GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
I G L + P C PE +M CW P R S ++ RL+ ++
Sbjct: 265 SNTEAIDCITQGREL------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 1145 TA 1146
A
Sbjct: 319 QA 320
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-60
Identities = 80/302 (26%), Positives = 126/302 (41%), Gaps = 47/302 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
L+ + LG G FG V G +A+K +K+ + E +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSE--HRALMS 79
Query: 928 EAHIISNL-HHPNVVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVLARKDR-------- 976
E I+ ++ HH NVV G P GP + + E+ G+L L R R
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 135
Query: 977 --------ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028
L + A GME+L + +H DL N+L++ ++ + K+ D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICD 191
Query: 1029 FGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEE 1084
FGL+R I + LP WMAPE + + + + DV+SFG+ +WEI + G
Sbjct: 192 FGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 1085 PYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
PY + L R + P+ PE + M +CW P+ RP+F+E+ L +
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 1145 TA 1146
A
Sbjct: 310 QA 311
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-59
Identities = 90/308 (29%), Positives = 132/308 (42%), Gaps = 60/308 (19%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
+++E ++++G G FG V++ + G T +A+K +K+ S +F R
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADM--QADFQR 99
Query: 928 EAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL---------------- 971
EA +++ +PN+V GV G M + EYM G L L
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 972 -------ARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024
+ L ++L + A GM YL + VH DL N LV + +
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVV 213
Query: 1025 KVGDFGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
K+ DFGLSR I +P WM PE + NR + + DV+++G+ +WEI +
Sbjct: 214 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFS 271
Query: 1082 -GEEPYANMHCGAII-----GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTE 1135
G +PY M +I G IL PE C E LM CWS PA RPSF
Sbjct: 272 YGLQPYYGMAHEEVIYYVRDGNIL------ACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 1136 ITNRLRVM 1143
I L+ M
Sbjct: 326 IHRILQRM 333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-59
Identities = 81/301 (26%), Positives = 131/301 (43%), Gaps = 52/301 (17%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
+L + LG G FG V + T +A+K +K++ S E +++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSE--LRDLLS 75
Query: 928 EAHIISNLHHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVL--------------- 971
E +++ ++HP+V+ YG +GP + + EY GSLR L
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 972 --------ARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023
+R L + + GM+YL +VH DL N+LV +
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRK 188
Query: 1024 CKVGDFGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEII 1080
K+ DFGLSR + +G +P WMA E L ++ + + DV+SFG+ +WEI+
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIV 246
Query: 1081 T-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139
T G PY + + + + R + P+ C E +LM +CW P RP F +I+
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
Query: 1140 L 1140
L
Sbjct: 306 L 306
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-59
Identities = 77/296 (26%), Positives = 121/296 (40%), Gaps = 47/296 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEF 925
L + LG G FG V + G +A+K +K +E++ + +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKD--LSDL 87
Query: 926 WREAHIISNL-HHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVL------------ 971
E ++ + H N++ G +GP + + EY G+LR L
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 972 ---ARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028
+ + + + A GMEYL + +H DL N+LV + + K+ D
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 200
Query: 1029 FGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEE 1084
FGL+R I G LP WMAPE L + + + DV+SFG+ MWEI T G
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 1085 PYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
PY + + + R P C E +M +CW P+ RP+F ++ L
Sbjct: 259 PYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-59
Identities = 84/297 (28%), Positives = 126/297 (42%), Gaps = 48/297 (16%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
+ L + LG+G FG V G +A+K +K S + E +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTE--REALMS 75
Query: 928 EAHIISNL-HHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDR--------- 976
E ++S L +H N+V G GP +TEY G L + L R+ R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFL-RRKRDSFICSKTS 131
Query: 977 ---ILDRRKKL----MLMM--DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027
+ D L +L A GM +L KN +H DL N+L+ I K+
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT----HGRITKIC 187
Query: 1028 DFGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GE 1083
DFGL+R IK ++ LP WMAPE + N + + DV+S+GI +WE+ + G
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGS 245
Query: 1084 EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
PY M + ++ R PE E +M+ CW +P RP+F +I +
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-58
Identities = 77/296 (26%), Positives = 121/296 (40%), Gaps = 47/296 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEF 925
L + LG G FG V + G +A+K +K +E++ + +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKD--LSDL 133
Query: 926 WREAHIISNL-HHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVL------------ 971
E ++ + H N++ G +GP + + EY G+LR L
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 972 ---ARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028
+ + + + A GMEYL + +H DL N+LV + + K+ D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 246
Query: 1029 FGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEE 1084
FGL+R I G LP WMAPE L + + + DV+SFG+ MWEI T G
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 1085 PYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
PY + + + R P C E +M +CW P+ RP+F ++ L
Sbjct: 305 PYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-57
Identities = 78/296 (26%), Positives = 123/296 (41%), Gaps = 47/296 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEF 925
L + LG G FG V + G T +A+K +K ++E++ + +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKD--LSDL 121
Query: 926 WREAHIISNL-HHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVL------------ 971
E ++ + H N++ G +GP + + EY G+LR L
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 972 ---ARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028
+ L + + A GMEYL K +H DL N+LV + + K+ D
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKIAD 234
Query: 1029 FGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEE 1084
FGL+R I G LP WMAPE L + + + DV+SFG+ +WEI T G
Sbjct: 235 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGS 292
Query: 1085 PYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
PY + + + + P C E +M +CW P+ RP+F ++ L
Sbjct: 293 PYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-57
Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 53/302 (17%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
+LE + LGSG FG V G +A+K +K+ E +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----DSSE--REALMS 97
Query: 928 EAHIISNL-HHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL- 984
E +++ L H N+V G +GP + + EY G L + L R R ++
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYL-RSKREKFSEDEIE 153
Query: 985 --------------------MLMM--DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022
+L A GME+L K+ VH DL N+LV
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HGK 209
Query: 1023 ICKVGDFGLSR-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEI 1079
+ K+ DFGL+R I ++ LP WMAPE L + K DV+S+GI +WEI
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEI 267
Query: 1080 IT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
+ G PY + A ++ N + P E +M+ CW+F+ RPSF +T+
Sbjct: 268 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327
Query: 1139 RL 1140
L
Sbjct: 328 FL 329
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 7e-57
Identities = 79/292 (27%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
++L+ + LG+G FG V G +A+K +K + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADE--KEALMS 98
Query: 928 EAHIISNL-HHPNVVAFYGVV-PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL- 984
E I+S+L H N+V G GP + +TEY G L + L RK R+L+
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 985 ----------MLMM--DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
+L A GM +L KN +H D+ N+L+ + K+GDFGL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT----NGHVAKIGDFGLA 211
Query: 1033 R-IKCNTLVSGGVRGTLP--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYAN 1088
R I ++ LP WMAPE + + + + DV+S+GI +WEI + G PY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269
Query: 1089 MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
+ + ++ + + P +M+ CW+ P RP+F +I + L
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-56
Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 21/262 (8%)
Query: 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
E+G G+F TVY+G ++A ++ + ++ E + F EA ++ L HP
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQ----DRKLTKSE--RQRFKEEAEMLKGLQHP 85
Query: 939 NVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
N+V FY + VTE M +G+L+ L R + + + G+++
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSW-CRQILKGLQF 144
Query: 997 LHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPE 1054
LH + I+H DLKCDN+ + K+GD GL+ +K + V GT +MAPE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAKA-VIGTPEFMAPE 200
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ-IPERCDP 1113
+ + E VDVY+FG+ M E+ T E PY+ A I +++ ++P + P
Sbjct: 201 MYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 1114 EWRKLMEECWSFNPAARPSFTE 1135
E ++++E C N R S +
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKD 279
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 71/261 (27%), Positives = 115/261 (44%), Gaps = 29/261 (11%)
Query: 883 LGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG GT+G VY G IAIK I + R S + E + +L H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRY---SQPLHEEIALHKHLKHKNI 81
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL-------MLMMDAAFG 993
V + G G + E + GSL +L K L ++ +L G
Sbjct: 82 VQYLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-----G 134
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-RIKCNTLVSGGVRGTLPWMA 1052
++YLH IVH D+K DN+L+ + + K+ DFG S R+ + GTL +MA
Sbjct: 135 LKYLHDNQIVHRDIKGDNVLI---NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM-HCGAIIGGILSNTLRPQIPERC 1111
PE+++ + D++S G + E+ TG+ P+ + A + + + P+IPE
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM 251
Query: 1112 DPEWRKLMEECWSFNPAARPS 1132
E + + +C+ +P R
Sbjct: 252 SAEAKAFILKCFEPDPDKRAC 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 41/298 (13%)
Query: 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D +E++ +GSG FG V++ K R G IKR+K + ++ RE +
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------------NEKAEREVKAL 58
Query: 933 SNLHHPNVVAFYG--------------VVPNGPGGTMATVTEYMVNGSLRHVL-ARKDRI 977
+ L H N+V + G + E+ G+L + R+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 978 LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
LD+ L L G++Y+H K +++ DLK N+ + K+GDFGL N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK----QVKIGDFGLVTSLKN 174
Query: 1038 TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGG 1097
+GTL +M+PE ++ + ++VD+Y+ G+ + E++ +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFETS------K 226
Query: 1098 ILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNHA 1155
++ I + D + + L+++ S P RP+ +EI L V + + R+ A
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTA 284
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 62/266 (23%), Positives = 95/266 (35%), Gaps = 22/266 (8%)
Query: 874 DSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ L LG G++G V++ + + A+KR F G L E
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP-FRGPKDRARKL-----AEVGS 109
Query: 932 ISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
+ HP V G G + TE SL+ L + + D
Sbjct: 110 HEKVGQHPCCVRLEQAWEEG--GILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPW 1050
+ +LH + +VH D+K N+ + R CK+GDFGL G +
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLG----PRGRCKLGDFGLLVELGTAGAGEVQEGDPRY 222
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110
MAPELL GS DV+S G+ + E+ E H G + L P+
Sbjct: 223 MAPELLQGSYG---TAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFTAG 276
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEI 1136
E R ++ +P R + +
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-43
Identities = 68/261 (26%), Positives = 110/261 (42%), Gaps = 30/261 (11%)
Query: 881 QELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+G G+FG V+R K G A+K+++ L +E + + L P
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEE--LV-------ACAGLSSP 110
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH 998
+V YG V GP + E + GSL ++ ++ L + L + A G+EYLH
Sbjct: 111 RIVPLYGAVREGP--WVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR------IKCNTLVSGGVRGTLPWMA 1052
+ I+H D+K DN+L+ + DFG + + + L + GT MA
Sbjct: 168 TRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-LRPQIPERC 1111
PE++ G KVD++S M ++ G P+ G + I S +IP C
Sbjct: 225 PEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282
Query: 1112 DPEWRKLMEECWSFNPAARPS 1132
P + ++E P R S
Sbjct: 283 APLTAQAIQEGLRKEPVHRAS 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 43/289 (14%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
+D E +Q LG G FG V+ K + D AIKRI+ +E ++ RE +
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-------NRELAREKVMREVKAL 57
Query: 933 SNLHHPNVVAFYGV----------VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
+ L HP +V ++ P+ P + + +L+ + + I +R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 983 KLML--MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------ 1034
+ L + A +E+LH K ++H DLK N+ + D + KVGDFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEE 173
Query: 1035 -------KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA 1087
G GT +M+PE ++G++ S KVD++S G+ ++E++
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLILFELLYP--FST 229
Query: 1088 NMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
M + + + P + + P ++++ S +P RP I
Sbjct: 230 QMERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
++ EL+++GSG FG+V++ R G AIKR KK G EQ L RE +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNAL-----REVYAH 64
Query: 933 SNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL---ARKDRILDRRKKLMLMM 988
+ L H +VV ++ M EY GSL + R + L++
Sbjct: 65 AVLGQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVN---------------LRDPQRPICKVGDFGLSR 1033
G+ Y+H ++VH D+K N+ ++ + + K+GD G
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 1034 IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN---MH 1090
+ V G ++A E+L + K D+++ + + E N H
Sbjct: 183 RISSPQV---EEGDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
I G L P+IP+ E+ +L++ +P RPS +
Sbjct: 239 --EIRQGRL-----PRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-42
Identities = 61/268 (22%), Positives = 119/268 (44%), Gaps = 29/268 (10%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
LQ++G G+FG K IK I + R S +E +E RE +++N+
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN----ISRMSSKER--EESRREVAVLANM 80
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARKDRILDRRKKLMLMMDAAFGM 994
HPN+V + G++ V +Y G L + A+K + + L + +
Sbjct: 81 KHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLVSGGVRGTL 1048
+++H + I+H D+K N+ + + ++GDFG++R+ + GT
Sbjct: 139 KHVHDRKILHRDIKSQNIFLT----KDGTVQLGDFGIARVLNSTVELARACI-----GTP 189
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
+++PE+ N + K D+++ G ++E+ T + + ++ I+S + P +
Sbjct: 190 YYLSPEICE--NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-VS 246
Query: 1109 ERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ R L+ + + NP RPS I
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 46/292 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
SD EE+ LG G FG V + + AIK+I+ + E++ + E ++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-------EEK--LSTILSEVMLL 56
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMAT-----------VTEYMVNGSLRHVLARKDRILDRR 981
++L+H VV +Y EY NG+L ++ ++ R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 982 KKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS 1041
+ L + Y+H + I+H DLK N+ + D R + K+GDFGL++ +L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV-KIGDFGLAKNVHRSLDI 172
Query: 1042 GGVR---------------GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
+ GT ++A E+L+G+ + +EK+D+YS GI +E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 1087 ANMHCGAIIGGILSNTLR--PQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
I+ + S ++ P + +K++ +P RP +
Sbjct: 232 MERV--NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 60/290 (20%), Positives = 122/290 (42%), Gaps = 31/290 (10%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+++G G F VYR +A+K+++ + + +E ++ L
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIF---DLMDAKA--RADCIKEIDLLKQL 89
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL---ARKDRILDRRKKLMLMMDAAF 992
+HPNV+ +Y + V E G L ++ ++ R++ R +
Sbjct: 90 NHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLVSGGVRG 1046
+E++H + ++H D+K N+ + + K+GD GL R ++LV G
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLV-----G 198
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA--NMHCGAIIGGILSNTLR 1104
T +M+PE ++ N + K D++S G ++E+ + P+ M+ ++ I
Sbjct: 199 TPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256
Query: 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNH 1154
P + E R+L+ C + +P RP T + + + M + +H
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHH 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 70/226 (30%), Positives = 113/226 (50%), Gaps = 33/226 (14%)
Query: 877 LEELQE----------LGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEF 925
L +L+E +G G FG VY+G R G +A+KR S Q I+EF
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR------RTPESSQG--IEEF 82
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR---ILDRRK 982
E +S HP++V+ G M + +YM NG+L+ L D + +
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC---NTL 1039
+L + + AA G+ YLH + I+H D+K N+L++ + + K+ DFG+S+ T
Sbjct: 141 RLEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFGISKKGTELDQTH 196
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP 1085
+S V+GTL ++ PE R++EK DVYSFG+ ++E++
Sbjct: 197 LSTVVKGTLGYIDPEYF--IKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 59/282 (20%), Positives = 108/282 (38%), Gaps = 29/282 (10%)
Query: 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
LG G V+RG+ + G AIK FL Q RE ++ L+H
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-------REFEVLKKLNHK 67
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI--LDRRKKLMLMMDAAFGMEY 996
N+V + + + E+ GSL VL L + L+++ D GM +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-----KCNTLVSGGVRGTLPWM 1051
L IVH ++K N++ + + + + K+ DFG +R + +L GT ++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-----GTEEYL 182
Query: 1052 APELLNGSNNRV------SEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105
P++ + R VD++S G+ + TG P+ ++ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147
+ P +K + P ++ L+V+ T +
Sbjct: 243 K-PSGAISGVQKAENGPIDW-SGDMPVSCSLSRGLQVLLTPV 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 34/278 (12%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E L +G+G++G + + + + K + G +E E + E +++ L
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELD----YGSMTEAE--KQMLVSEVNLLREL 62
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL---ARKDRILDRRKKLMLMMDAAF 992
HPN+V +Y + + T+ V EY G L V+ ++ + LD L +M
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 993 GMEYLHMKN-----IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLVS 1041
++ H ++ ++H DLK N+ ++ + K+GDFGL+RI T V
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101
GT +M+PE +N +EK D++S G ++E+ P+ + G I
Sbjct: 178 ----GTPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 231
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139
R IP R E +++ + RPS EI
Sbjct: 232 KFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 22/207 (10%)
Query: 883 LGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942
+G G FG VY+G T +A+K++ + ++E+ L ++F +E +++ H N+V
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEE--LKQQFDQEIKVMAKCQHENLVE 94
Query: 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR--ILD--RRKKLMLMMDAAFGMEYLH 998
G +G + V YM NGSL L+ D L R K+ AA G+ +LH
Sbjct: 95 LLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ--GAANGINFLH 150
Query: 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLVSGGVRGTLPWMAPEL 1055
+ +H D+K N+L L + K+ DFGL+R T+++ + GT +MAPE
Sbjct: 151 ENHHIHRDIKSANIL--LDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITG 1082
L G ++ K D+YSFG+ + EIITG
Sbjct: 207 LRG---EITPKSDIYSFGVVLLEIITG 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-39
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 24/279 (8%)
Query: 868 GLQIIKDSDLEELQELGSGTFGT-VYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFW 926
+ I+ LG G GT VYRG + D+A+KRI CF
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----------SFAD 65
Query: 927 REAHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
RE ++ HPNV+ ++ + E +L+ + +KD + +
Sbjct: 66 REVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIEL-CAATLQEYVEQKDFAHLGLEPIT 122
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC-KVGDFGLSRI----KCNTLV 1040
L+ G+ +LH NIVH DLK N+L+++ + I + DFGL + + +
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 1041 SGGVRGTLPWMAPELLNGSNN-RVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
GV GT W+APE+L+ + VD++S G + +I+ G P+ +
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
Query: 1099 LSNTL-RPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ +L + D R+L+E+ + +P RPS +
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-38
Identities = 59/282 (20%), Positives = 108/282 (38%), Gaps = 29/282 (10%)
Query: 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
LG G V+RG+ + G AIK FL Q RE ++ L+H
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-------REFEVLKKLNHK 67
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI--LDRRKKLMLMMDAAFGMEY 996
N+V + + + E+ GSL VL L + L+++ D GM +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-----KCNTLVSGGVRGTLPWM 1051
L IVH ++K N++ + + + + K+ DFG +R + +L GT ++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-----GTEEYL 182
Query: 1052 APELLNGSNNRV------SEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105
P++ + R VD++S G+ + TG P+ ++ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147
+ P +K + P ++ L+V+ T +
Sbjct: 243 K-PSGAISGVQKAENGPIDW-SGDMPVSCSLSRGLQVLLTPV 282
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-38
Identities = 72/338 (21%), Positives = 123/338 (36%), Gaps = 75/338 (22%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKS------------------ 909
L+ + LG G FG V G +A+K +K+
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 910 --------CFLGRSSEQE---WLIKEFWREAHIISNLH---------------HPNVVAF 943
LG ++ +I EF + ++ + L +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLAR--------------KDRILDRRKKLMLMMD 989
G +P + ++T + S V + L +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGTL 1048
A GME+L + +H DL N+L++ ++ + K+ DFGL+R I + L
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 1049 P--WMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105
P WMAPE + + + + DV+SFG+ +WEI + G PY + L R
Sbjct: 258 PLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+ P+ PE + M +CW P+ RP+F+E+ L +
Sbjct: 316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 58/282 (20%), Positives = 113/282 (40%), Gaps = 33/282 (11%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDI-AIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+K L+++GSG V++ I AIK + + + E
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE------EADNQTLDSYRNEIA 59
Query: 931 IISNLHHPN--VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLM 987
++ L + ++ Y + V E N L L +K I RK
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 116
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT--LVSGGV 1044
M + +H IVH DLK N L+ + K+ DFG++ ++ +T +V
Sbjct: 117 M--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 1045 RGTLPWMAPELLNGSNN---------RVSEKVDVYSFGIAMWEIITGEEPYANM-HCGAI 1094
GT+ +M PE + ++ ++S K DV+S G ++ + G+ P+ + + +
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ I+ + P+ + + + +++ C +P R S E+
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 58/282 (20%), Positives = 113/282 (40%), Gaps = 33/282 (11%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDI-AIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+K L+++GSG V++ I AIK + + + E
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE------EADNQTLDSYRNEIA 78
Query: 931 IISNLHHPN--VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLM 987
++ L + ++ Y + V E N L L +K I RK
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 135
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT--LVSGGV 1044
M + +H IVH DLK N L+ + K+ DFG++ ++ +T +V
Sbjct: 136 M--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 1045 RGTLPWMAPELLNGSNN---------RVSEKVDVYSFGIAMWEIITGEEPYANM-HCGAI 1094
GT+ +M PE + ++ ++S K DV+S G ++ + G+ P+ + + +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ I+ + P+ + + + +++ C +P R S E+
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 149 bits (376), Expect = 4e-37
Identities = 72/286 (25%), Positives = 112/286 (39%), Gaps = 29/286 (10%)
Query: 880 LQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+ LG+G FG V R + G +AIK+ ++ L + + W E I+ L+H
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWC-----LEIQIMKKLNH 71
Query: 938 PNVVAFYGVVPNGPGGTMAT----VTEYMVNGSLRHVLARKDR--ILDRRKKLMLMMDAA 991
PNVV+ V EY G LR L + + L L+ D +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-----KCNTLVSGGVRG 1046
+ YLH I+H DLK +N+++ + K+ D G ++ C V G
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFV-----G 185
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106
TL ++APELL + + VD +SFG +E ITG P+ G +
Sbjct: 186 TLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 1107 IPERCDPEWR-KLMEECWSFNPAARPSFTEITNRLRVMSTALQTKR 1151
I D K + N + ++ L+ M Q +R
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-37
Identities = 64/291 (21%), Positives = 109/291 (37%), Gaps = 31/291 (10%)
Query: 872 IKDSDLEELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
I + +Q+LG G F V G G A+KRI + + REA
Sbjct: 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQ---REA 77
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMAT--VTEYMVNGSLRHVL---ARKDRILDRRKKL 984
+ +HPN++ G + + G+L + + K L + L
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS--- 1041
L++ G+E +H K H DLK N+L+ + D G C +
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 1042 -------GGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPY-ANMHCG 1092
R T+ + APEL + S+ + E+ DV+S G ++ ++ GE PY G
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+ + N L R +L+ + +P RP + ++L +
Sbjct: 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-37
Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 34/218 (15%)
Query: 883 LGSGTFGTVYRGK-WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941
LG G FG VY+G+ GT +A+KR+K+ G +F E +IS H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE-------LQFQTEVEMISMAVHRNLL 90
Query: 942 AFYG--VVPNGPGGTMATVTEYMVNGSLRHVL---ARKDRILD--RRKKLMLMMDAAFGM 994
G + V YM NGS+ L LD +R+++ L +A G+
Sbjct: 91 RLRGFCM----TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL--GSARGL 144
Query: 995 EYLHMK---NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC--NTLVSGGVRGTLP 1049
YLH I+H D+K N+L L + VGDFGL+++ +T V+ VRGT+
Sbjct: 145 AYLHDHCDPKIIHRDVKAANIL--LDEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 1050 WMAPE-LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
+APE L G + SEK DV+ +G+ + E+ITG+ +
Sbjct: 201 HIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 71/284 (25%), Positives = 126/284 (44%), Gaps = 39/284 (13%)
Query: 870 QIIKDSDLEE----LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIK 923
+ +D D E + ELG G FG VY+ K + T A K I+ + E ++
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--------KSEEELE 61
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKK 983
++ E I++ HP +V G + G + + E+ G++ ++ DR L +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKCN 1037
++ + +LH K I+H DLK N+L+ L ++ DFG+S K +
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG----DIRLADFGVSAKNLKTLQKRD 175
Query: 1038 TLVSGGVRGTLPWMAPELLNGSNNRVS---EKVDVYSFGIAMWEIITGEEPYANMHCGAI 1094
+ + GT WMAPE++ + + K D++S GI + E+ E P+ ++ +
Sbjct: 176 SFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
Query: 1095 IGGILSN---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTE 1135
+ I + TL P + E+R ++ NP RPS +
Sbjct: 231 LLKIAKSDPPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 70/266 (26%), Positives = 127/266 (47%), Gaps = 31/266 (11%)
Query: 878 EELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+L+++G G+FG V++G +AIK I L + ++ I++ +E ++S
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDE---IEDIQQEITVLSQC 77
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
P V +YG + + EY+ GS +L + LD + ++ + G++
Sbjct: 78 DSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLD 133
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKCNTLVSGGVRGTLP 1049
YLH + +H D+K N+L++ + K+ DFG++ +IK NT V GT
Sbjct: 134 YLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPF 184
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109
WMAPE++ + K D++S GI E+ GE P++ +H ++ I N P +
Sbjct: 185 WMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEG 241
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTE 1135
++ +E C + P+ RP+ E
Sbjct: 242 NYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 56/282 (19%), Positives = 111/282 (39%), Gaps = 33/282 (11%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+K L+++GSG V++ AIK + + + E
Sbjct: 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE------EADNQTLDSYRNEIA 106
Query: 931 IISNLHHPN--VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLM 987
++ L + ++ Y + V E N L L +K I RK
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT--LVSGGV 1044
M + +H IVH DLK N L+ + K+ DFG++ ++ +T +V
Sbjct: 164 M--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 1045 RGTLPWMAPELLNGSNN---------RVSEKVDVYSFGIAMWEIITGEEPYANM-HCGAI 1094
G + +M PE + ++ ++S K DV+S G ++ + G+ P+ + + +
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ I+ + P+ + + + +++ C +P R S E+
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 51/288 (17%)
Query: 875 SDLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E + +GSG V + +AIKRI L + + E +E +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTS---MDELLKEIQAM 67
Query: 933 SNLHHPNVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM----- 985
S HHPN+V++Y VV + V + + GS+ ++ + + ++
Sbjct: 68 SQCHHPNIVSYYTSFVV----KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 986 --LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS----------- 1032
++ + G+EYLH +H D+K N+L+ + ++ DFG+S
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLG----EDGSVQIADFGVSAFLATGGDITR 179
Query: 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG 1092
T V GT WMAPE++ K D++SFGI E+ TG PY
Sbjct: 180 NKVRKTFV-----GTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATGAAPYHKYPPM 233
Query: 1093 AIIGGILSN---TLRPQIPERCD-----PEWRKLMEECWSFNPAARPS 1132
++ L N +L + ++ +RK++ C +P RP+
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-36
Identities = 45/229 (19%), Positives = 84/229 (36%), Gaps = 25/229 (10%)
Query: 875 SDLEELQELGSG--TFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
E L +G G TV K G + ++RI L S + + E H
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN----LEACSNEM--VTFLQGELH 78
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL-ARKDRILDRRKKLMLMMD 989
+ +HPN+V + + VT +M GS + ++ ++ ++
Sbjct: 79 VSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKCNTLVSGG 1043
++Y+H VH +K ++L++ + + + +
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 1044 VR--GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090
LPW++PE+L + K D+YS GI E+ G P+ +M
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 30/276 (10%)
Query: 872 IKDSDLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+KD D E++ ELG+G G V++ K G +A K I + + + RE
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-------HLEIKPAIRNQIIREL 82
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ + P +V FYG + G ++ E+M GSL VL + RI + + L +
Sbjct: 83 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSI 138
Query: 990 AAF-GMEYLH-MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG----LSRIKCNTLVSGG 1043
A G+ YL I+H D+K N+LVN R K+ DFG L N+ V
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV--- 191
Query: 1044 VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103
GT +M+PE L G++ S + D++S G+++ E+ G P +
Sbjct: 192 --GTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNR 1139
P + + + E+ +
Sbjct: 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 69/281 (24%), Positives = 123/281 (43%), Gaps = 34/281 (12%)
Query: 872 IKDSDLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
DL++L E+G G +G+V + K G +A+KRI RS+ E K+ +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-------RSTVDEKEQKQLLMDL 71
Query: 930 HII-SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR---KKLM 985
++ + P +V FYG + G E M + S +LD + L
Sbjct: 72 DVVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128
Query: 986 LMMDAAF-GMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG 1043
+ A + +L I+H D+K N+L++ + K+ DFG+S +++
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLCDFGISGQLVDSIAKTR 184
Query: 1044 VRGTLPWMAPELLNGSNNRV--SEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101
G P+MAPE ++ S +R + DV+S GI ++E+ TG PY + + L+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS---VFDQLTQ 241
Query: 1102 TLR---PQIPERCDPEWRKLMEE----CWSFNPAARPSFTE 1135
++ PQ+ + E+ C + + + RP + E
Sbjct: 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 42/282 (14%)
Query: 870 QIIKDSD----LEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIK 923
I+ D +++G G GTVY T +AI+++ L + ++E +I
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIIN 66
Query: 924 EFWREAHIISNLHHPNVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR 981
E ++ +PN+V + +V G + V EY+ GSL V+ + +D
Sbjct: 67 EI----LVMRENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVV--TETCMDEG 116
Query: 982 KKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIK 1035
+ + + +E+LH ++H D+K DN+L+ + K+ DFG + K
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSK 172
Query: 1036 CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII 1095
+T+V GT WMAPE++ KVD++S GI E+I GE PY N + +
Sbjct: 173 RSTMV-----GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
Query: 1096 GGILSNTLRPQI--PERCDPEWRKLMEECWSFNPAARPSFTE 1135
I +N P++ PE+ +R + C + R S E
Sbjct: 226 YLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 30/277 (10%)
Query: 872 IKDSDLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+K DLE + ELG G +G V + G +A+KRI R++ K +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-------RATVNSQEQKRLLMDL 56
Query: 930 HII-SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL----RHVLARKDRILDRRKKL 984
I + P V FYG + G + E M + SL + V+ + I L
Sbjct: 57 DISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFYKQVIDKGQTI--PEDIL 111
Query: 985 MLMMDAAF-GMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG 1042
+ + +E+LH K +++H D+K N+L+N K+ DFG+S + +
Sbjct: 112 GKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVKMCDFGISGYLVDDVAKD 167
Query: 1043 GVRGTLPWMAPELLNGSNNRV--SEKVDVYSFGIAMWEIITGEEPYANM-HCGAIIGGIL 1099
G P+MAPE +N N+ S K D++S GI M E+ PY + + ++
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 1100 SNTLRPQIP-ERCDPEWRKLMEECWSFNPAARPSFTE 1135
PQ+P ++ E+ +C N RP++ E
Sbjct: 228 -EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 64/281 (22%), Positives = 121/281 (43%), Gaps = 40/281 (14%)
Query: 870 QIIKDSD----LEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIK 923
++ D L+ ++G G+ G V + + + +A+K + L + +E L
Sbjct: 36 MVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD----LRKQQRRELLFN 91
Query: 924 EFWREAHIISNLHHPNVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR 981
E I+ + H NVV Y +V G + + E++ G+L ++ L+
Sbjct: 92 EV----VIMRDYQHFNVVEMYKSYLV----GEELWVLMEFLQGGALTDIV--SQVRLNEE 141
Query: 982 KKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIK 1035
+ + + YLH + ++H D+K D++L+ L K+ DFG K
Sbjct: 142 QIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPK 197
Query: 1036 CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII 1095
+LV GT WMAPE+++ S + +VD++S GI + E++ GE PY + +
Sbjct: 198 RKSLV-----GTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250
Query: 1096 GGILSN-TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTE 1135
+ + + + + P R +E +P R + E
Sbjct: 251 KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E ++ +G+GT+G VY+G+ T AIK + + E+E + +E +++
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEI----NMLKKY 77
Query: 936 -HHPNVVAFYG----VVPNGPGGTMATVTEYMVNGSLRHVL-ARKDRILDRRKKLMLMMD 989
HH N+ +YG P G + V E+ GS+ ++ K L + +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKCNTLVSGG 1043
G+ +LH ++H D+K N+L+ + K+ DFG+S + NT +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 1044 VRGTLPWMAPELLNGSNNRVS---EKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS 1100
GT WMAPE++ N + K D++S GI E+ G P +MH + I
Sbjct: 191 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248
Query: 1101 N---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
N L+ ++ +++ +E C N + RP+ ++
Sbjct: 249 NPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQL 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 30/267 (11%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+L+E+G G+FG VY + +AIK++ + G+ S ++W ++ +E + L
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEKW--QDIIKEVRFLQKL 111
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPN + + G T V EY GS +L + L + + A G+
Sbjct: 112 RHPNTIQYRGCYLRE--HTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGTLPWMAP 1053
YLH N++H D+K N+L++ + + K+GDFG + I N+ V GT WMAP
Sbjct: 169 YLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAPANSFV-----GTPYWMAP 219
Query: 1054 ELLNGSNNRV-SEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
E++ + KVDV+S GI E+ + P NM+ + + I N + P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQS 275
Query: 1113 PEWRKLMEE----CWSFNPAARPSFTE 1135
W + C P RP+
Sbjct: 276 GHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-33
Identities = 69/293 (23%), Positives = 116/293 (39%), Gaps = 57/293 (19%)
Query: 881 QELGSGTFGTV-YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI-ISNLHHP 938
+ LG G+ GTV ++G ++G +A+KR+ E + + HP
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----------DIALMEIKLLTESDDHP 69
Query: 939 NVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLM------L 986
NV+ +Y T E N +L+ ++ K+ + K L
Sbjct: 70 NVIRYYCSE--------TTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC---------KVGDFGLSRIKCN 1037
+ A G+ +LH I+H DLK N+LV+ + DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 1038 TLVSGGVR-----GTLPWMAPELLNGSNN-----RVSEKVDVYSFGIAMWEIIT-GEEPY 1086
S GT W APELL SNN R++ +D++S G + I++ G+ P+
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 1087 A--NMHCGAIIGGILS-NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
II GI S + ++ E L+ + +P RP+ ++
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 71/269 (26%), Positives = 127/269 (47%), Gaps = 36/269 (13%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L++LG G++G+VY+ + T +AIK++ E + ++E +E I+
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--------VESD--LQEIIKEISIMQQC 81
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
P+VV +YG + V EY GS+ ++ +++ L + ++ G+E
Sbjct: 82 DSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------RIKCNTLVSGGVRGTLP 1049
YLH +H D+K N+L+N K+ DFG++ K NT++ GT
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVI-----GTPF 190
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---TLRPQ 1106
WMAPE++ + D++S GI E+ G+ PYA++H I I +N T +
Sbjct: 191 WMAPEVIQEIG--YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF--R 246
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTE 1135
PE + +++C +P R + T+
Sbjct: 247 KPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 868 GLQIIKDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWL 921
G++ K +E+ +ELGSG F V + + + T + A K IKK R+S +
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQS--RASRRGVS 58
Query: 922 IKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR- 980
+E RE I+ + H NV+ + V N + + E + G L D + +
Sbjct: 59 REEIEREVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELF------DFLAQKE 110
Query: 981 ----RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036
+ + G+ YLH K I HFDLK +N+++ ++ P K+ DFGL+
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
+ + + GT ++APE++N + + D++S G+
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGV 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 62/277 (22%), Positives = 118/277 (42%), Gaps = 31/277 (11%)
Query: 872 IKDSDLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+ +DLE L E+GSGT G V++ + G IA+K++ R S + K +
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-------RRSGNKEENKRILMDL 74
Query: 930 HII-SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
++ + P +V +G + E M + + + I + L M
Sbjct: 75 DVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPI--PERILGKMT 130
Query: 989 DAAF-GMEYLH-MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG 1046
A + YL ++H D+K N+L++ +R K+ DFG+S + G
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDFGISGRLVDDKAKDRSAG 186
Query: 1047 TLPWMAPELLNGSNNRV---SEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103
+MAPE ++ + + DV+S GI++ E+ TG+ PY N +L+ L
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DFEVLTKVL 243
Query: 1104 RPQIP-----ERCDPEWRKLMEECWSFNPAARPSFTE 1135
+ + P +++ +++C + + RP + +
Sbjct: 244 QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 868 GLQIIKDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWL 921
G++ K +E+ +ELGSG F V + + + T + A K IKK R+S +
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQS--RASRRGVC 58
Query: 922 IKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR- 980
+E RE I+ + HPN++ + V N + + E + G L D + +
Sbjct: 59 REEIEREVSILRQVLHPNIITLHDVYENR--TDVVLILELVSGGELF------DFLAQKE 110
Query: 981 ----RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036
+ + G+ YLH K I HFDLK +N+++ ++ P K+ DFGL+
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
+ + + GT ++APE++N + + D++S G+
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGV 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 36/229 (15%)
Query: 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFL---------GRSSEQEWLIKEFWREAH 930
++ L G F + + A+K+ +KS + +F E
Sbjct: 36 IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKL 984
II+++ + + G+ + + EYM N S+ +
Sbjct: 96 IITDIKNEYCLTCEGI--------ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 985 MLMMDAAF-------GMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036
+ + Y+H KNI H D+K N+L+ D + K+ DFG S
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRV-KLSDFGESEYMV 203
Query: 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP 1085
+ + G RGT +M PE + ++ KVD++S GI ++ + P
Sbjct: 204 DKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 38/267 (14%)
Query: 883 LGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G+F VYR + T ++AIK I K + + +++ E I L HP++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKK-----AMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGM 994
+ Y V E NG + L + + + M GM
Sbjct: 74 LELYNY--------FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLP 1049
YLH I+H DL NLL+ I K+ DFGL+ L + GT
Sbjct: 126 LYLHSHGILHRDLTLSNLLL---TRNMNI-KIADFGLA----TQLKMPHEKHYTLCGTPN 177
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109
+++PE+ S + + DV+S G + ++ G P+ + ++ +P
Sbjct: 178 YISPEIATRSAH--GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MPS 233
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEI 1136
E + L+ + NPA R S + +
Sbjct: 234 FLSIEAKDLIHQLLRRNPADRLSLSSV 260
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 67/269 (24%), Positives = 110/269 (40%), Gaps = 43/269 (15%)
Query: 883 LGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G F + T A K + KS + ++ E I +L H +V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAF 992
V F+G V E SL + R+ + + R L ++
Sbjct: 104 VGFHGF--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG-- 153
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GT 1047
+YLH ++H DLK NL + + + K+GDFGL+ + G R GT
Sbjct: 154 -CQYLHRNRVIHRDLKLGNLFL---NEDLEV-KIGDFGLA----TKVEYDGERKKVLCGT 204
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
++APE+L+ + S +VDV+S G M+ ++ G+ P+ I N I
Sbjct: 205 PNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--I 260
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P+ +P L+++ +P ARP+ E+
Sbjct: 261 PKHINPVAASLIQKMLQTDPTARPTINEL 289
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 67/269 (24%), Positives = 110/269 (40%), Gaps = 43/269 (15%)
Query: 883 LGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G F + T A K + KS + ++ E I +L H +V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAF 992
V F+G V E SL + R+ + + R L ++
Sbjct: 78 VGFHGF--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG-- 127
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-----GT 1047
+YLH ++H DLK NL + + + K+GDFGL+ + G R GT
Sbjct: 128 -CQYLHRNRVIHRDLKLGNLFL---NEDLEV-KIGDFGLA----TKVEYDGERKKVLCGT 178
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
++APE+L+ + S +VDV+S G M+ ++ G+ P+ I N I
Sbjct: 179 PNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--I 234
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P+ +P L+++ +P ARP+ E+
Sbjct: 235 PKHINPVAASLIQKMLQTDPTARPTINEL 263
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 871 IIKDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKE 924
+ + ++++ +ELGSG F V + + + T + A K IKK +SS + ++
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT--KSSRRGVSRED 60
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR---- 980
RE I+ + HPNV+ + V N + + E + G L D + ++
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELF------DFLAEKESLT 112
Query: 981 -RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNT 1038
+ + G+ YLH I HFDLK +N+++ R+ +P K+ DFGL+ I
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 1039 LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
GT ++APE++N + + D++S G+
Sbjct: 173 EFKNIF-GTPEFVAPEIVNY--EPLGLEADMWSIGV 205
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 34/293 (11%), Positives = 70/293 (23%), Gaps = 49/293 (16%)
Query: 882 ELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN 939
L G V+ + A+K + ++ + L +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTM-----GAENSRSELERLHEATFAAARLLGES 123
Query: 940 VVAFYG------------------VVPNGPGGTMATVTEYMV-----NGSLRHVLARKDR 976
PG V Y++ + L + + D
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 977 ILDRRK------KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030
+ R +L L K +VH DNL + +GD
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR----LMLGDVS 239
Query: 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090
+ + + E LN S + ++ + G++++ + P+ +
Sbjct: 240 ALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSF-------NPAARPSFTEI 1136
G + P L + + + R E
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 68/295 (23%), Positives = 122/295 (41%), Gaps = 48/295 (16%)
Query: 858 AMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRS 915
A+AEM + + D + + LG G FG VY + + +A+K + KS
Sbjct: 2 ALAEMPKRKFTI-----DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS-----Q 51
Query: 916 SEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRH 969
E+E + + RE I S+L HPN++ Y + E+ G L
Sbjct: 52 LEKEGVEHQLRREIEIQSHLRHPNILRMYNY--------FHDRKRIYLMLEFAPRGELYK 103
Query: 970 VLARKDRILDR--RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027
L + R ++ + + DA + Y H + ++H D+K +NLL+ + + K+
Sbjct: 104 ELQKHGRFDEQRSATFMEELADA---LHYCHERKVIHRDIKPENLLM---GYKGEL-KIA 156
Query: 1028 DFGLSRIKCNTLVSGGVR----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
DFG S R GTL ++ PE++ G + EKVD++ G+ +E + G
Sbjct: 157 DFGWS-----VHAPSLRRRTMCGTLDYLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGM 209
Query: 1084 EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
P+ + I++ L+ P + L+ + ++P R +
Sbjct: 210 PPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 26/206 (12%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+ LGSG G V R T AI+ I K F S+ + E I+ L+HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 939 NVVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR-------KKLMLMMD 989
++ + V E M G L D+++ + K M
Sbjct: 201 CIIKIKNFFDAED-----YYIVLELMEGGEL------FDKVVGNKRLKEATCKLYFYQM- 248
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
++YLH I+H DLK +N+L++ ++ I K+ DFG S+I T + + GT
Sbjct: 249 -LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPT 306
Query: 1050 WMAPELLNGSNNRV-SEKVDVYSFGI 1074
++APE+L + VD +S G+
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGV 332
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 43/278 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E + LG G FG VY + + + +A+K + K+ E+ + + RE I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQ 63
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKL 984
S+L HPN++ YG + EY G++ L + + ++ +
Sbjct: 64 SHLRHPNILRLYGY--------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+ +A + Y H K ++H D+K +NLL+ + K+ DFG S
Sbjct: 116 TELANA---LSYCHSKRVIHRDIKPENLLL---GSAGEL-KIADFGWS-----VHAPSSR 163
Query: 1045 R----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS 1100
R GTL ++ PE++ G + EKVD++S G+ +E + G+ P+ I
Sbjct: 164 RTDLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221
Query: 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
P+ R L+ NP+ RP E+
Sbjct: 222 VEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-30
Identities = 69/266 (25%), Positives = 110/266 (41%), Gaps = 37/266 (13%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
++LGSG +G V + + T + AIK I+K+ S+ + E ++ L HP
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK------LLEEVAVLKLLDHP 96
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAAFG 993
N++ Y + V E G L D I+ R +++ G
Sbjct: 97 NIMKLYDFFEDK--RNYYLVMECYKGGELF------DEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
+ YLH NIVH DLK +NLL+ ++ I K+ DFGLS + N GT ++AP
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQKKMKERLGTAYYIAP 207
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113
E+L EK DV+S G+ ++ ++ G P+ I+ + P
Sbjct: 208 EVLRKK---YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD-----SP 259
Query: 1114 EWRKLMEECWSF-------NPAARPS 1132
EW+ + E + R S
Sbjct: 260 EWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+ LGSG G V R T AIK I K F S+ + E I+ L+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 939 NVVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK-------KLMLMMD 989
++ + V E M G L D+++ ++ M
Sbjct: 76 CIIKIKNFFDAED-----YYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQML 124
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-----KCNTLVSGGV 1044
A ++YLH I+H DLK +N+L++ ++ I K+ DFG S+I TL
Sbjct: 125 LA--VQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLC---- 177
Query: 1045 RGTLPWMAPELLNGSNNRV-SEKVDVYSFGI 1074
GT ++APE+L + VD +S G+
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 873 KDSDLEEL----QELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFW 926
+++L ++LGSG FG V+ + R + + IK I K RS ++
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD----RSQVPM---EQIE 68
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
E ++ +L HPN++ + V + M V E G L +RI+ + +
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGEL------LERIVSAQARGKA 120
Query: 987 M--MDAAFGM-------EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
+ A M Y H +++VH DLK +N+L P PI K+ DFGL+ + +
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKS 179
Query: 1038 TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
S GT +MAPE+ V+ K D++S G+
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRD---VTFKCDIWSAGV 213
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 875 SDLEEL----QELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWRE 928
S +E+ +ELGSG F V + + +GT + A K IKK SS + +E RE
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL--SSSRRGVSREEIERE 58
Query: 929 AHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKK 983
+I+ + HPN++ + + N + + E + G L D + ++ +
Sbjct: 59 VNILREIRHPNIITLHDIFENK--TDVVLILELVSGGELF------DFLAEKESLTEDEA 110
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSG 1042
+ G+ YLH K I HFDLK +N+++ ++ P K+ DFG++ I+
Sbjct: 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
GT ++APE++N + + D++S G+
Sbjct: 171 IF-GTPEFVAPEIVNY--EPLGLEADMWSIGV 199
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-30
Identities = 71/266 (26%), Positives = 113/266 (42%), Gaps = 36/266 (13%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+ LG G+FG V K + T A+K I K ++ + RE ++ L HP
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLLREVQLLKQLDHP 86
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAAFG 993
N++ Y + G V E G L D I+ R ++ G
Sbjct: 87 NIMKLYEFFEDK--GYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSG 138
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
+ Y+H IVH DLK +NLL+ + I ++ DFGLS + GT ++AP
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113
E+L+G+ EK DV+S G+ ++ +++G P+ GA IL + + P
Sbjct: 198 EVLHGT---YDEKCDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKGKY-TFELP 249
Query: 1114 EWRKLMEECWSF-------NPAARPS 1132
+W+K+ E P+ R S
Sbjct: 250 QWKKVSESAKDLIRKMLTYVPSMRIS 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-30
Identities = 37/286 (12%), Positives = 80/286 (27%), Gaps = 47/286 (16%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKE 924
+ + LG G F VY + +K K + W
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--------NPWEFYI 113
Query: 925 FWREAHIISNLHHPNVVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVLARK----DRIL 978
+ + + FY NG V E G+L + + ++++
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNG----SVLVGELYSYGTLLNAINLYKNTPEKVM 169
Query: 979 DRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC-------KVGDFGL 1031
+ + M + +E +H I+H D+K DN ++ ++ + D G
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 1032 SR----IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA 1087
S T+ + T + E+L+ + ++D + ++ ++ G
Sbjct: 230 SIDMKLFPKGTIFT-AKCETSGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMKV 286
Query: 1088 NMHCGAIIGGILSNTLRPQIPERCDPE-WRKLMEECWSFNPAARPS 1132
G + W + +
Sbjct: 287 KNEGGECK-------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLP 325
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 35/216 (16%)
Query: 872 IKDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEF 925
++ +++ + + LGSG F V+ K R T A+K IKKS
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--------SSL 53
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK--- 982
E ++ + H N+V + + V + + G L DRIL+R
Sbjct: 54 ENEIAVLKKIKHENIVTLEDIYEST--THYYLVMQLVSGGEL------FDRILERGVYTE 105
Query: 983 ----KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT 1038
++ + +A ++YLH IVH DLK +NLL + I + DFGLS+++ N
Sbjct: 106 KDASLVIQQVLSA--VKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKMEQNG 162
Query: 1039 LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
++S GT ++APE+L S+ VD +S G+
Sbjct: 163 IMSTAC-GTPGYVAPEVLAQ--KPYSKAVDCWSIGV 195
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 873 KDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFW 926
D E++ + +G G F V R R T A+K + + F ++
Sbjct: 18 DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLK 74
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
REA I L HP++V + G + V E+M L I+ R +
Sbjct: 75 REASICHMLKHPHIVELLETYSSD--GMLYMVFEFMDGADLC------FEIVKRADAGFV 126
Query: 987 M--MDAAFGM-------EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKC 1036
A+ M Y H NI+H D+K +L+ ++ P+ K+G FG++ +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGE 185
Query: 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
+ LV+GG GT +MAPE++ + VDV+ G+
Sbjct: 186 SGLVAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGV 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 7e-29
Identities = 70/335 (20%), Positives = 121/335 (36%), Gaps = 90/335 (26%)
Query: 875 SDLEELQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
+D E +Q +G G FG V+ + K + AIKRI+ +E ++ RE +
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRL-------PNRELAREKVMREVKAL 58
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEY-----------MVNGSLRHVLARKDRILDRR 981
+ L HP +V ++ P + + + S + K R +D
Sbjct: 59 AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118
Query: 982 KKLMLMMDAAFG---------MEY------------------------------------ 996
+ M+
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 997 -LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--------------KCNTLVS 1041
LH K ++H DLK N+ + D + KVGDFGL +
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101
G V GT +M+PE ++G+N S KVD++S G+ ++E++ M II + +
Sbjct: 235 GQV-GTKLYMSPEQIHGNNY--SHKVDIFSLGLILFELLYSFST--QMERVRIITDVRNL 289
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P + + P+ ++++ S +P RP T+I
Sbjct: 290 KF-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 37/288 (12%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+ +LG G TVY + +AIK I E+E +K F RE H S L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP-----REKEETLKRFEREVHNSSQLSH 70
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
N+V+ V V EY + G +L + L + G+++
Sbjct: 71 QNIVSMIDVDEED--DCYYLVMEY-IEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKH 126
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV--SGGVRGTLPWMAPE 1054
H IVH D+K N+L++ + K+ DFG+++ T + + V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILID-SNKT---LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--------ANMHCGAIIGGILSNTLRPQ 1106
G E D+YS GI ++E++ GE P+ A H + + + +R
Sbjct: 183 QAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT-DVRKD 239
Query: 1107 IPERCDPEWRKLMEECWSFNPAARP-SFTEITNRLRVMSTALQTKRRN 1153
IP ++ + A R + E+ + L + L R N
Sbjct: 240 IP----QSLSNVILRATEKDKANRYKTIQEMKDDLS---SVLHENRAN 280
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 40/273 (14%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKE-----FWREAHIIS 933
++LGSG +G V K + AIK IKKS F + E + E ++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK-------KLML 986
+L HPN++ + V + VTE+ G L ++I++R K +M
Sbjct: 102 SLDHPNIIKLFDVFEDK--KYFYLVTEFYEGGELF------EQIINRHKFDECDAANIMK 153
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG 1046
+ + + YLH NIVH D+K +N+L+ ++ I K+ DFGLS G
Sbjct: 154 QILSG--ICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSFFSKDYKLRDRLG 210
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106
T ++APE+L +EK DV+S G+ M+ ++ G P+ G I+ + +
Sbjct: 211 TAYYIAPEVLKKK---YNEKCDVWSCGVIMYILLCGYPPF----GGQNDQDIIKKVEKGK 263
Query: 1107 IPERCDPEWRKLMEECWSF-------NPAARPS 1132
+W+ + +E + R +
Sbjct: 264 YYFD-FNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 32/222 (14%)
Query: 868 GLQIIKDSDLEEL-----QELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEW 920
L + +ELG G F V + + T + A K +KK R +
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR----RRGQDC- 71
Query: 921 LIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD 979
E E ++ P V+ + V N + + EY G + L
Sbjct: 72 -RAEILHEIAVLELAKSCPRVINLHEVYENT--SEIILILEYAAGGEIF------SLCLP 122
Query: 980 RRKKLMLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
+++ D G+ YLH NIVH DLK N+L++ P I K+ DFG+S
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI-KIVDFGMS 181
Query: 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
R + + GT ++APE+LN + ++ D+++ GI
Sbjct: 182 RKIGHACELREIMGTPEYLAPEILNY--DPITTATDMWNIGI 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 57/256 (22%), Positives = 102/256 (39%), Gaps = 35/256 (13%)
Query: 833 SAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQI-IKDSDLEEL----QELGSGT 887
S H VRG + D ++ + +K + + +ELGSG
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 888 FGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945
FG V+R + T K I L + E I++ LHHP ++ +
Sbjct: 64 FGVVHRCVEKATGRVFVAKFINTPYPLDK--------YTVKNEISIMNQLHHPKLINLHD 115
Query: 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL------MLMMDAAFGMEYLHM 999
+ M + E++ G L DRI K+ M A G++++H
Sbjct: 116 AFEDK--YEMVLILEFLSGGELF------DRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGTLPWMAPELLNG 1058
+IVH D+K +N++ + + K+ DFGL+ + + +V T + APE+++
Sbjct: 168 HSIVHLDIKPENIMCETKKAS-SV-KIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDR 224
Query: 1059 SNNRVSEKVDVYSFGI 1074
V D+++ G+
Sbjct: 225 --EPVGFYTDMWAIGV 238
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 34/286 (11%)
Query: 798 TDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDA 857
T+++ + +S TE S + D
Sbjct: 16 TENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDH 75
Query: 858 AMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRS 915
+ + G + + + + LG G FG V++ + T + A K IK
Sbjct: 76 RIVTAKQG----AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GM 127
Query: 916 SEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD 975
++E E E +++ L H N++ Y + + V EY+ G L D
Sbjct: 128 KDKE----EVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVMEYVDGGELF------D 175
Query: 976 RILDRRKKL------MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029
RI+D L + M G+ ++H I+H DLK +N+L RD + I K+ DF
Sbjct: 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QI-KIIDF 233
Query: 1030 GLSR-IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
GL+R K + GT ++APE++N + VS D++S G+
Sbjct: 234 GLARRYKPREKLKVNF-GTPEFLAPEVVNY--DFVSFPTDMWSVGV 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 24/201 (11%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+ELG G F V R + T + A K I R + + REA I L HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 65
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAAFG 993
N+V + + V + + G L + I+ R +
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILES 117
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
+ Y H IVH +LK +NLL+ + + K+ DFGL+ ++ G GT +++P
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 1054 ELLNGSNNRVSEKVDVYSFGI 1074
E+L + S+ VD+++ G+
Sbjct: 177 EVLKK--DPYSKPVDIWACGV 195
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 58/294 (19%), Positives = 108/294 (36%), Gaps = 42/294 (14%)
Query: 877 LEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
L + L G F VY + G + A+KR+ E+ I +E +
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAII---QEVCFMKK 81
Query: 935 L-HHPNVVAFYGVVPNGPGGTMATVTEYMV-----NGSLRHVL--ARKDRILDRRKKLML 986
L HPN+V F G + E+++ G L L L L +
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 987 MMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG- 1043
++++H + I+H DLK +NLL++ + K+ DFG + +
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCDFGSATTISHYPDYSWS 197
Query: 1044 ------------VRGTLPWMAPELLNGSNNR-VSEKVDVYSFGIAMWEIITGEEPYANMH 1090
T + PE+++ +N + EK D+++ G ++ + + P+ +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
Query: 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
I+ G S L+ NP R S E+ ++L+ ++
Sbjct: 258 KLRIVNGKYSIPPHDTQYTVF----HSLIRAMLQVNPEERLSIAEVVHQLQEIA 307
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 870 QIIKDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIK 923
+ E LG G+FG V + K R T A+K I K+ + +
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST----- 67
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR--- 980
RE ++ L HPN++ + ++ + + V E G L D I+ R
Sbjct: 68 -ILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGEL------FDEIIKRKRF 118
Query: 981 --RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT 1038
++ G+ Y+H NIVH DLK +N+L+ ++ I K+ DFGLS
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQN 177
Query: 1039 LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
GT ++APE+L G+ + EK DV+S G+
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGTYD---EKCDVWSAGV 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 27/201 (13%)
Query: 881 QELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+G G++G V +GT A K+I K + + F +E I+ +L HP
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVD----RFKQEIEIMKSLDHP 66
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAAFG 993
N++ Y + + V E G L +R++ + +M D
Sbjct: 67 NIIRLYETFEDN--TDIYLVMELCTGGEL------FERVVHKRVFRESDAARIMKDVLSA 118
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
+ Y H N+ H DLK +N L P P+ K+ DFGL+ + GT +++P
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 1054 ELLNGSNNRVSEKVDVYSFGI 1074
++L G + D +S G+
Sbjct: 178 QVLEGLYG---PECDEWSAGV 195
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-28
Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 41/280 (14%)
Query: 871 IIKDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKE 924
+ E LG G+FG V + K R T A+K I K+ + +
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST------ 67
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR---- 980
RE ++ L HPN++ + ++ + + V E G L D I+ R
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGELF------DEIIKRKRFS 119
Query: 981 -RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039
++ G+ Y+H NIVH DLK +N+L+ ++ I K+ DFGLS
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNT 178
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099
GT ++APE+L G+ EK DV+S G+ ++ +++G P+ G IL
Sbjct: 179 KMKDRIGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPF----YGKNEYDIL 231
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSF-------NPAARPS 1132
+ P+WR + ++ +P+ R +
Sbjct: 232 KRVETGKY-AFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 36/269 (13%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+ LG G V+ + D+A+K + ++ + F REA + L+H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVK-VLRADL----ARDPSFYLRFRREAQNAAALNH 71
Query: 938 PNVVAFY--GVVPNGPGGTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDAAFGM 994
P +VA Y G G V EY V+G +LR ++ + + ++ + ++ DA +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVS----GGVRGTLPW 1050
+ H I+H D+K N+++ + KV DFG++R ++ S V GT +
Sbjct: 130 NFSHQNGIIHRDVKPANIMI---SATNAV-KVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY--------ANMHCGAIIGGILSNT 1102
++PE G V + DVYS G ++E++TGE P+ A H I +
Sbjct: 186 LSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--IPPSA 241
Query: 1103 LRPQIPERCDPEWRKLMEECWSFNPAARP 1131
+ + ++ + + NP R
Sbjct: 242 RHEGLS----ADLDAVVLKALAKNPENRY 266
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 58/310 (18%), Positives = 99/310 (31%), Gaps = 67/310 (21%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+G G++G V T AIK + K+ + + ++ E ++ LHHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD---VERIKTEVRLMKKLHHP 88
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM---------- 988
N+ Y V + + V E G L L + + ++
Sbjct: 89 NIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 989 ----------------------DAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDP 1019
+ + YLH + I H D+K +N L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 1020 QRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
I K+ DFGLS+ GT ++APE+LN +N K D +S G+
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 1075 AMWEIITGEEP-YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSF-------N 1126
+ ++ G P +S L ++ +P + L N
Sbjct: 265 LLHLLLMGAVPFPGVND-----ADTISQVLNKKL-CFENPNYNVLSPLARDLLSNLLNRN 318
Query: 1127 PAARPSFTEI 1136
R
Sbjct: 319 VDERFDAMRA 328
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 39/203 (19%), Positives = 81/203 (39%), Gaps = 31/203 (15%)
Query: 881 QELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
++LG G FG V+R + K +K + ++Q +E I++ H
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQV----LVKKEISILNIARHR 61
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL------MLMMDAAF 992
N++ + + + + E++ + +RI +L +
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIF------ERINTSAFELNEREIVSYVHQVCE 113
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGTLPWM 1051
+++LH NI HFD++ +N++ + + K+ +FG +R +K +
Sbjct: 114 ALQFLHSHNIGHFDIRPENII--YQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYY 170
Query: 1052 APELLNGSNNRVSEKVDVYSFGI 1074
APE+ + VS D++S G
Sbjct: 171 APEVHQH--DVVSTATDMWSLGT 191
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWL----IKEFWREAHI 931
E+L+++G GT+GTV++ K R T +A+KR++ L + E + + RE +
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVR----LD--DDDEGVPSSAL----REICL 54
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLMMD 989
+ L H N+V + V+ + T+ V E+ + L+ + LD K + +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTL--VFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRG 1046
G+ + H +N++H DLK NLL+N + K+ +FGL+R I + V
Sbjct: 112 K--GLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVV-- 163
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
TL + P++L G+ S +D++S G E+ P
Sbjct: 164 TLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
ELG G VYR K +GT A+K +KK+ K E ++ L HP
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------DKKIVRTEIGVLLRLSHP 108
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAAFG 993
N++ + ++ V E + G L DRI+++ R +
Sbjct: 109 NIIKLKEIFETP--TEISLVLELVTGGELF------DRIVEKGYYSERDAADAVKQILEA 160
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
+ YLH IVH DLK +NLL P P+ K+ DFGLS+I + ++ V GT + AP
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
Query: 1054 ELLNGSNNRVSEKVDVYSFGI 1074
E+L G +VD++S GI
Sbjct: 220 EILRGCA--YGPEVDMWSVGI 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 29/215 (13%)
Query: 872 IKDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEF 925
I + E +ELG G F V R A I R ++
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK------L 57
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR----- 980
REA I L HPN+V + + G + + + G L + I+ R
Sbjct: 58 EREARICRLLKHPNIVRLHDSISEE--GHHYLIFDLVTGGELF------EDIVAREYYSE 109
Query: 981 RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTL 1039
+ + + H +VH +LK +NLL+ + + K+ DFGL+ ++
Sbjct: 110 ADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEGEQQ 168
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
G GT +++PE+L + + VD+++ G+
Sbjct: 169 AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGV 201
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 24/201 (11%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+ELG G F V R + T + A K I R + + REA I L HP
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 88
Query: 939 NVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAAFG 993
N+V + + V + + G L + I+ R +
Sbjct: 89 NIVRLHDSIQEE--SFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILES 140
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
+ Y H IVH +LK +NLL+ + + K+ DFGL+ ++ G GT +++P
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 1054 ELLNGSNNRVSEKVDVYSFGI 1074
E+L + S+ VD+++ G+
Sbjct: 200 EVLKK--DPYSKPVDIWACGV 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-27
Identities = 62/271 (22%), Positives = 104/271 (38%), Gaps = 35/271 (12%)
Query: 818 DVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQI-IKDSD 876
+ + P D D + G+ S D + ++ Y + IK
Sbjct: 95 EPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDH 154
Query: 877 LEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+ + +ELG+G FG V+R R T A K + S++E +E
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKE----TVRKEIQ 206
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM----- 985
+S L HP +V + + M + E+M G L +++ D K+
Sbjct: 207 TMSVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELF------EKVADEHNKMSEDEAV 258
Query: 986 -LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGG 1043
M G+ ++H N VH DLK +N++ + K+ DFGL+ + V
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVT 316
Query: 1044 VRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
GT + APE+ G V D++S G+
Sbjct: 317 T-GTAEFAAPEVAEGKP--VGYYTDMWSVGV 344
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 50/227 (22%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEW------LIKEFWREA 929
E+L LG G F TVY+ + + T+ +AIK+IK LG SE + L RE
Sbjct: 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIK----LGHRSEAKDGINRTAL-----REI 63
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLM 987
++ L HPN++ + ++ V ++M L ++ +L K MLM
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISL--VFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGV 1044
G+EYLH I+H DLK +NLL++ + + K+ DFGL++ V
Sbjct: 121 TLQ--GLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 1045 RGTLPWM-APELLNGSNNRVSEKVDVYSFGIAMW-------EIITGE 1083
T W APELL G+ Y G+ MW E++
Sbjct: 175 --TR-WYRAPELLFGARM--------YGVGVDMWAVGCILAELLLRV 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 77/271 (28%), Positives = 118/271 (43%), Gaps = 42/271 (15%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
L+ +G G F V + G ++AIK I K+ L K F RE I+ L+H
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-----NPTSLQKLF-REVRIMKILNH 73
Query: 938 PNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMD 989
PN+V + V + T + EY G + L R+ ++ R K ++
Sbjct: 74 PNIVKLFEV--------IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR---- 1045
A ++Y H K IVH DLK +NLL+ D I K+ DFG S N GG
Sbjct: 126 A---VQYCHQKRIVHRDLKAENLLL---DADMNI-KIADFGFS----NEFTVGGKLDAFC 174
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105
G P+ APEL G +VDV+S G+ ++ +++G P+ + + +L R
Sbjct: 175 GAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR- 232
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
IP + L++ NP R + +I
Sbjct: 233 -IPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 63/297 (21%), Positives = 114/297 (38%), Gaps = 66/297 (22%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E++ ++G G++G V++ + R T +AIK+ S + + K RE ++ L
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIALREIRMLKQL 59
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLMMDAAFG 993
HPN+V V + V EY + ++ H L R R + K +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHL--VFEYC-DHTVLHELDRYQRGVPEHLVKSITWQT--LQA 114
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTL---VSGGVRGT 1047
+ + H N +H D+K +N+L+ + + K+ DFG +R + V+ T
Sbjct: 115 VNFCHKHNCIHRDVKPENILIT----KHSVIKLCDFGFARLLTGPSDYYDDEVA-----T 165
Query: 1048 LPWM-APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY----ANMH--------CG-- 1092
W +PELL G + VDV++ G E+++G P +++ G
Sbjct: 166 R-WYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDL 222
Query: 1093 --AIIGGILSN---------------TLRPQIPERCDPEWRKLMEECWSFNPAARPS 1132
+N L + P L++ C +P R +
Sbjct: 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFP-NISYPALGLLKGCLHMDPTERLT 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 56/268 (20%), Positives = 102/268 (38%), Gaps = 36/268 (13%)
Query: 824 PSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQEL 883
D + G E S E+ + + D ++ +
Sbjct: 45 RDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKD--VI 102
Query: 884 GSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNV 940
G G V R R T + A+K ++ + + E + + RE HI+ + HP++
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAAFGME 995
+ + + V + M G L D + ++ ++ +M +
Sbjct: 163 ITLIDSYESSSFMFL--VFDLMRKGELF------DYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-----KCNTLVSGGVRGTLPW 1050
+LH NIVH DLK +N+L+ D I ++ DFG S K L GT +
Sbjct: 215 FLHANNIVHRDLKPENILL---DDNMQI-RLSDFGFSCHLEPGEKLRELC-----GTPGY 265
Query: 1051 MAPELLNGSNNRV----SEKVDVYSFGI 1074
+APE+L S + ++VD+++ G+
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 68/298 (22%), Positives = 110/298 (36%), Gaps = 57/298 (19%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HH 937
Q LG G G V R T A+K + S + +E
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------------PKARQEVDHHWQASGG 81
Query: 938 PNVVAFYGVVPNGPGGTMAT--VTEYMVNGSLRHVLARKDRILDRRKKL-------MLMM 988
P++V V N G + E M G L RI +R + +M
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELF------SRIQERGDQAFTEREAAEIMR 135
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTL 1048
D +++LH NI H D+K +NLL ++ + K+ DFG ++ + T
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNALQTPC-YTP 193
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
++APE+L + D++S G+ M+ ++ G P+ + AI G+ Q
Sbjct: 194 YYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY- 250
Query: 1109 ERCDPEW-----------RKLMEECWSFNPAARPSFTE------ITNRLRVMSTALQT 1149
+PEW R L++ +P R + T+ I + V T L T
Sbjct: 251 GFPNPEWSEVSEDAKQLIRLLLK----TDPTERLTITQFMNHPWINQSMVVPQTPLHT 304
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 43/273 (15%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSS-EQEWLIKEFWREAHIISNLH 936
LG G FGTV+ G +AIK I ++ LG S E ++ +
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP---LEVALLWKVG 92
Query: 937 ----HPNVVAFYGVVPNGPGGTMAT------VTEYMVNGS-LRHVLARKDRILDR--RKK 983
HP V+ T V E + L + K + + R
Sbjct: 93 AGGGHPGVIRLLDW--------FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG 1043
++ A +++ H + +VH D+K +N+L+ D +R K+ DFG + + +
Sbjct: 145 FGQVVAA---IQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDF 198
Query: 1044 VRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103
GT + PE ++ + V+S GI +++++ G+ P+ I+ L
Sbjct: 199 D-GTRVYSPPEWISRHQYH-ALPATVWSLGILLYDMVCGDIPFERDQ--EILEAEL---- 250
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P P+ L+ C + P++RPS EI
Sbjct: 251 --HFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 878 EELQELGSGTFGTVYRGKWRGTDI-AIKRIKKSCFLGRSSEQEWL----IKEFWREAHII 932
L+++G GT+G VY+ + + A+K+I+ L E E + I RE I+
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIR----LE--KEDEGIPSTTI----REISIL 54
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLMMDA 990
L H N+V Y V+ + V E++ + L+ +L + L+ K +L +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVL--VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGT 1047
G+ Y H + ++H DLK NLL+N + K+ DFGL+R I V T
Sbjct: 112 --GIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYTHEIV--T 163
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
L + AP++L GS + S +D++S G E++ G
Sbjct: 164 LWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 55/298 (18%)
Query: 880 LQELGSGTFGTVYRGK--WRGTDIAIKRIKKS-----CFLGRSSEQEWLIKEFWREAHII 932
+ +G G G VY + R +A+K + ++ F R REA
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR----------MQREARTA 88
Query: 933 SNLHHPNVVAFY--GVVPNGPGGTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMD 989
L P+VV + G + G + +NG L +L R+ L + + ++
Sbjct: 89 GRLQEPHVVPIHDFGEI----DGQLYVDMRL-INGVDLAAMLRRQGP-LAPPRAVAIVRQ 142
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV--SGGVRGT 1047
++ H H D+K +N+LV+ D + DFG++ + + G GT
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADD----FAYLVDFGIASATTDEKLTQLGNTVGT 198
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGILSN--- 1101
L +MAPE + S + + D+Y+ ++E +TG PY G +++G ++
Sbjct: 199 LYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQ----GDQLSVMGAHINQAIP 252
Query: 1102 ---TLRPQIPERCDPEWRKLMEECWSFNPAAR-PSFTEITNRLRVMSTALQTKRRNHA 1155
T+RP IP D + M + NP R + +++ AL T ++ A
Sbjct: 253 RPSTVRPGIPVAFDAVIARGMAK----NPEDRYVTCGDLSAAAH---AALATADQDRA 303
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 32/216 (14%)
Query: 878 EELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWL----IKEFWREAHII 932
++L+++G GT+G VY+ K G +A+KRI+ L +E E + I RE ++
Sbjct: 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIR----LD--AEDEGIPSTAI----REISLL 73
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLMMDA 990
LHHPN+V+ V+ + T+ V E+M L+ VL L K + +
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTL--VFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVRGT 1047
G+ + H I+H DLK NLL+N K+ DFGL+R I + V T
Sbjct: 131 --GVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLARAFGIPVRSYTHEVV--T 182
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
L + AP++L GS + S VD++S G E+ITG+
Sbjct: 183 LWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGK 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E L +G G++G V + + + T +AIK+ S + + + K RE ++ L
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQL 81
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLMMDAAFG 993
H N+V V + V E++ + ++ L LD + +K + + G
Sbjct: 82 RHENLVNLLEVCKKKKRWYL--VFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIIN--G 136
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG------T 1047
+ + H NI+H D+K +N+LV+ + K+ DFG +R ++ T
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFART-----LAAPGEVYDDEVAT 187
Query: 1048 LPWM-APELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
W APELL G + + VDV++ G + E+ GE
Sbjct: 188 R-WYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWL----IKEFWREAHI 931
+ +LG GT+G VY+ T+ +AIKRI+ E+E + I RE +
Sbjct: 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAI----REVSL 86
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLMMDA 990
+ L H N++ V+ + + + EY L+ + + + + K + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHL--IFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQL-- 141
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICKVGDFGLSR---IKCNTLVSGGVRG 1046
G+ + H + +H DLK NLL+++ D + P+ K+GDFGL+R I +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-- 199
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
TL + PE+L GS S VD++S E++
Sbjct: 200 TLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKT 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 76/311 (24%), Positives = 118/311 (37%), Gaps = 57/311 (18%)
Query: 870 QIIKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWR 927
II D + Q LG G G V + + T A+K ++ + R
Sbjct: 58 AIIDDYKVTS-QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARR 103
Query: 928 EAHIISNL-HHPNVVAFYGVVPNGPGGTMAT--VTEYMVNGSLRHVLARKDRILDRRKKL 984
E + P++V V N G V E + G L RI DR +
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF------SRIQDRGDQA 157
Query: 985 -------MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
+M ++YLH NI H D+K +NLL + P + K+ DFG ++ +
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTDFGFAKETTS 216
Query: 1038 TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGG 1097
T ++APE+L + D++S G+ M+ ++ G P+ + H AI G
Sbjct: 217 HNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274
Query: 1098 ILSNTLRPQIPERCDPEW-----------RKLMEECWSFNPAARPSFTE------ITNRL 1140
+ + Q E +PEW R L++ P R + TE I
Sbjct: 275 MKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLK----TEPTQRMTITEFMNHPWIMQST 329
Query: 1141 RVMSTALQTKR 1151
+V T L T R
Sbjct: 330 KVPQTPLHTSR 340
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 47/261 (18%), Positives = 97/261 (37%), Gaps = 38/261 (14%)
Query: 879 ELQE-LGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN 934
E++ + G G +Y R G + +K + S E ++
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-------VHSGDAEAQAMAMAERQFLAE 135
Query: 935 LHHPNVVAFY--GVVPNGPGGTMA-TVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDA 990
+ HP++V + + G + V EY V G SL+ +K L + + +++
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKGQK---LPVAEAIAYLLEI 191
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPW 1050
+ YLH +V+ DLK +N+++ ++ K+ D G + G + GT +
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIML---TEEQL--KLIDLGAVSRINSF---GYLYGTPGF 243
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110
APE++ + D+Y+ G + + G + G+ + +
Sbjct: 244 QAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRN----GRYVDGLPEDDPVLKTY-- 294
Query: 1111 CDPEWRKLMEECWSFNPAARP 1131
+ +L+ +P R
Sbjct: 295 --DSYGRLLRRAIDPDPRQRF 313
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 35/212 (16%)
Query: 881 QELGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKE-FWREAHIISNL-H 936
+ LG G V R + T + A+K I + S+E+ ++E +E I+ +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAA 991
HPN++ + V + M G L D + ++ ++ +M
Sbjct: 83 HPNIIQLKDTYETNTFFFL--VFDLMKKGELF------DYLTEKVTLSEKETRKIMRALL 134
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-----KCNTLVSGGVRG 1046
+ LH NIVH DLK +N+L+ D I K+ DFG S K + G
Sbjct: 135 EVICALHKLNIVHRDLKPENILL---DDDMNI-KLTDFGFSCQLDPGEKLREVC-----G 185
Query: 1047 TLPWMAPELLNGSNNRV----SEKVDVYSFGI 1074
T ++APE++ S N ++VD++S G+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 883 LGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP 938
+G GT+G VY+ K + D A+K+I+ G S RE ++ L HP
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSA-------CREIALLRELKHP 78
Query: 939 NVVAFYGVVPNGPGGTMATVTEYM-------VNGSLRHVLARKDRILDRR--KKLMLMMD 989
NV++ V + + + +Y + +K L R K L+ +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-----IKCNTLVSGGV 1044
G+ YLH ++H DLK N+LV P+R K+ D G +R +K + V
Sbjct: 139 D--GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 1045 RGTLPWM-APELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
T W APELL G+ ++ +D+++ G E++T E
Sbjct: 197 V-TF-WYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 58/268 (21%), Positives = 112/268 (41%), Gaps = 31/268 (11%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+ LGSG FG V+ + ++ +K IKK L ++ + + E I+S + H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGS-LRHVLARKDRILDR--RKKLMLMMDAAFGM 994
N++ + N G V E +G L + R R+ + ++ A +
Sbjct: 89 ANIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA---V 143
Query: 995 EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR----GTLPW 1050
YL +K+I+H D+K +N+++ I K+ DFG + L G + GT+ +
Sbjct: 144 GYLRLKDIIHRDIKDENIVI---AEDFTI-KLIDFGSA----AYLERGKLFYTFCGTIEY 195
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110
APE+L G N +++++S G+ ++ ++ E P+ + + + P
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEAAIH------PPYL 246
Query: 1111 CDPEWRKLMEECWSFNPAARPSFTEITN 1138
E L+ P R + ++
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 70/267 (26%), Positives = 112/267 (41%), Gaps = 31/267 (11%)
Query: 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G++G V A+K +KK L R E +K +E ++ L H NV
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKK-LRRIPNGEANVK---KEIQLLRRLRHKNV 68
Query: 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA---F----- 992
+ V+ N M V EY ++ +L D + ++R + A F
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEY-CVCGMQEML---DSVPEKR----FPVCQAHGYFCQLID 120
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR---GTLP 1049
G+EYLH + IVH D+K NLL+ + K+ G++ R G+
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLL---TTGGTL-KISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109
+ PE+ NG + KVD++S G+ ++ I TG P+ + + I + IP
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA--IPG 234
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEI 1136
C P L++ + PA R S +I
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKE-F----WREAH 930
E+L ++G GTFG V++ + R T +A+K++ E E KE F RE
Sbjct: 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENE---KEGFPITALREIK 68
Query: 931 IISNLHHPNVVAFYGVV------PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--K 982
I+ L H NVV + N G++ V ++ + L +L+ K
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG 1042
++M M+ G+ Y+H I+H D+K N+L+ + + K+ DFGL+R + +
Sbjct: 128 RVMQMLLN--GLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLAR-AFSLAKNS 180
Query: 1043 GVRG------TLPWM-APELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
TL W PELL G +D++ G M E+ T
Sbjct: 181 QPNRYTNRVVTL-WYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 33/290 (11%), Positives = 75/290 (25%), Gaps = 49/290 (16%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQ-----------------EWLIK 923
LG + T + + ++ + + K
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMAT--VTEYMVNGSLRHVL------ARKD 975
R + P V + + + + +L+ +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 976 RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035
+ L +L L + + LH +VH L+ +++++ R + F +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG----VFLTGFEHLV-R 255
Query: 1036 CNTLVSGGVRGTLPWMAPELLN---------GSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
V + + PEL ++ D ++ G+ ++ I + P
Sbjct: 256 DGARVV--SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 1087 ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
I + IP R L+E + R +
Sbjct: 314 TKDAALGGSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQA 357
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 36/218 (16%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKE-----FWREAH 930
+L +LG GT+ TVY+GK + TD +A+K I+ E E E RE
Sbjct: 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIR--------LEHE----EGAPCTAIREVS 52
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR--KKLMLMM 988
++ +L H N+V + ++ T+ V EY+ + L+ L I++ K + +
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTL--VFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTLVSGGVR 1045
G+ Y H + ++H DLK NLL+N +R K+ DFGL+R I T + V
Sbjct: 110 --LRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYDNEVV- 162
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
TL + P++L GS S ++D++ G +E+ TG
Sbjct: 163 -TLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGR 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 40/220 (18%)
Query: 872 IKDSDLEEL-------QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLI 922
+KDS + + LG G+F + + ++ A+K I K +
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----------ME 49
Query: 923 KEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR- 980
+E + HPN+V + V + + V E + G L +RI +
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL--VMELLNGGELF------ERIKKKK 101
Query: 981 ----RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036
+ +M + ++H +VH DLK +NLL + I K+ DFG +R+K
Sbjct: 102 HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIIDFGFARLKP 160
Query: 1037 --NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
N + TL + APELLN N E D++S G+
Sbjct: 161 PDNQPLKTPC-FTLHYAAPELLNQ--NGYDESCDLWSLGV 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 35/286 (12%), Positives = 78/286 (27%), Gaps = 42/286 (14%)
Query: 883 LGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEW-----------------LIK 923
LG + T + + ++ ++ K
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYM--VNGSLRHVL------ARKD 975
R + P V + + + + +L+ +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 976 RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035
+ L +L L + + LH +VH L+ ++++ D + + + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGFEHLVRD 261
Query: 1036 CNTLVS--GGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090
+ VS G A +L ++ D ++ G+A++ I + P +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
I + IP R L+E + R +
Sbjct: 322 ALGGSEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQA 361
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 62/311 (19%), Positives = 118/311 (37%), Gaps = 29/311 (9%)
Query: 833 SAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVY 892
S+H H +D ++ G + + L LGSG FG+VY
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPL--LGSGGFGSVY 60
Query: 893 RGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--PNVVAFYGVVP 948
G +AIK ++K + E + E ++ + V+
Sbjct: 61 SGIRVSDNLPVAIKHVEKDR-ISDWGELPNGTRVP-MEVVLLKKVSSGFSGVIRLLDWFE 118
Query: 949 NGPGGTMATVTEYMVN-GSLRHVLARKDRILDR--RKKLMLMMDAAFGMEYLHMKNIVHF 1005
+ + E L + + + + R +++A + + H ++H
Sbjct: 119 RPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEA---VRHCHNCGVLHR 173
Query: 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSE 1065
D+K +N+L+ D R K+ DFG + +T+ + GT + PE +
Sbjct: 174 DIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYH-GR 228
Query: 1066 KVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSF 1125
V+S GI +++++ G+ P+ + II G + +R E + L+ C +
Sbjct: 229 SAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQV------FFRQRVSSECQHLIRWCLAL 280
Query: 1126 NPAARPSFTEI 1136
P+ RP+F EI
Sbjct: 281 RPSDRPTFEEI 291
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 41/268 (15%)
Query: 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG GTFG V G+ + G +A+K + + + IK RE + HP++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK--IK---REIQNLKLFRHPHI 73
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAF 992
+ Y V ++T V EY+ G L + + R+ + R+ ++ A
Sbjct: 74 IKLYQV--------ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA-- 123
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR----GTL 1048
++Y H +VH DLK +N+L+ D K+ DFGLS N + G G+
Sbjct: 124 -VDYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLS----NMMSDGEFLRTSCGSP 174
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
+ APE+++G +VD++S G+ ++ ++ G P+ + H + I IP
Sbjct: 175 NYAAPEVISG-RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--IP 231
Query: 1109 ERCDPEWRKLMEECWSFNPAARPSFTEI 1136
E + L+ +P R + +I
Sbjct: 232 EYLNRSVATLLMHMLQVDPLKRATIKDI 259
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 45/228 (19%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWL-----IKEFWREAH 930
E + E+G G +GTVY+ + + +A+K ++ + + RE
Sbjct: 12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVR----VPNGGGGGGGLPISTV----REVA 63
Query: 931 IISNLH---HPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVL-ARKDRILDRR-- 981
++ L HPNVV V V E++ + LR L L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETI 122
Query: 982 KKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC----- 1036
K LM G+++LH IVH DLK +N+LV K+ DFGL+RI
Sbjct: 123 KDLMRQFLR--GLDFLHANCIVHRDLKPENILVT----SGGTVKLADFGLARIYSYQMAL 176
Query: 1037 -NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+V TL + APE+L S + VD++S G E+ +
Sbjct: 177 TPVVV------TLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 43/224 (19%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQE------WLIKEFWREA 929
++L++LG+GT+ TVY+G + T +A+K +K + E + RE
Sbjct: 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAI-----REI 54
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRR-------K 982
++ L H N+V Y V+ T+ V E+M + L+ + + R K
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTL--VFEFM-DNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR---IKCNTL 1039
+ G+ + H I+H DLK NLL+N +R K+GDFGL+R I NT
Sbjct: 112 YFQWQLLQ--GLAFCHENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTF 165
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
S V TL + AP++L GS S +D++S G + E+ITG+
Sbjct: 166 SSEVV--TLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGK 206
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 36/213 (16%)
Query: 881 QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HH 937
LG G V T A+K I+K RS +RE ++ H
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--------VFREVEMLYQCQGH 70
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR-----RKKLMLMMDAAF 992
NV+ V E M GS+ I R + +++ D A
Sbjct: 71 RNVLELIEFFEEED--RFYLVFEKMRGGSIL------SHIHKRRHFNELEASVVVQDVAS 122
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVR------ 1045
+++LH K I H DLK +N+L + P+ K+ DF L IK N S
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 1046 -GTLPWMAPELLNGSNNRVS---EKVDVYSFGI 1074
G+ +MAPE++ + S ++ D++S G+
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 37/216 (17%)
Query: 873 KDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFW 926
+ +++G G++ R + T++ A+K I KS
Sbjct: 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------------ 63
Query: 927 REAHII-SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR----- 980
E I+ HPN++ V +G + VTE M G L D+IL +
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYV--VTELMKGGELL------DKILRQKFFSE 115
Query: 981 RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNT 1038
R+ ++ +EYLH + +VH DLK N+L ++ DFG ++ N
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 1039 LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGI 1074
L+ T ++APE+L D++S G+
Sbjct: 176 LLMTPC-YTANFVAPEVLER--QGYDAACDIWSLGV 208
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 69/284 (24%), Positives = 108/284 (38%), Gaps = 65/284 (22%)
Query: 883 LGSGTFGTVYRGKWRGT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G +G V R T +A+K + + E IK +E I L+H NV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPEN---IK---KEICINKMLNHENV 67
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAF 992
V FYG EY G L + + + ++ +M
Sbjct: 68 VKFYGH--------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG-- 117
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR------- 1045
+ YLH I H D+K +NLL+ D + + K+ DFGL+
Sbjct: 118 -VVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLA----TVFRYNNRERLLNKMC 168
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG----EEPYANMHCGAIIGGILSN 1101
GTLP++APELL +E VDV+S GI + ++ G ++P + S+
Sbjct: 169 GTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSD 220
Query: 1102 TLRPQIPERCDPEWRKLMEECWSF-------NPAARPSFTEITN 1138
+ W+K+ + NP+AR + +I
Sbjct: 221 WKEKKTYL---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 68/292 (23%), Positives = 108/292 (36%), Gaps = 75/292 (25%)
Query: 868 GLQIIKDSDLEEL----QELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWL 921
GLQI K++ +++ Q LG G G V + + T A+K ++
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------ 54
Query: 922 IKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMAT--VTEYMVNGSLRHVLARKDRIL 978
+ RE + P++V V N G V E + G L RI
Sbjct: 55 -PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL------FSRIQ 107
Query: 979 DRRKKLMLMMDAAFGM-------EYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031
DR + +A+ M +YLH NI H D+K +NLL + P + K+ DFG
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTDFGF 166
Query: 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
A E + + D++S G+ M+ ++ G P+ + H
Sbjct: 167 --------------------AKETTGEKYD---KSCDMWSLGVIMYILLCGYPPFYSNHG 203
Query: 1092 GAIIGGILSNTLRPQIPERCDPEW-----------RKLMEECWSFNPAARPS 1132
AI G+ + Q E +PEW R L++ P R +
Sbjct: 204 LAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLK----TEPTQRMT 250
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 54/291 (18%)
Query: 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFW------------ 926
E+G G++G V T A+K + K + ++
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 927 ------REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDR 980
+E I+ L HPNVV V+ + + V E + G + V + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSED 137
Query: 981 --RKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT 1038
R ++ G+EYLH + I+H D+K NLLV I K+ DFG+S N
Sbjct: 138 QARFYFQDLIK---GIEYLHYQKIIHRDIKPSNLLV---GEDGHI-KIADFGVS----NE 186
Query: 1039 LVSGGVR-----GTLPWMAPELLNGSNNRVS-EKVDVYSFGIAMWEIITGEEPY-----A 1087
GT +MAPE L+ + S + +DV++ G+ ++ + G+ P+
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 1088 NMHCGAIIGGILSNTLRPQIPERCD--PEWRKLMEECWSFNPAARPSFTEI 1136
+H I L + P++ D + + L+ NP +R EI
Sbjct: 247 CLH-SKIKSQAL------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 70/270 (25%), Positives = 114/270 (42%), Gaps = 42/270 (15%)
Query: 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G+FG V +A+K I + S+ ++ RE + L HP++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLK--KSDMHMRVE---REISYLKLLRHPHI 71
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAF 992
+ Y V + T V EY G L + K R+ + R+ ++ A
Sbjct: 72 IKLYDV--------ITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA-- 120
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR----GTL 1048
+EY H IVH DLK +NLL+ D + K+ DFGLS N + G G+
Sbjct: 121 -IEYCHRHKIVHRDLKPENLLL---DDNLNV-KIADFGLS----NIMTDGNFLKTSCGSP 171
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
+ APE++NG +VDV+S GI ++ ++ G P+ + + + S +P
Sbjct: 172 NYAAPEVING-KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV--MP 228
Query: 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITN 1138
+ P + L+ +P R + EI
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 57/279 (20%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D + + LG G+F TV + T AIK ++K + + ++ ++ RE ++
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVT----RERDVM 84
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLML 986
S L HP V Y T Y NG L + + +
Sbjct: 85 SRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----- 131
Query: 987 MMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI----- 1034
F +EYLH K I+H DLK +N+L+ + I ++ DFG +++
Sbjct: 132 ---TRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHI-QITDFGTAKVLSPES 184
Query: 1035 ---KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC 1091
+ N+ V GT +++PELL + D+++ G +++++ G P+ +
Sbjct: 185 KQARANSFV-----GTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237
Query: 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
I I+ PE+ P+ R L+E+ + R
Sbjct: 238 YLIFQKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKR 274
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-22
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 47/228 (20%)
Query: 878 EELQELGSGTFGTVYRGK-WRGTD--IAIKRIKKSCFLGRSSEQEWL----IKEFWREAH 930
E + E+G G +G V++ + + +A+KR++ + + +E + I RE
Sbjct: 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR----VQ--TGEEGMPLSTI----REVA 63
Query: 931 IISNLH---HPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVL-ARKDRILDRR-- 981
++ +L HPNVV + V V E++ + L L + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 982 KKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC----- 1036
K +M + G+++LH +VH DLK N+LV K+ DFGL+RI
Sbjct: 123 KDMMFQLLR--GLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMAL 176
Query: 1037 -NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ +V TL + APE+L S + VD++S G E+ +
Sbjct: 177 TSVVV------TLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 68/281 (24%), Positives = 104/281 (37%), Gaps = 59/281 (20%)
Query: 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG G +G V R +A+K + + E IK +E I L+H NV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPEN---IK---KEICINKMLNHENV 67
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAF 992
V FYG EY G L + + + ++ +M
Sbjct: 68 VKFYGH--------RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG-- 117
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR------- 1045
+ YLH I H D+K +NLL+ D + + K+ DFGL+
Sbjct: 118 -VVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLA----TVFRYNNRERLLNKMC 168
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105
GTLP++APELL +E VDV+S GI + ++ GE P+
Sbjct: 169 GTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-------DSCQEYSD 220
Query: 1106 QIP-ERCDPEWRKLMEECWSF-------NPAARPSFTEITN 1138
+ W+K+ + NP+AR + +I
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 54/262 (20%), Positives = 94/262 (35%), Gaps = 50/262 (19%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREA 929
++ D E L+ +G G F V K + T A+K + K L R + F E
Sbjct: 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE-----VSCFREER 112
Query: 930 HIISNLHHPNVV----AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD 979
++ N + AF Y V EY V G L +L++ +
Sbjct: 113 DVLVNGDRRWITQLHFAFQDENYLY------------LVMEYYVGGDLLTLLSKFGERIP 160
Query: 980 RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------- 1032
+ + ++ +H VH D+K DN+L+ D I ++ DFG
Sbjct: 161 AEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHI-RLADFGSCLKLRADG 216
Query: 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEK-----VDVYSFGIAMWEIITGEEPYA 1087
++ V GT +++PE+L D ++ G+ +E+ G+ P+
Sbjct: 217 TVRSLVAV-----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271
Query: 1088 NMHCGAIIGGILSNTLRPQIPE 1109
G I+ +P
Sbjct: 272 ADSTAETYGKIVHYKEHLSLPL 293
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 72/276 (26%), Positives = 107/276 (38%), Gaps = 49/276 (17%)
Query: 883 LGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
+GSG FG R K +A+K I++ + E ++ RE +L HPN+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DEN---VQ---REIINHRSLRHPNI 78
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAF 992
V F V + T + EY G L + R + R ++
Sbjct: 79 VRFKEV--------ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG-- 128
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR----GTL 1048
+ Y H I H DLK +N L L P K+ DFG S + V GT
Sbjct: 129 -VSYCHSMQICHRDLKLENTL--LDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTP 181
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG----EEPYANMHCGAIIGGILSNTLR 1104
++APE+L + DV+S G+ ++ ++ G E+P I ILS
Sbjct: 182 AYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240
Query: 1105 PQIPERC--DPEWRKLMEECWSFNPAARPSFTEITN 1138
IP+ PE L+ + +PA R S EI
Sbjct: 241 --IPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-21
Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 41/268 (15%)
Query: 883 LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV 940
LG GTFG V GK G +A+K + + + I+ RE + HP++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK--IR---REIQNLKLFRHPHI 78
Query: 941 VAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDR--RKKLMLMMDAAF 992
+ Y V ++T V EY+ G L + + R+ ++ R+ ++
Sbjct: 79 IKLYQV--------ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG-- 128
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR----GTL 1048
++Y H +VH DLK +N+L+ D K+ DFGLS N + G G+
Sbjct: 129 -VDYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLS----NMMSDGEFLRTSCGSP 179
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108
+ APE+++G +VD++S G+ ++ ++ G P+ + H + I P
Sbjct: 180 NYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY--TP 236
Query: 1109 ERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ +P L++ +P R + +I
Sbjct: 237 QYLNPSVISLLKHMLQVDPMKRATIKDI 264
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD-IAIKRIKK-SCFLGRSSEQEWLIKEFWREAHIISNL 935
+ +G+G+FG V++ K +D +AIK++ + F R E I+ +
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------------ELQIMRIV 89
Query: 936 HHPNVVAFYGVV-PNGPGGTMAT---VTEYM---VNGSLRHVLARKDRILDRRKKL---- 984
HPNVV NG V EY+ V + RH K + KL
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLVSG 1042
+L + Y+H I H D+K NLL++ P + K+ DFG ++ I VS
Sbjct: 150 LLR-----SLAYIHSIGICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ + APEL+ G+ N + +D++S G M E++ G+
Sbjct: 202 IC--SRYYRAPELIFGATN-YTTNIDIWSTGCVMAELMQGQ 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 63/283 (22%), Positives = 116/283 (40%), Gaps = 45/283 (15%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
E L+ +G G+FG V + T A+K + K + +E + +E I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVF----KELQIM 69
Query: 933 SNLHHPNVV----AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
L HP +V +F + VV + ++ G LR+ L + +
Sbjct: 70 QGLEHPFLVNLWYSFQDEEDMFMVV------------DLLLGGDLRYHLQQNVHFKEETV 117
Query: 983 KLMLMMDA--AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLV 1040
KL + ++YL + I+H D+K DN+L+ D + + DF ++ +
Sbjct: 118 KLFI---CELVMALDYLQNQRIIHRDMKPDNILL---DEHGHV-HITDFNIAAMLPRETQ 170
Query: 1041 SGGVRGTLPWMAPELLNGSNNRV-SEKVDVYSFGIAMWEIITGEEPY---ANMHCGAIIG 1096
+ GT P+MAPE+ + S VD +S G+ +E++ G PY ++ I+
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
Query: 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR-PSFTEITN 1138
+ + P E L+++ NP R +++ N
Sbjct: 231 TFETTVVT--YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-20
Identities = 78/326 (23%), Positives = 128/326 (39%), Gaps = 41/326 (12%)
Query: 820 SDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIY-GLQIIKDSDLE 878
+ + T ++ + ++ EME + + ++ E
Sbjct: 92 TPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE 151
Query: 879 ELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
L+ LG GTFG V K + T A+K +KK + + E + E ++ N
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLTEN----RVLQNSR 206
Query: 937 HPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
HP + A + T V EY G L L+R+ + R + +
Sbjct: 207 HPFLTALK--------YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEI 257
Query: 991 AFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR---- 1045
++YLH KN+V+ DLK +NL++ D I K+ DFGL C + G
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLML---DKDGHI-KITDFGL----CKEGIKDGATMKTF 309
Query: 1046 -GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104
GT ++APE+L N VD + G+ M+E++ G P+ N + IL +R
Sbjct: 310 CGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 1105 PQIPERCDPEWRKLMEECWSFNPAAR 1130
P PE + L+ +P R
Sbjct: 368 --FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 48/260 (18%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+ D E L+ +G G FG V K + D A+K + K L R+ F E
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----TACFREER 125
Query: 930 HIISNLHHPNVV----AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD 979
++ N + AF Y V +Y V G L +L++ + L
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLY------------LVMDYYVGGDLLTLLSKFEDRLP 173
Query: 980 RRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS------- 1032
+ + ++ +H + VH D+K DN+L+ D I ++ DFG
Sbjct: 174 EEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHI-RLADFGSCLKLMEDG 229
Query: 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSE---KVDVYSFGIAMWEIITGEEPYANM 1089
++ + V GT +++PE+L + D +S G+ M+E++ GE P+
Sbjct: 230 TVQSSVAV-----GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284
Query: 1090 HCGAIIGGILSNTLRPQIPE 1109
G I+++ R Q P
Sbjct: 285 SLVETYGKIMNHKERFQFPT 304
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 69/306 (22%), Positives = 113/306 (36%), Gaps = 83/306 (27%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEF-WREAHIISN 934
+ + +G+G+FG VY+ K G +AIK++ Q+ K F RE I+
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QD---KRFKNRELQIMRK 103
Query: 935 LHHPNVVAFYGVVPNGPGGTMAT----VTEYM---VNGSLRHVLARKDRILDRRKKL--- 984
L H N+V + V +Y+ V RH K + KL
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 985 -MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGG 1043
+ + Y+H I H D+K NLL++ P + K+ DFG ++ LV G
Sbjct: 164 QLFR-----SLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAK----QLVRG- 210
Query: 1044 VRGTLPWM----------APELLNGSNNRVSEKVDVYSFGIAMWEIITGE-----EPYAN 1088
APEL+ G+ + + +DV+S G + E++ G+ + +
Sbjct: 211 -----EPNVSYICSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 1089 --MHCGAIIG--------GILSNTLR---PQIPE---------RCDPEWRKLMEECWSFN 1126
+ ++G + N PQI R PE L +
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 1127 PAARPS 1132
P AR +
Sbjct: 325 PTARLT 330
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 55/277 (19%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
+D + L+ LG GTFG V + + T A+K ++K + + E + E+ ++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVT----ESRVL 59
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLML 986
N HP + A T V EY G L L+R+ + R
Sbjct: 60 QNTRHPFLTALK--------YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----- 106
Query: 987 MMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL 1039
A F +EYLH +++V+ D+K +NL++ D I K+ DFGL C
Sbjct: 107 ---ARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHI-KITDFGL----CKEG 155
Query: 1040 VSGGVR-----GTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA 1093
+S G GT ++APE+L ++ R VD + G+ M+E++ G P+ N
Sbjct: 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 1094 IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
+ IL +R P PE + L+ +P R
Sbjct: 213 LFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 43/256 (16%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+K D E ++ +G G FG V + + T A+K + K + RS FW E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEER 120
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKK 983
I++ + P VV + V EYM G L +++ + ++ +
Sbjct: 121 DIMAFANSPWVVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWAR 171
Query: 984 LMLM-MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS-------RIK 1035
+ A + +H +H D+K DN+L+ D + K+ DFG ++
Sbjct: 172 FYTAEVVLAL--DAIHSMGFIHRDVKPDNMLL---DKSGHL-KLADFGTCMKMNKEGMVR 225
Query: 1036 CNTLVSGGVRGTLPWMAPELL--NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA 1093
C+T V GT +++PE+L G + + D +S G+ ++E++ G+ P+
Sbjct: 226 CDTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280
Query: 1094 IIGGILSNTLRPQIPE 1109
I+++ P+
Sbjct: 281 TYSKIMNHKNSLTFPD 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 17/215 (7%)
Query: 878 EELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSS---EQEWLIKEFWREAHIIS 933
+ + SG++G V G G +AIKR+ + GR+ +L K RE +++
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84
Query: 934 NLHHPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
+ HHPN++ + + M VTE M L V+ + ++ + M
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVRGTL 1048
G+ LH +VH DL N+L+ + DF L+R
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADANKTHYVTHR 197
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ APEL+ ++ VD++S G M E+ +
Sbjct: 198 WYRAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 61/270 (22%), Positives = 112/270 (41%), Gaps = 44/270 (16%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
+ ++ LG+G+FG V K + + A+K + K + + + E + E I+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNE----KRIL 95
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLML 986
++ P +V + V EY+ G + L R R + +
Sbjct: 96 QAVNFPFLVKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY- 146
Query: 987 MMDAA---FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLV 1040
AA EYLH ++++ DLK +NLL+ D Q I +V DFG ++ + TL
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYI-QVTDFGFAKRVKGRTWTLC 199
Query: 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS 1100
GT +APE++ + ++ VD ++ G+ ++E+ G P+ I I+S
Sbjct: 200 -----GTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
Query: 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
+R P + + L+ + R
Sbjct: 253 GKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 35/283 (12%), Positives = 79/283 (27%), Gaps = 61/283 (21%)
Query: 880 LQELGSGTFGTVYRGKWRGTDIAIKR---IKKSCFL-GRSSEQEWLIKEFWREAHIISNL 935
L G W+ D A+ R + F+ + + +++E +S +
Sbjct: 36 LIFHGGVPPLQF----WQALDTALDRQVALT---FVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
P V VV GG + V E++ GSL+ V + M A +
Sbjct: 89 DKPGVARVLDVVHTRAGGLV--VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAAD 143
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
H + + V++ + M
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDG----DVVLAYPAT-------------------MPD-- 178
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN---------TLRPQ 1106
+ + D+ G +++ ++ P + + + +
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149
IP + + ++ + R + T + + + A +T
Sbjct: 232 IPFQISAVAARSVQG----DGGIRSASTLLNLMQQATAVADRT 270
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 44/224 (19%), Positives = 92/224 (41%), Gaps = 24/224 (10%)
Query: 866 IYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIK 923
+ ++ D + +++LG G + V+ + + +K +K ++ K
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKK---K 75
Query: 924 EFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
+ RE I+ NL PN++ +V + T A V E++ N + + + L
Sbjct: 76 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYD 131
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC-NTLVS 1041
M + ++Y H I+H D+K N++++ + + D+GL+ +
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI---DWGLAEFYHPGQEYN 188
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP 1085
V + + PELL +D++S G + +I +EP
Sbjct: 189 VRV-ASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEP 230
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-17
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 67/285 (23%)
Query: 875 SDLEELQELGSGTFGTVY---RGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREA 929
E L+ LG G +G V+ + T A+K +KK+ + + + E R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE--R-- 72
Query: 930 HIISNLHHPNVV----AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD 979
+I+ + HP +V AF Y + EY+ G L L R+ ++
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLY------------LILEYLSGGELFMQLEREGIFME 120
Query: 980 RRKKLMLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
A F + +LH K I++ DLK +N+++ + Q + K+ DFGL
Sbjct: 121 DT--------ACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHV-KLTDFGLC 168
Query: 1033 RI------KCNTLVSGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEP 1085
+ +T GT+ +MAPE+L S NR VD +S G M++++TG P
Sbjct: 169 KESIHDGTVTHTFC-----GTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPP 220
Query: 1086 YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
+ + I IL L +P E R L+++ N A+R
Sbjct: 221 FTGENRKKTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASR 263
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 45/229 (19%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+L+ LG G G V+ +AIK+I +K RE II L
Sbjct: 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--------VLTDPQSVKHALREIKIIRRL 65
Query: 936 HHPNVVAFYGVV-PNGPGGTMAT-----------VTEYMVNGSLRHVLARKDRILDRRKK 983
H N+V + ++ P+G T V EYM + + + +L+ +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHAR 123
Query: 984 L----MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCN 1037
L +L G++Y+H N++H DLK NL +N D K+GDFGL+RI
Sbjct: 124 LFMYQLLR-----GLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGLARIMDP 173
Query: 1038 TLVSGGVR----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
G T + +P LL S N ++ +D+++ G E++TG
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-17
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII--- 932
+ + G GTFGTV GK + G +AIK++ RE I+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRN--------RELQIMQDL 73
Query: 933 SNLHHPNVVAFYGVV-PNGPGGT----MATVTEYM---VNGSLRHVLARKDRILDRRKKL 984
+ LHHPN+V G + V EY+ ++ R+ R+ K+
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 985 ----MLMMDAAFGMEYLHMK--NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KC 1036
++ + LH+ N+ H D+K N+LVN K+ DFG ++
Sbjct: 134 FLFQLIR-----SIGCLHLPSVNVCHRDIKPHNVLVN---EADGTLKLCDFGSAKKLSPS 185
Query: 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
V+ + + APEL+ G+ + + VD++S G E++ GE
Sbjct: 186 EPNVAYIC--SRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLGE 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 75/352 (21%), Positives = 129/352 (36%), Gaps = 61/352 (17%)
Query: 807 SSSSVVPFVQDDVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGI 866
+ ++P V + +C + + + R E +S A A+ I
Sbjct: 113 TGPDLIPEVPRQLVTNCTQRLEQGPCK-------DLFQELTRLTHEYLSVAPFADYLDSI 165
Query: 867 Y----------GLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGR 914
Y Q + + + + LG G FG V + R T A K+++K R
Sbjct: 166 YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 225
Query: 915 SSEQEWLIKEFWREAHIISNLHHPNVV----AFYGVVPNGPGGTMATVTEYMVNGSLRHV 970
E L E I+ ++ VV A+ + V M G L+
Sbjct: 226 KGEAMALN-----EKQILEKVNSRFVVSLAYAYETK------DALCLVLTLMNGGDLKFH 274
Query: 971 LARKDRILDRRKKLMLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023
+ + A F G+E LH + IV+ DLK +N+L+ D I
Sbjct: 275 IYHM------GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHI 325
Query: 1024 CKVGDFGLSR-IKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
++ D GL+ + + G V GT+ +MAPE++ S D ++ G ++E+I G
Sbjct: 326 -RISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS--PDWWALGCLLYEMIAG 381
Query: 1083 EEPY----ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
+ P+ + + + ER P+ R L + +PA R
Sbjct: 382 QSPFQQRKKKIKREEVERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 67/336 (19%), Positives = 129/336 (38%), Gaps = 70/336 (20%)
Query: 830 ETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYG-LQIIKDSDLEELQELGSGTF 888
E DG + E + A + G + + + E L+ LG+G +
Sbjct: 8 HEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAY 67
Query: 889 GTVY-----RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV- 941
G V+ G G A+K +KK+ + ++ E E R ++ ++ P +V
Sbjct: 68 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE--R--QVLEHIRQSPFLVT 123
Query: 942 ---AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
AF + + +Y+ G L L++++R +
Sbjct: 124 LHYAFQTETKLH------------LILDYINGGELFTHLSQRERFTEHE--------VQI 163
Query: 993 -------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-------KCNT 1038
+E+LH I++ D+K +N+L+ D + + DFGLS+ +
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHV-VLTDFGLSKEFVADETERAYD 219
Query: 1039 LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY----ANMHCGAI 1094
GT+ +MAP+++ G ++ + VD +S G+ M+E++TG P+ I
Sbjct: 220 FC-----GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
Query: 1095 IGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
IL + P+ + L++ +P R
Sbjct: 275 SRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.1 bits (210), Expect = 5e-17
Identities = 76/467 (16%), Positives = 154/467 (32%), Gaps = 45/467 (9%)
Query: 678 PVSPGSSVKLSSKDEKSTMTEISQPVTPGSSGKLSVSSQAVANQEWISPSSKLTSAASSR 737
P G+ + + ++ KL S
Sbjct: 149 PSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSE 208
Query: 738 EATINDEDPRIYYNYGAEKIVISRSNEGQNPRIAVHAQVVLSENDDEHNVLKSAVIVEDV 797
E ++ R++V + + D + +
Sbjct: 209 SKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVE----IWDWDLTSRNDFMGSLSFGI 264
Query: 798 TDSIPPGILSSSSVVPFVQDDVSDDCPSPIVTETESAHPDSDHEDVRGDGREVDESISDA 857
++ G+ ++ + + + P P + E + A
Sbjct: 265 SELQKAGVDGWFKLLSQEEGE-YFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTA 323
Query: 858 AMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRS 915
+K +D L LG G+FG V + +GTD A+K +KK +
Sbjct: 324 NTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD 383
Query: 916 SEQEWLIKEFWREAHIIS-NLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLR 968
+ E + E +++ P + + T V EY+ G L
Sbjct: 384 -DVECTM----VEKRVLALPGKPPFLTQLHS--------CFQTMDRLYFVMEYVNGGDLM 430
Query: 969 HVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028
+ + + R + + A G+ +L K I++ DLK DN+++ D + I K+ D
Sbjct: 431 YHIQQVGRFKEPHAVF-YAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHI-KIAD 485
Query: 1029 FGLSRIKCNTLVSGGVR-----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
FG+ C + GV GT ++APE++ + VD ++FG+ ++E++ G+
Sbjct: 486 FGM----CKENIWDGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQ 539
Query: 1084 EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
P+ + I+ + + P+ E + + + +P R
Sbjct: 540 APFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-17
Identities = 66/294 (22%), Positives = 114/294 (38%), Gaps = 62/294 (21%)
Query: 824 PSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIK---------- 873
+ V + D + + R V + A E +Y L+ ++
Sbjct: 127 DAETVARARAGAGDGLFQPLL---RAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMG 183
Query: 874 DSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ + + LG G FG V+ + + T A K++ K R + + E I
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK-GYQGAMVE----KKI 238
Query: 932 ISNLHHPNVV----AFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL 984
++ +H +V AF T V M G +R+ + +D
Sbjct: 239 LAKVHSRFIVSLAYAFE---------TKTDLCLVMTIMNGGDIRYHIYN----VDEDNPG 285
Query: 985 MLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
A F G+E+LH +NI++ DLK +N+L+ D + ++ D GL
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNV-RISDLGL----AV 337
Query: 1038 TLVSGGVR-----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086
L +G + GT +MAPELL G S VD ++ G+ ++E+I P+
Sbjct: 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGPF 389
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-17
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 878 EELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+GSG +G+V K G +AIK++ + F + E K +RE ++ ++
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PF-----QSEIFAKRAYRELLLLKHM 80
Query: 936 HHPNVVAFYGVV-PNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL----MLM 987
H NV+ V P V +M L+ ++ + + + + ML
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLK 137
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVR 1045
G++Y+H +VH DLK NL VN C K+ DFGL+R + +G V
Sbjct: 138 -----GLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGYV- 184
Query: 1046 GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
T + APE++ S ++ VD++S G M E++TG+
Sbjct: 185 VTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 1e-16
Identities = 67/274 (24%), Positives = 123/274 (44%), Gaps = 52/274 (18%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D + L+ LG+G+FG V+ + R A+K +KK + R + E E ++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDE----RLML 60
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLML 986
S + HP ++ +G T + +Y+ G L +L + R +
Sbjct: 61 SIVTHPFIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----- 107
Query: 987 MMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KC 1036
A F +EYLH K+I++ DLK +N+L+ D I K+ DFG ++
Sbjct: 108 ---AKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHI-KITDFGFAKYVPDVT 160
Query: 1037 NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096
TL GT ++APE+++ ++ +D +SFGI ++E++ G P+ + +
Sbjct: 161 YTLC-----GTPDYIAPEVVS--TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 213
Query: 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
IL+ LR P + + + L+ + + + R
Sbjct: 214 KILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 66/287 (22%), Positives = 118/287 (41%), Gaps = 65/287 (22%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D + L+ +G G++ V + + TD A+K +KK + +W+ E H+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDWVQ----TEKHVF 63
Query: 933 S-NLHHPNVV----AFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL 984
+HP +V F T + V EY+ G L + R+ ++ +
Sbjct: 64 EQASNHPFLVGLHSCFQ---------TESRLFFVIEYVNGGDLMFHMQRQRKLPEEH--- 111
Query: 985 MLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
A F + YLH + I++ DLK DN+L+ D + I K+ D+G+ C
Sbjct: 112 -----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGM----CK 158
Query: 1038 TLVSGGVR-----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG 1092
+ G GT ++APE+L G + S VD ++ G+ M+E++ G P+ +
Sbjct: 159 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSS 216
Query: 1093 AIIGG---------ILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
IL +R IP + +++ + +P R
Sbjct: 217 DNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 70/338 (20%), Positives = 132/338 (39%), Gaps = 71/338 (21%)
Query: 824 PSPIVTETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQEL 883
+ + + E E+++ + + + GLQ D + L+ +
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSL-GLQ-----DFDLLRVI 60
Query: 884 GSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS-NLHHPNV 940
G G++ V + + TD A++ +KK + +W+ E H+ +HP +
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-DIDWVQ----TEKHVFEQASNHPFL 115
Query: 941 V----AFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF- 992
V F T + V EY+ G L + R+ ++ + A F
Sbjct: 116 VGLHSCFQ---------TESRLFFVIEYVNGGDLMFHMQRQRKLPEEH--------ARFY 158
Query: 993 ------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR- 1045
+ YLH + I++ DLK DN+L+ D + I K+ D+G+ C + G
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGM----CKEGLRPGDTT 210
Query: 1046 ----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGG---- 1097
GT ++APE+L G + S VD ++ G+ M+E++ G P+ +
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268
Query: 1098 -----ILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
IL +R IP + +++ + +P R
Sbjct: 269 YLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 880 LQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
L+ +GSG G V ++AIK++ + F + + K +RE ++ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PF-----QNQTHAKRAYRELVLMKCVNH 83
Query: 938 PNVVAFYGVV-PNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
N++ V P V E M + +L V+ + + +R L+ M G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-QMELDHERMSYLLYQM--LCG 139
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVRGTLPWM 1051
+++LH I+H DLK N++V C K+ DFGL+R + + T +
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRYYR 193
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
APE++ E VD++S G M E+I G
Sbjct: 194 APEVI--LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 48/252 (19%), Positives = 85/252 (33%), Gaps = 68/252 (26%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRI---KKSCFLGRSSEQEWLIKEFWREAHII 932
+ LG+G+FG V G A+K++ + RE I+
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---------------RELDIM 54
Query: 933 SNLHHPNVVA----FYGVVPNGPGGTMAT------------------------------- 957
L H N++ FY P
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 958 -VTEYM---VNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLL 1013
+ EY+ ++ L+ + I + + + ++H I H D+K NLL
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 1014 VNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYS 1071
VN + K+ DFG ++ V+ + + APEL+ G+ + +D++S
Sbjct: 174 VN---SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATE-YTPSIDLWS 227
Query: 1072 FGIAMWEIITGE 1083
G E+I G+
Sbjct: 228 IGCVFGELILGK 239
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 56/278 (20%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D + LG G+FG V+ +++ T+ AIK +KK L + E + E ++
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECTM----VEKRVL 71
Query: 933 S-NLHHPNVV----AFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL 984
S HP + F T V EY+ G L + + + R
Sbjct: 72 SLAWEHPFLTHMFCTFQ---------TKENLFFVMEYLNGGDLMYHIQSCHKFDLSR--- 119
Query: 985 MLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
A F G+++LH K IV+ DLK DN+L+ D I K+ DFG+ C
Sbjct: 120 -----ATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHI-KIADFGM----CK 166
Query: 1038 TLVSGGVR-----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG 1092
+ G + GT ++APE+L G + + VD +SFG+ ++E++ G+ P+
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
+ I + P + E + L+ + + P R
Sbjct: 225 ELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 1e-15
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 67/284 (23%)
Query: 875 SDLEELQELGSGTFGTVY-----RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
S E L+ LG G+FG V+ G A+K +KK+ R + E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKM-----ER 77
Query: 930 HIISNLHHPNVV----AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILD 979
I+ ++HP +V AF Y + +++ G L L+++ +
Sbjct: 78 DILVEVNHPFIVKLHYAFQTEGKLY------------LILDFLRGGDLFTRLSKEVMFTE 125
Query: 980 RRKKLMLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032
F +++LH I++ DLK +N+L+ D + I K+ DFGLS
Sbjct: 126 ED--------VKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHI-KLTDFGLS 173
Query: 1033 RIKCNTLVSGGVR-----GTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPY 1086
+ + + GT+ +MAPE++N + D +SFG+ M+E++TG P+
Sbjct: 174 KES----IDHEKKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLPF 226
Query: 1087 ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
+ IL L +P+ PE + L+ + NPA R
Sbjct: 227 QGKDRKETMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 58/299 (19%)
Query: 855 SDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFL 912
+++ G+ + + E ++ LG G+FG V + + T A+K +KK L
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 913 GRSSEQEWLIKEFWREAHIIS-NLHHPNVV----AFYGVVPNGPGGTMAT---VTEYMVN 964
+ E + E I+S +HP + F T V E++
Sbjct: 63 QDD-DVECTM----TEKRILSLARNHPFLTQLFCCFQ---------TPDRLFFVMEFVNG 108
Query: 965 GSLRHVLARKDRILDRRKKLMLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLR 1017
G L + + R + R A F + +LH K I++ DLK DN+L+
Sbjct: 109 GDLMFHIQKSRRFDEAR--------ARFYAAEIISALMFLHDKGIIYRDLKLDNVLL--- 157
Query: 1018 DPQRPICKVGDFGLSRIKCNTLVSGGVR-----GTLPWMAPELLNGSN-NRVSEKVDVYS 1071
D + K+ DFG+ C + GV GT ++APE+L VD ++
Sbjct: 158 DHEGHC-KLADFGM----CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPA---VDWWA 209
Query: 1072 FGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
G+ ++E++ G P+ + + IL++ + P + +++ + NP R
Sbjct: 210 MGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 63/322 (19%), Positives = 112/322 (34%), Gaps = 44/322 (13%)
Query: 782 DDEHNVLKSAVIVEDVTDSIPPGILS--SSSVVPFVQDDVSDDCPSP-IVTETESAHPDS 838
+E ++ S I + S S + VQ + P + +
Sbjct: 97 TEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQN 156
Query: 839 DHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRG 898
DV E D+ +E + +D + +G G FG VY +
Sbjct: 157 LRGDVFQKFIESDKFTRFCQWKNVELN----IHLTMNDFSVHRIIGRGGFGEVYGCRKAD 212
Query: 899 TDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHI---ISNLHHPNVVAFYGVVPNGPGG 953
T A+K + K + E L E + +S P +V
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALN-----ERIMLSLVSTGDCPFIVCMSY-------- 259
Query: 954 TMAT------VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA---FGMEYLHMKNIVH 1004
T + + M G L + L++ + + AA G+E++H + +V+
Sbjct: 260 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY----AAEIILGLEHMHNRFVVY 315
Query: 1005 FDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVS 1064
DLK N+L+ D + ++ D GL+ V GT +MAPE+L
Sbjct: 316 RDLKPANILL---DEHGHV-RISDLGLACDFSKKKPHASV-GTHGYMAPEVLQ-KGVAYD 369
Query: 1065 EKVDVYSFGIAMWEIITGEEPY 1086
D +S G +++++ G P+
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPF 391
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 874 DSDLEELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ +LQ +GSG +G V G +AIK++ + F + E K +RE +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PF-----QSELFAKRAYRELRL 77
Query: 932 ISNLHHPNVVAFYGVV-PNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL--- 984
+ ++ H NV+ V P+ V +M L ++ + +++ + R +
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVY 135
Query: 985 -MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVS 1041
ML G+ Y+H I+H DLK NL VN C K+ DFGL+R + + +
Sbjct: 136 QMLK-----GLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEM-T 183
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
G V T + APE++ + R ++ VD++S G M E+ITG+
Sbjct: 184 GYV-VTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 43/228 (18%)
Query: 878 EELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ LG G +G V K G +AIK+I F ++ RE I+ +
Sbjct: 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPF-----DKPLFALRTLREIKILKHF 66
Query: 936 HHPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL----MLMM 988
H N++ + + + E M + H + + D + L
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIYQTLR- 123
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSR-IKCNTLVSGGVR 1045
++ LH N++H DLK NLL+N C KV DFGL+R I + +
Sbjct: 124 ----AVKVLHGSNVIHRDLKPSNLLINSN------CDLKVCDFGLARIIDESAADNSEPT 173
Query: 1046 GTLPWM----------APELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
G M APE++ ++ + S +DV+S G + E+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L+ +GSG G V D +AIK++ + F + + K +RE ++ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PF-----QNQTHAKRAYRELVLMKCV 118
Query: 936 HHPNVVAFYGVVPNGPGGTMAT----VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+H N+++ V V E M + + + + +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLC- 175
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVRGTLP 1049
G+++LH I+H DLK N++V C K+ DFGL+R + + T
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ APE++ E VD++S G M E++ +
Sbjct: 229 YRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 56/278 (20%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
+D L LG G+FG V + +GTD A+K +KK + + E + E ++
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-DVECTM----VEKRVL 74
Query: 933 S-NLHHPNVV----AFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL 984
+ P + F TM V EY+ G L + + + R +
Sbjct: 75 ALPGKPPFLTQLHSCFQ---------TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH--- 122
Query: 985 MLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
A F G+ +L K I++ DLK DN+++ D + I K+ DFG+ C
Sbjct: 123 -----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHI-KIADFGM----CK 169
Query: 1038 TLVSGGVR-----GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG 1092
+ GV GT ++APE++ + VD ++FG+ ++E++ G+ P+
Sbjct: 170 ENIWDGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227
Query: 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
+ I+ + + P+ E + + + +P R
Sbjct: 228 ELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-15
Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 64/285 (22%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDI--AIKRIKKSCFLGRSSEQEWLIKEFWREA 929
K SD L+ +G G+FG V + + ++ A+K ++K L + E++ ++ E R
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-EEKHIMSE--R-- 89
Query: 930 HI-ISNLHHPNVV----AF------YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRIL 978
++ + N+ HP +V +F Y V +Y+ G L + L R+ L
Sbjct: 90 NVLLKNVKHPFLVGLHFSFQTADKLY------------FVLDYINGGELFYHLQRERCFL 137
Query: 979 DRRKKLMLMMDAAF-------GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031
+ R A F + YLH NIV+ DLK +N+L+ D Q I + DFGL
Sbjct: 138 EPR--------ARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHI-VLTDFGL 185
Query: 1032 SRIKCNTLVSGGVR-----GTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEP 1085
C + GT ++APE+L+ +R VD + G ++E++ G P
Sbjct: 186 ----CKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT---VDWWCLGAVLYEMLYGLPP 238
Query: 1086 YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR 1130
+ + + + IL+ L+ + R L+E + R
Sbjct: 239 FYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKR 281
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L +GSG +G+V G +A+K++ + F + K +RE ++ ++
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PF-----QSIIHAKRTYRELRLLKHM 85
Query: 936 HHPNVVAFYGVVPNGPGGTMAT------VTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
H NV+ V P ++ VT M L +++ K + L L+
Sbjct: 86 KHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIV--KCQKLTDDHVQFLIYQ 140
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVRGT 1047
G++Y+H +I+H DLK NL VN C K+ DFGL+R + + +G V T
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLARHTADEM-TGYV-AT 192
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
+ APE++ + ++ VD++S G M E++TG
Sbjct: 193 RWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 878 EELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
L +G G +G V +AIK+I S F E + + RE I+
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-----EHQTYCQRTLREIKILLRF 82
Query: 936 HHPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL----MLMM 988
H N++ ++ M V + M + + L + + + +L
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLYQILR- 139
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVR- 1045
G++Y+H N++H DLK NLL+N C K+ DFGL+R+ G
Sbjct: 140 ----GLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLT 189
Query: 1046 ---GTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
T + APE++ ++ ++ +D++S G + E+++
Sbjct: 190 EYVATRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 52/249 (20%), Positives = 91/249 (36%), Gaps = 53/249 (21%)
Query: 878 EELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+G G++G VY K ++AIK++ + F E K RE I++ L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MF-----EDLIDCKRILREITILNRL 82
Query: 936 HHPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKL----MLMM 988
++ Y ++ V E + L+ + + + K +L+
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLL- 140
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVRG 1046
G ++H I+H DLK N L+N +D C KV DFGL+R + + V
Sbjct: 141 ----GENFIHESGIIHRDLKPANCLLN-QD-----CSVKVCDFGLARTINSEKDTNIVND 190
Query: 1047 TLPWM-----------------------APELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
APEL+ N ++ +D++S G E++
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN-YTKSIDIWSTGCIFAELLNML 249
Query: 1084 EPYANMHCG 1092
+ + N
Sbjct: 250 QSHINDPTN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 59/243 (24%), Positives = 81/243 (33%), Gaps = 59/243 (24%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E +G+G++G V + +AIK+I R E K RE I++ L
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI------LRVFEDLIDCKRILREIAILNRL 109
Query: 936 HHPNVVAFYGVVPNGPGGTMAT---VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
+H +VV +V V E S L R L L+ +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRIKCNTLVSGGVRGTLPW 1050
G++Y+H I+H DLK N LVN C KV DFGL+R P
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 1051 M----------------------------APELLNGSNNRVSEKVDVYSFGIAMWEI--I 1080
APEL+ N Y+ I +W I I
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN--------YTEAIDVWSIGCI 273
Query: 1081 TGE 1083
E
Sbjct: 274 FAE 276
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 1e-12
Identities = 41/275 (14%), Positives = 74/275 (26%), Gaps = 64/275 (23%)
Query: 870 QIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+ L+ +++G G FG V++ T +AIK I + + +E E
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 930 HIISNLH---------HPNVVAFYGVV----------------------------PNGPG 952
I L + V
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDN 1011
+ V E+ G + K L K ++ + + H DL N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQL--TASLAVAEASLRFEHRDLHWGN 192
Query: 1012 LLVNLRDPQRPICKVG----------------DFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
+L+ ++ + D+ LSR++ G V M +L
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE----RDGIVVFCDVSMDEDL 248
Query: 1056 LNGSNNRVSEKVDVYSF-GIAMWEIITGEEPYANM 1089
G + + D+Y PY+N+
Sbjct: 249 FTGDGDY---QFDIYRLMKKENNNRWGEYHPYSNV 280
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 51/236 (21%)
Query: 878 EELQELGSGTFGTVYRG--KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E +++LG G +G V++ + G +A+K+I F + + +RE I++ L
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AF-----QNSTDAQRTFREIMILTEL 65
Query: 936 H-HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL----MLMMDA 990
H N+V V+ + V +YM + H + R + + K+ ++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLIK--- 120
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC--KVGDFGLSRI------------KC 1036
++YLH ++H D+K N+L+N C KV DFGLSR
Sbjct: 121 --VIKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 1037 NTLVSGGVRGTLPWM----------APELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082
+ P + APE+L GS + ++ +D++S G + EI+ G
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCG 227
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 1e-11
Identities = 72/508 (14%), Positives = 143/508 (28%), Gaps = 157/508 (30%)
Query: 248 LDALISVCSDEDLHHMIEEYQEQERI---------GGSQRLRIFLVSLGEPDSP---NSL 295
D S+ S E++ H+I + ++ F+ + + + +
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98
Query: 296 EGKTTQQTDADNQYVSAVNGMLDASPRKSSSGQTLTSHTTQMGRDSPTFAYISEIKDHSL 355
+ + Q + Y+ + R + Q + R P +++ L
Sbjct: 99 KTEQRQPSMMTRMYIEQRD-------RLYNDNQVFAKYNVS--RLQP----YLKLRQALL 145
Query: 356 N---SSNVG--GMFSNNANRLPPICVAGKSLNPSVPVTTFSSQSIDPFNSNAHFYVDWPC 410
+ NV G+ +GK+ V + S + F+++
Sbjct: 146 ELRPAKNVLIDGVLG-----------SGKT---WVALDVCLSYKVQCKMDFKIFWLNL-- 189
Query: 411 DGNGNDNPCVMDKF--LCDHSYDVNSLSHYDNLHDHHPLMNYHKHN-----QNLVETDQT 463
N N V++ L + D N + + DH + H+ + L+++
Sbjct: 190 -KNCNSPETVLEMLQKLL-YQIDPN----WTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 464 NNCHLHLHNCGLSRDI----------VHC-----TPERVLSD-------SRLRVHDNSST 501
NC L L ++ + C T + ++D + + + +S T
Sbjct: 244 ENCLLVL------LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 502 HRLEE---------GIISQS-PRNIGRAKSP---SVVSSSSRGFSMHWQ---DVIDEKHQ 545
+E Q PR + +P S+++ S R W V +K
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREV-LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT 356
Query: 546 GT--TCKN-------QPSFKML----ES------------CNDNFKTVQEI--KAMNGNL 578
+ N + F L S + V + K +L
Sbjct: 357 TIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 579 ASSDP-------HWKHHIGNKEVTPNNKAIENKI--NYQPSSNLPIRD-SPNSGSSNFSL 628
P ++ K N A+ I +Y D P
Sbjct: 417 VEKQPKESTISIP-SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD----- 470
Query: 629 QIATAESSAGFIIEHLYGYQLDTTTMPE 656
+ H+ G+ L PE
Sbjct: 471 ---------QYFYSHI-GHHLKNIEHPE 488
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 1e-11
Identities = 100/697 (14%), Positives = 193/697 (27%), Gaps = 237/697 (34%)
Query: 442 HDHHPLMNYHKHNQNLVETDQTNNCHLHLHNCGLSRDIVHCTPERVLSDSRLRVHDNSST 501
H HH M++ ET + +DI+ + + + D
Sbjct: 1 HHHHHHMDF--------ETGE-----HQYQY----KDILSVFEDAFVDN--FDCKD---V 38
Query: 502 HRLEEGIISQSP-RNIGRAKSPSVVSSSSRGFSMHW----------QDVIDEKHQ----- 545
+ + I+S+ +I S VS + R F W Q ++E +
Sbjct: 39 QDMPKSILSKEEIDHI--IMSKDAVSGTLRLF---WTLLSKQEEMVQKFVEEVLRINYKF 93
Query: 546 -----GTTCKNQPS--FKMLESC-----NDN----------FKTVQEIKA---------- 573
T + QPS +M NDN + +++
Sbjct: 94 LMSPIKTEQR-QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 574 -----MNGN----LASS---DP----------HWKHHIGNKEVTPNNKAIENKINYQPSS 611
+ G+ +A W ++ N + K+ YQ
Sbjct: 153 VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL-NLKNCNSPETVLEMLQKLLYQIDP 211
Query: 612 NLPIRDSPNSGSSNFSLQIATAESS-AGFIIEHLYGYQL----DTTTMPEFQVKNSNATK 666
N S + SSN L+I + ++ + Y L + V+N+ A
Sbjct: 212 NW---TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN--------VQNAKAWN 260
Query: 667 --DEKCA--LT----EISQPVSPGSSVKLSSKDEKSTMTE-----ISQPVTPGSSGKLSV 713
+ C LT +++ +S ++ +S T+T + L
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL-- 318
Query: 714 SSQAVANQEWISPSSKLTSAASSRE--ATINDEDPRIYY-NYGAEKI--VISRSNEGQNP 768
+ + +P A S R+ AT + + + +K+ +I S
Sbjct: 319 PREVLT----TNPRRLSIIAESIRDGLATWD------NWKHVNCDKLTTIIESSLN---- 364
Query: 769 RIAVHAQVVLSENDDEHNVLKSAVIVEDVTDSIPPGILSSSSVVPFVQDDVSDDCPSPIV 828
VL + + +V IP +LS + DV +V
Sbjct: 365 --------VLEPAEYRKMFDRLSVFPPSA--HIPTILLSL------IWFDVIKSDVMVVV 408
Query: 829 TETESAHPDSDHEDVRGDGREVDESISDAAMAEMEAGIYGLQIIKDSDLEELQELGSGTF 888
+ S+ + E I + + LE L +
Sbjct: 409 NKL------------------HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR-SI 449
Query: 889 GTVYRG--KWRGTDIAIKRIKK--SCFLG---RSSEQEWLIKEF--------WREAHIIS 933
Y + D+ + + +G ++ E + F + E I
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRH 509
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTE---YMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
+ N G + T+ + Y K I D K +++A
Sbjct: 510 D----------STAWNASGSILNTLQQLKFY------------KPYICDNDPKYERLVNA 547
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027
I+ F K + L+ + ++
Sbjct: 548 -----------ILDFLPKIEENLI--CSKYTDLLRIA 571
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 1e-09
Identities = 93/649 (14%), Positives = 161/649 (24%), Gaps = 212/649 (32%)
Query: 41 EEFSSEFLRDRVAVRRITVMNDGKYLQTIQAGVNINQNHQVVCGDLNGIVGLRRM----D 96
F F+ + D K +Q + + + + + + G R+
Sbjct: 23 SVFEDAFVDNF----------DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLL 72
Query: 97 NEGNANASDFAETFGYAVEAKKNNYPDNLSRCQLQYGAVGQNSGIF-FYENHCDQVATEL 155
++ F E E + NY +S + + Q S + Y D++ +
Sbjct: 73 SKQEEMVQKFVE------EVLRINYKFLMSPIKTEQR---QPSMMTRMYIEQRDRLYNDN 123
Query: 156 SGSPVYVVESPQSYH----------P------CG-PGYAESPFT----RKMKFLCSFGGR 194
Y V Q Y P G G ++ K C +
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK 183
Query: 195 IFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLPGEDLDALISV 254
IF W L CN P T+ L + L I
Sbjct: 184 IF-------------------------W--L---NLKNCNSPETVLEML--QKLLYQIDP 211
Query: 255 CSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLGEPDSPNSLEGKTTQQTDADN-QYVSAV 313
H I LR L N L N Q A
Sbjct: 212 NWTSRSDHSSNIKLRIHSI--QAELRRLLK---SKPYENCL-------LVLLNVQNAKAW 259
Query: 314 NGMLDASPRKSSSGQTLTSHTTQMGRDSPTFAYIS--EIKDHSLNSSNVG-------GMF 364
N + S + L TT R ++S SL+ ++ +
Sbjct: 260 NAF-NLSCK------ILL--TT---RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 365 SNNAN----RLPP---------ICVAGKSLNPSV------------PVTTFSSQSIDPFN 399
+ LP + + +S+ + +TT S++
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 400 SNA--HFYVD------------------WPCDGNGNDNPCVMDKF----LCD-------- 427
+ W D +D V++K L +
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIW-FDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 428 --HSYDVNSLSHYDNLHDHH--------PLMNYHKHNQNLVETDQTNNCHL--HLHNCGL 475
S + +N + H + + DQ H+ HL N
Sbjct: 427 SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH 486
Query: 476 SRDIVHCTPERVLSDSRLRVHDNSSTHRLEEGIISQSPRNIGRAKSPSVVSSSSRGFSMH 535
+ V D R LE+ I S + +
Sbjct: 487 PERMT--LFRMVFLDFRF----------LEQKIRHDSTAWNASGSILNTL---------- 524
Query: 536 WQDVIDEKHQGTTCKNQPSFKMLESCNDNFKTVQEIKAMNGNLASSDPH 584
Q + + ++ C N P ++ L + +F + + NL S +
Sbjct: 525 -QQL--KFYKPYICDNDPKYERLVNAILDF-----LPKIEENLICS-KY 564
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 8e-07
Identities = 89/638 (13%), Positives = 176/638 (27%), Gaps = 204/638 (31%)
Query: 642 EHLYGYQLDTTTMPEFQVKNSNATKDEKCA-LTEISQPVSPGSSVK--LSSKDEKSTMTE 698
EH Y Y+ D + F+ + C + ++ + + + + SKD S
Sbjct: 13 EHQYQYK-DI--LSVFE---DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 699 I-----SQPVTPGSSGKLSVSSQAVANQEWI---------SPSSKLTSAASSREATINDE 744
+ S+ + V N +++ PS R+ ND
Sbjct: 67 LFWTLLSKQ---EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 745 DPRIYYNYGAEKIVISRSNEGQNPRIAVHAQVVLSENDDEHNVL--------KSAVIVE- 795
YN +SR R A L E NVL K+ V ++
Sbjct: 124 QVFAKYN-------VSRLQPYLKLRQA------LLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 796 ----DVTDSIPPGIL--------SSSSVVPFVQD---------DVSDDCPSPIVTETESA 834
V + I S +V+ +Q D S I S
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 835 ------------HPDS----DHEDVRGDGREV--------------DESISDAAMAEMEA 864
+ + +V+ + + + ++D A
Sbjct: 231 QAELRRLLKSKPYENCLLVLL--NVQ-NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 865 GIYGLQIIKDSDLEELQELGSGTFGTVYRGKWRGTDI-------------AIKRIKKSCF 911
I +E++ L K+ + I +S
Sbjct: 288 HISLDHHSMTLTPDEVKSL----L-----LKYLDCRPQDLPREVLTTNPRRLSIIAESIR 338
Query: 912 LGRSSEQEWLIKEFWREAHIIS----NLHHPNVVAFY---GVVPNG---PGGTMATVTEY 961
G ++ W + II L + V P P ++ +
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD 398
Query: 962 MVNGSLRHVLA--RKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP 1019
++ + V+ K +++++ K + + ++ +LK N
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTI--------SIPS---IYLELKVKLE--NEYAL 445
Query: 1020 QRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFG-IA--M 1076
R I V + + + + ++ + +D Y + I +
Sbjct: 446 HRSI--VDHYNIPKTFDS----------------------DDLIPPYLDQYFYSHIGHHL 481
Query: 1077 WEIITGEEP------YANM--------HCGAIIG--GILSNTL------RPQIPERCDPE 1114
I E + + H G + NTL +P I + DP+
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DPK 540
Query: 1115 WRKLMEECWSFNPAARPSF--TEITNRLRVMSTALQTK 1150
+ +L+ F P + ++ T+ LR+ AL +
Sbjct: 541 YERLVNAILDFLPKIEENLICSKYTDLLRI---ALMAE 575
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 8e-04
Identities = 42/295 (14%), Positives = 92/295 (31%), Gaps = 72/295 (24%)
Query: 11 QPLCRDRGNVVSSNRVDAERSVNNVCLQTGE--EFSSEFLRDRVAVRRITVMNDGKYLQT 68
Q L + N +N+ L+ L+ + + V+ + + +
Sbjct: 203 QKLLYQ----IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA 258
Query: 69 IQAGVNIN-------QNHQVVCGDLNGIVGLRRMDNEGNANASDFAETFGYAVEAKK-NN 120
A N++ + QV + + + ++ ++ K +
Sbjct: 259 WNA-FNLSCKILLTTRFKQVT----DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 121 YPDNLSR--CQ---LQYGAVGQNSGIF-----FYEN-HCDQVATELSGSPVYVVESPQSY 169
P +L R + + ++ +++ +CD++ T + S V P Y
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS--LNVLEPAEY 371
Query: 170 HPCGPGYAESPFTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEEL---- 225
RKM S +FP I +I SL W ++
Sbjct: 372 -------------RKMFDRLS----VFPP-----------SAHIPTILLSLIWFDVIKSD 403
Query: 226 -------MRKTSAICNQPHTIKYQLPGEDLDALISVCSDEDLHH-MIEEYQEQER 272
+ K S + QP +P L+ + + ++ LH +++ Y +
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 43/217 (19%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 880 LQELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH- 936
+++LG G F TV+ K T +A+K ++ ++E E + + +A
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 937 -HPNVVAFYG--VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF- 992
+++ G + V E + +L ++ + + R L+ + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQ 139
Query: 993 ---GMEYLHMK-NIVHFDLKCDNLLVNLRDPQ--RPICKVGDFGLSRIKCNTLVSGGVRG 1046
G++Y+H + I+H D+K +N+L+ + D K+ D G + +
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ-- 197
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
T + +PE+L G+ D++S ++E+ITG+
Sbjct: 198 TREYRSPEVLLGA--PWGCGADIWSTACLIFELITGD 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 34/166 (20%), Positives = 59/166 (35%), Gaps = 21/166 (12%)
Query: 883 LGSGTFGTVYRG-KWRGTDIAIKRIKKSCFLGRSSEQ---EWLIKEFWREAHIISNLHHP 938
+G G FG +Y + + E + + I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 939 NVVAFYGVVPN--GPGGTMATVTEY--MV----NGSLRHVLARKDRILDRRKKLML---M 987
+ + GV P G G Y M+ L+ + + R+ L L +
Sbjct: 103 RKLKYLGV-PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 988 MDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
+D +EY+H VH D+K NLL+N ++P + + D+GL+
Sbjct: 162 LDI---LEYIHEHEYVHGDIKASNLLLNYKNPDQ--VYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 25/160 (15%)
Query: 881 QELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH- 937
+++GSG+FG +Y G G ++AIK ++ L E + ++
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC------VKTKHPQLHIE-SKIYKMMQGGVGI 67
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMV----NGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
P + G G MV SL + R + L+L
Sbjct: 68 PTIRWC------GAEGDY----NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
+EY+H KN +H D+K DN L+ L + + DFGL++
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 37/165 (22%), Positives = 64/165 (38%), Gaps = 22/165 (13%)
Query: 883 LGSGTFGTVYRGK--WRGTDIAIKRIKK-----------SCFLGRSSEQEWLIKEFWREA 929
+GSG FG +Y + A +K F R ++++ + K W E
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK--WIER 102
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMM 988
+ L P G+ V E + G L+ + ++ + L L +
Sbjct: 103 KQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGI 158
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
+EY+H VH D+K NLL+ ++P + + D+GLS
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ--VYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 19/158 (12%)
Query: 881 QELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH- 937
+++G G FG + GK + +AIK S L E +R + +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLE-YRFYKQLGSGDGI 67
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
P V ++G G A V E + G SL + DR + LM+ + MEY
Sbjct: 68 PQVY-YFGPC----GKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRP-ICKVGDFGLSR 1033
+H KN+++ D+K +N L+ + + + DF L++
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 37/158 (23%), Positives = 67/158 (42%), Gaps = 19/158 (12%)
Query: 881 QELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH- 937
+ +G G+FG ++ G +AIK R S+ L E +R +++
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLRDE-YRTYKLLAGCTGI 68
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
PNV ++G G V + + G SL +L R + M ++
Sbjct: 69 PNVY-YFGQE----GLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRP-ICKVGDFGLSR 1033
+H K++V+ D+K DN L+ + + + V DFG+ +
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 14/95 (14%)
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT----LVSGGVRGTL 1048
++ LH I+H DLK +N+L L+ R KV DFG S + + S R
Sbjct: 212 CLDALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--- 266
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
APE++ G+ R +D++S G + E++TG
Sbjct: 267 ---APEVILGA--RYGMPIDMWSLGCILAELLTGY 296
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 25/160 (15%)
Query: 881 QELGSGTFGTVYRGK--WRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH- 937
+++GSG+FG +Y G ++AIK ++ L+ E + I+
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLEN------VKTKHPQLLYE-SKIYRILQGGTGI 65
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMV----NGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
PNV F G G +V SL + R L + LML
Sbjct: 66 PNVRWF------GVEGDYN----VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033
+E++H K+ +H D+K DN L+ + + DFGL++
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAK 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 29/181 (16%), Positives = 62/181 (34%), Gaps = 41/181 (22%)
Query: 883 LGSGTFGTVYRG----------KWRGTDIAIK-------RIKKSCFLGRSSEQEWLIKEF 925
G +Y + ++K + F R+++ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV--NK 107
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMV----NGSLRHVLARKDR-ILDR 980
W++ + L P + F G ++V SL+ L + +L
Sbjct: 108 WKKLYSTPLLAIPTCMGF---------GVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSE 158
Query: 981 RKKLML---MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
R L + ++DA +E+LH VH ++ +N+ V+ D + + +G + C
Sbjct: 159 RSVLQVACRLLDA---LEFLHENEYVHGNVTAENIFVDPEDQSQ--VTLAGYGFAFRYCP 213
Query: 1038 T 1038
+
Sbjct: 214 S 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 48/266 (18%), Positives = 91/266 (34%), Gaps = 75/266 (28%)
Query: 880 LQELGSGTFGTVY--RGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI-ISNLH 936
+++LG G F TV+ +A+K + KS E + E + S+ +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS----AEHYTETALDEIRLLKSVRNSDPN 96
Query: 937 HPNVVAFYGVVP--------NGPGGT-MATVTEYMVNG-SLRHVLAR-KDRILDRRKKLM 985
PN +V +G GT + V E + G L + + + L
Sbjct: 97 DPN----REMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK 150
Query: 986 LMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDP------------------------- 1019
++ G++YLH K I+H D+K +N+L+++ +
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 1020 --------------------QRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGS 1059
++ K+ D G + T + + E+L GS
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGS 268
Query: 1060 NNRVSEKVDVYSFGIAMWEIITGEEP 1085
+ D++S +E+ TG+
Sbjct: 269 --GYNTPADIWSTACMAFELATGDYL 292
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 43/222 (19%)
Query: 880 LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREA------HI 931
+G G+FG V + R +AIK IK ++ E + E + +I
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR----ILDRRKKLMLM 987
+ H F + V E + + +L +L + + RK M
Sbjct: 119 VHLKRH-----FMF------RNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 988 MDAAFGMEYLHMK--NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT----LVS 1041
A + +L +I+H DLK +N+L L +P+R K+ DFG S + S
Sbjct: 167 CTA---LLFLATPELSIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 221
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE 1083
R +PE+L G +D++S G + E+ TGE
Sbjct: 222 RFYR------SPEVLLGM--PYDLAIDMWSLGCILVEMHTGE 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1157 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 2cu1_A | 103 | Mitogen-activated protein kinase kinase kinase 2; | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 1vd2_A | 89 | Protein kinase C, IOTA type; PB1 domain, OPCA moti | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.97 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.08 | |
| 2jrh_A | 94 | Mitogen-activated protein kinase kinase kinase 3; | 97.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.95 | |
| 2c60_A | 111 | Human mitogen-activated protein kinase kinase kina | 96.88 | |
| 2npt_B | 100 | Mitogen-activated protein kinase kinase kinase 2; | 96.83 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.48 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.44 | |
| 1q1o_A | 98 | Cell division control protein 24; PB1 domain, PCCR | 96.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.19 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.79 | |
| 1pqs_A | 77 | Cell division control protein 24; alpha and beta p | 95.77 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.7 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.93 | |
| 2ktr_A | 117 | Sequestosome-1; autophagy, NF-KB signaling, HOMO-o | 94.8 | |
| 2kkc_A | 102 | Sequestosome-1; P62, PB1, autophagy, ubiquitin-pro | 94.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.94 | |
| 1wmh_B | 86 | Partitioning defective-6 homolog alpha; kinase, PB | 93.08 | |
| 1oey_A | 83 | P67-PHOX, neutrophil cytosol factor 2; immune syst | 92.99 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.04 | |
| 1wj6_A | 101 | KIAA0049 protein, RSGI RUH-024; PB1 domain, protei | 90.5 | |
| 1ip9_A | 85 | BEM1 protein; ubiquitin alpha/beta roll, signaling | 90.31 | |
| 2bkf_A | 87 | Zinc-finger protein NBR1 (NEXT to breast cancer 1; | 89.97 | |
| 1oey_J | 107 | P40-PHOX, neutrophil cytosol factor 4; immune syst | 87.31 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=461.82 Aligned_cols=268 Identities=30% Similarity=0.559 Sum_probs=223.9
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.|++..+++++.++||+|+||+||+|++++ .||||+++... .. ....+.|.+|+++|++|+|||||++++++.
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~---~~---~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVD---PT---PEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSS---CC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecC---CC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 467888999999999999999999999875 59999987532 11 223578999999999999999999999875
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ +.+|||||||++|+|.++|......+++..++.|+.|++.||+|||+++||||||||+|||++ .++.+||+|
T Consensus 103 ~---~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~----~~~~~Ki~D 175 (307)
T 3omv_A 103 K---DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH----EGLTVKIGD 175 (307)
T ss_dssp S---SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE----TTEEEEECC
T ss_pred C---CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC----CCCcEEEee
Confidence 4 358999999999999999987767799999999999999999999999999999999999999 778999999
Q ss_pred cCCcccccC---CcccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-
Q 001103 1029 FGLSRIKCN---TLVSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL- 1103 (1157)
Q Consensus 1029 FGLAkl~~~---~~~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l- 1103 (1157)
||+|+.... .......+||+.|||||++.+. ...|+.++|||||||+||||++|+.||.+......+..++....
T Consensus 176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~ 255 (307)
T 3omv_A 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA 255 (307)
T ss_dssp CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 999986432 2233457899999999999754 34689999999999999999999999998776655555544432
Q ss_pred CC---CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1104 RP---QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1104 rp---eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
.+ .++..+++++++||.+||+.||++|||+.+|+++|+.+...+.+.
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~ 305 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC-
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCC
Confidence 22 356678999999999999999999999999999999988766543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=470.09 Aligned_cols=254 Identities=22% Similarity=0.413 Sum_probs=218.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|+++++||+|+||+||+|+++ |+.||||++.+.... ....+.+.+|+++|++|+|||||++|+++.+ .
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~ 95 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS------SKEREESRREVAVLANMKHPNIVQYRESFEE--N 95 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC------HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--C
Confidence 68999999999999999999984 788999999875321 2235788999999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
+.+|||||||+||+|.++|... ...+++..++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DFGl 171 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTVQLGDFGI 171 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC----TTCCEEECSTTE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCCEEEccccc
Confidence 7899999999999999999754 45579999999999999999999999999999999999998 778999999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
|+..... ......+||+.|||||++.+. .|+.++|||||||+||||++|++||.+....+++..+....++ .++..
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~ 248 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLH 248 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTT
T ss_pred ceeecCCcccccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCcc
Confidence 9865443 233456899999999999865 5799999999999999999999999999888888888876653 56778
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++++++||.+||++||.+|||+++++++.|..
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 999999999999999999999999999988764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=464.07 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=221.5
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ |+.||||++.+...... ...+.+.+|+++|++|+|||||++|++|.+ .
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~ 104 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-----NKVPYVTRERDVMSRLDHPFFVKLYFTFQD--D 104 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--C
Confidence 57999999999999999999984 77899999987533211 124678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~----~~g~vKl~DFGla 179 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTA 179 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc----CCCCEEEEEcCCc
Confidence 68999999999999999997654 599999999999999999999999999999999999998 7789999999999
Q ss_pred ccccC---CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1033 RIKCN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1033 kl~~~---~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
+.... .....+++||+.|||||++.+. .|+.++|||||||+||+|++|++||.+....+++..+....+ .+|.
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~p~ 255 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--DFPE 255 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCT
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCc
Confidence 86532 2344568999999999999865 579999999999999999999999999888888888877654 5678
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+++++++||.+||++||.+|||++|++.+.+.+
T Consensus 256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~ 289 (311)
T 4aw0_A 256 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 289 (311)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHH
Confidence 8999999999999999999999999875554443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=449.41 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=206.0
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|++ +|+.||||++.+..... ......+.+|+++|++|+|||||++++++.+ .
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~ 85 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-----SDMQGRIEREISYLRLLRHPHIIKLYDVIKS--K 85 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--C
Confidence 5899999999999999999998 47889999998753322 1224678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+||||||| +|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 86 ~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~----~~~~vkl~DFGla 159 (275)
T 3hyh_A 86 DEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD----EHLNVKIADFGLS 159 (275)
T ss_dssp SEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTCCEEECCSSCC
T ss_pred CEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC----CCCCEEEeecCCC
Confidence 6899999999 679999887654 599999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
+.........+.+||+.|||||++.+.. .++.++|||||||+||+|++|++||.+.....++..+..... .++..++
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~-y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--~~p~~~s 236 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--TLPKFLS 236 (275)
T ss_dssp ---------------CTTSCHHHHSSSS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTSC
T ss_pred eecCCCCccCCeeECcccCChhhhcCCC-CCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCCCCCC
Confidence 8766655556688999999999998753 246899999999999999999999999888888877776543 4678899
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++++||.+||++||++|||+++++++.|.
T Consensus 237 ~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 237 PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 999999999999999999999999999886
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=451.95 Aligned_cols=260 Identities=33% Similarity=0.569 Sum_probs=219.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeE
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVk 942 (1157)
..+...+|.+.++||+|+||+||+|+++ ++.||||+++... ....+.|.+|+++|++|+|||||+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--------HHHHHHHHHHHHHHHhCCCCCCCc
Confidence 4456678999999999999999999874 5679999987531 223578999999999999999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhcccc--------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD--------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLK 1008 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g--------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLK 1008 (1157)
+|+++.+ ...+|||||||++|+|.+++++.. ..+++.+++.|+.|++.||.|||+++|||||||
T Consensus 108 l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK 185 (329)
T 4aoj_A 108 FFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 185 (329)
T ss_dssp EEEEECS--SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred EEEEEEE--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence 9999987 568999999999999999986532 358999999999999999999999999999999
Q ss_pred ccceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCC
Q 001103 1009 CDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEE 1084 (1157)
Q Consensus 1009 PENILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~ 1084 (1157)
|+|||++ .++.+||+|||+|+..... ......+||+.|||||++.+. .|+.++|||||||+||||+| |+.
T Consensus 186 p~NILl~----~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~ 259 (329)
T 4aoj_A 186 TRNCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQ 259 (329)
T ss_dssp GGGEEEE----TTTEEEECCCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred HhhEEEC----CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCC
Confidence 9999999 7889999999999864332 223446799999999999864 68999999999999999999 999
Q ss_pred CCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1085 PYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1085 PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
||.+....+++..+..+ .++..|..+++++.+||.+||+.||++|||+.+|+++|+.+...
T Consensus 260 Pf~~~~~~~~~~~i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 260 PWYQLSNTEAIDCITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TTCSSCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCHHHHHHHHHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 99999888887777654 45677889999999999999999999999999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=451.24 Aligned_cols=261 Identities=33% Similarity=0.571 Sum_probs=224.6
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCcee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIV 941 (1157)
++.|...+|.+.++||+|+||+||+|++. +..||||+++... ....+.|.+|+++|++|+|||||
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~HpnIV 78 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------DNARKDFHREAELLTNLQHEHIV 78 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--------hHHHHHHHHHHHHHHhCCCCCCc
Confidence 45577789999999999999999999874 5679999987531 22357799999999999999999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCc
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKC 1009 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKP 1009 (1157)
++|+++.+ .+.+|||||||++|+|.++|.+.+ ..+++..++.++.|++.||.|||+++||||||||
T Consensus 79 ~l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp 156 (299)
T 4asz_A 79 KFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 156 (299)
T ss_dssp CEEEEECS--SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cEEEEEee--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCH
Confidence 99999987 568999999999999999997532 4589999999999999999999999999999999
Q ss_pred cceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 001103 1010 DNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEP 1085 (1157)
Q Consensus 1010 ENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~P 1085 (1157)
+|||++ .++.+||+|||+|+...... .....+||+.|||||++.+. .|+.++|||||||+||||+| |+.|
T Consensus 157 ~NILl~----~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~P 230 (299)
T 4asz_A 157 RNCLVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQP 230 (299)
T ss_dssp GGEEEC----GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred hhEEEC----CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999998 77899999999998543322 23345699999999999854 68999999999999999998 9999
Q ss_pred CCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1086 YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1086 F~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
|.+....+++..+..+. ++..|..+++++.+||.+||+.||++|||+.+|.+.|+.+...
T Consensus 231 f~~~~~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 231 WYQLSNNEVIECITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TTTSCHHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99998888887776554 4567888999999999999999999999999999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=462.74 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=220.2
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|+++++||+|+||+||+|+++ |+.||||++.+..... .+.+.+|+++|+.|+|||||++|++|.+ .
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~ 143 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLV--G 143 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--------GGGGHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 46999999999999999999994 7789999998653211 2457799999999999999999999988 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+||+|.+++.+ +.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DFGla 217 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFC 217 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC----CCCCEEEecCcCc
Confidence 689999999999999999865 3489999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-CCCCCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-RPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-rpeip~~ 1110 (1157)
+..... .....++||+.|||||++.+. .|+.++|||||||+||||++|++||.+....+.+..+..... ....+..
T Consensus 218 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 218 AQVSKEVPRRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 295 (346)
T ss_dssp EECCSSSCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGG
T ss_pred eecCCCCCcccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcccc
Confidence 865443 345568999999999999864 579999999999999999999999999888888877765432 2334457
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+++++++||.+||++||++|||+.++++|.|...
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 8999999999999999999999999999988653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=459.74 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=217.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|++.++||+|+||+||+|+++ |+.||||+++...+ ..+|+.+|+.|+|||||++|+++.+ .
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~--~ 122 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVRE--G 122 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEE--T
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 56899999999999999999985 77899999986522 1369999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC-eEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP-ICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g-~VKLiDFGL 1031 (1157)
+.+|||||||+||+|.++|++.+ .+++..++.++.||+.||+|||++|||||||||+|||++ .++ ++||+|||+
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~~vKl~DFGl 197 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS----SDGSRAALCDFGH 197 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC----TTSCCEEECCCTT
T ss_pred CEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe----CCCCEEEEeeCCC
Confidence 68999999999999999997654 599999999999999999999999999999999999998 454 699999999
Q ss_pred cccccCCc------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC-
Q 001103 1032 SRIKCNTL------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR- 1104 (1157)
Q Consensus 1032 Akl~~~~~------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr- 1104 (1157)
|+...... ....++||+.|||||++.+. .|+.++|||||||+||||++|++||.+.....++..+.....+
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~ 275 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 275 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc
Confidence 98654321 22346899999999999865 5799999999999999999999999988777777777665443
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
..++..+++++++||.+||++||.+|||+.||+++|........
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 24678899999999999999999999999999999988876654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=445.22 Aligned_cols=259 Identities=32% Similarity=0.546 Sum_probs=222.0
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCcee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIV 941 (1157)
+.++...+++++++||+|+||+||+|++. ++.||||+++.... ....+.|.+|+.++++|+|||||
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-------~~~~~~f~~E~~il~~l~HpNIV 92 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-------GPLREEFRHEAMLRARLQHPNVV 92 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-------C-CHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-------hHHHHHHHHHHHHHHhCCCCCCC
Confidence 44566678999999999999999999973 46799999875421 11246789999999999999999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhccc---------------cccccHHHHHHHHHHHHHHHHHHHHCCceecc
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK---------------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFD 1006 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~---------------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRD 1006 (1157)
++|+++.+ .+.++||||||++|+|.++|... ...+++..++.++.||+.||+|||+++|||||
T Consensus 93 ~l~g~~~~--~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 170 (308)
T 4gt4_A 93 CLLGVVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKD 170 (308)
T ss_dssp CEEEEECS--SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CcceEEEE--CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999987 56789999999999999998542 24589999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-C
Q 001103 1007 LKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-G 1082 (1157)
Q Consensus 1007 LKPENILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-G 1082 (1157)
|||+|||++ +++.+||+|||+|+..... ......+||+.|||||++.+. .|+.++|||||||+||||+| |
T Consensus 171 LK~~NILl~----~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g 244 (308)
T 4gt4_A 171 LATRNVLVY----DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYG 244 (308)
T ss_dssp CSGGGEEEC----GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccceEEC----CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCC
Confidence 999999998 7789999999999864322 234456799999999999854 68999999999999999998 8
Q ss_pred CCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1083 k~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+.||.+....+++..+..+ .+++.|..+++++.+||.+||+.||.+|||+.+|+++|+.+
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 245 LQPYCGYSNQDVVEMIRNR-QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CCTTTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHcC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999999888887777654 44567889999999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=444.72 Aligned_cols=255 Identities=30% Similarity=0.488 Sum_probs=213.6
Q ss_pred CCCe-eEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 874 DSDL-EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdY-eILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
..+| ++.++||+|+||+||+|+++ +..||||++...... ....+.+.+|+++|++|+|||||++|+++.+.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence 3455 67788999999999999995 667999999865321 22357789999999999999999999998642
Q ss_pred --CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCCCCeEEE
Q 001103 951 --PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 951 --~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
....+|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||+++ ||||||||+|||++. .++.+||
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~---~~g~vKl 173 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKI 173 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS---TTSCEEE
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC---CCCCEEE
Confidence 245789999999999999999764 45899999999999999999999998 999999999999971 3578999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCCCC
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLRP 1105 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~lrp 1105 (1157)
+|||+|+..... ...+.+||+.|||||++.+ .|+.++|||||||+||||++|++||.+..... +...+.....++
T Consensus 174 ~DFGla~~~~~~-~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~ 249 (290)
T 3fpq_A 174 GDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp CCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred EeCcCCEeCCCC-ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC
Confidence 999999864433 3345789999999999874 48999999999999999999999998765544 444444444445
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.++..+++++++||.+||++||.+|||++++++|.|.
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 5677789999999999999999999999999998774
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=465.06 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=220.5
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|+++++||+|+||+||+|+++ |+.||||++....... .+.+.+|+.+|+.|+|||||++|++|.+ .
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~ 220 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLV--G 220 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--------GGGHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCCCceEEEEEE--C
Confidence 56999999999999999999994 7789999998642211 2457899999999999999999999988 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+||+|.++++.. .+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~----~~g~vKl~DFGla 294 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFC 294 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC----TTCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEecCccc
Confidence 6899999999999999998643 489999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-CCCCCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-RPQIPER 1110 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-rpeip~~ 1110 (1157)
+..... ......+||+.|||||++.+. .|+.++|||||||+||||++|++||.+....+.+..+..... ....+..
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 372 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 372 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred eECCCCCccccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccccc
Confidence 865433 345568899999999999865 579999999999999999999999999888888877765532 3345567
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+++++++||.+||++||.+|||+.++++|.|...
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 8999999999999999999999999999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=453.46 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=215.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
..++|++++.||+|+||+||+|++ .++.||||++++....... ...+.+|+++|++|+|||||++|+++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------CC------CCCCCCCCTTEECEEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------HHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 346899999999999999999987 2567999999875432211 13567899999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.+ .+.+|||||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+
T Consensus 96 ~~--~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~ 168 (304)
T 3ubd_A 96 QT--EGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLT 168 (304)
T ss_dssp EE--TTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTSCEEEE
T ss_pred EE--CCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc----CCCCEEec
Confidence 88 678999999999999999997654 599999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1028 DFGLSRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1028 DFGLAkl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|||+|+.... .....+.+||+.|||||++.+. .|+.++|||||||+||||++|++||.+....+++..+..... .
T Consensus 169 DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--~ 244 (304)
T 3ubd_A 169 DFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--G 244 (304)
T ss_dssp SSEEEEC-----CCCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C
T ss_pred ccccceeccCCCccccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--C
Confidence 9999986433 3344568899999999999865 578999999999999999999999999988888888876644 5
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPS-----FTEITNRLRVM 1143 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~L 1143 (1157)
+|..+|+++++||.+||++||++||| ++++++|.|+-
T Consensus 245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~ 286 (304)
T 3ubd_A 245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286 (304)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence 67889999999999999999999998 58999988753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=449.37 Aligned_cols=263 Identities=29% Similarity=0.508 Sum_probs=225.2
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC-Ccee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH-PNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H-PNIV 941 (1157)
|++..++|++.++||+|+||+||+|++.+ +.||||+++.... ....+.+.+|+++|+++.| ||||
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-------~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------hHHHHHHHHHHHHHHHcCCCCcEE
Confidence 56777899999999999999999999854 3599999875421 2224678999999999965 9999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceecc
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFD 1006 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRD 1006 (1157)
++++++..+ ...+|||||||++|+|.++|++.. ..+++..++.++.||+.||+|||+++|||||
T Consensus 132 ~l~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 132 NLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CEEEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 999998653 456899999999999999996532 3488999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-C
Q 001103 1007 LKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-G 1082 (1157)
Q Consensus 1007 LKPENILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-G 1082 (1157)
|||+|||++ .++.+||+|||+|+..... ......+||+.|||||++.+. .|+.++|||||||+||||+| |
T Consensus 211 LK~~NILl~----~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 211 LAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp CSGGGEEEC----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCccceeeC----CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCC
Confidence 999999998 7789999999999864332 233456799999999999864 68999999999999999998 9
Q ss_pred CCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1083 k~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
+.||.+......+...+....++..|..+++++.+||.+||+.||.+|||+.+|+++|..+...
T Consensus 285 ~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 285 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 9999988766666666666777888999999999999999999999999999999999887643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=443.49 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=214.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG- 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de- 950 (1157)
.++|++++.||+|+||+||+|+++ |+.||||++++... .....+.+.+|+++|+.|+|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD------VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc------chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 368999999999999999999984 78899999976421 122346788999999999999999999998643
Q ss_pred ---CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 ---PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 ---~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
..+.+|||||||+ |+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+
T Consensus 127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~----~~~~~Ki~ 200 (398)
T 4b99_A 127 PYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN----ENCELKIG 200 (398)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTCCEEEC
T ss_pred ccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC----CCCCEEEe
Confidence 2467999999996 6799988754 4599999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccC-----CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1028 DFGLSRIKCN-----TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1028 DFGLAkl~~~-----~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
|||+|+.... .....+.+||+.|+|||++.+. ..|+.++|||||||+||||++|++||.+....+.+..|....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9999985432 2234567899999999998865 347999999999999999999999999988877777665322
Q ss_pred CCCC-----------------------------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1103 LRPQ-----------------------------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1103 lrpe-----------------------------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+. +...+++++++||.+||.+||.+|||+.++|+|.|.-
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 1110 1124689999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=428.58 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=193.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~- 951 (1157)
.+|++++.||+|+||+||+|+++ |+.||||+++... .+...+.+.+|+++|++|+|||||++|++|.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 36999999999999999999985 7789999997541 1233567899999999999999999999986532
Q ss_pred ---------CCcEEEEEEeecCCcchhhhcccc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCC
Q 001103 952 ---------GGTMATVTEYMVNGSLRHVLARKD--RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQ 1020 (1157)
Q Consensus 952 ---------~~~LyLVMEYmeGGSL~dlLkr~g--r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e 1020 (1157)
..++|||||||.+|+|.+++.... ...++..++.++.||+.||+|||++|||||||||+|||++ .
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~----~ 153 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT----M 153 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----T
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC----C
Confidence 225799999999999999997643 2345667889999999999999999999999999999998 6
Q ss_pred CCeEEEEecCCcccccCCc-------------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 001103 1021 RPICKVGDFGLSRIKCNTL-------------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA 1087 (1157)
Q Consensus 1021 ~g~VKLiDFGLAkl~~~~~-------------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~ 1087 (1157)
++.+||+|||+|+...... ..++.+||+.|||||++.+. .|+.++|||||||+||||++ ||.
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCC
Confidence 7799999999998643321 12346899999999999865 67999999999999999996 886
Q ss_pred CCChh-HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1088 NMHCG-AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1088 g~~~e-eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..... ..+..+....++ +.....++.+++||.+||++||.+|||+.+++++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 229 TQMERVRTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp SHHHHHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CccHHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 53221 223333322222 2223356778899999999999999999999997654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=421.91 Aligned_cols=256 Identities=30% Similarity=0.458 Sum_probs=204.0
Q ss_pred CCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC--
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG-- 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~-- 952 (1157)
.+|.+.++||+|+||+||+|+++|+.||||+++... . . ...+..|+..+.+|+|||||++++++.++..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~------~-~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------E-R--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG------H-H--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc------h-h--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence 468889999999999999999999999999987531 1 1 1223456667778999999999999976432
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC--------CceeccCCccceeeccCCCCCCeE
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK--------NIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk--------GIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
..+|||||||++|+|.+++++. .+++..+++++.|++.||.|||++ +||||||||+|||++ .++.+
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~----~~~~~ 147 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC----TTSCE
T ss_pred eEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC----CCCCE
Confidence 2589999999999999999753 488999999999999999999987 999999999999998 77899
Q ss_pred EEEecCCcccccCCc-----ccCCCCCCCcccCcccccCCC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----
Q 001103 1025 KVGDFGLSRIKCNTL-----VSGGVRGTLPWMAPELLNGSN----NRVSEKVDVYSFGIAMWEIITGEEPYANMH----- 1090 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~----~~yS~KSDIWSLGVILYELLTGk~PF~g~~----- 1090 (1157)
||+|||+|+...... .....+||+.|||||++.+.. ..++.++|||||||+||||++|.+||....
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 999999998654322 223467999999999997532 236789999999999999999987664221
Q ss_pred ----------hhHHHHHhhhcCCCCCCCCC-----CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1091 ----------CGAIIGGILSNTLRPQIPER-----CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1091 ----------~eeil~~Il~~~lrpeip~~-----iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.......+....+++.+|.. +++.+.+||.+||+.||++|||+.+|++.|..+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 12344445556667766654 23578999999999999999999999999988764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=448.01 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=223.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ |+.||||++.+.. ....+.+.+|+++|+.|+|||||+++++|.+ .
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 226 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--D 226 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--S
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--C
Confidence 57999999999999999999984 7789999997642 1124678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|||||||.||+|.++|.+....+++..+..++.||+.||+|||++||+||||||+|||++.+ ..+.+||+|||+|
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~--~~~~vKl~DFG~a 304 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLT 304 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCSSC
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC--CCCCEEEeeccce
Confidence 78999999999999999997666679999999999999999999999999999999999999732 3478999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC--CCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--PQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--peip~~ 1110 (1157)
+...........+||+.|||||++.+. .|+.++|||||||+||||++|++||.+....+.+..+...... ......
T Consensus 305 ~~~~~~~~~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 382 (573)
T 3uto_A 305 AHLDPKQSVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382 (573)
T ss_dssp EECCTTSEEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT
T ss_pred eEccCCCceeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC
Confidence 987666555667899999999999875 5799999999999999999999999999988888888766443 234467
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++++++||.+||++||.+|||+.++++|.|.
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 89999999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=420.82 Aligned_cols=248 Identities=20% Similarity=0.253 Sum_probs=199.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
++|+++++||+|+||+||+|+++ ++.||||++.+.. . ..++.+|+++|+.+ +|||||++++++.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----H-----PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----C-----HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----C-----HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 57999999999999999999873 4569999986541 1 24577899999998 6999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ .+.+|||||||++|+|.++++ .+++..++.++.||+.||+|||++|||||||||+|||++. +.+.+||+|
T Consensus 91 ~--~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~---~~~~~kl~D 161 (361)
T 4f9c_A 91 K--NDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR---RLKKYALVD 161 (361)
T ss_dssp E--TTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEECC
T ss_pred E--CCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC---CCCeEEECc
Confidence 8 678999999999999999984 3889999999999999999999999999999999999982 337999999
Q ss_pred cCCcccccCC-----------------------------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHH
Q 001103 1029 FGLSRIKCNT-----------------------------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEI 1079 (1157)
Q Consensus 1029 FGLAkl~~~~-----------------------------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYEL 1079 (1157)
||+|+..... ......+||+.|+|||++.+. ..|+.++||||+||+||||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHH
Confidence 9999743221 112346799999999999864 3479999999999999999
Q ss_pred HcCCCCCCCCC-hhHHHHHhhhc----------------------------------------------------CCCCC
Q 001103 1080 ITGEEPYANMH-CGAIIGGILSN----------------------------------------------------TLRPQ 1106 (1157)
Q Consensus 1080 LTGk~PF~g~~-~eeil~~Il~~----------------------------------------------------~lrpe 1106 (1157)
++|+.||.... ....+..+... .....
T Consensus 241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 99999996543 33333222110 00011
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
....+++++++||.+||++||++|+|++|+++|.|+
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 234578999999999999999999999999998875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=447.36 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=216.1
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+..++|++++.||+|+||+||+|+++ |+.||||++++........ .........++.+++.++|||||+++++|.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~--~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC--HHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh--HHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 44578999999999999999999984 7789999998764332222 2223334456777888899999999999998
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|||||||.||+|.++|.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+ .++++||+||
T Consensus 264 --~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld----~~G~vKL~DF 336 (689)
T 3v5w_A 264 --PDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDL 336 (689)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe----CCCCEEeccc
Confidence 668999999999999999997654 599999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hhHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH---CGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~---~eeil~~Il~~~lrpe 1106 (1157)
|+|+...... ..+.+||+.|||||++.+. ..|+.++|||||||+||||++|++||.+.. ...+...+... ...
T Consensus 337 GlA~~~~~~~-~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~ 412 (689)
T 3v5w_A 337 GLACDFSKKK-PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVE 412 (689)
T ss_dssp TTCEECSSCC-CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCC
T ss_pred ceeeecCCCC-CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCC
Confidence 9998655443 3457899999999999642 357999999999999999999999997543 23344444433 345
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPS-----FTEITNRLRVM 1143 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~L 1143 (1157)
+|..+++++++||.+||++||.+|++ +++|++|.|+-
T Consensus 413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~ 454 (689)
T 3v5w_A 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454 (689)
T ss_dssp CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence 77889999999999999999999997 79999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=386.82 Aligned_cols=263 Identities=40% Similarity=0.706 Sum_probs=219.9
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
.+...+|++.+.||+|+||+||+|+++++.||||++..... .....+.+.+|++++++++||||+++++++..
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 105 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF------HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ- 105 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-
Confidence 45567999999999999999999999999999999876422 12235678899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhcccc--ccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCCCCeEEE
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKD--RILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~g--r~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
...+++||||+.+++|.+++.+.. ..+++..++.++.|++.||+|||++| |+||||||+|||++ .++.+||
T Consensus 106 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~----~~~~~kL 180 (309)
T 3p86_A 106 -PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKV 180 (309)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC----TTCCEEE
T ss_pred -CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe----CCCcEEE
Confidence 557899999999999999997643 34899999999999999999999999 99999999999998 7789999
Q ss_pred EecCCcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1027 GDFGLSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1027 iDFGLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.......
T Consensus 181 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp CCCC-----------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCCCCCccccccccccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999997544332 23446799999999999864 56899999999999999999999999988888777776666777
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.++..+++++.+||.+||+.||.+|||+.++++.|+.+....
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 788899999999999999999999999999999999887643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=391.68 Aligned_cols=254 Identities=25% Similarity=0.443 Sum_probs=222.7
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||+|++ .|+.||||++.+... .....+.+.+|+++++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 85 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL------NPTSLQKLFREVRIMKILNHPNIVKLFEVIET-- 85 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--
Confidence 36899999999999999999998 578899999986532 12235678899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+|+||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DFG~ 160 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD----ADMNIKIADFGF 160 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTC
T ss_pred CCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc----CCCCEEEeeccC
Confidence 568999999999999999997654 489999999999999999999999999999999999998 778999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
+............+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+.........+..... .+|..+
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 237 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYM 237 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHHHTCC-CCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTS
T ss_pred ceecCCCCccccccCCcceeCcccccCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCC
Confidence 98766555556678999999999998652 235899999999999999999999999988888887776654 456778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
++++.+||.+||+.||.+|||+++++++.|.-
T Consensus 238 s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 238 STDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 99999999999999999999999999987753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=375.36 Aligned_cols=264 Identities=25% Similarity=0.367 Sum_probs=216.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCCh------------------hHHHHHHHHHHHHHHH
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSS------------------EQEWLIKEFWREAHII 932 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~------------------e~e~likqflrEIkIL 932 (1157)
...+|++.+.||+|+||.||+|++ .++.||||++.+........ ......+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 346899999999999999999988 47789999998653221100 0112245688999999
Q ss_pred HhCCCCceeEEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Q 001103 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNL 1012 (1157)
Q Consensus 933 K~L~HPNIVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENI 1012 (1157)
++++||||+++++++.+.....+++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 99999999999999987656789999999999999887643 4589999999999999999999999999999999999
Q ss_pred eeccCCCCCCeEEEEecCCcccccCC-cccCCCCCCCcccCcccccCCCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 001103 1013 LVNLRDPQRPICKVGDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNR-VSEKVDVYSFGIAMWEIITGEEPYANMH 1090 (1157)
Q Consensus 1013 LLd~dd~e~g~VKLiDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~-yS~KSDIWSLGVILYELLTGk~PF~g~~ 1090 (1157)
|++ .++.+||+|||++...... .......||+.|+|||++.+.... ++.++|||||||++|+|++|+.||....
T Consensus 169 l~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 169 LVG----EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEC----TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEC----CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 998 6779999999999865433 233456799999999999764322 3788999999999999999999999888
Q ss_pred hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1091 ~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.......+............+++++++||.+||+.||.+|||+.+++++.|.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 7777776666655555556789999999999999999999999999998875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=367.57 Aligned_cols=260 Identities=27% Similarity=0.468 Sum_probs=226.2
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
.+...+|++++.||+|+||+||+|+++++.||||+++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW------STRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC------CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc------CHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 34557899999999999999999999999999999986421 122346789999999999999999999999886
Q ss_pred CCCcEEEEEEeecCCcchhhhccccc-cccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr-~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.....++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~----~~~~~~l~ 155 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID----EDMTARIS 155 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC----TTSCEEEE
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc----CCcceeEE
Confidence 55789999999999999999976543 5899999999999999999999999 99999999999998 67789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|||++..... ....||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||...........+......+.
T Consensus 156 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T 3kmu_A 156 MADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231 (271)
T ss_dssp GGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred eccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC
Confidence 9988754222 2356899999999997642 2234589999999999999999999999988888888887888888
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
++..+++++.+||.+||+.||.+|||+.++++.|..+.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 89999999999999999999999999999999998774
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=368.27 Aligned_cols=258 Identities=32% Similarity=0.605 Sum_probs=223.8
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+.+...+|++++.||+|+||+||++++ ++..||||++...... .+.+.+|++++++++||||+++++++.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456778999999999999999999999 5677999999864211 245789999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ....++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~D 149 (269)
T 4hcu_A 76 E--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSD 149 (269)
T ss_dssp S--SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----GGGCEEECC
T ss_pred c--CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc----CCCCEEecc
Confidence 7 5679999999999999999987777799999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+... ...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~ 226 (269)
T 4hcu_A 150 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRL 226 (269)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC
T ss_pred ccccccccccccccccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccC
Confidence 99997654332 22345578899999999754 57999999999999999999 99999998887777666543 445
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
..+..+++.+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 5677789999999999999999999999999999998874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=367.47 Aligned_cols=260 Identities=34% Similarity=0.602 Sum_probs=213.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
+...+|++.+.||+|+||.||+|++.++.||||+++..... ......+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 77 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-- 77 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcc----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence 45679999999999999999999999999999998764211 112234678899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeeccCCC----CCCeE
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN---IVHFDLKCDNLLVNLRDP----QRPIC 1024 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG---IIHRDLKPENILLd~dd~----e~g~V 1024 (1157)
.+..++||||+++++|.+++.. +.+++..++.++.|++.||.|||++| |+||||||+|||++.+.. ..+.+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred CCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 5678999999999999999853 45899999999999999999999999 999999999999984221 26789
Q ss_pred EEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1025 KVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
||+|||++........ ....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+......
T Consensus 156 kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 156 KITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232 (271)
T ss_dssp EECCCCC--------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred EEccCCcccccccccc-cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence 9999999976544332 245799999999999754 5799999999999999999999999998888887777777777
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...+..+++.+.+||.+||+.||.+|||+.+++++|..
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 78888999999999999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=382.54 Aligned_cols=264 Identities=29% Similarity=0.504 Sum_probs=222.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
+.+...+|++.+.||+|+||.||+|++. ++.||||+++... .....+.+.+|+++++++ +||||+
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-------CHHHHHHHHHHHHHHHhhcCCccee
Confidence 3456679999999999999999999863 3569999997541 122246789999999999 799999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhccccc---------------------------------------------
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR--------------------------------------------- 976 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr--------------------------------------------- 976 (1157)
++++++... ...+++||||+.+|+|.+++.....
T Consensus 90 ~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 90 NLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CEEEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999998763 4468999999999999999875432
Q ss_pred --------------------cccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 977 --------------------ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 977 --------------------~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIY 244 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCGGGSCTT
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCcEEEEeccceeeec
Confidence 288999999999999999999999999999999999998 66789999999997543
Q ss_pred CC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1037 NT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1037 ~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+......+...+........+..++
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 322 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCC
T ss_pred ccccchhccccCCCceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCC
Confidence 22 223345689999999999754 67999999999999999998 9999998876666666666666677888899
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
+++.+||.+||+.||.+|||+.+++++|..+..+.
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.28 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=219.9
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+++.+ |+.||||++++...... .....+.+|+.+|+.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-- 76 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFLTALKYAFQT-- 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh-----hHHHHHHHHHHHHHhCCCCcCcceEEEEEe--
Confidence 468999999999999999999984 77899999986532111 124567899999999999999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+|+||||+++|+|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL~DFG~ 151 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGL 151 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC----CCCCEEEeeccc
Confidence 56899999999999999988754 4589999999999999999999999999999999999998 778999999999
Q ss_pred ccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1032 SRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1032 Akl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..... .++..
T Consensus 152 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~ 227 (337)
T 1o6l_A 152 CKEGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRT 227 (337)
T ss_dssp CBCSCCTTCCBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTT
T ss_pred hhhcccCCCcccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCC
Confidence 98532 23344567899999999999864 578999999999999999999999998888877777766543 46778
Q ss_pred CcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARP-----SFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~L 1143 (1157)
+++++++||.+||++||.+|| ++++++++.+..
T Consensus 228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 999999999999999999999 999999987764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=372.75 Aligned_cols=263 Identities=32% Similarity=0.527 Sum_probs=215.5
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
.+...+|++++.||+|+||+||++++ .++.||||++.... ....+.+.+|++++++++||||++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~ 77 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRDFEREIEILKSLQHDNIVKYK 77 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--------HHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 45567999999999999999999985 46779999987531 22346788999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+++.......+++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+
T Consensus 78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~~ 153 (295)
T 3ugc_A 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENRV 153 (295)
T ss_dssp EEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEE
T ss_pred EEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc----CCCeE
Confidence 99865445578999999999999999987777799999999999999999999999999999999999998 67799
Q ss_pred EEEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--------
Q 001103 1025 KVGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-------- 1092 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-------- 1092 (1157)
||+|||++....... ......+|..|+|||++.+. .++.++||||||+++|+|++|..||......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 231 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence 999999998643321 22234578889999999854 5799999999999999999999998653211
Q ss_pred -------HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1093 -------AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1093 -------eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
...........+...+..+++++.+||.+||+.||.+|||+.++++.|..+...+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0112223344455677889999999999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=365.91 Aligned_cols=260 Identities=36% Similarity=0.579 Sum_probs=220.8
Q ss_pred ccccccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 868 GLQIIKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 868 ~i~~I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
..+.+...+|++++.||+|+||+||++++++ ..||||+++..... .+.+.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---------HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 4455677899999999999999999999864 46999999864211 2457899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.+ ...+++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||
T Consensus 88 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~----~~~~~kl 161 (283)
T 3gen_A 88 CTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKV 161 (283)
T ss_dssp ECS--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTSCEEE
T ss_pred Eec--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc----CCCCEEE
Confidence 977 5689999999999999999987666799999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1027 GDFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1027 iDFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
+|||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+.. ..
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~ 238 (283)
T 3gen_A 162 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GL 238 (283)
T ss_dssp CSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TC
T ss_pred ccccccccccccccccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-cc
Confidence 9999997654332 22334578889999999854 57999999999999999998 9999998887777666654 34
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
....+..+++.+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 455677789999999999999999999999999999998874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=390.11 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=222.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|++++.||+|+||+||+|+++ |..||||++++........ ....+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 87 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYEN--R 87 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--C
Confidence 57999999999999999999985 7789999998764322111 1113568899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.....+||+|||++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 6899999999999999999754 458999999999999999999999999999999999999843323348999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip~~ 1110 (1157)
............+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......+..+....... ..+..
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred eEcCCCCccccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 876655555567899999999999854 57899999999999999999999999988888888776654432 23356
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++++++||.+||..||.+|||+.+++++.|..
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 899999999999999999999999999987753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=367.97 Aligned_cols=267 Identities=38% Similarity=0.658 Sum_probs=221.0
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
...+...+|++.+.||+|+||+||+|++ .++.||||++........ .......+.+.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE-TEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCC-HHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 3456678999999999999999999998 477899999876432211 1111112678899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCC-CCCCe
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRD-PQRPI 1023 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd-~e~g~ 1023 (1157)
+.+. .++||||+.+++|.+++.+....+++..++.++.|++.||+|||++| |+||||||+|||++.++ .....
T Consensus 92 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 92 MHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp ETTT----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred ecCC----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 8763 27899999999999988777777999999999999999999999999 99999999999998433 12234
Q ss_pred EEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHH--HHHhhhc
Q 001103 1024 CKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI--IGGILSN 1101 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eei--l~~Il~~ 1101 (1157)
+||+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|+.||........ ...+...
T Consensus 168 ~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp EEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred EEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 999999999754432 334679999999999965455678999999999999999999999987654433 4555566
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...+.++..+++++.+||.+||+.||.+|||+.++++.|..
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 77778888999999999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=380.80 Aligned_cols=264 Identities=34% Similarity=0.576 Sum_probs=222.6
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+...+|++.+.||+|+||+||+|++. +..||||+++... .....+.+.+|+.+++.++||||+++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-------TERQRRDFLSEASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 455678999999999999999999983 3349999987531 1223467889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.+ ....++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 118 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~k 191 (325)
T 3kul_A 118 VVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCK 191 (325)
T ss_dssp EECG--GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEE
T ss_pred EEEe--CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC----CCCCEE
Confidence 9977 5678999999999999999977766799999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1026 VGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
|+|||+++...... ......+|+.|+|||++.+. .++.++|||||||+||+|++ |..||...........+..
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 99999998643321 22334578889999999754 57899999999999999999 9999999888777776654
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
. .....+..+++.+.+||.+||+.||.+|||+.++++.|..+....+..
T Consensus 270 ~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 270 G-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred C-CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 4 455677789999999999999999999999999999999988654443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=382.38 Aligned_cols=256 Identities=18% Similarity=0.208 Sum_probs=221.7
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||+||+|++. +..||+|++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 72 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---------TDQVLVKKEISILNIARHRNILHLHESFES-- 72 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---------ccHHHHHHHHHHHHhCCCCCCCeEeEEEec--
Confidence 368999999999999999999984 6779999987431 113567899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~--~~~~~kl~Dfg~ 150 (321)
T 1tki_A 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQ 150 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTT
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC--CCCCEEEEECCC
Confidence 568999999999999999998766679999999999999999999999999999999999999832 267899999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--CCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ--IPE 1109 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe--ip~ 1109 (1157)
+.............||+.|+|||++.+. .++.++|||||||++|+|++|..||........+..+........ ...
T Consensus 151 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T 1tki_A 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CeECCCCCccccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence 9876555444456799999999999864 468999999999999999999999999888888888876655432 224
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+++++++||.+||..||.+|||+.+++++.|...
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 68999999999999999999999999999988753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=376.36 Aligned_cols=263 Identities=32% Similarity=0.538 Sum_probs=216.8
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+...+|++.+.||+|+||+||++++. +..||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--------DEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 355679999999999999999999984 778999988542 1233577899999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ .+..++||||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 78 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~D 151 (310)
T 3s95_A 78 K--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVAD 151 (310)
T ss_dssp E--TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC----TTSCEEECC
T ss_pred c--CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC----CCCCEEEee
Confidence 7 5689999999999999999987677799999999999999999999999999999999999998 778899999
Q ss_pred cCCcccccCCcc---------------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH
Q 001103 1029 FGLSRIKCNTLV---------------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA 1093 (1157)
Q Consensus 1029 FGLAkl~~~~~~---------------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee 1093 (1157)
||++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 999975433221 1146799999999999864 67899999999999999999999987543221
Q ss_pred HH-HHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1094 II-GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1094 il-~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
.. ............+..+++.+.+||.+||+.||.+|||+.++++.|+.+...+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp TTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 10 000001111224567888999999999999999999999999999999887654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=386.43 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=221.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||+|+++ +..||||++...... ....+.+.+|+.+++.|+||||+++++++.+ .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~ 100 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQE--E 100 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--C
Confidence 47999999999999999999984 778999999865321 2234678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+.+||+|||++
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~DfG~a 178 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGLA 178 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS-TTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCCEEEeecCcc
Confidence 6899999999999999888654 4589999999999999999999999999999999999998433 4467999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--CC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--ER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~~ 1110 (1157)
............+||+.|+|||++.+. .++.++|||||||++|+|++|++||...........+.........+ ..
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGG
T ss_pred eEecCCcccccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 876655555567899999999999854 57899999999999999999999999988888887777665543322 45
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++++++||.+||+.||.+|||+.+++++.|..
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 799999999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=391.99 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=215.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||+|+++ ++.||||++++.... .......+.+|..+++.+ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLFCCFQ 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-----chhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence 44579999999999999999999984 678999999865221 122245678899999988 7999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+|+||||+.+|+|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++++||+|
T Consensus 95 ~--~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~----~~g~ikL~D 167 (353)
T 3txo_A 95 T--PDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLAD 167 (353)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred e--CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC----CCCCEEEcc
Confidence 8 56899999999999999998764 4589999999999999999999999999999999999998 778999999
Q ss_pred cCCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+..... .+
T Consensus 168 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~ 243 (353)
T 3txo_A 168 FGMCKEGICNGVTTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VY 243 (353)
T ss_dssp CTTCBCSCC---------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CC
T ss_pred ccceeecccCCccccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CC
Confidence 99998533 33344567899999999999854 578999999999999999999999999998888888876654 45
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCH------HHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSF------TEITNRLRVM 1143 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSa------eELLe~Lr~L 1143 (1157)
+..+++++++||++||++||.+||++ .++++|.++-
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 77799999999999999999999998 8999987753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=361.59 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=222.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||+|.++ +..||+|++..... .......+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 76 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL------SARDFQKLEREARICRKLQHPNIVRLHDSIQE-- 76 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--
Confidence 468999999999999999999984 77899999986532 12234678899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....++||||+.+++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ ....+||+|||+
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGL 154 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-TTCCEEECCCTT
T ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-CCCcEEEeecee
Confidence 56889999999999998888654 4589999999999999999999999999999999999998433 455699999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--CCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ--IPE 1109 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe--ip~ 1109 (1157)
+.............||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred eEEcccCccccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence 9876666555667899999999999854 578999999999999999999999999888887777766554333 334
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+++++.+||.+||+.||.+|||+.+++++.+..
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 6899999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=375.28 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=215.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|++ .++.||||++....... .+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 88 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLV-- 88 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--------HHHHHHHHHHHhcCCCCCCCeEeEEEEE--
Confidence 35899999999999999999987 47789999987642111 2557889999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+++||||+.+++|.+++.+. .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC----CCCCEEEeeCCC
Confidence 56899999999999999999654 489999999999999999999999999999999999998 677999999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCCCCC
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPE 1109 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpeip~ 1109 (1157)
+...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... ......+.
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T 3fxz_A 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (297)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGG
T ss_pred ceecCCcccccCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Confidence 8765433 233456799999999999864 5789999999999999999999999988776665555443 33445567
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+++.+++||.+||+.||.+|||+.+++++.+.
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 789999999999999999999999999997664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=362.30 Aligned_cols=256 Identities=33% Similarity=0.595 Sum_probs=220.1
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
.+...+|++++.||+|+||+||++++++ ..||||+++..... ...+.+|++++++++||||+++++++.+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---------EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4566799999999999999999999864 46999999764211 2457899999999999999999999977
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++||||+++++|.+++...+..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~l~Df 148 (268)
T 3sxs_A 75 --EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD----RDLCVKVSDF 148 (268)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC----TTCCEEECCT
T ss_pred --CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC----CCCCEEEccC
Confidence 5679999999999999999987777799999999999999999999999999999999999998 6789999999
Q ss_pred CCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1030 GLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1030 GLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
|++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+... ....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 225 (268)
T 3sxs_A 149 GMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLY 225 (268)
T ss_dssp TCEEECCTTCEEECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCC
T ss_pred ccceecchhhhhcccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-CCCC
Confidence 9998654332 22344577889999999754 46889999999999999999 99999988877766665543 3445
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+..+++.+.+||.+||+.||.+|||+.+++++|+.+.
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 56778999999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=374.53 Aligned_cols=266 Identities=20% Similarity=0.311 Sum_probs=215.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++.+.||+|+||+||+|++. ++.||||+++....... .+.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 44578999999999999999999995 77899999986432211 3566799999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccc--cccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDR--ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr--~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.....+++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+...+...+.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 666689999999999999999976443 389999999999999999999999999999999999983322267789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCC------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHH
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGS------NNRVSEKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGG 1097 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~------~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~ 1097 (1157)
|||+++............||+.|+|||++... ...++.++|||||||++|||++|+.||..... .+.+..
T Consensus 159 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred cCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 99999876665555567899999999998521 24678999999999999999999999975432 233444
Q ss_pred hhhcCCC-----------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1098 ILSNTLR-----------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1098 Il~~~lr-----------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+...... ..++..+++.+.+||.+||++||++|||++++++++..-.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 4332211 1122334667899999999999999999999999987644
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=375.03 Aligned_cols=255 Identities=29% Similarity=0.401 Sum_probs=209.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..+|++++.||+|+||+||+|++ +++.||||+++.... .......+.+|++++++++||||+++++++.+ .
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 91 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE------DEGIPSTAIREISLLKELHHPNIVSLIDVIHS--E 91 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--S
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc------cchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--C
Confidence 46899999999999999999998 577899999875421 12234677899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Dfg~a 166 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLA 166 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTTC
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC----CCCCEEEccCcCc
Confidence 689999999985 88888877666799999999999999999999999999999999999998 6779999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC------
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP------ 1105 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp------ 1105 (1157)
...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+......+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred eecCCCcccccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 865432 233445799999999998764 357899999999999999999999999877666555553311100
Q ss_pred ----------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1106 ----------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1106 ----------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+...+++++.+||.+||++||.+|||+++++++.|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 0123467899999999999999999999999998765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=384.14 Aligned_cols=262 Identities=28% Similarity=0.499 Sum_probs=222.0
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCce
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR---------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNV 940 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k---------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNI 940 (1157)
.+...+|++.+.||+|+||+||+|++. +..||||+++... .......+.+|+.+++.+ +||||
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpnI 149 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 149 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-------BHHHHHHHHHHHHHHHHSCCCTTB
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-------CHHHHHHHHHHHHHHHHhcCCCCE
Confidence 345578999999999999999999873 2359999987541 123356789999999999 89999
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
+++++++.. .+.+|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||
T Consensus 150 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 227 (370)
T 2psq_A 150 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227 (370)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred eeEEEEEcc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 999999987 567999999999999999987543 347889999999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||+||||++
T Consensus 228 Dlkp~NIll~----~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 228 DLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp CCCGGGEEEC----TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTT
T ss_pred ccchhhEEEC----CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcC
Confidence 9999999998 67899999999998543322 22334578899999999854 58999999999999999999
Q ss_pred CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1082 GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1082 Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
|+.||.+......+..+.. ..++..+..+++++.+||.+||+.||.+|||+.++++.|..+.....
T Consensus 302 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 302 GGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp SCCSSTTCCGGGHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 9999998887776665543 44566788899999999999999999999999999999999886544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=376.94 Aligned_cols=267 Identities=30% Similarity=0.483 Sum_probs=221.0
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEE-------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKW-------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~-------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
+.+...+|++.+.||+|+||+||+|++ .+..||||+++.... ......+.+|+.+++++ +||||+
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-------HHHHHHHHHHHHHHHhhcCCCCee
Confidence 345667999999999999999999997 234699999975421 12246788999999999 899999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhccccc----------------------cccHHHHHHHHHHHHHHHHHHHH
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR----------------------ILDRRKKLMLMMDAAFGMEYLHM 999 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr----------------------~L~e~qVlkIa~QLa~ALeYLHS 999 (1157)
++++++.. .+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||+
T Consensus 113 ~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 190 (344)
T 1rjb_A 113 NLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190 (344)
T ss_dssp CEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEee--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999987 5678999999999999999976432 37889999999999999999999
Q ss_pred CCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHH
Q 001103 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAM 1076 (1157)
Q Consensus 1000 kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVIL 1076 (1157)
+||+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||+|
T Consensus 191 ~~ivH~Dikp~NIll~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il 264 (344)
T 1rjb_A 191 KSCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILL 264 (344)
T ss_dssp TTEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHH
T ss_pred CCcccCCCChhhEEEc----CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHH
Confidence 9999999999999998 77899999999997543322 22345578899999998754 579999999999999
Q ss_pred HHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 001103 1077 WEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKR 1151 (1157)
Q Consensus 1077 YELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesks 1151 (1157)
|+|++ |..||........+..+.........+..+++++.+||.+||+.||.+|||+.+++++|+.+........
T Consensus 265 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 265 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340 (344)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred HHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence 99998 9999998877666666766777777888899999999999999999999999999999999887665543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=366.93 Aligned_cols=262 Identities=31% Similarity=0.508 Sum_probs=223.3
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE-------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeE
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW-------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVA 942 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~-------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVk 942 (1157)
.+...+|++.+.||+|+||+||+|++ .+..||||+++... . ....+.+.+|+++++++ +||||++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----H---LTEREALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----C---HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----h---HHHHHHHHHHHHHHhhcccCCCeee
Confidence 45567899999999999999999986 24579999987542 1 12246788999999999 9999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhccccc-----------------cccHHHHHHHHHHHHHHHHHHHHCCceec
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-----------------ILDRRKKLMLMMDAAFGMEYLHMKNIVHF 1005 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr-----------------~L~e~qVlkIa~QLa~ALeYLHSkGIIHR 1005 (1157)
+++++.. .+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||
T Consensus 92 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 169 (313)
T 1t46_A 92 LLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (313)
T ss_dssp EEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 9999987 5678999999999999999876432 48999999999999999999999999999
Q ss_pred cCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 001103 1006 DLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT- 1081 (1157)
Q Consensus 1006 DLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT- 1081 (1157)
||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 170 dlkp~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~ 243 (313)
T 1t46_A 170 DLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSL 243 (313)
T ss_dssp CCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTT
T ss_pred CCccceEEEc----CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhC
Confidence 9999999998 67899999999997654332 22344578899999998754 57999999999999999999
Q ss_pred CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1082 GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1082 Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
|+.||.....................+..+++++.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 244 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp TCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 999999887766666666666666677889999999999999999999999999999999887643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=375.76 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=218.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|++.+.||+|+||+||+++++ +..||||++++........ ....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 86 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYEN--K 86 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--C
Confidence 46999999999999999999984 7789999998753322111 0113568899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.....+||+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 6899999999999999999754 458999999999999999999999999999999999999844333448999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip~~ 1110 (1157)
.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+....... .....
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred eECCCCCccccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 876544444557799999999999754 57899999999999999999999999888777777665543322 22356
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++.+++||.+||+.||.+|||+.+++++.+.
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 88999999999999999999999999998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=368.02 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=208.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
++|++++.||+|+||+||+|++. ++.||||++....... .....+.+|+++++.++||||+++++++.. .+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHT--KK 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SS
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc------ccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CC
Confidence 57999999999999999999984 7789999997642211 112567789999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+++||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred eEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEeECcccc
Confidence 89999999986 89888877666799999999999999999999999999999999999998 67799999999997
Q ss_pred cccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC---------
Q 001103 1034 IKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL--------- 1103 (1157)
Q Consensus 1034 l~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l--------- 1103 (1157)
..... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 149 AFGIPVRKYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HHCC---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCccccccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 64332 223345799999999999753 3579999999999999999999999998877666555532100
Q ss_pred -------CC-----------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 -------RP-----------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 -------rp-----------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+ .+...+++++.+||.+||+.||.+|||+.+++++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00 1224578999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=374.43 Aligned_cols=261 Identities=32% Similarity=0.565 Sum_probs=220.4
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEE
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAF 943 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkL 943 (1157)
.+...+|++++.||+|+||.||+|++.+ +.||||+++... .......+.+|+.++++++||||+++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 115 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3455789999999999999999999864 679999987541 12335678999999999999999999
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhhhcccc-----------------------ccccHHHHHHHHHHHHHHHHHHHHC
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-----------------------RILDRRKKLMLMMDAAFGMEYLHMK 1000 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g-----------------------r~L~e~qVlkIa~QLa~ALeYLHSk 1000 (1157)
++++.+ ...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 116 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 116 LGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEcc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999987 567899999999999999987532 5689999999999999999999999
Q ss_pred CceeccCCccceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHH
Q 001103 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMW 1077 (1157)
Q Consensus 1001 GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILY 1077 (1157)
||+||||||+|||++ .++.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|
T Consensus 194 ~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ 267 (343)
T 1luf_A 194 KFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLW 267 (343)
T ss_dssp TCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHH
T ss_pred CeecCCCCcceEEEC----CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHH
Confidence 999999999999998 6679999999999754322 122345688999999998754 5799999999999999
Q ss_pred HHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1078 EIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1078 ELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
+|++ |..||.+.........+..... ...+..+++++.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 268 el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 268 EIFSYGLQPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHhcCCCcCCCCChHHHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9999 9999999888777776655433 4567789999999999999999999999999999999876544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=372.46 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=214.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|++. +..||||++.+....... ....+.+.+|++++++++||||+++++++.+ .
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN---PKDVERIKTEVRLMKKLHHPNIARLYEVYED--E 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccC---HHHHHHHHHHHHHHHhCCCCCcceeehhhcc--C
Confidence 47999999999999999999984 667999999865322111 1234678899999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccc---------------------------------------cccccHHHHHHHHHHHHHH
Q 001103 953 GTMATVTEYMVNGSLRHVLARK---------------------------------------DRILDRRKKLMLMMDAAFG 993 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~---------------------------------------gr~L~e~qVlkIa~QLa~A 993 (1157)
...++||||+++|+|.+++... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 6899999999999999988521 2235678899999999999
Q ss_pred HHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCC-----cccCCCCCCCcccCcccccCCCCCCCchhH
Q 001103 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT-----LVSGGVRGTLPWMAPELLNGSNNRVSEKVD 1068 (1157)
Q Consensus 994 LeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~-----~~sts~~GTp~YmAPEVL~G~~~~yS~KSD 1068 (1157)
|.|||++||+||||||+|||++.+ ....+||+|||++...... .......||+.|+|||++.+....++.++|
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTN--KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCS--SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHCCccccCCChhhEEEecC--CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999999721 2348999999999754221 123346799999999999865567899999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1069 VYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1069 IWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
||||||+||+|++|+.||...........+.........+ ..+++++++||.+||+.||.+|||+.+++++.+.-
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~ 335 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence 9999999999999999999998888888877765544333 24789999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=378.87 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=219.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+++.+ |+.||||++++...... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-- 77 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-----KQVEHTNDERLMLSIVTHPFIIRMWGTFQD-- 77 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----hHHHHHHHHHHHHhhCCCCCCceEeEEEEe--
Confidence 468999999999999999999984 77899999986532111 123567789999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+|+||||+++|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~Dfg~ 152 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGF 152 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCSS
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc----CCCCEEEeecCc
Confidence 568999999999999999997544 589999999999999999999999999999999999998 778999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
++..... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+..... .++..+
T Consensus 153 a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 226 (318)
T 1fot_A 153 AKYVPDV--TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFF 226 (318)
T ss_dssp CEECSSC--BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTS
T ss_pred ceecCCc--cccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCC
Confidence 9865433 3346899999999999864 578999999999999999999999999888888888876643 467789
Q ss_pred cHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARP-----SFTEITNRLRVM 1143 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~L 1143 (1157)
++++++||.+||+.||.+|| +++++++|.+.-
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~ 263 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence 99999999999999999999 999999987753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=379.24 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=214.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|+++ ++.||||++........... ..+.+.+|+.+++.++||||+++++++.+ .
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGL---STEDLKREASICHMLKHPHIVELLETYSS--D 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSC---CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccc---hHHHHHHHHHHHHhCCCCCCCcEEEEEEe--C
Confidence 57999999999999999999984 77899999976432211110 13568899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 GTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
+.+|+|||||++++|.+.+.+. +..+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~-~~~~vkl~Df 177 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-NSAPVKLGGF 177 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS-TTCCEEECCC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC-CCCcEEEecC
Confidence 6899999999999998877543 23589999999999999999999999999999999999998433 4456999999
Q ss_pred CCcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--
Q 001103 1030 GLSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ-- 1106 (1157)
Q Consensus 1030 GLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe-- 1106 (1157)
|++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ......+........
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 9998654433 24456799999999999854 57899999999999999999999998753 445555554443322
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
....+++++++||.+||+.||.+|||+.+++++.|...
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 22468999999999999999999999999999887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.12 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=214.5
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+...+|++++.||+|+||.||++++. +..||||++..... ......+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 81 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-----EKEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-----CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-----ccHHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence 344578999999999999999999984 77899999875421 12334578899999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. .+.+|+||||+++++|.+++.+.+ .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 82 ~--~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~D 154 (294)
T 4eqm_A 82 E--DDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID----SNKTLKIFD 154 (294)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECC
T ss_pred e--CCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEEe
Confidence 7 668999999999999999997554 589999999999999999999999999999999999998 677999999
Q ss_pred cCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC-
Q 001103 1029 FGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP- 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp- 1105 (1157)
||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...............+.
T Consensus 155 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 232 (294)
T 4eqm_A 155 FGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV 232 (294)
T ss_dssp CSSSTTC-------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH
T ss_pred CCCccccccccccccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc
Confidence 99997654332 23345799999999999864 56889999999999999999999999888766655555443322
Q ss_pred --CCCCCCcHHHHHHHHHHhccCCCCCC-CHHHHHHHHHHHH
Q 001103 1106 --QIPERCDPEWRKLMEECWSFNPAARP-SFTEITNRLRVMS 1144 (1157)
Q Consensus 1106 --eip~~iSpeLrdLIkrCLqkDPskRP-SaeELLe~Lr~Lk 1144 (1157)
..+..+++.+.++|.+||++||.+|| ++.++++.|..+.
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 24567899999999999999999998 8999988887654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.46 Aligned_cols=260 Identities=30% Similarity=0.572 Sum_probs=211.2
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+...+|++.+.||+|+||+||+|++. +..||||+++... .....+.+.+|+.++++++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 455679999999999999999999884 3358999876431 1234567889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.+ +..++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+|
T Consensus 84 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~k 156 (281)
T 1mp8_A 84 VITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVK 156 (281)
T ss_dssp EECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEE
T ss_pred EEcc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC----CCCCEE
Confidence 9854 468899999999999999987666799999999999999999999999999999999999998 677999
Q ss_pred EEecCCcccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC
Q 001103 1026 VGDFGLSRIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~ 1102 (1157)
|+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+...
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~- 233 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG- 233 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-
Confidence 999999986543322 2234578899999999754 57899999999999999997 99999988877777666544
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
....++..+++++.+||.+||+.||.+|||+.++++.|..+...-
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 334567789999999999999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=365.48 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=207.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|++. ++.||||+++..... ......+.+|+.++++++||||+++++++.+ .
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 73 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHS--D 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc------CCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--C
Confidence 57999999999999999999994 677999999865321 1224667899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+.+ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~----~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 74 KKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp TEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 689999999986 66666655556799999999999999999999999999999999999998 6789999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChhHHHHHhhhcCCC------
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP-YANMHCGAIIGGILSNTLR------ 1104 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~P-F~g~~~eeil~~Il~~~lr------ 1104 (1157)
...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+......+..+......
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred eecCCccccccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 865433 233456799999999999764 3479999999999999999988777 5555555555554321100
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1105 ---------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 ---------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
......+++++++||.+||+.||.+|||+++++++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 01223578999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.87 Aligned_cols=258 Identities=33% Similarity=0.617 Sum_probs=222.0
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+.+...+|++.+.||+|+||.||++++ .+..||+|++..... . .+.+.+|+++++.++||||+++++++.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 73 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----S-----EEDFIEEAEVMMKLSHPKLVQLYGVCL 73 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB----C-----HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC----C-----HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 346668999999999999999999998 466799999986421 1 246789999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ .+..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 74 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~d 147 (267)
T 3t9t_A 74 E--QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSD 147 (267)
T ss_dssp S--SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----GGGCEEECC
T ss_pred c--CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC----CCCCEEEcc
Confidence 7 5678999999999999999987666789999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+... ...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~ 224 (267)
T 3t9t_A 148 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRL 224 (267)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC
T ss_pred cccccccccccccccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcC
Confidence 99997653322 22345678899999999754 57899999999999999999 99999988877776666543 444
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
..+..+++.+.+||.+||+.||.+|||+.+++++|..+..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5677789999999999999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=385.69 Aligned_cols=261 Identities=33% Similarity=0.576 Sum_probs=222.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
+.+...+|++.+.||+|+||.||+|+++ ++.||||+++... .......+.+|++++++++||||+++++++
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-------CHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456678999999999999999999995 7789999987531 122345788999999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.. ...+++||||+++|+|.+++...+..+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+
T Consensus 182 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~----~~~~~kl~ 255 (377)
T 3cbl_A 182 TQ--KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT----EKNVLKIS 255 (377)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEEC
T ss_pred ec--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc----CCCcEEEC
Confidence 77 5678999999999999999987777799999999999999999999999999999999999998 67799999
Q ss_pred ecCCcccccCCccc---CCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1028 DFGLSRIKCNTLVS---GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~~~s---ts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
|||+++........ ....+++.|+|||++.+. .++.++|||||||+||||++ |..||...........+. ...
T Consensus 256 DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~ 332 (377)
T 3cbl_A 256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGG 332 (377)
T ss_dssp CGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTC
T ss_pred cCCCceecCCCceeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence 99999764433221 112357789999999754 57899999999999999998 999999888776655554 445
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
+...+..+++++.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 5667888999999999999999999999999999999988753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.82 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=209.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+...+|++++.||+|+||.||++++ .++.||||++++...... ......+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN----AKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh----hhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 4457899999999999999999987 467799999987532211 1223567789999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.. .+.+|+||||+.+++|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 90 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~----~~~~~kl 162 (327)
T 3a62_A 90 FQT--GGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN----HQGHVKL 162 (327)
T ss_dssp EEC--SSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTSCEEE
T ss_pred EEc--CCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC----CCCcEEE
Confidence 987 568999999999999999987543 588999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1027 GDFGLSRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1027 iDFGLAkl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
+|||+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-- 238 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-- 238 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--
Confidence 99999975332 2334456899999999999754 578999999999999999999999999888877777766543
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
.++..+++++++||.+||+.||.+|| ++.+++++.+.
T Consensus 239 ~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 239 NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 46778899999999999999999999 89999998775
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=379.13 Aligned_cols=256 Identities=22% Similarity=0.365 Sum_probs=215.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||.||+++++ ++.||||++++..... ......+.+|+.+++++ +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-----hHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 34568999999999999999999985 6779999998753221 22356788999999988 8999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+|+||||+++|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 81 ~--~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~D 153 (345)
T 3a8x_A 81 T--ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTD 153 (345)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred e--CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEEEEe
Confidence 7 56899999999999999998754 3589999999999999999999999999999999999998 778999999
Q ss_pred cCCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---------ChhHHHHHh
Q 001103 1029 FGLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM---------HCGAIIGGI 1098 (1157)
Q Consensus 1029 FGLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~---------~~eeil~~I 1098 (1157)
||+++... ........+||+.|+|||++.+. .++.++|||||||+||||++|+.||... ........+
T Consensus 154 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp GGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred ccccccccCCCCcccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 99998532 23344567899999999999864 5789999999999999999999999752 222344444
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCH------HHHHHHHHHH
Q 001103 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSF------TEITNRLRVM 1143 (1157)
Q Consensus 1099 l~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSa------eELLe~Lr~L 1143 (1157)
... ...++..+++++++||.+||++||.+||++ .++++|.+.-
T Consensus 232 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 232 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 443 335677899999999999999999999985 8999987763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=379.36 Aligned_cols=265 Identities=28% Similarity=0.509 Sum_probs=224.7
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC---------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCc
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPN 939 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG---------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPN 939 (1157)
+.+...+|++.+.||+|+||+||+|++.+ ..||||+++... .......+.+|+++++++ +|||
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpn 136 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKN 136 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-------CHHHHHHHHHHHHHHHHhcCCch
Confidence 34556789999999999999999999732 459999987541 122356788999999999 9999
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVH 1004 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIH 1004 (1157)
|+++++++.. .+.+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 137 Iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 214 (382)
T 3tt0_A 137 IINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 214 (382)
T ss_dssp BCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hhhheeeecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 9999999987 567899999999999999997643 35899999999999999999999999999
Q ss_pred ccCCccceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1005 FDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1005 RDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
|||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 215 ~Dlkp~NIll~----~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 215 RDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp SCCCGGGEEEC----TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCcceEEEc----CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHh
Confidence 99999999998 6779999999999864432 223345678899999999854 67999999999999999999
Q ss_pred -CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1082 -GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
|..||...........+. .......+..+++++.+||.+||+.||.+|||+.+++++|+.+.......
T Consensus 289 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 289 LGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp TSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred CCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 999999888777666554 44455677889999999999999999999999999999999998765443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=359.76 Aligned_cols=268 Identities=32% Similarity=0.569 Sum_probs=227.4
Q ss_pred cccCCCeeEEE-EecccCcEEEEEEEE----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQ-ELGSGTFGTVYRGKW----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILr-kLGsGsFGtVYlAr~----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+...+|.+++ .||+|+||.||+|.+ .+..||||+++... .....+.+.+|+++++.++||||+++++
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-------chhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 34557888887 999999999999986 36679999987641 1233567889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.. +..++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+|
T Consensus 78 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~k 150 (287)
T 1u59_A 78 VCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAK 150 (287)
T ss_dssp EEES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEE
T ss_pred EecC---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc----CCCCEE
Confidence 9844 468999999999999999977667799999999999999999999999999999999999998 677999
Q ss_pred EEecCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1026 VGDFGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
|+|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+..
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 999999986533221 2234578999999999754 57899999999999999998 9999998887776665544
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhcccccc
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNHA 1155 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesksRn~a 1155 (1157)
..++.++..+++++.+||.+||+.||.+||++.+++++|+.+........+-+.
T Consensus 229 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~ 282 (287)
T 1u59_A 229 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282 (287)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred -CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence 344567788999999999999999999999999999999999998887766554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=384.04 Aligned_cols=255 Identities=20% Similarity=0.347 Sum_probs=218.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||+++++ ++.||||++++...... .....+.+|..+++.+ +||+|+++++++.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-----~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-----DDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcc-----hHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 44579999999999999999999996 45699999987532111 1235678899999988 8999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++++||+|
T Consensus 92 ~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL~D 164 (353)
T 2i0e_A 92 T--MDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIAD 164 (353)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred c--CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc----CCCcEEEEe
Confidence 7 568999999999999999997544 489999999999999999999999999999999999998 778999999
Q ss_pred cCCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....++..+..... .+
T Consensus 165 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~ 240 (353)
T 2i0e_A 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AY 240 (353)
T ss_dssp CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CC
T ss_pred CCcccccccCCcccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--CC
Confidence 99998632 23344567899999999999854 578999999999999999999999999888888888876644 46
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
+..+++++++||.+||++||.+|| ++++++++.+.
T Consensus 241 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 778999999999999999999999 46999998765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.18 Aligned_cols=260 Identities=30% Similarity=0.518 Sum_probs=220.2
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeE
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVk 942 (1157)
+.+...+|++.+.||+|+||.||++++. +..||||+++... .....+.+.+|+++++.++||||++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-------SPSELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCceee
Confidence 3455678999999999999999999872 3569999987531 1223567889999999999999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhcccc-----------------------ccccHHHHHHHHHHHHHHHHHHHH
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-----------------------RILDRRKKLMLMMDAAFGMEYLHM 999 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g-----------------------r~L~e~qVlkIa~QLa~ALeYLHS 999 (1157)
+++++.. .+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 91 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 91 LYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp EEEEECS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999977 567899999999999999997533 348899999999999999999999
Q ss_pred CCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHH
Q 001103 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAM 1076 (1157)
Q Consensus 1000 kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVIL 1076 (1157)
+||+||||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++
T Consensus 169 ~~ivH~dikp~NIli~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il 242 (314)
T 2ivs_A 169 MKLVHRDLAARNILVA----EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLL 242 (314)
T ss_dssp TTEECCCCSGGGEEEE----TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHH
T ss_pred CCCcccccchheEEEc----CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHH
Confidence 9999999999999998 67899999999997543322 12334578899999999754 578999999999999
Q ss_pred HHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1077 WEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1077 YELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
|+|++ |..||.+.........+.. ......+..+++++.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 243 ~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 243 WEIVTLGGNPYPGIPPERLFNLLKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHhhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999 9999998887776655543 34556777899999999999999999999999999999998864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=376.68 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=210.9
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
.+...+|++++.||+|+||+||+|++.++.||||++.... .......+|+.++++++||||+++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---------KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---------hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 4566799999999999999999999999999999987531 1124456699999999999999999998764
Q ss_pred C--CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC----------CceeccCCccceeeccCC
Q 001103 951 P--GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK----------NIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 951 ~--~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk----------GIIHRDLKPENILLd~dd 1018 (1157)
. ...+++||||+++|+|.++++.. .+++..++.++.|++.||.|||++ ||+||||||+|||++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~--- 165 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK--- 165 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---
Confidence 3 23579999999999999999653 489999999999999999999999 999999999999998
Q ss_pred CCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-
Q 001103 1019 PQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSN---NRVSEKVDVYSFGIAMWEIITGEEPYANMHC- 1091 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~---~~yS~KSDIWSLGVILYELLTGk~PF~g~~~- 1091 (1157)
..+.+||+|||+++...... ......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+...
T Consensus 166 -~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 166 -NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp -TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred -CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 67899999999997643322 233467999999999997631 2356788999999999999999999975421
Q ss_pred ---------------hHHHHHhhhcCCCCCCCCC-----CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1092 ---------------GAIIGGILSNTLRPQIPER-----CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1092 ---------------eeil~~Il~~~lrpeip~~-----iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
......+.....++.++.. .++++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1222233333344433332 245699999999999999999999999999988753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=379.07 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=201.9
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||+||++++. ++.||||++...... .+.+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~~- 87 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---------DENVQREIINHRSLRHPNIVRFKEVILT- 87 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---------CHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---------cHHHHHHHHHHHhCCCCCCCcEEEEEee-
Confidence 3468999999999999999999994 778999999764211 1456789999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
...+++||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ ..+.+||+|||
T Consensus 88 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~--~~~~~kl~Dfg 163 (361)
T 3uc3_A 88 -PTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICDFG 163 (361)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS--SSCCEEECCCC
T ss_pred -CCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC--CCceEEEeecC
Confidence 568999999999999999986544 58999999999999999999999999999999999999722 23459999999
Q ss_pred CcccccCCcccCCCCCCCcccCcccccCCCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHhhhcCCCC
Q 001103 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVS-EKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGGILSNTLRP 1105 (1157)
Q Consensus 1031 LAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS-~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~Il~~~lrp 1105 (1157)
+++...........+||+.|+|||++.+. .++ .++|||||||++|+|++|+.||..... ...+..+.......
T Consensus 164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (361)
T 3uc3_A 164 YSKSSVLHSQPKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241 (361)
T ss_dssp CC---------------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC
T ss_pred ccccccccCCCCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC
Confidence 99754444444556799999999999764 344 448999999999999999999987543 34444455444444
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.....+++++++||.+||+.||.+|||+.+++++.|...
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 444568999999999999999999999999999998743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.89 Aligned_cols=264 Identities=29% Similarity=0.502 Sum_probs=220.9
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeE
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVA 942 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVk 942 (1157)
.+...+|++.+.||+|+||+||+|++. ++.||||+++... .......+.+|+++++++ +||||++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-------CcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345679999999999999999999863 3669999987541 122346788999999999 7999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhccccc---------------cccHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR---------------ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDL 1007 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr---------------~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDL 1007 (1157)
+++++... ...+++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||
T Consensus 96 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~di 174 (316)
T 2xir_A 96 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174 (316)
T ss_dssp EEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccC
Confidence 99998763 4568999999999999999976433 2889999999999999999999999999999
Q ss_pred CccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CC
Q 001103 1008 KCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GE 1083 (1157)
Q Consensus 1008 KPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk 1083 (1157)
||+|||++ ..+.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++ |+
T Consensus 175 kp~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 175 AARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp SGGGEEEC----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccceEEEC----CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCC
Confidence 99999998 66789999999997543321 22345688999999999754 57999999999999999998 99
Q ss_pred CCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1084 EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1084 ~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
.||........+............+..+++++.++|.+||+.||.+|||+.+++++|..+.....
T Consensus 249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 249 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 99988775555555555555566777899999999999999999999999999999999986554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=381.03 Aligned_cols=259 Identities=21% Similarity=0.365 Sum_probs=211.5
Q ss_pred ccCCCeeEEEEeccc--CcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 872 IKDSDLEELQELGSG--TFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 872 I~~sdYeILrkLGsG--sFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
....+|++++.||+| +||+||+|+++ ++.||||+++.... .......+.+|+.+++.++|||||++++++
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC------SNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc------ChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 345789999999999 99999999995 77899999986521 123457788999999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.+ .+.+|+|||||++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 96 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~----~~~~~kl 169 (389)
T 3gni_B 96 IA--DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYL 169 (389)
T ss_dssp EE--TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEE
T ss_pred EE--CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEE
Confidence 87 56899999999999999998764 35589999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCC--------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHh
Q 001103 1027 GDFGLSRIKCNT--------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGI 1098 (1157)
Q Consensus 1027 iDFGLAkl~~~~--------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~I 1098 (1157)
+|||++...... ......+||+.|+|||++.+....++.++|||||||++|+|++|+.||.+......+..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999987643211 112234799999999999864456899999999999999999999999887655554443
Q ss_pred hhcCCC--------------------------------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHH
Q 001103 1099 LSNTLR--------------------------------------------PQIPERCDPEWRKLMEECWSFNPAARPSFT 1134 (1157)
Q Consensus 1099 l~~~lr--------------------------------------------peip~~iSpeLrdLIkrCLqkDPskRPSae 1134 (1157)
.....+ ...+..+++++++||.+||+.||.+|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 322111 123455788999999999999999999999
Q ss_pred HHHHHHHH
Q 001103 1135 EITNRLRV 1142 (1157)
Q Consensus 1135 ELLe~Lr~ 1142 (1157)
+++++.+.
T Consensus 330 ell~hp~f 337 (389)
T 3gni_B 330 TLLNHSFF 337 (389)
T ss_dssp HHTTSGGG
T ss_pred HHhcCHHH
Confidence 99998665
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=381.63 Aligned_cols=266 Identities=28% Similarity=0.501 Sum_probs=222.0
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeE
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVk 942 (1157)
..+...+|++++.||+|+||+||+|++. +..||||+++... . ......+.+|+.++++++||||++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~~E~~~l~~l~hpnIv~ 138 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----S---EQDELDFLMEALIISKFNHQNIVR 138 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----C---HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----C---hhhHHHHHHHHHHHHhCCCCCCCe
Confidence 4456678999999999999999999963 4469999986431 1 222456889999999999999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhcccc------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecc
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNL 1016 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~ 1016 (1157)
+++++.. ....++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 139 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 139 CIGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp EEEEECS--SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred EEEEEec--CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence 9999987 567899999999999999997643 35889999999999999999999999999999999999984
Q ss_pred CCCCCCeEEEEecCCcccccC---CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChh
Q 001103 1017 RDPQRPICKVGDFGLSRIKCN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCG 1092 (1157)
Q Consensus 1017 dd~e~g~VKLiDFGLAkl~~~---~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~e 1092 (1157)
++ ....+||+|||+++.... ........||+.|+|||++.+. .++.++|||||||+||||++ |..||......
T Consensus 217 ~~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~ 293 (367)
T 3l9p_A 217 PG-PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293 (367)
T ss_dssp SS-TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CC-CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 43 445799999999974322 1222335689999999999754 57999999999999999998 99999998887
Q ss_pred HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1093 eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
.....+.... ....+..+++.+.+||.+||+.||.+|||+.+|+++|+.+.....
T Consensus 294 ~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 294 EVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 7776665443 445677899999999999999999999999999999999876443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=361.43 Aligned_cols=260 Identities=28% Similarity=0.503 Sum_probs=213.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
+....|++++.||+|+||.||+|++ .++.||||+++.... ......+.+|+++++.++||||+++++
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-------GNHIADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-------chhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 4456799999999999999999985 467799999875421 112366889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.......+++||||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++ .++.+|
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~k 166 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVK 166 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEE
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc----CCCCEE
Confidence 9988655789999999999999999977767799999999999999999999999999999999999998 677999
Q ss_pred EEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC------------
Q 001103 1026 VGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM------------ 1089 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~------------ 1089 (1157)
|+|||++....... ......||..|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcc
Confidence 99999998654332 23345688899999999754 5689999999999999999999886422
Q ss_pred --ChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1090 --HCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1090 --~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.....+............+..+++++.+||.+||+.||.+|||+.++++.|..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1122223333445556678889999999999999999999999999999998774
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=384.46 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=217.7
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||+|+++ ++.||||++++...... .....+.+|..+++.+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-----DDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhh-----hhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 45579999999999999999999984 67799999987532111 1135577899999877 9999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 89 ~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL~D 161 (345)
T 1xjd_A 89 T--KENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIAD 161 (345)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred e--CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC----CCCCEEEeE
Confidence 8 568999999999999999997543 589999999999999999999999999999999999998 678999999
Q ss_pred cCCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....++..+.... +.+
T Consensus 162 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~ 237 (345)
T 1xjd_A 162 FGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFY 237 (345)
T ss_dssp CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCC
T ss_pred ChhhhhcccCCCcccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CCC
Confidence 99998543 23334567899999999999864 57899999999999999999999999988888887776553 346
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHH-HHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFT-EITNRLRV 1142 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSae-ELLe~Lr~ 1142 (1157)
+..+++++++||.+||+.||.+||++. +++++.+.
T Consensus 238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 778999999999999999999999998 88887664
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=356.32 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=218.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||+||+|+++ +..+|+|++....... .+.+.+|++++++++||||+++++++.+ .
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 78 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--------VDRFKQEIEIMKSLDHPNIIRLYETFED--N 78 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--------HHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 47999999999999999999995 4569999987642211 3567899999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||+..++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLA 156 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTTC
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEecccc
Confidence 6899999999999999988654 4589999999999999999999999999999999999994322 6778999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC--CCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI--PER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei--p~~ 1110 (1157)
.............||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+......... ...
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLN 233 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTC---BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred eeccCccchhccCCCCCccChHHhccc---CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhc
Confidence 876655555567899999999998753 788999999999999999999999998888877777665443321 125
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+++++.+||.+||+.||.+|||+.+++++.+.-..
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 78999999999999999999999999999887543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=360.47 Aligned_cols=264 Identities=18% Similarity=0.230 Sum_probs=217.6
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVV 947 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf 947 (1157)
.+...+|++.+.||+|+||+||+|++ .++.||||++..... ...+.+|+.+++.+ +|++++++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------APQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----------cHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 34567899999999999999999996 578899999875421 13467899999999 799999999998
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-CCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd-~e~g~VKL 1026 (1157)
.. ....++||||+ +++|.+++...++.+++..++.++.||+.||.|||++||+||||||+|||++.++ .....+||
T Consensus 76 ~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 76 QE--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CC--CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 77 66899999999 9999999987776799999999999999999999999999999999999998443 23455999
Q ss_pred EecCCcccccCCc--------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hhHHH
Q 001103 1027 GDFGLSRIKCNTL--------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH---CGAII 1095 (1157)
Q Consensus 1027 iDFGLAkl~~~~~--------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~---~eeil 1095 (1157)
+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... ....+
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 9999998654322 23456799999999999864 57999999999999999999999998743 33333
Q ss_pred HHhhhcCC---CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1096 GGILSNTL---RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1096 ~~Il~~~l---rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
..+..... ...+...+++++.+||.+||+.||.+|||+++|++.|..+...+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 33332211 1223456899999999999999999999999999999999876654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.67 Aligned_cols=263 Identities=27% Similarity=0.348 Sum_probs=208.7
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC---CCCceeEEeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL---HHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L---~HPNIVkLygv 946 (1157)
+...+|++++.||+|+||+||+|++ .++.||||++............ ...+.+|+.+++.+ +||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL---PISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCC---CHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccccc---chhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 3457999999999999999999997 5778999999864322111111 13345666666655 59999999999
Q ss_pred eecCCCC---cEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 947 VPNGPGG---TMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 947 f~de~~~---~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
+...... .+++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~----~~~ 157 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGG 157 (308)
T ss_dssp EEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC----TTS
T ss_pred eeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCC
Confidence 8764322 58999999974 9999887644 3489999999999999999999999999999999999998 677
Q ss_pred eEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1023 ICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
.+||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+......+..+....
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999999876655555567899999999999754 57899999999999999999999999988777766664321
Q ss_pred CCC---C----------------------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1103 LRP---Q----------------------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1103 lrp---e----------------------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+ . ....+++++.+||.+||++||.+|||+.+++++.|.-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 110 0 11357889999999999999999999999999877644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=389.65 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=213.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||+++++ ++.||||++++...... .....+.+|..+++++ +|||||++++++.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-----~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-----EDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-----HHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 44578999999999999999999985 66799999987643221 1235577899999887 8999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+|+||||+.+|+|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++++||+|
T Consensus 124 ~--~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL~D 196 (396)
T 4dc2_A 124 T--ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTD 196 (396)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred E--CCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC----CCCCEEEee
Confidence 8 56899999999999999998754 4589999999999999999999999999999999999998 778999999
Q ss_pred cCCcccc-cCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------hhHHHHHh
Q 001103 1029 FGLSRIK-CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH---------CGAIIGGI 1098 (1157)
Q Consensus 1029 FGLAkl~-~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~---------~eeil~~I 1098 (1157)
||+++.. .........+||+.|+|||++.+. .++.++|||||||+||||++|+.||.... .......+
T Consensus 197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i 274 (396)
T 4dc2_A 197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274 (396)
T ss_dssp CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred cceeeecccCCCccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence 9999863 333445567899999999999865 57899999999999999999999996432 22234444
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCH------HHHHHHHHHH
Q 001103 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSF------TEITNRLRVM 1143 (1157)
Q Consensus 1099 l~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSa------eELLe~Lr~L 1143 (1157)
... ...+|..+++++++||.+||++||.+||++ .+++++.++-
T Consensus 275 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 275 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred hcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 443 345778899999999999999999999984 7999987753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=381.94 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=221.1
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
....+|++++.||+|+||.||+++++ |+.||||++.+...... .....+.+|+++++.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-----KQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44578999999999999999999984 77899999976532111 124567899999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 113 --~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~DF 185 (350)
T 1rdq_E 113 --NSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDF 185 (350)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC----CCCCEEEccc
Confidence 568999999999999999997654 489999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
|+++..... ....+||+.|+|||++.+. .++.++|||||||+||+|++|+.||........+..+..... .++.
T Consensus 186 g~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~ 259 (350)
T 1rdq_E 186 GFAKRVKGR--TWTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPS 259 (350)
T ss_dssp TTCEECSSC--BCCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCT
T ss_pred ccceeccCC--cccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCC
Confidence 999865433 2346899999999999864 578999999999999999999999999888888888876643 4677
Q ss_pred CCcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPS-----FTEITNRLRVM 1143 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~L 1143 (1157)
.+++++++||.+||+.||.+||+ +++|+++.+..
T Consensus 260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 89999999999999999999998 99999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=391.89 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=219.9
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|.+ .|..||+|++..... .....+.+.+|+++++.|+|||||++++++.+ .
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 82 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL------SARDHQKLEREARICRLLKHPNIVRLHDSISE--E 82 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--S
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--C
Confidence 4799999999999999999988 477899999986532 12234678899999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+..|+|||||.+|+|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+. ..+.+||+|||++
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~-~~~~vkL~DFG~a 160 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL-KGAAVKLADFGLA 160 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS-TTCCEEECCCSSC
T ss_pred CEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC-CCCcEEEccCcee
Confidence 78999999999999999887544 589999999999999999999999999999999999998433 4578999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC--CC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI--PE 1109 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei--p~ 1109 (1157)
...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+......+..+......... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred EEecCCCceeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc
Confidence 765433 233457899999999999854 5789999999999999999999999998888888888776554333 34
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+++++++||.+||+.||.+|||+.+++++.|...
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 68999999999999999999999999999877543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=387.81 Aligned_cols=256 Identities=34% Similarity=0.631 Sum_probs=221.2
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+.+...+|++++.||+|+||.||+|+++++.||||+++... ..+.+.+|+++|++++||||+++++++..
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----------TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----------HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 45667899999999999999999999999999999997642 13568899999999999999999999876
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccc-cccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr-~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ...+++|||||++|+|.+++.+.+. .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 258 ~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~D 332 (450)
T 1k9a_A 258 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSD 332 (450)
T ss_dssp T-TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTSCEEECC
T ss_pred C-CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC----CCCCEEEee
Confidence 3 3478999999999999999986543 378999999999999999999999999999999999998 678999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++....... ...+++.|+|||++.+. .++.++|||||||+||||++ |+.||......+....+. ...+...
T Consensus 333 fG~a~~~~~~~~--~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~ 407 (450)
T 1k9a_A 333 FGLTKEASSTQD--TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDA 407 (450)
T ss_dssp CTTCEECC--------CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCC
T ss_pred CCCccccccccc--CCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 999985433222 23578999999999854 68999999999999999998 999999888777766654 4456677
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+..+++++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 88899999999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=373.49 Aligned_cols=255 Identities=27% Similarity=0.339 Sum_probs=210.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|++. ++.||||++...... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRRE-- 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-------chHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 468999999999999999999984 778999998754221 123567899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kl~Dfg~ 151 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGL 151 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe----CCCCEEEEEeec
Confidence 66899999999999999999754 3489999999999999999999999999999999999998 677999999999
Q ss_pred cccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCCCCCC
Q 001103 1032 SRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLRPQI 1107 (1157)
Q Consensus 1032 Akl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~lrpei 1107 (1157)
+...... ......+||+.|+|||++.+.. .++.++|||||||+||+|++|+.||....... ..............
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc
Confidence 9754321 2234567999999999997642 24778999999999999999999998765542 23333333333333
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
...+++++.+||.+||+.||.+|||+.+++++.|..
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 456899999999999999999999999999988764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=360.88 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=209.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++.+.||+|+||+||+++++ +..+|+|++....... ..+.+.+|++++++++||||+++++++.+ .
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-------PMEQIEAEIEVLKSLDHPNIIKIFEVFED--Y 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-------CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-------hHHHHHHHHHHHHhCCCchHHhHHHheec--C
Confidence 47999999999999999999984 6789999998753211 13567899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 GTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
..+++||||+++++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++..+ ..+.+||+||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-~~~~~kl~Df 171 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSPIKIIDF 171 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-TTCCEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-CCCCEEEEee
Confidence 6899999999999999888543 35689999999999999999999999999999999999996332 5678999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC-CC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ-IP 1108 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe-ip 1108 (1157)
|++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+........ ..
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred ecceecCCcccCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc
Confidence 99986555555556779999999999863 478999999999999999999999998887776665544433222 22
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+++++.+||.+||+.||.+|||+.+++++.+.
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 3478999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=361.88 Aligned_cols=262 Identities=32% Similarity=0.598 Sum_probs=206.9
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
..++...+|++.++||+|+||+||++++.+ .||||+++.... .....+.+.+|++++++++||||++++++..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 90 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP------TPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC------CHHHHHHHHHHHHHHHhCCCCcEEEEEeecc
Confidence 346777899999999999999999998765 599999875421 1233577889999999999999999999754
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ..+++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 91 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~D 163 (289)
T 3og7_A 91 A---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGD 163 (289)
T ss_dssp S---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTTEEEECC
T ss_pred C---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC----CCCCEEEcc
Confidence 3 458999999999999999977777799999999999999999999999999999999999998 678999999
Q ss_pred cCCcccccC---CcccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhh-hcCC
Q 001103 1029 FGLSRIKCN---TLVSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL-SNTL 1103 (1157)
Q Consensus 1029 FGLAkl~~~---~~~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il-~~~l 1103 (1157)
||++..... ........||+.|+|||++... ...++.++||||||+++|+|++|+.||........+.... ....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence 999975432 2223345799999999998632 2457889999999999999999999998876555444443 3333
Q ss_pred CC---CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1104 RP---QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1104 rp---eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+ .+...+++++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 22 234578899999999999999999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=381.25 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=201.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~ 951 (1157)
.+|++++.||+|+||+||+|.+. ++.||||++.+.. ........+.+|+.+++.+. ||||+++++++....
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF------QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc------cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 68999999999999999999884 7789999986531 11223467789999999997 999999999998765
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+|+|||||. ++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~DFG~ 155 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN----AECHVKVADFGL 155 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc----CCCCEEecCCcc
Confidence 668999999997 589888865 3588999999999999999999999999999999999998 778999999999
Q ss_pred cccccC----------------------CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 001103 1032 SRIKCN----------------------TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM 1089 (1157)
Q Consensus 1032 Akl~~~----------------------~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~ 1089 (1157)
|+.... .......+||+.|+|||++.+. ..++.++|||||||+||||++|++||.+.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 975422 1123446899999999999763 46899999999999999999999999998
Q ss_pred ChhHHHHHhhhcCCCC---------------------------------------------CCCCCCcHHHHHHHHHHhc
Q 001103 1090 HCGAIIGGILSNTLRP---------------------------------------------QIPERCDPEWRKLMEECWS 1124 (1157)
Q Consensus 1090 ~~eeil~~Il~~~lrp---------------------------------------------eip~~iSpeLrdLIkrCLq 1124 (1157)
.....+..+....-.+ ..+..+++++.+||.+||+
T Consensus 235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 8777666654321110 0112578899999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 001103 1125 FNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1125 kDPskRPSaeELLe~Lr~ 1142 (1157)
+||.+|||++++++|.+.
T Consensus 315 ~dP~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 315 FNPNKRISANDALKHPFV 332 (388)
T ss_dssp SSGGGSCCHHHHTTSTTT
T ss_pred cCcccCCCHHHHhCCHHH
Confidence 999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=375.29 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=218.1
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|++++.||+|+||+||+|++ .++.||||++..... ......+.+.+|++++++++||||+++++++.. .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 126 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--E 126 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-----cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--C
Confidence 3589999999999999999997 477899999976421 123345678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+. |+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a 201 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 201 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTC
T ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEeeccCc
Confidence 68999999997 588888876666799999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
...... ....||+.|+|||++.+ ....++.++|||||||++|||++|+.||........+..+.....+...+..+
T Consensus 202 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (348)
T 1u5q_A 202 SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 278 (348)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred eecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Confidence 765432 34679999999999853 23457899999999999999999999999888777777776665555556778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
++.+++||.+||+.||.+|||+++++++.+..
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 99999999999999999999999999987764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=358.26 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=202.6
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||+||++++ +++.||||+++... ........+.++..+++.++||||+++++++.+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 4567899999999999999999998 57889999987541 112223445556666888999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEE
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
.+..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++ ..+.+|
T Consensus 78 --~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~k 150 (290)
T 3fme_A 78 --EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVK 150 (290)
T ss_dssp --SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC----TTCCEE
T ss_pred --cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEE
Confidence 5689999999975 88777654 345699999999999999999999998 999999999999998 677999
Q ss_pred EEecCCcccccCCcccCCCCCCCcccCcccccC--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChhHHHHHhhhcC
Q 001103 1026 VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNG--SNNRVSEKVDVYSFGIAMWEIITGEEPYANM-HCGAIIGGILSNT 1102 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G--~~~~yS~KSDIWSLGVILYELLTGk~PF~g~-~~eeil~~Il~~~ 1102 (1157)
|+|||++.............||+.|+|||++.. ....++.++|||||||++|+|++|+.||... .....+.......
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (290)
T 3fme_A 151 MCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230 (290)
T ss_dssp BCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred EeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence 999999987655554455679999999999732 1345789999999999999999999999863 3444455555554
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.....+..+++++.+||.+||+.||.+|||+.+++++.+.-...
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 44444567899999999999999999999999999998876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=390.34 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=220.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|++. ++.||||++.+....... ...+.+|++++++++||||+++++++.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 93 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNIMKLFEILED--S 93 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH------HHHHHHHHHHHHhCCCCCcCeEEEEEEc--C
Confidence 47999999999999999999984 778999999764322211 3567899999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+|||||.+++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGLS 171 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-TTCCEEECSCSCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCCEEEEECCcC
Confidence 6899999999999999888654 4589999999999999999999999999999999999997433 5678999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--CC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--ER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~~ 1110 (1157)
............+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+......+..+.........+ ..
T Consensus 172 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (486)
T 3mwu_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248 (486)
T ss_dssp TTBCCC----CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGG
T ss_pred eECCCCCccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCC
Confidence 87655555556789999999999975 47999999999999999999999999998888888887766554433 46
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+++++++||.+||+.||.+|||+.+++++.|...
T Consensus 249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 8999999999999999999999999999988653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=367.30 Aligned_cols=265 Identities=29% Similarity=0.525 Sum_probs=224.3
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeE
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVA 942 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVk 942 (1157)
.+...+|++.+.||+|+||+||+|++.+ ..||+|+++... .......+.+|+.+++.+ +||||++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-------HADEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-------ChHHHHHHHHHHHHHHhhcCCCCeee
Confidence 4566899999999999999999999843 359999987542 122346788999999999 8999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhcccc-------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCc
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKC 1009 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g-------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKP 1009 (1157)
+++++.. .+.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 115 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 115 LLGACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp EEEEECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEec--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 9999977 567899999999999999987542 3478999999999999999999999999999999
Q ss_pred cceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 001103 1010 DNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEP 1085 (1157)
Q Consensus 1010 ENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~P 1085 (1157)
+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 193 ~NIl~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 193 RNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp GGCEEE----GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ceEEEC----CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCC
Confidence 999998 67799999999997543222 22334578899999998754 57999999999999999998 9999
Q ss_pred CCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1086 YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1086 F~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
|.+......+..+.........+..+++.+.+||.+||+.||.+|||+.+++++|+.+....+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp STTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred CcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 99877666666666666666777888999999999999999999999999999999988765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=358.55 Aligned_cols=263 Identities=32% Similarity=0.601 Sum_probs=224.7
Q ss_pred ccccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 868 GLQIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 868 ~i~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
..+.+...+|++.+.||+|+||+||+|+++ +..||||++.... . ..+.+.+|+++++.++||||+++++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~----~~~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----M----EVEEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-----T----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-----H----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 345567789999999999999999999995 6779999987531 1 1467889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
++.+ ...+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 77 ~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~ 150 (288)
T 3kfa_A 77 VCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLV 150 (288)
T ss_dssp EECS--SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC----GGGCE
T ss_pred EEcc--CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc----CCCCE
Confidence 9977 56799999999999999999763 35589999999999999999999999999999999999998 66789
Q ss_pred EEEecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhc
Q 001103 1025 KVGDFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~ 1101 (1157)
||+|||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...........+. .
T Consensus 151 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~ 227 (288)
T 3kfa_A 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-K 227 (288)
T ss_dssp EECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-T
T ss_pred EEccCccceeccCCccccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-c
Confidence 999999998654332 22334578899999999754 57999999999999999999 999999887766655554 4
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
......+..+++.+.+||.+||+.||.+|||+.++++.|..+.....
T Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 45556778899999999999999999999999999999998887544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=358.78 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=215.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||+||+|++. +..||||++..... ........+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-----chhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 34468999999999999999999985 55699999876421 112224668899999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~----~~~~~~l~Df 153 (279)
T 3fdn_A 81 --ATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADF 153 (279)
T ss_dssp --SSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC----TTSCEEECSC
T ss_pred --CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc----CCCCEEEEec
Confidence 56899999999999999998754 3489999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
|++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.... ..++.
T Consensus 154 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 228 (279)
T 3fdn_A 154 GWSVHAPSSR-RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPD 228 (279)
T ss_dssp CEESCC---------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCT
T ss_pred cccccCCccc-ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--CCCCC
Confidence 9986543332 2345799999999999864 56889999999999999999999999888777776665443 34677
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.+++.+++||.+||+.||.+|||+.+++++.|....
T Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 229 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 789999999999999999999999999999887654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=383.68 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=215.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|++ .++.||||++.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 80 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-----SDMHMRVEREISYLKLLRHPHIIKLYDVITT-- 80 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-----hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--
Confidence 36899999999999999999998 57789999997642211 1113567899999999999999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+++||||+ +|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kl~DFG~ 154 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD----DNLNVKIADFGL 154 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC----TTCCEEECCSSC
T ss_pred CCEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc----CCCCEEEEEecc
Confidence 56899999999 678888886544 589999999999999999999999999999999999998 778999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
+............+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+.. ....++..+
T Consensus 155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~ 231 (336)
T 3h4j_B 155 SNIMTDGNFLKTSCGSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMPDFL 231 (336)
T ss_dssp TBTTTTSBTTCCCTTSTTTSCGGGSCCSG-GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS--SCCCCCTTS
T ss_pred ceeccCCcccccccCCcCcCCHHHHcCCC-CCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCCCcccC
Confidence 98766666566678999999999998653 237899999999999999999999987654443333322 233467778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
++++++||.+||+.||.+|||+.+++++.|.-.
T Consensus 232 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 232 SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 999999999999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=394.52 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=219.3
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||+||+++++ +..||||++++........ ...+.+|+.+++.++|||||++++++.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~-----~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCC-----CSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHH-----HHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 45678999999999999999999994 6679999998642211111 2347789999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+|||||+||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++ .++++||+||
T Consensus 141 --~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL~DF 212 (410)
T 3v8s_A 141 --DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADF 212 (410)
T ss_dssp --SSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC----CCCCEEEecc
Confidence 66899999999999999998643 489999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCc--ccCCCCCCCcccCcccccCCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC--C
Q 001103 1030 GLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNN--RVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT--L 1103 (1157)
Q Consensus 1030 GLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~--~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~--l 1103 (1157)
|+++...... .....+||+.|+|||++.+... .++.++|||||||+||||++|++||.+......+..++... +
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 9998654432 2346789999999999975421 26889999999999999999999999988888888877543 3
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCC--CCCHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAA--RPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPsk--RPSaeELLe~Lr~L 1143 (1157)
..+....+++++++||.+||+.+|.+ ||++++|++|.++-
T Consensus 293 ~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~ 334 (410)
T 3v8s_A 293 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 334 (410)
T ss_dssp CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence 33334468999999999999999988 99999999998864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=369.01 Aligned_cols=265 Identities=29% Similarity=0.500 Sum_probs=219.0
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
.+...+|++++.||+|+||.||++++ .+..||||++.... ....+.+.+|++++++++||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--------PDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--------HHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 35667999999999999999999985 46679999987541 22346788999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+++.......+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~----~~~~~ 166 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE----SEAHV 166 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC----CCCCE
Confidence 99876657789999999999999999987666799999999999999999999999999999999999998 67799
Q ss_pred EEEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--------
Q 001103 1025 KVGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-------- 1092 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-------- 1092 (1157)
||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 244 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence 999999998643322 22335688899999999754 5689999999999999999999998643321
Q ss_pred ------HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1093 ------AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1093 ------eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
..+............+..+++++.+||.+||+.||.+|||+.+++++|+.+......
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 222333444556667888999999999999999999999999999999988665443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.69 Aligned_cols=255 Identities=29% Similarity=0.528 Sum_probs=203.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHh--CCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN--LHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~--L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||+||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----------chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 345789999999999999999999999999999986531 2345567777776 799999999998654
Q ss_pred C--CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHH--------HCCceeccCCccceeeccCCC
Q 001103 950 G--PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH--------MKNIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 950 e--~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLH--------SkGIIHRDLKPENILLd~dd~ 1019 (1157)
. ....+++||||+++|+|.++++. ..+++..++.++.|++.||.||| +++|+||||||+|||++
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---- 147 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---- 147 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC----
T ss_pred ccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc----
Confidence 2 23468999999999999999954 35899999999999999999999 99999999999999998
Q ss_pred CCCeEEEEecCCcccccCCcc-----cCCCCCCCcccCcccccCCCC----CCCchhHHHHHHHHHHHHHcC--------
Q 001103 1020 QRPICKVGDFGLSRIKCNTLV-----SGGVRGTLPWMAPELLNGSNN----RVSEKVDVYSFGIAMWEIITG-------- 1082 (1157)
Q Consensus 1020 e~g~VKLiDFGLAkl~~~~~~-----sts~~GTp~YmAPEVL~G~~~----~yS~KSDIWSLGVILYELLTG-------- 1082 (1157)
.++.+||+|||+++....... .....||+.|+|||++.+... .++.++|||||||++|||++|
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 677999999999975433221 233579999999999976422 345789999999999999999
Q ss_pred --CCCCCCCCh-----hHHHHHhhhcCCCCCCCC-----CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1083 --EEPYANMHC-----GAIIGGILSNTLRPQIPE-----RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1083 --k~PF~g~~~-----eeil~~Il~~~lrpeip~-----~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+.||..... ......+......+.++. .+++++.+||.+||+.||.+|||+.++++.|..+
T Consensus 228 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 888865322 222222222333333332 2557899999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=354.13 Aligned_cols=264 Identities=33% Similarity=0.573 Sum_probs=221.0
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+.+...+|++++.||+|+||.||+|++++ ..||||+++.... . .+.+.+|+++++.++||||+++++++.
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----S-----PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----C-----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----c-----HHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 44566799999999999999999999864 5799999875421 1 256789999999999999999999986
Q ss_pred cCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. +..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 79 ~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~ 151 (279)
T 1qpc_A 79 Q---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIA 151 (279)
T ss_dssp S---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEEC
T ss_pred C---CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc----CCCCEEEC
Confidence 4 35889999999999999997643 3689999999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1028 DFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|||++....... ......++..|+|||++.+. .++.++||||||+++|+|++ |+.||...........+.. ...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~ 228 (279)
T 1qpc_A 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYR 228 (279)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCC
T ss_pred CCcccccccCcccccccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-ccC
Confidence 999998654332 22334578899999999754 57899999999999999999 9999998887776666543 344
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesksR 1152 (1157)
...+..+++++.+||.+||+.||.+|||+.++++.|..+........+
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 556778999999999999999999999999999999999887655443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=386.34 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=216.7
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||.||+++++ ++.||||++.+...... .....+.+|+++|+.++|||||++++++.+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-----NEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccH-----HHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 44578999999999999999999985 56799999986532211 124678899999999999999999999988
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+||||+.+|+|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 87 --~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL~DF 159 (384)
T 4fr4_A 87 --EEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD----EHGHVHITDF 159 (384)
T ss_dssp --SSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC----CCCCEEEecc
Confidence 56899999999999999999764 4589999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHhhhcCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHC---GAIIGGILSNTLRP 1105 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~---eeil~~Il~~~lrp 1105 (1157)
|++............+||+.|+|||++.+. ...++.++|||||||+||+|++|+.||..... ......+... ..
T Consensus 160 G~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~ 237 (384)
T 4fr4_A 160 NIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--VV 237 (384)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--CC
T ss_pred ceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--cc
Confidence 999876665556678899999999999743 23578999999999999999999999975432 3333333332 34
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCC-HHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPS-FTEITNRLRV 1142 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPS-aeELLe~Lr~ 1142 (1157)
.++..+++++.+||.+||+.||.+||+ +++++++.+.
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f 275 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence 567789999999999999999999998 8888887664
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=357.89 Aligned_cols=256 Identities=34% Similarity=0.627 Sum_probs=213.1
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
.+...+|++++.||+|+||+||+++++|+.||||+++... ..+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred cCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 3556799999999999999999999999999999987531 135688999999999999999999987653
Q ss_pred CCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+.+++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Df 161 (278)
T 1byg_A 87 -KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDF 161 (278)
T ss_dssp ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECCC
T ss_pred -CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe----CCCcEEEeec
Confidence 457899999999999999997654 3478999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
|++........ ...+++.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+.. ......+
T Consensus 162 g~~~~~~~~~~--~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 236 (278)
T 1byg_A 162 GLTKEASSTQD--TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAP 236 (278)
T ss_dssp CC--------------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCC
T ss_pred ccccccccccc--CCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCc
Confidence 99875443322 24588999999999754 57999999999999999998 9999998877776665543 3455677
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
..+++.+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 88999999999999999999999999999999988753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=379.12 Aligned_cols=255 Identities=23% Similarity=0.306 Sum_probs=213.4
Q ss_pred eeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCc
Q 001103 877 LEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~ 954 (1157)
+...+.||+|+||.||+|++ .|..||||+++.... ...+.+.+|++++++|+||||+++++++.. .+.
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 160 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--------KDKEEVKNEISVMNQLDHANLIQLYDAFES--KND 160 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCE
Confidence 34467899999999999998 477899999986421 124678899999999999999999999987 568
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+..+ ..+.+||+|||+++.
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR--DAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET--TTTEEEECCCSSCEE
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC--CCCcEEEEeCCCcee
Confidence 999999999999999987766679999999999999999999999999999999999999421 457899999999987
Q ss_pred ccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--CCCCCc
Q 001103 1035 KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ--IPERCD 1112 (1157)
Q Consensus 1035 ~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe--ip~~iS 1112 (1157)
..........+||+.|+|||++.+. .++.++|||||||+||+|++|+.||.+......+..+........ ....++
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 316 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDIS 316 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSC
T ss_pred cCCccccccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCC
Confidence 6655555556799999999999754 578999999999999999999999999888888877776544322 235689
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+++++||.+||+.||.+|||+.+++++.+....
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999998876544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=388.18 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=217.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|+++ +..||||++.+....... ...+.+|+.+++.++|||||++++++.+ .
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 108 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS------NSKLLEEVAVLKLLDHPNIMKLYDFFED--K 108 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT------THHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH------HHHHHHHHHHHHhCCCCCCCeEEEEEEe--C
Confidence 36999999999999999999994 677999999875322211 3567899999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+|||||.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||++
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~DfG~a 186 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE-KDALIKIVDFGLS 186 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC-CCCcEEEEECCCC
Confidence 6899999999999999888654 3589999999999999999999999999999999999997433 4567999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--CC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--ER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~~ 1110 (1157)
............+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+......+..+.........+ ..
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTT
T ss_pred eECCCCccccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhccc
Confidence 87666555566789999999999863 47899999999999999999999999998888888887765544333 46
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+++++++||.+||+.||.+|||+.+++++.|....
T Consensus 264 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 89999999999999999999999999999887553
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=364.94 Aligned_cols=261 Identities=24% Similarity=0.320 Sum_probs=218.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++++. |..||||+++......... ....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 87 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYEN--R 87 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 46999999999999999999984 7789999998754322111 1113568899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.....+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 6899999999999999999754 458999999999999999999999999999999999999833322338999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip~~ 1110 (1157)
.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+....... .+...
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred eecCccccccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 876555545556799999999999754 57899999999999999999999999888777777766543322 22356
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++.+++||.+||+.||.+|||+.+++++.+.
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 88999999999999999999999999998664
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=389.90 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=224.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|++. +..||||++.+........ ...+.+|+.++++++||||+++++++.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~-- 97 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLLREVQLLKQLDHPNIMKLYEFFED-- 97 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC-----HHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence 357999999999999999999984 7789999998654322211 3568899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGL 175 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCTTH
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-CCCcEEEEeeee
Confidence 678999999999999999886544 589999999999999999999999999999999999996332 567899999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--C
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--E 1109 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~ 1109 (1157)
+............+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+......+..+.........+ .
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 252 (484)
T 3nyv_A 176 STHFEASKKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252 (484)
T ss_dssp HHHBCCCCSHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGG
T ss_pred eEEcccccccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence 986655544445679999999999975 47899999999999999999999999999888888887776654443 4
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.+++++++||.+||++||.+|||+.+++++.|....
T Consensus 253 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 689999999999999999999999999999887543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=387.23 Aligned_cols=266 Identities=23% Similarity=0.329 Sum_probs=205.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||+||+|.+. ++.||||++.+................+.+|+.+|++++||||+++++++..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--- 211 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 211 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES---
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 68999999999999999999984 6789999998764433222222233467899999999999999999999865
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHS 289 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-SSCCEEECCSSTT
T ss_pred CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC-CcceEEEeecccc
Confidence 3579999999999999988754 4589999999999999999999999999999999999997433 4557999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCCC--CCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLR--PQIP 1108 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~lr--peip 1108 (1157)
+...........+||+.|+|||++.+ ....++.++|||||||+||+|++|+.||....... ....+...... +...
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 87666555566789999999999864 23457899999999999999999999998754432 33333333222 1223
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
..+++.+.+||.+||+.||.+|||+.+++++.|.-..
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 5689999999999999999999999999998876433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=353.93 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=216.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||++++. ++.||+|+++......... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR--GVSREEIEREVNILREIRHPNIITLHDIFEN--K 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc--chHHHHHHHHHHHHHhCCCCCeeehhheecC--C
Confidence 47999999999999999999995 7789999998764322111 1113578899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.....+||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 6899999999999999999654 458999999999999999999999999999999999999844434458999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip~~ 1110 (1157)
.............||+.|+|||++.+. .++.++||||||+++|+|++|+.||........+..+....... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred eeccCCCcccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 876554444456799999999999754 57899999999999999999999999888777766665443322 22356
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+++.+.+||.+||+.||.+|||+.+++++.+....
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 78999999999999999999999999998876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=360.90 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=210.1
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC---------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCcee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG---------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIV 941 (1157)
.+...+|++.+.||+|+||+||+|++.. ..||+|++.... ....+.+.+|+.++++++||||+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv 75 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--------RNYSESFFEAASMMSKLSHKHLV 75 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--------GGGHHHHHHHHHHHHTSCCTTBC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--------HHHHHHHHHHHHHHHhCCCCCEe
Confidence 4566799999999999999999998742 459999986532 11246788999999999999999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCC--
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP-- 1019 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~-- 1019 (1157)
++++++.+ ....++||||+.+++|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 76 LNYGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp CEEEEECC--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGG
T ss_pred EEEEEEEe--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccc
Confidence 99999987 55789999999999999999877777999999999999999999999999999999999999983321
Q ss_pred --CCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhHHHH
Q 001103 1020 --QRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG-EEPYANMHCGAIIG 1096 (1157)
Q Consensus 1020 --e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG-k~PF~g~~~eeil~ 1096 (1157)
..+.+||+|||++....... ...||+.|+|||++.+. ..++.++|||||||++|+|++| .+||..........
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~ 229 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPKD---ILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred ccccceeeeccCcccccccCcc---ccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence 11239999999986543332 23588999999999752 3579999999999999999995 55666555444433
Q ss_pred HhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1097 ~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
... . ...++...++++.+||.+||+.||.+|||+.+++++|..+....
T Consensus 230 ~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 230 FYE-D--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHH-T--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred Hhh-c--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 332 2 33455667889999999999999999999999999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=366.47 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=208.3
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||+||++++ .++.||||+++.... ........+.+|++++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-----RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-----TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-----CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 346899999999999999999997 477899999986422 1233456788999999999999999999998753
Q ss_pred CC--CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 951 PG--GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 951 ~~--~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
.. ...|+||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~D 159 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMD 159 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTSCEEECC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc----CCCCEEEee
Confidence 22 24599999999999999997544 589999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1029 FGLSRIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1029 FGLAkl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+................
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 9999754332 122345699999999999864 5799999999999999999999999988877766666554433
Q ss_pred CC--CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1105 PQ--IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1105 pe--ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+. ....+++++.+||.+||+.||.+||+..+++.+.+.-.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 22 23568999999999999999999998777776655443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=353.69 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=210.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++.+.||+|+||.||+|++. ++.||||++...... .......+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-----SLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-----chhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 44578999999999999999999984 788999999764211 11124578899999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 83 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~df 155 (276)
T 2h6d_A 83 --PTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD----AHMNAKIADF 155 (276)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC----TTSCEEECCC
T ss_pred --CCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC----CCCCEEEeec
Confidence 568999999999999999997544 488999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
|++.............||+.|+|||++.+.. ..+.++||||||+++|+|++|+.||...........+..... .++.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 232 (276)
T 2h6d_A 156 GLSNMMSDGEFLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF--YIPE 232 (276)
T ss_dssp CGGGCCCC-------------CCTGGGTTSC-CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCT
T ss_pred ccccccCCCcceecccCCccccCHHHHcCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--cCch
Confidence 9998765554444567999999999998642 236899999999999999999999998877777666654433 4567
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+++++.+||.+||+.||.+|||+.+++++.+..
T Consensus 233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 7899999999999999999999999999998763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=389.86 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=211.1
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||.||++++. ++.||||++++..... ......+.+|+.+++.++||||+++++++..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-----hHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 34468999999999999999999984 7789999998653221 1224567789999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
.+.+|+||||+++++|.+++.+. +.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|
T Consensus 220 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~----~~~~~kl~D 292 (446)
T 4ejn_A 220 --HDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITD 292 (446)
T ss_dssp --TTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC----SSSCEEECC
T ss_pred --CCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC----CCCCEEEcc
Confidence 56899999999999999988654 458999999999999999999998 9999999999999998 677999999
Q ss_pred cCCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++... ........+||+.|+|||++.+. .++.++|||||||+||||++|+.||...........+..... .+
T Consensus 293 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~ 368 (446)
T 4ejn_A 293 FGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RF 368 (446)
T ss_dssp CCCCCTTCC-----CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CC
T ss_pred CCCceeccCCCcccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CC
Confidence 99997533 23334557899999999999754 579999999999999999999999999888888777766544 46
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRVM 1143 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~L 1143 (1157)
+..+++++.+||.+||++||.+|| +++++++|.++.
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~ 409 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence 778999999999999999999999 999999987764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=368.55 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=196.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|+++ ++.||||+++...... ....+.+|++++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-------TPSTAIREISLMKELKHENIVRLYDVIHT-- 74 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC-------SCHHHHHHHHHHTTCCBTTBCCEEEEECC--
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc-------cHHHHHHHHHHHHhcCCCCcceEEEEEEE--
Confidence 358999999999999999999884 7789999997653111 12457789999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhcccc-----ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKD-----RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~g-----r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.+.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl 149 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKL 149 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEE
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc----CCCCEEE
Confidence 568999999998 48988886532 4589999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC--
Q 001103 1027 GDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-- 1103 (1157)
Q Consensus 1027 iDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-- 1103 (1157)
+|||++...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred CcCccceecCCCcccCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999999865432 233446799999999999753 3578999999999999999999999998887766655533100
Q ss_pred ------------------------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 ------------------------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 ------------------------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+..+..+++++++||.+||+.||.+|||+.+++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 001123578899999999999999999999999998765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=397.18 Aligned_cols=262 Identities=21% Similarity=0.330 Sum_probs=220.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||+||+++++ ++.||||++++....... ....+.+|+.+++.++||||+++++++.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~-----~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA-----ETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTT-----TTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHH-----HHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 45578999999999999999999995 567999999864221111 12347789999999999999999999988
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+|||||++|+|.+++.+..+.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+||
T Consensus 146 --~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~----~~g~vkL~DF 219 (437)
T 4aw2_A 146 --DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADF 219 (437)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc----CCCCEEEcch
Confidence 6689999999999999999987666799999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCc--ccCCCCCCCcccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1030 GLSRIKCNTL--VSGGVRGTLPWMAPELLNG---SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1030 GLAkl~~~~~--~sts~~GTp~YmAPEVL~G---~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|+|+...... .....+||+.|+|||++.+ ....++.++|||||||+||||++|+.||.+....+.+..++.....
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 9997644332 2344689999999999862 1235789999999999999999999999998888888777654322
Q ss_pred CCCC---CCCcHHHHHHHHHHhccCCCC--CCCHHHHHHHHHHHH
Q 001103 1105 PQIP---ERCDPEWRKLMEECWSFNPAA--RPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1105 peip---~~iSpeLrdLIkrCLqkDPsk--RPSaeELLe~Lr~Lk 1144 (1157)
..+| ..+++++++||++||..+|.+ ||++++++++.+.-.
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 2333 458999999999999988888 999999999988743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=361.17 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=205.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|++. ++.||||++.... ......+.+.+|++++++++||||+++++++.. .
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 74 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--K 74 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc------cchHHHHHHHHHHHHHHhCCCCCccchhheeec--C
Confidence 58999999999999999999995 7789999986542 123345678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+..++||||+++++|..++... +.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 75 RRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT----KHSVIKLCDFGFA 149 (311)
T ss_dssp TEEEEEEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CeEEEEEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc----CCCCEEEeeCCCc
Confidence 6899999999999998887644 4589999999999999999999999999999999999998 6789999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC---------
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT--------- 1102 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~--------- 1102 (1157)
...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp EECC------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhccCcccccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 865432 233456799999999999753 457999999999999999999999999887665544432210
Q ss_pred ----------CCCCC----------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 ----------LRPQI----------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 ----------lrpei----------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..... ...+++++.+||.+||+.||.+|||+++++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 00000 13578899999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=363.78 Aligned_cols=264 Identities=31% Similarity=0.508 Sum_probs=206.6
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECCc-----eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRGT-----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kGt-----~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+...+|++++.||+|+||+||+|++... .||||+++..... ....+.+.+|++++++++||||+++++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA------SSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC------HHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 45667999999999999999999987432 6999998764211 122567889999999999999999999
Q ss_pred eeecCCCC----cEEEEEEeecCCcchhhhcccc-----ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecc
Q 001103 946 VVPNGPGG----TMATVTEYMVNGSLRHVLARKD-----RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNL 1016 (1157)
Q Consensus 946 vf~de~~~----~LyLVMEYmeGGSL~dlLkr~g-----r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~ 1016 (1157)
++...... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~- 171 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA- 171 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc-
Confidence 98764321 2489999999999999986432 2589999999999999999999999999999999999998
Q ss_pred CCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChh
Q 001103 1017 RDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCG 1092 (1157)
Q Consensus 1017 dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~e 1092 (1157)
.++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+....
T Consensus 172 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 172 ---EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp ---TTSCEEECCCCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred ---CCCCEEEeeccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 67899999999997643322 12234578899999999754 57999999999999999999 99999998887
Q ss_pred HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1093 AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1093 eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.....+.... ....+..+++++.+||.+||+.||.+|||+.++++.|+.+....
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 247 EIYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp GHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 7777665443 34567789999999999999999999999999999999887643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=369.18 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=211.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC--CceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--PNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H--PNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||++.+ +++.||||++..... .......+.+|+.+|+.|+| |||+++++++.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc------chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 4567899999999999999999988 466799999876421 12335778899999999986 99999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ...+++||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 80 ~--~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-----~~~~kl~D 150 (343)
T 3dbq_A 80 T--DQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLID 150 (343)
T ss_dssp C--SSEEEEEEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEEEECC
T ss_pred e--CCEEEEEEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-----CCcEEEee
Confidence 7 568999999 5678999999764 4588999999999999999999999999999999999996 35799999
Q ss_pred cCCcccccCCc---ccCCCCCCCcccCcccccC---------CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hHHH
Q 001103 1029 FGLSRIKCNTL---VSGGVRGTLPWMAPELLNG---------SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-GAII 1095 (1157)
Q Consensus 1029 FGLAkl~~~~~---~sts~~GTp~YmAPEVL~G---------~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~-eeil 1095 (1157)
||++....... .....+||+.|+|||++.+ ....++.++|||||||+||+|++|+.||..... ...+
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 230 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH
Confidence 99998654322 2335679999999999864 124678999999999999999999999987543 3445
Q ss_pred HHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1096 GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1096 ~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+........++...++++.+||.+||+.||.+|||+.+++++.|..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 555555666677888899999999999999999999999999998874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=353.46 Aligned_cols=261 Identities=29% Similarity=0.517 Sum_probs=216.2
Q ss_pred CeeEEEEecccCcEEEEEEEEC--Cc---eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GT---DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt---~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
.|++.+.||+|+||+||+|++. +. .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-------EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-------cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 5677899999999999999872 22 59999886531 122356788999999999999999999998763
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....++||||+.+++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 95 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~----~~~~~kl~Dfg 169 (298)
T 3pls_A 95 -EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFG 169 (298)
T ss_dssp -SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECCTT
T ss_pred -CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCcEEeCcCC
Confidence 3445899999999999999987777799999999999999999999999999999999999998 77799999999
Q ss_pred CcccccCC-----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1031 LSRIKCNT-----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1031 LAkl~~~~-----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
++...... .......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||...........+. ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~ 246 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRR 246 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCC
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCC
Confidence 99754322 222345688999999999854 57999999999999999999 555566655555554444 4444
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKR 1151 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesks 1151 (1157)
...+..+++.+.+||.+||+.||.+|||+.++++.|..+...+....
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 56677899999999999999999999999999999999988776544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=365.56 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=202.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~ 951 (1157)
.+|+++++||+|+||+||+|++. ++.||||++..... .... ......|+..+.++ +||||+++++++.+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-- 128 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-----GPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEE-- 128 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-----SHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-----ChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEe--
Confidence 47999999999999999999994 77899998765421 1111 23344555555544 99999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+++||||+ +++|.+++...+..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~DFG~ 203 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG----PRGRCKLGDFGL 203 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----GGGCEEECCCTT
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEcccee
Confidence 67899999999 6699888877777799999999999999999999999999999999999998 667999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
+.............||+.|+|||++.+ .++.++|||||||++|||++|..||... .....+.....++.++..+
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~ 277 (311)
T 3p1a_A 204 LVELGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGL 277 (311)
T ss_dssp CEECC------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTS
T ss_pred eeecccCCCCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCC
Confidence 987655555556679999999999875 4789999999999999999997766543 2333444444444566778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
++++.+||.+||++||.+|||+.+++++.|.
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 9999999999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=389.64 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=219.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCC-----ChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGR-----SSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r-----~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
..+|+++++||+|+||+||+|+++ +..||||++.+...... ....+...+.+.+|+.++++|+||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 358999999999999999999984 67799999987533211 00111234678899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.+ ...+|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl 190 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN-SLLNIKI 190 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT-CCSSEEE
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC-CCccEEE
Confidence 987 66899999999999999988654 4589999999999999999999999999999999999998332 3347999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+......+..+....+...
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999987666555566789999999999874 478999999999999999999999999998888888877655433
Q ss_pred C--CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 I--PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 i--p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
. ...+++++++||.+||++||.+|||+.+++++.|...
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 2 2568999999999999999999999999999988743
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=368.26 Aligned_cols=260 Identities=28% Similarity=0.543 Sum_probs=213.3
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC--Cce----EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEE
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTD----IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAF 943 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~----VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkL 943 (1157)
..+...+|++++.||+|+||+||+|++. +.. ||+|.++... .....+.+.+|+.++++++||||+++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~ 82 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCE
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-------CHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 4466789999999999999999999983 444 4666654321 11224678899999999999999999
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
++++... ..++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 83 ~~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~----~~~~ 155 (327)
T 3poz_A 83 LGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQH 155 (327)
T ss_dssp EEEEESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTE
T ss_pred EEEEecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC----CCCC
Confidence 9999873 37899999999999999987777799999999999999999999999999999999999998 6779
Q ss_pred EEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhh
Q 001103 1024 CKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il 1099 (1157)
+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++ |+.||...........+.
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 233 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH
Confidence 9999999998643322 22334578899999999854 67999999999999999999 999999887766655444
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1100 ~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.......+..++.++.+||.+||+.||.+|||+.+++++|..+...
T Consensus 234 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 -KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 4444556778899999999999999999999999999999888654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=383.43 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=209.5
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHH-HHhCCCCceeEEeeeeec
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI-ISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkI-LK~L~HPNIVkLygvf~d 949 (1157)
...+|++++.||+|+||+||+++++ +..||||++++....... ....+.+|..+ ++.++||||+++++++.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~-----~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-----EEKHIMSERNVLLKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEEC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH-----HHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence 3468999999999999999999995 567999999876433221 23456667776 577899999999999988
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+||||+.||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++++||+||
T Consensus 111 --~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~ikL~DF 183 (373)
T 2r5t_A 111 --ADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDF 183 (373)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEEEeeC
Confidence 56899999999999999998754 3588999999999999999999999999999999999998 7789999999
Q ss_pred CCccccc-CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1030 GLSRIKC-NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1030 GLAkl~~-~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
|+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|+.||........+..+..... .++
T Consensus 184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~~ 259 (373)
T 2r5t_A 184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLK 259 (373)
T ss_dssp CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--CCC
T ss_pred ccccccccCCCccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--CCC
Confidence 9998633 33345567899999999999864 578999999999999999999999999888888888876643 466
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCH----HHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSF----TEITNRLRV 1142 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSa----eELLe~Lr~ 1142 (1157)
..+++++++||.+||++||.+||++ .+++++.+.
T Consensus 260 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 7899999999999999999999986 577776554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=366.92 Aligned_cols=260 Identities=19% Similarity=0.258 Sum_probs=210.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||+|++ .++.||||++..... ...+.+|+++++.| +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----------APQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----------SCCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----------hHHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 3457899999999999999999997 577899999876421 13467899999999 9999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-CCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd-~e~g~VKLi 1027 (1157)
. ....++||||+ +++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .....+||+
T Consensus 76 ~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 76 C--GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp E--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred c--CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 8 56899999999 9999999987666799999999999999999999999999999999999998332 112239999
Q ss_pred ecCCcccccCCcc--------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---HHHH
Q 001103 1028 DFGLSRIKCNTLV--------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIG 1096 (1157)
Q Consensus 1028 DFGLAkl~~~~~~--------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---eil~ 1096 (1157)
|||+++....... ....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.... ..+.
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 9999986433221 2456799999999999864 5799999999999999999999999875432 3333
Q ss_pred HhhhcCCCC---CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1097 GILSNTLRP---QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1097 ~Il~~~lrp---eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.+....... .....++ ++.+||.+||+.||.+||++++|++.|+.+....
T Consensus 231 ~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 231 KIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 332221111 1123345 9999999999999999999999999999887654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.39 Aligned_cols=265 Identities=34% Similarity=0.580 Sum_probs=219.1
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEE
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAF 943 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkL 943 (1157)
..+...+|++.+.||+|+||+||+|+++. ..||||+++... .......+.+|+++++.++||||+++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~ 111 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRL 111 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 35667899999999999999999998742 249999987531 12234578899999999999999999
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
++++.. ....++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 112 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~ 185 (333)
T 1mqb_A 112 EGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLV 185 (333)
T ss_dssp EEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCC
T ss_pred EEEEec--CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC----CCCc
Confidence 999977 5689999999999999999987667799999999999999999999999999999999999998 6789
Q ss_pred EEEEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHh
Q 001103 1024 CKVGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~I 1098 (1157)
+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 9999999997643321 12223468899999999754 57899999999999999999 99999988877776666
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1099 l~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
... .+...+..+++.+.+||.+||+.||.+||++.++++.|+.+.......
T Consensus 264 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 264 NDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp HTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred HCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 543 445567789999999999999999999999999999999988765543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=381.80 Aligned_cols=254 Identities=21% Similarity=0.332 Sum_probs=218.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|+++ +..||+|++.... ......+.+|+.+|+.|+||||+++++++.+ .
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~ 120 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFED--K 120 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--S
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--C
Confidence 57999999999999999999984 6779999987541 1113568899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+ ..+.+||+|||++
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~~~vkL~DFG~a 198 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGLA 198 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC--CCCceEEEecccc
Confidence 68999999999999999998766679999999999999999999999999999999999999722 3467999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC--CCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--PQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--peip~~ 1110 (1157)
............+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+...... ......
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 276 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred eecCCCcceeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccc
Confidence 876554444456799999999999854 5789999999999999999999999998877777777655432 334456
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++++++||.+||+.||.+|||+.+++++.+.
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 89999999999999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=367.41 Aligned_cols=259 Identities=29% Similarity=0.525 Sum_probs=213.8
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--Cce----EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GTD----IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~----VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
.+...+|++++.||+|+||+||+|++. +.. ||+|++........ ...+.+|+.+++.++||||++++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-------FQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-------BCSCCHHHHHHHTCCCTTBCCEE
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-------HHHHHHHHHHHhcCCCCCcCeEE
Confidence 456789999999999999999999984 444 66776654321111 23466899999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+++.+ ...++||||+.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+
T Consensus 82 ~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~~ 154 (325)
T 3kex_A 82 GLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK----SPSQV 154 (325)
T ss_dssp EEECB---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES----SSSCE
T ss_pred EEEcC---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC----CCCeE
Confidence 99864 468999999999999999987766799999999999999999999999999999999999998 67789
Q ss_pred EEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1025 KVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
||+|||+++...... ......||..|+|||++.+. .++.++|||||||++|+|++ |+.||...........+..
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 232 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 999999998653322 23445688899999999854 57999999999999999999 9999998876666555543
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
......+..+++++.+||.+||+.||.+|||+.+++++|..+...
T Consensus 233 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 233 -GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 334556677888999999999999999999999999999988653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=357.48 Aligned_cols=261 Identities=33% Similarity=0.579 Sum_probs=213.1
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC---Cc--eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR---GT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k---Gt--~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+...+|++++.||+|+||+||+|++. ++ .||||+++..... .....+.+.+|++++++++||||+++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLYG 88 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-----CHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 455678999999999999999999873 22 4899988764221 1223577889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++... ..++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+|
T Consensus 89 ~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~----~~~~~k 161 (291)
T 1u46_A 89 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVK 161 (291)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEccC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc----CCCCEE
Confidence 98763 37899999999999999987667799999999999999999999999999999999999998 677999
Q ss_pred EEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1026 VGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
|+|||++....... ......+|..|+|||++.+. .++.++||||||+++|+|++ |+.||........+..+..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence 99999997643322 12234578899999999754 46899999999999999999 9999999988888888877
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.......+..+++++.+||.+||+.||.+|||+.+++++|..+..
T Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 666667778899999999999999999999999999999987754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.49 Aligned_cols=259 Identities=32% Similarity=0.556 Sum_probs=216.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC-----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG-----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+...+|++.+.||+|+||+||+|++.+ ..||||++.... .....+.+.+|+.+++.++||||++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-------TLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-------CHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-------CchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 455789999999999999999998742 249999887541 12234678899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.+. ..++||||+.+++|.+++.+....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||
T Consensus 82 ~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl 154 (281)
T 3cc6_A 82 IEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA----SPECVKL 154 (281)
T ss_dssp ECSS---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----ETTEEEE
T ss_pred EcCC---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC----CCCcEEe
Confidence 8653 46899999999999999987766799999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1027 GDFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1027 iDFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
+|||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+... .
T Consensus 155 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~ 231 (281)
T 3cc6_A 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-D 231 (281)
T ss_dssp CCCCGGGCC---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-C
T ss_pred CccCCCcccccccccccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-C
Confidence 9999997644332 22334578899999999754 57899999999999999998 99999887777666555443 3
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
....+..+++.+.+||.+||+.||.+|||+.+++++|..+...-
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 34567778999999999999999999999999999999887643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.67 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=198.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||+|+++ ++.||||+++.... ....+.+.+|++++++|+||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-------ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-------TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 47999999999999999999994 77899999986421 1124678899999999999999999998865321
Q ss_pred -------------------------------------------------------CcEEEEEEeecCCcchhhhcccc--
Q 001103 953 -------------------------------------------------------GTMATVTEYMVNGSLRHVLARKD-- 975 (1157)
Q Consensus 953 -------------------------------------------------------~~LyLVMEYmeGGSL~dlLkr~g-- 975 (1157)
.++++|||||++++|.+++.+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 24899999999999999997643
Q ss_pred ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCC-------------cccC
Q 001103 976 RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT-------------LVSG 1042 (1157)
Q Consensus 976 r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~-------------~~st 1042 (1157)
...++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..... ....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTTCEECSCC--------------CCC
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe----CCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 3356667899999999999999999999999999999998 6779999999999865433 1234
Q ss_pred CCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHH
Q 001103 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEEC 1122 (1157)
Q Consensus 1043 s~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrC 1122 (1157)
..+||+.|+|||++.+. .++.++|||||||++|+|++|..|+.. .......+... ..+......++++++||.+|
T Consensus 235 ~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL-KFPLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT-CCCHHHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc-CCCcccccCChhHHHHHHHH
Confidence 46799999999999864 579999999999999999998777532 11222222222 22222234567889999999
Q ss_pred hccCCCCCCCHHHHHHHHH
Q 001103 1123 WSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1123 LqkDPskRPSaeELLe~Lr 1141 (1157)
|+.||.+|||+.+++++.+
T Consensus 310 l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HCSSGGGSCCHHHHHHSTT
T ss_pred ccCCCCcCCCHHHHhhchh
Confidence 9999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=376.91 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=211.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~ 951 (1157)
.+|++++.||+|+||+||+|+++ ++.||||++++... ...+|++++.++ +||||+++++++.+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------~~~~E~~~l~~~~~hp~iv~~~~~~~~-- 87 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------------DPTEEIEILLRYGQHPNIITLKDVYDD-- 87 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------------CCHHHHHHHHHHTTSTTBCCEEEEEEC--
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------------ChHHHHHHHHHhcCCCCcCeEEEEEEc--
Confidence 57999999999999999999985 67899999986521 123577888887 79999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+|+|||||.+|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||+..++...+.+||+|||+
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 66899999999999999998754 45899999999999999999999999999999999999964433445799999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---ChhHHHHHhhhcCCCC--
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM---HCGAIIGGILSNTLRP-- 1105 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~---~~eeil~~Il~~~lrp-- 1105 (1157)
++..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||... ...+++..+....+..
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 244 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc
Confidence 9864432 334457899999999999754 4688999999999999999999999863 3455666666554433
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+..+++++++||.+||+.||.+|||+.+++++.|..
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 23467899999999999999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=369.91 Aligned_cols=258 Identities=20% Similarity=0.267 Sum_probs=209.7
Q ss_pred ccccccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-----CCce
Q 001103 868 GLQIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-----HPNV 940 (1157)
Q Consensus 868 ~i~~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-----HPNI 940 (1157)
....+...+|+++++||+|+||+||+|++ .++.||||+++.. ......+.+|+.+++.+. ||||
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---------KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---------HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---------hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 33445567999999999999999999999 5778999998742 122456678999999997 9999
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD- 1018 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd- 1018 (1157)
+++++++.. ...+++||||+ +++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++...
T Consensus 99 v~~~~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 99 VKYHGKFMY--YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CCEEEEEEE--TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred ecccceeeE--CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 999999987 56899999999 889999987643 4589999999999999999999999999999999999997311
Q ss_pred --------------------CCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHH
Q 001103 1019 --------------------PQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWE 1078 (1157)
Q Consensus 1019 --------------------~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYE 1078 (1157)
...+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||+||+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCC--CCCCccchHHHHHHHHH
Confidence 12678999999999864433 2346799999999999864 57999999999999999
Q ss_pred HHcCCCCCCCCChhHHHHHhhhcCCCC------------------------CCC--------------------CCCcHH
Q 001103 1079 IITGEEPYANMHCGAIIGGILSNTLRP------------------------QIP--------------------ERCDPE 1114 (1157)
Q Consensus 1079 LLTGk~PF~g~~~eeil~~Il~~~lrp------------------------eip--------------------~~iSpe 1114 (1157)
|++|+.||........+..+....... .++ ...++.
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 999999999877666555443211110 011 112377
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1115 WRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1115 LrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+.+||.+||+.||.+|||+.+++++.|
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 889999999999999999999998865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=392.39 Aligned_cols=260 Identities=21% Similarity=0.306 Sum_probs=217.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||+||+++++ ++.||||++++.... .......+.+|..++..++||||+++++++.+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-----~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-----KRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 45679999999999999999999984 778999999864211 11123457889999999999999999999988
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+||||+++|+|.+++.+.+..+++..++.++.||+.||+|||++||+||||||+|||++ .++++||+||
T Consensus 133 --~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld----~~g~vkL~DF 206 (412)
T 2vd5_A 133 --ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD----RCGHIRLADF 206 (412)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec----CCCCEEEeec
Confidence 5689999999999999999987666799999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCc--ccCCCCCCCcccCcccccCC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1030 GLSRIKCNTL--VSGGVRGTLPWMAPELLNGS-----NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1030 GLAkl~~~~~--~sts~~GTp~YmAPEVL~G~-----~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
|+++...... .....+||+.|+|||++.+. ...++.++|||||||++|||++|+.||......+.+..+....
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 9998654332 23456899999999998731 2357899999999999999999999999988888777776432
Q ss_pred --C-CCCCCCCCcHHHHHHHHHHhccCCCCC---CCHHHHHHHHHHH
Q 001103 1103 --L-RPQIPERCDPEWRKLMEECWSFNPAAR---PSFTEITNRLRVM 1143 (1157)
Q Consensus 1103 --l-rpeip~~iSpeLrdLIkrCLqkDPskR---PSaeELLe~Lr~L 1143 (1157)
. .+..+..+++++++||.+||. +|.+| |+++++++|.++-
T Consensus 287 ~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 287 EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence 1 223346799999999999999 99998 6999999998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=373.40 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=197.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..|++.+.||+|+||+||+|++. ++.||||+++... ..+.+.+|++++++++||||+++++++.. .
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 120 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------DKKIVRTEIGVLLRLSHPNIIKLKEIFET--P 120 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEEC--S
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----------hHHHHHHHHHHHHhCCCCCCcceeeeEec--C
Confidence 57999999999999999999995 5679999998641 12457789999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~-~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA-PDAPLKIADFGLS 198 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS-TTCCEEECCCC--
T ss_pred CeEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC-CCCCEEEccCccc
Confidence 68999999999999999987544 589999999999999999999999999999999999997322 4778999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCCC--CCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLR--PQIPE 1109 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~lr--peip~ 1109 (1157)
+...........+||+.|+|||++.+. .++.++|||||||+||+|++|+.||....... .+..+...... .....
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 276 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWD 276 (349)
T ss_dssp --------------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTT
T ss_pred cccCcccccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhh
Confidence 876555445557799999999999864 57999999999999999999999998766554 44555444332 23346
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.+++++++||.+||+.||.+|||+.+++++.+.
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 789999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=379.40 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=200.7
Q ss_pred CCeeEE-EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHH-hCCCCceeEEeeeeec-
Q 001103 875 SDLEEL-QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS-NLHHPNVVAFYGVVPN- 949 (1157)
Q Consensus 875 sdYeIL-rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK-~L~HPNIVkLygvf~d- 949 (1157)
.+|.++ +.||+|+||+||+++++ +..||||+++.. ..+.+|+.++. .++||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 578777 68999999999999984 677999998742 34567888774 5589999999998854
Q ss_pred -CCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 950 -GPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 950 -e~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.....+|+|||||.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++.+||+
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~~~~kl~ 206 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLT 206 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-TTCCEEEC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC-CCccEEEE
Confidence 22457899999999999999997653 4699999999999999999999999999999999999998332 36889999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH----HHHHhhhcCC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA----IIGGILSNTL 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee----il~~Il~~~l 1103 (1157)
|||+++...........+||+.|+|||++.+. .++.++|||||||+||+|++|+.||....... ....+....+
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 99999876555445567899999999999754 67899999999999999999999998655322 3344444433
Q ss_pred CCC--CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1104 RPQ--IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 rpe--ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
... ....+++++++||.+||+.||.+|||+.+++++.|..
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 322 2356899999999999999999999999999998875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.37 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=221.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~ 951 (1157)
.+|++.+.||+|+||.||+|++. |+.||||++............+...+.+.+|+.+++++ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 47999999999999999999984 78899999986532222233344567788999999999 89999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~----~~~~ikl~DfG~ 246 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD----DNMQIRLSDFGF 246 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEEecCc
Confidence 56899999999999999998754 4589999999999999999999999999999999999998 678999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGS----NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~----~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
+............+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||........+..+.........
T Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 9876655555567899999999998642 234788999999999999999999999988877777777665544332
Q ss_pred C--CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1108 P--ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p--~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+ ..+++.+.+||.+||+.||.+|||+.+++++.|.
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 2 4678899999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.45 Aligned_cols=264 Identities=26% Similarity=0.480 Sum_probs=218.3
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
+....|++++.||+|+||+||++.+ +++.||||+++... .......+.+|++++++++||||+++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSGWKQEIDILRTLYHEHIIKYKG 100 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCcchhhEEE
Confidence 3334459999999999999999876 46779999997541 1223567889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.+.....+++||||+++++|.+++.+.. +++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~----~~~~~k 174 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD----NDRLVK 174 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEE
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc----CCCCEE
Confidence 998865678999999999999999997543 89999999999999999999999999999999999998 678999
Q ss_pred EEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---------
Q 001103 1026 VGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG--------- 1092 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e--------- 1092 (1157)
|+|||++....... ......||..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred ECCccccccccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence 99999998654332 22335688899999999854 5689999999999999999999999753221
Q ss_pred -----HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1093 -----AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1093 -----eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
..+............+..+++++.+||.+||+.||.+|||+.++++.|..+...++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred cchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1122334445566678889999999999999999999999999999999998877653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.07 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=194.2
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||+|++ .++.||||++...... .......+.+|+.++++++||||+++++++.+ .
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 83 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-----KAGMVQRVQNEVKIHCQLKHPSILELYNYFED--S 83 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--S
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-----hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--C
Confidence 5799999999999999999998 5788999999764211 11124678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~dfg~~ 159 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT----RNMNIKIADFGLA 159 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC----TTCCEEECCCTTC
T ss_pred CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEEeecce
Confidence 689999999999999999987767799999999999999999999999999999999999998 6778999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
...... .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||........+..+... ....+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSFL 235 (278)
T ss_dssp EECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--CCCCCTTS
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--ccCCcccc
Confidence 764422 222345799999999999754 5688999999999999999999999877655554444332 23456778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
++++++||.+||+.||.+|||+.+++++.+...
T Consensus 236 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 999999999999999999999999999877543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.81 Aligned_cols=264 Identities=28% Similarity=0.495 Sum_probs=222.1
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCc
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR---------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPN 939 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k---------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPN 939 (1157)
+.+...+|++.+.||+|+||+||+|++. +..||||+++... .......+.+|+++++.+ +|||
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-------cHHHHHHHHHHHHHHHHhhcCCC
Confidence 4566689999999999999999999874 4569999987541 123356788999999999 8999
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVH 1004 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIH 1004 (1157)
|+++++++.. .+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 103 iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (334)
T 2pvf_A 103 IINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 180 (334)
T ss_dssp BCCEEEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EeeEEEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 9999999977 568899999999999999997543 24889999999999999999999999999
Q ss_pred ccCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1005 FDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1005 RDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
|||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 181 ~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 181 RDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp SCCSGGGEEEC----TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHT
T ss_pred CCCccceEEEc----CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHh
Confidence 99999999998 67799999999997654322 22334578899999998754 57899999999999999999
Q ss_pred -CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1082 -GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
|+.||.+.........+... .....+..+++++.+||.+||+.||.+|||+.+++++|..+......
T Consensus 255 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 255 LGGSPYPGIPVEELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp TSCCSSTTCCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCCCcCcCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 99999988877766655443 34556778999999999999999999999999999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.15 Aligned_cols=267 Identities=30% Similarity=0.514 Sum_probs=220.6
Q ss_pred ccCCCeeEEE-EecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQ-ELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILr-kLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+...+|++.+ .||+|+||+||+|.+. +..||||+++.... .....+.+.+|+++++.++||||++++++
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc------CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4456899988 9999999999999652 46699999876421 12235678899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+. ....++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 87 ~~---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~----~~~~~kl 158 (291)
T 1xbb_A 87 CE---AESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKI 158 (291)
T ss_dssp EE---SSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEE
T ss_pred EC---CCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe----CCCcEEE
Confidence 84 34689999999999999999764 4589999999999999999999999999999999999998 6679999
Q ss_pred EecCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhc
Q 001103 1027 GDFGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~ 1101 (1157)
+|||++........ .....+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+..
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~- 235 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK- 235 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence 99999976433221 1223467899999999754 46889999999999999999 9999998887766655543
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhcccccc
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNHA 1155 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesksRn~a 1155 (1157)
..++..+..+++++.+||.+||+.||.+|||+.++++.|+.+........+.++
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 289 (291)
T 1xbb_A 236 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHH 289 (291)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHHC--
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcccccc
Confidence 344567788999999999999999999999999999999999998877766543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.29 Aligned_cols=260 Identities=29% Similarity=0.515 Sum_probs=215.4
Q ss_pred CCeeEEEEecccCcEEEEEEEECC-----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kG-----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
.+|++.+.||+|+||+||+|++.. ..+|+|++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-------CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 468999999999999999998732 248888886531 12235678899999999999999999998654
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
. .+..++||||+.+++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 98 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~Df 172 (298)
T 3f66_A 98 S-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVADF 172 (298)
T ss_dssp S-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSC
T ss_pred C-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC----CCCCEEECcc
Confidence 3 4578899999999999999987777789999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1030 GLSRIKCNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1030 GLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
|++....... ......||+.|+|||++.+. .++.++||||||+++|+|++ |.+||...........+... .
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-~ 249 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-R 249 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT-C
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC-C
Confidence 9997543322 22345678899999999754 57899999999999999999 67788877766666555543 3
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
....+..+++.+.+||.+||+.||.+|||+.++++.|..+...+..
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 4455777899999999999999999999999999999998875543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=356.47 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=209.8
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN-- 949 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d-- 949 (1157)
..+|++++.||+|+||.||++++. ++.||||+++... ..+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 357999999999999999999995 7889999997641 245689999999999999999998753
Q ss_pred ------------CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecc
Q 001103 950 ------------GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNL 1016 (1157)
Q Consensus 950 ------------e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~ 1016 (1157)
.....+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~- 156 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV- 156 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc-
Confidence 1134689999999999999999754 35689999999999999999999999999999999999998
Q ss_pred CCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 001103 1017 RDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096 (1157)
Q Consensus 1017 dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~ 1096 (1157)
.++.+||+|||++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||... .....
T Consensus 157 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~ 229 (284)
T 2a19_B 157 ---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFET--SKFFT 229 (284)
T ss_dssp ---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred ---CCCCEEECcchhheeccccccccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence 6779999999999876555444556799999999999854 5789999999999999999999987532 12222
Q ss_pred HhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 001103 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152 (1157)
Q Consensus 1097 ~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesksR 1152 (1157)
.+.. ..++..+++.+++||.+||+.||.+|||+.+++++|+.+....++..+
T Consensus 230 ~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 230 DLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281 (284)
T ss_dssp HHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred Hhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence 2222 234567889999999999999999999999999999999877665544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.20 Aligned_cols=265 Identities=26% Similarity=0.415 Sum_probs=217.9
Q ss_pred cccccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 867 YGLQIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 867 y~i~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
..+..+...+|++++.||+|+||+||++++. +..||+|++.... .......+.+|+.+++.++||||++++
T Consensus 25 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 97 (360)
T 3eqc_A 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFY 97 (360)
T ss_dssp HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-------CHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-------CHHHHHHHHHHHHHHHHCCCCCEEEEe
Confidence 3455677789999999999999999999995 7789999987641 123357789999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCe
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
+++.. .+.+++||||+++++|.+++.+.+ .+++..++.++.|++.||.|||++ ||+||||||+|||++ .++.
T Consensus 98 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~ 170 (360)
T 3eqc_A 98 GAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGE 170 (360)
T ss_dssp EEEEE--TTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCC
T ss_pred EEEEE--CCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC----CCCC
Confidence 99987 568999999999999999997644 488999999999999999999996 999999999999998 6778
Q ss_pred EEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH--------
Q 001103 1024 CKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII-------- 1095 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil-------- 1095 (1157)
+||+|||++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus 171 ~kl~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 247 (360)
T 3eqc_A 171 IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247 (360)
T ss_dssp EEECCCCCCHHHHHHC-----CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----
T ss_pred EEEEECCCCccccccc-ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccc
Confidence 9999999987543322 2345799999999999864 5799999999999999999999999876543321
Q ss_pred ----------------------------------HHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1096 ----------------------------------GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1096 ----------------------------------~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+............+++++++||.+||+.||.+|||+++++++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp --------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 2222222222233457899999999999999999999999999999
Q ss_pred HHHHHHh
Q 001103 1142 VMSTALQ 1148 (1157)
Q Consensus 1142 ~Lk~aLe 1148 (1157)
.-.....
T Consensus 328 ~~~~~~~ 334 (360)
T 3eqc_A 328 IKRSDAE 334 (360)
T ss_dssp HHHHHHS
T ss_pred hhcchHh
Confidence 8765543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=356.66 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=215.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||++++. ++.||+|++..... .....+.+.+|++++++++||||+++++++.....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence 58999999999999999999984 77899999986422 12235678899999999999999999998865446
Q ss_pred CcEEEEEEeecCCcchhhhcccc---ccccHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCccceeeccCCCCCCeE
Q 001103 953 GTMATVTEYMVNGSLRHVLARKD---RILDRRKKLMLMMDAAFGMEYLHMKN-----IVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~g---r~L~e~qVlkIa~QLa~ALeYLHSkG-----IIHRDLKPENILLd~dd~e~g~V 1024 (1157)
..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++ .++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~----~~~~~ 155 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNV 155 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC----SSSCE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc----CCCCE
Confidence 78999999999999999987532 34899999999999999999999999 99999999999998 67799
Q ss_pred EEEecCCcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC
Q 001103 1025 KVGDFGLSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l 1103 (1157)
||+|||++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 156 KLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233 (279)
T ss_dssp EECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred EEecCchheeeccccccccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc
Confidence 999999987644322 12235699999999999854 578999999999999999999999998887777666655543
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..++..+++++.+||.+||+.||.+|||+.+++++++.
T Consensus 234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 -RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 45677899999999999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.43 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=218.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++.+.||+|+||.||+|++. +..||||++....... ......+.+|+++++.++||||+++++++.+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-----EGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-----HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 34468999999999999999999985 5679999987642111 1123568899999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 86 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~Df 158 (284)
T 2vgo_A 86 --RKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG----YKGELKIADF 158 (284)
T ss_dssp --SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTCCEEECCC
T ss_pred --CCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc----CCCCEEEecc
Confidence 568999999999999999987654 589999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
|++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.... ..++.
T Consensus 159 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~ 233 (284)
T 2vgo_A 159 GWSVHAPSLR-RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPP 233 (284)
T ss_dssp TTCEECSSSC-BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCT
T ss_pred cccccCcccc-cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--cCCCC
Confidence 9987544332 3346799999999999864 56889999999999999999999999888777766665443 34677
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+++++++||.+||+.||.+|||+++++++.+...
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 88999999999999999999999999999988754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=370.23 Aligned_cols=257 Identities=24% Similarity=0.326 Sum_probs=202.3
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|++ .++.||||+++.... .......+.+|++++++++||||+++++++.+ .
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 105 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE------EEGVPGTAIREVSLLKELQHRNIIELKSVIHH--N 105 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEE--T
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc------ccccchhHHHHHHHHHHcCCCCcceEEEEEec--C
Confidence 5899999999999999999988 477899999875421 12234567799999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-CCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd-~e~g~VKLiDFGL 1031 (1157)
..+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+.+||+|||+
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred CEEEEEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 689999999985 9999887544 489999999999999999999999999999999999996443 2567799999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC----
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ---- 1106 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe---- 1106 (1157)
+...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+......+.
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 9764322 233445789999999999764 3579999999999999999999999998887766666543211110
Q ss_pred ------------C------------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 ------------I------------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ------------i------------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+ +..+++++.+||.+||+.||.+|||+.+++++.|.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 0 11167899999999999999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.70 Aligned_cols=256 Identities=34% Similarity=0.589 Sum_probs=208.0
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
.+...+|++.+.||+|+||+||+++++++.||||++.... ..+.+.+|++++++++||||+++++++.+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 72 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----------ERKAFIVELRQLSRVNHPNIVKLYGACLN- 72 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT----------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 3556789999999999999999999999999999986421 23678899999999999999999999865
Q ss_pred CCCcEEEEEEeecCCcchhhhcccc--ccccHHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeeccCCCCCC-eE
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKD--RILDRRKKLMLMMDAAFGMEYLHM---KNIVHFDLKCDNLLVNLRDPQRP-IC 1024 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~g--r~L~e~qVlkIa~QLa~ALeYLHS---kGIIHRDLKPENILLd~dd~e~g-~V 1024 (1157)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ +||+||||||+|||++ .++ .+
T Consensus 73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~----~~~~~~ 145 (307)
T 2eva_A 73 ---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV----AGGTVL 145 (307)
T ss_dssp ---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE----TTTTEE
T ss_pred ---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe----CCCCEE
Confidence 3789999999999999997644 247888999999999999999999 8999999999999998 444 48
Q ss_pred EEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCC
Q 001103 1025 KVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTL 1103 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~l 1103 (1157)
||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..........
T Consensus 146 kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (307)
T 2eva_A 146 KICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221 (307)
T ss_dssp EECCCCC--------------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred EEccccccccccccc--ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence 999999997543322 234699999999999854 57899999999999999999999998654322 1222223344
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
.+..+..+++.+.+||.+||+.||.+|||+.++++.|..+...+.
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 556677899999999999999999999999999999998876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.27 Aligned_cols=250 Identities=22% Similarity=0.386 Sum_probs=212.7
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|+..+.||+|+||.||+|++. |+.||||++...... ..+.+.+|+.+++.++||||+++++++.. ..
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--------RRELLFNEVVIMRDYQHFNVVEMYKSYLV--GE 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------SHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TT
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--------HHHHHHHHHHHHHhCCCCCcceEEEEEEE--CC
Confidence 3778889999999999999984 788999999754211 13567899999999999999999999987 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..++||||+++++|.+++.+. .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT----LDGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCcEEEeeeeeee
Confidence 899999999999999998643 489999999999999999999999999999999999998 67799999999987
Q ss_pred cccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC-CCCCCCC
Q 001103 1034 IKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR-PQIPERC 1111 (1157)
Q Consensus 1034 l~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr-peip~~i 1111 (1157)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.....+ ...+..+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGS
T ss_pred ecccCccccccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccC
Confidence 65433 233456799999999999754 5789999999999999999999999988877776666544322 1233467
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
++++++||.+||+.||.+|||+.+++++.+..
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 89999999999999999999999999987764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.59 Aligned_cols=262 Identities=32% Similarity=0.564 Sum_probs=217.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC--Cce--EEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEe
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFY 944 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~--VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLy 944 (1157)
..+...+|++.+.||+|+||.||+|++. +.. +|||+++.... ......+.+|+++++++ +||||++++
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-------hHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 3455679999999999999999999874 444 49998875311 12245688999999999 899999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCc
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKC 1009 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKP 1009 (1157)
+++.+ .+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 93 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 170 (327)
T 1fvr_A 93 GACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 170 (327)
T ss_dssp EEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeeee--CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence 99987 568999999999999999987543 3689999999999999999999999999999999
Q ss_pred cceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 001103 1010 DNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYAN 1088 (1157)
Q Consensus 1010 ENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g 1088 (1157)
+|||++ .++.+||+|||+++............+++.|+|||++.+. .++.++|||||||++|+|++ |+.||..
T Consensus 171 ~NIl~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 171 RNILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp GGEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceEEEc----CCCeEEEcccCcCccccccccccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 999998 6679999999998754333333344578899999999754 57899999999999999998 9999998
Q ss_pred CChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1089 MHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1089 ~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.........+... .....+..+++++.+||.+||+.||.+|||+.+++++|..+....
T Consensus 245 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 245 MTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp CCHHHHHHHGGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CcHHHHHHHhhcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 8877776666543 445567788999999999999999999999999999999887643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=349.94 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=208.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~ 951 (1157)
.+|++++.||+|+||+||+|++. ++.||||+++..... ......+.+|+.++..+ +||||+++++++.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-- 82 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG------SVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-- 82 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT------SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc------cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--
Confidence 57999999999999999999994 788999999864211 11235678899999999 99999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhcccc---ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC----------
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKD---RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD---------- 1018 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~g---r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd---------- 1018 (1157)
.+.+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 568999999999999999997642 4589999999999999999999999999999999999997332
Q ss_pred -----CCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH
Q 001103 1019 -----PQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA 1093 (1157)
Q Consensus 1019 -----~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee 1093 (1157)
.....+||+|||++....... ...||+.|+|||++.+. ..++.++|||||||++|+|++|.+|+.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred cccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 144579999999998655433 24599999999999754 3567899999999999999999988754432
Q ss_pred HHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1094 IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1094 il~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
...+.. ...+.++..+++++.+||.+||+.||.+|||+.+++++.+...
T Consensus 237 -~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 237 -WHEIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp -HHHHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred -HHHHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 233332 3345677889999999999999999999999999999877543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=358.91 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=207.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~ 948 (1157)
....+|++++.||+|+||+||+|++ .++.||||+++... .+.+.+|++++++|. ||||+++++++.
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----------hHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 3457899999999999999999988 47789999987431 256789999999997 999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC-eEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP-ICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g-~VKLi 1027 (1157)
+......++||||+.+++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+
T Consensus 102 ~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~~~kl~ 173 (330)
T 3nsz_A 102 DPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID----HEHRKLRLI 173 (330)
T ss_dssp CTTTCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTTTEEEEC
T ss_pred cCCCCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc----CCCCEEEEE
Confidence 8667789999999999999988853 78889999999999999999999999999999999998 444 89999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhHHHHHhhh------
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAIIGGILS------ 1100 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-~eeil~~Il~------ 1100 (1157)
|||+++............||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.... ....+..+..
T Consensus 174 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~ 252 (330)
T 3nsz_A 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252 (330)
T ss_dssp CCTTCEECCTTCCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred eCCCceEcCCCCccccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence 99999876555555567899999999998753 357999999999999999999999995433 2222211110
Q ss_pred -------c----------------------CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1101 -------N----------------------TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1101 -------~----------------------~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
. ......+..+++++++||.+||+.||.+|||+++++++.|.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 0 01111223378999999999999999999999999998765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=385.75 Aligned_cols=260 Identities=32% Similarity=0.553 Sum_probs=221.9
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+.+...+|++.+.||+|+||+||+|+++ +..||||+++.... ..+.+.+|+++|++|+|||||++++++.
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 253 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANVMKTLQHDKLVKLHAVVT 253 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---------CHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---------cHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 3456678999999999999999999995 66799999986421 1367889999999999999999999986
Q ss_pred cCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. ..+++|||||.+|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 254 ~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~ 326 (454)
T 1qcf_A 254 K---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIA 326 (454)
T ss_dssp S---SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTCCEEEC
T ss_pred C---CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC----CCCcEEEe
Confidence 3 46899999999999999997643 4588899999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1028 DFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|||+++...... ......+|..|+|||++.+. .++.++|||||||+||||++ |+.||.+....+.+..+.. ..+
T Consensus 327 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~ 403 (454)
T 1qcf_A 327 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYR 403 (454)
T ss_dssp STTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCC
T ss_pred eCCCceEcCCCceeccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCC
Confidence 999998654322 22334578899999999754 57999999999999999999 9999999888777766654 445
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
...+..+++++.+||.+||+.||.+|||+++|++.|+.+.....
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 56678899999999999999999999999999999988765443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.49 Aligned_cols=263 Identities=23% Similarity=0.274 Sum_probs=221.5
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCC-ChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeec
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGR-SSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPN 949 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r-~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~d 949 (1157)
..+|++.+.||+|+||.||+|++ .++.||||++........ ..+.....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46899999999999999999998 467899999986532111 1223445677889999999995 9999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~df 168 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 168 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred --CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc----CCCcEEEecc
Confidence 66899999999999999999754 4589999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccC----CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNG----SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G----~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
|++.............||+.|+|||++.+ ....++.++||||||+++|+|++|+.||...........+.......
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 99987655555555779999999999852 12357889999999999999999999999888777777776655443
Q ss_pred CCC--CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 QIP--ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 eip--~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+ ..+++.+.+||.+||+.||.+|||+.+++++.+..
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 333 45889999999999999999999999999987653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=390.35 Aligned_cols=257 Identities=24% Similarity=0.431 Sum_probs=222.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|.+.+.||+|+||+||+|++. |+.||||++.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-----LDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH-----TTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34468999999999999999999984 7889999998642211 1124678899999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+|+||||+++++|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 88 --~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~----~~~~vkL~DF 160 (476)
T 2y94_A 88 --PSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD----AHMNAKIADF 160 (476)
T ss_dssp --SSEEEEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe----cCCCeEEEec
Confidence 568999999999999999997544 589999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
|++............+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+....+ ..+.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~ 237 (476)
T 2y94_A 161 GLSNMMSDGEFLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--YTPQ 237 (476)
T ss_dssp SSCEECCTTCCBCCCCSCSTTCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--CCCT
T ss_pred cchhhccccccccccCCCcCeEChhhccCCC-CCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--CCCc
Confidence 9998766555555678999999999998652 247899999999999999999999998887777777766543 4567
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+++++++||.+||+.||.+|||+.+++++.|..
T Consensus 238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 7899999999999999999999999999998864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=360.70 Aligned_cols=258 Identities=31% Similarity=0.533 Sum_probs=216.9
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEE
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAF 943 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkL 943 (1157)
.+...+|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+++++.++||||+++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-------CHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 344578999999999999999999875 4669999987531 11224568899999999999999999
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhhhcccc---------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLV 1014 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILL 1014 (1157)
++++.+ ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 94 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 94 LGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred EEEEcc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 999977 567899999999999999987533 346889999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 001103 1015 NLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMH 1090 (1157)
Q Consensus 1015 d~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~ 1090 (1157)
+ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++ |+.||....
T Consensus 172 ~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 172 A----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp C----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred c----CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 8 67799999999997543322 12234578899999998754 57999999999999999999 899999888
Q ss_pred hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1091 CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1091 ~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.......+..... ...+..+++.+.+||.+||+.||.+|||+.+++++|+...
T Consensus 246 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 246 NEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 7777776665443 4456789999999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=377.68 Aligned_cols=260 Identities=31% Similarity=0.576 Sum_probs=210.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+...+|++.+.||+|+||.||+|+++ +..||||+++... .....+.+.+|+.++++++||||++++++
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-------TEKQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45568999999999999999999874 5569999987531 12235678999999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.. ...+++||||+++++|.+++.+.+..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 115 ~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kl 188 (373)
T 2qol_A 115 VTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN----SNLVCKV 188 (373)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEE
T ss_pred Eee--CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc----CCCCEEE
Confidence 987 5678999999999999999987777799999999999999999999999999999999999998 6789999
Q ss_pred EecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhc
Q 001103 1027 GDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1027 iDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~ 1101 (1157)
+|||+++...... ......+|+.|+|||++.+. .++.++|||||||+||||++ |+.||...........+...
T Consensus 189 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~ 266 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266 (373)
T ss_dssp CCC----------------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT
T ss_pred CcCccccccccCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998644321 12223467889999999754 57999999999999999998 99999988877776665443
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.+...+..+++++.+||.+||+.||.+||++.++++.|..+....
T Consensus 267 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 -YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 344556778999999999999999999999999999999887643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=375.26 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=212.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--CCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--HPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||++.+. ++.||||++..... .......+.+|+.+|++|. ||||+++++++.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc------cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 44567999999999999999999884 67799999976421 1233577899999999996 599999999988
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ...+|+||| +.+++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 127 ~--~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-----~~~~kl~D 197 (390)
T 2zmd_A 127 T--DQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLID 197 (390)
T ss_dssp C--SSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-----SSCEEECC
T ss_pred c--CCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-----CCeEEEEe
Confidence 7 567999999 56889999997654 588889999999999999999999999999999999995 36899999
Q ss_pred cCCcccccCCc---ccCCCCCCCcccCcccccCC---------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhHHH
Q 001103 1029 FGLSRIKCNTL---VSGGVRGTLPWMAPELLNGS---------NNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAII 1095 (1157)
Q Consensus 1029 FGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~---------~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-~eeil 1095 (1157)
||+++...... .....+||+.|+|||++.+. ...++.++|||||||+||+|++|+.||.... ....+
T Consensus 198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 277 (390)
T 2zmd_A 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277 (390)
T ss_dssp CSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH
T ss_pred cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH
Confidence 99998654322 23456799999999998752 1357999999999999999999999998754 33455
Q ss_pred HHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1096 GGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1096 ~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+........++...++++.+||.+||+.||.+|||+.+++++.|..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 666666666677888899999999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=374.23 Aligned_cols=272 Identities=18% Similarity=0.208 Sum_probs=209.7
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHH----HHHHHHHHHHHHHhCCCCce
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEW----LIKEFWREAHIISNLHHPNV 940 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~----likqflrEIkILK~L~HPNI 940 (1157)
+...+|++++.||+|+||+||+|++. +..||||++....... ..+... ....+.+|+..++.++||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL-FTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHH-HHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhH-HHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 45679999999999999999999884 3569999987642100 000000 01234556777888899999
Q ss_pred eEEeeeeecCCC--CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC
Q 001103 941 VAFYGVVPNGPG--GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 941 VkLygvf~de~~--~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd 1018 (1157)
+++++++..... .+.+|||||+ +++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~- 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK- 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-
Confidence 999999876322 4689999999 999999998776779999999999999999999999999999999999999732
Q ss_pred CCCCeEEEEecCCcccccCCc--------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 001103 1019 PQRPICKVGDFGLSRIKCNTL--------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl~~~~~--------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~ 1090 (1157)
..+.+||+|||+++...... .....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+..
T Consensus 189 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 189 -NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp -CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred -CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 45789999999997543221 11345699999999999864 57999999999999999999999998643
Q ss_pred hhHHHHHhhhcCCCCC---------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1091 CGAIIGGILSNTLRPQ---------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1091 ~eeil~~Il~~~lrpe---------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
................ ....+++++.+||..||+.||.+||++.+|++.|..+......
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 2222211111000000 1256789999999999999999999999999999998876544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.68 Aligned_cols=257 Identities=24% Similarity=0.304 Sum_probs=209.5
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~- 951 (1157)
.+|++++.||+|+||+||+|++ .|+.||||++......... ...+.+|+++++.++||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------PITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS------CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc------hHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 5899999999999999999998 4778999998765322211 245678999999999999999999987643
Q ss_pred -----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 952 -----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 952 -----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.+.+++||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~----~~~~~kl 165 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKL 165 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEE
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCCEEE
Confidence 3568999999986 77777766666799999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccC-----CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc
Q 001103 1027 GDFGLSRIKCN-----TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1027 iDFGLAkl~~~-----~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~ 1101 (1157)
+|||++..... ........||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+......+..+...
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999975431 2223456799999999998754 35789999999999999999999999988877665555332
Q ss_pred --CCCCCCCCC----------------------------CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1102 --TLRPQIPER----------------------------CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1102 --~lrpeip~~----------------------------iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
...+..... .++.+.+||.+||+.||.+|||+++++++.|..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 111111111 267899999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=353.97 Aligned_cols=263 Identities=21% Similarity=0.410 Sum_probs=207.3
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||.||+|++ ++..||||+++..... .......+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 103 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-----DAKARADCIKEIDLLKQLNHPNVIKYYASFIE-- 103 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence 35899999999999999999997 4788999999764221 12335678899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 952 GGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
.+..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~----~~~~~kl~D 179 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGD 179 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECC
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc----CCCCEEEEe
Confidence 5689999999999999998864 345689999999999999999999999999999999999998 677999999
Q ss_pred cCCcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hhHHHHHhhhcCCCC
Q 001103 1029 FGLSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH--CGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~--~eeil~~Il~~~lrp 1105 (1157)
||++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.. .......+.....+.
T Consensus 180 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T 2wqm_A 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257 (310)
T ss_dssp C------------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred ccceeeecCCCccccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence 99987644322 23345799999999999754 57899999999999999999999997643 234444444444444
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
.....+++++.+||.+||+.||.+|||+.++++.|+.+......
T Consensus 258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 44567899999999999999999999999999999999876654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=352.11 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=212.2
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++.+.||+|+||+||+|++ .++.||||++..... ...+.+|+.+++.+.|++++..+..+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----------hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 357899999999999999999997 578899999876421 13477899999999988877666555432
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....++||||+ +++|.+++....+.+++..++.++.|++.||.|||++||+||||||+|||++.++ ..+.+||+|||
T Consensus 77 -~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg 153 (296)
T 3uzp_A 77 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 153 (296)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCT
T ss_pred -CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC-CCCeEEEeeCC
Confidence 56889999999 8999999986666799999999999999999999999999999999999995222 56789999999
Q ss_pred CcccccCCcc--------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHhh
Q 001103 1031 LSRIKCNTLV--------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC---GAIIGGIL 1099 (1157)
Q Consensus 1031 LAkl~~~~~~--------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~---eeil~~Il 1099 (1157)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ...+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 9986443321 2446799999999999864 579999999999999999999999986432 22333332
Q ss_pred hcCCC---CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1100 SNTLR---PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1100 ~~~lr---peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
..... ..++..+++++.+||.+||+.||.+|||+.++++.|+.+......
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 22211 123466899999999999999999999999999999998876544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.05 Aligned_cols=260 Identities=29% Similarity=0.549 Sum_probs=212.2
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC--CceE----EEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEE
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTDI----AIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAF 943 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~V----AVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkL 943 (1157)
..+...+|++++.||+|+||+||+|++. +..+ |+|.+.... .. .....+.+|+.+++.++||||+++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~----~~---~~~~~~~~E~~~l~~l~hp~iv~~ 82 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SP---KANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS----SC---CCHHHHHHHHHHHTTCCBTTBCCC
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc----CH---HHHHHHHHHHHHHHhCCCCCeeEE
Confidence 3466789999999999999999999983 4545 555554321 11 113568899999999999999999
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
++++... ..++||+|+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ..+.
T Consensus 83 ~~~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~ 155 (327)
T 3lzb_A 83 LGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQH 155 (327)
T ss_dssp CEEEESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTE
T ss_pred EEEEecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc----CCCC
Confidence 9999873 37899999999999999987777799999999999999999999999999999999999998 6779
Q ss_pred EEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhh
Q 001103 1024 CKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il 1099 (1157)
+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+.
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 233 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 9999999998643322 22334578899999999854 57999999999999999999 999999888776665554
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1100 ~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.......+..+++++.+||.+||+.||.+|||+.++++.|..+...
T Consensus 234 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 -KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 3444556778999999999999999999999999999999988754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.41 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=214.8
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||.||++++ .+..||||+++....... ......+.+|+++++.++||||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI----PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS----TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc----chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 5899999999999999999998 467799999986532111 1124678899999999999999999999866556
Q ss_pred CcEEEEEEeecCCcchhhhcc-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr-~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...++||||+.++ |.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~----~~~~~kl~dfg~ 155 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT----TGGTLKISALGV 155 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----CCCcEEeecccc
Confidence 7899999999887 6565543 345689999999999999999999999999999999999998 677999999999
Q ss_pred cccccC---CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1032 SRIKCN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1032 Akl~~~---~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
+..... ........||+.|+|||++.+....++.++||||||+++|+|++|+.||...........+..... .++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~ 233 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY--AIP 233 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC--CCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC--CCC
Confidence 976432 222334569999999999986544457899999999999999999999998887777776665533 467
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+++.+.+||.+||+.||.+|||+.+++++.+...
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 788999999999999999999999999999987643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=357.30 Aligned_cols=265 Identities=30% Similarity=0.496 Sum_probs=211.8
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+...+|++.+.||+|+||+||+|++. +..||||+++.... .....+.+.+|+.++++++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS------SQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC------CHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc------chhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 455678999999999999999999873 23699999875421 1223567889999999999999999999
Q ss_pred eeecCCCC---cEEEEEEeecCCcchhhhcc-----ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccC
Q 001103 946 VVPNGPGG---TMATVTEYMVNGSLRHVLAR-----KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLR 1017 (1157)
Q Consensus 946 vf~de~~~---~LyLVMEYmeGGSL~dlLkr-----~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~d 1017 (1157)
++...... ..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~-- 181 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-- 181 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC--
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc--
Confidence 98764332 56999999999999998842 335689999999999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhH
Q 001103 1018 DPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGA 1093 (1157)
Q Consensus 1018 d~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~ee 1093 (1157)
.++.+||+|||++....... ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||.......
T Consensus 182 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 182 --DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp --TTSCEEECSCSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred --CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 67799999999997543321 12234578899999999754 67999999999999999999 999999888777
Q ss_pred HHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1094 IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1094 il~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
....+... .....+..+++++.+||.+||+.||.+|||+.+++++|..+...+.
T Consensus 258 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 MYDYLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 77666544 3456677899999999999999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=355.00 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=214.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||++++. |+.||||+++.... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--------FRDSSLENEIAVLKKIKHENIVTLEDIYES--T 78 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--------cchHHHHHHHHHHHhCCCCCeeehhhhccc--C
Confidence 47999999999999999999984 77899999986421 112467899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||+..++ ..+.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGLS 156 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTT
T ss_pred CEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEEEccCCcc
Confidence 68999999999999999886543 589999999999999999999999999999999999994222 6778999999998
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC--CCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--PQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--peip~~ 1110 (1157)
....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...... ......
T Consensus 157 ~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (304)
T 2jam_A 157 KMEQNGI-MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233 (304)
T ss_dssp CCCCCBT-THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTT
T ss_pred eecCCCc-cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccccc
Confidence 7544332 2234699999999999754 5789999999999999999999999988887777777665443 234567
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++++.+||.+||+.||.+|||+.+++++.+.-
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 899999999999999999999999999987753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=364.41 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=205.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||+|++. ++.||||++..................+.+|+++++.++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 47999999999999999999984 67899999976533211111222335678999999999999999999998763
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHS 164 (322)
T ss_dssp -SEEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-SSCCEEECCCTTC
T ss_pred -ceEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC-CCCeEEEccCccc
Confidence 389999999999999988654 4589999999999999999999999999999999999998433 3456999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhcCCC--CCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSNTLR--PQIP 1108 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~~lr--peip 1108 (1157)
.............||+.|+|||++.+ ....++.++|||||||++|+|++|+.||...... .....+...... +..+
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 87655444344579999999999742 2345789999999999999999999999865443 233333333222 1223
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+++++.+||.+||+.||.+|||+.+++++.+.
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 5678999999999999999999999999987553
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=352.12 Aligned_cols=256 Identities=27% Similarity=0.352 Sum_probs=219.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++.+.||+|+||.||++++. ++.||+|++.+..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-----PHQREKMSMEISIHRSLAHQHVVGFHGFFED- 86 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC-----HHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-
Confidence 3468999999999999999999995 6679999998653221 2234678899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.+..++||||+.+++|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg 160 (294)
T 2rku_A 87 -NDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFG 160 (294)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCT
T ss_pred -CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc----CCCCEEEEecc
Confidence 56899999999999999988654 4589999999999999999999999999999999999998 67789999999
Q ss_pred CcccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
++..... ........||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.... ..++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 236 (294)
T 2rku_A 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPK 236 (294)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCT
T ss_pred CceecccCccccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CCCcc
Confidence 9976432 2233446799999999999754 56889999999999999999999999888777666665443 34677
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+++.+.+||.+||+.||.+|||+.+++++.+...
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 88999999999999999999999999999988754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=355.82 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=210.8
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPN 949 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~d 949 (1157)
...+|++++.||+|+||.||+|++ .++.||||++..... . ...+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----E-----EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----T-----THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----c-----HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 356899999999999999999999 578899999875421 1 24677899999999 89999999999876
Q ss_pred CC----CCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 950 GP----GGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 950 e~----~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
.. ...+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~----~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc----CCCCE
Confidence 43 45789999999999999999764 35689999999999999999999999999999999999998 67789
Q ss_pred EEEecCCcccccCC-cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhh
Q 001103 1025 KVGDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~ 1100 (1157)
||+|||++...... .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...........+..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 99999998764332 223345799999999998632 23578999999999999999999999998887776666665
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
...+...+..+++.+++||.+||..||.+||++.+++++.+..
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 5555455667899999999999999999999999999986653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.11 Aligned_cols=267 Identities=28% Similarity=0.502 Sum_probs=218.6
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEE-------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCcee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKW-------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV 941 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~-------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIV 941 (1157)
+..+...+|++++.||+|+||.||+|++ .+..||||++.... .......+.+|+.++++++||||+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQNIV 96 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-------chhhHHHHHHHHHHHhhCCCCCCC
Confidence 3456668999999999999999999984 35569999986431 122245788999999999999999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVN 1015 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd 1015 (1157)
++++++.. ....++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~ 174 (327)
T 2yfx_A 97 RCIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174 (327)
T ss_dssp CEEEEECS--SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred eEEEEEcC--CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEe
Confidence 99999987 557899999999999999997643 3488999999999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 001103 1016 LRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHC 1091 (1157)
Q Consensus 1016 ~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~ 1091 (1157)
.++ ....+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++ |+.||.....
T Consensus 175 ~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 175 CPG-PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp CSS-TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCC-CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 443 45679999999987432221 12234689999999998754 57999999999999999998 9999998877
Q ss_pred hHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1092 eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
......+... .....+..+++.+.+||.+||+.||.+|||+.+++++|+.+.....
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 252 QEVLEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 7666655543 3445677899999999999999999999999999999999876443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=367.77 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=207.8
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||+|++. |+.||||++....... ........+.+|+++++.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGH-- 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch---hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--
Confidence 368999999999999999999984 7789999987542111 111223467899999999999999999999977
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....++||||+.+ +|..++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~----~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGL 158 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGG
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc----CCCCEEEEeccc
Confidence 5678999999986 88888877666789999999999999999999999999999999999998 677999999999
Q ss_pred cccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC---C-
Q 001103 1032 SRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP---Q- 1106 (1157)
Q Consensus 1032 Akl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp---e- 1106 (1157)
++..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+..+......+ .
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ceeccCCcccCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 9865332 234456799999999999754 357899999999999999999999999888777666664421110 0
Q ss_pred ----------------------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1107 ----------------------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1107 ----------------------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+...+++++++||.+||+.||.+|||+.+++++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 0144678999999999999999999999999988753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=368.97 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=205.2
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|++. ++.||||+++..... .....+.+|+++++.++||||+++++++.. .
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHT--E 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--S
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-------ccchhHHHHHHHHHhcCCCCCCeeeeEEee--C
Confidence 57999999999999999999984 677999998754211 111234579999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+++||||+.+ +|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 73 KSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLA 147 (324)
T ss_dssp SCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC----TTCCEEECSSSEE
T ss_pred CEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC----CCCCEEEccCccc
Confidence 689999999975 89888887777799999999999999999999999999999999999998 6779999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC---C--
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP---Q-- 1106 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp---e-- 1106 (1157)
...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+......+ .
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 148 RAKSIPTKTYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp ECC------------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCccccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 754432 233445789999999998764 357999999999999999999999999988776665554311110 0
Q ss_pred -----------------------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1107 -----------------------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1107 -----------------------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
....+++++++||.+||+.||.+|||+++++++.|...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 11246889999999999999999999999999988754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=351.48 Aligned_cols=257 Identities=24% Similarity=0.406 Sum_probs=218.8
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||+|++ .++.||||++........ ....+.+|++++++++||||+++++++.. .
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 93 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK------DTSTILREVELLKKLDHPNIMKLFEILED--S 93 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH------HHHHHHHHHHHHHhccCCCccEEEEEEeC--C
Confidence 5899999999999999999998 477899999986532211 13568899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~-~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGLS 171 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TTCCEEECSTTGG
T ss_pred CeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC-CcccEEEeccCcc
Confidence 68999999999999998886543 589999999999999999999999999999999999997433 4568999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC--CC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP--ER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip--~~ 1110 (1157)
.............||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.........+ ..
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred eeecCCCccccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh
Confidence 86555444444568999999999875 37899999999999999999999999988887777777665544433 46
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+++++.+||.+||+.||.+|||+.+++++.+...
T Consensus 249 ~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 8999999999999999999999999999877643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=385.92 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=203.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|++. ++.||||++.+.. ......+++.+|+.+|+.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG------GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc------cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 468999999999999999999884 7789999998641 11233567889999999999999999999986532
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
...+|+||||+.++ |...+.. .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 135 ~~~~~~~~~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~----~~~~~kl~ 206 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 206 (464)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEEC
T ss_pred ccccCCeEEEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe----CCCCEEEE
Confidence 24689999999874 5555532 388999999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP-- 1105 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp-- 1105 (1157)
|||+++...........+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+......+..++.....+
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp CCCCC-----CCCC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEEeeeecCCCcccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999876665555667899999999999865 67899999999999999999999999988766665554321110
Q ss_pred ------------------C---------CCCC-----------CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 ------------------Q---------IPER-----------CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 ------------------e---------ip~~-----------iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
. ++.. .++++++||.+||++||.+|||++++++|.|.-
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 0 0000 156799999999999999999999999997753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.28 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=210.8
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG- 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de- 950 (1157)
...|++.+.||+|+||+||+|.+. +..||+|++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 445889999999999999999984 566999998864221 22357788999999999999999999988642
Q ss_pred -CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 -PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 -~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
....+++||||+++++|.+++.+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~kl~ 174 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---GPTGSVKIG 174 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---STTSCEEEC
T ss_pred CCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE---CCCCCEEEe
Confidence 245789999999999999999754 45899999999999999999999999 99999999999996 245689999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHH-HHHhhhcCCCCC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI-IGGILSNTLRPQ 1106 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eei-l~~Il~~~lrpe 1106 (1157)
|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ ...+........
T Consensus 175 Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 175 DLGLATLKRASF-AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp CTTGGGGCCTTS-BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred eCCCcccccccc-cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence 999997544433 234579999999999874 478999999999999999999999988655444 344443434445
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
++...++++.+||.+||+.||.+|||+.+++++.+.
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 566778999999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=346.48 Aligned_cols=253 Identities=27% Similarity=0.348 Sum_probs=209.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||+|++. ++.||||++...... ...+.+.+|+.+++.++||||+++++++.+ .
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 77 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRRE--G 77 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-------THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--T
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-------hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--C
Confidence 47999999999999999999984 778999999764211 124678899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg~~ 152 (276)
T 2yex_A 78 NIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLA 152 (276)
T ss_dssp TEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc----cCCCEEEeeCCCc
Confidence 6889999999999999998654 4589999999999999999999999999999999999998 6778999999999
Q ss_pred ccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhcCCCCCCC
Q 001103 1033 RIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1033 kl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~~lrpeip 1108 (1157)
...... .......||+.|+|||++.+.. .++.++||||||+++|+|++|+.||...... ..+..+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSS-BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTG
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCch
Confidence 754322 2234567999999999997542 2477899999999999999999999876543 2333333332222333
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+++.+.+||.+||+.||.+|||+.+++++.+.
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 5689999999999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.14 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=208.3
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++.+.||+|+||+||+|++ .++.||||++..... ...+.+|+++++.++|++++..+..+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----------chHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 346899999999999999999997 577899998765421 13467899999999988877776665432
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
....++||||+ +++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+.+||+|||
T Consensus 77 -~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg 153 (296)
T 4hgt_A 77 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 153 (296)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG-GTTCEEECCCT
T ss_pred -CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC-CCCeEEEecCc
Confidence 56889999999 9999999986666799999999999999999999999999999999999993222 66789999999
Q ss_pred CcccccCCc--------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---HHHHHhh
Q 001103 1031 LSRIKCNTL--------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGIL 1099 (1157)
Q Consensus 1031 LAkl~~~~~--------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---eil~~Il 1099 (1157)
++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+.
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 998644322 22346799999999999864 5799999999999999999999999875432 2222222
Q ss_pred hcCCCC---CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1100 SNTLRP---QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1100 ~~~lrp---eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
...... .....+++++.+||.+||+.||.+|||+.++++.|+.+......
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 222111 23356789999999999999999999999999999999877653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=374.60 Aligned_cols=266 Identities=20% Similarity=0.313 Sum_probs=215.7
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
....+|++.+.||+|+||+||+|++. ++.||||+++....... .+.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 34568999999999999999999995 77899999986432211 3566789999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccc--cccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDR--ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr--~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
......++||||+.+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+...+...+.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 666688999999999999999976443 389999999999999999999999999999999999983322267789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCC------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hhHHHHH
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGS------NNRVSEKVDVYSFGIAMWEIITGEEPYANMH----CGAIIGG 1097 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~------~~~yS~KSDIWSLGVILYELLTGk~PF~g~~----~eeil~~ 1097 (1157)
|||+++............||+.|+|||++.+. ...++.++|||||||++|||++|+.||.... ..+.+..
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 99999876665555567899999999998641 1246789999999999999999999997532 2344444
Q ss_pred hhhcCCCC-----------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1098 ILSNTLRP-----------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1098 Il~~~lrp-----------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+....... .++..+++.+.+||.+||++||++||+++++++.+..+.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 44332110 122335567899999999999999999999999987765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.33 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=208.5
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||+||+|++ .|..||||++..... ...+|+++++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------~~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------------YKNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHHcCCCCccchhheeeec
Confidence 356899999999999999999998 477899999875421 123699999999999999999998542
Q ss_pred ------------------------------------CCCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHH
Q 001103 951 ------------------------------------PGGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAA 991 (1157)
Q Consensus 951 ------------------------------------~~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa 991 (1157)
...++++||||+++ +|.+.+.. .++.+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 23458999999985 77776653 346699999999999999
Q ss_pred HHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHH
Q 001103 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYS 1071 (1157)
Q Consensus 992 ~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWS 1071 (1157)
.||.|||++||+||||||+|||++ ...+.+||+|||+++............||+.|+|||++.+. ..++.++||||
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Diws 227 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVN---SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA-TEYTPSIDLWS 227 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEE---TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC-SSCCTHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEc---CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC-CCCCcchhhhh
Confidence 999999999999999999999997 24679999999999876555555567899999999998764 34799999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC---------------------------CCCCCCCCcHHHHHHHHHHhc
Q 001103 1072 FGIAMWEIITGEEPYANMHCGAIIGGILSNTL---------------------------RPQIPERCDPEWRKLMEECWS 1124 (1157)
Q Consensus 1072 LGVILYELLTGk~PF~g~~~eeil~~Il~~~l---------------------------rpeip~~iSpeLrdLIkrCLq 1124 (1157)
|||++|+|++|+.||.+....+.+..++.... ...++..+++++.+||.+||+
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 99999999999999999887776666543110 001355688999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHH
Q 001103 1125 FNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1125 kDPskRPSaeELLe~Lr~L 1143 (1157)
.||.+|||+.+++++.+.-
T Consensus 308 ~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGH
T ss_pred CChhhCCCHHHHhcCHHHH
Confidence 9999999999999987653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=365.84 Aligned_cols=256 Identities=28% Similarity=0.476 Sum_probs=208.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
..+|++.+.||+|+||+||+|+++ +..||||++..... ...+.+.+|+++++.++||||+++++++.. .
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 107 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--------QGIEEFETEIETLSFCRHPHLVSLIGFCDE--R 107 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--------SHHHHHHHHHHGGGSCCCTTBCCEEEECCC--T
T ss_pred HhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--C
Confidence 368999999999999999999984 77899998765411 124678899999999999999999999877 5
Q ss_pred CcEEEEEEeecCCcchhhhcccc---ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 953 GTMATVTEYMVNGSLRHVLARKD---RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~g---r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Df 183 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDF 183 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC----TTCCEEECCC
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC----CCCCEEEeec
Confidence 67899999999999999986543 3589999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHH---HHH----h-
Q 001103 1030 GLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI---IGG----I- 1098 (1157)
Q Consensus 1030 GLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eei---l~~----I- 1098 (1157)
|++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ... .
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 999753322 223345689999999998754 578999999999999999999999976433211 110 0
Q ss_pred -------hhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1099 -------LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1099 -------l~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
........++...++.+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 01111122333456779999999999999999999999999998875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=378.89 Aligned_cols=258 Identities=24% Similarity=0.296 Sum_probs=191.3
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|+++ ++.||||++.+.. ......+.+.+|+++|+.|+|||||++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 468999999999999999999884 6789999987531 11223567889999999999999999999985432
Q ss_pred ---CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 952 ---GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 952 ---~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~----~~~~~kl~D 199 (458)
T 3rp9_A 126 VEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN----QDCSVKVCD 199 (458)
T ss_dssp TTTCCCEEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTCCEEECC
T ss_pred cccCceEEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC----CCCCEeecc
Confidence 357999999984 6898888654 4589999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCC----------------------------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHH
Q 001103 1029 FGLSRIKCNT----------------------------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEII 1080 (1157)
Q Consensus 1029 FGLAkl~~~~----------------------------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELL 1080 (1157)
||+++..... ......+||+.|+|||++... ..|+.++|||||||+||||+
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHH
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHH
Confidence 9999864321 123456799999999987533 35899999999999999999
Q ss_pred c-----------CCCCCCCCCh--------------------hHHHHHhhh----------------------cCCCC--
Q 001103 1081 T-----------GEEPYANMHC--------------------GAIIGGILS----------------------NTLRP-- 1105 (1157)
Q Consensus 1081 T-----------Gk~PF~g~~~--------------------eeil~~Il~----------------------~~lrp-- 1105 (1157)
+ |+++|.+... ...+..+.. ..++.
T Consensus 279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 358 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE 358 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence 8 7777765431 111111110 00000
Q ss_pred -----CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1106 -----QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1106 -----eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.....+++++.+||.+||.+||.+|||++++++|.+.-.
T Consensus 359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 112346899999999999999999999999999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.67 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=194.9
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVV 947 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf 947 (1157)
.+...+|++.+.||+|+||.||++++ .++.||||++.... ......+.+|+.+++++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--------EEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--------HHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--------hHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 34556899999999999999999999 57789999986531 223467889999999996 99999999998
Q ss_pred ec------CCCCcEEEEEEeecCCcchhhhcc--ccccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccC
Q 001103 948 PN------GPGGTMATVTEYMVNGSLRHVLAR--KDRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLR 1017 (1157)
Q Consensus 948 ~d------e~~~~LyLVMEYmeGGSL~dlLkr--~gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~d 1017 (1157)
.. .....++++|||+. |+|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-- 172 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-- 172 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC--
T ss_pred cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC--
Confidence 42 22446899999996 689888865 3455999999999999999999999999 99999999999998
Q ss_pred CCCCCeEEEEecCCcccccCCcc-------------cCCCCCCCcccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCC
Q 001103 1018 DPQRPICKVGDFGLSRIKCNTLV-------------SGGVRGTLPWMAPELLNG-SNNRVSEKVDVYSFGIAMWEIITGE 1083 (1157)
Q Consensus 1018 d~e~g~VKLiDFGLAkl~~~~~~-------------sts~~GTp~YmAPEVL~G-~~~~yS~KSDIWSLGVILYELLTGk 1083 (1157)
.++.+||+|||++........ .....||+.|+|||++.. ....++.++|||||||++|+|++|+
T Consensus 173 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 173 --NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp --TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred --CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 677999999999976443221 113569999999999842 2346789999999999999999999
Q ss_pred CCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1084 EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1084 ~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
.||........ .........+...++.+.+||.+||+.||.+|||+.+++++|+.+......
T Consensus 251 ~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 251 HPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp CCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 99986554333 223334444566778899999999999999999999999999999876543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.95 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=207.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCC---hhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRS---SEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~---~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
..+|++++.||+|+||.||+|.+ .+..||||++......... .......+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 46899999999999999999987 5778999998765332211 1223445788999999999999999999999854
Q ss_pred ---CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 950 ---GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 950 ---e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.....+|+||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA----DNNDITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEE
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc----CCCCEEE
Confidence 22447899999998 588888877666799999999999999999999999999999999999998 6778999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC-
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP- 1105 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp- 1105 (1157)
+|||++.............||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+......+
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccccccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999865555555556799999999998753 357999999999999999999999999887666655553211110
Q ss_pred -----------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 -----------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 -----------------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.....+++.+.+||.+||+.||.+|||+.+++++.+.-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 321 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence 11234688999999999999999999999999987753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=362.31 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=211.9
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
..+...+|++++.||+|+||.||++++ .++.||||++.... ....+.+.+|+++++.++||||+++++++
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--------QQDREEAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--------HHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 446678999999999999999999997 57789999986531 22346788999999999999999999998
Q ss_pred ecC--CCCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 948 PNG--PGGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 948 ~de--~~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
... .....++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~----~~~ 171 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEG 171 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTS
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc----CCC
Confidence 632 24478999999999999998875 356689999999999999999999999999999999999998 677
Q ss_pred eEEEEecCCcccccCCc----------ccCCCCCCCcccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-
Q 001103 1023 ICKVGDFGLSRIKCNTL----------VSGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMH- 1090 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~----------~sts~~GTp~YmAPEVL~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~- 1090 (1157)
.+||+|||++....... ......||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||....
T Consensus 172 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 251 (317)
T 2buj_A 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251 (317)
T ss_dssp CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH
T ss_pred CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc
Confidence 89999999987533211 012245799999999987542 236889999999999999999999996421
Q ss_pred -hhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 001103 1091 -CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKR 1151 (1157)
Q Consensus 1091 -~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesks 1151 (1157)
...... ..........+..+++++.+||.+||+.||.+|||+.+++++|+.+........
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 252 KGDSVAL-AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp TTSCHHH-HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred ccchhhH-HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 111112 222333444456789999999999999999999999999999998765444433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.31 Aligned_cols=263 Identities=32% Similarity=0.522 Sum_probs=216.2
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE------CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW------RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~------kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
+...+|++++.||+|+||.||++++ .+..||||++.... ....+.+.+|++++++++||||+++++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--------SHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4456899999999999999999985 46779999987531 123467889999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.......+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~----~~~~~k 185 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENRVK 185 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc----CCCcEE
Confidence 9877555678999999999999999987766799999999999999999999999999999999999998 677999
Q ss_pred EEecCCcccccCCcc----cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---------
Q 001103 1026 VGDFGLSRIKCNTLV----SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG--------- 1092 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~----sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e--------- 1092 (1157)
|+|||++........ .....++..|+|||++.+. .++.++||||||+++|+|++|..||......
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~ 263 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTC
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcccc
Confidence 999999986543321 2234578889999999754 4689999999999999999999998643110
Q ss_pred ------HHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1093 ------AIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1093 ------eil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
..+...+....+...+..+++++.+||.+||+.||.+|||+.++++.|+.+...+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 01122233344456678899999999999999999999999999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.10 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=217.9
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
...|++++.||+|+||.||+|++. ++.||||++...... ...+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 91 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-------DEIEDIQQEITVLSQCDSPYVTKYYGSYLK-- 91 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-------TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-------HHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence 357999999999999999999884 778999999765321 114678899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGV 165 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTT
T ss_pred CCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC----CCCCEEEeeccc
Confidence 5689999999999999999864 3589999999999999999999999999999999999998 677899999999
Q ss_pred cccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1032 SRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1032 Akl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
+....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+... ..+.++..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (303)
T 3a7i_A 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGN 242 (303)
T ss_dssp CEECBTTBCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCCSS
T ss_pred ceecCccccccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-CCCCCccc
Confidence 97654332 23456799999999999754 5788999999999999999999999988776666555433 34566778
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+++.+.+||.+||+.||.+|||+.+++++++....
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 99999999999999999999999999999887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=358.93 Aligned_cols=264 Identities=19% Similarity=0.279 Sum_probs=206.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++.+.||+|+||.||++++. ++.||||++..... ......+.+.+|+.+++.++||||+++++++..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-- 105 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-----SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-- 105 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-----GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-----cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--
Confidence 368999999999999999999984 77899999876421 123345778899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~----~~~~~kl~Dfg~ 180 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS----ADDFAYLVDFGI 180 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSCCC
T ss_pred CCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc----CCCCEEEecCcc
Confidence 56899999999999999999754 3589999999999999999999999999999999999998 667999999999
Q ss_pred cccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-CCCCC
Q 001103 1032 SRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-RPQIP 1108 (1157)
Q Consensus 1032 Akl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-rpeip 1108 (1157)
+....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+..... ....+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR 258 (309)
T ss_dssp ----------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTS
T ss_pred CccccccccccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccC
Confidence 87644332 22345799999999999754 568899999999999999999999988765533333322221 12355
Q ss_pred CCCcHHHHHHHHHHhccCCCCCC-CHHHHHHHHHHHHHHHhhcc
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARP-SFTEITNRLRVMSTALQTKR 1151 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRP-SaeELLe~Lr~Lk~aLesks 1151 (1157)
..+++++.+||.+||+.||.+|| +++++++.|+.+........
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 67899999999999999999999 99999999988765554433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=360.83 Aligned_cols=256 Identities=27% Similarity=0.356 Sum_probs=219.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++.+.||+|+||.||++++. +..||+|++.+..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 112 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-----PHQREKMSMEISIHRSLAHQHVVGFHGFFED- 112 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 3468999999999999999999985 6679999998653221 2235678899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.+.+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 113 -~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~~kl~Dfg 186 (335)
T 2owb_A 113 -NDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFG 186 (335)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCT
T ss_pred -CCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc----CCCCEEEeecc
Confidence 56899999999999999988654 4589999999999999999999999999999999999998 67789999999
Q ss_pred CcccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
++..... ........||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+..... .++.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~ 262 (335)
T 2owb_A 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPK 262 (335)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--CCCT
T ss_pred CceecccCcccccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--CCCc
Confidence 9976432 2233446799999999999854 568999999999999999999999998877776666655433 4667
Q ss_pred CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.+++++.+||.+||+.||.+|||+.+++++.+...
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 88999999999999999999999999999988654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=360.01 Aligned_cols=257 Identities=22% Similarity=0.286 Sum_probs=211.4
Q ss_pred CCeeEE-EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC
Q 001103 875 SDLEEL-QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNG 950 (1157)
Q Consensus 875 sdYeIL-rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de 950 (1157)
..|.+. +.||+|+||+||+|++. ++.||||+++....... ....+.+|+.+++.+ .||||+++++++.+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~- 100 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD------CRAEILHEIAVLELAKSCPRVINLHEVYEN- 100 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE------CHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH------HHHHHHHHHHHHHhccCCCCEEEEEEEEEe-
Confidence 467776 88999999999999985 78899999986532111 135678999999999 56999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+++||||+.+++|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++... ..+.+||+||
T Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~-~~~~~kL~Df 178 (327)
T 3lm5_A 101 -TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-PLGDIKIVDF 178 (327)
T ss_dssp -SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT-TBCCEEECCG
T ss_pred -CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC-CCCcEEEeeC
Confidence 66899999999999999998653 45689999999999999999999999999999999999998322 3678999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC--CCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT--LRPQI 1107 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~--lrpei 1107 (1157)
|++.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... .....
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 256 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred ccccccCCccccccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence 999876655555557899999999999754 57899999999999999999999999888777766665443 33344
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...+++.+++||.+||+.||.+|||+++++++.|.
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 46789999999999999999999999999998765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=360.12 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=202.1
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHH--HHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWRE--AHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrE--IkILK~L~HPNIVkLygvf~ 948 (1157)
.+...+|++++.||+|+||+||+|+++++.||||++.... ...+..| +..++.++||||+++++.+.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----------RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 3556899999999999999999999999999999997531 1223334 44455689999999997543
Q ss_pred ---cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC---------CceeccCCccceeecc
Q 001103 949 ---NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK---------NIVHFDLKCDNLLVNL 1016 (1157)
Q Consensus 949 ---de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk---------GIIHRDLKPENILLd~ 1016 (1157)
......+++||||+++|+|.+++.... +++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~- 154 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK- 154 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC-
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc-
Confidence 222346789999999999999996543 57888999999999999999999 999999999999998
Q ss_pred CCCCCCeEEEEecCCcccccCC---------cccCCCCCCCcccCcccccCCC-----CCCCchhHHHHHHHHHHHHHcC
Q 001103 1017 RDPQRPICKVGDFGLSRIKCNT---------LVSGGVRGTLPWMAPELLNGSN-----NRVSEKVDVYSFGIAMWEIITG 1082 (1157)
Q Consensus 1017 dd~e~g~VKLiDFGLAkl~~~~---------~~sts~~GTp~YmAPEVL~G~~-----~~yS~KSDIWSLGVILYELLTG 1082 (1157)
.++.+||+|||+++..... .......||+.|+|||++.+.. ..++.++|||||||+||||++|
T Consensus 155 ---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 155 ---NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp ---TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ---CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 6779999999999754322 1223457999999999997521 2356789999999999999999
Q ss_pred CCCCCCCCh------------------hHHHHHhhhcCCCCCCCCC------CcHHHHHHHHHHhccCCCCCCCHHHHHH
Q 001103 1083 EEPYANMHC------------------GAIIGGILSNTLRPQIPER------CDPEWRKLMEECWSFNPAARPSFTEITN 1138 (1157)
Q Consensus 1083 k~PF~g~~~------------------eeil~~Il~~~lrpeip~~------iSpeLrdLIkrCLqkDPskRPSaeELLe 1138 (1157)
..||..... ......+.....++.++.. +++++.+||.+||+.||.+|||+.++++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 776633211 1111122223334444443 3457999999999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001103 1139 RLRVMSTALQTK 1150 (1157)
Q Consensus 1139 ~Lr~Lk~aLesk 1150 (1157)
.|..+...++..
T Consensus 312 ~L~~ll~~~~~~ 323 (336)
T 3g2f_A 312 RMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHCCCC-
T ss_pred HHHHHHHHHHhc
Confidence 999998655543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=369.46 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=205.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||+|++ .|+.||||++.... ......+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 36899999999999999999998 47789999986531 11234577889999999999999999999987642
Q ss_pred C----CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 G----GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ~----~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. ..+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~ 170 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKIL 170 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc----CCCCEEEE
Confidence 1 3579999999 7899999865 3589999999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC---
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--- 1104 (1157)
|||+++..... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 171 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 171 DFGLARQADSE--MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp CCTTCEECCSS--CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeecccccccc--cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999865433 3446799999999998763 35799999999999999999999999988776665555331110
Q ss_pred --------------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1105 --------------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 --------------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+...+++++.+||.+||+.||.+|||+.+++++.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 01234578999999999999999999999999998765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.42 Aligned_cols=258 Identities=20% Similarity=0.259 Sum_probs=203.0
Q ss_pred CCCeeEE-EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 001103 874 DSDLEEL-QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPN 949 (1157)
Q Consensus 874 ~sdYeIL-rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~d 949 (1157)
...|++. +.||+|+||+||+|++ .++.||||++..... . ....+.+|+++++++ +||||+++++++.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---H-----IRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---C-----CHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---h-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3578885 6799999999999987 477899999976421 1 135678999999985 79999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+.+++||||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ ....+||+||
T Consensus 83 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~~~kl~Df 158 (316)
T 2ac3_A 83 --EDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QVSPVKICDF 158 (316)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS-SSCSEEECCT
T ss_pred --CCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC-CcCceEEEEc
Confidence 56899999999999999999764 4589999999999999999999999999999999999998332 3345999999
Q ss_pred CCcccccCC--------cccCCCCCCCcccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------
Q 001103 1030 GLSRIKCNT--------LVSGGVRGTLPWMAPELLNGSN---NRVSEKVDVYSFGIAMWEIITGEEPYANMHC------- 1091 (1157)
Q Consensus 1030 GLAkl~~~~--------~~sts~~GTp~YmAPEVL~G~~---~~yS~KSDIWSLGVILYELLTGk~PF~g~~~------- 1091 (1157)
|++...... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.....
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 998753211 1122356999999999986411 2367899999999999999999999987542
Q ss_pred --------hHHHHHhhhcCCCCCC--CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1092 --------GAIIGGILSNTLRPQI--PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1092 --------eeil~~Il~~~lrpei--p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
......+......... ...+++++++||.+||+.||.+|||+.+++++.+..
T Consensus 239 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp --CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 2234444444332211 145789999999999999999999999999987754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=354.83 Aligned_cols=256 Identities=32% Similarity=0.569 Sum_probs=202.2
Q ss_pred CCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC--CCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL--HHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L--~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||.||+|+++++.||||++.... ...+.+|.+++..+ +||||+++++++.....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 589999999999999999999999999999986531 12334555555544 89999999999876432
Q ss_pred --CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC--------CceeccCCccceeeccCCCCCC
Q 001103 953 --GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK--------NIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 953 --~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk--------GIIHRDLKPENILLd~dd~e~g 1022 (1157)
..+++||||+++|+|.++++.. .+++..++.++.|++.||.|||++ ||+||||||+|||++ .++
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~----~~~ 179 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNG 179 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC----TTS
T ss_pred CCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC----CCC
Confidence 5789999999999999999653 489999999999999999999999 999999999999998 677
Q ss_pred eEEEEecCCcccccCCcc-----cCCCCCCCcccCcccccCCCCCCC----chhHHHHHHHHHHHHHcC----------C
Q 001103 1023 ICKVGDFGLSRIKCNTLV-----SGGVRGTLPWMAPELLNGSNNRVS----EKVDVYSFGIAMWEIITG----------E 1083 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~~-----sts~~GTp~YmAPEVL~G~~~~yS----~KSDIWSLGVILYELLTG----------k 1083 (1157)
.+||+|||++........ .....||+.|+|||++.+...... .++|||||||++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 999999999975433221 224579999999999976432211 249999999999999999 7
Q ss_pred CCCCCCCh-----hHHHHHhhhcCCCCCCCC-----CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1084 EPYANMHC-----GAIIGGILSNTLRPQIPE-----RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1084 ~PF~g~~~-----eeil~~Il~~~lrpeip~-----~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
.||..... ......+.....++.++. .+++++.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 77764321 222222333344444443 45678999999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=402.47 Aligned_cols=256 Identities=20% Similarity=0.348 Sum_probs=220.2
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||+++++ ++.||||++++...... .....+..|..++..+ +||+|+++++++.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~-----~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-----DDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHT-----TTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccH-----HHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 45679999999999999999999985 56699999986532211 1235677899999987 7999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...+||||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++ .++++||+|
T Consensus 413 ~--~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~----~~g~ikL~D 485 (674)
T 3pfq_A 413 T--MDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIAD 485 (674)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC----SSSCEEECC
T ss_pred e--CCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc----CCCcEEEee
Confidence 7 568999999999999999997654 589999999999999999999999999999999999998 778999999
Q ss_pred cCCcccc-cCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIK-CNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~-~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++.. ........++||+.|+|||++.+. .|+.++|||||||+||||++|++||.+....+++..+..... .+
T Consensus 486 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~ 561 (674)
T 3pfq_A 486 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AY 561 (674)
T ss_dssp CTTCEECCCTTCCBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC--CC
T ss_pred cceeeccccCCcccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--CC
Confidence 9999853 233345567899999999999854 579999999999999999999999999998888888876544 46
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCH-----HHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSF-----TEITNRLRVM 1143 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSa-----eELLe~Lr~L 1143 (1157)
+..+++++++||++||++||.+||++ ++|+++.++-
T Consensus 562 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 77899999999999999999999997 8999887653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=373.35 Aligned_cols=260 Identities=22% Similarity=0.385 Sum_probs=211.7
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYG 945 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLyg 945 (1157)
+...+|++++.||+|+||+||++++ .++.||||++++........ ....+.+|+++++++ +||||+++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----TTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES----SGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh----HHHHHHHHHHHHHHccCCCceeEEEE
Confidence 3446899999999999999999998 57789999987643211111 123456789999999 6999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.. ...+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 127 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~k 199 (355)
T 1vzo_A 127 AFQT--ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVV 199 (355)
T ss_dssp EEEE--TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEE
T ss_pred EEee--CceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCcEE
Confidence 9987 568999999999999999997544 589999999999999999999999999999999999998 677999
Q ss_pred EEecCCcccccCC--cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHhh
Q 001103 1026 VGDFGLSRIKCNT--LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGGIL 1099 (1157)
Q Consensus 1026 LiDFGLAkl~~~~--~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~Il 1099 (1157)
|+|||+++..... ......+||+.|+|||++.+....++.++|||||||+||+|++|+.||..... ..+...+.
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 9999999754322 22334679999999999986555678999999999999999999999975432 23333333
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHHH
Q 001103 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRVMS 1144 (1157)
Q Consensus 1100 ~~~lrpeip~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~Lk 1144 (1157)
. ..+.++..+++.+++||.+||+.||.+|| ++++++++++...
T Consensus 280 ~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 280 K--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred c--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 2 23456778999999999999999999999 9999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=385.54 Aligned_cols=257 Identities=33% Similarity=0.629 Sum_probs=220.7
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVV 947 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf 947 (1157)
+.+...+|++.+.||+|+||.||+|+++ +..||||+++.... . .+.+.+|+.+|++|+|||||++++++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~-----~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----E-----VEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----C-----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----c-----hHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4566678999999999999999999996 67899999875421 1 35688999999999999999999999
Q ss_pred ecCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.. ...+++|||||.+|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||
T Consensus 286 ~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl 359 (495)
T 1opk_A 286 TR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG----ENHLVKV 359 (495)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----GGGCEEE
T ss_pred ec--CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC----CCCcEEE
Confidence 87 56789999999999999999763 35589999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1027 GDFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1027 iDFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
+|||+++...... ......++..|+|||++.+. .++.++|||||||+||||++ |+.||.+.....+...+ ....
T Consensus 360 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~ 436 (495)
T 1opk_A 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDY 436 (495)
T ss_dssp CCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTC
T ss_pred eecccceeccCCceeecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCC
Confidence 9999998654332 22334577899999999754 57899999999999999999 99999988877666554 4455
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+...+..+++++.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 66778889999999999999999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.71 Aligned_cols=253 Identities=27% Similarity=0.477 Sum_probs=210.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||.||+|++. |+.||||++..... ...+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVVKYYGSYFK- 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----------CHHHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----------HHHHHHHHHHHHhCCCCCCccEEEEEEe-
Confidence 3468999999999999999999985 77899999976421 2567889999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.+.+++||||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 96 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg 170 (314)
T 3com_A 96 -NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN----TEGHAKLADFG 170 (314)
T ss_dssp -TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCT
T ss_pred -CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC----CCCCEEEeecc
Confidence 5689999999999999999976666799999999999999999999999999999999999998 66789999999
Q ss_pred CcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-CCCCCC
Q 001103 1031 LSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-LRPQIP 1108 (1157)
Q Consensus 1031 LAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~-lrpeip 1108 (1157)
++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.... .....+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T 3com_A 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP 248 (314)
T ss_dssp TCEECBTTBSCBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred cchhhhhhccccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCc
Confidence 997654332 23446799999999999854 57889999999999999999999999877665555443332 222345
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+++.+.+||.+||+.||.+|||+.+++++.+.-
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 56789999999999999999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=370.19 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=209.1
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|++++.||+|+||+||+|++ .++.||||+++.................+.+|+.++++++||||+++++++.+ .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~ 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--Q 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--C
Confidence 4799999999999999999987 47789999998764322210001112456789999999999999999999987 6
Q ss_pred CcEEEEEEeecCC-cchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 953 GTMATVTEYMVNG-SLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 953 ~~LyLVMEYmeGG-SL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
+.+++||||+.+| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc----CCCcEEEeeccc
Confidence 6899999999777 9999887544 489999999999999999999999999999999999998 678999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
+............+||+.|+|||++.+.. .++.++|||||||++|+|++|+.||..... ... .....+..+
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~--~~~~~~~~~ 247 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNP-YRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE--AAIHPPYLV 247 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT--TCCCCSSCC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCC-CCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh--hccCCCccc
Confidence 98766555555578999999999998642 238899999999999999999999975321 111 122345668
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
++++.+||.+||+.||.+|||+.+++++.|.
T Consensus 248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 9999999999999999999999999998774
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=377.93 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=204.2
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG-- 950 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de-- 950 (1157)
.+|++++.||+|+||+||+|++ .+..||||++.... ....+|+++|+.|+|||||++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------------TSCCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------------hhHHHHHHHHHHcCCCCccceeeEEeccCC
Confidence 4799999999999999999999 47789999987542 1123699999999999999999988431
Q ss_pred --CCCcEEEEEEeecCCcchhhhcc---ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 951 --PGGTMATVTEYMVNGSLRHVLAR---KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 951 --~~~~LyLVMEYmeGGSL~dlLkr---~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
...++++||||+.+ +|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+.+|
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~~k 197 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---DTAVLK 197 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET---TTTEEE
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC---CCCeEE
Confidence 12357899999986 56555542 3456899999999999999999999999999999999999982 346799
Q ss_pred EEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC---
Q 001103 1026 VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT--- 1102 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~--- 1102 (1157)
|+|||+++............||+.|+|||++.+. ..++.++|||||||+||||++|+.||.+....+.+..++...
T Consensus 198 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp ECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eccchhhhhcccCCCceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999875554444557899999999998754 357999999999999999999999999887666555543310
Q ss_pred ------------CCCC------------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 ------------LRPQ------------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 ------------lrpe------------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.... ++..+++++.+||.+||++||.+|||+.+++++.++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 0001 234578999999999999999999999999998876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=371.98 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=200.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|++. ++.||||+++... ......+.+.+|+++|+.++||||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 468999999999999999999984 6779999997531 11233567889999999999999999999987642
Q ss_pred C---CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 952 G---GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 952 ~---~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
. ..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~----~~~~~kL~D 172 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN----QDCSVKVCD 172 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECC
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC----CCCCEEEcc
Confidence 2 57899999987 4999998654 4589999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCCc-----------------------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC---
Q 001103 1029 FGLSRIKCNTL-----------------------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG--- 1082 (1157)
Q Consensus 1029 FGLAkl~~~~~-----------------------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG--- 1082 (1157)
||+++...... .....+||+.|+|||++... ..++.++|||||||+||||++|
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccc
Confidence 99998643321 23557899999999987543 3589999999999999999984
Q ss_pred --------CCCCCCCCh-----------------hHHHHHhhh------------------------cCCCCC-----CC
Q 001103 1083 --------EEPYANMHC-----------------GAIIGGILS------------------------NTLRPQ-----IP 1108 (1157)
Q Consensus 1083 --------k~PF~g~~~-----------------eeil~~Il~------------------------~~lrpe-----ip 1108 (1157)
+++|.+... ...+..+.. ...... ..
T Consensus 252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (432)
T 3n9x_A 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY 331 (432)
T ss_dssp TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence 444443321 111111110 001111 01
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+++++.+||.+||++||.+|||+++++++.+.-
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 366 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence 35789999999999999999999999999987754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=365.35 Aligned_cols=268 Identities=19% Similarity=0.228 Sum_probs=201.7
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHH----HHHHHHHHHHHHHhCCCCce
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEW----LIKEFWREAHIISNLHHPNV 940 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~----likqflrEIkILK~L~HPNI 940 (1157)
..+...+|++.+.||+|+||+||+|++. +..+|||++....... ..+... ....+.+|+.+++.++||||
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL-FSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHH-HHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcch-HHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 3355678999999999999999999994 4569999987642100 001110 11346788999999999999
Q ss_pred eEEeeeeecC--CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC
Q 001103 941 VAFYGVVPNG--PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 941 VkLygvf~de--~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd 1018 (1157)
+++++++... ....+|+||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~- 187 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK- 187 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-
Confidence 9999998662 245799999999 999999997655 69999999999999999999999999999999999999832
Q ss_pred CCCCeEEEEecCCcccccCCc--------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 001103 1019 PQRPICKVGDFGLSRIKCNTL--------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH 1090 (1157)
Q Consensus 1019 ~e~g~VKLiDFGLAkl~~~~~--------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~ 1090 (1157)
..+.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||+||+|++|+.||....
T Consensus 188 -~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 188 -NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp -STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred -CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 12389999999997543221 12345799999999999864 57999999999999999999999996532
Q ss_pred h-hHHHHHhhhcCCCCCCC---------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1091 C-GAIIGGILSNTLRPQIP---------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1091 ~-eeil~~Il~~~lrpeip---------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
. ........ ......++ ..+++++++||.+||+.||.+|||+.+|++.|+.+..
T Consensus 265 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPVAVQTAK-TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHHHHHHHH-HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccHHHHHHH-HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 2 11111111 11111111 2688999999999999999999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=380.39 Aligned_cols=261 Identities=34% Similarity=0.571 Sum_probs=217.4
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+.+...+|++.+.||+|+||.||+|++++ ..||||+++.... . .+.+.+|+++|++|+||||+++++++.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----S-----PEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----C-----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC----C-----HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 44566789999999999999999999975 5699999876421 1 256889999999999999999999986
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
+ ..+++||||+.+|+|.+++... +..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 250 ~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~ 322 (452)
T 1fmk_A 250 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVA 322 (452)
T ss_dssp S---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred C---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC----CCCCEEEC
Confidence 5 4589999999999999999753 35589999999999999999999999999999999999998 67799999
Q ss_pred ecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1028 DFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|||+++...... ......+|..|+|||++.+. .++.++|||||||+||||++ |+.||.+....+.+..+. ...+
T Consensus 323 DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~ 399 (452)
T 1fmk_A 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 399 (452)
T ss_dssp CCCTTC--------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred CCccceecCCCceecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 999998654322 22334578899999999754 57999999999999999999 999999988877776664 4455
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
...+..+++.+.+||.+||+.||.+|||+++|++.|..+......
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 667788999999999999999999999999999999887654443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=371.04 Aligned_cols=259 Identities=14% Similarity=0.090 Sum_probs=192.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC--CCCceeEEe------
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL--HHPNVVAFY------ 944 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L--~HPNIVkLy------ 944 (1157)
.+|++++.||+|+||+||+|++. ++.||||++..... ........+.+|+.+++.| +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-----NSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-----THHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-----ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 35999999999999999999984 77899999987522 1233346677785544444 699988865
Q ss_pred -eeeecCCC---------------CcEEEEEEeecCCcchhhhccccccccHHHH------HHHHHHHHHHHHHHHHCCc
Q 001103 945 -GVVPNGPG---------------GTMATVTEYMVNGSLRHVLARKDRILDRRKK------LMLMMDAAFGMEYLHMKNI 1002 (1157)
Q Consensus 945 -gvf~de~~---------------~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qV------lkIa~QLa~ALeYLHSkGI 1002 (1157)
+++..+.. ..+|+|||||+ ++|.+++...+..+++..+ +.++.||+.||+|||++||
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 33332111 34899999999 7999999876555666666 7788999999999999999
Q ss_pred eeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC
Q 001103 1003 VHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG 1082 (1157)
Q Consensus 1003 IHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG 1082 (1157)
+||||||+|||++ .++.+||+|||+++....... ...+|+.|+|||++.+....++.++|||||||+||+|++|
T Consensus 216 vHrDikp~NIll~----~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 216 VHGHFTPDNLFIM----PDGRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EETTCSGGGEEEC----TTSCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred ccCcCCHHHEEEC----CCCCEEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999998 677999999999986543332 2457799999999986335689999999999999999999
Q ss_pred CCCCCCCChhHH--HH-----HhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1083 EEPYANMHCGAI--IG-----GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1083 k~PF~g~~~eei--l~-----~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+.||........ .. ...........+..+++.+++||.+||+.||.+|||+.+++++.|.-..
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 999987643211 00 0011122223335789999999999999999999999999998776544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=350.97 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=208.4
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|.....||+|+||.||+|++ ++..||||++..... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 91 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--------RYSQPLHEEIALHKHLKHKNIVQYLGSFSE--N 91 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----------HHHHHHHHHHHTCCCTTBCCEEEEEEE--T
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--------HHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--C
Confidence 3455556899999999999998 466799999876421 123668899999999999999999999987 5
Q ss_pred CcEEEEEEeecCCcchhhhcccc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 953 GTMATVTEYMVNGSLRHVLARKD--RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~g--r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++. ..+.+||+|||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~kl~Dfg 168 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT---YSGVLKISDFG 168 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTCCEEECCTT
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC---CCCCEEEeecc
Confidence 68999999999999999987643 34668889999999999999999999999999999999982 26799999999
Q ss_pred CcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCCCCCCC
Q 001103 1031 LSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1031 LAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~lrpeip 1108 (1157)
++...... .......||+.|+|||++.+....++.++||||||+++|+|++|+.||....... ...........+.++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 2clq_A 169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP 248 (295)
T ss_dssp TCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred cccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc
Confidence 99764432 2234467999999999997543447899999999999999999999997644322 222222334456678
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhc
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesk 1150 (1157)
..+++++.+||.+||+.||.+|||+.+++++.+.......++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 290 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC------
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCC
Confidence 889999999999999999999999999999877654443333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=360.51 Aligned_cols=266 Identities=27% Similarity=0.392 Sum_probs=216.4
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+.+...+|++.+.||+|+||.||+|++++ .+|+|+++........ .+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ------LKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC------CCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH------HHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 44667899999999999999999999876 5999998764221111 2346689999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+++||||+.+++|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 101 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-----~~~~~l~Df 173 (319)
T 2y4i_B 101 --PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-----NGKVVITDF 173 (319)
T ss_dssp --SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-------CCEECCC
T ss_pred --CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-----CCCEEEeec
Confidence 5579999999999999999987776799999999999999999999999999999999999996 358999999
Q ss_pred CCcccccC------CcccCCCCCCCcccCcccccCC-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 001103 1030 GLSRIKCN------TLVSGGVRGTLPWMAPELLNGS-------NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096 (1157)
Q Consensus 1030 GLAkl~~~------~~~sts~~GTp~YmAPEVL~G~-------~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~ 1096 (1157)
|++..... ........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||..........
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 253 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99865321 1222334689999999998752 2357899999999999999999999999988877777
Q ss_pred HhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1097 GILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1097 ~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
.+.........+..+++++.+||.+||+.||.+|||+.++++.|+.+......
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 66655544444556889999999999999999999999999999988765443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=352.60 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=210.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||.||+|++. +..||+|++..... .....+.+|+++++.++||||+++++++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--------EELEDYIVEIEILATCDHPYIVKLLGAYYH- 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--------HHHHHHHHHHHHHhcCCCCCEeeeeeeeee-
Confidence 3468999999999999999999995 67899999875421 114678899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.+.+++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 88 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Dfg 162 (302)
T 2j7t_A 88 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT----LEGDIRLADFG 162 (302)
T ss_dssp -C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTSCEEECCCH
T ss_pred -CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC----CCCCEEEEECC
Confidence 5689999999999999999877667799999999999999999999999999999999999998 67789999999
Q ss_pred CcccccCC-cccCCCCCCCcccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC-C
Q 001103 1031 LSRIKCNT-LVSGGVRGTLPWMAPELLNG---SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR-P 1105 (1157)
Q Consensus 1031 LAkl~~~~-~~sts~~GTp~YmAPEVL~G---~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr-p 1105 (1157)
++...... .......||+.|+|||++.. ....++.++||||||+++|+|++|+.||...........+...... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T 2j7t_A 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL 242 (302)
T ss_dssp HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc
Confidence 87542221 12234579999999999841 1245789999999999999999999999988877766666554332 2
Q ss_pred CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1106 eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+..++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 345678999999999999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=361.06 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=209.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||.||+|++. ++.||||++.... ......+.+.+|+++++.++||||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 95 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK- 95 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-
Confidence 3468999999999999999999995 7789999987542 112334667899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
...+++||||+.+++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 96 -~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg 169 (331)
T 4aaa_A 96 -KKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS----QSGVVKLCDFG 169 (331)
T ss_dssp -TTEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCCT
T ss_pred -CCEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc----CCCcEEEEeCC
Confidence 66899999999999998876543 3589999999999999999999999999999999999998 67799999999
Q ss_pred CcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-------
Q 001103 1031 LSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT------- 1102 (1157)
Q Consensus 1031 LAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~------- 1102 (1157)
++...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+....
T Consensus 170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 170 FARTLAAPGEVYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp TC------------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CceeecCCccccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 99754332 233446799999999999754 357899999999999999999999999887666554443210
Q ss_pred -------------CCCC---------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1103 -------------LRPQ---------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1103 -------------lrpe---------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
..+. ....+++.+.+||.+||+.||.+|||+.+++++.+.-..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0000 112478999999999999999999999999999887543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=355.44 Aligned_cols=255 Identities=31% Similarity=0.543 Sum_probs=209.8
Q ss_pred CCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHh--CCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN--LHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~--L~HPNIVkLygvf~de~~ 952 (1157)
.+|++.+.||+|+||+||+++++++.||||++.... ...+.+|.++++. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 579999999999999999999999999999986531 2456788888887 789999999999877432
Q ss_pred --CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHH--------HCCceeccCCccceeeccCCCCCC
Q 001103 953 --GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH--------MKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 953 --~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLH--------SkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
..+++||||+++|+|.+++.+. .+++..++.++.|++.||.||| +++|+||||||+|||++ .++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~----~~~ 184 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNG 184 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC----TTS
T ss_pred ccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC----CCC
Confidence 2789999999999999999653 4899999999999999999999 89999999999999998 677
Q ss_pred eEEEEecCCcccccCCc-----ccCCCCCCCcccCcccccCCCC----CCCchhHHHHHHHHHHHHHcC----------C
Q 001103 1023 ICKVGDFGLSRIKCNTL-----VSGGVRGTLPWMAPELLNGSNN----RVSEKVDVYSFGIAMWEIITG----------E 1083 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~~----~yS~KSDIWSLGVILYELLTG----------k 1083 (1157)
.+||+|||++....... ......||+.|+|||++.+... .++.++|||||||++|+|++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999997654332 2344579999999999975421 233689999999999999999 7
Q ss_pred CCCCCCC-----hhHHHHHhhhcCCCCCCCC-----CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1084 EPYANMH-----CGAIIGGILSNTLRPQIPE-----RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1084 ~PF~g~~-----~eeil~~Il~~~lrpeip~-----~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.||.... .......+.....++.++. .+++.+.+||.+||+.||.+|||+.+++++|+.+...
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 8987642 2334444444555555553 2346799999999999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.84 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=201.7
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~- 951 (1157)
.+|++++.||+|+||.||+|++ .++.||||++... ......+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 4799999999999999999998 4778999998653 223467889999999999999999999876532
Q ss_pred ----------CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCC
Q 001103 952 ----------GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021 (1157)
Q Consensus 952 ----------~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~ 1021 (1157)
...+++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~----~~ 152 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----ES 152 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TT
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc----CC
Confidence 3578999999999999999987666788899999999999999999999999999999999998 67
Q ss_pred CeEEEEecCCcccccCC---------------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 001103 1022 PICKVGDFGLSRIKCNT---------------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086 (1157)
Q Consensus 1022 g~VKLiDFGLAkl~~~~---------------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF 1086 (1157)
+.+||+|||++...... .......||+.|+|||++.+. ..++.++|||||||++|+|++ ||
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---cc
Confidence 78999999998754321 122345699999999999753 357899999999999999998 55
Q ss_pred CCCC-hhHHHHHhhh--cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1087 ANMH-CGAIIGGILS--NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1087 ~g~~-~eeil~~Il~--~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.... .......+.. ..+++.++...++.+++||.+||+.||.+|||+.+++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 229 STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp SSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred CCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 5322 2233333332 233445666778899999999999999999999999998765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=353.71 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=206.0
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 877 LEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
|...+.||+|+||+||+|+++++.||||++........ +...+.+.+|+.+++.++||||+++++++.+ ....+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT----EELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT----TTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcch----HHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceE
Confidence 34458899999999999999999999999876422111 2235678899999999999999999999987 56789
Q ss_pred EEEEeecCCcchhhhccc--cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 957 TVTEYMVNGSLRHVLARK--DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~--gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
+||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD----EAFTAKISDFGLARA 182 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc----CCCcEEEeecccccc
Confidence 999999999999998643 34589999999999999999999999999999999999998 678999999999875
Q ss_pred ccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH----HHhhhc------
Q 001103 1035 KCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII----GGILSN------ 1101 (1157)
Q Consensus 1035 ~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil----~~Il~~------ 1101 (1157)
.... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||........+ ..+...
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred cccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 4332 22334579999999999875 3688999999999999999999999865432211 111110
Q ss_pred ---CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1102 ---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1102 ---~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
......+...++.+.+||.+||+.||.+|||+.+++++|+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 0111223345677999999999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=364.04 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=185.0
Q ss_pred EEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCcEEE
Q 001103 881 QELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~LyL 957 (1157)
+.||+|+||+||+|+++ ++.||||++.+.. ...+.+|+.+++.+. ||||+++++++.+ ....|+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~l 83 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----------EANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFL 83 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh-----------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEE
Confidence 67999999999999995 7789999997531 245678999999997 9999999999987 568999
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
||||+++++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN-DNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCCTTCEECCC
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC-CcccEEEeccccceecCC
Confidence 99999999999999764 4589999999999999999999999999999999999998332 344899999999985433
Q ss_pred C-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------hHHHHHhhhcCCCCCC--
Q 001103 1038 T-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-------GAIIGGILSNTLRPQI-- 1107 (1157)
Q Consensus 1038 ~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~-------eeil~~Il~~~lrpei-- 1107 (1157)
. ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .+.+..+.........
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp ----------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCcccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 2 233456799999999999754 579999999999999999999999986443 3445555444332221
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...+++++++||.+||+.||.+|||+.+++++.|.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 13579999999999999999999999999988665
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=362.03 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=198.7
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||+||+|++ .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC------ChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 36899999999999999999988 477899999976421 1233567889999999999999999999987642
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
...+|+||||+.+ +|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~ 169 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 169 (371)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEEC
T ss_pred ccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEE
Confidence 2378999999975 7777774 2488999999999999999999999999999999999998 67799999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP-- 1105 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp-- 1105 (1157)
|||++............+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+......+
T Consensus 170 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp CCCC----------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred EeecccccccccccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999876555445557899999999999864 57899999999999999999999999887766665554321110
Q ss_pred ------------------CC--------------CC------CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 ------------------QI--------------PE------RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 ------------------ei--------------p~------~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+ +. ..++++++||.+||+.||.+|||+++++++.+.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 00 00 0156789999999999999999999999998864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=364.45 Aligned_cols=260 Identities=18% Similarity=0.238 Sum_probs=200.9
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--------CCc
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--------HPN 939 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--------HPN 939 (1157)
..+...+|++++.||+|+||+||+|++. ++.||||+++.. ......+.+|+.+++.+. |||
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 102 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---------EHYTETALDEIRLLKSVRNSDPNDPNREM 102 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---------CcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence 3445678999999999999999999884 678999998743 223467789999999985 788
Q ss_pred eeEEeeeeecC--CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecc
Q 001103 940 VVAFYGVVPNG--PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNL 1016 (1157)
Q Consensus 940 IVkLygvf~de--~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~ 1016 (1157)
|+++++++... ....+++||||+.++.+..++....+.+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 103 iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp BCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 99999998731 24579999999955444444444446699999999999999999999999 9999999999999983
Q ss_pred CCC---------------------------------------------CCCeEEEEecCCcccccCCcccCCCCCCCccc
Q 001103 1017 RDP---------------------------------------------QRPICKVGDFGLSRIKCNTLVSGGVRGTLPWM 1051 (1157)
Q Consensus 1017 dd~---------------------------------------------e~g~VKLiDFGLAkl~~~~~~sts~~GTp~Ym 1051 (1157)
++. ....+||+|||++...... .....||+.|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~ 260 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYR 260 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGC
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCccc
Confidence 210 1137999999999765433 33457999999
Q ss_pred CcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh------hHHHHHhhh--cCC--------------------
Q 001103 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC------GAIIGGILS--NTL-------------------- 1103 (1157)
Q Consensus 1052 APEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~------eeil~~Il~--~~l-------------------- 1103 (1157)
|||++.+. .++.++|||||||+||+|++|+.||..... ...+..+.. +..
T Consensus 261 aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 261 SLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp CHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred CChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999865 578999999999999999999999986542 122222111 000
Q ss_pred ------------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 ------------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 ------------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...++...++.+.+||.+||+.||.+|||+.+++++.|.
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 001123345678999999999999999999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.10 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=209.7
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||++++. +..||||++.... .......+.+|++++++++||||+++++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-------CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 468999999999999999999984 6779999987431 1233567889999999999999999999986532
Q ss_pred ---CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 952 ---GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 952 ---~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
....|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~D 171 (364)
T 3qyz_A 99 IEQMKDVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICD 171 (364)
T ss_dssp TTTCCCEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECC
T ss_pred ccccceEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC----CCCCEEEEe
Confidence 2478999999975 89888864 3489999999999999999999999999999999999998 777899999
Q ss_pred cCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC
Q 001103 1029 FGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1029 FGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
||++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99998644322 12345799999999987643 34789999999999999999999999988776666555421110
Q ss_pred C-----------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1105 P-----------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1105 p-----------------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+ .+...+++++.+||.+||++||.+|||+.+++++.+.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 318 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 0 01245788999999999999999999999999987753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=363.45 Aligned_cols=256 Identities=30% Similarity=0.497 Sum_probs=203.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
+...+|++.+.||+|+||+||+|++ +++.||||++........ ...+.+|+++++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 98 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNLLRLRGFCMT- 98 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-------CCHHHHHHHGGGTCCCTTBCCCCEEECC-
T ss_pred HHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-------HHHHHHHHHHHHhccCCCccceEEEEec-
Confidence 3457899999999999999999987 477899999876422111 1257899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhcccc---ccccHHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeeccCCCCCCeE
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKD---RILDRRKKLMLMMDAAFGMEYLHMK---NIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~g---r~L~e~qVlkIa~QLa~ALeYLHSk---GIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++ ||+||||||+|||++ .++.+
T Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~----~~~~~ 173 (326)
T 3uim_A 99 -PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD----EEFEA 173 (326)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC----TTCCE
T ss_pred -CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC----CCCCE
Confidence 557889999999999999997643 3489999999999999999999999 999999999999998 67899
Q ss_pred EEEecCCcccccC--CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChhHHHH-
Q 001103 1025 KVGDFGLSRIKCN--TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANM-----HCGAIIG- 1096 (1157)
Q Consensus 1025 KLiDFGLAkl~~~--~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~-----~~eeil~- 1096 (1157)
||+|||++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||... .......
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999986432 2234446699999999999754 4789999999999999999999999521 1111111
Q ss_pred --Hhhh---------cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1097 --GILS---------NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1097 --~Il~---------~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.... .......+...++.+.+||.+||+.||.+|||+.+++++|+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1110 111112222334779999999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.30 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=206.0
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE---CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc------ee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW---RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN------VV 941 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~---kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN------IV 941 (1157)
.+...+|++++.||+|+||+||+|.+ .++.||||+++.. ......+.+|+++++.++|++ ++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---------DRYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---------CchhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 34457999999999999999999987 4678999998743 123466788999999887654 99
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCC
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQ 1020 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e 1020 (1157)
++++++.. .+.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+..
T Consensus 81 ~~~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 81 QMLEWFEH--HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp CEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEE
T ss_pred eeeccccc--CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccc
Confidence 99999987 56899999999 889999887654 458899999999999999999999999999999999999832210
Q ss_pred ---------------CCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC
Q 001103 1021 ---------------RPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP 1085 (1157)
Q Consensus 1021 ---------------~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~P 1085 (1157)
.+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCC
Confidence 567999999999764433 2346799999999999864 579999999999999999999999
Q ss_pred CCCCChhHHHHHhhhcC--CC----------------------------------------CCCCCCCcHHHHHHHHHHh
Q 001103 1086 YANMHCGAIIGGILSNT--LR----------------------------------------PQIPERCDPEWRKLMEECW 1123 (1157)
Q Consensus 1086 F~g~~~eeil~~Il~~~--lr----------------------------------------peip~~iSpeLrdLIkrCL 1123 (1157)
|...........+.... .+ .......++++.+||.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 99877655443332110 00 0011223577999999999
Q ss_pred ccCCCCCCCHHHHHHHHHH
Q 001103 1124 SFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1124 qkDPskRPSaeELLe~Lr~ 1142 (1157)
+.||.+|||+.+++++.+.
T Consensus 314 ~~dP~~Rpt~~ell~hp~f 332 (339)
T 1z57_A 314 EYDPAKRITLREALKHPFF 332 (339)
T ss_dssp CSSTTTSCCHHHHTTSGGG
T ss_pred CcCcccccCHHHHhcCHHH
Confidence 9999999999999998664
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.40 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=195.8
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
.+...+|++.+.||+|+||+||++++ ++..||||++..... ......+.+|+.++++++||||+++++++.
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-------QTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-------chhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 45568999999999999999999987 577899998865321 122456789999999999999999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhcc-------ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCC
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLAR-------KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr-------~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~ 1021 (1157)
. .+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 84 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~ 157 (303)
T 2vwi_A 84 V--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG----ED 157 (303)
T ss_dssp S--SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TT
T ss_pred e--cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc----CC
Confidence 7 4579999999999999999864 234589999999999999999999999999999999999998 67
Q ss_pred CeEEEEecCCcccccCC------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 001103 1022 PICKVGDFGLSRIKCNT------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII 1095 (1157)
Q Consensus 1022 g~VKLiDFGLAkl~~~~------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil 1095 (1157)
+.+||+|||++...... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.........
T Consensus 158 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 236 (303)
T 2vwi_A 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236 (303)
T ss_dssp CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence 78999999998754321 122345799999999998642 24789999999999999999999999987766655
Q ss_pred HHhhhcCCC--------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1096 GGILSNTLR--------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1096 ~~Il~~~lr--------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
......... ......+++++.+||.+||+.||.+|||+.+++++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp HHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred HHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 544433221 1233567899999999999999999999999999876544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.50 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=203.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG- 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de- 950 (1157)
..+|++++.||+|+||.||+|++. ++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--------PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--------hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 478999999999999999999995 7789999987531 22356788999999999999999999987432
Q ss_pred -----------CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCC
Q 001103 951 -----------PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDP 1019 (1157)
Q Consensus 951 -----------~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~ 1019 (1157)
.....++||||+. |+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--- 155 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--- 155 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET---
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC---
Confidence 2457899999998 599998864 35889999999999999999999999999999999999972
Q ss_pred CCCeEEEEecCCcccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 001103 1020 QRPICKVGDFGLSRIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII 1095 (1157)
Q Consensus 1020 e~g~VKLiDFGLAkl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil 1095 (1157)
..+.+||+|||++...... .......+|..|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4568999999999864322 122334589999999988653 35799999999999999999999999988776655
Q ss_pred HHhhhcCCC-----------------------C-----CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1096 GGILSNTLR-----------------------P-----QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1096 ~~Il~~~lr-----------------------p-----eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+...... + .....+++++++||.+||+.||.+|||+.+++++.+.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 554432110 0 12245789999999999999999999999999998864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=371.00 Aligned_cols=262 Identities=29% Similarity=0.517 Sum_probs=210.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC---C--ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR---G--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k---G--t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
..|++.+.||+|+||+||+|++. + ..||||.++... . ....+.+.+|+.++++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---D----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS---C----SHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC---C----HHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 35788999999999999999873 2 248999876421 1 1225678899999999999999999998754
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
. .+..++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 162 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DF 236 (373)
T 3c1x_A 162 S-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADF 236 (373)
T ss_dssp C-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECCC
T ss_pred C-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC----CCCCEEEeec
Confidence 3 4578899999999999999987777789999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1030 GLSRIKCNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1030 GLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
|+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++ |.+||......+....+... .
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-~ 313 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-R 313 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-C
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-C
Confidence 9997543221 12334578899999999754 57999999999999999999 78899887766665555443 3
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKR 1151 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesks 1151 (1157)
+...+..+++.+.+||.+||+.||.+|||+.++++.|..+...+....
T Consensus 314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 445677899999999999999999999999999999999987665543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.15 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=214.7
Q ss_pred cCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChh---------HHHHHHHHHHHHHHHHhCCCCceeEE
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSE---------QEWLIKEFWREAHIISNLHHPNVVAF 943 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e---------~e~likqflrEIkILK~L~HPNIVkL 943 (1157)
...+|++++.||+|+||.||+|++.+..||||++........... .......+.+|+.++++++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 347999999999999999999999999999999986532211100 00112678899999999999999999
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhh------hccc-cccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeec
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHV------LARK-DRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVN 1015 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dl------Lkr~-gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd 1015 (1157)
++++.+ .+.+++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 109 ~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999988 5689999999999999998 5542 4669999999999999999999999 9999999999999998
Q ss_pred cCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCh-hH
Q 001103 1016 LRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSE-KVDVYSFGIAMWEIITGEEPYANMHC-GA 1093 (1157)
Q Consensus 1016 ~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~-KSDIWSLGVILYELLTGk~PF~g~~~-ee 1093 (1157)
.++.+||+|||++...... ......||+.|+|||++.+.. .++. ++|||||||++|+|++|+.||..... ..
T Consensus 187 ----~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 187 ----KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ----TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred ----CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 6779999999999865443 334467999999999998642 3455 99999999999999999999998766 55
Q ss_pred HHHHhhhcCCCCCC-----------------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1094 IIGGILSNTLRPQI-----------------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1094 il~~Il~~~lrpei-----------------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
....+......... ...+++++.+||.+||+.||.+|||+.+++++.+.
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 65555544332221 15689999999999999999999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.33 Aligned_cols=256 Identities=27% Similarity=0.346 Sum_probs=208.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC---CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC---CCCceeEEeeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL---HHPNVVAFYGVV 947 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k---Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L---~HPNIVkLygvf 947 (1157)
..+|++++.||+|+||+||+|++. ++.||||+++........ ...+.+|+.+++.+ .||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------CchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence 368999999999999999999983 677999999765322111 12344566666655 899999999998
Q ss_pred ec---CCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 948 PN---GPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 948 ~d---e~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
.. .....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~----~~~~ 158 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQ 158 (326)
T ss_dssp EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCC
T ss_pred eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc----CCCC
Confidence 62 12557899999998 59999887643 4589999999999999999999999999999999999998 6779
Q ss_pred EEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC
Q 001103 1024 CKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l 1103 (1157)
+||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEecCcccccccCCCCccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 999999999866554445567799999999999754 578999999999999999999999998887766665543110
Q ss_pred -------------------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 -------------------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 -------------------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...+...+++.+++||.+||+.||.+|||+.+++++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 011335688999999999999999999999999988664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.93 Aligned_cols=256 Identities=17% Similarity=0.222 Sum_probs=206.4
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC----------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeE
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR----------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k----------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVk 942 (1157)
...+|++.+.||+|+||+||+|++. +..||||++... ..+.+|++++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~ 106 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVN 106 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhh
Confidence 3578999999999999999999984 567999998754 34678999999999999988
Q ss_pred ---------------EeeeeecCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceecc
Q 001103 943 ---------------FYGVVPNGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFD 1006 (1157)
Q Consensus 943 ---------------Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRD 1006 (1157)
+++++.. ....+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus 107 ~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D 184 (352)
T 2jii_A 107 KWKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184 (352)
T ss_dssp HHHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSC
T ss_pred hhhhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 4555543 256889999999 99999999765 46699999999999999999999999999999
Q ss_pred CCccceeeccCCCCCC--eEEEEecCCcccccCCc--------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHH
Q 001103 1007 LKCDNLLVNLRDPQRP--ICKVGDFGLSRIKCNTL--------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAM 1076 (1157)
Q Consensus 1007 LKPENILLd~dd~e~g--~VKLiDFGLAkl~~~~~--------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVIL 1076 (1157)
|||+|||++ .++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||+|
T Consensus 185 ikp~NIl~~----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il 258 (352)
T 2jii_A 185 VTAENIFVD----PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCM 258 (352)
T ss_dssp CCGGGEEEE----TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHH
T ss_pred CCHHHEEEc----CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHH
Confidence 999999998 555 89999999997543221 12345799999999999864 579999999999999
Q ss_pred HHHHcCCCCCCCCC-hhHHHHHhhh--cCCCCCCC------CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1077 WEIITGEEPYANMH-CGAIIGGILS--NTLRPQIP------ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1077 YELLTGk~PF~g~~-~eeil~~Il~--~~lrpeip------~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
|+|++|+.||.... ....+..... ......+. ..+++++.+||.+||+.||.+|||+.++++.|+.+....
T Consensus 259 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 99999999998764 2222222211 11111111 246899999999999999999999999999999998766
Q ss_pred hh
Q 001103 1148 QT 1149 (1157)
Q Consensus 1148 es 1149 (1157)
..
T Consensus 339 ~~ 340 (352)
T 2jii_A 339 RV 340 (352)
T ss_dssp TC
T ss_pred CC
Confidence 53
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=348.92 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=192.8
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++++.||+|+||.||+|++. |+.||||++.... ........+.++..+++.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~- 95 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG------NKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT- 95 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-
Confidence 4468999999999999999999994 7889999997642 112223445556667888999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
...+++||||+ ++.+..++......+++..++.++.|++.||.|||++ ||+||||||+|||++ .++.+||+||
T Consensus 96 -~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~kl~df 169 (318)
T 2dyl_A 96 -NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDF 169 (318)
T ss_dssp -SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred -CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC----CCCCEEEEEC
Confidence 56899999999 5566666655556799999999999999999999996 999999999999998 6779999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhHHHHHhhhcCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNG---SNNRVSEKVDVYSFGIAMWEIITGEEPYANMH-CGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G---~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~-~eeil~~Il~~~lrp 1105 (1157)
|++.............||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.... ....+..+.... .+
T Consensus 170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~ 248 (318)
T 2dyl_A 170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PP 248 (318)
T ss_dssp TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CC
T ss_pred CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CC
Confidence 99976554444445679999999999853 12457899999999999999999999998744 344444444432 22
Q ss_pred CCC--CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1106 QIP--ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1106 eip--~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.++ ..+++++.+||.+||+.||.+|||+.+++++.+...
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 222 458999999999999999999999999999877644
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=387.12 Aligned_cols=264 Identities=33% Similarity=0.559 Sum_probs=219.7
Q ss_pred ccCCCeeEEE-EecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQ-ELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILr-kLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+...++.+.+ +||+|+||.||+|.++ +..||||+++..... ...+.+.+|+++|++++|||||+++++
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~E~~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------ADTEEMMREAQIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-------TTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4455676666 8999999999999873 445999998764211 114678899999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.. ..+++|||||.+|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||
T Consensus 405 ~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~----~~~~vkL 477 (613)
T 2ozo_A 405 CQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV----NRHYAKI 477 (613)
T ss_dssp EES---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEE
T ss_pred ecc---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc----CCCcEEE
Confidence 876 358999999999999999987777799999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhc
Q 001103 1027 GDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1027 iDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~ 1101 (1157)
+|||+++...... ......+|+.|+|||++.+. .++.++|||||||+||||++ |+.||.+....++...+..
T Consensus 478 ~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~- 554 (613)
T 2ozo_A 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ- 554 (613)
T ss_dssp CCCSTTTTCC--------------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-
T ss_pred eeccCcccccCCCceeeeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-
Confidence 9999998643321 11223467899999999754 68999999999999999998 9999999888777766654
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesksR 1152 (1157)
..+...+..+++++.+||.+||+.||.+||++.+|++.|..+...+..+..
T Consensus 555 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 555 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 445667888999999999999999999999999999999999887765543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=371.36 Aligned_cols=252 Identities=13% Similarity=0.054 Sum_probs=196.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHH---HHHHhCCCCceeEEe----
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA---HIISNLHHPNVVAFY---- 944 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEI---kILK~L~HPNIVkLy---- 944 (1157)
..+|++.+.||+|+||+||+|++ .|+.||||++.+...... ...+.+.+|+ +++++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-----NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT-----THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch-----HHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 46799999999999999999997 478899999986432221 1246788999 556666899999998
Q ss_pred ---eeeecCCC----------C-----cEEEEEEeecCCcchhhhccccc------cccHHHHHHHHHHHHHHHHHHHHC
Q 001103 945 ---GVVPNGPG----------G-----TMATVTEYMVNGSLRHVLARKDR------ILDRRKKLMLMMDAAFGMEYLHMK 1000 (1157)
Q Consensus 945 ---gvf~de~~----------~-----~LyLVMEYmeGGSL~dlLkr~gr------~L~e~qVlkIa~QLa~ALeYLHSk 1000 (1157)
+++..... + ..|+||||+ +|+|.+++.+.+. .+++..++.++.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 55544211 1 378999999 6799999976432 244588889999999999999999
Q ss_pred CceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCC---------CCCCCchhHHHH
Q 001103 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGS---------NNRVSEKVDVYS 1071 (1157)
Q Consensus 1001 GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~---------~~~yS~KSDIWS 1071 (1157)
||+||||||+|||++ .++.+||+|||+++.... .....+| +.|+|||++.+. ...++.++||||
T Consensus 226 ~ivHrDikp~NIll~----~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 226 GLVHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp TEECSCCCGGGEEEC----TTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred CeecCCCCHHHEEEc----CCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 999999999999998 667999999999986433 2334678 999999999753 015799999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1072 FGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1072 LGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
|||+||||++|+.||...........+.. ....+++++++||.+||+.||.+|||+.+++++.+.-.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999999999987654433333321 23568999999999999999999999999999766543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=385.24 Aligned_cols=260 Identities=34% Similarity=0.573 Sum_probs=221.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+.+...+|++.++||+|+||.||+|++++ ..||||+++.... . .+.+.+|+++|++|+||||+++++++.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~-----~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----S-----PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS----C-----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC----C-----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45666789999999999999999999975 5699999986421 1 256889999999999999999999986
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
+ ..+|||||||.+|+|.+++... +..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 333 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~ 405 (535)
T 2h8h_A 333 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVA 405 (535)
T ss_dssp S---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred e---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc----CCCcEEEc
Confidence 5 4689999999999999999753 35589999999999999999999999999999999999998 66799999
Q ss_pred ecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCC
Q 001103 1028 DFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|||+++...... ......++..|+|||++.+. .++.++|||||||+||||++ |+.||.+....+++..+. ...+
T Consensus 406 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~ 482 (535)
T 2h8h_A 406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 482 (535)
T ss_dssp CTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred ccccceecCCCceecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 999998654322 12334578899999998754 58999999999999999999 999999988877776664 4455
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
...+..+++++.+||.+||+.||.+|||+++|++.|+.+.....
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 56778899999999999999999999999999999988765443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=392.08 Aligned_cols=257 Identities=22% Similarity=0.327 Sum_probs=218.0
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||.||+|++ +|+.||||++.+....... ....+.+|+++|+.++|||||++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~-----~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK-----GEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhH-----HHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 5567899999999999999999998 4778999999865322111 13567889999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
...+|+||||++||+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 256 --~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld----~~g~vKL~D 329 (576)
T 2acx_A 256 --KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD----DHGHIRISD 329 (576)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEECC
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe----CCCCeEEEe
Confidence 568999999999999999887643 3489999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHhhhcCCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC----GAIIGGILSNTLR 1104 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~----eeil~~Il~~~lr 1104 (1157)
||+++...........+||+.|+|||++.+. .++.++|||||||+||||++|+.||..... ..+...+.. .+
T Consensus 330 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~ 405 (576)
T 2acx_A 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VP 405 (576)
T ss_dssp CTTCEECCTTCCEECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CC
T ss_pred cccceecccCccccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--cc
Confidence 9999876555444557899999999999864 578999999999999999999999987542 333333332 34
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRVM 1143 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~L 1143 (1157)
..++..+++++++||.+||+.||.+|| +++++++|.+.-
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 456788999999999999999999999 899999987764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=368.59 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=204.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~- 951 (1157)
..+|++++.||+|+||+||+|++. +..+|+|++..... ...+|+++++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------------~~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------FKNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------------hHHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 357999999999999999999994 45699998865421 1226999999999999999999985422
Q ss_pred ---CCcEEEEEEeecCCcchhhhc--cccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 952 ---GGTMATVTEYMVNGSLRHVLA--RKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 952 ---~~~LyLVMEYmeGGSL~dlLk--r~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
..++++||||+.++.+..+.. ...+.+++..++.++.||+.||+|||++||+||||||+|||++ ...+.+||
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~~kL 183 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLKL 183 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEEE
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc---CCCCcEEE
Confidence 234889999998754443332 2345689999999999999999999999999999999999997 24679999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC----
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT---- 1102 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~---- 1102 (1157)
+|||+++............||+.|+|||++.+. ..++.++|||||||+||||++|+.||.+......+..+....
T Consensus 184 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCCCcccccCCCCCcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999876555555567899999999998764 357999999999999999999999999888766655554310
Q ss_pred -----------CCC------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 -----------LRP------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 -----------lrp------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
... .++..+++++.+||.+||++||.+|||+.++++|.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 000 1234578999999999999999999999999998775
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=352.66 Aligned_cols=256 Identities=24% Similarity=0.329 Sum_probs=207.0
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
...+|++.+.||+|+||+||+|++. |+.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-------KPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-------cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 3579999999999999999999985 7789999986431 122346778999999999999999999987653
Q ss_pred C---CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 P---GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 ~---~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. ....++||||+. ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~----~~~~~kl~ 154 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN----SNCDLKVC 154 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEEC
T ss_pred ccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc----CCCcEEEE
Confidence 1 357899999997 589888865 3589999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccCCc-----------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 001103 1028 DFGLSRIKCNTL-----------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG 1096 (1157)
Q Consensus 1028 DFGLAkl~~~~~-----------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~ 1096 (1157)
|||++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+.
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 233 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999997643221 12235799999999987643 357999999999999999999999999877655444
Q ss_pred HhhhcCCCC------------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1097 GILSNTLRP------------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1097 ~Il~~~lrp------------------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+......+ .....+++++.+||.+||+.||.+|||+.+++++.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 332210000 01235789999999999999999999999999987764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=347.01 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=211.4
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--CCceeEEeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--HPNVVAFYGV 946 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--HPNIVkLygv 946 (1157)
..+...+|++++.||+|+||.||++++. ++.||||++..... .......+.+|+++++++. ||||++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC------CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc------cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3455678999999999999999999884 67799999976421 1233577889999999997 5999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.. ...+++||| +.+++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ + +.+||
T Consensus 97 ~~~--~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~-~~~kL 167 (313)
T 3cek_A 97 EIT--DQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----D-GMLKL 167 (313)
T ss_dssp EEC--SSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----T-TEEEE
T ss_pred eec--CCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----C-CeEEE
Confidence 987 568999999 56889999997643 588999999999999999999999999999999999996 2 68999
Q ss_pred EecCCcccccCCc---ccCCCCCCCcccCcccccCC---------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hH
Q 001103 1027 GDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGS---------NNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-GA 1093 (1157)
Q Consensus 1027 iDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~---------~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~-ee 1093 (1157)
+|||++....... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||..... ..
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 9999997643322 22345799999999998751 13578999999999999999999999987543 34
Q ss_pred HHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1094 IIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1094 il~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.+..+........++...++++.+||.+||+.||.+|||+.+++++.+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 4455555556666777889999999999999999999999999999887543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=360.00 Aligned_cols=256 Identities=16% Similarity=0.199 Sum_probs=205.0
Q ss_pred cccCCCeeEEEEecccCcEEEEEEE-----E--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC---CCce
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGK-----W--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH---HPNV 940 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr-----~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~---HPNI 940 (1157)
.+...+|++.+.||+|+||+||+|. . .++.||||+++... ...+.+|+++++.+. |+||
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~i 129 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------PWEFYIGTQLMERLKPSMQHMF 129 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------HHHHHHHHHHHHHSCGGGGGGB
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------hhHHHHHHHHHHHhhhhhhhhh
Confidence 3456789999999999999999994 2 57789999987541 245677888888887 9999
Q ss_pred eEEeeeeecCCCCcEEEEEEeecCCcchhhhcc----ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecc
Q 001103 941 VAFYGVVPNGPGGTMATVTEYMVNGSLRHVLAR----KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNL 1016 (1157)
Q Consensus 941 VkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr----~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~ 1016 (1157)
+++++++.. .+..|+|||||++|+|.+++.. ..+.+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 130 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 130 MKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp CCEEEEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhheeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 999999987 5678999999999999999975 3456999999999999999999999999999999999999983
Q ss_pred C-------CCCCCeEEEEecCCccccc---CCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 001103 1017 R-------DPQRPICKVGDFGLSRIKC---NTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086 (1157)
Q Consensus 1017 d-------d~e~g~VKLiDFGLAkl~~---~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF 1086 (1157)
+ +...+.+||+|||+|+... ........+||+.|+|||++.+. .++.++|||||||+||||++|+.||
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCcc
Confidence 1 1127899999999996432 33344567899999999999865 5799999999999999999999999
Q ss_pred CCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCC-CCHHHHHHHHHHHHHHH
Q 001103 1087 ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAAR-PSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1087 ~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskR-PSaeELLe~Lr~Lk~aL 1147 (1157)
........ .....+. ....++.+.+++..||+.+|.+| |++.++.+.|..+....
T Consensus 286 ~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 286 VKNEGGEC---KPEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EEEETTEE---EECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCce---eechhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 64332110 0111111 11246789999999999999998 78888888888776654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.48 Aligned_cols=256 Identities=22% Similarity=0.241 Sum_probs=196.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~- 951 (1157)
.+|++.+.||+|+||+||+|++. +..||||++...... ...+.+|++.++.++||||+++++++....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---------RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---------CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---------cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 58999999999999999999985 778999998654211 124557788889999999999999985421
Q ss_pred ----CCcEEEEEEeecCCcchhhhc---cccccccHHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeeccCCCCCC
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLA---RKDRILDRRKKLMLMMDAAFGMEYLH--MKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLk---r~gr~L~e~qVlkIa~QLa~ALeYLH--SkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
..++++||||+.++ |...+. .....+++..++.++.|++.||.||| ++||+||||||+|||++. .++
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE---ADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET---TTT
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC---CCC
Confidence 22488999999874 443332 23456889999999999999999999 999999999999999981 267
Q ss_pred eEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1023 ICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
.+||+|||++.............||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999999876655555567799999999998754 347999999999999999999999999888776665554311
Q ss_pred C------------------------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1103 L------------------------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1103 l------------------------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
. ........++++++||.+||+.||.+|||+.+++++.|.-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 0 01222336789999999999999999999999999987644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=386.00 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=216.5
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||+||+++++ |+.||||++.+...... .....+.+|+++++.++||||+++++++.+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-----KGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhh-----HHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 45578999999999999999999984 77899999986532211 123567899999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
...+|+||||++||+|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 257 --~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~----~~g~vkL 330 (543)
T 3c4z_A 257 --KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVRI 330 (543)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEE
T ss_pred --CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe----CCCCEEE
Confidence 56899999999999999888653 34689999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hhHHHHHhhhc
Q 001103 1027 GDFGLSRIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH----CGAIIGGILSN 1101 (1157)
Q Consensus 1027 iDFGLAkl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~----~eeil~~Il~~ 1101 (1157)
+|||+++...... .....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.... ...+...+...
T Consensus 331 ~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~ 408 (543)
T 3c4z_A 331 SDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408 (543)
T ss_dssp CCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred eecceeeeccCCCcccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence 9999998654433 33456899999999999864 57899999999999999999999998753 34455555544
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHHH
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPS-----FTEITNRLRVM 1143 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~L 1143 (1157)
. ..++..+++++++||.+||++||.+||+ +++|+++.++-
T Consensus 409 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~ 453 (543)
T 3c4z_A 409 A--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453 (543)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred c--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence 3 3467789999999999999999999995 58899887654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.19 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=190.6
Q ss_pred CeeE-EEEecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 876 DLEE-LQELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 876 dYeI-LrkLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
.|++ .++||+|+||+||+|+++ +..||||++..... ...+.+|+.+|+.|+||||+++++++...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----------CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----------CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 4555 357999999999999974 56799999875421 13567899999999999999999999765
Q ss_pred CCCcEEEEEEeecCCcchhhhcccc--------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKD--------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~g--------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
....+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+..++...+
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 57789999999975 7877775321 24899999999999999999999999999999999999964434778
Q ss_pred eEEEEecCCcccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh------
Q 001103 1023 ICKVGDFGLSRIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG------ 1092 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e------ 1092 (1157)
.+||+|||+++..... ......+||+.|+|||++.+. ..++.++|||||||+||+|++|++||.+....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 9999999999865432 223446799999999999864 34799999999999999999999999765431
Q ss_pred ---HHHHHhhhcCCCC------------------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCH
Q 001103 1093 ---AIIGGILSNTLRP------------------------------------QIPERCDPEWRKLMEECWSFNPAARPSF 1133 (1157)
Q Consensus 1093 ---eil~~Il~~~lrp------------------------------------eip~~iSpeLrdLIkrCLqkDPskRPSa 1133 (1157)
..+..+....-.+ ......++.+.+||.+||++||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 2222222110000 0011236788999999999999999999
Q ss_pred HHHHHHHHHHH
Q 001103 1134 TEITNRLRVMS 1144 (1157)
Q Consensus 1134 eELLe~Lr~Lk 1144 (1157)
++++++.|+..
T Consensus 329 ~e~L~hp~f~~ 339 (405)
T 3rgf_A 329 EQAMQDPYFLE 339 (405)
T ss_dssp HHHHTSGGGTS
T ss_pred HHHhcChhhcc
Confidence 99999988754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=367.50 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=205.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC------CCCceeEEee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL------HHPNVVAFYG 945 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L------~HPNIVkLyg 945 (1157)
..+|++++.||+|+||+||+|++. ++.||||+++.. ......+.+|+++++.+ +|+||+++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 468999999999999999999984 678999998753 12235667788888877 5779999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe-
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI- 1023 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~- 1023 (1157)
++.. ...+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..+.
T Consensus 167 ~~~~--~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~----~~~~~ 239 (429)
T 3kvw_A 167 NFTF--RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK----QQGRS 239 (429)
T ss_dssp EEEE--TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES----STTSC
T ss_pred eccc--CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc----cCCCc
Confidence 9987 568999999996 58888886643 4589999999999999999999999999999999999998 4444
Q ss_pred -EEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1024 -CKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1024 -VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||+||||++|++||.+....+.+..+....
T Consensus 240 ~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~ 315 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315 (429)
T ss_dssp CEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ceEEeecccceecCCc--ccccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 999999999764433 2346799999999999865 57999999999999999999999999888766655543210
Q ss_pred CCC---------------------------------------------------------CCCCCCcHHHHHHHHHHhcc
Q 001103 1103 LRP---------------------------------------------------------QIPERCDPEWRKLMEECWSF 1125 (1157)
Q Consensus 1103 lrp---------------------------------------------------------eip~~iSpeLrdLIkrCLqk 1125 (1157)
-.+ .++...++++.+||.+||++
T Consensus 316 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~ 395 (429)
T 3kvw_A 316 GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395 (429)
T ss_dssp CCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred CCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence 000 01223478899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHH
Q 001103 1126 NPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1126 DPskRPSaeELLe~Lr~Lk~ 1145 (1157)
||.+|||+.+++++.|....
T Consensus 396 dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 396 DPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp STTTSCCHHHHHTSTTTC--
T ss_pred ChhhCCCHHHHhCChhhccC
Confidence 99999999999999876544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=365.09 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=192.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|++++.||+|+||.||+|++ .|+.||||++.... ........+.+|+++++.++||||+++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 36899999999999999999987 47789999987531 11223467889999999999999999999986531
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
...+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kL~ 174 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKIL 174 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEEC
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC----CCCCEEEe
Confidence 25689999999 6799998865 4589999999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP-- 1105 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp-- 1105 (1157)
|||+++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+......+
T Consensus 175 DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp C-----------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ecccccccccc--CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999764433 3346799999999998763 357899999999999999999999999887766555543311000
Q ss_pred -------------------C--------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 -------------------Q--------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 -------------------e--------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
. .....++.+.+||.+||+.||.+|||+.+++++.+.-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 0 1134688999999999999999999999999987753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=359.00 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=205.1
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|.+.+.||+|+||+||+|++. |+.||||++.... ..+.....+.+|+.+++.++||||+++++++....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc------cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 368999999999999999999984 7789999987642 11334577889999999999999999999997643
Q ss_pred CC----cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 GG----TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ~~----~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.. .+++||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kL~ 186 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDCELKIL 186 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEEC
T ss_pred CcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC----CCCCEEEE
Confidence 21 2499999997 58877774 3389999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP-- 1105 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp-- 1105 (1157)
|||+++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+.+..+......+
T Consensus 187 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 187 DFGLARHADAE--MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCcccccccC--cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999765433 3346799999999999763 357899999999999999999999999887766655553311100
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 ---------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 ---------------------------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.....+++++++||.+||+.||.+|||+.+++++.+.-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 11235689999999999999999999999999998763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=348.78 Aligned_cols=257 Identities=18% Similarity=0.204 Sum_probs=203.8
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--C-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc------eeE
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--G-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN------VVA 942 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--G-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN------IVk 942 (1157)
....+|++++.||+|+||+||+|++. + ..||||+++.. ......+.+|+.+++.+.|++ ++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---------GKYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---------ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 44579999999999999999999984 3 57999998753 122466778999999997665 899
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC---
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD--- 1018 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd--- 1018 (1157)
+++++.. .+.+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 87 ~~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 87 MSDWFNF--HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred eeeeeee--CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 9999887 56899999999 55666665543 35689999999999999999999999999999999999995321
Q ss_pred ------------CCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 001103 1019 ------------PQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY 1086 (1157)
Q Consensus 1019 ------------~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF 1086 (1157)
...+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||+||+|++|+.||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCC
Confidence 15678999999999764433 2346799999999999854 5789999999999999999999999
Q ss_pred CCCChhHHHHHhhhcCCCC------------------------------------------CCCCCCcHHHHHHHHHHhc
Q 001103 1087 ANMHCGAIIGGILSNTLRP------------------------------------------QIPERCDPEWRKLMEECWS 1124 (1157)
Q Consensus 1087 ~g~~~eeil~~Il~~~lrp------------------------------------------eip~~iSpeLrdLIkrCLq 1124 (1157)
........+..+....... ......++++.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 9877655444332211000 0011124578999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHH
Q 001103 1125 FNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1125 kDPskRPSaeELLe~Lr~Lk 1144 (1157)
.||.+|||+.+++++.+...
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGG
T ss_pred CChhhCcCHHHHhcChhhcC
Confidence 99999999999999877643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=349.08 Aligned_cols=263 Identities=22% Similarity=0.400 Sum_probs=188.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHH-HHHhCCCCceeEEeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH-IISNLHHPNVVAFYGV 946 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIk-ILK~L~HPNIVkLygv 946 (1157)
+.+...+|++++.||+|+||.||+|+++ ++.||||+++... . ......+.+|+. +++.++||||++++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~---~~~~~~~~~e~~~~~~~~~h~niv~~~~~ 89 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----D---EKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----C---HHHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----C---chHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence 3456689999999999999999999995 7889999997642 1 112344555655 6777899999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhcc----ccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCC
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLAR----KDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQR 1021 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr----~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~ 1021 (1157)
+.. .+..++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++ .+
T Consensus 90 ~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~----~~ 162 (327)
T 3aln_A 90 LFR--EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD----RS 162 (327)
T ss_dssp EEC--SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE----TT
T ss_pred EEe--CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc----CC
Confidence 987 5689999999986 77777653 245689999999999999999999999 999999999999998 77
Q ss_pred CeEEEEecCCcccccCCcccCCCCCCCcccCcccccC--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHh
Q 001103 1022 PICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNG--SNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGI 1098 (1157)
Q Consensus 1022 g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G--~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~I 1098 (1157)
+.+||+|||++.............||+.|+|||++.+ ....++.++|||||||++|+|++|+.||...... ..+..+
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (327)
T 3aln_A 163 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242 (327)
T ss_dssp TEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC
T ss_pred CCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH
Confidence 8999999999986655444444579999999999842 1235789999999999999999999999875432 222222
Q ss_pred hhcCC---CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1099 LSNTL---RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1099 l~~~l---rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
..... .......+++.+.+||.+||+.||.+|||+.+++++.+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 22211 1122346899999999999999999999999999998876654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.39 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=205.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|.+.+.||+|+||.||+|+++ |+.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 368999999999999999999984 7789999987642 11334567889999999999999999999987643
Q ss_pred C----CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 G----GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ~----~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
. ..+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~----~~~~~kl~ 168 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDCELKIL 168 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTCCEEEC
T ss_pred ccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC----CCCcEEEe
Confidence 2 23599999997 588887743 489999999999999999999999999999999999998 67799999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-----
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT----- 1102 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~----- 1102 (1157)
|||++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..+....
T Consensus 169 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 169 DFGLARHADAE--MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred ecccccCCCCC--ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999764433 2345799999999998753 357899999999999999999999999877665554443210
Q ss_pred ---------------------CC---CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1103 ---------------------LR---PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1103 ---------------------lr---peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.+ ......+++++++||.+||+.||.+|||+.+++++.+.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 01 123346789999999999999999999999999988753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=384.57 Aligned_cols=250 Identities=31% Similarity=0.540 Sum_probs=209.2
Q ss_pred EEecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 881 QELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
++||+|+||+||+|.+. +..||||+++..... ....+.+.+|+++|++|+|||||++++++.. ..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~ 445 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------PALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWM 445 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC------GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEE
Confidence 57999999999999762 456999999864211 1224678899999999999999999999865 3588
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
+|||||.+|+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+++...
T Consensus 446 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~----~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEECCTTHHHHTT
T ss_pred EEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe----CCCCEEEEEcCCccccc
Confidence 999999999999999654 4589999999999999999999999999999999999999 67799999999997643
Q ss_pred CCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1037 NTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1037 ~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
... ......+|+.|+|||++.+. .++.++|||||||+||||++ |+.||.+.....+...+.. ..+...+..+
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~ 597 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGC 597 (635)
T ss_dssp C-------------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTC
T ss_pred cCccccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCC
Confidence 322 12234578899999999754 68999999999999999998 9999999888777666654 4456678889
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
++++.+||.+||+.||.+||++.+|++.|+.+...+
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.52 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=181.6
Q ss_pred CCCeeEEE-EecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 874 DSDLEELQ-ELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILr-kLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
..+|++++ .||+|+||+||+|+++ ++.||||++.... ....+....++.+.||||+++++++...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------------KARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------------HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------------HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 46899966 5999999999999995 7889999987531 1112233346777999999999998652
Q ss_pred --CCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 --PGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 --~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
....+++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+.+||+
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~-~~~~~kl~ 173 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE-KDAVLKLT 173 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCCEEEC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC-CCceEEEe
Confidence 2346899999999999999997653 4699999999999999999999999999999999999998433 45679999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH----Hhhhc--
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG----GILSN-- 1101 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~----~Il~~-- 1101 (1157)
|||++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .+...
T Consensus 174 Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 174 DFGFAKETTQNA-LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp CCTTCEEC-----------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccccceeccccc-cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 999997654332 2345789999999998754 57889999999999999999999997665443321 11111
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+......+++++++||.+||+.||.+|||+.+++++.|...
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 1222333568999999999999999999999999999988754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=354.67 Aligned_cols=259 Identities=19% Similarity=0.264 Sum_probs=203.3
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-----------CC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-----------HP 938 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-----------HP 938 (1157)
+...+|++++.||+|+||+||+|++ .++.||||++... ......+.+|+++++++. ||
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---------ccchhhhhHHHHHHHHhhcccccchhccccc
Confidence 4567999999999999999999998 4778999998753 122456778999998886 89
Q ss_pred ceeEEeeeeecCC--CCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceee
Q 001103 939 NVVAFYGVVPNGP--GGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLV 1014 (1157)
Q Consensus 939 NIVkLygvf~de~--~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILL 1014 (1157)
||+++++++.... ...+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEE
Confidence 9999999987532 23789999999 88999998763 34589999999999999999999998 99999999999999
Q ss_pred ccCC--CCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-
Q 001103 1015 NLRD--PQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC- 1091 (1157)
Q Consensus 1015 d~dd--~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~- 1091 (1157)
+.++ ...+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||+||+|++|+.||.....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 6332 24458999999999765433 2335799999999999864 578999999999999999999999986542
Q ss_pred -----hHHHHHhhhc--C--------------------------------------CCCCCCCCCcHHHHHHHHHHhccC
Q 001103 1092 -----GAIIGGILSN--T--------------------------------------LRPQIPERCDPEWRKLMEECWSFN 1126 (1157)
Q Consensus 1092 -----eeil~~Il~~--~--------------------------------------lrpeip~~iSpeLrdLIkrCLqkD 1126 (1157)
...+..+... . ....++..+++++.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence 1222222110 0 011233445678999999999999
Q ss_pred CCCCCCHHHHHHHHHHHH
Q 001103 1127 PAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1127 PskRPSaeELLe~Lr~Lk 1144 (1157)
|.+|||+.+++++.+...
T Consensus 322 P~~Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 322 PRKRADAGGLVNHPWLKD 339 (373)
T ss_dssp TTTCBCHHHHHTCGGGTT
T ss_pred ccccCCHHHHhhChhhhc
Confidence 999999999999887643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=353.17 Aligned_cols=251 Identities=20% Similarity=0.232 Sum_probs=203.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CC-----ceeEEee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HP-----NVVAFYG 945 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HP-----NIVkLyg 945 (1157)
..+|++++.||+|+||+||+|++. ++.||||+++.. ......+.+|+.+++.+. |+ +|+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---------HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 478999999999999999999984 677999998753 123456778888888885 54 4999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeeccCCCCCC
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLH--MKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLH--SkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
++.. ...+|+||||+.+ +|.+++.... +.+++..++.++.|++.||.||| ++||+||||||+|||++.+ ..+
T Consensus 124 ~~~~--~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~--~~~ 198 (382)
T 2vx3_A 124 HFMF--RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP--KRS 198 (382)
T ss_dssp EEEE--TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST--TSC
T ss_pred eecc--CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC--CCC
Confidence 9987 5689999999965 9999887643 55899999999999999999999 5799999999999999621 467
Q ss_pred eEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC
Q 001103 1023 ICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~ 1102 (1157)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+......+..+....
T Consensus 199 ~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274 (382)
T ss_dssp CEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cEEEEeccCceecccc--cccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 8999999999865433 2346799999999999865 57999999999999999999999999888776665554321
Q ss_pred CCCC----------------CCC----------------------------------------------CCcHHHHHHHH
Q 001103 1103 LRPQ----------------IPE----------------------------------------------RCDPEWRKLME 1120 (1157)
Q Consensus 1103 lrpe----------------ip~----------------------------------------------~iSpeLrdLIk 1120 (1157)
..+. ++. ..++++++||.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 0000 000 00147899999
Q ss_pred HHhccCCCCCCCHHHHHHHHHH
Q 001103 1121 ECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1121 rCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+||++||++|||+.+++++.|.
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGG
T ss_pred HhcCCChhhCCCHHHHhcCccc
Confidence 9999999999999999998775
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=368.06 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=208.9
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC-ceeEEeeeeec
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP-NVVAFYGVVPN 949 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP-NIVkLygvf~d 949 (1157)
...+|+++++||+|+||.||+|++. +..||||++...... ..+.+|+++++.|.|+ +|+.+..++..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----------CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4578999999999999999999984 788999988764221 2367899999999874 45555555444
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
....+|||||+ +++|.+++....+.+++..++.++.||+.||+|||++|||||||||+||||+.++ ..+.+||+||
T Consensus 75 --~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DF 150 (483)
T 3sv0_A 75 --GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDF 150 (483)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTTCEEECCC
T ss_pred --CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCC-CCCeEEEEeC
Confidence 56889999999 8999999987667799999999999999999999999999999999999994222 6679999999
Q ss_pred CCcccccCCcc--------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---HHHHHh
Q 001103 1030 GLSRIKCNTLV--------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGI 1098 (1157)
Q Consensus 1030 GLAkl~~~~~~--------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---eil~~I 1098 (1157)
|+++....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.... ..+..+
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 99986543321 2256799999999999864 5799999999999999999999999875542 223333
Q ss_pred hhcCC---CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1099 LSNTL---RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1099 l~~~l---rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
..... ...++..+++++.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 22211 11233567899999999999999999999999999999987643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=376.74 Aligned_cols=258 Identities=31% Similarity=0.583 Sum_probs=217.1
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+...+|++.+.||+|+||+||+|++. +..||||+++... .....+.+.+|+.++++++||||++++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 44578999999999999999999984 2358998876431 12345778999999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.+ +.+++||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||
T Consensus 460 ~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~----~~~~vkL 532 (656)
T 2j0j_A 460 ITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKL 532 (656)
T ss_dssp ECS---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEE
T ss_pred Eec---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe----CCCCEEE
Confidence 854 358999999999999999987666789999999999999999999999999999999999998 6779999
Q ss_pred EecCCcccccCCcc--cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCC
Q 001103 1027 GDFGLSRIKCNTLV--SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~--sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~l 1103 (1157)
+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+......+..+... .
T Consensus 533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~ 609 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-E 609 (656)
T ss_dssp CCCCCCCSCCC----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-C
T ss_pred EecCCCeecCCCcceeccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-C
Confidence 99999986543322 2234578899999999754 67999999999999999997 99999998887777766554 3
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
+..++..+++.+.+||.+||+.||.+|||+.+|++.|..+...
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 4457788999999999999999999999999999999988754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=340.09 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=198.3
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC----CCCceeEEeeee
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL----HHPNVVAFYGVV 947 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L----~HPNIVkLygvf 947 (1157)
..+|++.+.||+|+||.||+|++ .++.||||++.......... ......+.+|+.+++++ +||||+++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP--LSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccccc--chhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 46899999999999999999988 46789999997653321111 11123456789999998 899999999998
Q ss_pred ecCCCCcEEEEEEe-ecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEY-MVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEY-meGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.. .+..++|||| +.+++|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||
T Consensus 108 ~~--~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~kl 181 (312)
T 2iwi_A 108 ET--QEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID---LRRGCAKL 181 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE---TTTTEEEE
T ss_pred ec--CCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe---CCCCeEEE
Confidence 77 5578999999 78999999997643 589999999999999999999999999999999999997 24568999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
+|||++....... .....||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.... . +... ...
T Consensus 182 ~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~~--~~~ 251 (312)
T 2iwi_A 182 IDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQ-YHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILEA--ELH 251 (312)
T ss_dssp CCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHT--CCC
T ss_pred EEcchhhhcccCc-ccccCCcccccCceeeecCC-CCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhhh--ccC
Confidence 9999998655433 33467999999999987542 23568999999999999999999997532 1 2222 234
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
++..+++++++||.+||+.||.+|||+.+++++.+.
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 667789999999999999999999999999997664
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=344.54 Aligned_cols=253 Identities=21% Similarity=0.320 Sum_probs=205.5
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--CCceeEEeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--HPNVVAFYGVV 947 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--HPNIVkLygvf 947 (1157)
....+|++.+.||+|+||.||+|++ .++.||||+++.......... .....+.+|+.+++++. ||||+++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh--hhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3457899999999999999999988 477899999987543221000 01134567999999996 59999999999
Q ss_pred ecCCCCcEEEEEEeecC-CcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 948 PNGPGGTMATVTEYMVN-GSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeG-GSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.. .+..++|||++.+ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ ...+.+||
T Consensus 118 ~~--~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~kL 191 (320)
T 3a99_A 118 ER--PDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID---LNRGELKL 191 (320)
T ss_dssp EC--SSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTTEEEE
T ss_pred ec--CCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe---CCCCCEEE
Confidence 87 5689999999986 8999998754 4589999999999999999999999999999999999997 24578999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe 1106 (1157)
+|||++....... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.... . +... ...
T Consensus 192 ~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~~~--~~~ 261 (320)
T 3a99_A 192 IDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRG--QVF 261 (320)
T ss_dssp CCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHC--CCC
T ss_pred eeCcccccccccc-ccCCCCCccCCChHHhccCC-CCCccchHHhHHHHHHHHHHCCCCCCChh--h----hhcc--ccc
Confidence 9999998655433 33467999999999987542 24788999999999999999999997532 1 1222 223
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
++..+++++.+||.+||+.||.+|||+.+++++.+.
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 566789999999999999999999999999997654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=362.43 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=198.1
Q ss_pred cccccCCCeeEEEEecccCcEEE-EEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeee
Q 001103 869 LQIIKDSDLEELQELGSGTFGTV-YRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGV 946 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtV-YlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygv 946 (1157)
...+...+|++.+.||+|+||+| |++..+++.||||++..... ..+.+|+++|+.+ +|||||+++++
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----------~~~~~E~~~l~~l~~HpnIv~l~~~ 86 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----------SFADREVQLLRESDEHPNVIRYFCT 86 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----------EECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----------HHHHHHHHHHHhccCCCCcCeEEEE
Confidence 34455668999999999999985 45666889999999875421 1245799999999 79999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-CCCCeEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICK 1025 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd-~e~g~VK 1025 (1157)
+.+ ...+|+|||||. |+|.+++......+.+..++.++.||+.||.|||++||+||||||+|||++.++ .....+|
T Consensus 87 ~~~--~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~k 163 (432)
T 3p23_A 87 EKD--RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAM 163 (432)
T ss_dssp EEE--TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred Eec--CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEE
Confidence 887 668999999996 599999977665566666788999999999999999999999999999996432 1345688
Q ss_pred EEecCCcccccCC----cccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhh
Q 001103 1026 VGDFGLSRIKCNT----LVSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1026 LiDFGLAkl~~~~----~~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il 1099 (1157)
|+|||+++..... ......+||+.|+|||++.+. ...++.++|||||||++|||++ |..||...........+.
T Consensus 164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~ 243 (432)
T 3p23_A 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243 (432)
T ss_dssp ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT
T ss_pred EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc
Confidence 9999999865432 223446799999999999742 2456889999999999999999 999997655443322222
Q ss_pred hcCCCCC-CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1100 SNTLRPQ-IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1100 ~~~lrpe-ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
....... .+...+..+++||.+||+.||.+|||+.+++++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 1111111 122345668999999999999999999999987543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=351.17 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=190.7
Q ss_pred CCCeeEEEEecccCcEEEEEE-EECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRG-KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlA-r~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~ 951 (1157)
...|.+.+.||+|+||+||.+ ..+|+.||||++.... .+.+.+|+++++++ +|||||++++++.+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-- 80 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----------CDIALMEIKLLTESDDHPNVIRYYCSETT-- 80 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC--
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----------HHHHHHHHHHHHhccCCCCcCeEEEEEec--
Confidence 345667789999999999754 4478999999987531 24567899999876 89999999999887
Q ss_pred CCcEEEEEEeecCCcchhhhcccccc------ccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-------
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRI------LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD------- 1018 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~------L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd------- 1018 (1157)
...+|+|||||. |+|.+++...... ..+..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc
Confidence 568999999996 5999999764321 12234577999999999999999999999999999997431
Q ss_pred --CCCCeEEEEecCCcccccCCc-----ccCCCCCCCcccCcccccCC-----CCCCCchhHHHHHHHHHHHHHc-CCCC
Q 001103 1019 --PQRPICKVGDFGLSRIKCNTL-----VSGGVRGTLPWMAPELLNGS-----NNRVSEKVDVYSFGIAMWEIIT-GEEP 1085 (1157)
Q Consensus 1019 --~e~g~VKLiDFGLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~-----~~~yS~KSDIWSLGVILYELLT-Gk~P 1085 (1157)
.....+||+|||+++...... .....+||+.|+|||++.+. ...++.++|||||||++|||++ |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 245689999999998654332 12345799999999999752 2468999999999999999999 9999
Q ss_pred CCCCChhHHHHHhhhcCCCCC-C----CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1086 YANMHCGAIIGGILSNTLRPQ-I----PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1086 F~g~~~eeil~~Il~~~lrpe-i----p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
|....... ..+........ . ...+++++++||.+||+.||.+|||+.+++++.+.
T Consensus 240 f~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 240 FGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp TCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 97654332 22322222211 1 12346789999999999999999999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.05 Aligned_cols=233 Identities=24% Similarity=0.359 Sum_probs=185.5
Q ss_pred CCeeEE-EEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHH-HhCCCCceeEEeeeeec-
Q 001103 875 SDLEEL-QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII-SNLHHPNVVAFYGVVPN- 949 (1157)
Q Consensus 875 sdYeIL-rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkIL-K~L~HPNIVkLygvf~d- 949 (1157)
.+|.++ +.||+|+||.||++++ .+..||||+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 478887 7799999999999998 4778999998753 3456788887 56699999999999864
Q ss_pred -CCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 950 -GPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 950 -e~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.....+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~kl~ 162 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLT 162 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEEC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC-CCCcEEEe
Confidence 22457899999999999999997643 4699999999999999999999999999999999999998332 36789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC--C
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--P 1105 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--p 1105 (1157)
|||++..... ..++.++|||||||++|+|++|+.||...........+...... .
T Consensus 163 Dfg~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 163 DFGFAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp CCTTCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred cccccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 9999854211 24678999999999999999999999876554433222211111 1
Q ss_pred CCC----CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1106 QIP----ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1106 eip----~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
.++ ..+++++++||.+||+.||.+|||+.+++++.+...
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 122 467999999999999999999999999999988754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.81 Aligned_cols=234 Identities=12% Similarity=0.087 Sum_probs=188.9
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+...+|++++.||+|+||.||+|++. ++.||||++...... .......+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-----PDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-----CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 34468999999999999999999995 788999998765221 12345778899999999999999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+..|+||||++|++|.+++++. .....+..++.||+.||+|||++||+||||||+|||++ .++.+||+++
T Consensus 103 --~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~----~~g~~kl~~~ 173 (286)
T 3uqc_A 103 --RAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS----IDGDVVLAYP 173 (286)
T ss_dssp --TTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----TTSCEEECSC
T ss_pred --CCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc----CCCCEEEEec
Confidence 56899999999999999999542 34556888999999999999999999999999999998 6778998744
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHH---HhhhcCCCC-
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIG---GILSNTLRP- 1105 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~---~Il~~~lrp- 1105 (1157)
+ |++ .++.++|||||||+||+|++|+.||.+......+. .........
T Consensus 174 ~-------------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T 3uqc_A 174 A-------------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225 (286)
T ss_dssp C-------------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred c-------------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence 3 333 25889999999999999999999998765433221 111111111
Q ss_pred -CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1106 -QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1106 -eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
.+...+++++++||.+||++||.+| |+.++++.|..+.....
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 2345689999999999999999999 99999999998875544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.04 Aligned_cols=254 Identities=17% Similarity=0.173 Sum_probs=189.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC---------CCceeEEe
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH---------HPNVVAFY 944 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~---------HPNIVkLy 944 (1157)
..+|++++.||+|+||+||+|+++|+.||||+++...............+.+.+|+.+++.|+ |||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 357888999999999999999999999999999876322111111112356778998888886 66666665
Q ss_pred eee-----------------ec-----------CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHH
Q 001103 945 GVV-----------------PN-----------GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996 (1157)
Q Consensus 945 gvf-----------------~d-----------e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeY 996 (1157)
+.+ .+ .....+|+|||||.+|++.+.+.+ +.+++..++.++.||+.||.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence 543 22 014689999999999987777644 458999999999999999999
Q ss_pred HH-HCCceeccCCccceeeccCCC----------------CCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCC
Q 001103 997 LH-MKNIVHFDLKCDNLLVNLRDP----------------QRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGS 1059 (1157)
Q Consensus 997 LH-SkGIIHRDLKPENILLd~dd~----------------e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~ 1059 (1157)
|| ++||+||||||+|||++.++. ....+||+|||+|+..... ..+||+.|+|||++.+.
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCC
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCC
Confidence 99 999999999999999983321 1128999999999865443 24699999999999865
Q ss_pred CCCCCchhHHHHHHHH-HHHHHcCCCCCCCCCh-hHHHHHhhhc-CCCC----CCCCCCcHHHHHHHHHHhccCCCCCCC
Q 001103 1060 NNRVSEKVDVYSFGIA-MWEIITGEEPYANMHC-GAIIGGILSN-TLRP----QIPERCDPEWRKLMEECWSFNPAARPS 1132 (1157)
Q Consensus 1060 ~~~yS~KSDIWSLGVI-LYELLTGk~PF~g~~~-eeil~~Il~~-~lrp----eip~~iSpeLrdLIkrCLqkDPskRPS 1132 (1157)
. +.++||||||++ .++++.|..||..... ......+... .... ..+..+++++++||.+||++| |
T Consensus 253 ~---~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 253 G---DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp S---SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred C---ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 2 889999998777 7888889999864321 1122222211 1111 112346889999999999977 9
Q ss_pred HHHHH-HHHH
Q 001103 1133 FTEIT-NRLR 1141 (1157)
Q Consensus 1133 aeELL-e~Lr 1141 (1157)
+++++ +|.+
T Consensus 325 a~e~l~~Hp~ 334 (336)
T 2vuw_A 325 ATDLLCQHSL 334 (336)
T ss_dssp HHHHHHHCGG
T ss_pred HHHHHhcCCC
Confidence 99999 8765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=342.71 Aligned_cols=248 Identities=15% Similarity=0.063 Sum_probs=186.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC-Ccee----------
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH-PNVV---------- 941 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H-PNIV---------- 941 (1157)
..|...+.||+|+||+||+|++. |+.||||+++...... ....+.+.+|+.+++.+.| ++..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~-----~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-----SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc-----HHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 35788899999999999999985 8889999987432111 1224668899999999977 2111
Q ss_pred -----------EEeeeeecCC---CCcEEEEEEeecCCcchhhhc------cccccccHHHHHHHHHHHHHHHHHHHHCC
Q 001103 942 -----------AFYGVVPNGP---GGTMATVTEYMVNGSLRHVLA------RKDRILDRRKKLMLMMDAAFGMEYLHMKN 1001 (1157)
Q Consensus 942 -----------kLygvf~de~---~~~LyLVMEYmeGGSL~dlLk------r~gr~L~e~qVlkIa~QLa~ALeYLHSkG 1001 (1157)
.++.++.... ...++++|+++ +++|.+++. ...+.+++..++.++.||+.||+|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 1111111111 22456777765 679998884 33566888999999999999999999999
Q ss_pred ceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccC--------CCCCCCchhHHHHHH
Q 001103 1002 IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNG--------SNNRVSEKVDVYSFG 1073 (1157)
Q Consensus 1002 IIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G--------~~~~yS~KSDIWSLG 1073 (1157)
|+||||||+|||++ .++.+||+|||+++..... ....+| +.|+|||++.+ ....++.++||||||
T Consensus 232 iiHrDiKp~NILl~----~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 LVHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp EECSCCCGGGEEEC----TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred cccCCcccceEEEe----cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 99999999999998 6678999999998765443 344678 99999999831 123578899999999
Q ss_pred HHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1074 IAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1074 VILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
|+||||++|+.||...........+.. ....+++++++||.+||+.||.+||++.+++++.+
T Consensus 305 vil~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~ 366 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 999999999999987665443333322 12357899999999999999999999999988643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=356.90 Aligned_cols=244 Identities=19% Similarity=0.248 Sum_probs=193.3
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC---CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k---Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
+...+|++++.||+|+||+||++++. ++.||||++.... . ......+.+|++++++++|||||++++++.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----D---AEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----C---HHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----C---HHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 44579999999999999999999983 6789999886431 1 223467889999999999999999999987
Q ss_pred cCCCC---cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 949 NGPGG---TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 949 de~~~---~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
..... ..||||||++|++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++ . +.+|
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~-~~~k 221 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----E-EQLK 221 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----S-SCEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----C-CcEE
Confidence 63221 26999999999999988754 589999999999999999999999999999999999997 3 3899
Q ss_pred EEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1026 VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
|+|||+++..... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||.+.... ....
T Consensus 222 l~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~ 286 (681)
T 2pzi_A 222 LIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPE 286 (681)
T ss_dssp ECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCT
T ss_pred EEecccchhcccC---CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcccccc---------cccc
Confidence 9999999865443 346799999999998754 488999999999999999999998752211 0110
Q ss_pred C-CCCCCcHHHHHHHHHHhccCCCCCCC-HHHHHHHHHHHHH
Q 001103 1106 Q-IPERCDPEWRKLMEECWSFNPAARPS-FTEITNRLRVMST 1145 (1157)
Q Consensus 1106 e-ip~~iSpeLrdLIkrCLqkDPskRPS-aeELLe~Lr~Lk~ 1145 (1157)
. .....++.+.+||.+||++||.+||+ ++++...|..+..
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 01123578999999999999999994 6666666665543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=363.28 Aligned_cols=257 Identities=27% Similarity=0.353 Sum_probs=201.5
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec---
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN--- 949 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d--- 949 (1157)
.+|++.+.||+|+||+||+|++ .|..||||+++... .......+.+|++++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-------SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-------CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 6899999999999999999987 47789999886531 12235678899999999999999999998754
Q ss_pred -CCCCcEEEEEEeecCCcchhhhcccc--ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 950 -GPGGTMATVTEYMVNGSLRHVLARKD--RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 950 -e~~~~LyLVMEYmeGGSL~dlLkr~g--r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
......++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ ....+||
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g-~~~~vKL 165 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP-QRLIHKI 165 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS-SSCEEEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC-CceeEEE
Confidence 22557899999999999999997643 3588899999999999999999999999999999999998433 4456999
Q ss_pred EecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHH---------
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGG--------- 1097 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~--------- 1097 (1157)
+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||........+..
T Consensus 166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred cccccccccccccccccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 999999876665555667899999999999754 678999999999999999999999976432211100
Q ss_pred h-----hhcC--------CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1098 I-----LSNT--------LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1098 I-----l~~~--------lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
+ ..+. .+..+...+++.+.+||.+||.+||.+|||+.+++++.+
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 0 0000 011223346788999999999999999999999776544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=299.85 Aligned_cols=192 Identities=16% Similarity=0.060 Sum_probs=134.4
Q ss_pred EEecccCcEEEEEEEE--CCceEEEEEEecccccCC--ChhHHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCCCcE
Q 001103 881 QELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGR--SSEQEWLIKEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r--~~e~e~likqflrEIkILK~L-~HPNIVkLygvf~de~~~~L 955 (1157)
..++.|++|.+..++. .|..||+|++.+...... ..+.+...+.+.+|+++|+++ .|+||+++++++.+ .+.+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEE
Confidence 4577788887776554 688999999987643332 223344567899999999999 79999999999988 6789
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
|||||||+|++|.++|.+.+ .+++. .|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 318 yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~----~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD----ARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC----TTSCEEECCCTTEESC
T ss_pred EEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC----CCCCEEEeecccCeeC
Confidence 99999999999999997654 46654 4789999999999999999999999999998 6789999999999865
Q ss_pred cCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC
Q 001103 1036 CNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP 1085 (1157)
Q Consensus 1036 ~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~P 1085 (1157)
... ....+.+||+.|+|||++.+. +..++|+|++|+++++|.++..|
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAEN---KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCCCccccCceechhhccHHHhCCC---CCCcccccccccchhhhccccch
Confidence 433 234457899999999999864 46779999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-27 Score=275.05 Aligned_cols=189 Identities=16% Similarity=0.179 Sum_probs=148.3
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCcee--EEeeeeecCCCCcEEE
Q 001103 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVV--AFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIV--kLygvf~de~~~~LyL 957 (1157)
.+.||+|+||+||++++.+..+++|+.................+++.+|++++++++||||+ .++++ . ....||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--~--~~~~~l 416 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV--D--LDNKRI 416 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE--E--TTTTEE
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE--e--CCccEE
Confidence 56899999999999988999999998766433222222333456789999999999999999 66655 3 335699
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccccC
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~ 1037 (1157)
||||+++++|.+++.+ ++.++.|++.||+|||++||+||||||+|||++ . .+||+|||+++....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~----~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD----K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----S--SEEECCCTTCEECCC
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----C--eEEEEECccCEECCC
Confidence 9999999999999975 567899999999999999999999999999998 4 899999999987654
Q ss_pred Ccc--------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 001103 1038 TLV--------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYA 1087 (1157)
Q Consensus 1038 ~~~--------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~ 1087 (1157)
... ...++||+.|+|||++.+....|+..+|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 321 23567999999999998643457788999999999999888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=8.2e-21 Score=203.56 Aligned_cols=152 Identities=17% Similarity=0.026 Sum_probs=115.7
Q ss_pred CCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCC--ChhH--------HHHHHHHHHHHHHHHhCCCCceeEE
Q 001103 875 SDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGR--SSEQ--------EWLIKEFWREAHIISNLHHPNVVAF 943 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r--~~e~--------e~likqflrEIkILK~L~HPNIVkL 943 (1157)
..|++.+.||+|+||.||+|++ .|+.||||+++....... .... ......+.+|+.++++++| +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 4567779999999999999999 478899999875321111 0000 1235678899999999984 555
Q ss_pred eeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 944 YGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 944 ygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
++++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++.
T Consensus 167 ~~~~~~---~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-----~~~ 230 (282)
T 1zar_A 167 PKVYAW---EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-----EEG 230 (282)
T ss_dssp CCEEEE---ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-----TTE
T ss_pred CeEEec---cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-----CCc
Confidence 554433 35699999999999988 432 12346899999999999999999999999999997 458
Q ss_pred EEEEecCCcccccCCcccCCCCCCCcccCccccc
Q 001103 1024 CKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLN 1057 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~ 1057 (1157)
+||+|||+|. .+..|.|||++.
T Consensus 231 vkl~DFG~a~------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSV------------EVGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCE------------ETTSTTHHHHHH
T ss_pred EEEEECCCCe------------ECCCCCHHHHHH
Confidence 9999999985 345678999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=188.04 Aligned_cols=143 Identities=15% Similarity=0.068 Sum_probs=106.1
Q ss_pred CeeEEEEecccCcEEEEEEEE--CCce--EEEEEEecccccCCC----------------hhHHHHHHHHHHHHHHHHhC
Q 001103 876 DLEELQELGSGTFGTVYRGKW--RGTD--IAIKRIKKSCFLGRS----------------SEQEWLIKEFWREAHIISNL 935 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~--kGt~--VAVKVIkk~~l~~r~----------------~e~e~likqflrEIkILK~L 935 (1157)
-|++.+.||+|+||.||+|++ .|+. ||||+++........ .........+.+|+.+|+.|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 368899999999999999998 7888 999997654211000 00112234678999999999
Q ss_pred CCCc--eeEEeeeeecCCCCcEEEEEEeecC-C----cchhhhccccccccHHHHHHHHHHHHHHHHHHH-HCCceeccC
Q 001103 936 HHPN--VVAFYGVVPNGPGGTMATVTEYMVN-G----SLRHVLARKDRILDRRKKLMLMMDAAFGMEYLH-MKNIVHFDL 1007 (1157)
Q Consensus 936 ~HPN--IVkLygvf~de~~~~LyLVMEYmeG-G----SL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLH-SkGIIHRDL 1007 (1157)
.|++ ++..++. . ..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| ++||+||||
T Consensus 128 ~~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 8875 3445443 2 45899999943 4 45444322 234567789999999999999 999999999
Q ss_pred CccceeeccCCCCCCeEEEEecCCccc
Q 001103 1008 KCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1008 KPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
||+|||++ . .++|+|||+|..
T Consensus 198 kp~NILl~----~--~~~liDFG~a~~ 218 (258)
T 1zth_A 198 SEYNIMYI----D--KVYFIDMGQAVT 218 (258)
T ss_dssp STTSEEES----S--SEEECCCTTCEE
T ss_pred CHHHEEEc----C--cEEEEECccccc
Confidence 99999997 4 899999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.7e-15 Score=168.67 Aligned_cols=146 Identities=13% Similarity=0.006 Sum_probs=101.3
Q ss_pred CeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCC------------ChhH--HHHHHHHHHHHHHHHhCCCCce
Q 001103 876 DLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGR------------SSEQ--EWLIKEFWREAHIISNLHHPNV 940 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r------------~~e~--e~likqflrEIkILK~L~HPNI 940 (1157)
-|++.+.||+|+||.||+|.. .|+.||||+++......+ .... ........+|...|.+|.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 489999999999999999987 588999999865322111 0000 0011123457777777755443
Q ss_pred e--EEeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC
Q 001103 941 V--AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD 1018 (1157)
Q Consensus 941 V--kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd 1018 (1157)
. ..++. . ..+|||||++|++|..+... + ....++.||+.+|.|||++|||||||||.|||++.++
T Consensus 176 ~vp~p~~~--~----~~~LVME~i~G~~L~~l~~~-----~--~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ--S----RHTIVMSLVDALPMRQVSSV-----P--DPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE--E----TTEEEEECCSCEEGGGCCCC-----S--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCeeeec--c----CceEEEEecCCccHhhhccc-----H--HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 2 23322 2 23799999999998766532 1 2346789999999999999999999999999998432
Q ss_pred CC------CCeEEEEecCCccc
Q 001103 1019 PQ------RPICKVGDFGLSRI 1034 (1157)
Q Consensus 1019 ~e------~g~VKLiDFGLAkl 1034 (1157)
.. ...+.|+||+.+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 10 11488999998754
|
| >2cu1_A Mitogen-activated protein kinase kinase kinase 2; PB1 domain, MAPK/ERK kinase kinase 2, MEK kinase 2, MEKK 2, signaling protein; NMR {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=99.31 E-value=7.2e-12 Score=117.41 Aligned_cols=73 Identities=25% Similarity=0.431 Sum_probs=66.1
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcCCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEeeCC
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVSLG 287 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLFp~~ 287 (1157)
+||+||+.|+|+++|.||..|+...||..+.|.|+ +++.||+++|+|||+..||+|||.. ...-||+||-+..
T Consensus 16 ~GEkRIi~f~RPv~f~eL~~Kv~~~fGq~ldL~y~----n~EllIpl~sQeDLDkaIellDrss---~~kSLrIlL~~~~ 88 (103)
T 2cu1_A 16 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT----NNELVIPLTTQDDLDKAVELLDRSI---HMKSLKILLVING 88 (103)
T ss_dssp TTEEEEEEEESSCCHHHHHHHHHHHHSSCEEEEEC----SSSSCEECCSHHHHHHHHHHHHHCS---SCCSEEEEEEECC
T ss_pred cCeEEEEeccCCccHHHHHHHHHHHhCCeeeEEEe----cceEEEeccCHHHHHHHHHHHccCC---cccceEEEEecCC
Confidence 67899999999999999999999999999999999 9999999999999999999999963 3345888988643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.3e-11 Score=124.01 Aligned_cols=138 Identities=14% Similarity=0.063 Sum_probs=107.9
Q ss_pred CeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCc
Q 001103 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~ 954 (1157)
.|++...++.|+++.||++...+..+++|+...... .. ...+.+|+.+++.|. +..+++++++... .+.
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~-~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~ 84 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK-GT-------TYDVEREKDMMLWLEGKLPVPKVLHFERH--DGW 84 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGT-TS-------TTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccC-CC-------HHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCc
Confidence 578888899999999999988888999999875311 11 124678999999884 6778889988776 567
Q ss_pred EEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 001103 955 MATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM----------------------------------- 999 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS----------------------------------- 999 (1157)
.|+||||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred eEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 8999999999998776421 11234677889999999998
Q ss_pred ------------------------CCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 1000 ------------------------KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 1000 ------------------------kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..++|+|++|.|||++ ....+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK----DGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE----TTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE----CCcEEEEEEchhcc
Confidence 4589999999999997 44456799999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.99 E-value=1.3e-09 Score=110.92 Aligned_cols=132 Identities=19% Similarity=0.099 Sum_probs=92.7
Q ss_pred CeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc--eeEEeeeeecCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN--VVAFYGVVPNGPG 952 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN--IVkLygvf~de~~ 952 (1157)
.+.+....+.|..+.||++... |..+++|+..... ...+.+|+.+++.|.+.+ +++++++... .
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----------LNELQDEAARLSWLATTGVPCAAVLDVVTE--A 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--S
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----------chhhhHHHHHHHHHHhCCCCCCeEEEeccC--C
Confidence 4444333346667999998764 5679999875431 123567888888885433 5668887765 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN------------------------------- 1001 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG------------------------------- 1001 (1157)
+..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 5689999999999884 211 11 1245667777777777643
Q ss_pred ---------------------------ceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 1002 ---------------------------IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 1002 ---------------------------IIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
++|+|++|.|||++ ....+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE----NGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE----TTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE----CCcEEEEEcchhcc
Confidence 99999999999997 44566799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=2e-09 Score=117.32 Aligned_cols=146 Identities=17% Similarity=0.212 Sum_probs=107.0
Q ss_pred eeEEEEecccCcEEEEEEEECCceEEEEEEe--cccccCCChhHHHHHHHHHHHHHHHHhCC--CCceeEEeeeeecCC-
Q 001103 877 LEELQELGSGTFGTVYRGKWRGTDIAIKRIK--KSCFLGRSSEQEWLIKEFWREAHIISNLH--HPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 877 YeILrkLGsGsFGtVYlAr~kGt~VAVKVIk--k~~l~~r~~e~e~likqflrEIkILK~L~--HPNIVkLygvf~de~- 951 (1157)
...++.|+.|.++.||+.+..+..+++|+.. ..... .....+.+|..+++.|. +..+++++.++.+..
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~ 112 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV 112 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred CceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence 3457889999999999998887888888765 32110 01245778999999997 456788888876532
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH--------------------------------
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-------------------------------- 999 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-------------------------------- 999 (1157)
.+..|+||||++|..+.+... ..++......++.+++..|..||+
T Consensus 113 ~g~~~~vme~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 113 IGRAFYIMEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp TSSCEEEEECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 146789999999988854221 225677788889999999999997
Q ss_pred --------------------------CCceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 1000 --------------------------KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1000 --------------------------kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
..++|+|++|.|||++.++ ...+.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~--~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE--PRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS--SCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC--CcEEEEECcccccc
Confidence 3599999999999998322 13579999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=4.8e-09 Score=111.99 Aligned_cols=190 Identities=17% Similarity=0.128 Sum_probs=120.1
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCc--eeEEeeeeecCC-CCcE
Q 001103 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPN--VVAFYGVVPNGP-GGTM 955 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPN--IVkLygvf~de~-~~~L 955 (1157)
++.++.|.+..||+.. ..+++|+.... .....+.+|..+|+.|. +.. +++.+....... ....
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 4569999999999764 56888875431 22466888999998883 322 445555433211 1245
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM------------------------------------ 999 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS------------------------------------ 999 (1157)
|+||++++|.+|..... ..++..+...++.+++..|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred eEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 88999999988865332 235666677778888888888885
Q ss_pred ----------------------CCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCccccc
Q 001103 1000 ----------------------KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLN 1057 (1157)
Q Consensus 1000 ----------------------kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~ 1057 (1157)
..++|+|++|.|||++.+ ....+.|+||+.+.................-..|+...
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~--~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE--KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT--TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC--CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence 137999999999999821 14568899999987543221110000000002222211
Q ss_pred C---CCC---------CCCchhHHHHHHHHHHHHHcCCCCCC
Q 001103 1058 G---SNN---------RVSEKVDVYSFGIAMWEIITGEEPYA 1087 (1157)
Q Consensus 1058 G---~~~---------~yS~KSDIWSLGVILYELLTGk~PF~ 1087 (1157)
. ... ......+.|+++.++|.+.+|..+|.
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 000 01223689999999999999988763
|
| >1vd2_A Protein kinase C, IOTA type; PB1 domain, OPCA motif, APKC, ZIP/P62, MEK5, molecular recognition, transferase; NMR {Homo sapiens} SCOP: d.15.2.2 PDB: 1wmh_A | Back alignment and structure |
|---|
Probab=98.32 E-value=3.9e-06 Score=78.07 Aligned_cols=82 Identities=20% Similarity=0.363 Sum_probs=70.4
Q ss_pred CCCcEEEEeecCCccccCCCCCCceeecCceEEEEccCCCCHHHHHHHHHhhcC----CCceEEEeCCCCCCCcEEeecC
Q 001103 181 FTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICN----QPHTIKYQLPGEDLDALISVCS 256 (1157)
Q Consensus 181 ~~~~vklmcSyGG~I~pr~~d~~l~YvGG~triv~v~r~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LisV~~ 256 (1157)
+++.||+-..|+|. .|++.|+.+++|.+|..|+.++|+ .++++||- .|| ..+|++++
T Consensus 3 ~~~~vkvK~~~~gd----------------i~~~~v~~~i~~~~L~~kv~~~~~~~~~~~f~lky~--DEe-GD~itisS 63 (89)
T 1vd2_A 3 LGSQVRVKAYYRGD----------------IMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEE-GDPCTVSS 63 (89)
T ss_dssp CSSCEEEEEESSSC----------------EEEEEECTTCCHHHHHHHHHHHTTCCSSCCEEEEEC--CSS-SCCEECCS
T ss_pred CCCeEEEEEEeCCe----------------EEEEECCCCCCHHHHHHHHHHHhCCCCCCeEEEEEE--CCC-CCcccccC
Confidence 34567777777665 789999999999999999999997 46999998 776 89999999
Q ss_pred hhHHHHHHHHHHHhhhcCCCCeEEEEEee
Q 001103 257 DEDLHHMIEEYQEQERIGGSQRLRIFLVS 285 (1157)
Q Consensus 257 DeDL~~m~~eydr~~~~~~~~rlR~FLFp 285 (1157)
|+||+..+.-|.... .+.|.+.+||
T Consensus 64 d~EL~eAl~l~~~n~----~~~l~ihvf~ 88 (89)
T 1vd2_A 64 QLELEEAFRLYELNK----DSELLIHVFP 88 (89)
T ss_dssp HHHHHHHHHHHHHTS----CCCEEEEEEE
T ss_pred HHHHHHHHHHHHccC----CCCEEEEEcc
Confidence 999999999888754 4789999997
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.3e-05 Score=86.68 Aligned_cols=139 Identities=22% Similarity=0.178 Sum_probs=90.1
Q ss_pred EEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC---ceeEEeeeeecCCCCcE
Q 001103 879 ELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP---NVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP---NIVkLygvf~de~~~~L 955 (1157)
-++.++.|....||+. +..+++|+-.. ......+.+|.++|+.|.+. .+++.+.+... ..+..
T Consensus 23 ~v~~l~~G~~n~v~~v---g~~~VlR~~~~----------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~ 88 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV---NGDWVFRFPKS----------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNP 88 (306)
T ss_dssp CEEEEEECSSEEEEEE---TTTEEEEEESS----------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCE
T ss_pred eeeecCCCcceeEEEE---CCEEEEEecCC----------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCce
Confidence 3567899999999987 67889987432 12246788999999999642 35566666542 24567
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-----------------------------------
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK----------------------------------- 1000 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk----------------------------------- 1000 (1157)
++|||+++|..|...... .++......++.++...|..||+.
T Consensus 89 ~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 89 FVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp EEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred EEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 899999999888652110 122223333333333333333321
Q ss_pred -------------------------CceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 1001 -------------------------NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1001 -------------------------GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.++|+|++|.|||++.++.....+.|+||+.+..
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3699999999999983221234568999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=2e-05 Score=85.49 Aligned_cols=88 Identities=9% Similarity=-0.045 Sum_probs=55.9
Q ss_pred eeEEEEe-cccCcEEEEEEEEC--------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-C--CceeEEe
Q 001103 877 LEELQEL-GSGTFGTVYRGKWR--------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-H--PNVVAFY 944 (1157)
Q Consensus 877 YeILrkL-GsGsFGtVYlAr~k--------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-H--PNIVkLy 944 (1157)
...++.| +.|....+|+.... +..+++|+........... ...+.+|..+++.|. + ..+++++
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-----~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-----TYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-----CCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-----hhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 4456788 89999999988765 6678888755432000000 023456777777773 2 3567777
Q ss_pred eeeecCC-CCcEEEEEEeecCCcchh
Q 001103 945 GVVPNGP-GGTMATVTEYMVNGSLRH 969 (1157)
Q Consensus 945 gvf~de~-~~~LyLVMEYmeGGSL~d 969 (1157)
.+..+.. .+..++||||++|..+.+
T Consensus 97 ~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 97 WIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EEccCCCccCCceEEEEecCCCChhh
Confidence 7765421 145689999999877653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=4.7e-05 Score=78.97 Aligned_cols=130 Identities=18% Similarity=0.136 Sum_probs=86.1
Q ss_pred EecccCcE-EEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCcEEE
Q 001103 882 ELGSGTFG-TVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGTMAT 957 (1157)
Q Consensus 882 kLGsGsFG-tVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~LyL 957 (1157)
.+..|..| .||+.... +..+.+|+-... ....+.+|...|+.|. +--+.+++.+..+ .+..++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~l 97 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----------VANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWL 97 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----------CHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEE
Confidence 34445544 68987653 456899976532 1345778999998884 3346678877766 457899
Q ss_pred EEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 001103 958 VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK------------------------------------- 1000 (1157)
Q Consensus 958 VMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk------------------------------------- 1000 (1157)
|||+++|.++.+...... .....+..++...|.-||+.
T Consensus 98 vme~l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEECCCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEeeCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999999988765543211 11122344444455555531
Q ss_pred ---------------------CceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 1001 ---------------------NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 1001 ---------------------GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.++|+|+.+.|||++ ..+.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~----~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD----EGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE----TTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE----CCeEEEEEECcccc
Confidence 169999999999998 45567799999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=5.9e-05 Score=80.06 Aligned_cols=76 Identities=14% Similarity=0.207 Sum_probs=43.0
Q ss_pred eEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--CCceeEEeee-----e-ec
Q 001103 878 EELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--HPNVVAFYGV-----V-PN 949 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--HPNIVkLygv-----f-~d 949 (1157)
..++.|+.|..+.||+....+..+++|+.... . ..+..|..+++.|. .-.+++++.. + ..
T Consensus 35 ~~~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~------~------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~ 102 (346)
T 2q83_A 35 EKIDVIQGNQMALVWKVHTDSGAVCLKRIHRP------E------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH 102 (346)
T ss_dssp CEEEECC----CEEEEEEETTEEEEEEEECSC------H------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE
T ss_pred EEeeeccccccCcEEEEEeCCCCEEEEecCCC------H------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE
Confidence 34567877789999999887667999988642 0 12223444444442 1123333331 1 12
Q ss_pred CCCCcEEEEEEeecCCcc
Q 001103 950 GPGGTMATVTEYMVNGSL 967 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL 967 (1157)
.+..+++|+|++|..+
T Consensus 103 --~~~~~~l~~~i~G~~~ 118 (346)
T 2q83_A 103 --GSFLFVVYDWIEGRPF 118 (346)
T ss_dssp --TTEEEEEEECCCCBCC
T ss_pred --CCEEEEEEEeecCccC
Confidence 4567899999998654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.0002 Score=79.33 Aligned_cols=82 Identities=20% Similarity=0.133 Sum_probs=49.5
Q ss_pred eEEEEecccCcEEEEEEEE--CCceEEEEEEecccc-cCCChhHHHHHHHHHHHHHHHHhCCC--C-ceeEEeeeeecCC
Q 001103 878 EELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCF-LGRSSEQEWLIKEFWREAHIISNLHH--P-NVVAFYGVVPNGP 951 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l-~~r~~e~e~likqflrEIkILK~L~H--P-NIVkLygvf~de~ 951 (1157)
..++.||.|.++.||+++. .+..++||....... .... .......+..|.++|+.+.. | .++++|.+..
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~--~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~--- 107 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES--WPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--- 107 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC---------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET---
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC--CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC---
Confidence 3568899999999999964 457799998653211 0000 00012345678888887732 3 4456665422
Q ss_pred CCcEEEEEEeecCC
Q 001103 952 GGTMATVTEYMVNG 965 (1157)
Q Consensus 952 ~~~LyLVMEYmeGG 965 (1157)
...++|||++.+.
T Consensus 108 -~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 -EMAVTVMEDLSHL 120 (397)
T ss_dssp -TTTEEEECCCTTS
T ss_pred -CccEEEEEeCCCc
Confidence 2357999999874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0037 Score=66.98 Aligned_cols=138 Identities=12% Similarity=0.120 Sum_probs=93.4
Q ss_pred cchhhhccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCC
Q 001103 966 SLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044 (1157)
Q Consensus 966 SL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~ 1044 (1157)
+|.++|...+.++.++++|.++.|.+.+|.-+-. +.-..+=+.|..|++. .+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~----~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW----RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE----TTSCEEECC-C--------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe----cCCceeccc-cccc-----------
Confidence 8999999999999999999999999988876621 1212333456888887 566665542 1110
Q ss_pred CCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhc
Q 001103 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWS 1124 (1157)
Q Consensus 1045 ~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLq 1124 (1157)
.....+.+||... ...+.+.=|||||++||.-+--..| ..-+..+|++|.+||..|..
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHh
Confidence 1233567888764 2347889999999999998863332 23455689999999999986
Q ss_pred c-------------------------CCCCCCCHHHHHHHHH
Q 001103 1125 F-------------------------NPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1125 k-------------------------DPskRPSaeELLe~Lr 1141 (1157)
. .+..|+++++|++...
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 5 2457899999987543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0016 Score=73.09 Aligned_cols=79 Identities=19% Similarity=0.197 Sum_probs=47.0
Q ss_pred HCCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCcccCCCCC--CCcccCcccccCCC-CCCCchhHHHHHHHH
Q 001103 999 MKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRG--TLPWMAPELLNGSN-NRVSEKVDVYSFGIA 1075 (1157)
Q Consensus 999 SkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~G--Tp~YmAPEVL~G~~-~~yS~KSDIWSLGVI 1075 (1157)
...++|+|++|.|||++ .++ ++|+||+.+.............. ...|++|+...... ..-....++..+...
T Consensus 231 ~~~liHGDl~~~Nil~~----~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVT----QDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CCEEECSCCSGGGEEEC----SSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEe----CCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 45799999999999997 333 89999999875332111100111 12356665543110 011234556688888
Q ss_pred HHHHHcC
Q 001103 1076 MWEIITG 1082 (1157)
Q Consensus 1076 LYELLTG 1082 (1157)
+|+++.+
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887765
|
| >2jrh_A Mitogen-activated protein kinase kinase kinase 3; kinase signaling domain, transferase; NMR {Homo sapiens} PDB: 2pph_A | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0029 Score=58.78 Aligned_cols=71 Identities=27% Similarity=0.520 Sum_probs=62.1
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcCCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEee
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVS 285 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLFp 285 (1157)
-||.||+-++|.++|.||..|+...+|..+.+-|- +. .-+|.+.|.|||+.-++..||... ---||+.|-.
T Consensus 12 ~gEKRIi~f~RPvkf~dl~qkv~~afGq~ldl~y~--nn--EL~iPL~~Q~DLDkAvelLDrs~~---mkSLRIlL~~ 82 (94)
T 2jrh_A 12 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NN--ELSILLKNQDDLDKAIDILDRSSS---MKSLRILLLS 82 (94)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHCSSEEEEEE--CS--SCEEECCSHHHHHHHHHHHHHSTT---TTEEEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cc--eeEEeccCHHHHHHHHHHhccCcc---ccceEEEEEc
Confidence 47899999999999999999999999999999998 33 369999999999999999998432 3458999985
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0049 Score=67.89 Aligned_cols=79 Identities=19% Similarity=0.162 Sum_probs=60.6
Q ss_pred CeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC---CCceeEEeeeeecCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH---HPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~---HPNIVkLygvf~de~~ 952 (1157)
....++.|+.|.+..+|+....+..+++|+..... ...+.+|...|+.|. ...+++.+.+... .
T Consensus 37 ~i~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~ 103 (312)
T 3jr1_A 37 FIKHKEKLYSGEMNEIWLINDEVQTVFVKINERSY-----------RSMFRAEADQLALLAKTNSINVPLVYGIGNS--Q 103 (312)
T ss_dssp CCCEEEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--S
T ss_pred ceeeeEEeCCccceeeeEEEECCCeEEEEeCCccc-----------HHHHHHHHHHHHHHHhhCCCCcceEEEEeec--C
Confidence 34457889999999999998777889999865420 345778888888873 3567788877665 4
Q ss_pred CcEEEEEEeecCCcc
Q 001103 953 GTMATVTEYMVNGSL 967 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL 967 (1157)
+..++||||++|..+
T Consensus 104 g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 104 GHSFLLLEALNKSKN 118 (312)
T ss_dssp SEEEEEEECCCCCCC
T ss_pred CceEEEEEeccCCCC
Confidence 678999999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0038 Score=66.58 Aligned_cols=144 Identities=13% Similarity=0.087 Sum_probs=79.3
Q ss_pred CeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCC--ceeEEeeeeec----
Q 001103 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHP--NVVAFYGVVPN---- 949 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HP--NIVkLygvf~d---- 949 (1157)
+...++.|+.|....||+....+..+++|+..... . ...+..|..+++.|... .+++++.....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~--------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~ 92 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--E--------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 92 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--C--------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEE
Confidence 44557888889999999998866678999876520 0 12344567777666321 13333322100
Q ss_pred CCCCcEEEEEEeecCCcchhh--------------hccc----ccc-------ccHHHHHH------------HHHHHHH
Q 001103 950 GPGGTMATVTEYMVNGSLRHV--------------LARK----DRI-------LDRRKKLM------------LMMDAAF 992 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dl--------------Lkr~----gr~-------L~e~qVlk------------Ia~QLa~ 992 (1157)
.-.+..+++|+|++|..+... ++.. ... ..+...+. +...+..
T Consensus 93 ~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~ 172 (322)
T 2ppq_A 93 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 172 (322)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred EECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHH
Confidence 002456899999998654210 1100 000 01111000 0011334
Q ss_pred HHHHHHH-------CCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 993 GMEYLHM-------KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 993 ALeYLHS-------kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+++|.+ .+++|+|+.+.|||++ ....+.|+||+.+.
T Consensus 173 ~~~~l~~~~~~~~~~~liHgDl~~~Nil~~----~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 173 EIDYLAAHWPKDLPAGVIHADLFQDNVFFL----GDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEE----TTEEEEECCCTTCE
T ss_pred HHHHHHhhCcccCCcccCCCCCCccCEEEe----CCceEEEecchhcc
Confidence 5555553 3699999999999997 44455799999875
|
| >2c60_A Human mitogen-activated protein kinase kinase kinase 3 isoform 2; MAP3K3, MAP/ERK kinase kinase 3, MAPKKK3, MEKK3, serine threonine phosphorylation; HET: MSE; 1.25A {Homo sapiens} SCOP: d.15.2.2 PDB: 2o2v_B | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0042 Score=59.03 Aligned_cols=70 Identities=26% Similarity=0.517 Sum_probs=60.5
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcCCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEe
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLF 284 (1157)
-||.||+-++|.++|.||..|+...+|..+.+-|- +. .-+|.+.|.|||+.-++..||... ---||+.|-
T Consensus 39 ~gEKRIiqf~RPvkf~dl~qkv~~afGq~ldl~y~--nn--EL~IPL~~Q~DLDkAvelLDrs~~---mkSLRIlL~ 108 (111)
T 2c60_A 39 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NN--ELSILLKNQDDLDKAIDILDRSSS---MKSLRILLL 108 (111)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--CS--SCEEECCSHHHHHHHHHHHHHCSS---CCSEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cc--eEEEecccHHHHHHHHHHhccCcc---ccceEEEEe
Confidence 36799999999999999999999999999999998 33 368999999999999999998432 235888886
|
| >2npt_B Mitogen-activated protein kinase kinase kinase 2; MAP2K5, MEK5, MKK PRKMK5, MAP kinase kinase 5, PHOX, PHOX-domain; 1.75A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.004 Score=58.48 Aligned_cols=71 Identities=24% Similarity=0.445 Sum_probs=60.9
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcCCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEee
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLVS 285 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLFp 285 (1157)
-||.||+-++|.+.|.||..|+...+|..+.|-|- +. .-+|.+.|.+||+.-|+..||... ---||+.|-.
T Consensus 28 ~gEkRIi~f~RPv~f~el~~kv~~afGq~ldl~y~--nn--EL~iPL~~Q~DLDkAvelLDrs~~---~kSLrIlL~~ 98 (100)
T 2npt_B 28 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--NN--ELVIPLTTQDDLDKAVELLDRSIH---MKSLKILLVI 98 (100)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--ET--TEEEECCCHHHHHHHHHHHHHCSS---CCSEEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cc--eeEEecccHHHHHHHHHHhccCcc---ccceEEEEec
Confidence 36799999999999999999999999999999998 33 368999999999999999998432 2358888863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.01 Score=62.94 Aligned_cols=81 Identities=17% Similarity=0.110 Sum_probs=56.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-C--CceeEEeeeee
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-H--PNVVAFYGVVP 948 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-H--PNIVkLygvf~ 948 (1157)
...+..-++.+|.|..+.||+.+. +|+.|.+|+........ ...+.+|...|+.|. . --+++.+.+..
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~ 84 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--------DGLFRAEALGLDWLGRSFGSPVPQVAGWDD 84 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--------TTHHHHHHHHHHHHTCSTTCCSCCEEEEET
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--------hhHHHHHHHHHHHHHhhCCCCcceEEeccC
Confidence 345677789999999999999998 58889999765431110 134668888888884 2 23556665422
Q ss_pred cCCCCcEEEEEEeecCCcc
Q 001103 949 NGPGGTMATVTEYMVNGSL 967 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL 967 (1157)
-++||||+.++..
T Consensus 85 ------~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 ------RTLAMEWVDERPP 97 (288)
T ss_dssp ------TEEEEECCCCCCC
T ss_pred ------ceEEEEeecccCC
Confidence 3789999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0085 Score=63.91 Aligned_cols=71 Identities=20% Similarity=0.075 Sum_probs=42.8
Q ss_pred EEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCcEEEE
Q 001103 880 LQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGTMATV 958 (1157)
Q Consensus 880 LrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~LyLV 958 (1157)
++.|+.|....+|+. ..+.+|+........ ....+|..+++.+. +.-.++++.+..+ .-+++
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~---------~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~~~v 85 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY---------INRANEAVAAREAAKAGVSPEVLHVDPA----TGVMV 85 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C---------CCHHHHHHHHHHHHHTTSSCCEEEECTT----TCCEE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce---------eCHHHHHHHHHHHHHcCCCCceEEEECC----CCEEE
Confidence 788999999999998 568888776431100 01134666666653 2112566655432 23679
Q ss_pred EEee-cCCcc
Q 001103 959 TEYM-VNGSL 967 (1157)
Q Consensus 959 MEYm-eGGSL 967 (1157)
+||+ +|.+|
T Consensus 86 ~e~i~~g~~l 95 (301)
T 3dxq_A 86 TRYIAGAQTM 95 (301)
T ss_dssp EECCTTCEEC
T ss_pred EeecCCCccC
Confidence 9999 66555
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.01 Score=67.62 Aligned_cols=73 Identities=12% Similarity=0.247 Sum_probs=49.2
Q ss_pred EEEEecccCcEEEEEEEEC---------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeee
Q 001103 879 ELQELGSGTFGTVYRGKWR---------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVP 948 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~k---------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~ 948 (1157)
.++.|+.|....||++... +..+.+|+.... .. ...+.+|..+++.|. +.-.+++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~------~~~li~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET------ESHLVAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC------HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc------HHHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence 4678888999999999874 356888877331 00 023446888888874 323467777654
Q ss_pred cCCCCcEEEEEEeecCCcc
Q 001103 949 NGPGGTMATVTEYMVNGSL 967 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL 967 (1157)
+ .+||||++|.+|
T Consensus 147 ~------g~v~e~l~G~~l 159 (429)
T 1nw1_A 147 G------GRLEEYIPSRPL 159 (429)
T ss_dssp T------EEEECCCCEEEC
T ss_pred C------CEEEEEeCCccc
Confidence 3 379999987555
|
| >1q1o_A Cell division control protein 24; PB1 domain, PCCR, PC motif, OPCA motif, yeast, cell polarity, protein-protein interaction; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 2kfj_A 2kfk_B | Back alignment and structure |
|---|
Probab=96.21 E-value=0.015 Score=55.10 Aligned_cols=85 Identities=24% Similarity=0.290 Sum_probs=61.1
Q ss_pred cEEEEeecCCccccCCCCCCceeecCceEEEEccCCCCHHHHHHHHHhhcC--------CCceEEEeCCCCCCCcEEeec
Q 001103 184 KMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICN--------QPHTIKYQLPGEDLDALISVC 255 (1157)
Q Consensus 184 ~vklmcSyGG~I~pr~~d~~l~YvGG~triv~v~r~~~f~~l~~kl~~~~~--------~~~~lkYqLP~edLD~LisV~ 255 (1157)
.||+-++|+.- ..- -.-++++.+.|+.+|+|.+|..|+.+-++ ..+.|||| .||= ..|.+.
T Consensus 5 sikVKv~y~~~-------~~~-~~~~d~~~i~V~~~i~f~~L~~kI~~Kl~~~~~~~i~~~~klkYk--DEdG-D~Vtl~ 73 (98)
T 1q1o_A 5 SILFRISYNNN-------SNN-TSSSEIFTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ--DEDG-DFVVLG 73 (98)
T ss_dssp CEEEEEEECSS-------CSS-CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHCSSCCCCCCCEEEE--CSSS-CEEEEC
T ss_pred cEEEEEEecCc-------ccc-cccCcEEEEEecCCCCHHHHHHHHHHHHcCCccccccceeEEEEE--cCCC-CEEEEc
Confidence 47777777732 000 00158899999999999999999887654 23679999 5532 799999
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCeEEEEE
Q 001103 256 SDEDLHHMIEEYQEQERIGGSQRLRIFL 283 (1157)
Q Consensus 256 ~DeDL~~m~~eydr~~~~~~~~rlR~FL 283 (1157)
+||||+-.++..... +.++|-+.+
T Consensus 74 sddDl~~A~e~~~e~----~~~~l~Iwv 97 (98)
T 1q1o_A 74 SDEDWNVAKEMLAEN----NEKFLNIRL 97 (98)
T ss_dssp SHHHHHHHHHHHHHT----TCCEEEEEE
T ss_pred CHHHHHHHHHHHHhh----hcCeEEEEE
Confidence 999999999887443 245666654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0084 Score=64.61 Aligned_cols=36 Identities=25% Similarity=0.192 Sum_probs=27.3
Q ss_pred CCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 1000 kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
..++|+|+.+.|||++.+......+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 369999999999999732111257899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0091 Score=65.51 Aligned_cols=74 Identities=11% Similarity=0.181 Sum_probs=43.0
Q ss_pred EEEEecccCcEEEEEEEECC----------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc-eeEEeeee
Q 001103 879 ELQELGSGTFGTVYRGKWRG----------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN-VVAFYGVV 947 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kG----------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN-IVkLygvf 947 (1157)
.++.|+.|....+|+....+ ..+++|+....... ......|..+++.|.... .+++++..
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~~~~E~~~l~~L~~~g~~P~~~~~~ 107 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---------LYNTISEFEVYKTMSKYKIAPQLLNTF 107 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---------TSCHHHHHHHHHHHHHTTSSCCEEEEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---------eecHHHHHHHHHHHHhcCCCCceEEec
Confidence 46778889999999998754 56888875432100 001245777777764222 45666554
Q ss_pred ecCCCCcEEEEEEeecCCcc
Q 001103 948 PNGPGGTMATVTEYMVNGSL 967 (1157)
Q Consensus 948 ~de~~~~LyLVMEYmeGGSL 967 (1157)
. + ++||||++|..+
T Consensus 108 ~----~--~~v~e~i~G~~l 121 (369)
T 3c5i_A 108 N----G--GRIEEWLYGDPL 121 (369)
T ss_dssp T----T--EEEEECCCSEEC
T ss_pred C----C--cEEEEEecCCcC
Confidence 2 1 679999998654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.033 Score=63.05 Aligned_cols=144 Identities=15% Similarity=0.189 Sum_probs=80.5
Q ss_pred CCeeEEEEecccCcEEEEEEEEC---------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEe
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR---------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFY 944 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k---------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLy 944 (1157)
.+++ ++.|..|-...+|++... +..+.+|+.-.. . . . ...+.+|.++++.|. +.-.++++
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~-~--~----~~~~~rE~~vl~~L~~~gv~P~ll 120 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L-Q--G----VDSLVLESVMFAILAERSLGPQLY 120 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------C--C----HHHHHHHHHHHHHHHHTTSSCCEE
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c-c--h----HHHHHHHHHHHHHHHhcCCCCeEE
Confidence 4444 467877888999998863 356888874221 0 0 0 234458888888773 33346777
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhh--------------hc---cc----cccc--cHHHHHHHHHHHH----------
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHV--------------LA---RK----DRIL--DRRKKLMLMMDAA---------- 991 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dl--------------Lk---r~----gr~L--~e~qVlkIa~QLa---------- 991 (1157)
+++.+ .+||||++|..|..- |. .. ++.. -+.++.++..++.
T Consensus 121 ~~~~~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~ 194 (379)
T 3feg_A 121 GVFPE------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEM 194 (379)
T ss_dssp EEETT------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSC
T ss_pred EEcCC------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchh
Confidence 76543 289999998765311 00 00 1111 1344444444332
Q ss_pred ---------HHHHHHH----HC----CceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 992 ---------FGMEYLH----MK----NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 992 ---------~ALeYLH----Sk----GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
..+..|. .. .++|+|+.+.|||++.++...+.+.|+||..+..
T Consensus 195 ~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 195 NLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1233332 22 4999999999999984322246899999998853
|
| >1pqs_A Cell division control protein 24; alpha and beta protein, cell cycle; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 1tz1_A | Back alignment and structure |
|---|
Probab=95.77 E-value=0.025 Score=51.45 Aligned_cols=68 Identities=25% Similarity=0.293 Sum_probs=55.3
Q ss_pred ceEEEEccCCCCHHHHHHHHHhhcC--------CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEE
Q 001103 210 ETRIISIRKSLTWEELMRKTSAICN--------QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRI 281 (1157)
Q Consensus 210 ~triv~v~r~~~f~~l~~kl~~~~~--------~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~ 281 (1157)
+++.|.|+.+|+|.+|..|+.+-.+ ..+.|||| .| =+..|++.+||||.--++..... +.++|-+
T Consensus 2 D~~~i~V~~~i~f~~L~~kI~~kl~~~~~~~~~~~~~lkYk--DE-dGD~Vti~sddDl~~A~~~~~~~----~~~~lei 74 (77)
T 1pqs_A 2 EIFTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ--DE-DGDFVVLGSDEDWNVAKEMLAEN----NEKFLNI 74 (77)
T ss_dssp CEEEEECTTCCCSHHHHHHHHHHTTTTTSSCSCSTTCCEEE--ET-TTEEEECCSTTHHHHHHHHHHHH----CCCEEEE
T ss_pred CEEEEEeCCCCCHHHHHHHHHHHHcccccccccceeEEEEE--cC-CCCEEEEcCHHHHHHHHHHHHhh----hcCeEEE
Confidence 6899999999999999999998776 34779999 55 34899999999999988877443 2467777
Q ss_pred EEe
Q 001103 282 FLV 284 (1157)
Q Consensus 282 FLF 284 (1157)
.+|
T Consensus 75 Wv~ 77 (77)
T 1pqs_A 75 RLY 77 (77)
T ss_dssp ECC
T ss_pred EEC
Confidence 665
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.70 E-value=0.043 Score=58.60 Aligned_cols=76 Identities=13% Similarity=0.067 Sum_probs=46.5
Q ss_pred EEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC--CceeEEeeeeecC----CCC
Q 001103 881 QELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH--PNVVAFYGVVPNG----PGG 953 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H--PNIVkLygvf~de----~~~ 953 (1157)
..|+ |....||+.... |..+++|+...... . ...+..|..+++.|.. -.+++++.. ... ..+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~------~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g 100 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---T------ADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQG 100 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---C------HHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETT
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---C------HHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECC
Confidence 4566 888899988763 55799998863211 0 1345567777777632 224444443 110 134
Q ss_pred cEEEEEEeecCCcc
Q 001103 954 TMATVTEYMVNGSL 967 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL 967 (1157)
..+++|++++|..+
T Consensus 101 ~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 101 FYFAVFPSVGGRQF 114 (328)
T ss_dssp EEEEEEECCCCEEC
T ss_pred EEEEEEEecCCCCC
Confidence 56889999988654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.93 E-value=0.21 Score=57.84 Aligned_cols=74 Identities=20% Similarity=0.173 Sum_probs=48.3
Q ss_pred EEEEecccCcEEEEEEEECC--ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCCCCcE
Q 001103 879 ELQELGSGTFGTVYRGKWRG--TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN-VVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~kG--t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPN-IVkLygvf~de~~~~L 955 (1157)
.++.|+.|-...+|+....+ ..+.+|+..... .... ...+|..+++.|...+ .+++++++..
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~i-------dR~~E~~vl~~L~~~gl~P~ll~~~~~------ 176 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEII-------NREREKKISCILYNKNIAKKIYVFFTN------ 176 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCS-------CHHHHHHHHHHHTTSSSBCCEEEEETT------
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhc-------CHHHHHHHHHHHHhcCCCCCEEEEeCC------
Confidence 46789889999999998865 678888764321 0000 0136888888885433 4677777632
Q ss_pred EEEEEeecCCcc
Q 001103 956 ATVTEYMVNGSL 967 (1157)
Q Consensus 956 yLVMEYmeGGSL 967 (1157)
.+||||++|..|
T Consensus 177 G~v~e~I~G~~l 188 (458)
T 2qg7_A 177 GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEECCCSEEC
T ss_pred eEEEEeeCCccC
Confidence 259999998655
|
| >2ktr_A Sequestosome-1; autophagy, NF-KB signaling, HOMO-oligomer, PB1 dimer, signaling protein, transport protein; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=94.80 E-value=0.043 Score=53.54 Aligned_cols=68 Identities=22% Similarity=0.299 Sum_probs=54.1
Q ss_pred ecCceEEEEccCC-----------CCHHHHHHHHHhhc----CCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhh
Q 001103 207 VGGETRIISIRKS-----------LTWEELMRKTSAIC----NQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQE 271 (1157)
Q Consensus 207 vGG~triv~v~r~-----------~~f~~l~~kl~~~~----~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~ 271 (1157)
.++|.|-++++++ .+|..|..++.+++ +..+.|||. .|| .-||.+++||||..-+..-
T Consensus 33 ~~~EIRRF~l~~~~~p~~~~~~~~~s~~~L~~kV~~lFp~L~~~~f~l~Yk--DEd-GDlItISsDeEL~~Al~~~---- 105 (117)
T 2ktr_A 33 AAREIRRFSFCFSPEPEAEAAAGPGPSERLLSRVAVLFPALRPGGFQAHYR--AER-GDLVAFSSDEELTMAMSYV---- 105 (117)
T ss_dssp CEEEEEEEEECSSSCSCSSSCCSCCHHHHHHHHHHHHCTTSCSSCEEEEEE--CTT-CCEEEECSHHHHHHHHHHC----
T ss_pred CCCcEEEEEeccCCCccccccccCCCHHHHHHHHHHHccccCCCcEEEEEE--CCC-CCEEEecCHHHHHHHHHhc----
Confidence 4689999999864 39999999999999 457999999 333 4699999999999877631
Q ss_pred hcCCCCeEEEEEe
Q 001103 272 RIGGSQRLRIFLV 284 (1157)
Q Consensus 272 ~~~~~~rlR~FLF 284 (1157)
...-||||+=
T Consensus 106 ---~~~~lRlyVk 115 (117)
T 2ktr_A 106 ---KDDIFRIYIK 115 (117)
T ss_dssp ---CSSEEEEEEE
T ss_pred ---CCCeEEEEEE
Confidence 1357899873
|
| >2kkc_A Sequestosome-1; P62, PB1, autophagy, ubiquitin-proteasome system, NF-KB signaling, alternative splicing, apoptosis, cytoplasm, differentiation; NMR {Rattus norvegicus} PDB: 2ktr_B | Back alignment and structure |
|---|
Probab=94.79 E-value=0.081 Score=50.42 Aligned_cols=67 Identities=22% Similarity=0.324 Sum_probs=53.8
Q ss_pred ecCceEEEEccCC-----------CCHHHHHHHHHhhc----CCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhh
Q 001103 207 VGGETRIISIRKS-----------LTWEELMRKTSAIC----NQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQE 271 (1157)
Q Consensus 207 vGG~triv~v~r~-----------~~f~~l~~kl~~~~----~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~ 271 (1157)
.|+|.|=.+++++ .+|.+|..++.+++ +..+.|||. .|| .-||.+++||||...+..-
T Consensus 18 ~~~EiRRF~l~~~~~p~~~~~~~~~s~~~L~~~V~~lFp~l~~~~f~l~Y~--Ded-GDlItiSsDeEL~~Al~~~---- 90 (102)
T 2kkc_A 18 AAREIRRFSFCFSPEPEAEAAAGPGPCERLLSRVAVLFPALRPGGFQAHYR--AER-GDLVAFSSDEELTMAMSYV---- 90 (102)
T ss_dssp CEEEEEEEEEESSSCSCSSSCCSCCHHHHHHHHHHHHCTTSCSSCEEEEEE--CTT-CCEEEECSHHHHHHHHHHC----
T ss_pred CCCceEEEEeccCCCcccccccccccHHHHHHHHHHHccccCCCcEEEEEE--CCC-CCEEEecCHHHHHHHHHhc----
Confidence 3689999999874 48999999999998 457999999 333 4699999999999887631
Q ss_pred hcCCCCeEEEEE
Q 001103 272 RIGGSQRLRIFL 283 (1157)
Q Consensus 272 ~~~~~~rlR~FL 283 (1157)
...-||||+
T Consensus 91 ---~~~~lRlyV 99 (102)
T 2kkc_A 91 ---KDDIFRIYI 99 (102)
T ss_dssp ---CSSEEEEEE
T ss_pred ---CCCeEEEEE
Confidence 135789987
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.14 E-value=0.16 Score=55.74 Aligned_cols=30 Identities=20% Similarity=0.304 Sum_probs=25.9
Q ss_pred CceeccCCccceeeccCCCCCCeEEEEecCCccc
Q 001103 1001 NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1001 GIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl 1034 (1157)
.++|+|+.+.|||++ ..+.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~----~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG----NEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEEC----GGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEe----CCCeEEEEECCCCee
Confidence 599999999999997 445789999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.04 E-value=0.21 Score=57.44 Aligned_cols=74 Identities=15% Similarity=0.162 Sum_probs=47.3
Q ss_pred EEEEecccCcEEEEEEEEC---------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeee
Q 001103 879 ELQELGSGTFGTVYRGKWR---------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVP 948 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~k---------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~ 948 (1157)
.++.|..|-...+|+.... +..|.+++..... ... -...+|..+++.|. +.-.+++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~-------idR~~E~~~l~~L~~~gi~P~l~~~~~ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKF-------YDSKVELDVFRYLSNINIAPNIIADFP 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CC-------CCHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chh-------cCHHHHHHHHHHHHhcCCCCCEEEEcC
Confidence 4677877999999999875 5678888754321 000 01235777777763 333456665443
Q ss_pred cCCCCcEEEEEEeecCCcc
Q 001103 949 NGPGGTMATVTEYMVNGSL 967 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL 967 (1157)
. ++||||++|..|
T Consensus 145 ~------~~I~efI~G~~l 157 (424)
T 3mes_A 145 E------GRIEEFIDGEPL 157 (424)
T ss_dssp T------EEEEECCCSEEC
T ss_pred C------CEEEEEeCCccC
Confidence 2 679999998765
|
| >1wmh_B Partitioning defective-6 homolog alpha; kinase, PB1 domain, OPCA motif, APKC, cell polarity, transferase/cell cycle complex; 1.50A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=93.08 E-value=0.24 Score=46.01 Aligned_cols=67 Identities=19% Similarity=0.387 Sum_probs=51.7
Q ss_pred eecCceEEEEccCC--CCHHHHHHHHHhhcC---CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEE
Q 001103 206 YVGGETRIISIRKS--LTWEELMRKTSAICN---QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLR 280 (1157)
Q Consensus 206 YvGG~triv~v~r~--~~f~~l~~kl~~~~~---~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR 280 (1157)
.-|+|.|=.+++|+ .+|.+|..++..+.. .++.|.|. .+| ..||.+++||+|..-+ . .+.+-||
T Consensus 12 kf~aE~RRFs~d~~~~~~fe~f~~lv~~lh~L~~~~f~i~Y~--D~d-GDLlpInnDdnl~~Al-------~-~a~plLR 80 (86)
T 1wmh_B 12 KFDAEFRRFALPRASVSGFQEFSRLLRAVHQIPGLDVLLGYT--DAH-GDLLPLTNDDSLHRAL-------A-SGPPPLR 80 (86)
T ss_dssp EETTEEEEEEEEGGGCCCHHHHHHHHHHHTTCTTCCCEEEEE--CTT-SCEEECCSHHHHHHHT-------T-SSSSCEE
T ss_pred ecCCeeeEeEccCCCCCCHHHHHHHHHHHcCCCCCCEEEEEE--CCC-CCEeeecCHHHHHHHH-------H-hCCCcEE
Confidence 45788999999876 799999999998864 58999999 333 4699999999876432 2 2234799
Q ss_pred EEE
Q 001103 281 IFL 283 (1157)
Q Consensus 281 ~FL 283 (1157)
||+
T Consensus 81 l~I 83 (86)
T 1wmh_B 81 LLV 83 (86)
T ss_dssp EEE
T ss_pred EEE
Confidence 987
|
| >1oey_A P67-PHOX, neutrophil cytosol factor 2; immune system, PB1 heterodimer/complex, NADPH oxidase, PB1 D heterodimerization; 2.0A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=92.99 E-value=0.17 Score=46.64 Aligned_cols=65 Identities=12% Similarity=0.188 Sum_probs=51.5
Q ss_pred ceEEEEccCCCCHHHHHHHHHhhcCC---CceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEe
Q 001103 210 ETRIISIRKSLTWEELMRKTSAICNQ---PHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 210 ~triv~v~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLF 284 (1157)
.|..+.||+.++|++|..||++-.+- .+.|.|.=| |=..++ +.+||||+.++. | .+.+||+|+..
T Consensus 14 ~tvairvp~~~~y~~L~~~l~~kL~l~~~~~~LsYk~~--~s~~~v-i~~d~dl~~aw~---~----~~n~~LtL~C~ 81 (83)
T 1oey_A 14 YTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPR--DSNELV-PLSEDSMKDAWG---Q----VKNYCLTLWCE 81 (83)
T ss_dssp SEEEEEECTTCCHHHHHHHHHHHTTCCGGGCCEEECCT--TCSSCE-ECCTTTHHHHHT---T----CBTTEEEEEEC
T ss_pred EEEEEECCCCCCHHHHHHHHHHHhCCCcceeEEEeeCC--CCCCee-ccChHHHHHHHH---h----ccCCcEEEEEe
Confidence 79999999999999999999997763 457899844 566778 999999998764 2 22357888764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.04 E-value=1.3 Score=49.84 Aligned_cols=33 Identities=21% Similarity=0.205 Sum_probs=26.1
Q ss_pred ceeccCCccceeeccCC--CCCCeEEEEecCCccc
Q 001103 1002 IVHFDLKCDNLLVNLRD--PQRPICKVGDFGLSRI 1034 (1157)
Q Consensus 1002 IIHRDLKPENILLd~dd--~e~g~VKLiDFGLAkl 1034 (1157)
++|.|+.+.|||+..+. .+...++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999995221 2456799999999864
|
| >1wj6_A KIAA0049 protein, RSGI RUH-024; PB1 domain, protein binding, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=90.50 E-value=2.5 Score=40.32 Aligned_cols=83 Identities=13% Similarity=0.255 Sum_probs=62.4
Q ss_pred CCCCCcEEEEeecCCccccCCCCCCceeecCceEE--EEccCCCCHHHHHHHHHhhcC-CCceEEEeCCCCCCCcEEeec
Q 001103 179 SPFTRKMKFLCSFGGRIFPRPSDGKLRYVGGETRI--ISIRKSLTWEELMRKTSAICN-QPHTIKYQLPGEDLDALISVC 255 (1157)
Q Consensus 179 ~~~~~~vklmcSyGG~I~pr~~d~~l~YvGG~tri--v~v~r~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~ 255 (1157)
.++...|.|-+.|.|+ ++. |+-.|.++|.||.+.+...|+ .++.|||- . |=+-.|+|+
T Consensus 9 ~~m~~~v~lkV~f~ge----------------~~rF~Vs~~~~~tweel~~mvk~~f~L~~~~IkY~--D-EenD~V~i~ 69 (101)
T 1wj6_A 9 HSMEPQVTLNVTFKNE----------------IQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--D-EENEEVSIN 69 (101)
T ss_dssp CSSCSCEEEEEEETTE----------------EEEEEESCTTTSCHHHHHHHHHHHHCCSSBCCEEE--C-TTSCEECCC
T ss_pred cccCccEEEEEEEcCC----------------eeEEEecCCCCCCHHHHHHHHHHHcCCCceEEEEe--c-CCCCEEEEe
Confidence 3445578888888776 444 445789999999999999999 67889997 4 345789999
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCeEEEEEee
Q 001103 256 SDEDLHHMIEEYQEQERIGGSQRLRIFLVS 285 (1157)
Q Consensus 256 ~DeDL~~m~~eydr~~~~~~~~rlR~FLFp 285 (1157)
++++++.++.-+..- .-.|++++|-
T Consensus 70 Sq~E~eEAlkva~k~-----~n~L~m~V~~ 94 (101)
T 1wj6_A 70 SQGEYEEALKMAVKQ-----GNQLQMQVHE 94 (101)
T ss_dssp SHHHHHHHHHHHHHH-----TSEEEEECCB
T ss_pred cHHHHHHHHHHhccC-----CCEEEEEEee
Confidence 999988777633321 2369998883
|
| >1ip9_A BEM1 protein; ubiquitin alpha/beta roll, signaling protein; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 1ipg_A 2kfk_A | Back alignment and structure |
|---|
Probab=90.31 E-value=1.4 Score=40.84 Aligned_cols=65 Identities=15% Similarity=0.293 Sum_probs=49.1
Q ss_pred CCcEEEEeecCCccccCCCCCCceeecCceEEEEccCCCCHHHHHHHHHhhcCC-CceEEEeCCCCCCCcEEeecChhHH
Q 001103 182 TRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICNQ-PHTIKYQLPGEDLDALISVCSDEDL 260 (1157)
Q Consensus 182 ~~~vklmcSyGG~I~pr~~d~~l~YvGG~triv~v~r~~~f~~l~~kl~~~~~~-~~~lkYqLP~edLD~LisV~~DeDL 260 (1157)
.+++|+-..|.+-|+ ++.||-+|+|.+|..||..-... ++.+.+-. +|.... .+.+|+||
T Consensus 10 ~~~~KVK~yy~DDIi----------------AIrvP~di~~~~L~dKi~~RLk~~~~~l~~yk-de~~g~--~i~sD~dl 70 (85)
T 1ip9_A 10 LKTTKIKFYYKDDIF----------------ALMLKGDTTYKELRSKIAPRIDTDNFKLQTKL-FDGSGE--EIKTDSQV 70 (85)
T ss_dssp CCCEEEEECBTTCCE----------------EEEECSCCCHHHHHHHHHHHHTSSCEEEEECC-SSSCCS--CCCSHHHH
T ss_pred cCceEEEEEecCcEE----------------EEECCCCCCHHHHHHHHHHHhcccceEEEEec-CCCCCC--cccCHHHH
Confidence 356777666666654 89999999999999999987763 44443333 665655 99999999
Q ss_pred HHHHH
Q 001103 261 HHMIE 265 (1157)
Q Consensus 261 ~~m~~ 265 (1157)
..-|.
T Consensus 71 ~~aiq 75 (85)
T 1ip9_A 71 SNIIQ 75 (85)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99886
|
| >2bkf_A Zinc-finger protein NBR1 (NEXT to breast cancer 1; PB1 domain, interaction domain, Z finger; 1.56A {Homo sapiens} SCOP: d.15.2.2 PDB: 2g4s_A | Back alignment and structure |
|---|
Probab=89.97 E-value=1.3 Score=41.20 Aligned_cols=68 Identities=16% Similarity=0.261 Sum_probs=51.0
Q ss_pred CceEE--EEccCCCCHHHHHHHHHhhcC-CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEe
Q 001103 209 GETRI--ISIRKSLTWEELMRKTSAICN-QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 209 G~tri--v~v~r~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLF 284 (1157)
|+++. |+-.|.++|.+|.+.+...|| .++.|||- .| =+-.|+|+++++++.++.-+.. . ...|++++|
T Consensus 15 ge~~rf~vs~~~~~tweel~~mvk~~f~L~~~~ikY~--DE-enD~v~i~Sq~E~eEAlkva~k----~-~n~L~m~v~ 85 (87)
T 2bkf_A 15 NEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--DE-ENEEVSINSQGEYEEALKMAVK----Q-GNQLQMQVH 85 (87)
T ss_dssp TEEEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE--CT-TSCEEEECSHHHHHHHHHHHHH----T-TTEEEEEEE
T ss_pred CCeeEEEeccCCCCCHHHHHHHHHHHcCCCceEEEEE--cC-CCCEEEEecHHHHHHHHHHhcc----C-CCEEEEEEe
Confidence 44566 445789999999999999999 68889997 43 4578999999998877753322 2 236888776
|
| >1oey_J P40-PHOX, neutrophil cytosol factor 4; immune system, PB1 heterodimer/complex, NADPH oxidase, PB1 D heterodimerization; 2.0A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=87.31 E-value=1.2 Score=42.76 Aligned_cols=57 Identities=19% Similarity=0.293 Sum_probs=46.6
Q ss_pred cCceEEEEccCCC----CHHHHHHHHHhhcC-CCceEEEeCCCCCCCcEEeecChhHHHHHHHHH
Q 001103 208 GGETRIISIRKSL----TWEELMRKTSAICN-QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEY 267 (1157)
Q Consensus 208 GG~triv~v~r~~----~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~~DeDL~~m~~ey 267 (1157)
|-.+|=|+|.-++ +|.||+..+...+. .+++|+|+=+.. -||-+-+|||+..|+.+=
T Consensus 17 ~~~irdI~veedl~~~P~ykdLl~lmr~~F~~~DIaLNYrD~eG---DLIrilddeDv~lmi~~s 78 (107)
T 1oey_J 17 ISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAEG---DLVRLLSDEDVALMVRQA 78 (107)
T ss_dssp EEEEEEEEECSCTTCCCCHHHHHHHHHHHHCCSSEEEEEECTTS---CEEECCSHHHHHHHHHHC
T ss_pred CceeeeEEEccccccCCCHHHHHHHHHHHhcccceeeeeecCCC---CEEEEcchHHHHHHHHHh
Confidence 5567778886554 79999999999987 589999994443 589999999999999865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1157 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-72 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-17 | |
| d1ip9a_ | 85 | d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker' | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 3e-72
Identities = 84/284 (29%), Positives = 147/284 (51%), Gaps = 22/284 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
I D + Q +GSG+FGTVY+GKW G D+A+K + + + Q+ ++ F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT----APTPQQ--LQAFKNEVGV 57
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ H N++ F G +A VT++ SL H L + + K + + A
Sbjct: 58 LRKTRHVNILLFMGY---STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC---NTLVSGGVRGTL 1048
GM+YLH K+I+H DLK +N+ ++ + K+GDFGL+ +K + + G++
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 1049 PWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--- 1104
WMAPE++ + N S + DVY+FGI ++E++TG+ PY+N++ I ++
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 1105 -PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147
++ C ++LM EC RP F +I + +++ +L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 3e-66
Identities = 91/276 (32%), Positives = 136/276 (49%), Gaps = 22/276 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+ +L+ LQ +G G FG V G +RG +A+K IK + F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASV 53
Query: 932 ISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-ILDRRKKLMLMMDA 990
++ L H N+V GV+ GG + VTEYM GSL L + R +L L +D
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPW 1050
MEYL N VH DL N+LV+ + + KV DFGL++ +T +G + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109
APE L + S K DV+SFGI +WEI + G PY + ++ + + P+
Sbjct: 167 TAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD 223
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145
C P ++M+ CW + A RPSF ++ +L + T
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-64
Identities = 92/274 (33%), Positives = 125/274 (45%), Gaps = 22/274 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I DL L+ELG+G FG V GKWR D+AIK IK+ S E EF EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------SMSE---DEFIEEAK 51
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDA 990
++ NL H +V YGV + +TEYM NG L + L ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 991 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGTL 1048
MEYL K +H DL N LVN + + KV DFGLSR S G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W PE+L ++ S K D+++FG+ MWEI + G+ PY I LR
Sbjct: 166 RWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 222
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
P + +M CW RP+F + + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 7e-64
Identities = 89/295 (30%), Positives = 133/295 (45%), Gaps = 26/295 (8%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKE 924
L + +D+ L ELG G FG+V +G +R D+AIK +K+ ++ +E
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEE 55
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
REA I+ L +P +V GV + V E G L L K +
Sbjct: 56 MMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVA 112
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI----KCNTLV 1040
L+ + GM+YL KN VH DL N+L+ R K+ DFGLS+
Sbjct: 113 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTA 168
Query: 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099
+ L W APE +N + S + DV+S+G+ MWE ++ G++PY M ++ I
Sbjct: 169 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNH 1154
R + P C PE LM +CW + RP F + R+R +L +K H
Sbjct: 227 QG-KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-63
Identities = 86/281 (30%), Positives = 128/281 (45%), Gaps = 24/281 (8%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTD-----IAIKRIKKSCFLGRSSEQEWLIKEF 925
+I + DL L++LG G+FG V RG+W +A+K +K Q + +F
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----SQPEAMDDF 58
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
RE + + +L H N++ YGVV P M VTE GSL L +
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC----NTLVS 1041
+ A GM YL K +H DL NLL+ RD + K+GDFGL R + ++
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQ 171
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100
+ W APE L S D + FG+ +WE+ T G+EP+ ++ I+ I
Sbjct: 172 EHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
R PE C + +M +CW+ P RP+F + + L
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 9e-63
Identities = 84/279 (30%), Positives = 125/279 (44%), Gaps = 22/279 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+ L+ ++ LG+G FG V+ G + T +A+K +K+ F EA+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---------SMSPDAFLAEAN 60
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLMMD 989
++ L H +V Y VV P + +TEYM NGSL L I L K L +
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGT 1047
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+R+ G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
+ W APE +N + K DV+SFGI + EI+T + L R
Sbjct: 174 IKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146
P+ C E +LM CW P RP+F + + L TA
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-62
Identities = 75/262 (28%), Positives = 129/262 (49%), Gaps = 21/262 (8%)
Query: 882 ELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPN 939
E+G G+F TVY+G T +A ++ + ++ E + F EA ++ L HPN
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDR----KLTKSE--RQRFKEEAEMLKGLQHPN 69
Query: 940 VVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
+V FY + VTE M +G+L+ L ++ +++ + G+++L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 998 HMKN--IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
H + I+H DLKCDN+ + K+GD GL+ +K + + V GT +MAPE+
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEFMAPEM 184
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP-QIPERCDPE 1114
+ E VDVY+FG+ M E+ T E PY+ A I +++ ++P + PE
Sbjct: 185 YEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 1115 WRKLMEECWSFNPAARPSFTEI 1136
++++E C N R S ++
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (543), Expect = 2e-62
Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 18/262 (6%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+L+E+G G+FG VY + +AIK++ S + ++ +E + L
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS-----GKQSNEKWQDIIKEVRFLQKL 72
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPN + + G T V EY + + + K + L + + A G+
Sbjct: 73 RHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLA 129
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
YLH N++H D+K N+L++ + + K+GDFG + I GT WMAPE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEV 182
Query: 1056 LNGSNN-RVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDPE 1114
+ + + KVDV+S GI E+ + P NM+ + + I N
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 1115 WRKLMEECWSFNPAARPSFTEI 1136
+R ++ C P RP+ +
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 6e-62
Identities = 65/272 (23%), Positives = 118/272 (43%), Gaps = 24/272 (8%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D E L +G+G++G + + + + K + S E + E +++
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG------SMTEAEKQMLVSEVNLLR 58
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR---ILDRRKKLMLMMDA 990
L HPN+V +Y + + T+ V EY G L V+ + + LD L +M
Sbjct: 59 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118
Query: 991 AFGMEYLHMKN-----IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGV 1044
++ H ++ ++H DLK N+ ++ + K+GDFGL+R + +T +
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFAKAF 174
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104
GT +M+PE +N +EK D++S G ++E+ P+ + G I
Sbjct: 175 VGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-F 231
Query: 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+IP R E +++ + RPS EI
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-61
Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 20/274 (7%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+I S+L +QE+GSG FG V+ G W +AIK I++ ++F EA
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---------AMSEEDFIEEA 51
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ L HP +V YGV + V E+M +G L L + + L + +D
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN--TLVSGGVRGT 1047
GM YL ++H DL N LV + + KV DFG++R + S G +
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
+ W +PE+ + +R S K DV+SFG+ MWE+ + + + + +S R
Sbjct: 166 VKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
P ++M CW P RP+F+ + +L
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-61
Identities = 67/278 (24%), Positives = 122/278 (43%), Gaps = 25/278 (8%)
Query: 870 QIIKDSDLEE----LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIK 923
+ +D + E+ + ELG G FG VY+ + + T A K I SE+E ++
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK------SEEE--LE 54
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKK 983
++ E I+++ HPN+V + + E+ G++ V+ +R L +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQI 112
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL-VSG 1042
++ + YLH I+H DLK N+L K+ DFG+S T+
Sbjct: 113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKNTRTIQRRD 168
Query: 1043 GVRGTLPWMAPELLNGSNNR---VSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGIL 1099
GT WMAPE++ ++ K DV+S GI + E+ E P+ ++ ++ I
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
Query: 1100 SN-TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ P R ++ +++C N AR + +++
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-61
Identities = 79/274 (28%), Positives = 122/274 (44%), Gaps = 27/274 (9%)
Query: 877 LEELQELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
LE+ +ELGSG FGTV +G ++ +A+K +K + L E EA+++
Sbjct: 10 LED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAEANVM 62
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
L +P +V G+ V E G L L + + + + L+ +
Sbjct: 63 QQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSM 118
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI----KCNTLVSGGVRGTL 1048
GM+YL N VH DL N+L+ + K+ DFGLS+ + + +
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107
W APE +N + S K DV+SFG+ MWE + G++PY M + + R
Sbjct: 175 KWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 231
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
P C E LM CW+++ RP F + RLR
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 9e-61
Identities = 77/290 (26%), Positives = 136/290 (46%), Gaps = 27/290 (9%)
Query: 869 LQIIKDSDLEELQELGSGTFGTVYRGKWRGTD------IAIKRIKKSCFLGRSSEQEWLI 922
L+I+K+++ ++++ LGSG FGTVY+G W +AIK ++++
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKAN 55
Query: 923 KEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRK 982
KE EA++++++ +P+V G+ T+ +T+ M G L + + +
Sbjct: 56 KEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 983 KLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN---TL 1039
L + A GM YL + +VH DL N+LV K+ DFGL+++
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEY 168
Query: 1040 VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098
+ G + + WMA E + + + DV+S+G+ +WE++T G +PY + I I
Sbjct: 169 HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-I 225
Query: 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148
L R P C + +M +CW + +RP F E+ M+ Q
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 8e-59
Identities = 68/264 (25%), Positives = 118/264 (44%), Gaps = 19/264 (7%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D E + LG G FG VY + + + +A+K + K+ E+ + + RE I
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQ 60
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
S+L HPN++ YG + + + EY G++ L +K D ++ + + A
Sbjct: 61 SHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELAN 117
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMA 1052
+ Y H K ++H D+K +NLL+ K+ DFG S ++ + GTL ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
PE++ G EKVD++S G+ +E + G+ P+ I + P+
Sbjct: 173 PEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVT 228
Query: 1113 PEWRKLMEECWSFNPAARPSFTEI 1136
R L+ NP+ RP E+
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-58
Identities = 80/278 (28%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-----IAIKRIKKSCFLGRSSEQEWLIKEFW 926
I+ +E + +G G FG V++G + + +AIK K + + ++F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFL 56
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
+EA + HP++V GV+ P + + E G LR L + LD ++
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGV 1044
+ + YL K VH D+ N+LV+ K+GDFGLSR +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDSTYYKASKG 169
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTL 1103
+ + WMAPE +N R + DV+ FG+ MWEI+ G +P+ + +IG I +
Sbjct: 170 KLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 226
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
R +P C P LM +CW+++P+ RP FTE+ +L
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-58
Identities = 83/285 (29%), Positives = 120/285 (42%), Gaps = 22/285 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-IAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I L +LG G FG V+ G W GT +AIK +K + F +EA
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG---------TMSPEAFLQEAQ 64
Query: 931 IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSL-RHVLARKDRILDRRKKLMLMMD 989
++ L H +V Y VV P + VTEYM GSL + + L + + +
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--KCNTLVSGGVRGT 1047
A GM Y+ N VH DL+ N+LV + +CKV DFGL+R+ G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
+ W APE R + K DV+SFGI + E+ T + + R
Sbjct: 178 IKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRR 1152
P C LM +CW P RP+F + L T+ + + +
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-58
Identities = 84/306 (27%), Positives = 124/306 (40%), Gaps = 49/306 (16%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKE 924
+LE + LGSG FG V G +A+K +K+ ++ E +
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-----KADSSE--REA 86
Query: 925 FWREAHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR------- 976
E +++ L H N+V G G + + EY G L + L K
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 977 ---------------ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQR 1021
+L L A GME+L K+ VH DL N+LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HG 200
Query: 1022 PICKVGDFGLSRI---KCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWE 1078
+ K+ DFGL+R N +V G R + WMAPE L + K DV+S+GI +WE
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWE 258
Query: 1079 IIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEIT 1137
I + G PY + A ++ N + P E +M+ CW+F+ RPSF +T
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 1138 NRLRVM 1143
+ L
Sbjct: 319 SFLGCQ 324
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (506), Expect = 1e-57
Identities = 91/284 (32%), Positives = 134/284 (47%), Gaps = 28/284 (9%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-----IAIKRIKKSCFLGRSSEQEWLIKEFW 926
I S ++ Q +G+G FG V G + +AIK +K +E++ ++F
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-----YTEKQ--RRDFL 75
Query: 927 REAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
EA I+ HPNV+ GVV + +TE+M NGSL L + D + + +
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 133
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI------KCNTLV 1040
+ A GM+YL N VH DL N+LVN +CKV DFGLSR
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTS 189
Query: 1041 SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099
+ G + + W APE + + + DV+S+GI MWE+++ GE PY +M +I I
Sbjct: 190 ALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247
Query: 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
+ R P C +LM +CW + RP F +I N L M
Sbjct: 248 QD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 1e-57
Identities = 86/277 (31%), Positives = 130/277 (46%), Gaps = 22/277 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
++ +D+ +LG G +G VY G W+ +A+K +K+ ++EF +EA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEA 64
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-LDRRKKLMLMM 988
++ + HPN+V GV P +TE+M G+L L +R + L +
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 989 DAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN--TLVSGGVRG 1046
+ MEYL KN +H DL N LV + + KV DFGLSR+ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106
+ W APE L N+ S K DV++FG+ +WEI T + + +L R +
Sbjct: 179 PIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
PE C + +LM CW +NP+ RPSF EI M
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-57
Identities = 87/313 (27%), Positives = 129/313 (41%), Gaps = 56/313 (17%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
I + L+E +G G FG V+RGKWRG ++A+K E+ W + E +
Sbjct: 1 IARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSS------REERSWFRE---AEIY 49
Query: 931 IISNLHHPNVVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMM 988
L H N++ F NG + V++Y +GSL L R ++ KL L
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-- 107
Query: 989 DAAFGMEYLHM--------KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN--- 1037
A G+ +LHM I H DLK N+LV + C + D GL+ +
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATD 163
Query: 1038 --TLVSGGVRGTLPWMAPELLNGSNN----RVSEKVDVYSFGIAMWEIITG--------- 1082
+ GT +MAPE+L+ S N ++ D+Y+ G+ WEI
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
Query: 1083 -EEPYANMHCG-----AIIGGILSNTLRPQIPER-----CDPEWRKLMEECWSFNPAARP 1131
+ PY ++ + + LRP IP R K+M ECW N AAR
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 1132 SFTEITNRLRVMS 1144
+ I L +S
Sbjct: 284 TALRIKKTLSQLS 296
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 6e-57
Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 50/303 (16%)
Query: 875 SDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
+++E ++++G G FG V++ + T +A+K +K+ + +F R
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-------ASADMQADFQR 65
Query: 928 EAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR----------- 976
EA +++ +PN+V GV G M + EYM G L L
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 977 ------------ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024
L ++L + A GM YL + VH DL N LV + +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVV 179
Query: 1025 KVGDFGLSRIKCN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081
K+ DFGLSR + G + WM PE + NR + + DV+++G+ +WEI +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFS 237
Query: 1082 -GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
G +PY M +I + PE C E LM CWS PA RPSF I L
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 1141 RVM 1143
+ M
Sbjct: 297 QRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-57
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 881 QELGSGTFGTVYRGKWRGTD-----IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ +G G FG VY G D A+K + + + +F E I+ +
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------TDIGEVSQFLTEGIIMKDF 85
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPNV++ G+ G + V YM +G LR+ + + + + + A GM+
Sbjct: 86 SHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK-----CNTLVSGGVRGTLPW 1050
+L K VH DL N +++ ++ KV DFGL+R + G + + W
Sbjct: 145 FLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPE 1109
MA E L + + K DV+SFG+ +WE++T G PY +++ I +L R PE
Sbjct: 201 MALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPE 257
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
C ++M +CW RPSF+E+ +R+ +
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-56
Identities = 85/280 (30%), Positives = 129/280 (46%), Gaps = 25/280 (8%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD------IAIKRIKKSCFLGRSSEQEWLIKEF 925
I S + + +G+G FG VY+G + + +AIK +K E +F
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-------YTEKQRVDF 56
Query: 926 WREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLM 985
EA I+ H N++ GV+ + +TEYM NG+L L KD + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 986 LMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN----TLVS 1041
++ A GM+YL N VH DL N+LVN +CKV DFGLSR+ + T +
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101
G + + W APE ++ + + DV+SFGI MWE++T E + +++
Sbjct: 171 SGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
R P C +LM +CW A RP F +I + L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-56
Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 26/275 (9%)
Query: 870 QIIKDSDLEE----LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIK 923
I+ D ++ +++G G GTVY G ++AI+++ +Q+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--------QQQPKKE 62
Query: 924 EFWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKK 983
E ++ +PN+V + G + V EY+ GSL V+ +
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAA 120
Query: 984 LMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSG 1042
+ +E+LH ++H D+K DN+L+ K+ DFG I
Sbjct: 121 VCREC--LQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFCAQITPEQSKRS 174
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN- 1101
+ GT WMAPE++ KVD++S GI E+I GE PY N + + I +N
Sbjct: 175 TMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
T Q PE+ +R + C + R S E+
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-56
Identities = 86/294 (29%), Positives = 135/294 (45%), Gaps = 37/294 (12%)
Query: 871 IIKDSDLEELQELGSGTFGTVYRGKWRGT----DIAIKRIKKSCFLGRSSEQEWLIKEFW 926
++ +D++ +G G FG V + + + D AIKR+K+ +S+ + ++F
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDD--HRDFA 58
Query: 927 REAHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI-------- 977
E ++ L HHPN++ G + G + EY +G+L L + +
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 978 -------LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030
L ++ L D A GM+YL K +H DL N+LV + + K+ DFG
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFG 172
Query: 1031 LSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANM 1089
LSR + + R + WMA E LN S + DV+S+G+ +WEI++ G PY M
Sbjct: 173 LSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230
Query: 1090 HCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143
C + + R + P CD E LM +CW P RPSF +I L M
Sbjct: 231 TCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 192 bits (489), Expect = 1e-54
Identities = 55/263 (20%), Positives = 107/263 (40%), Gaps = 18/263 (6%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L+ELGSG FG V+R + T K I L + E I++ L
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--------YTVKNEISIMNQL 83
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HHP ++ + + M + E++ G L +A +D + + + M A G++
Sbjct: 84 HHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
++H +IVH D+K +N++ + K+ DFGL+ + T + APE+
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--TLRPQIPERCDP 1113
++ V D+++ G+ + +++G P+A + + P
Sbjct: 200 VDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 1114 EWRKLMEECWSFNPAARPSFTEI 1136
E + ++ P R + +
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 192 bits (488), Expect = 1e-54
Identities = 55/263 (20%), Positives = 103/263 (39%), Gaps = 18/263 (6%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ +ELG+G FG V+R R T A K + E + +E +S L
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--------PHESDKETVRKEIQTMSVL 80
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HP +V + + M + E+M G L +A + + + + M G+
Sbjct: 81 RHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
++H N VH DLK +N++ + K+ DFGL+ GT + APE+
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--TLRPQIPERCDP 1113
G V D++S G+ + +++G P+ + + + S +
Sbjct: 197 AEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 1114 EWRKLMEECWSFNPAARPSFTEI 1136
+ + + + +P R + +
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-54
Identities = 70/310 (22%), Positives = 125/310 (40%), Gaps = 62/310 (20%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+KD D E++ ELG+G G V++ + + +A K I + + + RE
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIREL 55
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ + P +V FYG + G ++ E+M GSL VL + R + + + +
Sbjct: 56 QVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIA 112
Query: 990 AAFGMEYLHMKN-IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTL 1048
G+ YL K+ I+H D+K N+LVN R K+ DFG+S +++ + V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV-GTR 167
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY---------------------- 1086
+M+PE L G S + D++S G+++ E+ G P
Sbjct: 168 SYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 1087 --------------------ANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFN 1126
M ++ I++ E++ + +C N
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 1127 PAARPSFTEI 1136
PA R ++
Sbjct: 286 PAERADLKQL 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 4e-54
Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 21/267 (7%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D + +Q LG G +G V R T+ +A+K + + +E I
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-------RAVDCPENIKKEICINK 58
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
L+H NVV FYG G EY G L + D + G
Sbjct: 59 MLNHENVVKFYGHRREG--NIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 115
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI---KCNTLVSGGVRGTLPW 1050
+ YLH I H D+K +NLL++ +R K+ DFGL+ + + + GTLP+
Sbjct: 116 VVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 1051 MAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLRPQIPE 1109
+APELL +E VDV+S GI + ++ GE P+ +
Sbjct: 172 VAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ D L+ + NP+AR + +I
Sbjct: 231 KIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-54
Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 21/278 (7%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
+ D + + LG G+F TV + T AIK ++K R +E + RE
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTRER 59
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++S L HP V Y + + Y NG L + + D +
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 116
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN---TLVSGGVRG 1046
+EYLH K I+H DLK +N+L+N + ++ DFG +++ + G
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVLSPESKQARANSFVG 172
Query: 1047 TLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ 1106
T +++PELL + D+++ G +++++ G P+ + I I+ L
Sbjct: 173 TAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYD 228
Query: 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144
PE+ P+ R L+E+ + R E+ + +
Sbjct: 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-53
Identities = 76/295 (25%), Positives = 114/295 (38%), Gaps = 38/295 (12%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKE 924
+ L + LG+G FG V +A+K +K S L +
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-------REA 72
Query: 925 FWREAHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARK--------- 974
E ++S L +H N+V G G G +TEY G L + L RK
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 975 --------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026
+ LD L A GM +L KN +H DL N+L+ IC
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDF 189
Query: 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEP- 1085
G + N +V G R + WMAPE + + + DV+S+GI +WE+ +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFSLGSSP 247
Query: 1086 YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
Y M + ++ R PE E +M+ CW +P RP+F +I +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 4e-53
Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 18/269 (6%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREA 929
I+D + LG+G F V + + T +AIK I K G+ E
Sbjct: 7 IRD-IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-------GSMENEI 58
Query: 930 HIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ + HPN+VA + +G G + + + + G L + K R L+
Sbjct: 59 AVLHKIKHPNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQ 115
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
++YLH IVH DLK +NLL D I + DFGLS+++ V GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACGTPG 174
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP- 1108
++APE+L S+ VD +S G+ + ++ G P+ + + + IL P
Sbjct: 175 YVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232
Query: 1109 -ERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ + + +P R + +
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 62/274 (22%), Positives = 119/274 (43%), Gaps = 15/274 (5%)
Query: 871 IIKDSDLEE----LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKE 924
+ + ++++ +ELGSG F V + + + T A K IKK +SS + ++
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT--KSSRRGVSRED 59
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
RE I+ + HPNV+ + V N + + E + G L LA K+ L +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES-LTEEEAT 116
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+ G+ YLH I HFDLK +N+++ R+ +P K+ DFGL+ +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--T 1102
GT ++APE++N + + D++S G+ + +++G P+ + + +
Sbjct: 177 FGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ + + +P R + +
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-51
Identities = 47/261 (18%), Positives = 104/261 (39%), Gaps = 19/261 (7%)
Query: 880 LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
++LG G FG V+R + K +K + ++Q +E I++ H
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQV----LVKKEISILNIARH 60
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
N++ + + + + E++ + + L+ R+ + + +++L
Sbjct: 61 RNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLN 1057
H NI HFD++ +N++ R K+ +FG +R + + APE+
Sbjct: 119 HSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 1058 GSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--TLRPQIPERCDPEW 1115
+ VS D++S G ++ +++G P+ II I++ T + + E
Sbjct: 177 H--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 1116 RKLMEECWSFNPAARPSFTEI 1136
++ +R + +E
Sbjct: 235 MDFVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 180 bits (457), Expect = 3e-51
Identities = 65/271 (23%), Positives = 110/271 (40%), Gaps = 17/271 (6%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQ-EWLIKEFWREAHII 932
+ E + LG G V R + T A+K I + S+E+ + L + +E I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 933 SNLH-HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+ HPN++ V + M G L L K L ++ +M
Sbjct: 64 RKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALL 120
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWM 1051
+ LH NIVH DLK +N+L++ K+ DFG S V GT ++
Sbjct: 121 EVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 1052 APELLNGSNNR----VSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQI 1107
APE++ S N ++VD++S G+ M+ ++ G P+ + ++ I+S +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 1108 PE--RCDPEWRKLMEECWSFNPAARPSFTEI 1136
PE + L+ P R + E
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-50
Identities = 76/296 (25%), Positives = 117/296 (39%), Gaps = 39/296 (13%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKE 924
L+ + LG G FG V G D +A+K +K+ +
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRAL 63
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDR-------- 976
+I HH NVV G PGG + + E+ G+L L K
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 977 -------ILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029
L + A GME+L + +H DL N+L++ ++ + K+ DF
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDF 178
Query: 1030 GLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEE-P 1085
GL+R + G R L WMAPE + + + DV+SFG+ +WEI + P
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASP 236
Query: 1086 YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
Y + L R + P+ PE + M +CW P+ RP+F+E+ L
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-50
Identities = 62/264 (23%), Positives = 115/264 (43%), Gaps = 20/264 (7%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D + LG G+FG V+ +++ T+ AIK +KK L ++ E ++S
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD-----VECTMVEKRVLS 57
Query: 934 -NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
HP + + + V EY+ G L + + + D + +
Sbjct: 58 LAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIIL 114
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGTLPWM 1051
G+++LH K IV+ DLK DN+L++ + K+ DFG+ + + GT ++
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 170
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
APE+L G + + VD +SFG+ ++E++ G+ P+ + I + P P
Sbjct: 171 APEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWL 226
Query: 1112 DPEWRKLMEECWSFNPAARPSFTE 1135
+ E + L+ + + P R
Sbjct: 227 EKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 176 bits (446), Expect = 7e-50
Identities = 54/261 (20%), Positives = 109/261 (41%), Gaps = 14/261 (5%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E + LG G V+ + D+A+K ++ + F REA + L
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-----LARDPSFYLRFRREAQNAAAL 64
Query: 936 HHPNVVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
+HP +VA Y G V EY+ +LR ++ + + ++ + ++ DA
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQA 123
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
+ + H I+H D+K N++++ + + + ++ + + V GT +++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPERC 1111
E G + V + DVYS G ++E++TGE P+ ++ + P E
Sbjct: 184 EQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 1112 DPEWRKLMEECWSFNPAARPS 1132
+ ++ + + NP R
Sbjct: 242 SADLDAVVLKALAKNPENRYQ 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 7e-50
Identities = 73/295 (24%), Positives = 114/295 (38%), Gaps = 39/295 (13%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD---------IAIKRIKKSCFLGRSSEQEWLI 922
+ L + LG G FG V + G D +A+K +K ++E++ +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKD--L 62
Query: 923 KEFWREAHIISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVL---------- 971
+ E ++ + H N++ G G + + EY G+LR L
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 972 -----ARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026
+ L + + A GMEYL K +H DL N+LV D I
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADF 179
Query: 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEP 1085
G + R + WMAPE L + + DV+SFG+ +WEI T G P
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 1086 YANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRL 1140
Y + + +L R P C E +M +CW P+ RP+F ++ L
Sbjct: 238 YPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-49
Identities = 80/290 (27%), Positives = 124/290 (42%), Gaps = 36/290 (12%)
Query: 872 IKDSDLEELQELGSGTFGTVYRGKWRGTD-------IAIKRIKKSCFLGRSSEQEWLIKE 924
+ + +ELG G+FG VY G +G +AIK + ++ +S +E E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-----ASMRE--RIE 69
Query: 925 FWREAHIISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRI------- 977
F EA ++ + +VV GVV G + E M G L+ L
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 978 --LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035
K + + + A GM YL+ VH DL N +V + K+GDFG++R
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 183
Query: 1036 CN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEE-PYANMHC 1091
G + WM+PE L + + DV+SFG+ +WEI T E PY +
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 1092 GAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
++ ++ P+ C +LM CW +NP RPSF EI + ++
Sbjct: 242 EQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-49
Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 32/285 (11%)
Query: 868 GLQIIKDSDLEE----LQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWL 921
GLQI K++ +++ Q LG G G V + + T A+K ++
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------ 48
Query: 922 IKEFWREAHIISNL-HHPNVVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVL-ARKDRI 977
+ RE + P++V V + V E + G L + R D+
Sbjct: 49 -PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 107
Query: 978 LDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCN 1037
R+ +M ++YLH NI H D+K +NLL + P I K+ DFG ++ +
Sbjct: 108 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTS 166
Query: 1038 TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGG 1097
T ++APE+L + + D++S G+ M+ ++ G P+ + H AI G
Sbjct: 167 HNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224
Query: 1098 ILSNTLRPQI------PERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ + Q E + L+ P R + TE
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 54/267 (20%), Positives = 99/267 (37%), Gaps = 21/267 (7%)
Query: 874 DSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHI 931
+S + LGSG FG+VY G + +AIK ++K E +
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN--GTRVPMEVVL 60
Query: 932 ISNLH--HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
+ + V+ + + E + L
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
+ + H ++H D+K +N+L+ D R K+ DFG + +T+ + GT
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYT-DFDGTRV 174
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109
+ PE + V+S GI +++++ G+ P+ + II G + +
Sbjct: 175 YSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQ 225
Query: 1110 RCDPEWRKLMEECWSFNPAARPSFTEI 1136
R E + L+ C + P+ RP+F EI
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 1e-46
Identities = 51/278 (18%), Positives = 96/278 (34%), Gaps = 31/278 (11%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+++GSG+FG +Y G G ++AIK + + E+ I +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----------KTKHPQLHIESKIYKMMQG 61
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
+ G G + ++ SL + R + L+L +EY+
Sbjct: 62 GVGIPTIRWC--GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI--------KCNTLVSGGVRGTLP 1049
H KN +H D+K DN L+ L + + DFGL++ + + GT
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILS------NTL 1103
+ + G S + D+ S G + G P+ + +T
Sbjct: 179 YASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141
+ + E+ + C S +P ++ + R
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (421), Expect = 1e-45
Identities = 52/260 (20%), Positives = 102/260 (39%), Gaps = 14/260 (5%)
Query: 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D + +G G FG VY + G A+K + K + + E L ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLVS 62
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
P +V ++ + + M G L + L++ + + + G
Sbjct: 63 TGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAEIILG 119
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
+E++H + +V+ DLK N+L++ + ++ D GL+ GT +MAP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAP 174
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGI-LSNTLRPQIPERCD 1112
E+L D +S G +++++ G P+ ++ T+ ++P+
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 1113 PEWRKLMEECWSFNPAARPS 1132
PE R L+E + R
Sbjct: 234 PELRSLLEGLLQRDVNRRLG 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (416), Expect = 2e-45
Identities = 58/265 (21%), Positives = 125/265 (47%), Gaps = 20/265 (7%)
Query: 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
D + L+ LG+G+FG V+ + R G A+K +KK + ++ E ++
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-----VEHTNDERLML 58
Query: 933 SNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
S + HP ++ +G + + + +Y+ G L +L + R + K +
Sbjct: 59 SIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCL 115
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMA 1052
+EYLH K+I++ DLK +N+L++ + K+ DFG ++ + + + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
PE+++ ++ +D +SFGI ++E++ G P+ + + IL+ + P +
Sbjct: 170 PEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFN 225
Query: 1113 PEWRKLMEECWSFNPAARPSFTEIT 1137
+ + L+ + + + R +
Sbjct: 226 EDVKDLLSRLITRDLSQRLGNLQNG 250
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (413), Expect = 3e-45
Identities = 51/288 (17%), Positives = 101/288 (35%), Gaps = 31/288 (10%)
Query: 880 LQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH 937
+ +G G+FG ++ G +AIK + S+ L E+ R +++
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEY-RTYKLLAGCTG 62
Query: 938 PNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYL 997
V ++G G + ++ SL +L R + M ++ +
Sbjct: 63 IPNVYYFGQE-----GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 998 HMKNIVHFDLKCDNLLVNLRDPQRPIC-KVGDFGLSRIKCNTLVS--------GGVRGTL 1048
H K++V+ D+K DN L+ + + V DFG+ + + + + GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 1049 PWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAI------IGGILSNT 1102
+M+ G S + D+ + G + G P+ + IG +T
Sbjct: 178 RYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTK 1150
++ E+ K M + A P + + + L T
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-44
Identities = 63/265 (23%), Positives = 111/265 (41%), Gaps = 19/265 (7%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D + L+ LG GTFG V + + T A+K ++K + + + E+ ++
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-----VAHTVTESRVLQ 60
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
N HP + A + V EY G L L+R+ + R + +
Sbjct: 61 NTRHPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERAR-FYGAEIVSA 117
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR-IKCNTLVSGGVRGTLPWMA 1052
+EYLH +++V+ D+K +NL+++ + K+ DFGL + + GT ++A
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112
PE+L N VD + G+ M+E++ G P+ N + IL + P
Sbjct: 174 PEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLS 229
Query: 1113 PEWRKLMEECWSFNPAARPSFTEIT 1137
PE + L+ +P R
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSD 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 46/297 (15%)
Query: 874 DSDLEELQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
D E + E+G G +G V++ + G +A+KR++ + +E + RE
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVA 59
Query: 931 IISNL---HHPNVVAFYGVVPNGP---GGTMATVTEYMVNGSLRHVLARKDRILDRRKKL 984
++ +L HPNVV + V + V E++ ++ + +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+M G+++LH +VH DLK N+LV K+ DFGL+RI + V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMALTSV 175
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104
TL + APE+L S + VD++S G E+ + + +G IL
Sbjct: 176 VVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 1105 P-------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P + D + L+ +C +FNPA R S
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 40/288 (13%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E+L LG G F TVY+ + + T+ +AIK+IK RS ++ + + RE ++ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQEL 57
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
HPN++ G ++ V ++M + +L M+ G+E
Sbjct: 58 SHPNIIGLLDA--FGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVR-GTLPWMAPE 1054
YLH I+H DLK +NLL++ + + K+ DFGL++ + + + T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 1055 LLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--------- 1105
LL G VD+++ G + E++ + I P
Sbjct: 171 LLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 1106 -----------------QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
I + L++ + FNP AR + T+
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 60/291 (20%), Positives = 112/291 (38%), Gaps = 43/291 (14%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
+ ++++++G GT+G VY+ + + T +A+K+I+ +E E + RE ++
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TETEGVPSTAIREISLLK 56
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
L+HPN+V V+ + V E++ + + A + + G
Sbjct: 57 ELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPW-MA 1052
+ + H ++H DLK NLL+N K+ DFGL+R + + W A
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP------- 1105
PE+L G S VD++S G E++T + + I P
Sbjct: 171 PEILLG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 1106 --------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
++ D + R L+ + ++P R S
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-41
Identities = 58/296 (19%), Positives = 108/296 (36%), Gaps = 51/296 (17%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
L +G G +G V +AIK+I E + + RE I+
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRF 63
Query: 936 HHPNVVAFYGVV--PNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
H N++ ++ P + +++ L +L K + L + G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI----KCNTLVSGGVRGTLP 1049
++Y+H N++H DLK NLL+N K+ DFGL+R+ +T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 1050 WMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP---- 1105
+ APE++ S ++ +D++S G + E+++ + H + IL P
Sbjct: 178 YRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 1106 -------------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
++ D + L+++ +FNP R +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-41
Identities = 56/272 (20%), Positives = 119/272 (43%), Gaps = 21/272 (7%)
Query: 876 DLEELQELGSGTFGTVYRG-----KWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
+ E L+ LG+G +G V+ G A+K +KK+ ++ + E
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA----TIVQKAKTTEHTRTERQ 80
Query: 931 IISNL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
++ ++ P +V + + + +Y+ G L L++++R + ++ + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIY-VGE 137
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR--IKCNTLVSGGVRGT 1047
+E+LH I++ D+K +N+L++ + DFGLS+ + T + GT
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 1048 LPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--P 1105
+ +MAP+++ G ++ + VD +S G+ M+E++TG P+ I L+ P
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253
Query: 1106 QIPERCDPEWRKLMEECWSFNPAARPSFTEIT 1137
P+ + L++ +P R
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRD 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (380), Expect = 5e-41
Identities = 55/287 (19%), Positives = 102/287 (35%), Gaps = 41/287 (14%)
Query: 878 EELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936
L+++G GT+G VY+ + G A+K+I+ E E + RE I+ L
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE------KEDEGIPSTTIREISILKELK 58
Query: 937 HPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEY 996
H N+V Y V+ + ++ L+ +L + L+ ++ G+ Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 997 LHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELL 1056
H + ++H DLK NLL+N K+ DFGL+R + W +
Sbjct: 116 CHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 1057 NGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP----------- 1105
+ + S +D++S G E++ G + + + I P
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 1106 ----------------QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ D L+ + +P R + +
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 1e-39
Identities = 53/264 (20%), Positives = 106/264 (40%), Gaps = 20/264 (7%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
+ ++ LG+G+FG V K + + A+K + K + + I+ E I+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRILQ 96
Query: 934 NLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFG 993
++ P +V + + V EY+ G + L R R
Sbjct: 97 AVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLT 153
Query: 994 MEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAP 1053
EYLH ++++ DLK +NLL++ + +V DFG ++ + + GT +AP
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKRVKGRTWT--LCGTPEALAP 207
Query: 1054 ELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCDP 1113
E++ ++ VD ++ G+ ++E+ G P+ I I+S + + P
Sbjct: 208 EIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSS 263
Query: 1114 EWRKLMEECWSFNPAARPSFTEIT 1137
+ + L+ + R +
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNG 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-39
Identities = 59/299 (19%), Positives = 107/299 (35%), Gaps = 51/299 (17%)
Query: 873 KDSDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAH 930
++ + + +G+G+FG VY+ K + +AIK++ + + RE
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQ 65
Query: 931 IISNLHHPNVVAFYGVV----PNGPGGTMATVTEYMVNGSLRHVL--ARKDRILDRRKKL 984
I+ L H N+V + V +Y+ R +R + L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 985 MLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGV 1044
+ M + Y+H I H D+K NLL+ DP + K+ DFG ++ +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 1045 RGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR 1104
+ + APEL+ G+ + + +DV+S G + E++ G+ + + I+
Sbjct: 183 ICSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 1105 PQ---------------------------IPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
P R PE L + P AR + E
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 60/305 (19%), Positives = 105/305 (34%), Gaps = 55/305 (18%)
Query: 875 SDLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHII 932
S E+L ++G GTFG V++ + R T +A+K++ +E+E RE I+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALREIKIL 63
Query: 933 SNLHHPNVVAFYGVVPNGP------GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLML 986
L H NVV + G++ V ++ + + + + +
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV 122
Query: 987 MMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRI-----KCNTLVS 1041
M G+ Y+H I+H D+K N+L+ + + K+ DFGL+R
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 1042 GGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101
TL + PELL G + +D++ G M E+ T + I
Sbjct: 179 TNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 1102 TLRPQ------------------------------IPERCDPEWRKLMEECWSFNPAARP 1131
DP L+++ +PA R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 1132 SFTEI 1136
+
Sbjct: 298 DSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 59/289 (20%), Positives = 108/289 (37%), Gaps = 43/289 (14%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
E+L+++G GT+GTV++ K R T +A+KR++ + E + RE ++ L
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLKEL 58
Query: 936 HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGME 995
H N+V + V+ + T+ V E+ ++ + + K + G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSF-LFQLLKGLG 115
Query: 996 YLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPEL 1055
+ H +N++H DLK NLL+N + K+ +FGL+R + W P
Sbjct: 116 FCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 1056 LNGSNNRVSEKVDVYSFGIAMWEIITGEEP-YANMHCGAIIGGILSNTLRP--------- 1105
+ S +D++S G E+ P + + I P
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 1106 ------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ + + R L++ NP R S E
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 139 bits (352), Expect = 7e-37
Identities = 50/300 (16%), Positives = 103/300 (34%), Gaps = 58/300 (19%)
Query: 876 DLEELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS 933
D + +++LG G + V+ + + +K +K K+ RE I+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----------KKKKIKREIKILE 84
Query: 934 NL-HHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
NL PN++ +V + T A V E++ N + + + L M +
Sbjct: 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILK 140
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMA 1052
++Y H I+H D+K N+++ D + ++ D+GL+ + +
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMH---------------------- 1090
PELL +D++S G + +I +EP+ + H
Sbjct: 198 PELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 1091 --------------CGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
G + + PE +++ ++ +R + E
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 5e-36
Identities = 67/294 (22%), Positives = 112/294 (38%), Gaps = 51/294 (17%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+LQ +GSG +G V G +AIK++ + + E K +RE ++ ++
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHM 74
Query: 936 HHPNVVAFYGVVPNGPGGTMAT----VTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
H NV+ V T V +M G+ L + ++ L + L+
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQML 131
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWM 1051
G+ Y+H I+H DLK NL VN + K+ DFGL+R + + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP------ 1105
APE++ R ++ VD++S G M E+ITG+ + + I+ T P
Sbjct: 186 APEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 1106 -----------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
I P L+E+ + R + E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 4e-32
Identities = 56/293 (19%), Positives = 111/293 (37%), Gaps = 49/293 (16%)
Query: 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L +GSG +G+V G +A+K++ + + K +RE ++ ++
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHM 74
Query: 936 HHPNVVAFYGVVPNGPG---GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAF 992
H NV+ V + +++ L +++ + D + L+ +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--LR 132
Query: 993 GMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMA 1052
G++Y+H +I+H DLK NL VN + K+ DFGL+R + + T + A
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMTG--YVATRWYRA 186
Query: 1053 PELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP------- 1105
PE++ ++ VD++S G M E++TG + + IL P
Sbjct: 187 PEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 1106 ----------------------QIPERCDPEWRKLMEECWSFNPAARPSFTEI 1136
+ +P L+E+ + R + +
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 7e-32
Identities = 54/265 (20%), Positives = 102/265 (38%), Gaps = 23/265 (8%)
Query: 878 EELQELGSGTFGTVYRGKWRGTD--IAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL 935
+ L+ +GSG G V D +AIK++ + + + K +RE ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR------PFQNQTHAKRAYRELVLMKCV 73
Query: 936 HHPNVVAFYGVVPNGP----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAA 991
+H N+++ V + V E M + + D + L+
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQML 129
Query: 992 FGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWM 1051
G+++LH I+H DLK N++V K+ DFGL+R + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 1052 APELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111
APE++ G E VD++S G M E++ + + ++ P PE
Sbjct: 186 APEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-CPEFM 242
Query: 1112 DPEWRKLMEECWSFNPAARPSFTEI 1136
+ + A +F ++
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKL 267
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 2e-26
Identities = 49/320 (15%), Positives = 107/320 (33%), Gaps = 55/320 (17%)
Query: 870 QIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWR 927
+ KD+ +++LG G F TV+ K T +A+K ++ ++E E + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 928 EAHII--SNLHHPNVVAFYGV--VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKK 983
+A ++ +++ G + V E + L + + R +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 984 LMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSG 1042
+ G++Y+H + I+H D+K +N+L+ + D + ++ L
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 1043 GVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPY---------ANMHCGA 1093
T + +PE+L G+ D++S ++E+ITG+ + + A
Sbjct: 188 NSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 1094 IIGGILSN-------------------------------------TLRPQIPERCDPEWR 1116
I +L T + + + E
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 1117 KLMEECWSFNPAARPSFTEI 1136
+ +P R +
Sbjct: 306 DFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 5e-17
Identities = 30/212 (14%), Positives = 57/212 (26%), Gaps = 43/212 (20%)
Query: 881 QELGSGTFGTVYRGK-WRGTDIAIK--RIKKSCFLGRSSEQEWLIKEFWREAH------- 930
+ +G G V+ + + +K ++ + F ++++ F A
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 931 -IISNLHHPNVVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMD 989
+ L V Y N A + E + L V ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPD--------EVLDM 111
Query: 990 AAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1049
+ + + IVH DL N+LV+ + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQS------------VEVGE 154
Query: 1050 WMAPELLNGSNNRVSEKVD-VYSFGIAMWEII 1080
E+L + Y + I
Sbjct: 155 EGWREILERDVRNIITYFSRTYRTEKDINSAI 186
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 85 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 36.3 bits (84), Expect = 0.002
Identities = 8/67 (11%), Positives = 26/67 (38%), Gaps = 5/67 (7%)
Query: 203 KLRYVGGETRIISIRKSLTWEELMRKTSAICN-QPHTIKYQLPGEDLDALISVCSDEDLH 261
K Y + + ++ T++EL K + + ++ + + + +D +
Sbjct: 16 KFYY-KDDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK---LFDGSGEEIKTDSQVS 71
Query: 262 HMIEEYQ 268
++I+
Sbjct: 72 NIIQAKL 78
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1157 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.06 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 97.95 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.29 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 97.12 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 96.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.73 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 96.49 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.66 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.89 | |
| d1wmha_ | 83 | Protein kinase C, iota type {Human (Homo sapiens) | 93.04 | |
| d2npta1 | 105 | Mitogen activated protein kinase kinase 5, Map2k5 | 85.81 | |
| d1oeyj_ | 105 | Neutrophil cytosol factor 4 (p40phox component of | 82.26 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=434.70 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=221.1
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ ++.||||++.+..... ......+.+|++++++++|||||++++++.+ .
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~ 78 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----AGVEHQLRREVEIQSHLRHPNILRLYGYFHD--A 78 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-----hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--C
Confidence 58999999999999999999994 6779999998643211 1224678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|+|||||++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~~kl~DFG~a 153 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFGWS 153 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCCCSC
T ss_pred CEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec----CCCCEeeccccee
Confidence 68999999999999999997544 589999999999999999999999999999999999998 6779999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
+....... ...+||+.|+|||++.+. .|+.++|||||||+||+|++|+.||.+....+.+..+.... ..+|..++
T Consensus 154 ~~~~~~~~-~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s 228 (263)
T d2j4za1 154 VHAPSSRR-TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVT 228 (263)
T ss_dssp SCCCCCCC-EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSC
T ss_pred eecCCCcc-cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccCC
Confidence 86544332 346799999999999865 57899999999999999999999999988888877776544 45678899
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
+++++||.+||++||.+|||++++++|.|...
T Consensus 229 ~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 229 EGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999999988754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=438.46 Aligned_cols=264 Identities=32% Similarity=0.583 Sum_probs=219.9
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
|++..++|++.++||+|+||+||+|++++ .||||+++...... ...+.+.+|+++|++++|||||++++++..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP------QQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT------THHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH------HHHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 45777899999999999999999998765 59999987642211 124678899999999999999999998754
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
..+++|||||++|+|.+++...+..+++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+||
T Consensus 76 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~----~~~~~Kl~DF 148 (276)
T d1uwha_ 76 ---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDF 148 (276)
T ss_dssp ---SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTSSEEECCC
T ss_pred ---cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc----CCCCEEEccc
Confidence 358999999999999999987767799999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCC---cccCCCCCCCcccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC-CC
Q 001103 1030 GLSRIKCNT---LVSGGVRGTLPWMAPELLNGSN-NRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT-LR 1104 (1157)
Q Consensus 1030 GLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~-~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~-lr 1104 (1157)
|+|+..... .......||+.|+|||++.+.. ..|+.++|||||||+||||++|+.||.+......+....... ..
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 999764332 2334568999999999997542 358999999999999999999999999877665554444433 22
Q ss_pred C---CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1105 P---QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1105 p---eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
+ .++..+++++++||.+||+.||.+|||+++|+++|+.+...+
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 2 356678999999999999999999999999999999887654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=437.11 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=209.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ |+.||||++.+... .+...+.+.+|+++|++++|||||++|+++.+...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS------CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 58999999999999999999984 77899999986532 12235678999999999999999999999987666
Q ss_pred CcEEEEEEeecCCcchhhhccc---cccccHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCccceeeccCCCCCCeE
Q 001103 953 GTMATVTEYMVNGSLRHVLARK---DRILDRRKKLMLMMDAAFGMEYLHMKN-----IVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~---gr~L~e~qVlkIa~QLa~ALeYLHSkG-----IIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+.+|+|||||++|+|.+++.+. .+.+++..++.++.||+.||+|||+++ ||||||||+|||++ .++.+
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~----~~~~v 153 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNV 153 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----TTSCE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC----CCCcE
Confidence 7899999999999999998652 456999999999999999999999976 99999999999998 67899
Q ss_pred EEEecCCcccccCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC
Q 001103 1025 KVGDFGLSRIKCNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL 1103 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l 1103 (1157)
||+|||+|+..... ......+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+....++...+.....
T Consensus 154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~ 231 (269)
T d2java1 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 231 (269)
T ss_dssp EECCHHHHHHC-----------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred EEeeccceeecccCCCccccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999999865443 334557899999999999854 579999999999999999999999999888888887776654
Q ss_pred CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1104 RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1104 rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
. .++..+++++++||.+||+.||.+|||+.+++++.|
T Consensus 232 ~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 232 R-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 3 577889999999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=433.52 Aligned_cols=254 Identities=27% Similarity=0.338 Sum_probs=211.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.++|++++.||+|+||+||+|+++ |+.||||++.+... ....+.+.+|+++|++|+|||||++|+++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-- 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRRE-- 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEE--
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-------chHHHHHHHHHHHHHhCCCCCEeeEeeeecc--
Confidence 358999999999999999999984 77899999976421 1123568899999999999999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+|||||||++|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----~~~~~KL~DFG~ 149 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGL 149 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTT
T ss_pred CceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC----CCCCEEEccchh
Confidence 66899999999999999999754 4599999999999999999999999999999999999998 677999999999
Q ss_pred cccccC---CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhhcCCCCCC
Q 001103 1032 SRIKCN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILSNTLRPQI 1107 (1157)
Q Consensus 1032 Akl~~~---~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~~~lrpei 1107 (1157)
|+.... .......+||+.|+|||++.+.. .++.++|||||||+||||++|++||....... ....+.........
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCC-CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence 986432 22345578999999999998653 24678999999999999999999997765433 33333333333334
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...+++++++||.+||+.||.+|||+++++++.|.
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 45689999999999999999999999999998775
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=434.72 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=219.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
+.|++++.||+|+||+||+|+++ +..||||++++... . ..+.+.+|+++|++|+|||||++++++.+ .
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~ 81 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE----E----ELEDYMVEIDILASCDHPNIVKLLDAFYY--E 81 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS----G----GGGGTHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH----H----HHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 46899999999999999999984 66799999976421 1 13567899999999999999999999988 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|+|||||++|+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~----~~~~~Kl~DFG~a 157 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVS 157 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC----CCCCEEEEechhh
Confidence 689999999999999999877677799999999999999999999999999999999999998 6779999999999
Q ss_pred ccccCC-cccCCCCCCCcccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC-CCCC
Q 001103 1033 RIKCNT-LVSGGVRGTLPWMAPELLNGS---NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-RPQI 1107 (1157)
Q Consensus 1033 kl~~~~-~~sts~~GTp~YmAPEVL~G~---~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-rpei 1107 (1157)
+..... ......+||+.|+|||++.+. ...|+.++|||||||+||||++|++||.+....+.+..+..... ....
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS
T ss_pred hccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 754332 233457899999999998532 34578999999999999999999999999888888887776543 3345
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+..+++++++||.+||++||.+|||+.++++|.|.
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 66789999999999999999999999999998654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=422.23 Aligned_cols=256 Identities=33% Similarity=0.610 Sum_probs=212.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
+..++|+++++||+|+||+||+|++. +..||||+++.... . .+.+.+|++++++++|||||++++++..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~----~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----S-----EEDFIEEAEVMMKLSHPKLVQLYGVCLE- 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS----C-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC----c-----HHHHHHHHHHHHhcCCCCcccccceecc-
Confidence 45679999999999999999999995 56799999875421 1 2468899999999999999999999987
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
.+.+++|||||++|+|.+++......+++..++.++.|++.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 72 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~----~~~~~Kl~DFG 146 (263)
T d1sm2a_ 72 -QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG 146 (263)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC----GGGCEEECSCC
T ss_pred -CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec----CCCCeEecccc
Confidence 5578999999999999999887777799999999999999999999999999999999999999 77899999999
Q ss_pred CcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1031 LSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1031 LAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
+++...... ......||+.|+|||++.+. .|+.++|||||||+||||++ |++||......+++..+.. ..++..
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~ 223 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYK 223 (263)
T ss_dssp ------------------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCC
T ss_pred hheeccCCCceeecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCC
Confidence 998654332 23346799999999999864 58999999999999999999 5777777776666666554 455667
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
|..+++++.+||.+||+.||.+|||+++|+++|+.+..
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 88899999999999999999999999999999998864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=428.83 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=225.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ |+.||||++++........ ....+.+.+|+++|++|+|||||++++++.+ .
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 85 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYEN--K 85 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 57999999999999999999985 7789999998764432221 1124678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|||||||++|+|.+++.+.+ .+++..++.++.|++.||+|||+++|+||||||+|||++.++.....+||+|||+|
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 78999999999999999997654 59999999999999999999999999999999999999865545567999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip~~ 1110 (1157)
.............||+.|+|||++.+. .++.++|||||||+||||++|+.||.+....+.+..+....... ..+..
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred hhcCCCccccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence 877666556667899999999999864 57999999999999999999999999998888888877654433 23467
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++++++||++||+.||.+|||+++++++.|.
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 89999999999999999999999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-50 Score=434.34 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=219.4
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
.|+++++||+|+||+||+|++. ++.||||++.+... ......+.+.+|+++|++|+|||||++++++.+ .+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~ 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EH 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TT
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CC
Confidence 4999999999999999999984 67799999986422 123345778999999999999999999999988 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
.+|+|||||.+|+|..++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|.
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSAS 163 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTCB
T ss_pred EEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC----CCCCEEEeeccccc
Confidence 89999999999999766543 45699999999999999999999999999999999999999 77899999999997
Q ss_pred cccCCcccCCCCCCCcccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1034 IKCNTLVSGGVRGTLPWMAPELLNGS-NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1034 l~~~~~~sts~~GTp~YmAPEVL~G~-~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
..... ...+||+.|+|||++.+. ...|+.++|||||||+||||++|+.||.+......+..+.....+...+..++
T Consensus 164 ~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 164 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp SSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred ccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC
Confidence 65432 346799999999999753 24589999999999999999999999999888888888877766666677789
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++++||.+||+.||.+|||+.++++|.+.
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 999999999999999999999999987665
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=439.59 Aligned_cols=259 Identities=27% Similarity=0.458 Sum_probs=212.2
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
+..++|+++++||+|+||+||+|++. |..||||++++... . ....++.+|+++|++++|||||+++++|.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----P---AIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----T---THHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----H---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 45679999999999999999999984 77899999986421 1 124678899999999999999999999988
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMK-NIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSk-GIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
...+|||||||++|+|.+++.+.+ .+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|
T Consensus 76 --~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----~~~~vkl~D 148 (322)
T d1s9ja_ 76 --DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 148 (322)
T ss_dssp --SSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEEECC
T ss_pred --CCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC----CCCCEEEee
Confidence 568999999999999999997654 489999999999999999999975 999999999999998 778999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHH-------------
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAII------------- 1095 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil------------- 1095 (1157)
||+|+...... ..+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.......
T Consensus 149 FGla~~~~~~~-~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 149 FGVSGQLIDSM-ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCCCHHHHHHT-C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCCccccCCCc-cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 99998654332 3457899999999999865 5899999999999999999999999765432210
Q ss_pred -----------------------------HHhhhcCCCCCCC-CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1096 -----------------------------GGILSNTLRPQIP-ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1096 -----------------------------~~Il~~~lrpeip-~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
..+. ....+.++ ..+++++++||.+||..||.+|||++|+++|.+.-..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV-NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------------CCCCHHHHHHHHH-TSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccccccccccccccchhHHHHHhhhh-ccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 1111 11111222 2368899999999999999999999999999887654
Q ss_pred HHh
Q 001103 1146 ALQ 1148 (1157)
Q Consensus 1146 aLe 1148 (1157)
..+
T Consensus 305 ~~~ 307 (322)
T d1s9ja_ 305 DAE 307 (322)
T ss_dssp HHS
T ss_pred Ccc
Confidence 443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=433.83 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=217.5
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|+++++||+|+||+||+|+++ |+.||||+++...... .+.+.+|+++|++++|||||++++++.+ .
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 89 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLV--G 89 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--------HHHHHHHHHHHHhCCCCCEeeEeEEEEE--C
Confidence 47999999999999999999974 8889999998652211 3568899999999999999999999988 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+||+|.+++.+ +.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~vkl~DFG~a 163 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 163 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC----CCCcEeeccchhh
Confidence 689999999999999998764 3589999999999999999999999999999999999998 6679999999999
Q ss_pred ccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc-CCCCCCCCC
Q 001103 1033 RIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN-TLRPQIPER 1110 (1157)
Q Consensus 1033 kl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~-~lrpeip~~ 1110 (1157)
+.... .......+||+.|+|||++.+. .|+.++|||||||+||+|++|+.||.+......+..+... ......+..
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred eeeccccccccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 86543 3344567899999999999864 5789999999999999999999999988877766666544 334556778
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++++++||.+||++||.+|||++++++|.|.
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 99999999999999999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-50 Score=436.68 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=205.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
+.|++++.||+|+||+||+|+++ ++.||||++.+..... ....+.+|+++|++|+|||||++++++.+ .
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 79 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------KEGSMENEIAVLHKIKHPNIVALDDIYES--G 79 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-------HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 46999999999999999999985 6779999998653211 13567899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+...+ .++.+||+|||+|
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~a 157 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLS 157 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC---
T ss_pred CEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC-CCceEEEecccee
Confidence 7899999999999999999764 4599999999999999999999999999999999999997433 5678999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip~~ 1110 (1157)
+...........+||+.|+|||++.+. .|+.++|||||||+||+|++|++||.+.........+....... ..+..
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235 (307)
T ss_dssp ---------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTT
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccC
Confidence 876665555667899999999999865 57999999999999999999999999988888888887665443 34567
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+|+++++||.+||++||.+|||+.|++++.|.
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 89999999999999999999999999997654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=432.63 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=218.2
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.++|++++.||+|+||+||+|+++ ++.||||++.+..... +...+.+.+|+++|++|+|||||++++++.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-- 79 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-- 79 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-----HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--
Confidence 358999999999999999999984 7789999998643211 1124678899999999999999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+|+|||||+||+|.+++...+ .+++..++.++.|++.||+|||++|||||||||+|||++ .++.+||+|||+
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~----~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGT 154 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCTT
T ss_pred CCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC----CCceEEeccccc
Confidence 578999999999999999887544 589999999999999999999999999999999999998 778999999999
Q ss_pred cccccC---CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1032 SRIKCN---TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1032 Akl~~~---~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
|+.... .......+||+.|+|||++.+. .|+.++|||||||+||+|++|+.||.+.....++..+.... ..++
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~p 230 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFP 230 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCCC
T ss_pred ceecccCCcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CCCC
Confidence 986532 2234456899999999999865 57999999999999999999999999988888888877654 3567
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..+++++++||.+||++||.+|||++|++++.+.+.
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~ 266 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHc
Confidence 889999999999999999999999999877666543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=433.21 Aligned_cols=258 Identities=32% Similarity=0.514 Sum_probs=220.4
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECCc-------eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRGT-------DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kGt-------~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
|++..++|++.+.||+|+||+||+|++.+. .||||++..... ......+.+|+.+|+++ +|||||
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-------HHHHHHHHHHHHHHHHhcCCCcEe
Confidence 456678999999999999999999998432 489998865421 12245788999999998 899999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc----------------------ccccHHHHHHHHHHHHHHHHHHHH
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD----------------------RILDRRKKLMLMMDAAFGMEYLHM 999 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g----------------------r~L~e~qVlkIa~QLa~ALeYLHS 999 (1157)
++|+++.+ .+.+|+|||||++|+|.++|+... ..+++..++.++.|++.||+|||+
T Consensus 105 ~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~ 182 (325)
T d1rjba_ 105 NLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 182 (325)
T ss_dssp CEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEee--CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999987 567999999999999999996543 347889999999999999999999
Q ss_pred CCceeccCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHH
Q 001103 1000 KNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAM 1076 (1157)
Q Consensus 1000 kGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVIL 1076 (1157)
++||||||||+|||++ .++.+||+|||+|+...... ...+..||+.|+|||++.+. .|+.++|||||||+|
T Consensus 183 ~~IiHRDlKp~Nill~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 183 KSCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILL 256 (325)
T ss_dssp TTEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHH
T ss_pred CCeeeccCchhccccc----cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHH
Confidence 9999999999999998 77899999999998643322 23345689999999999854 679999999999999
Q ss_pred HHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1077 WEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1077 YELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
|||++ |++||.+......+..++....++..|..+++++++||.+||+.||++|||+++|+++|..
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 99998 8999998887777788888888888899999999999999999999999999999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-50 Score=426.47 Aligned_cols=261 Identities=32% Similarity=0.578 Sum_probs=220.9
Q ss_pred cccccccCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 867 YGLQIIKDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 867 y~i~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
+..|++..++|++.++||+|+||+||+|+++ ++.||||+++.... . .+.+.+|+++|++|+|||||++|
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~-----~~~~~~E~~il~~l~HpnIv~~~ 79 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----E-----VEEFLKEAAVMKEIKHPNLVQLL 79 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----C-----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----h-----HHHHHHHHHHHHhCCCCCEecCC
Confidence 3345677789999999999999999999994 67799999875421 1 35688999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhcc-ccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCe
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLAR-KDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPI 1023 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr-~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~ 1023 (1157)
+++.+ .+.+++|||||++|+|.+++.+ ....+++..++.++.|++.||+|||++||+||||||+|||++ .++.
T Consensus 80 ~~~~~--~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~----~~~~ 153 (287)
T d1opja_ 80 GVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHL 153 (287)
T ss_dssp EEECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGC
T ss_pred ccEee--CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC----CCCc
Confidence 99987 5688999999999999999865 346689999999999999999999999999999999999998 6779
Q ss_pred EEEEecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc
Q 001103 1024 CKVGDFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1024 VKLiDFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~ 1101 (1157)
+||+|||+|+...... ......||+.|+|||++.+. .|+.++|||||||++|||++|..||........+..++..
T Consensus 154 ~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~ 231 (287)
T d1opja_ 154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231 (287)
T ss_dssp EEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEEccccceeecCCCCceeeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc
Confidence 9999999998654332 23345689999999999854 6899999999999999999976665444444444555566
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
..++..+..+++++++||.+||+.||.+|||+.++++.|+.+.
T Consensus 232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 6778888999999999999999999999999999999887653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=422.03 Aligned_cols=253 Identities=29% Similarity=0.485 Sum_probs=211.4
Q ss_pred CCe-eEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-
Q 001103 875 SDL-EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG- 950 (1157)
Q Consensus 875 sdY-eILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de- 950 (1157)
.+| ++.++||+|+||+||+|+++ +..||+|++...... ....+.+.+|+++|++|+|||||++|+++.+.
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 344 66778999999999999985 667999998865321 22356789999999999999999999998642
Q ss_pred -CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 -PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKN--IVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 -~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkG--IIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
....+|+|||||++|+|.+++.+. +.+++..++.++.||+.||+|||+++ |+||||||+|||++. .++.+||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~---~~~~~Kl~ 157 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIG 157 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---TTSCEEEC
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC---CCCCEEEe
Confidence 245689999999999999999754 45899999999999999999999998 999999999999961 45789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-HHHHHhhhcCCCCC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-AIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-eil~~Il~~~lrpe 1106 (1157)
|||+|+...... ....+||+.|+|||++.+ .|+.++|||||||+||||++|+.||...... .+...+.....+..
T Consensus 158 DFGla~~~~~~~-~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 158 DLGLATLKRASF-AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 233 (270)
T ss_dssp CTTGGGGCCTTS-BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred ecCcceeccCCc-cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc
Confidence 999998644333 345689999999999974 4799999999999999999999999876544 44455554445555
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
++..+++++++||.+||++||++|||++|+++|.|
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 67778999999999999999999999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-49 Score=438.11 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=222.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ |+.||||++.+.. ....+.+.+|+++|++|+|||||++++++.+ .
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 95 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--D 95 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--T
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 47999999999999999999984 7789999987542 1124678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+||+|.+++.+....+++..++.++.||+.||+|||++|||||||||+|||++.+ ..+.+||+|||+|
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vkL~DFG~a 173 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLT 173 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC--CCCeEEEeecchh
Confidence 78999999999999999997666679999999999999999999999999999999999999632 3578999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC--CCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--QIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--eip~~ 1110 (1157)
+............||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+....+.+..+....... .....
T Consensus 174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 251 (350)
T d1koaa2 174 AHLDPKQSVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251 (350)
T ss_dssp EECCTTSCEEEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG
T ss_pred eecccccccceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 876665555567899999999999865 57899999999999999999999999988888888887665433 23356
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++++++||.+||+.||++|||++++++|.|.
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~ 283 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 89999999999999999999999999998654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=420.93 Aligned_cols=266 Identities=33% Similarity=0.578 Sum_probs=226.4
Q ss_pred ccCCCeeEEE-EecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQ-ELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILr-kLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+..++|.+.+ +||+|+||+||+|.++ +..||||+++... .....+.+.+|+++|++|+|||||+++++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-------CHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 4556788888 4999999999999874 3469999987541 12235678999999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+..+ .+|||||||++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||
T Consensus 78 ~~~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----~~~~~Kl 150 (285)
T d1u59a_ 78 CQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKI 150 (285)
T ss_dssp EESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEEE
T ss_pred eccC---eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec----cCCceee
Confidence 8653 58999999999999999877767799999999999999999999999999999999999998 6789999
Q ss_pred EecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhc
Q 001103 1027 GDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1027 iDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~ 1101 (1157)
+|||+|+...... ......||+.|+|||++.+. .++.++|||||||+||||++ |+.||.+....++...+. .
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~ 227 (285)
T d1u59a_ 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-Q 227 (285)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-T
T ss_pred ccchhhhcccccccccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 9999998654322 22345689999999999754 57999999999999999998 999999988777766655 4
Q ss_pred CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhhccccc
Q 001103 1102 TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQTKRRNH 1154 (1157)
Q Consensus 1102 ~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLesksRn~ 1154 (1157)
..++.+|..+++++.+||.+||+.||++|||+.+|++.|+.....+.++-+.+
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~~ 280 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccchh
Confidence 45667888999999999999999999999999999999998887776665544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-49 Score=423.92 Aligned_cols=258 Identities=36% Similarity=0.598 Sum_probs=211.4
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEEC--Cc---eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWR--GT---DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~k--Gt---~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
+...+|++.+.||+|+||+||+|+++ +. .||||++.... .....+.+.+|+++|++|+|||||+++++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g~ 95 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLEGV 95 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 45578999999999999999999984 22 37888776431 12234678999999999999999999999
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
+.+ .+.+++|||||++|+|.+++....+.+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||
T Consensus 96 ~~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~----~~~~~Kl 169 (299)
T d1jpaa_ 96 VTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKV 169 (299)
T ss_dssp ECS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEE
T ss_pred Eee--CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC----CCCcEEE
Confidence 977 5679999999999999999887777799999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCCcc------cCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhh
Q 001103 1027 GDFGLSRIKCNTLV------SGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~------sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il 1099 (1157)
+|||+|+....... .....||+.|+|||++.+. .++.++|||||||+||||++ |+.||.+....+++..+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp CCC-----------------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CCcccceEccCCCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999986443221 2234589999999999854 68999999999999999998 899999988877777665
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1100 ~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
. ..++..+..+++++.+||.+||+.||.+|||+.+|++.|..+..
T Consensus 248 ~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 Q-DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp T-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred c-CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 4 45566788899999999999999999999999999999987754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=416.61 Aligned_cols=258 Identities=33% Similarity=0.565 Sum_probs=218.6
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
|++..++|+++++||+|+||+||+|+++ ++.||||+++.... . .+.+.+|++++++++|||||++++++.
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----S-----PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----C-----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC----C-----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 4566789999999999999999999996 46799999975421 1 256889999999999999999999876
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
+ +.+++|||||++|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 79 ~---~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~----~~~~~Kl~ 151 (272)
T d1qpca_ 79 Q---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIA 151 (272)
T ss_dssp S---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEEC
T ss_pred c---CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee----cccceeec
Confidence 5 3578999999999999877653 34589999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhHHHHHhhhcCCC
Q 001103 1028 DFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG-EEPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG-k~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|||+|+...... ......||+.|+|||++.+. .++.++|||||||+||||++| ++||......+.+..+. ...+
T Consensus 152 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~ 228 (272)
T d1qpca_ 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYR 228 (272)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred cccceEEccCCccccccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCC
Confidence 999998754432 33456799999999999854 579999999999999999995 55666666666655554 4566
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
+..+..+++++++||.+||+.||++|||+++|++.|+.+..+
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 677889999999999999999999999999999999887653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=434.10 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=222.7
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG 950 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de 950 (1157)
.-++|++++.||+|+||+||+|+++ |+.||||++++....... ....+.+|+.+|++++|||||++++++.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~-----~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 76 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-----EVAHTVTESRVLQNTRHPFLTALKYAFQT- 76 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT-----CHHHHHHHHHHHHSCCCTTBCCEEEEEEC-
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHH-----HHHHHHHHHHHHHhCCCCCEEEEEeeecc-
Confidence 3468999999999999999999984 778999999875332211 24678899999999999999999999998
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
...+|+|||||+||+|..++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||
T Consensus 77 -~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~----~~g~vkl~DFG 150 (337)
T d1o6la_ 77 -HDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFG 150 (337)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCT
T ss_pred -ccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec----CCCCEEEeecc
Confidence 678999999999999999987644 589999999999999999999999999999999999998 77899999999
Q ss_pred CcccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCC
Q 001103 1031 LSRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPE 1109 (1157)
Q Consensus 1031 LAkl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~ 1109 (1157)
+|+.... .......+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.....++..+.... ..+|.
T Consensus 151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~ 226 (337)
T d1o6la_ 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPR 226 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCT
T ss_pred cccccccCCcccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCc
Confidence 9986543 3445567899999999999865 57899999999999999999999999999888888887664 45788
Q ss_pred CCcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHH
Q 001103 1110 RCDPEWRKLMEECWSFNPAARPS-----FTEITNRLRV 1142 (1157)
Q Consensus 1110 ~iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~ 1142 (1157)
.+++++++||.+||++||.+|++ +.++++|.++
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence 89999999999999999999994 8999998765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-49 Score=435.66 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=222.6
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ |+.||||++++.. . .....+.+|+++|++|+|||||+++++|.+ .
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~ 98 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----P---LDKYTVKNEISIMNQLHHPKLINLHDAFED--K 98 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----H---HHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--S
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----h---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 47999999999999999999984 7789999987642 1 113567899999999999999999999987 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+||+|.+++.+.+..+++..++.++.||+.||+|||++|||||||||+|||++.. ..+.+||+|||+|
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~--~~~~vkL~DFGla 176 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGLA 176 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc--CCCeEEEeecccc
Confidence 78999999999999999887777779999999999999999999999999999999999999732 4578999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC--CCCCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR--PQIPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr--peip~~ 1110 (1157)
+............||+.|+|||++.+. .|+.++|||||||+||+|++|++||.+......+..+...... ......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 254 (352)
T d1koba_ 177 TKLNPDEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254 (352)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred eecCCCCceeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 877665555567899999999999864 5799999999999999999999999999888888888766543 334567
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
+++++++||.+||++||.+|||+.++++|.|.
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 89999999999999999999999999997553
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=414.62 Aligned_cols=261 Identities=34% Similarity=0.579 Sum_probs=214.4
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
++..++|++.+.||+|+||+||+|++++ ..||||+++... . ......+.+|++++++|+|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~---~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----T---EKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----C---HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----C---hHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 4566789999999999999999998853 259999986531 1 12245688999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeE
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
+++.+ ...+++|||||.++++.+++......+++..++.++.|++.||+|||+++|+||||||+|||++ .++.+
T Consensus 76 g~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~----~~~~~ 149 (283)
T d1mqba_ 76 GVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVC 149 (283)
T ss_dssp EEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCE
T ss_pred EEEec--CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC----CCCeE
Confidence 99987 5679999999999999998887777799999999999999999999999999999999999998 77899
Q ss_pred EEEecCCcccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCC-CCCCCCChhHHHHHhh
Q 001103 1025 KVGDFGLSRIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE-EPYANMHCGAIIGGIL 1099 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk-~PF~g~~~eeil~~Il 1099 (1157)
||+|||+|+..... .......||+.|+|||++.+. .++.++|||||||+||||++|. +||......+++..+
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i- 226 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI- 226 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-
Confidence 99999999864332 123345689999999999854 6899999999999999999954 555555555555544
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1100 SNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1100 ~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
....+++.+..+++++.+||.+||+.||.+|||+.+|++.|..+....
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 455667788889999999999999999999999999999998877543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-48 Score=417.28 Aligned_cols=262 Identities=23% Similarity=0.261 Sum_probs=227.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCC-hhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeec
Q 001103 874 DSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRS-SEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPN 949 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~-~e~e~likqflrEIkILK~L~-HPNIVkLygvf~d 949 (1157)
.++|++++.||+|+||+||+|++ +|+.||||++++....... ...+...+.+.+|+.++++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999998 5788999999876443322 233445678899999999997 9999999999988
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.+.+|||||||++|+|.++++..+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~~kl~DF 154 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 154 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred --CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc----CCCCeEEccc
Confidence 678999999999999999997644 599999999999999999999999999999999999998 7789999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGS----NNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~----~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
|+++...........+||+.|+|||++.+. ...++.++|||||||+||+|++|++||.+.........+.......
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 999876665555667899999999998642 2346889999999999999999999999998888888887765543
Q ss_pred C--CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1106 Q--IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1106 e--ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
. ....+|+++++||.+||+.||.+|||+++++++.|.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 3 334689999999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=411.88 Aligned_cols=251 Identities=36% Similarity=0.595 Sum_probs=220.6
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..++|+++++||+|+||+||+|+++ ++.||||++++... . .+.+.+|++++++++|||||++|+++.+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~----~-----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-- 70 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----S-----EDEFIEEAKVMMNLSHEKLVQLYGVCTK-- 70 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS----C-----HHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC----C-----HHHHHHHHHHHHhcCCCceeeEEEEEee--
Confidence 4578999999999999999999996 55799999986522 1 2468899999999999999999999987
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+++||||+++|+|..++......+++..+++++.|++.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~----~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGL 146 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC----TTCCEEECCCSS
T ss_pred CCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc----CCCcEEECcchh
Confidence 5679999999999999999877777799999999999999999999999999999999999998 778999999999
Q ss_pred cccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1032 SRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1032 Akl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++ |+.||.+....++...+.. ..++..|
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p 223 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRP 223 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCC
T ss_pred heeccCCCceeecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCc
Confidence 97543332 23346799999999999854 57999999999999999998 8999999998887777754 4566788
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLR 1141 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr 1141 (1157)
..+++++++||.+||+.||.+|||+.+|+++|.
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 899999999999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=411.12 Aligned_cols=259 Identities=31% Similarity=0.579 Sum_probs=212.4
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC-----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG-----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
++..++|++.+.||+|+||+||+|++.. ..||||+++... .....+.+.+|+++|++++|||||++|+
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4566799999999999999999998842 347888765421 1333577899999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.+ +.+|+||||+++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+|
T Consensus 76 ~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~----~~~~~K 148 (273)
T d1mp8a_ 76 VITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVK 148 (273)
T ss_dssp EECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEE
T ss_pred EEec---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec----CCCcEE
Confidence 9854 468999999999999998877777799999999999999999999999999999999999999 778999
Q ss_pred EEecCCcccccCC--cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcC
Q 001103 1026 VGDFGLSRIKCNT--LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNT 1102 (1157)
Q Consensus 1026 LiDFGLAkl~~~~--~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~ 1102 (1157)
|+|||+|+..... .......||+.|+|||++.+. .++.++|||||||+||||++ |.+||......+++..+...
T Consensus 149 l~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~- 225 (273)
T d1mp8a_ 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG- 225 (273)
T ss_dssp ECC-------------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred EccchhheeccCCcceeccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999864432 223445689999999999854 57999999999999999998 89999998888888777654
Q ss_pred CCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1103 LRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1103 lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
.+++++..+++++++||.+||+.||.+|||+.+|+++|..+...
T Consensus 226 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 44567888999999999999999999999999999999887654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.1e-49 Score=424.87 Aligned_cols=250 Identities=23% Similarity=0.412 Sum_probs=219.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ |+.||||++++...... ...+.+.+|+.+|+.++|||||++++++.+ .
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 76 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-----KQVEHTNDERLMLSIVTHPFIIRMWGTFQD--A 76 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--S
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCH-----HHHHHHHHHHHHHHhccCcChhheeeeEee--C
Confidence 57999999999999999999984 78899999986532211 124678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~----~~g~vkL~DFG~a 151 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFA 151 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCSSC
T ss_pred CeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc----CCCCEEEecCccc
Confidence 78999999999999998886544 478889999999999999999999999999999999998 7789999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCCc
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERCD 1112 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~iS 1112 (1157)
+...... ...+||+.|+|||++.+. .|+.++|||||||+||+|++|+.||.+....+.+..+..... .++..++
T Consensus 152 ~~~~~~~--~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s 225 (316)
T d1fota_ 152 KYVPDVT--YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFFN 225 (316)
T ss_dssp EECSSCB--CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTSC
T ss_pred eEecccc--ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC--CCCCCCC
Confidence 8755433 347899999999999865 578999999999999999999999999988888888876643 5677899
Q ss_pred HHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1113 PEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1113 peLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
++++++|.+||.+||.+|+ |++++++|.+.
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 9999999999999999995 99999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.9e-48 Score=407.61 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=212.9
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.++|++++.||+|+||+||+|++. |+.||||++++.... .......+.+|+++++.++|||||++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 357999999999999999999984 788999999865321 1334577899999999999999999999987643
Q ss_pred C--CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 952 G--GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 952 ~--~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
. ..+|||||||+|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ ..+.++|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~----~~~~~~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTSCEEECCC
T ss_pred CCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC----ccccceeehh
Confidence 2 35899999999999998886544 589999999999999999999999999999999999999 7788999999
Q ss_pred CCcccccCC----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC
Q 001103 1030 GLSRIKCNT----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP 1105 (1157)
Q Consensus 1030 GLAkl~~~~----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp 1105 (1157)
|++...... ......+||+.|+|||++.+. .++.++|||||||+||+|++|++||.+....+.+..+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC
Confidence 998753322 233456799999999999864 67999999999999999999999999988887777776654433
Q ss_pred --CCCCCCcHHHHHHHHHHhccCCCCCC-CHHHHHHHHHHHH
Q 001103 1106 --QIPERCDPEWRKLMEECWSFNPAARP-SFTEITNRLRVMS 1144 (1157)
Q Consensus 1106 --eip~~iSpeLrdLIkrCLqkDPskRP-SaeELLe~Lr~Lk 1144 (1157)
.....+|+++++||.+||++||.+|| |++++++.|..+.
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 34567899999999999999999998 8999998887653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=411.79 Aligned_cols=251 Identities=31% Similarity=0.543 Sum_probs=209.7
Q ss_pred EEecccCcEEEEEEEEC----CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcEE
Q 001103 881 QELGSGTFGTVYRGKWR----GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 881 rkLGsGsFGtVYlAr~k----Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~Ly 956 (1157)
++||+|+||+||+|.++ ++.||||+++.... .....+.+.+|+++|++|+|||||++++++..+ ..+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC------CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEE
Confidence 57999999999999873 34699999875421 122346789999999999999999999998652 478
Q ss_pred EEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCccccc
Q 001103 957 TVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKC 1036 (1157)
Q Consensus 957 LVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~ 1036 (1157)
||||||++|+|.+++.+. +.+++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+|||+++...
T Consensus 84 lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~----~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc----ccCcccccchhhhhhcc
Confidence 999999999999998754 4589999999999999999999999999999999999999 77899999999998643
Q ss_pred CCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1037 NTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1037 ~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
... ......||+.|+|||++.+. .++.++|||||||++|||++ |++||.+....++...+. ...++..|..+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 235 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGC 235 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccccccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccc
Confidence 321 22345699999999999854 57899999999999999998 899999988777666554 44566788899
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHh
Q 001103 1112 DPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQ 1148 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLe 1148 (1157)
++++++||.+||+.||++|||+.+|++.|+.......
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 9999999999999999999999999998887765543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=421.92 Aligned_cols=254 Identities=18% Similarity=0.224 Sum_probs=221.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|++++.||+|+||+||+|+++ ++.||||++++.. .. ...+.+|+++|+.++|||||++++++.+ .
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~ 73 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TD---QVLVKKEISILNIARHRNILHLHESFES--M 73 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE--T
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------cc---HHHHHHHHHHHHhCCCCCCCeEEEEEEE--C
Confidence 57999999999999999999984 6789999997642 11 2457799999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+|||||||+||+|.+++.+.+..+++..++.++.||+.||+|||++||+||||||+|||++.+ ....+||+|||++
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQA 151 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC--CceEEEEcccchh
Confidence 68999999999999999998776679999999999999999999999999999999999999732 3468999999999
Q ss_pred ccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCC--CCCC
Q 001103 1033 RIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQ--IPER 1110 (1157)
Q Consensus 1033 kl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpe--ip~~ 1110 (1157)
.............||+.|+|||.+.+. .|+.++|||||||+||+|++|++||........+..+........ ....
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred hccccCCcccccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccC
Confidence 876555544556799999999999854 578999999999999999999999999998888888877655432 2346
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
+++++++||.+||.+||.+|||++++++|.|.-
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 899999999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=411.75 Aligned_cols=262 Identities=28% Similarity=0.492 Sum_probs=212.2
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
|++..++|+++++||+|+||+||+|++. ++.||||+++.... ....+.+.+|..++.++ +|+|||
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~~e~~~l~~~~~h~~iv 80 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVV 80 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-------HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------cHHHHHHHHHHHHHHhhcCCCeEE
Confidence 3466678999999999999999999974 24699999875321 12245677788887776 689999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCceecc
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFD 1006 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRD 1006 (1157)
.+++++... ...+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++|||||
T Consensus 81 ~~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrD 159 (299)
T d1ywna1 81 NLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 159 (299)
T ss_dssp CEEEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EeeeeeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCc
Confidence 999987653 457899999999999999986532 3488999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-
Q 001103 1007 LKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG- 1082 (1157)
Q Consensus 1007 LKPENILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG- 1082 (1157)
|||+|||++ .++.+||+|||+|+..... .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 160 lKp~NILl~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 160 LAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp CCGGGEEEC----GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCccceeEC----CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCC
Confidence 999999998 6789999999999754322 233456799999999999854 679999999999999999986
Q ss_pred CCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1083 EEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1083 k~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
.+||.+......+...+....++..+..+++++++||.+||+.||.+|||+.+++++|..+..
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 234 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 578988776666666666677778889999999999999999999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=423.18 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=207.7
Q ss_pred CCeeEEEE-ecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHh-CCCCceeEEeeeeec-
Q 001103 875 SDLEELQE-LGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISN-LHHPNVVAFYGVVPN- 949 (1157)
Q Consensus 875 sdYeILrk-LGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~-L~HPNIVkLygvf~d- 949 (1157)
++|+++++ ||+|+||+||+|++. ++.||||++++. ..+.+|+.++.+ ++|||||++|++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 58998865 999999999999984 778999998753 456689988665 589999999999865
Q ss_pred -CCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 950 -GPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 950 -e~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
.....+|||||||+||+|.+++.+. .+.+++..++.++.||+.||+|||++||+||||||+|||++..+ ..+.+||+
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~Kl~ 156 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLT 156 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEEEC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc-cccccccc
Confidence 2345799999999999999999764 35699999999999999999999999999999999999998433 56789999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc----CC
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN----TL 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~----~l 1103 (1157)
|||+|+...........+||+.|+|||++.+. .|+.++|||||||+||+|++|++||.+.........+... ..
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 99999876666566667899999999999864 5799999999999999999999999876654443333222 22
Q ss_pred CCC--CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1104 RPQ--IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1104 rpe--ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
..+ ....+++++++||.+||++||.+|||+.+++++.|..
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 111 1135789999999999999999999999999987764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-48 Score=425.94 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=219.8
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.++|++++.||+|+||+||+|+++ |+.||||++.+...... ...+.+.+|+++|+.++|||||++++++.+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-- 112 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-----KQIEHTLNEKRILQAVNFPFLVKLEFSFKD-- 112 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCH-----HHHHHHHHHHHHHHHcCCCcEeeccccccc--
Confidence 368999999999999999999984 78899999986432111 124678899999999999999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
...+++||||+.+|+|..++.+.+ .+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGF 187 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTT
T ss_pred ccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC----CCCCEEeeecee
Confidence 668999999999999999987554 589999999999999999999999999999999999998 678999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPERC 1111 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~i 1111 (1157)
|+..... ....+||+.|+|||++.+. .|+.++|||||||+||+|++|++||.+......+..+..... .++..+
T Consensus 188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 261 (350)
T d1rdqe_ 188 AKRVKGR--TWTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHF 261 (350)
T ss_dssp CEECSSC--BCCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTC
T ss_pred eeecccc--cccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC--CCCccC
Confidence 9875443 2346899999999999865 578999999999999999999999999888888888876644 457789
Q ss_pred cHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1112 DPEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1112 SpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
++++.+||.+||++||.+|+ |++++++|.|+
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 99999999999999999994 99999998775
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=412.29 Aligned_cols=259 Identities=32% Similarity=0.570 Sum_probs=214.6
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEECC-----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~kG-----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLyg 945 (1157)
.+...+|+++++||+|+||+||+|++++ ..||||++++..... +...+.+.+|+++|++++|||||++|+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----PEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-----HHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3556789999999999999999998732 258999987653211 223567899999999999999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
++.++ .+++|||||++|+|.+.+....+.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 79 ~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~----~~~~vk 151 (273)
T d1u46a_ 79 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVK 151 (273)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEeec---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc----ccccee
Confidence 99652 57899999999999998877777799999999999999999999999999999999999999 677999
Q ss_pred EEecCCcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhh
Q 001103 1026 VGDFGLSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILS 1100 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~ 1100 (1157)
|+|||+++...... ......||..|+|||++.+. .++.++|||||||++|||++ |++||.+....+.+..+..
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~ 229 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred eccchhhhhcccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh
Confidence 99999998653322 22334688899999999864 57999999999999999998 8999999999999888888
Q ss_pred cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1101 NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1101 ~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
...+++.+..+++++++||.+||+.||.+|||+.+|++.|.++
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8888888899999999999999999999999999999888764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=413.55 Aligned_cols=261 Identities=29% Similarity=0.540 Sum_probs=217.9
Q ss_pred cccccCCCeeEEEEecccCcEEEEEEEEC--Cc----eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeE
Q 001103 869 LQIIKDSDLEELQELGSGTFGTVYRGKWR--GT----DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942 (1157)
Q Consensus 869 i~~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt----~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVk 942 (1157)
++.++..+|++++.||+|+||+||+|++. |+ .||||+++.... ....+.+.+|++++++++|||||+
T Consensus 3 ~~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~ 75 (317)
T d1xkka_ 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-------PKANKEILDEAYVMASVDNPHVCR 75 (317)
T ss_dssp SEECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 35567789999999999999999999984 33 478887764311 112467899999999999999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCC
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRP 1022 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g 1022 (1157)
+++++.++ ..+++|||+.+|+|.+.+......+++..++.++.||+.||+|||+++||||||||+|||++ .++
T Consensus 76 l~g~~~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~----~~~ 148 (317)
T d1xkka_ 76 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQ 148 (317)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETT
T ss_pred EEEEEecC---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC----CCC
Confidence 99999763 47889999999999998888777899999999999999999999999999999999999998 778
Q ss_pred eEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHh
Q 001103 1023 ICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGI 1098 (1157)
Q Consensus 1023 ~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~I 1098 (1157)
.+||+|||+|+...... ......||+.|+|||++.+. .|+.++|||||||+||||+| |++||.+....++...+
T Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred CeEeeccccceecccccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 99999999998643322 23345689999999999864 68999999999999999998 89999988777765555
Q ss_pred hhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1099 LSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1099 l~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
. ...++..+..+++++.+||.+||+.||.+|||+.+|+++|..+...
T Consensus 227 ~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 227 E-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp H-HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H-cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 4 4455677888999999999999999999999999999999887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=407.41 Aligned_cols=256 Identities=34% Similarity=0.629 Sum_probs=216.3
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPN 949 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~d 949 (1157)
|++..++|++++.||+|+||.||+|+++|+.||||++++.. ..+.+.+|++++++++|||||++|+++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 45667789999999999999999999999999999987541 13568899999999999999999998865
Q ss_pred CCCCcEEEEEEeecCCcchhhhcccc-ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKD-RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~g-r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ .+.+|+||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 72 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----~~~~~kl~d 146 (262)
T d1byga_ 72 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECC
T ss_pred c-CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec----CCCCEeecc
Confidence 3 346799999999999999996543 4589999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhHHHHHhhhcCCCCCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT-GEEPYANMHCGAIIGGILSNTLRPQI 1107 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT-Gk~PF~g~~~eeil~~Il~~~lrpei 1107 (1157)
||+++...... ....+|+.|+|||++.+. .++.++|||||||++|||++ |++||.......+...+. ...++++
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~ 221 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDA 221 (262)
T ss_dssp CCC--------------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCC
T ss_pred cccceecCCCC--ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 99998654332 235689999999999854 68999999999999999998 799999888877777765 4466778
Q ss_pred CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1108 PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1108 p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
+..+++++++||.+||..||.+|||+.+|+++|+.++.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 88999999999999999999999999999999988764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.1e-48 Score=424.79 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=212.3
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
-++|++++.||+|+||+||+|++. |+.||||++.+....... .+.......+|+++++.++|||||++++++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~--~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHT-- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhh--HHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--
Confidence 468999999999999999999984 778999999765322111 12222334456778888899999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+|+|||||+||+|.+++.+.. .+++..++.++.||+.||+|||++|||||||||+|||++ ..+.+||+|||+
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~----~~g~iKl~DFGl 153 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGL 153 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSSCEEECCCTT
T ss_pred CCEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc----CCCcEEEeeece
Confidence 568999999999999999997654 588999999999999999999999999999999999998 778999999999
Q ss_pred cccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHh-hhcCCCCCCCCC
Q 001103 1032 SRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGI-LSNTLRPQIPER 1110 (1157)
Q Consensus 1032 Akl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~I-l~~~lrpeip~~ 1110 (1157)
|+...... ....+||+.|+|||++... ..|+.++|||||||+||||++|+.||............ ........++..
T Consensus 154 a~~~~~~~-~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (364)
T d1omwa3 154 ACDFSKKK-PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231 (364)
T ss_dssp CEECSSSC-CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSS
T ss_pred eeecCCCc-ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Confidence 98655443 3446799999999998743 35799999999999999999999999875543322211 122344567788
Q ss_pred CcHHHHHHHHHHhccCCCCCCC-----HHHHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPS-----FTEITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPS-----aeELLe~Lr~ 1142 (1157)
+++++++||.+||++||.+||| ++++++|.|+
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 9999999999999999999999 7999998775
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=410.47 Aligned_cols=254 Identities=25% Similarity=0.328 Sum_probs=205.1
Q ss_pred eEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCCcE
Q 001103 878 EELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGGTM 955 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~~L 955 (1157)
|.++.||+|+||+||+|+++ |+.||||+++...... ..+...+.+.+|+++|++++|||||++++++.+ .+.+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCC
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh---hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCce
Confidence 45789999999999999984 7789999987653211 112234568899999999999999999999988 5679
Q ss_pred EEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcccc
Q 001103 956 ATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIK 1035 (1157)
Q Consensus 956 yLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~ 1035 (1157)
|+||||+.++++..++. ....+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+|+..
T Consensus 76 ~ivmE~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGGSTT
T ss_pred eehhhhhcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec----CCCccccccCcccccc
Confidence 99999999988776664 445688999999999999999999999999999999999998 7789999999999765
Q ss_pred cCC-cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC---------
Q 001103 1036 CNT-LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--------- 1105 (1157)
Q Consensus 1036 ~~~-~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--------- 1105 (1157)
... ......+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+....+.+..+......+
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred CCCcccccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 443 234456799999999998754 357999999999999999999999999888777766654321100
Q ss_pred ---------C--------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1106 ---------Q--------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1106 ---------e--------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
. +...+++++.+||.+||++||++|||++|+++|.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 0 012468899999999999999999999999998764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=404.33 Aligned_cols=256 Identities=25% Similarity=0.327 Sum_probs=210.7
Q ss_pred CCeeEEEEecccCcEEEEEEEEC---CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC---CCCceeEEeeeee
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR---GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL---HHPNVVAFYGVVP 948 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k---Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L---~HPNIVkLygvf~ 948 (1157)
++|+++++||+|+||+||+|++. ++.||||+++......... ..+.+|+.+|+.| +||||+++++++.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH------HHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 68999999999999999999983 4569999998653322111 2344566666555 8999999999985
Q ss_pred c---CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEE
Q 001103 949 N---GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICK 1025 (1157)
Q Consensus 949 d---e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VK 1025 (1157)
. +....++++|||+.++.+..........+++..++.++.|++.||+|||+++||||||||+|||++ ..+.+|
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~----~~~~~k 156 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIK 156 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEE
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc----CCCCee
Confidence 3 224578999999999888766666666799999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC--
Q 001103 1026 VGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL-- 1103 (1157)
Q Consensus 1026 LiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l-- 1103 (1157)
|+|||+++............||+.|+|||++.+. .|+.++|||||||+||||++|++||.+....+.+..+.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 157 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecchhhhhhhcccccCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 9999999876666666678899999999999864 679999999999999999999999998887776666543100
Q ss_pred -----------------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 -----------------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 -----------------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
...+...+++.+++||.+||++||.+|||+.|+++|.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 012345678999999999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=416.34 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=215.3
Q ss_pred CCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHH-hCCCCceeEEeeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIIS-NLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK-~L~HPNIVkLygvf~de~ 951 (1157)
++|++++.||+|+||+||+|++ +++.||||++++...... ...+.+.+|..++. .++|||||++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~-----~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-- 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-----DDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-- 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh-----HHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--
Confidence 5899999999999999999999 477899999986432111 11345556666655 7899999999999988
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
.+.+|||||||++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~----~~~~~kl~DFG~ 149 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGM 149 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred CCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec----CCCceeccccch
Confidence 678999999999999999997544 589999999999999999999999999999999999998 778999999999
Q ss_pred cccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCCCC
Q 001103 1032 SRIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIPER 1110 (1157)
Q Consensus 1032 Akl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip~~ 1110 (1157)
++.... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.....++..+.... +.+|..
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~ 225 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRW 225 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTT
T ss_pred hhhcccccccccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcc
Confidence 986443 3334456899999999999865 57899999999999999999999999988888888776553 467788
Q ss_pred CcHHHHHHHHHHhccCCCCCCCHH-HHHHHHHH
Q 001103 1111 CDPEWRKLMEECWSFNPAARPSFT-EITNRLRV 1142 (1157)
Q Consensus 1111 iSpeLrdLIkrCLqkDPskRPSae-ELLe~Lr~ 1142 (1157)
+++++++||.+||++||.+|||+. ++++|.+.
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence 999999999999999999999995 78876554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-47 Score=407.13 Aligned_cols=257 Identities=32% Similarity=0.561 Sum_probs=218.2
Q ss_pred ccCCCeeEEEEecccCcEEEEEEEECC-------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEe
Q 001103 872 IKDSDLEELQELGSGTFGTVYRGKWRG-------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFY 944 (1157)
Q Consensus 872 I~~sdYeILrkLGsGsFGtVYlAr~kG-------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLy 944 (1157)
+..++|+++++||+|+||+||+|++++ +.||||+++... .....+.+.+|+++|++++||||++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-------ChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 445689999999999999999999854 569999987531 122356789999999999999999999
Q ss_pred eeeecCCCCcEEEEEEeecCCcchhhhccc-----------------------cccccHHHHHHHHHHHHHHHHHHHHCC
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSLRHVLARK-----------------------DRILDRRKKLMLMMDAAFGMEYLHMKN 1001 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL~dlLkr~-----------------------gr~L~e~qVlkIa~QLa~ALeYLHSkG 1001 (1157)
+++.. ...++++|||+.+|+|.+++... ...+++..++.++.|++.||+|||+++
T Consensus 83 ~~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 83 GVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeecc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 99987 56789999999999999988532 124788999999999999999999999
Q ss_pred ceeccCCccceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHH
Q 001103 1002 IVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWE 1078 (1157)
Q Consensus 1002 IIHRDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYE 1078 (1157)
||||||||+|||++ .++.+||+|||+|+..... .......||+.|+|||++.+. .|+.++|||||||+|||
T Consensus 161 ivHrDlKp~NILld----~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 161 FVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWE 234 (301)
T ss_dssp CCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHH
T ss_pred eEeeEEcccceEEC----CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHH
Confidence 99999999999998 6789999999999754322 223456789999999999854 68999999999999999
Q ss_pred HHcCC-CCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 001103 1079 IITGE-EPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMS 1144 (1157)
Q Consensus 1079 LLTGk-~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk 1144 (1157)
|++|. +||.+....+++..+.... .+.++..+++++.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 235 ll~~~~~p~~~~~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 235 IFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHccCCCCCCCCCHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 99985 6899888888887776554 56678889999999999999999999999999999998763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=405.69 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=208.5
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|+++++||+|+||+||+|++. |+.||||+++..... +.....+.+|+++|++++|||||++++++.+ .
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~ 73 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHT--E 73 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC------hHHHHHHHHHHHHHHhCCCCcEEEecccccc--c
Confidence 58999999999999999999984 788999999754211 1224678899999999999999999999988 6
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
..+|+||||+.++.+..........+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 74 ~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~----~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 149 (298)
T ss_dssp TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTHH
T ss_pred cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec----ccCcceeccCCcc
Confidence 689999999987655555455566799999999999999999999999999999999999998 6779999999999
Q ss_pred ccccC-CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC-------
Q 001103 1033 RIKCN-TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR------- 1104 (1157)
Q Consensus 1033 kl~~~-~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr------- 1104 (1157)
+.... ........||+.|+|||++... ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred eeccCCcccceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 86543 2344456799999999998764 34688999999999999999999999988776665554321000
Q ss_pred ---------CCC-----------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1105 ---------PQI-----------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 ---------pei-----------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+ ...+++++++||.+||+.||.+|||+.|+++|.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 000 12467899999999999999999999999998664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=408.04 Aligned_cols=261 Identities=33% Similarity=0.560 Sum_probs=212.6
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC-ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG-TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVP 948 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG-t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~ 948 (1157)
|.+..++|++.+.||+|+||+||+|++++ ..||||+++.... . .+.|.+|+.++++++|||||++|+++.
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~----~-----~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----S-----PEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----C-----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC----C-----HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 44566799999999999999999999954 5699999875421 1 256889999999999999999999986
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccc-cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARK-DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~-gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
+ +.+++|||||++|+|.+++... .+.+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 83 ~---~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~----~~~~~kl~ 155 (285)
T d1fmka3 83 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVA 155 (285)
T ss_dssp S---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred c---CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC----CCCcEEEc
Confidence 5 3478999999999999888653 45699999999999999999999999999999999999998 67899999
Q ss_pred ecCCcccccCCc--ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCC-CCCCCCChhHHHHHhhhcCCC
Q 001103 1028 DFGLSRIKCNTL--VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGE-EPYANMHCGAIIGGILSNTLR 1104 (1157)
Q Consensus 1028 DFGLAkl~~~~~--~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk-~PF~g~~~eeil~~Il~~~lr 1104 (1157)
|||+|+...... ......||+.|+|||++... .++.++|||||||+||||++|. +||......+.+..+. ...+
T Consensus 156 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~ 232 (285)
T d1fmka3 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 232 (285)
T ss_dssp CCCTTC--------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred ccchhhhccCCCceeeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCC
Confidence 999998653332 23345699999999999754 6799999999999999999954 5555555555655554 4456
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
.+.+..+++++++||.+||+.||++|||+++|++.|+.+......
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 678889999999999999999999999999999988876544433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=405.60 Aligned_cols=259 Identities=33% Similarity=0.564 Sum_probs=217.6
Q ss_pred cccCCCeeEEEEecccCcEEEEEEEEC--Cc--eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCceeEEee
Q 001103 871 IIKDSDLEELQELGSGTFGTVYRGKWR--GT--DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVVAFYG 945 (1157)
Q Consensus 871 ~I~~sdYeILrkLGsGsFGtVYlAr~k--Gt--~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIVkLyg 945 (1157)
.+..++|++.++||+|+||+||+|+++ +. .||||+++.... ....+.+.+|+++|+++ +|||||++|+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-------hHHHHHHHHHHHHHHhccCCCCEeeEEE
Confidence 355679999999999999999999984 33 377887764321 11245789999999999 7999999999
Q ss_pred eeecCCCCcEEEEEEeecCCcchhhhccc---------------cccccHHHHHHHHHHHHHHHHHHHHCCceeccCCcc
Q 001103 946 VVPNGPGGTMATVTEYMVNGSLRHVLARK---------------DRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCD 1010 (1157)
Q Consensus 946 vf~de~~~~LyLVMEYmeGGSL~dlLkr~---------------gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPE 1010 (1157)
++.+ .+.+++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+++|+||||||+
T Consensus 79 ~~~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~ 156 (309)
T d1fvra_ 79 ACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156 (309)
T ss_dssp EEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEec--CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccc
Confidence 9987 67899999999999999998643 356899999999999999999999999999999999
Q ss_pred ceeeccCCCCCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 001103 1011 NLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG-EEPYANM 1089 (1157)
Q Consensus 1011 NILLd~dd~e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG-k~PF~g~ 1089 (1157)
|||++ ..+.+||+|||+|+............||..|+|||.+.+. .++.++|||||||++|||++| .+||.+.
T Consensus 157 NIL~~----~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 157 NILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp GEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEEc----CCCceEEccccccccccccccccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 99998 6779999999999865544444456799999999999854 679999999999999999996 4678888
Q ss_pred ChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1090 HCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1090 ~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
...++...+.. ..++..+..+++++++||.+||+.||++|||+++++++|..+..
T Consensus 231 ~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 231 TCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp CHHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 88777777654 45677888899999999999999999999999999999988764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=400.96 Aligned_cols=260 Identities=29% Similarity=0.517 Sum_probs=217.4
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEECC---------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCc
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPN 939 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~kG---------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPN 939 (1157)
|.+..++|++++.||+|+||.||+|+..+ ..||||++++.. .+.....+.+|...+.++ +|||
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-------ChHHHHHHHHHHHHHHHhcCCCe
Confidence 44667899999999999999999998732 359999987542 122356788899999888 7999
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------------RILDRRKKLMLMMDAAFGMEYLHMKNIVH 1004 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIH 1004 (1157)
||++++++.+ .+.+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++|||
T Consensus 81 Iv~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH 158 (299)
T d1fgka_ 81 IINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 158 (299)
T ss_dssp BCCEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEeccccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEe
Confidence 9999999987 568999999999999999986432 35899999999999999999999999999
Q ss_pred ccCCccceeeccCCCCCCeEEEEecCCcccccCCc---ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1005 FDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTL---VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1005 RDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~~---~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
|||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .|+.++|||||||+||||++
T Consensus 159 rDiKp~NiLl~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 159 RDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp SCCSGGGEEEC----TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHT
T ss_pred eeecccceeec----CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhcc
Confidence 99999999998 77899999999998654332 23446799999999999854 68999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1082 -GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
|.+||.+.....++..+. ...++..+..+++++++||.+||++||.+|||+.+|++.|..+..
T Consensus 233 ~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 799999888777665554 456778889999999999999999999999999999999988754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=401.03 Aligned_cols=261 Identities=31% Similarity=0.510 Sum_probs=224.5
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNL-HHPNVV 941 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L-~HPNIV 941 (1157)
|++..++|++.++||+|+||.||+|++. ++.||||+++... . ......+.+|+.+++++ +|||||
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~---~~~~~~~~~E~~~~~~l~~HpnIv 90 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----H---LTEREALMSELKVLSYLGNHMNIV 90 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----C---HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----C---HHHHHHHHHHHHHHHhccCCCCEE
Confidence 4566689999999999999999999873 3469999997642 1 22246788999999999 699999
Q ss_pred EEeeeeecCCCCcEEEEEEeecCCcchhhhcccc-----------------ccccHHHHHHHHHHHHHHHHHHHHCCcee
Q 001103 942 AFYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD-----------------RILDRRKKLMLMMDAAFGMEYLHMKNIVH 1004 (1157)
Q Consensus 942 kLygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g-----------------r~L~e~qVlkIa~QLa~ALeYLHSkGIIH 1004 (1157)
++++++.+ ...+++|||||++|+|.+++.+.. ..+++..++.++.||+.||+|||+++|||
T Consensus 91 ~~~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH 168 (311)
T d1t46a_ 91 NLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168 (311)
T ss_dssp CEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEee--CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 99999987 457899999999999999986532 24889999999999999999999999999
Q ss_pred ccCCccceeeccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 001103 1005 FDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIIT 1081 (1157)
Q Consensus 1005 RDLKPENILLd~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLT 1081 (1157)
|||||+|||++ ..+.+||+|||+++..... ......+||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 169 rDLKp~NIl~~----~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 169 RDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp SCCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccc----ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHh
Confidence 99999999998 7789999999999865432 234456799999999999854 67999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1082 -GEEPYANMHCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1082 -Gk~PF~g~~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
|.+||......+.+..++....++..+..+++++.+||.+||+.||.+|||+.+|++.|+....
T Consensus 243 ~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp TTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 7777888777777777887888888888999999999999999999999999999999987654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-46 Score=395.15 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=207.8
Q ss_pred CCeeEEEEecccCcEEEEEEEEC-CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR-GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k-Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~~ 953 (1157)
++|+++++||+|+||+||+|+++ |+.||||+++..... +...+.+.+|+.+|++++|||||++++++.. .+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED------EGIPSTTIREISILKELKHSNIVKLYDVIHT--KK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SS
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC------hHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CC
Confidence 58999999999999999999984 678999999765321 1123678899999999999999999999988 56
Q ss_pred cEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCcc
Q 001103 954 TMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSR 1033 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLAk 1033 (1157)
..+++|||+.++.+..+.. ..+.+++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+|||+|.
T Consensus 74 ~~~i~~e~~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~----~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred ceeEEEEeehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc----CCCCEEecccccce
Confidence 8999999998877766654 445699999999999999999999999999999999999998 67899999999998
Q ss_pred cccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC--------
Q 001103 1034 IKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR-------- 1104 (1157)
Q Consensus 1034 l~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr-------- 1104 (1157)
...... ......|++.|+|||.+.+. ..++.++|||||||++|||++|+.||.+....+.+.++......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ecccCccccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 654432 23445699999999999754 35789999999999999999999999988776666554321000
Q ss_pred -------------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1105 -------------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1105 -------------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
......+++++++||++||++||++|||+.|+++|.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 11234578999999999999999999999999988653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=399.82 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=205.6
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--CCceeEEeeeeec
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--HPNVVAFYGVVPN 949 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--HPNIVkLygvf~d 949 (1157)
.++|++.+.||+|+||+||+|++. |+.||||++++.......... ...++.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~--~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP--NGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT--TCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhh--HHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 358999999999999999999984 778999999875433211110 1134568999999996 8999999999988
Q ss_pred CCCCcEEEEEEeecC-CcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 950 GPGGTMATVTEYMVN-GSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 950 e~~~~LyLVMEYmeG-GSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
.+.+++||||+.+ +++.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++ .+.+.+||+|
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~---~~~~~vkl~D 154 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID---LNRGELKLID 154 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEEECC
T ss_pred --CCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe---cCCCeEEECc
Confidence 5689999999976 5677777544 4589999999999999999999999999999999999997 2347899999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCCCCC
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRPQIP 1108 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrpeip 1108 (1157)
||+|+...... ....+||+.|+|||++.+.. .++.++|||||||+||+|++|+.||.... .+... ...++
T Consensus 155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~ 224 (273)
T d1xwsa_ 155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFR 224 (273)
T ss_dssp CTTCEECCSSC-BCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCS
T ss_pred cccceeccccc-ccccccCCCcCCHHHHcCCC-CCCcccccccceeeehhHhhCCCCCCCch------HHhhc--ccCCC
Confidence 99998654433 34578999999999997642 34678999999999999999999997532 22222 23466
Q ss_pred CCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1109 ERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1109 ~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..+|+++++||.+||++||++|||+++++++.|.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 7899999999999999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-45 Score=392.70 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=207.5
Q ss_pred cCCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeec
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPN 949 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~d 949 (1157)
..++|+++++||+|+||+||+|++. |+.||||++++.. .+.+.+|+++|+++. ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 4468999999999999999999984 7789999987531 256789999999995 9999999999987
Q ss_pred CCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEec
Q 001103 950 GPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 1029 (1157)
Q Consensus 950 e~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDF 1029 (1157)
.....+++|||||.+++|..+.+ .+++..++.++.||+.||+|||++||+||||||+|||++. +...+||+||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~---~~~~vkl~DF 174 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHRKLRLIDW 174 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEEECCG
T ss_pred cCCCceeEEEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC---CCCeeeeccc
Confidence 66778999999999999977653 4899999999999999999999999999999999999982 3457999999
Q ss_pred CCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhH-HHHHhhh--------
Q 001103 1030 GLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGA-IIGGILS-------- 1100 (1157)
Q Consensus 1030 GLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~ee-il~~Il~-------- 1100 (1157)
|+|+...........+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp GGCEECCTTCCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred ccceeccCCCcccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 999876665556667899999999998764 357899999999999999999999997654321 1111100
Q ss_pred ---------------------------cCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1101 ---------------------------NTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1101 ---------------------------~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
..........+++++++||++||.+||.+|||++|+|+|.|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 001111223478999999999999999999999999998775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=395.27 Aligned_cols=257 Identities=28% Similarity=0.479 Sum_probs=211.3
Q ss_pred eEEEEecccCcEEEEEEEECC-----ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 878 EELQELGSGTFGTVYRGKWRG-----TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~kG-----t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+.++||+|+||+||+|++.. ..||||++++.. .....+.+.+|+++|++|+|||||++++++... .
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~ 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-E 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-T
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-C
Confidence 346789999999999999832 248999986431 122357899999999999999999999997653 4
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
+.+++|||||++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ +.+.+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSSGGG
T ss_pred CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC----CCCCEEEecccch
Confidence 578999999999999999987777788999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCCc-----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hHHHHHhhhcCCCCC
Q 001103 1033 RIKCNTL-----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHC-GAIIGGILSNTLRPQ 1106 (1157)
Q Consensus 1033 kl~~~~~-----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~-eeil~~Il~~~lrpe 1106 (1157)
+...... ......||+.|+|||.+... .++.++||||||++||||++|..||..... ......+. ...++.
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~ 254 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLL 254 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCC
T ss_pred hhccccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 8643321 22335689999999998754 679999999999999999997777765433 33334443 445667
Q ss_pred CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHHhh
Q 001103 1107 IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTALQT 1149 (1157)
Q Consensus 1107 ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aLes 1149 (1157)
.|..+++++.+||.+||+.||.+|||+.+|+++|+.+......
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 7888999999999999999999999999999999988765444
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=396.65 Aligned_cols=258 Identities=31% Similarity=0.522 Sum_probs=219.7
Q ss_pred ccccCCCeeEEEEecccCcEEEEEEEEC-------CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeE
Q 001103 870 QIIKDSDLEELQELGSGTFGTVYRGKWR-------GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVA 942 (1157)
Q Consensus 870 ~~I~~sdYeILrkLGsGsFGtVYlAr~k-------Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVk 942 (1157)
|++..++|++.++||+|+||+||+|+++ ++.||||++++.. . ......+.+|++++++++|||||+
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-----~--~~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----S--MRERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-----C--HHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-----C--hHHHHHHHHHHHHHHHcCCCCEee
Confidence 4566789999999999999999999885 3569999987531 1 122457889999999999999999
Q ss_pred EeeeeecCCCCcEEEEEEeecCCcchhhhcccc---------ccccHHHHHHHHHHHHHHHHHHHHCCceeccCCcccee
Q 001103 943 FYGVVPNGPGGTMATVTEYMVNGSLRHVLARKD---------RILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLL 1013 (1157)
Q Consensus 943 Lygvf~de~~~~LyLVMEYmeGGSL~dlLkr~g---------r~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENIL 1013 (1157)
+++++.. ...+++|||||.+|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 88 ~~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 88 LLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165 (308)
T ss_dssp EEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEec--CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCcee
Confidence 9999977 557899999999999999886432 23688899999999999999999999999999999999
Q ss_pred eccCCCCCCeEEEEecCCcccccCC---cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 001103 1014 VNLRDPQRPICKVGDFGLSRIKCNT---LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITG-EEPYANM 1089 (1157)
Q Consensus 1014 Ld~dd~e~g~VKLiDFGLAkl~~~~---~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTG-k~PF~g~ 1089 (1157)
++ .++++||+|||+|+..... .......||+.|+|||.+.+. .++.++|||||||+||||++| ++||.+.
T Consensus 166 ld----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 166 VA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp EC----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ec----CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 98 7789999999999854332 223345689999999999854 578999999999999999998 5889998
Q ss_pred ChhHHHHHhhhcCCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1090 HCGAIIGGILSNTLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1090 ~~eeil~~Il~~~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
...+.+..+.... ++..+..+++.+++||.+||+.||.+|||+.+|+++|+..
T Consensus 240 ~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 240 SNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CHHHHHHHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 8888887776544 4567788999999999999999999999999999988765
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=401.68 Aligned_cols=251 Identities=23% Similarity=0.280 Sum_probs=204.6
Q ss_pred CeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC---
Q 001103 876 DLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG--- 950 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de--- 950 (1157)
+|+.+++||+|+||+||+|++. |+.||||++++... .+.+|+++|++|+|||||+++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 7899999999999999999994 77899999976421 123699999999999999999998532
Q ss_pred -CCCcEEEEEEeecCCcchhhhc--cccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 951 -PGGTMATVTEYMVNGSLRHVLA--RKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 951 -~~~~LyLVMEYmeGGSL~dlLk--r~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
...++|||||||+++.+..+.. .....+++..++.++.||+.||+|||++||+||||||+|||++. +...+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~---~~~~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---DTAVLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT---TTCCEEEC
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec---CCCceeEe
Confidence 2446899999998765444332 23456999999999999999999999999999999999999982 23489999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc------
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN------ 1101 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~------ 1101 (1157)
|||+++...........+||+.|+|||++.+. ..|+.++|||||||++|||++|+.||......+.+..+...
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccchhhccCCcccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 99999876655555667899999999998754 35799999999999999999999999988776665554321
Q ss_pred ---------CCC------------CCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1102 ---------TLR------------PQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1102 ---------~lr------------peip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
... ......+++++.+||.+||++||.+|||+.|+++|.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 000 01223578999999999999999999999999998664
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=393.93 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=202.9
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
..+|+++++||+|+||+||+|+++ |+.||||++++... .+...+.+.+|+++|++|+|||||+++++|....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 468999999999999999999984 78899999975421 1234578899999999999999999999997643
Q ss_pred ----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEE
Q 001103 952 ----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVG 1027 (1157)
Q Consensus 952 ----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLi 1027 (1157)
...+|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~----~~~~~kl~ 163 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKIL 163 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc----cccccccc
Confidence 23579999999 5677777653 3599999999999999999999999999999999999998 77899999
Q ss_pred ecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCC----
Q 001103 1028 DFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTL---- 1103 (1157)
Q Consensus 1028 DFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~l---- 1103 (1157)
|||+|+...... +...||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+......+..+.....
T Consensus 164 Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 164 DFGLARQADSEM--TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCTTCEECCSSC--CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccceeccCCcc--ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 999998654433 346799999999998764 3468999999999999999999999998776555433322100
Q ss_pred -------------------------CCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1104 -------------------------RPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1104 -------------------------rpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.......+++++.+||.+||..||.+|||++++|+|.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 011234578999999999999999999999999998664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=384.92 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=202.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP- 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~- 951 (1157)
++|+++++||+|+||+||+|+++ |+.||||++.+..... .....+.+|+++|++++||||+++++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch------HHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 58999999999999999999984 7789999987653221 12356789999999999999999999885532
Q ss_pred -----CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 952 -----GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 952 -----~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
...+|+||||+.++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----~~~~~kl 158 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKL 158 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEE
T ss_pred cccccCceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec----CCCcEEe
Confidence 34689999999887665444 4455689999999999999999999999999999999999998 7789999
Q ss_pred EecCCcccccCC-----cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc
Q 001103 1027 GDFGLSRIKCNT-----LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN 1101 (1157)
Q Consensus 1027 iDFGLAkl~~~~-----~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~ 1101 (1157)
+|||+++..... ......+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.........+...
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 999999754321 122345799999999998764 35789999999999999999999999988776665554332
Q ss_pred C--CCCCCCC----------------------------CCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1102 T--LRPQIPE----------------------------RCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1102 ~--lrpeip~----------------------------~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
. ..+.... ..++++.+||.+||++||++|||++|+++|.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 1 1111100 136778899999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=390.56 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=201.9
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
.+|+++++||+|+||+||+|+++ |+.||||++++.. .....+.+.+|+.+|++|+||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 57999999999999999999984 7889999997531 12335678899999999999999999999865321
Q ss_pred --CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecC
Q 001103 953 --GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFG 1030 (1157)
Q Consensus 953 --~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFG 1030 (1157)
...+++|+|+.+|+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++ ..+.+||+|||
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~----~~~~~kl~DfG 154 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFG 154 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCT
T ss_pred cccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC----CCCCEEEcccC
Confidence 1234455667799999999643 589999999999999999999999999999999999998 77899999999
Q ss_pred CcccccCCc----ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcC----
Q 001103 1031 LSRIKCNTL----VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNT---- 1102 (1157)
Q Consensus 1031 LAkl~~~~~----~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~---- 1102 (1157)
+|+...... .....+||+.|+|||++... ..++.++||||+||++|+|++|+.||................
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred ceeeccCCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence 997543322 23456799999999998654 457899999999999999999999998876554443332110
Q ss_pred ------------------CCC-------CCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1103 ------------------LRP-------QIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1103 ------------------lrp-------eip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
... .....+++++++||.+||+.||.+|||+.+++++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 000 1123578899999999999999999999999998653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=375.69 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=207.3
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~ 952 (1157)
++|+++++||+|+||+||+|++. ++.||||+++..... +....++.+|+.+|+.++|||||++++++.+ .
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 73 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHS--D 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC------hHHHHHHHHHHHHHHhcCcCCEEeecccccc--c
Confidence 48999999999999999999984 667999999765321 1235778899999999999999999999988 5
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCCc
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLS 1032 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGLA 1032 (1157)
...+++|+++.+++|..++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++ ..+.+||+|||.|
T Consensus 74 ~~~~iv~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~----~~~~~kl~DFG~a 148 (292)
T d1unla_ 74 KKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp SEEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred cceeEEeeecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc----cCCceeeeecchh
Confidence 688999999999988777754 45688999999999999999999999999999999999998 6778999999999
Q ss_pred ccccCCc-ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhHHHHHhhhc---------
Q 001103 1033 RIKCNTL-VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYAN-MHCGAIIGGILSN--------- 1101 (1157)
Q Consensus 1033 kl~~~~~-~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g-~~~eeil~~Il~~--------- 1101 (1157)
+...... ......+++.|+|||++.+. ..++.++|||||||++|||++|+.||.. ....+.+..+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred hcccCCCccceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 8654433 33345678899999998764 3468999999999999999999998644 3434444333211
Q ss_pred ------------------CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHH
Q 001103 1102 ------------------TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRV 1142 (1157)
Q Consensus 1102 ------------------~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~ 1142 (1157)
.........+++++++||.+||+.||.+|||++|+++|.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 01112334578899999999999999999999999998654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=386.63 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=203.0
Q ss_pred CCeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCC--
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGPG-- 952 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~~-- 952 (1157)
.+|.+.++||+|+||+||+|+++|+.||||+++... . . ......|+..++.++|||||++++++.++..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~------~-~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------E-R--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG------H-H--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc------h-h--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 478889999999999999999999999999986531 1 1 1222345666678899999999999976433
Q ss_pred CcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHH--------CCceeccCCccceeeccCCCCCCeE
Q 001103 953 GTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHM--------KNIVHFDLKCDNLLVNLRDPQRPIC 1024 (1157)
Q Consensus 953 ~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHS--------kGIIHRDLKPENILLd~dd~e~g~V 1024 (1157)
..+|+|||||++|+|.+++++. .+++..++.++.|++.||.|||+ +|||||||||+|||++ .++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~----~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC----TTSCE
T ss_pred eEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc----CCCCe
Confidence 2689999999999999999754 48899999999999999999996 5999999999999998 77899
Q ss_pred EEEecCCcccccCCc-----ccCCCCCCCcccCcccccCCCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCC-----
Q 001103 1025 KVGDFGLSRIKCNTL-----VSGGVRGTLPWMAPELLNGSNN----RVSEKVDVYSFGIAMWEIITGEEPYANMH----- 1090 (1157)
Q Consensus 1025 KLiDFGLAkl~~~~~-----~sts~~GTp~YmAPEVL~G~~~----~yS~KSDIWSLGVILYELLTGk~PF~g~~----- 1090 (1157)
||+|||+++...... ......||+.|+|||++.+... .++.++|||||||+||||++|..||....
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 999999998653322 2345679999999999875422 25778999999999999999988874321
Q ss_pred ----------hhHHHHHhhhcCCCCCCCCCC-----cHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001103 1091 ----------CGAIIGGILSNTLRPQIPERC-----DPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTA 1146 (1157)
Q Consensus 1091 ----------~eeil~~Il~~~lrpeip~~i-----SpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~a 1146 (1157)
............+++.++... ...+.+||.+||+.||++|||+.+|++.|.++...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 123333444455555555432 34589999999999999999999999999988743
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-44 Score=379.79 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=201.0
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEE-eeeeecCC
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAF-YGVVPNGP 951 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkL-ygvf~de~ 951 (1157)
.+|+++++||+|+||+||+|++. |+.||||++...... ..+.+|+++++.++|+++|.+ +.++.+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-- 74 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE-- 74 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEE--
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----------HHHHHHHHHHHHccCCCcccEEEEEEec--
Confidence 57999999999999999999984 778999998764211 236689999999987765554 454455
Q ss_pred CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEecCC
Q 001103 952 GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGL 1031 (1157)
Q Consensus 952 ~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiDFGL 1031 (1157)
....++||||+. ++|...+....+.+++..++.++.|++.||+|||++|||||||||+|||++..+ ....+||+|||+
T Consensus 75 ~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~-~~~~vkl~DFG~ 152 (299)
T d1ckia_ 75 GDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGL 152 (299)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCSS
T ss_pred CCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC-CCceeeeeccCc
Confidence 568899999994 566666666667799999999999999999999999999999999999987443 456899999999
Q ss_pred cccccCCc--------ccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHh---hh
Q 001103 1032 SRIKCNTL--------VSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGI---LS 1100 (1157)
Q Consensus 1032 Akl~~~~~--------~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~I---l~ 1100 (1157)
|+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ ..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 98644321 23456799999999999865 5799999999999999999999999876544322221 11
Q ss_pred c---CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHH
Q 001103 1101 N---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMST 1145 (1157)
Q Consensus 1101 ~---~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~ 1145 (1157)
. ...+.+...+|+++.+||.+||+.+|.+||++.+|.+.|+.+..
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 1 11122445789999999999999999999999999888877654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=394.14 Aligned_cols=257 Identities=22% Similarity=0.382 Sum_probs=211.3
Q ss_pred CCeeEEEEecccCcEEEEEEEE-----CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC-CceeEEeeeee
Q 001103 875 SDLEELQELGSGTFGTVYRGKW-----RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH-PNVVAFYGVVP 948 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~-----kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H-PNIVkLygvf~ 948 (1157)
++|++++.||+|+||+||+|+. +|+.||||++++........ ..+.+.+|+++|++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~----~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----TTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES----SGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH----HHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 6799999999999999999987 36779999997653321111 13457789999999976 89999999998
Q ss_pred cCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 949 NGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 949 de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
+ ...++++|||+.+|+|.+++...+ .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 100 ~--~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~vkL~D 172 (322)
T d1vzoa_ 100 T--ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTD 172 (322)
T ss_dssp E--TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEESC
T ss_pred c--CCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec----CCCCEEEee
Confidence 8 568999999999999999987654 467889999999999999999999999999999999998 677999999
Q ss_pred cCCcccccC--CcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhc--CCC
Q 001103 1029 FGLSRIKCN--TLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSN--TLR 1104 (1157)
Q Consensus 1029 FGLAkl~~~--~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~--~lr 1104 (1157)
||+++.... ........|++.|+|||.+.+....++.++|||||||+||+|++|+.||...........+... ...
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 999975432 2234456799999999999876667889999999999999999999999876554433333322 234
Q ss_pred CCCCCCCcHHHHHHHHHHhccCCCCCC-----CHHHHHHHHHH
Q 001103 1105 PQIPERCDPEWRKLMEECWSFNPAARP-----SFTEITNRLRV 1142 (1157)
Q Consensus 1105 peip~~iSpeLrdLIkrCLqkDPskRP-----SaeELLe~Lr~ 1142 (1157)
+.++..+++++.+||.+||.+||.+|| |++|+++|.+.
T Consensus 253 ~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 253 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 556778999999999999999999999 58999998775
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=387.01 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=205.0
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNGP 951 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de~ 951 (1157)
.++|+++++||+|+||+||+|++. |+.||||++++... .....+.+.+|+++|++|+|||||++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 368999999999999999999984 78899999986421 1222467889999999999999999999986431
Q ss_pred ---CCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 952 ---GGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 952 ---~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
....+++|+|+.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~----~~~~~kl~d 164 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILD 164 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECC
T ss_pred ccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc----ccccccccc
Confidence 2344566778889999999854 3599999999999999999999999999999999999998 778999999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCCC---
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLRP--- 1105 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lrp--- 1105 (1157)
||++...... ..+..||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.........+......+
T Consensus 165 fg~a~~~~~~--~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 165 FGLARHTDDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp C----CCTGG--GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cchhcccCcc--cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 9999754333 3346799999999998754 346889999999999999999999999887666555543321111
Q ss_pred ------------------C--------CCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1106 ------------------Q--------IPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1106 ------------------e--------ip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
. ....+++++++||.+||+.||.+|||++|+++|.|.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 0 1134789999999999999999999999999987753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.8e-43 Score=371.73 Aligned_cols=259 Identities=18% Similarity=0.231 Sum_probs=211.4
Q ss_pred CCCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCC-CceeEEeeeeecC
Q 001103 874 DSDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHH-PNVVAFYGVVPNG 950 (1157)
Q Consensus 874 ~sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~H-PNIVkLygvf~de 950 (1157)
..+|+++++||+|+||+||+|++. |+.||||++..... ...+.+|+++++.|.| +|++.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~- 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------APQLRDEYRTYKLLAGCTGIPNVYYFGQE- 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----------cHHHHHHHHHHHHhcCCCCCCEEEEEeec-
Confidence 568999999999999999999984 77899999875421 1235678889999965 899999999887
Q ss_pred CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCC-CCCCeEEEEec
Q 001103 951 PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRD-PQRPICKVGDF 1029 (1157)
Q Consensus 951 ~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd-~e~g~VKLiDF 1029 (1157)
....++||||+ +++|.+++...+..+++..++.++.|++.||+|||++|||||||||+|||++... ...+.+||+||
T Consensus 73 -~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 73 -GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred -CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence 66889999999 6799999887777899999999999999999999999999999999999997432 23578999999
Q ss_pred CCcccccCC--------cccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---HHHHHh
Q 001103 1030 GLSRIKCNT--------LVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG---AIIGGI 1098 (1157)
Q Consensus 1030 GLAkl~~~~--------~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e---eil~~I 1098 (1157)
|+|+..... .....++||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... .....+
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 999864322 123356799999999999864 5899999999999999999999999865432 222222
Q ss_pred hhc---CCCCCCCCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 001103 1099 LSN---TLRPQIPERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVMSTAL 1147 (1157)
Q Consensus 1099 l~~---~lrpeip~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~Lk~aL 1147 (1157)
... .....++..+|+++.+||..|++.+|.+||++..+.+.|..+....
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 221 1222345668899999999999999999999999999888876544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=387.27 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=195.4
Q ss_pred CCeeEEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--
Q 001103 875 SDLEELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNVVAFYGVVPNG-- 950 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNIVkLygvf~de-- 950 (1157)
.+|+++++||+|+||+||+|+++ |+.||||++++... ......++.+|+.+|++++|||||+++++|...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 57999999999999999999984 78899999986521 122346788999999999999999999998653
Q ss_pred --CCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEEEe
Q 001103 951 --PGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 1028 (1157)
Q Consensus 951 --~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKLiD 1028 (1157)
....+|+|||||.++.+.. +. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~----~~~~~kl~d 162 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 162 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECC
T ss_pred cccCceeEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc----cccceeeec
Confidence 2468999999997765544 32 3488999999999999999999999999999999999998 678899999
Q ss_pred cCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhHHHHHhhhcCCC----
Q 001103 1029 FGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCGAIIGGILSNTLR---- 1104 (1157)
Q Consensus 1029 FGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~eeil~~Il~~~lr---- 1104 (1157)
||+++...........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......
T Consensus 163 f~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp CCC---------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhhhhccccccccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 9999876666666667899999999999864 6789999999999999999999999887765554443221100
Q ss_pred ------------------CC------------C------CCCCcHHHHHHHHHHhccCCCCCCCHHHHHHHHHHH
Q 001103 1105 ------------------PQ------------I------PERCDPEWRKLMEECWSFNPAARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1105 ------------------pe------------i------p~~iSpeLrdLIkrCLqkDPskRPSaeELLe~Lr~L 1143 (1157)
.. . ....++++.+||++||.+||++|||++++|+|.|.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 00 0 011356789999999999999999999999998764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-39 Score=347.07 Aligned_cols=258 Identities=18% Similarity=0.235 Sum_probs=193.1
Q ss_pred cCCCeeEEEEecccCcEEEEEEEE--CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-----------CCc
Q 001103 873 KDSDLEELQELGSGTFGTVYRGKW--RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-----------HPN 939 (1157)
Q Consensus 873 ~~sdYeILrkLGsGsFGtVYlAr~--kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-----------HPN 939 (1157)
...+|+++++||+|+||+||+|++ +|+.||||++++.. ...+.+.+|+++++.++ |+|
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---------cchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 345799999999999999999998 47889999998641 22356678888888875 578
Q ss_pred eeEEeeeeecCCCCcEEEEEEeecCCcchhh--hccccccccHHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecc
Q 001103 940 VVAFYGVVPNGPGGTMATVTEYMVNGSLRHV--LARKDRILDRRKKLMLMMDAAFGMEYLHM-KNIVHFDLKCDNLLVNL 1016 (1157)
Q Consensus 940 IVkLygvf~de~~~~LyLVMEYmeGGSL~dl--Lkr~gr~L~e~qVlkIa~QLa~ALeYLHS-kGIIHRDLKPENILLd~ 1016 (1157)
||++++++........+++|+++..+..... .......+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 9999998876445567777777766544322 22344568899999999999999999998 89999999999999974
Q ss_pred CCC--CCCeEEEEecCCcccccCCcccCCCCCCCcccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--
Q 001103 1017 RDP--QRPICKVGDFGLSRIKCNTLVSGGVRGTLPWMAPELLNGSNNRVSEKVDVYSFGIAMWEIITGEEPYANMHCG-- 1092 (1157)
Q Consensus 1017 dd~--e~g~VKLiDFGLAkl~~~~~~sts~~GTp~YmAPEVL~G~~~~yS~KSDIWSLGVILYELLTGk~PF~g~~~e-- 1092 (1157)
++. ....+||+|||.+...... ....+||+.|+|||++.+. .++.++|+|||||++++|++|+.||......
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cCcccccceeeEeecccccccccc--cccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 321 2235999999999754433 2346799999999999854 5789999999999999999999999754321
Q ss_pred ----HHHHHhhh--c------------------------C--------------CCCCCCCCCcHHHHHHHHHHhccCCC
Q 001103 1093 ----AIIGGILS--N------------------------T--------------LRPQIPERCDPEWRKLMEECWSFNPA 1128 (1157)
Q Consensus 1093 ----eil~~Il~--~------------------------~--------------lrpeip~~iSpeLrdLIkrCLqkDPs 1128 (1157)
..+..... + . .........++++++||.+||++||.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 11111100 0 0 01112223467899999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 001103 1129 ARPSFTEITNRLRVM 1143 (1157)
Q Consensus 1129 kRPSaeELLe~Lr~L 1143 (1157)
+|||++|+|+|.++-
T Consensus 318 ~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLK 332 (362)
T ss_dssp TCBCHHHHHTCGGGT
T ss_pred HCcCHHHHhcCcccC
Confidence 999999999987654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.1e-23 Score=203.44 Aligned_cols=171 Identities=16% Similarity=0.021 Sum_probs=120.4
Q ss_pred eEEEEecccCcEEEEEEEE-CCceEEEEEEecccccCC----------ChhHHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 001103 878 EELQELGSGTFGTVYRGKW-RGTDIAIKRIKKSCFLGR----------SSEQEWLIKEFWREAHIISNLHHPNVVAFYGV 946 (1157)
Q Consensus 878 eILrkLGsGsFGtVYlAr~-kGt~VAVKVIkk~~l~~r----------~~e~e~likqflrEIkILK~L~HPNIVkLygv 946 (1157)
.+.++||+|+||+||+|++ +|+.||||+++....... ............+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4689999999999999987 688899998764321100 00111223455678999999999999998876
Q ss_pred eecCCCCcEEEEEEeecCCcchhhhccccccccHHHHHHHHHHHHHHHHHHHHCCceeccCCccceeeccCCCCCCeEEE
Q 001103 947 VPNGPGGTMATVTEYMVNGSLRHVLARKDRILDRRKKLMLMMDAAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKV 1026 (1157)
Q Consensus 947 f~de~~~~LyLVMEYmeGGSL~dlLkr~gr~L~e~qVlkIa~QLa~ALeYLHSkGIIHRDLKPENILLd~dd~e~g~VKL 1026 (1157)
.. .+++|||+++..+..+ +...+..++.|++.+|.|||++||+||||||+|||++ + ..++|
T Consensus 83 ~~------~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~-~~~~l 143 (191)
T d1zara2 83 EG------NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E-EGIWI 143 (191)
T ss_dssp ET------TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T-TEEEE
T ss_pred cC------CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----C-CCEEE
Confidence 32 2789999988766443 2334567899999999999999999999999999997 3 35899
Q ss_pred EecCCcccccCCcccCCCCCCCcccCc------ccccCCCCCCCchhHHHHHHHHHH
Q 001103 1027 GDFGLSRIKCNTLVSGGVRGTLPWMAP------ELLNGSNNRVSEKVDVYSFGIAMW 1077 (1157)
Q Consensus 1027 iDFGLAkl~~~~~~sts~~GTp~YmAP------EVL~G~~~~yS~KSDIWSLGVILY 1077 (1157)
+|||+|.....+... .|... +.+. ..|+.++|+||+.--+.
T Consensus 144 iDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWR-------EILERDVRNIITYFS---RTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHH-------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHHH
T ss_pred EECCCcccCCCCCcH-------HHHHHHHHHHHHHHc---CCCCCcccHHHHHHHHh
Confidence 999998754332211 11111 1121 24677899999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.06 E-value=7.9e-06 Score=81.92 Aligned_cols=85 Identities=9% Similarity=-0.037 Sum_probs=58.2
Q ss_pred CeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCCCc
Q 001103 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFYGVVPNGPGGT 954 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLygvf~de~~~~ 954 (1157)
.|+.++..+.++.+.||+....+..+.||+........ ...+.+|..+++.|. +--+++++.+... .+.
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~ 84 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERH--DGW 84 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTE
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--------hhhHHHHHHHHHHHhccCCCCcEEEEEec--CCc
Confidence 56666665556667899988888888999876542111 123567888877774 4335677766655 467
Q ss_pred EEEEEEeecCCcchhh
Q 001103 955 MATVTEYMVNGSLRHV 970 (1157)
Q Consensus 955 LyLVMEYmeGGSL~dl 970 (1157)
.++||++++|.++...
T Consensus 85 ~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEEECCSSEEHHHH
T ss_pred eEEEEEeccccccccc
Confidence 8999999999877544
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.95 E-value=7.1e-06 Score=73.16 Aligned_cols=66 Identities=12% Similarity=0.188 Sum_probs=56.3
Q ss_pred CCcEEEEeecCCccccCCCCCCceeecCceEEEEccCCCCHHHHHHHHHhhcC-CCceEEEeCCCCCCCcEEeecChhHH
Q 001103 182 TRKMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICN-QPHTIKYQLPGEDLDALISVCSDEDL 260 (1157)
Q Consensus 182 ~~~vklmcSyGG~I~pr~~d~~l~YvGG~triv~v~r~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~~DeDL 260 (1157)
..+||+-+.|+ +++|++.|+.+++|.+|+.++.+.++ ..+.|||+ .|| +.+|+++||+||
T Consensus 10 ~~~ikVKv~~~----------------~D~~~~~l~~~it~~dL~~kI~~rf~~~~~~lkY~--Ded-gd~v~i~sD~Dl 70 (85)
T d1ip9a_ 10 LKTTKIKFYYK----------------DDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK--LFD-GSGEEIKTDSQV 70 (85)
T ss_dssp CCCEEEEECBT----------------TCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEEC--CSS-SCCSCCCSHHHH
T ss_pred CCCEEEEEEEC----------------CcEEEEEeCCCCCHHHHHHHHHHHhCCCceEEEEE--cCC-CCEEEEeCHHHH
Confidence 45788888876 46789999999999999999999887 67899999 433 677999999999
Q ss_pred HHHHHH
Q 001103 261 HHMIEE 266 (1157)
Q Consensus 261 ~~m~~e 266 (1157)
+.+|++
T Consensus 71 ~~ai~~ 76 (85)
T d1ip9a_ 71 SNIIQA 76 (85)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 999973
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.29 E-value=0.00048 Score=68.32 Aligned_cols=76 Identities=20% Similarity=0.133 Sum_probs=48.7
Q ss_pred EEecccCc-EEEEEEEECCc-eEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC--CCceeEEeeeeecCCCCcEE
Q 001103 881 QELGSGTF-GTVYRGKWRGT-DIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH--HPNVVAFYGVVPNGPGGTMA 956 (1157)
Q Consensus 881 rkLGsGsF-GtVYlAr~kGt-~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~--HPNIVkLygvf~de~~~~Ly 956 (1157)
+.+..|.. +.||+...++. .+.+|....... ..+..|...++.|. .-.+++++.+..+ .+..+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~ 82 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDW 82 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----------hHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceE
Confidence 34555553 67999887644 478887554311 22456777777663 2336677777665 45789
Q ss_pred EEEEeecCCcchh
Q 001103 957 TVTEYMVNGSLRH 969 (1157)
Q Consensus 957 LVMEYmeGGSL~d 969 (1157)
+||++++|.++..
T Consensus 83 ~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 83 LLLGEVPGQDLLS 95 (255)
T ss_dssp EEEECCSSEETTT
T ss_pred EEEEeeecccccc
Confidence 9999999877643
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.12 E-value=0.00091 Score=58.47 Aligned_cols=70 Identities=26% Similarity=0.535 Sum_probs=60.3
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcCCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEe
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLF 284 (1157)
-||.||+.++|.++|.+|..|....+|..+.+-|- +.+ -+|.+++.+||+.-++..||.... --||+.|.
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n~E--l~IPl~~Q~DLDkAvellDrs~~~---ksLrilL~ 79 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NNE--LSILLKNQDDLDKAIDILDRSSSM---KSLRILLL 79 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--CSS--CEEECCSHHHHHHHHHHHHHCSSC---CSEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cCe--EEEecccHHHHHHHHHHHccCccc---ceeEEEEe
Confidence 48999999999999999999999999999999998 433 579999999999999999985431 23888774
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.93 E-value=0.0015 Score=57.41 Aligned_cols=70 Identities=24% Similarity=0.479 Sum_probs=60.3
Q ss_pred cCceEEEEccCCCCHHHHHHHHHhhcCCCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHHhhhcCCCCeEEEEEe
Q 001103 208 GGETRIISIRKSLTWEELMRKTSAICNQPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 208 GG~triv~v~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr~~~~~~~~rlR~FLF 284 (1157)
-||.||+.++|.++|.+|..|....+|..+.+-|- +. .-+|.+++.+||+.-++..||.... --||+.|.
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n~--EL~IPl~~Q~DLDkAvellDrs~~~---ksLrilL~ 79 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--NN--ELVIPLTTQDDLDKAVELLDRSIHM---KSLKILLV 79 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--ET--TEEEECCCHHHHHHHHHHHHHCSSC---CSEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEe--cC--eEEEecccHHHHHHHHHHHccCccc---cceEEEEE
Confidence 48999999999999999999999999999999998 33 4699999999999999999985331 23777765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.73 E-value=0.0014 Score=71.13 Aligned_cols=84 Identities=18% Similarity=0.102 Sum_probs=48.5
Q ss_pred EEEEecccCcEEEEEEEEC--CceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-C--CceeEEeeeeecCCCC
Q 001103 879 ELQELGSGTFGTVYRGKWR--GTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-H--PNVVAFYGVVPNGPGG 953 (1157)
Q Consensus 879 ILrkLGsGsFGtVYlAr~k--Gt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-H--PNIVkLygvf~de~~~ 953 (1157)
..+.||.|....||+.... ++.+.||.-............ ....+...|.+.|+.+. + ..++++|.+..+
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~---- 104 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFYSDTE---- 104 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT----
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCC-CCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC----
Confidence 3678999999999998763 556888865432111100000 00123445777777652 2 356677765332
Q ss_pred cEEEEEEeecCCcc
Q 001103 954 TMATVTEYMVNGSL 967 (1157)
Q Consensus 954 ~LyLVMEYmeGGSL 967 (1157)
..++|||++.+..+
T Consensus 105 ~~~lvmE~L~~~~~ 118 (392)
T d2pula1 105 MAVTVMEDLSHLKI 118 (392)
T ss_dssp TTEEEECCCTTSEE
T ss_pred CCEEEEeccCCccc
Confidence 34789999987543
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.49 E-value=0.0042 Score=55.31 Aligned_cols=79 Identities=14% Similarity=0.239 Sum_probs=57.3
Q ss_pred cEEEEeecCCccccCCCCCCceeecCceEEEEccCCCCHHHHHHHHHhhcC-CCceEEEeCCCCCCCcEEeecChhHHHH
Q 001103 184 KMKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICN-QPHTIKYQLPGEDLDALISVCSDEDLHH 262 (1157)
Q Consensus 184 ~vklmcSyGG~I~pr~~d~~l~YvGG~triv~v~r~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~~DeDL~~ 262 (1157)
+|.+-.+|||.++ | -.|++|+..+|.+|.+++...++ .++.|||. . |=+-.|.++||+||+.
T Consensus 4 ~vtvKvtf~~dt~--------R------F~ls~~~~~~~~~L~~~i~~rf~l~~~~lkY~--D-dd~e~v~l~~d~dl~E 66 (85)
T d2bkfa1 4 QVTLNVTFKNEIQ--------S------FLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--D-EENEEVSINSQGEYEE 66 (85)
T ss_dssp CEEEEEEETTEEE--------E------EEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE--C-TTSCEEEECSHHHHHH
T ss_pred cEEEEEEECCceE--------E------EEecCCCCCcHHHHHHHHHHhcCcccceEEEE--c-CCCCEEEEecHHHHHH
Confidence 5666667766543 0 12567899999999999999998 57899998 3 4457899999999976
Q ss_pred HHHHHHHhhhcCCCCeEEEEEe
Q 001103 263 MIEEYQEQERIGGSQRLRIFLV 284 (1157)
Q Consensus 263 m~~eydr~~~~~~~~rlR~FLF 284 (1157)
-++-+ .. ....||++++
T Consensus 67 ~~~~a----~~-~~~~irl~v~ 83 (85)
T d2bkfa1 67 ALKMA----VK-QGNQLQMQVH 83 (85)
T ss_dssp HHHHH----HH-TTTEEEEEEE
T ss_pred HHHHH----hc-CCCEEEEEEe
Confidence 65543 22 2246777765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.66 E-value=0.025 Score=60.53 Aligned_cols=76 Identities=14% Similarity=0.288 Sum_probs=49.0
Q ss_pred CCeeEEEEecccCcEEEEEEEECC---------ceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC-CCceeEEe
Q 001103 875 SDLEELQELGSGTFGTVYRGKWRG---------TDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH-HPNVVAFY 944 (1157)
Q Consensus 875 sdYeILrkLGsGsFGtVYlAr~kG---------t~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~-HPNIVkLy 944 (1157)
++++ ++.|+.|-.-.+|++.... ..|.+++.-.. ... -...+|..+++.+. +.-.+++|
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~-----idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETE-----SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCH-----HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chh-----hHHHHHHHHHHHHHhCCCCCeEE
Confidence 4444 4788889999999998742 23555543311 111 12346888888774 54456888
Q ss_pred eeeecCCCCcEEEEEEeecCCcc
Q 001103 945 GVVPNGPGGTMATVTEYMVNGSL 967 (1157)
Q Consensus 945 gvf~de~~~~LyLVMEYmeGGSL 967 (1157)
+++.+ .+||||++|..|
T Consensus 112 ~~~~~------g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT------EEEECCCCEEEC
T ss_pred EEcCC------ceEEEEeccccC
Confidence 88754 679999988655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.18 E-value=0.057 Score=55.15 Aligned_cols=51 Identities=8% Similarity=0.060 Sum_probs=31.7
Q ss_pred CeeEEEEecccCcEEEEEEEECCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCC
Q 001103 876 DLEELQELGSGTFGTVYRGKWRGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLH 936 (1157)
Q Consensus 876 dYeILrkLGsGsFGtVYlAr~kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~ 936 (1157)
.+.-++.|..|---+.|+.+.++..+++|+..... . ...+..|++++..|.
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~--------~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--E--------KNDLPFFLGLMQHLA 69 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHH
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--C--------HHHHHHHHHHHHhhh
Confidence 45556778888889999998877779999876431 0 123445666666663
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.89 E-value=0.024 Score=59.22 Aligned_cols=73 Identities=12% Similarity=0.046 Sum_probs=42.6
Q ss_pred cCcEEEEEEEE-CCceEEEEEEecccccCCChhHHHHHHHHHHHHHHHHhCCCCce--eEEeee---eecCCCCcEEEEE
Q 001103 886 GTFGTVYRGKW-RGTDIAIKRIKKSCFLGRSSEQEWLIKEFWREAHIISNLHHPNV--VAFYGV---VPNGPGGTMATVT 959 (1157)
Q Consensus 886 GsFGtVYlAr~-kGt~VAVKVIkk~~l~~r~~e~e~likqflrEIkILK~L~HPNI--VkLygv---f~de~~~~LyLVM 959 (1157)
+---.||+++. +|..|++|+.+.... . .+++..|...+..|....+ +..... ......+..+.++
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~----s-----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW----T-----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS----C-----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC----C-----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 33458999987 577899999765311 1 2456678888877742222 111111 0001144678899
Q ss_pred EeecCCcc
Q 001103 960 EYMVNGSL 967 (1157)
Q Consensus 960 EYmeGGSL 967 (1157)
+++.|..+
T Consensus 104 ~~~~G~~~ 111 (325)
T d1zyla1 104 PSVGGRQF 111 (325)
T ss_dssp ECCCCEEC
T ss_pred eecCCcCC
Confidence 99887544
|
| >d1wmha_ d.15.2.2 (A:) Protein kinase C, iota type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Protein kinase C, iota type species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.04 E-value=0.4 Score=41.95 Aligned_cols=78 Identities=23% Similarity=0.408 Sum_probs=61.7
Q ss_pred EEEEeecCCccccCCCCCCceeecCceEEEEccCCCCHHHHHHHHHhhcC----CCceEEEeCCCCCCCcEEeecChhHH
Q 001103 185 MKFLCSFGGRIFPRPSDGKLRYVGGETRIISIRKSLTWEELMRKTSAICN----QPHTIKYQLPGEDLDALISVCSDEDL 260 (1157)
Q Consensus 185 vklmcSyGG~I~pr~~d~~l~YvGG~triv~v~r~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LisV~~DeDL 260 (1157)
||+...|+|.|+ |..++.+|+|.+|...+..+|+ ..+++|+= .|+=| =++|+++.+|
T Consensus 2 iriK~~y~G~i~----------------it~~~~~it~e~l~~evr~~C~f~~~q~fT~KWi--DeEGD-PCTISSQmEL 62 (83)
T d1wmha_ 2 VRVKAYYRGDIM----------------ITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEEGD-PCTVSSQLEL 62 (83)
T ss_dssp EEEEEEETTEEE----------------EEEECTTCCHHHHHHHHHHHTTCCTTCCCEEEEE--CTTSC-EEECCSHHHH
T ss_pred eEEEEEecCeEE----------------EEecCCCccHHHHHHHHHHHhCCCcCCcEEEEEE--cCCCC-ceeeecHHHH
Confidence 566666666655 8999999999999999999997 47999997 55555 4889999999
Q ss_pred HHHHHHHHHhhhcCCCCeEEEEEee
Q 001103 261 HHMIEEYQEQERIGGSQRLRIFLVS 285 (1157)
Q Consensus 261 ~~m~~eydr~~~~~~~~rlR~FLFp 285 (1157)
+.-+-.|.... .+-|-+-+||
T Consensus 63 ~EA~RLye~n~----dseL~iHVFP 83 (83)
T d1wmha_ 63 EEAFRLYELNK----DSELLIHVFP 83 (83)
T ss_dssp HHHHHHHHHTT----CSCEEEEEEC
T ss_pred HHHHHHHHccC----CcceEEEecC
Confidence 88887777644 3567777775
|
| >d2npta1 d.15.2.2 (A:4-108) Mitogen activated protein kinase kinase 5, Map2k5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen activated protein kinase kinase 5, Map2k5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.81 E-value=0.75 Score=41.48 Aligned_cols=50 Identities=24% Similarity=0.431 Sum_probs=40.8
Q ss_pred cCCCCHHHHHHHHHhhcC--CCceEEEeCCCCCCCcEEeecChhHHHHHHHHHHH
Q 001103 217 RKSLTWEELMRKTSAICN--QPHTIKYQLPGEDLDALISVCSDEDLHHMIEEYQE 269 (1157)
Q Consensus 217 ~r~~~f~~l~~kl~~~~~--~~~~lkYqLP~edLD~LisV~~DeDL~~m~~eydr 269 (1157)
++.++|.++...++.... ....+.|- .||=|. |.|.+||+|..||.=|..
T Consensus 33 ~~~l~F~dvL~~i~q~~p~at~taFEYE--DEdGDR-ITVRSDEEl~AMisyy~~ 84 (105)
T d2npta1 33 GPQLLFRDVLDVIGQVLPEATTTAFEYE--DEDGDR-ITVRSDEEMKAMLSYYYS 84 (105)
T ss_dssp --CCCHHHHHHHHHHHSTTSCCSEEEEE--CTTSCE-EEECSHHHHHHHHHHHHH
T ss_pred CceeeHHHHHHHHHHhcccccccceeec--cccCCE-eEEccHHHHHHHHHHHHH
Confidence 579999999999999875 34568887 777665 899999999999999855
|
| >d1oeyj_ d.15.2.2 (J:) Neutrophil cytosol factor 4 (p40phox component of NADPH oxidase) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Neutrophil cytosol factor 4 (p40phox component of NADPH oxidase) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.26 E-value=1.4 Score=39.81 Aligned_cols=56 Identities=21% Similarity=0.341 Sum_probs=48.5
Q ss_pred cCceEEEEccCCC----CHHHHHHHHHhhcC-CCceEEEeCCCCCCCcEEeecChhHHHHHHHH
Q 001103 208 GGETRIISIRKSL----TWEELMRKTSAICN-QPHTIKYQLPGEDLDALISVCSDEDLHHMIEE 266 (1157)
Q Consensus 208 GG~triv~v~r~~----~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LisV~~DeDL~~m~~e 266 (1157)
|+.+|=|+|.-++ +|.+|+..+...++ .+++|-|.=|..| ||-+-+|||++-|+.|
T Consensus 15 ~~~~rDI~veedl~~~P~ykdLl~lmr~~f~~~dIaLNYrD~eGD---LIRllddeDv~LMv~~ 75 (105)
T d1oeyj_ 15 ISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAEGD---LVRLLSDEDVALMVRQ 75 (105)
T ss_dssp EEEEEEEEECSCTTCCCCHHHHHHHHHHHHCCSSEEEEEECTTSC---EEECCSHHHHHHHHHH
T ss_pred cceeeeEEEccccccCccHHHHHHHHHHHhccceeEeeeecCCCC---EEEEcchhhHHHHHHH
Confidence 6889999997665 79999999999987 5899999976655 7888999999999986
|